Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cytoplasmic translation (GO:0002181),0.9556661631102814,2.717078230529809,0.0,0.0,0.0,75/91,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.9628888576148211,2.7121632525762815,0.0,0.0,0.0,77/87,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;SEC61B;RPL10;RPS6;RPL10A
prerank,protein targeting to ER (GO:0045047),0.9445060845927523,2.6891531242711917,0.0,0.0,0.0,76/99,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,cotranslational protein targeting to membrane (GO:0006613),0.9523054998031146,2.687222366817544,0.0,0.0,0.0,77/91,2.38%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;SSR2;RPS6;RPL10A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.9336151234933124,2.6547303591631835,0.0,0.0,0.0,78/110,2.78%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A;MAGOHB;MAGOH
prerank,peptide biosynthetic process (GO:0043043),0.8966305593150689,2.5916377234513948,0.0,0.0,0.0,82/153,2.38%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL17;MRPL23;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.870124063122021,2.5266870495810076,0.0,0.0,0.0,79/168,2.90%,RPLP1;RPL41;RPL18A;RPS23;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPS8;RPSA;RPS3;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A;MAGOHB;MAGOH;POLR2D
prerank,rRNA metabolic process (GO:0016072),0.85057427341628,2.4903776706728205,0.0,0.0,0.0,59/160,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,translation (GO:0006412),0.8454611573152075,2.474600501505783,0.0,0.0,0.0,87/208,2.38%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL17;MRPL23;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;LARS2;EEF2;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;EEF1B2;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;RPL10;MRPS34;RPS6;RPL10A;EEF1G
prerank,rRNA processing (GO:0006364),0.8338604632764922,2.4579192377132166,0.0,0.0,0.0,59/172,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,ribosome biogenesis (GO:0042254),0.8089942337648536,2.3905257467279313,0.0,0.0,0.0,59/187,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,ncRNA processing (GO:0034470),0.8014326054739206,2.3670306598087714,0.0,0.0,0.0,59/200,2.38%,RPLP1;RPL41;RPL18A;RPL26;RPL19;RPS24;RPL17;RPL23;RPL27A;RPL13;RPL8;RPL32;RPL37A;RPL28;RPL35A;RPS9;RPL11;RPS15;RPS16;RPS14;RPL38;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RPL24;RPL21;RPL34;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;RPL35;RPL4;RPL10;RPS6;RPL10A
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.7931115212048905,2.362267855373298,0.0,0.0,0.0,94/306,3.75%,RPLP1;RPL41;APOE;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL17;MRPL23;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;PTMA;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;EEF2;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;PTMS;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;EEF1B2;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;POLR2E;RPL10;RPS6;RPL10A;EEF1G;EIF4G2;POLR2D;MRPL43;POLR2F;EEF1D
prerank,ribosome assembly (GO:0042255),0.8479161220338862,2.2570769175233143,0.0,0.0,0.0,18/47,3.10%,RPSA;RPL11;RPS15;RPS14;RPS5;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;RPS28;RPL10;NPM1;RPS27L
prerank,cellular protein metabolic process (GO:0044267),0.7512481168678427,2.2462259908787883,0.0,0.0,0.0,127/396,7.48%,RPLP1;RPL41;APOE;CST3;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL17;MRPL23;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;SFTPA1;SFTPA2;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;IGFBP6;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;SPARCL1;RPL7A;RPL14;RPL31;SPP1;RPL36A;LGALS1;RPS28;MRPL34;RPL35;RPL4;RPL10;C3;LAMC1;LAMB2;RPS6;LGMN;RPL10A;PNPLA2;CKAP4;RPN1;IGFBP3;MFGE8;MRPL43;IGFBP4;HSP90B1;IGFBP5;CHEK2;RPN2;SHISA5;MRPL35;UBE2G2;UBL5;PDIA6;MRPL55;PSENEN;EEF1A2;CPE;LOX;CDC34;MRPL28;PENK;FN1;OMA1;SFTPB;UBA52;SPCS1;MRPL41;MRPL27;P4HB;MRPS11
prerank,gene expression (GO:0010467),0.7454404585375647,2.220867016701095,0.0,0.0,0.0,91/348,3.45%,RPLP1;RPL41;RPL18A;RPS23;EEF1A1;RPL26;RPL19;RPS24;RPL17;MRPL23;RPL23;RPL27A;MRPL13;RPL13;RPS8;RPSA;RPS3;MRPS12;RPS12;RPL8;RPL32;RPL37A;RPL28;RPS27A;RPS11;RPL35A;RPS9;RPS29;RPL11;PTMA;RPS4X;RPS15A;RPS15;RPS16;RPS14;RPL38;RPS21;RPS5;RPL30;RPL18;RPL39;RPL37;RPS7;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPS13;RPL21;RPL34;RPS20;RPS18;RPL36;RPL22;RPS25;RPL27;RPL29;RPL6;RPL9;RPS10;RPLP2;RPLP0;RPL3;RPL15;RPS2;RPL12;RPL13A;RPS26;RPL7;RPS17;RPL23A;RPL7A;RPL14;RPL31;RPL36A;RPS28;MRPL34;RPL35;RPL4;POLR2E;RPL10;RPS6;RPL10A;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;MRPL43;POLR2F
prerank,ribosomal small subunit biogenesis (GO:0042274),0.8376358758043222,2.184498399994418,0.0,0.0,0.0,19/39,7.48%,RPS24;RPSA;RPS15;RPS16;RPS14;RPS5;RPS7;RPS19;RPS27;RPS25;RPS17;RPS28;RPS6;NPM1;RPS27L;LSM6;EMG1;SRFBP1;MRPS11
prerank,response to copper ion (GO:0046688),0.9272311065519433,2.168175584643787,0.0,0.0,0.0,12/20,2.47%,MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;ATP5F1D;MT3;MT2A;PRNP
prerank,response to cadmium ion (GO:0046686),0.8867197263488028,2.1526547041678583,0.0,0.0,0.0,12/26,2.16%,MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;MT3;MT2A;MAPK3;AKT1
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.6531610149061464,-2.136462695398776,0.0,0.0756646428645434,0.061,16/26,19.27%,SETD5;TET2;SETD2;OGT;TET3;KMT2A;KMT5C;KMT5B;KMT2D;WDR82;SETD4;PRDM9;SETD1B;SETD3;VCPKMT;BEND3
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.786005914625065,2.1337156986602666,0.0,0.0,0.0,19/57,4.99%,RPL26;RPS24;RPL35A;RPL11;RPS15;RPS16;RPL38;RPS7;RPS19;RPL5;RPS25;RPL7;RPS17;RPL14;RPS28;RPS6;NPM1;EMG1;LTO1
prerank,cellular response to cadmium ion (GO:0071276),0.8870828579015325,2.1236373941659026,0.0,0.0,0.0,12/24,2.16%,MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;MT3;MT2A;MAPK3;AKT1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.7759290295915567,2.105759869174429,0.0,0.0,0.0,16/54,3.04%,RPL26;RPL35A;RPL11;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL7;RPL23A;RPL7A;RPL14;RPL10;RPL10A;NPM1
prerank,cellular response to copper ion (GO:0071280),0.9349770140251109,2.101881709507779,0.0,0.0,0.0,11/16,2.47%,MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;MT3;MT2A;PRNP
prerank,ribosomal large subunit assembly (GO:0000027),0.8715861429800146,2.09364762371381,0.0,0.0,0.0,10/24,4.50%,RPL11;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;RPL10;DDX28
prerank,response to zinc ion (GO:0010043),0.8677833447467147,2.0861593454531797,0.0,0.0,0.0,11/25,1.88%,CRIP1;MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;MT3;MT2A
prerank,cellular zinc ion homeostasis (GO:0006882),0.8418075906609263,2.067512336791948,0.0,0.0,0.0,11/26,1.88%,MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;MT3;SLC30A1;MT2A
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.7492809134257434,2.0669593856158057,0.0,0.0,0.0,45/69,15.83%,COX4I1;UQCR11;COX6C;UQCR10;NDUFA2;COX6B1;COX7C;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;CYC1;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;UQCRC1;NDUFB9;UQCRB;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX5A;COX7B
prerank,aerobic electron transport chain (GO:0019646),0.7516486455404957,2.065017690462269,0.0,0.0,0.0,45/68,15.83%,COX4I1;UQCR11;COX6C;UQCR10;NDUFA2;COX6B1;COX7C;COX5B;NDUFA13;NDUFB7;COX8A;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;CYC1;NDUFB4;COX6A1;NDUFA6;NDUFS6;COX7A2L;UQCRH;NDUFA3;UQCRQ;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;UQCRC1;NDUFB9;UQCRB;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;COX5A;COX7B
prerank,zinc ion homeostasis (GO:0055069),0.825960322615788,2.0464012457488945,0.0,3.3506249273127856e-05,0.001,11/28,1.88%,MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;MT3;SLC30A1;MT2A
prerank,outflow tract septum morphogenesis (GO:0003148),-0.6151344870849422,-2.0445627946174407,0.0,0.14737665513168527,0.2,12/24,16.29%,SMAD6;PARVA;ACVR1;BMPR1A;ROBO1;NRP1;ZFPM2;FGFR2;NRP2;SMAD4;BMP4;BMPR2
prerank,negative regulation of peptidase activity (GO:0010466),0.7725568860310957,2.034619444566364,0.0,3.238937429735693e-05,0.001,20/47,12.85%,CST3;GAPDH;VTN;PARK7;UBXN1;TIMP2;SERPINH1;AKT1;SPOCK2;SERPINF1;SERPINE2;AGT;ECM1;SPOCK1;CSTB;SPOCK3;TIMP1;SERPING1;TIMP3;SERPINA9
prerank,retina homeostasis (GO:0001895),0.8409811579958711,2.021117571604982,0.0,6.268911154327148e-05,0.002,6/23,1.79%,POTEF;ACTB;ACTG1;B2M;HSPB1;SOD1
prerank,ribosomal small subunit assembly (GO:0000028),0.8924899641616785,2.004500602255738,0.0,0.0001214601536150885,0.003,8/16,3.10%,RPSA;RPS15;RPS14;RPS5;RPS19;RPS27;RPS28;RPS27L
prerank,embryonic limb morphogenesis (GO:0030326),-0.568032931831647,-1.9992493615511586,0.0,0.1788094794062593,0.343,10/34,5.80%,CACNA1C;AFF3;CREBBP;GLI3;FBXW4;NIPBL;SKI;LRP6;RARG;WDPCP
prerank,ATP synthesis coupled proton transport (GO:0015986),0.8866805622538453,1.9967575849574242,0.0,0.00011777954289947974,0.003,11/17,2.65%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A
prerank,androgen receptor signaling pathway (GO:0030521),-0.7839850277420455,-1.9964950323455504,0.0,0.13721274788122423,0.347,8/11,13.24%,ZMIZ1;ARID1A;KDM3A;PMEPA1;DDX17;RNF14;AR;PLPP1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.897499937383513,1.9928242743525455,0.0,0.00011431543869655386,0.003,11/16,2.65%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A
prerank,cellular response to zinc ion (GO:0071294),0.8977456327602671,1.9870155155257698,0.0,0.00011104928330522376,0.003,10/15,1.88%,MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;MT3;MT2A
prerank,cellular transition metal ion homeostasis (GO:0046916),0.6968407919899872,1.9856732752639792,0.0,0.00010796458099118977,0.003,26/91,7.01%,FTH1;FTL;MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;ATOX1;MT3;BOLA2;SLC30A1;HMOX1;SOD1;TMPRSS6;MT2A;PRNP;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;SLC39A10;TFRC;SLC39A7
prerank,negative regulation of viral life cycle (GO:1903901),0.8987260833930492,1.9811110607661766,0.0,0.00013130827417847404,0.004,6/15,0.98%,IFITM3;PPIA;LY6E;IFITM2;GSN;IFITM1
prerank,glycolytic process (GO:0006096),0.7892002175074634,1.9732842582149484,0.0,0.00012785279327904051,0.004,11/28,6.42%,ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;PKM;ENO1;LDHA;PGK1
prerank,inner mitochondrial membrane organization (GO:0007007),0.7484089782843037,1.9653526535189332,0.0,0.00019931922644527341,0.006,18/47,5.54%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;TIMM8B;ATP5MC1;TIMM13;ATP5MG;NDUFA13;ATP5PF;ATP5ME;ATP5F1A;MICOS13;ROMO1;GHITM;TIMM10B
prerank,negative regulation of hippo signaling (GO:0035331),-0.7429547282984285,-1.963868410610249,0.0034602076124567475,0.1653328912741665,0.478,6/12,17.31%,WWC2;VGLL4;DLG5;MARK3;LIMD1;MAPK14
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.8627613530473741,1.9580376823750374,0.0,0.00021862827650715927,0.007,9/17,3.20%,COX4I1;COX6C;COX6B1;COX7C;COX5B;COX8A;NDUFA4;COX6A1;COX7A2L
prerank,limb morphogenesis (GO:0035108),-0.6489711275643564,-1.9489445390957796,0.004651162790697674,0.16281073651201505,0.538,7/20,7.84%,GLI3;FBXW4;NIPBL;SKI;LRP6;PCSK5;IQCE
prerank,regulation of complement activation (GO:0030449),0.7542951475990349,1.9449751765436447,0.0,0.0005213899277135505,0.019,9/40,4.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C4B;C3;C5AR1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.6660247559407486,1.9402839488182015,0.0,0.0005552464165261187,0.021,33/132,7.48%,RPSA;RPL11;RPS15;RPS14;RPL38;RPS5;RPS19;RPS27;RPL5;RSL24D1;RPL24;RPL6;RPLP0;RPL3;RPL23A;HSP90AA1;HSP90AB1;SNRPG;RPS28;RPL10;GEMIN7;POLR2D;RPS27L;DDX39B;SNRPD2;LSM4;SNRPE;PUF60;SNRPF;SRSF9;STRAP;XAB2;MRPS11
prerank,regulation of immune effector process (GO:0002697),0.7474997083162327,1.940148272394379,0.0,0.0005423337091650462,0.021,9/41,4.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C4B;C3;C5AR1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.776918372216337,1.9356020018648985,0.0,0.0006183426002222687,0.025,5/29,0.50%,RPS8;RPS16;RPS14;RPS21;RPS19
prerank,regulation of humoral immune response (GO:0002920),0.7424746462818276,1.9338295022426097,0.0,0.0006693804021453764,0.026,9/44,4.49%,C1QB;CLU;C1QA;VTN;CD81;C1QC;C4B;C3;C5AR1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.7580397153843053,1.9320266057828095,0.0,0.0006759521592491881,0.027,30/38,18.07%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFA4;NDUFV3;NDUFB11;NDUFS7;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;NDUFA7;NDUFS8;NDUFA9;NDUFS3;NDUFV1;NDUFB2
prerank,regulation of viral entry into host cell (GO:0046596),0.7793364588345292,1.9310181443148149,0.0,0.0006822442671145395,0.028,7/30,1.44%,IFITM3;CD74;LY6E;IFITM2;GSN;IFITM1;LGALS1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.7505859801125915,-1.9306788884726505,0.0,0.16794646742428504,0.609,10/11,22.76%,TET2;OGT;TET3;KMT2A;KMT2D;WDR82;PRDM9;SETD1B;BEND3;CTR9
prerank,cristae formation (GO:0042407),0.8019432551648948,1.9282948011957128,0.0,0.000749004280626379,0.032,12/27,3.31%,ATP5F1E;ATP5MF;ATP5F1B;ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5PF;ATP5ME;ATP5F1A;MICOS13
prerank,pyruvate metabolic process (GO:0006090),0.7035164232350256,1.921563292732657,0.0,0.0008526998539508253,0.037,14/52,6.70%,BSG;ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;GLO1;PKM;ENO1;LDHA;PGK1;SDS
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.8472492379005554,1.9149335950172837,0.0,0.0009328139797638795,0.041,4/16,1.69%,TPT1;RPS3;CLU;CXCL12
prerank,negative regulation of endopeptidase activity (GO:0010951),0.7244263480474016,1.9040790969924961,0.0,0.0014670481299391082,0.064,17/47,12.85%,GAPDH;VTN;MT3;TIMP2;SERPINH1;AKT1;SPOCK2;SERPINF1;SERPINE2;AGT;SORL1;SPOCK1;SPOCK3;TIMP1;SERPING1;TIMP3;SERPINA9
prerank,substantia nigra development (GO:0021762),0.7471035160533969,1.9031937506076222,0.0,0.0014762080208603062,0.066,15/37,5.43%,ACTB;CALM1;S100A1;MBP;PLP1;COX6B1;CKB;DYNLL1;ATP5PF;HSPA5;CNP;CALM3;NDRG2;YWHAH;YWHAE
prerank,catecholamine metabolic process (GO:0006584),-0.6927823461481798,-1.8982071621903,0.0038910505836575876,0.21287739074576761,0.737,3/14,6.77%,SNCAIP;PRKN;ATP7A
prerank,translational elongation (GO:0006414),0.6695756203752035,1.896327920365935,0.0,0.0015950239040773884,0.074,54/101,21.66%,EEF1A1;MRPL23;MRPL13;MRPS12;EEF2;RACK1;EEF1B2;MRPL34;AURKAIP1;MRPS34;EEF1G;MRPL43;EEF1D;MRPL35;MRPL55;MRPL4;EEF1A2;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL37;MRPL2;MRPL44;MRPS24;TUFM;CHCHD1;MRPL17;TSFM;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35
prerank,negative regulation of viral entry into host cell (GO:0046597),0.9129075556898143,1.8907570290043811,0.0,0.0017094391990271711,0.08,5/12,0.98%,IFITM3;LY6E;IFITM2;GSN;IFITM1
prerank,regulation of glucose import (GO:0046324),-0.5416666334382029,-1.8866124505986606,0.0,0.21406945394180937,0.773,15/30,16.96%,PRKAG2;SORBS1;PID1;OSBPL8;APPL2;IRS1;GRB10;INSR;IGF1;ENPP1;PRKCI;CREBL2;RHOQ;OCLN;APPL1
prerank,negative regulation of cell activation (GO:0050866),0.87088639860015,1.88610497470152,0.0,0.002067030977885869,0.095,6/14,4.06%,APOE;THBD;TREM2;GPER1;PDGFB;NR1D1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.8020322440642348,1.8778628507308874,0.0,0.002654771929015505,0.121,7/22,3.46%,RPL23;RPS15;RPL37;RPS7;RPS20;UBB;EIF5A
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.7439772753155797,-1.874514722583778,0.014184397163120567,0.21400671377359665,0.807,3/11,6.50%,AFDN;RAPGEF2;RAPGEF6
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.6872840509258218,1.8684450121750524,0.0,0.0033241726252550533,0.154,14/56,6.79%,SFTPA1;SFTPA2;RPS27A;CTSB;UBC;UBB;S100A1;CTSL;CTSS;LGMN;HSP90B1;S100A8;S100A9;UBA52
prerank,response to interferon-beta (GO:0035456),0.7893527976625824,1.8677222904177488,0.0,0.0033338718026762215,0.158,7/22,6.18%,IFITM3;IFITM2;IFITM1;NDUFA13;SHFL;UBE2G2;CDC34
prerank,negative regulation of hemostasis (GO:1900047),0.8822926626700548,1.8674496065304285,0.0,0.003310303847679022,0.16,5/12,2.98%,APOE;VTN;THBD;SERPINE2;CD34
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.8279261353601461,1.8670623368568056,0.0,0.003303716178330407,0.16,7/17,7.41%,PPIA;HSPB1;SOD1;AKT1;TREM2;BAG5;P4HB
prerank,mitochondrial translational elongation (GO:0070125),0.6616986457800738,1.8650701601312125,0.0,0.003440707302407752,0.169,49/88,22.70%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL37;MRPL2;MRPL44;MRPS24;TUFM;CHCHD1;MRPL17;TSFM;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,modulation by symbiont of host process (GO:0044003),0.9009805267166308,1.862324490199415,0.0013679890560875513,0.0036516407473955637,0.184,8/10,6.79%,RPS27A;UBC;B2M;UBB;MRC1;ENO1;PGK1;UBA52
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.6982712311129015,-1.8534914461648158,0.007168458781362007,0.23592584708645958,0.856,8/13,14.11%,BMP6;RBPMS;BMPR1A;DAB2;TGFBR1;SMAD4;BMP4;TGFB3
prerank,amyloid fibril formation (GO:1990000),0.68648870386782,1.8514717292006955,0.0,0.004781288586752689,0.236,16/51,8.71%,CST3;RPS27A;UBC;B2M;UBB;GSN;H3-3A;ITM2B;MFGE8;FKBP1A;SORL1;PSENEN;TTR;UBA52;CALB1;MAPT
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.742559053190097,1.847353574838352,0.0,0.005283516682256349,0.262,9/32,8.39%,RPL30;RPL39;RPS19;GAPDH;PGLYRP1;ROMO1;ANG;S100A9;CXCL10
prerank,aggrephagy (GO:0035973),0.7550708777812911,1.845129260780352,0.0,0.0054414148819559634,0.273,7/27,1.79%,RPS27A;UBC;VIM;UBB;DYNLL2;PARK7;DYNLL1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.876934201712677,1.8421420758555012,0.0,0.005727030273487202,0.283,6/12,3.44%,APOE;CLU;PFDN5;TREM2;CRYAB;PFDN6
prerank,eye development (GO:0001654),-0.48037080430278556,-1.8398676383154886,0.0,0.25278013772905916,0.892,14/54,7.79%,PBX1;CACNA1C;COL5A2;FBN1;COL5A1;SMOC1;PBX3;NIPBL;SHROOM2;SKI;LAMA1;EFEMP1;SIPA1L3;CEP290
prerank,cellular response to interleukin-12 (GO:0071349),0.6913717547828603,1.8382646654495232,0.0,0.006337682045348498,0.308,15/48,8.93%,PPIA;RPLP0;BOLA2;CFL1;SOD1;TALDO1;PSME2;CNN2;MIF;SIRPA;AIP;MSN;GSTO1;P4HB;LCP1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.8412766892182515,1.8379452397807827,0.0,0.006273059698473393,0.309,5/15,6.66%,APOE;PLTP;APOC1;ABCG1;LIPG
prerank,mitochondrial translational termination (GO:0070126),0.6533643605019861,1.8370550500562197,0.0,0.006294804483008063,0.312,47/88,22.70%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL37;MRPL2;MRPL44;MRPS24;CHCHD1;MRPL17;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.6830893092197232,1.8307108194113522,0.0,0.007007053369118344,0.351,38/56,22.68%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFAF8;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;TMEM126A;DMAC1;NDUFS3;NDUFV1;NDUFB2;NDUFA12;NDUFAF3;NDUFAF2;NDUFA10;NDUFAB1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.6830893092197232,1.8307108194113522,0.0,0.007007053369118344,0.351,38/56,22.68%,NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFAF8;NDUFB4;NDUFA6;NDUFS6;NDUFA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;TMEM126A;DMAC1;NDUFS3;NDUFV1;NDUFB2;NDUFA12;NDUFAF3;NDUFAF2;NDUFA10;NDUFAB1
prerank,regulation of amyloid fibril formation (GO:1905906),0.8300766817344324,1.8295863448624694,0.0,0.0070446889096751324,0.358,6/15,3.44%,APOE;CLU;PFDN5;TREM2;CRYAB;PFDN6
prerank,negative regulation of interleukin-2 production (GO:0032703),0.7951461447426483,1.8290164938859546,0.0,0.007081293339531733,0.362,8/18,10.02%,LAPTM5;PRNP;CD34;HOMER2;PTPRC;TNFAIP3;NAV3;ZFP36
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.7300358577944461,1.828422767216741,0.0,0.007051254323384055,0.366,7/30,4.88%,TPT1;RPS3;CD74;CLU;CXCL12;DDX39B;MIF
prerank,glucose catabolic process to pyruvate (GO:0061718),0.7543862796842585,1.824248355338181,0.0,0.0075688853621191975,0.392,9/24,6.42%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,canonical glycolysis (GO:0061621),0.7543862796842585,1.824248355338181,0.0,0.0075688853621191975,0.392,9/24,6.42%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,carbohydrate catabolic process (GO:0016052),0.6990286476860337,1.8227402675719748,0.0,0.007710353647669513,0.404,12/38,6.42%,ALDOA;GAPDH;ALDOC;PGAM4;PGAM1;TPI1;PFKL;PKM;ENO1;LDHA;MAN2B2;PGK1
prerank,neutrophil activation involved in immune response (GO:0002283),0.6096923593937219,1.8218017621099165,0.0,0.007773449831365662,0.409,160/428,18.27%,FTH1;CST3;FTL;EEF1A1;PSAP;HSPA8;CTSD;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;PRG2;CTSZ;TYROBP;ATP6V0C;HSP90AA1;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;C3;PGLYRP1;S100A11;TIMP2;NPC2;VAT1;CKAP4;CYBA;ITGB2;PSMD2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;TMEM30A;PRDX4;SRP14;TOLLIP;PTPRC;CYB5R3;LGALS3;FCER1G;RAC1;PKM;PSMD1;DNAJC5;C5AR1;CD93;ORMDL3;ATP8B4;FABP5;S100A8;S100A9;MIF;HSPA1B;PSMC3;ACTR1B;SIRPA;PSMD6;NDUFC2;VCP;LRG1;ARHGAP9;CYBB;IQGAP2;RHOG;APRT;DDOST;TTR;SELL;SYNGR1;MGST1;CREG1;RAB14;SURF4;CSTB;CD53;TRAPPC1;GUSB;HVCN1;COTL1;SLC15A4;VAMP2;PTPRN2;TICAM2;SLCO4C1;CD68;ALAD;HMGB1;CCT8;RAB3D;GAA;PSMD13;PECAM1;FUCA1;ATP8A1;FGL2;SVIP;ATP6AP2;PNP;TRPM2;LCN2;CTSA;CMTM6;VAMP8;PTPRB;ARPC5;SLC11A1;BST2;HSPA1A;RHOA;ARHGAP45;LILRB3;LAMTOR3;NME2;CAT;CLEC4D;CTSH;SDCBP;LRRC7;CAP1;NFASC;GOLGA7;YPEL5;HP;DEGS1;PSMB1;NEU1;HPSE;PLAU;OSCAR;BRI3;RAB5C;MLEC;ATP11B;MAGT1;CD300A;TMBIM1;GCA;SYK;SLC2A3;CTSC;LAMP2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.761756155676423,1.8207698491592208,0.0,0.007785749593757064,0.413,7/24,5.15%,APOE;UBB;GPX1;PSME1;PSME2;PINK1;ATP5IF1
prerank,neutrophil degranulation (GO:0043312),0.6094456970454323,1.8201488980449732,0.0,0.007822033892811699,0.416,159/425,18.27%,FTH1;CST3;FTL;EEF1A1;PSAP;HSPA8;CTSD;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;PRG2;CTSZ;TYROBP;ATP6V0C;HSP90AA1;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;C3;PGLYRP1;S100A11;TIMP2;NPC2;VAT1;CKAP4;CYBA;ITGB2;PSMD2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;TMEM30A;PRDX4;SRP14;TOLLIP;PTPRC;CYB5R3;LGALS3;FCER1G;RAC1;PKM;PSMD1;DNAJC5;C5AR1;CD93;ORMDL3;ATP8B4;FABP5;S100A8;S100A9;MIF;HSPA1B;PSMC3;ACTR1B;SIRPA;PSMD6;NDUFC2;VCP;LRG1;ARHGAP9;CYBB;IQGAP2;RHOG;APRT;DDOST;TTR;SELL;SYNGR1;MGST1;CREG1;RAB14;SURF4;CSTB;CD53;TRAPPC1;GUSB;HVCN1;COTL1;SLC15A4;VAMP2;PTPRN2;TICAM2;SLCO4C1;CD68;ALAD;HMGB1;CCT8;RAB3D;GAA;PSMD13;PECAM1;FUCA1;ATP8A1;FGL2;SVIP;ATP6AP2;PNP;TRPM2;LCN2;CTSA;CMTM6;VAMP8;PTPRB;ARPC5;SLC11A1;BST2;HSPA1A;RHOA;ARHGAP45;LILRB3;LAMTOR3;NME2;CAT;CLEC4D;CTSH;SDCBP;LRRC7;CAP1;NFASC;GOLGA7;YPEL5;HP;DEGS1;PSMB1;NEU1;HPSE;PLAU;OSCAR;BRI3;RAB5C;MLEC;ATP11B;MAGT1;CD300A;TMBIM1;GCA;SLC2A3;CTSC;LAMP2
prerank,regulation of membrane depolarization (GO:0003254),-0.6153158866363426,-1.819240210108221,0.0,0.280767078918719,0.934,5/18,8.88%,LRRK2;CAMK2D;FHL1;PTPN3;SMAD7
prerank,alcohol catabolic process (GO:0046164),0.8809152961524074,1.815784937195334,0.0,0.008469221575531108,0.444,3/10,2.26%,APOE;MT3;SNX17
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.7488684950438302,1.8144635484445069,0.0,0.008685882204864376,0.458,9/25,6.42%,ALDOA;GAPDH;ALDOC;PGAM1;TPI1;PFKL;PKM;ENO1;PGK1
prerank,neutrophil mediated immunity (GO:0002446),0.6064786173011631,1.813311070307586,0.0,0.008768545065802533,0.465,160/432,18.27%,FTH1;CST3;FTL;EEF1A1;PSAP;HSPA8;CTSD;PPIA;ALDOA;EEF2;TUBB;CTSB;CD63;B2M;GSN;LAMP1;PRG2;CTSZ;TYROBP;ATP6V0C;HSP90AA1;HSP90AB1;GRN;ALDOC;GM2A;TUBB4B;HEXB;PGAM1;CTSS;PGRMC1;DYNLL1;C3;PGLYRP1;S100A11;TIMP2;NPC2;VAT1;CKAP4;CYBA;ITGB2;PSMD2;SNAP25;DOCK2;PRDX6;CNN2;LAMTOR2;NFAM1;CSNK2B;HRNR;PFKL;CCT2;TMEM30A;PRDX4;SRP14;TOLLIP;PTPRC;CYB5R3;LGALS3;FCER1G;RAC1;PKM;PSMD1;DNAJC5;C5AR1;CD93;ORMDL3;ATP8B4;FABP5;S100A8;S100A9;MIF;HSPA1B;PSMC3;ACTR1B;SIRPA;PSMD6;NDUFC2;VCP;LRG1;ARHGAP9;CYBB;IQGAP2;RHOG;APRT;DDOST;TTR;SELL;SYNGR1;MGST1;CREG1;RAB14;SURF4;CSTB;CD53;TRAPPC1;GUSB;HVCN1;COTL1;SLC15A4;VAMP2;PTPRN2;TICAM2;SLCO4C1;CD68;ALAD;HMGB1;CCT8;RAB3D;GAA;PSMD13;PECAM1;FUCA1;ATP8A1;FGL2;SVIP;ATP6AP2;PNP;TRPM2;LCN2;CTSA;CMTM6;VAMP8;PTPRB;ARPC5;SLC11A1;BST2;HSPA1A;RHOA;ARHGAP45;LILRB3;LAMTOR3;NME2;CAT;CLEC4D;CTSH;SDCBP;LRRC7;CAP1;NFASC;GOLGA7;YPEL5;HP;DEGS1;PSMB1;NEU1;HPSE;PLAU;OSCAR;BRI3;RAB5C;MLEC;ATP11B;ADAM17;MAGT1;CD300A;TMBIM1;GCA;SLC2A3;CTSC;LAMP2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.685470051728539,1.8132975939957197,0.0,0.008664157624542979,0.465,14/46,8.93%,PPIA;RPLP0;BOLA2;CFL1;SOD1;TALDO1;PSME2;CNN2;MIF;AIP;MSN;GSTO1;P4HB;LCP1
prerank,eye morphogenesis (GO:0048592),-0.6255441298770765,-1.8069550507452459,0.013333333333333334,0.2920913345549165,0.946,14/19,19.09%,COL5A2;FBN1;COL5A1;NIPBL;SHROOM2;SKI;RARG;EFEMP1;STAT3;IFT122;MFAP5;NF1;NKD1;AGTPBP1
prerank,translational termination (GO:0006415),0.6367803442730927,1.805424509729312,0.0,0.010345547202038126,0.526,49/95,22.90%,MRPL23;MRPL13;MRPS12;MRPL34;AURKAIP1;MRPS34;MRPL43;TRMT112;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL37;MRPL2;MRPL44;MRPS24;CHCHD1;MRPL17;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38;ETF1
prerank,protein localization to vacuole (GO:0072665),0.8336022545470568,1.805383934973372,0.0,0.010225250141549309,0.526,8/13,10.01%,CD81;LAMTOR4;LAMTOR5;GLMP;RTN4;ATP13A2;RNF128;MFSD1
prerank,platelet aggregation (GO:0070527),0.723801179190022,1.8053532498688414,0.0,0.010130056030242323,0.527,13/33,12.51%,ACTB;ACTG1;PPIA;MYL9;HSPB1;MYL12A;METAP1;FLNA;FN1;CSRP1;P2RY12;ACTN1;CLIC1
prerank,regulation of endopeptidase activity (GO:0052548),0.6687704928307022,1.8034263220108526,0.0,0.010401405882310305,0.532,22/59,12.85%,GAPDH;VTN;PSME1;TIMP2;SERPINH1;AKT1;SPOCK2;PSME2;SERPINF1;PSMB8;SERPINE2;AGT;PSENEN;SPOCK1;VSIR;SPOCK3;TIMP1;ATP13A2;SERPING1;PSMB9;TIMP3;SERPINA9
prerank,regulation of tau-protein kinase activity (GO:1902947),0.8857942598611855,1.8028188513720658,0.0,0.010404631586083535,0.534,6/10,9.30%,CLU;HSP90AA1;HSP90AB1;C5AR1;SORL1;EGR1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.768214089261113,1.8014458169072063,0.0,0.010558936020938358,0.544,4/21,0.52%,RPL23;RPL11;RPS7;RPL5
prerank,reverse cholesterol transport (GO:0043691),0.8566457882659817,1.7997581395056084,0.0,0.010934083279283571,0.567,4/13,6.66%,APOE;CLU;ABCG1;LIPG
prerank,negative regulation of coagulation (GO:0050819),0.8149360461542442,1.7972344890856389,0.0,0.01154399546967754,0.589,7/14,10.54%,APOE;VTN;THBD;SERPINE2;CD34;HS3ST5;PROCR
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.6987367726513963,1.7940169888253001,0.001141552511415525,0.012307962232995632,0.614,12/35,9.28%,CLU;B2M;VTN;C3;CCL19;APOC1;HNRNPK;RAC1;FLOT1;SNAP91;LRPAP1;ARF6
prerank,platelet degranulation (GO:0002576),0.6247331406594908,1.793564438556886,0.0,0.012321744945462593,0.619,38/118,15.48%,TMSB4X;PSAP;SPARC;CLU;ALDOA;CD63;CALM1;SELENOP;F13A1;TAGLN2;ISLR;SOD1;A2M;ANXA5;PDGFB;TUBA4A;LGALS3BP;ECM1;FLNA;RARRES2;MANF;ENDOD1;FN1;LEFTY2;APLP2;CLEC3B;TIMP1;SERPING1;SRGN;PECAM1;ITIH3;ACTN1;TIMP3;TEX264;GAS6;PF4;IGF2;PDGFA
prerank,maturation of SSU-rRNA (GO:0030490),0.6972409915691782,1.787886624928481,0.0,0.013736504109900112,0.659,9/34,10.07%,RPS8;RPS16;RPS14;RPS19;RPS28;LSM6;SRFBP1;MRPS11;WDR3
prerank,postsynaptic membrane organization (GO:0001941),0.7956874168359038,1.7878478537903355,0.0,0.013593415525421985,0.659,8/17,6.40%,APOE;NRXN1;NLGN1;SHISA7;LRP4;LHFPL4;MUSK;GPHN
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.5809098219347963,-1.78721447990355,0.009708737864077669,0.3243415735924905,0.976,8/21,14.11%,BMP6;RBPMS;BMPR1A;DAB2;TGFBR1;SMAD4;BMP4;TGFB3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5934772232064264,-1.7857066882136594,0.0045662100456621,0.3075993597049255,0.977,10/21,15.76%,SAMD4A;CNOT4;PAN3;CNOT1;PARN;TUT7;CNOT10;CNOT7;TNKS1BP1;TUT4
prerank,negative regulation of lipid catabolic process (GO:0050995),0.8034575767441642,1.7854613443605207,0.0013245033112582781,0.014144473146763294,0.673,7/17,8.69%,AKT1;APOC1;TNF;SORL1;BSCL2;PDE3B;MFSD2A
prerank,positive regulation of lipid transport (GO:0032370),0.8356170311838599,1.78525997673429,0.0028208744710860366,0.01407946270476944,0.676,3/12,1.34%,APOE;DBI;SPP1
prerank,regulation of hippo signaling (GO:0035330),-0.6186990721587216,-1.7845178617747877,0.004081632653061225,0.2930261103384556,0.978,8/17,17.31%,WWC2;VGLL4;DLG5;MOB3B;MARK3;NF2;LIMD1;MAPK14
prerank,negative regulation of lipid metabolic process (GO:0045833),0.7611547243359958,1.7821326462535045,0.0,0.014800962557701287,0.706,6/22,5.48%,APOD;APOC1;GPER1;TNF;BSCL2;PDE3B
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.7351462570302019,1.7818834562219363,0.002403846153846154,0.014779271491883964,0.709,7/25,6.46%,RPL23;RPL11;RPS7;RPL5;HSP90AB1;GABARAPL2;HIPK2
prerank,cellular glucan metabolic process (GO:0006073),-0.699983707343799,-1.7814102561990166,0.01567398119122257,0.2849031038539731,0.979,5/11,13.55%,PRKAG2;PHKB;PHKA1;GBE1;GSK3B
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.6489731554973209,1.7812345616865848,0.0,0.014806112983257123,0.713,29/67,16.22%,B2M;PSMB4;CALR;PSME1;PSMB6;PSME2;PSMB8;CYBA;PSMD2;TAPBP;PSMD1;PSMC3;PSMD6;TAP2;CYBB;PSMA7;PDIA3;PSMD5;VAMP3;FCGR1A;PSMB9;PSMD13;PSMB3;VAMP8;PSMB11;PSMB10;PSMB1;NCF1;PSMB5
prerank,cellular component disassembly (GO:0022411),0.6691632383075511,1.7798641505535426,0.0,0.015022953902038788,0.717,15/53,11.31%,BSG;GSN;CTSL;CAPNS1;CTSS;LAMC1;TMPRSS6;TIMP2;A2M;ADAM15;FLOT1;ADAMTS4;LCP1;TIMP1;MMP3
prerank,negative regulation of platelet activation (GO:0010544),0.797433021023325,1.7784014524551481,0.0013531799729364006,0.0152261505192041,0.723,4/16,3.89%,APOE;THBD;SERPINE2;PDGFB
prerank,regulation of peptidase activity (GO:0052547),0.760201403231871,1.7755962579603013,0.0,0.015929966301055833,0.736,8/19,9.60%,CST3;NDUFA13;RCN3;PSMB8;PINK1;ECM1;CSTB;ATP13A2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.6861695727265174,1.7748604786558013,0.0,0.016028113223720625,0.739,17/37,17.16%,RPS3;RPS7;RACK1;UBB;SOD1;EIF5A;S100A8;S100A9;NUPR1;BAX;MSX1;PMAIP1;BBC3;BAD;CAV1;BCAP31;DNM1L
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.8067188919333709,1.7735110883799052,0.0,0.01623440996621296,0.748,6/15,5.97%,RPL23;RPL11;RPS7;RPL5;PARK7;BAG5
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.6456524685326889,1.7722777870298692,0.0,0.01649133749271033,0.758,30/70,16.22%,B2M;PSMB4;CALR;PSME1;PSMB6;PSME2;PSMB8;CYBA;PSMD2;FCER1G;TAPBP;PSMD1;PSMC3;PSMD6;TAP2;CYBB;PSMA7;PDIA3;PSMD5;VAMP3;FCGR1A;PSMB9;PSMD13;PSMB3;VAMP8;PSMB11;PSMB10;PSMB1;NCF1;PSMB5
prerank,immunoglobulin mediated immune response (GO:0016064),0.8557650604665068,1.7690124603895854,0.0,0.017328315249085957,0.784,3/10,4.09%,CD74;CD81;FCER1G
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.60550215649457,1.768822544421157,0.0,0.017222826919952364,0.785,23/107,9.60%,TPT1;MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;CALR;MT3;SLC30A1;CXCL12;MT2A;CCL19;SLC24A4;SLC24A2;SLC39A10;DRD5;SLC39A7;TMCO1;HTR2C;ATP13A2
prerank,positive regulation of peptidase activity (GO:0010952),0.7520592653259659,1.768534623396577,0.001277139208173691,0.01712809002615684,0.787,13/20,19.19%,GRN;NDUFA13;PSME1;RCN3;PSME2;PINK1;PSENEN;VCP;VSIR;CTSH;APH1B;PRELID1;DDRGK1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.6145257413998021,-1.7679597860752871,0.0,0.30212362897130723,0.986,11/18,18.12%,ASH1L;SETD2;EHMT1;KMT2A;KMT2D;SETD7;EHMT2;SETD4;PRDM9;SETD1B;SETD3
prerank,positive regulation of cellular component movement (GO:0051272),0.7267817544705308,1.7679269125683836,0.0012468827930174563,0.017148860607708705,0.789,12/24,17.48%,RPS19;CAVIN1;CCL19;SPOCK2;TUBB2B;NTN1;PHPT1;CSF1R;STK11;TRIM32;TWIST1;ADAM17
prerank,extracellular matrix disassembly (GO:0022617),0.6671568312581216,1.7678826458753394,0.0,0.017004421506112383,0.789,15/53,11.31%,BSG;GSN;CTSL;CAPNS1;CTSS;LAMC1;TMPRSS6;TIMP2;A2M;ADAM15;FLOT1;ADAMTS4;LCP1;TIMP1;MMP3
prerank,mitochondrial translation (GO:0032543),0.6229496977927687,1.7677421636811328,0.0,0.016922731491291622,0.789,51/104,22.70%,MRPL23;MRPL13;MRPS12;LARS2;MRPL34;AURKAIP1;MRPS34;MRPL43;MRPL35;MRPL55;MRPL4;MRPL30;MRPL28;MRPL14;MRPL41;MRPL27;MRPS11;MRPL11;MRPS14;MRPL52;MRPL36;MRPL51;MRPL54;MRPL58;MRPL50;MRPL57;MRPL37;MRPL2;MRPL44;NDUFA7;MRPS24;TUFM;CHCHD1;MRPL17;TSFM;MRPL32;MRPL12;MRPS2;MRPS6;MRPL46;MRPS16;MRPL18;MRPL39;MRPS21;MRPS31;MRPL49;MRPS18C;MRPS28;MRPS35;MRPS17;MRPL38
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.8330303086736142,1.7646079450412089,0.0,0.01777153826578663,0.803,2/12,0.25%,ACTB;ACTG1
prerank,toll-like receptor signaling pathway (GO:0002224),0.6214737633506986,1.7641205657007375,0.0,0.017794440592234874,0.809,26/84,15.58%,SFTPA1;SFTPA2;RPS27A;CTSB;UBC;UBB;S100A1;CTSL;CTSS;LGMN;ITGB2;HSP90B1;S100A8;S100A9;TIRAP;UBA52;HSPD1;TICAM2;HMGB1;RIPK2;TLR6;TRAF3;TRIL;UNC93B1;TLR5;TLR1
prerank,regulation of phagocytosis (GO:0050764),0.6597048327238256,1.759326295962934,0.0,0.01916557458422913,0.828,20/53,13.55%,RACK1;CALR;CYBA;TREM2;DOCK2;TGM2;TNF;PTPRC;FCER1G;LMAN2;CAMK1D;SIRPA;IL2RB;SPACA3;SYT11;GATA2;HCK;IL2RG;SLC11A1;GAS6
prerank,regulation of tube diameter (GO:0035296),-0.663290614426709,-1.7588861236052686,0.007434944237918215,0.2964204061615943,0.993,3/13,5.09%,ROCK2;ROCK1;AGTR1
prerank,vascular process in circulatory system (GO:0003018),-0.663290614426709,-1.7588861236052686,0.007434944237918215,0.2964204061615943,0.993,3/13,5.09%,ROCK2;ROCK1;AGTR1
prerank,microglial cell activation (GO:0001774),0.7573722743901672,1.7560460094100752,0.0,0.020106326967666954,0.845,12/21,14.99%,CLU;C1QA;TYROBP;GRN;ITGB2;TREM2;TNF;C5AR1;MAPT;AIF1;CX3CR1;IFNGR1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.7252085987868172,1.7529967633716939,0.0024271844660194173,0.021097011088939438,0.869,5/24,4.88%,TPT1;CD74;CLU;CXCL12;MIF
prerank,DNA methylation or demethylation (GO:0044728),-0.5792590769272887,-1.7526347065952363,0.012048192771084338,0.2850804130250091,0.995,8/19,14.96%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,DNA alkylation (GO:0006305),-0.5792590769272887,-1.7526347065952363,0.012048192771084338,0.2850804130250091,0.995,8/19,14.96%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,gluconeogenesis (GO:0006094),0.6790030032316253,1.7499244448096198,0.0,0.022152698941696473,0.883,12/39,9.20%,ALDOA;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;SLC25A11
prerank,negative regulation of blood coagulation (GO:0030195),0.6756047055648561,1.7483252065385992,0.00117096018735363,0.022729243413170223,0.893,7/38,3.89%,APOE;VTN;THBD;A2M;SERPINE2;CD34;PDGFB
prerank,pre-replicative complex assembly (GO:0036388),0.6412591397358615,1.7473905803890701,0.0,0.02288670663160345,0.9,24/64,16.22%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;MCM5;PSMD6;UBA52;PSMA7;GMNN;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5
prerank,neutrophil chemotaxis (GO:0030593),0.6508275704175963,1.7472672202142443,0.0,0.022738933676791973,0.9,18/53,18.94%,BSG;PPIA;PPIB;PDE4B;CCL19;ITGB2;LGALS3;FCER1G;S100A8;S100A9;CXCL10;CCL2;PF4;CCL3;PIK3CD;CCL8;SYK;EDN3
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.7213660526730581,1.7430745492664732,0.0,0.02438682889169289,0.917,9/26,5.97%,PPIA;HSPB1;PARK7;ATF4;AKT1;TXN;PINK1;GPR37L1;BAG5
prerank,regulation of protein-containing complex assembly (GO:0043254),0.6052332101110317,1.742073687204229,0.0,0.024613312419676965,0.92,28/110,11.61%,APOE;RPS3;HSPA8;GFAP;CLU;RACK1;GSN;HSP90AA1;PARK7;HSPA5;NRG1;CRYAB;PINK1;TNF;RHOC;LGALS3;SORL1;TIRAP;VCP;TFRC;SAR1A;MTLN;HCK;PIH1D1;MMP3;BAX;SVIP;WARS1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6566872044299228,1.7402350725981806,0.0,0.025178204003793385,0.926,14/54,9.82%,TMSB4X;APOE;ATP5F1B;HSPB1;AKT1;ATP5F1A;CSNK2B;TNF;PDGFB;ACVRL1;VASH1;KDR;GATA2;HMGB1
prerank,negative regulation of secretion by cell (GO:1903531),0.6623318061803566,1.7389454116248495,0.0011682242990654205,0.02570328203168825,0.935,18/38,21.21%,APOE;SLC30A1;TRH;IL1RAPL1;GRM7;SYT11;VAMP3;DPH3;SYT4;CHGA;IL11;VAMP8;LILRB1;TNFRSF1A;SNCA;NOTCH1;ERP29;RSAD2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.8543725459838203,1.7343200198561164,0.0013986013986013986,0.027658485374396528,0.945,7/10,8.07%,ATP5MC3;ATP5F1D;ATP5PD;ATP5MC1;ATP5MG;ATP5F1A;ATP5MC2
prerank,neutrophil migration (GO:1990266),0.6377657486825163,1.7278014337006484,0.0,0.03059277619180041,0.957,19/58,18.94%,BSG;PPIA;PPIB;PDE4B;CCL19;ITGB2;LGALS3;FCER1G;S100A8;S100A9;CXCL10;PECAM1;CCL2;PF4;CCL3;PIK3CD;CCL8;SYK;EDN3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6825141314672085,-1.7246625440906915,0.014388489208633094,0.342373097936827,0.997,5/11,7.78%,MLLT3;DAB2;PLEKHA4;WNT5B;RSPO3
prerank,positive regulation of phospholipid transport (GO:2001140),0.8259170541926331,1.7231999430588771,0.0058309037900874635,0.033127550734831576,0.966,3/10,3.73%,APOE;DBI;TMEM30A
prerank,skeletal system morphogenesis (GO:0048705),-0.46803761723174336,-1.7221384739289383,0.0,0.33599618723968583,0.999,11/42,8.39%,WWOX;HOXB3;ANKRD11;HOXA3;LRP5;SKI;LRP6;HOXB4;HOXC4;TGFBR1;FGFR2
prerank,granulocyte chemotaxis (GO:0071621),0.6344887097852909,1.7193112550594893,0.0,0.03510011577701265,0.971,18/55,18.94%,BSG;PPIA;PPIB;PDE4B;CCL19;ITGB2;LGALS3;FCER1G;S100A8;S100A9;CXCL10;CCL2;PF4;CCL3;PIK3CD;CCL8;SYK;EDN3
prerank,pteridine-containing compound metabolic process (GO:0042558),0.7971359381815616,1.7192612878874756,0.004026845637583893,0.034876680445688306,0.971,5/13,12.50%,CALM1;HSP90AA1;AKT1;SPR;QDPR
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.6641904120651719,1.7191979579243368,0.0,0.03464190805530947,0.972,7/40,3.00%,CLU;CD63;B2M;VTN;C3;CCL19;HNRNPK
prerank,response to metal ion (GO:0010038),0.6236939822539559,1.7159713869887963,0.0,0.03636864028246078,0.977,14/67,8.71%,CRIP1;MT1A;MT1X;CALM1;ATP5F1D;PPP1CA;MT3;MT2A;CALM3;SLC25A13;GPHN;NDRG1;HVCN1;MAPT
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6806994251148303,-1.715812487975216,0.013333333333333334,0.33914439235726457,0.999,5/11,6.98%,PARP4;PARP9;PARP12;PARP16;PARP3
prerank,protein localization to lysosome (GO:0061462),0.6957234947843671,1.7142216242121888,0.0012062726176115801,0.03725744891189998,0.978,14/28,19.09%,CD81;LAPTM5;LAMTOR4;LAMTOR5;GLMP;RTN4;SORL1;ATP13A2;RNF128;MFSD1;M6PR;NCOA4;VPS4A;SNX16
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.7667953010453445,1.714025161752666,0.006765899864682003,0.037125420583503786,0.979,7/17,4.82%,APOE;CLU;PRNP;NTRK2;RTN4;PIN1;SORL1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.74642267817159,1.7137322077622135,0.0012626262626262627,0.03704534685260199,0.979,6/18,5.97%,PPIA;HSPB1;PARK7;AKT1;PINK1;BAG5
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.6452725915455827,1.7129688530395777,0.004550625711035267,0.03720758924757688,0.979,18/46,16.83%,TSPO;TIMM8B;TIMM13;AKT1;TOMM5;TOMM7;PINK1;ROMO1;AIP;TIMM10B;DNLZ;HSPD1;TOMM40L;GDAP1;TIMM50;TOMM20L;MFF;BCAP31
prerank,regulated exocytosis (GO:0045055),0.5838444915524119,1.71284815813011,0.0,0.03707879240214817,0.979,65/173,20.16%,TMSB4X;PSAP;SPARC;CLU;ALDOA;CD63;CALM1;SELENOP;F13A1;TAGLN2;ISLR;SOD1;A2M;SNAP25;ANXA5;PDGFB;TUBA4A;LGALS3BP;DNAJC5;ECM1;SYNGR2;FLNA;RARRES2;MANF;ENDOD1;SYT1;FN1;RIMS2;LEFTY2;SYNGR1;RIMS1;APLP2;SDF4;SYT12;SYT11;CLEC3B;TIMP1;VAMP2;SERPING1;SYT6;SYT4;SRGN;PECAM1;ITIH3;ACTN1;TIMP3;TEX264;GAS6;PF4;RAB26;IGF2;SYT10;PDGFA;CDK5;SYT2;SCCPDH;SCG3;SCIN;LAMP2;SNCA;RAB31;HGF;TGFB1;CYB5R1;QSOX1
prerank,lipoprotein catabolic process (GO:0042159),0.8101603655708352,1.7120780909833158,0.002840909090909091,0.037329336420407054,0.979,3/11,3.56%,APOE;CTSD;LYPLA2
prerank,cholesterol efflux (GO:0033344),0.7343846331837284,1.7112610694073784,0.0012531328320802004,0.03762488529985113,0.98,4/20,5.55%,APOE;NPC2;APOC1;ABCG1
prerank,mitochondrial transport (GO:0006839),0.6374047515361095,1.710449752582806,0.0022123893805309734,0.03784043707803977,0.98,20/53,16.83%,TSPO;HSP90AA1;TIMM8B;TIMM13;TOMM5;SLC25A5;TOMM7;SLC25A4;SLC25A13;AIP;TIMM10B;TMEM14A;GDAP1;PMAIP1;TMEM14C;SPG7;ABCB10;BAD;MFF;BCAP31
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.6738986641369351,1.7096192002308874,0.0011534025374855825,0.03813506682235989,0.982,10/37,6.46%,RPL23;RPL11;RPS7;RPL5;HSP90AB1;PARK7;UBXN1;MAP1A;BAG5;HIPK2
prerank,histone H3-K9 demethylation (GO:0033169),-0.6695787101042528,-1.70884267795368,0.011363636363636364,0.3443598699302299,0.999,7/11,14.04%,KDM3B;KDM7A;JMJD1C;KDM3A;KDM4C;PHF8;KDM4D
prerank,negative regulation of protein binding (GO:0032091),0.6176401674369313,1.706396978494208,0.0,0.04000200975284061,0.986,21/71,12.09%,ACTB;RACK1;B2M;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;ADAM15;PDGFB;PIN1;SORL1;TLE5;LRPAP1;IFIT1;MAP2;CAMK1;BAX;DNAJB2;DDX11
prerank,positive regulation of transport (GO:0051050),0.6004678084590046,1.705257003152169,0.0,0.04037200550439302,0.988,26/85,13.79%,APOE;ACTB;CHCHD10;CALR;CD151;CCL19;CYBA;TREM2;DOCK2;TNF;FCER1G;LMAN2;CAMK1D;FLOT1;SIRPA;IL2RB;MLC1;SPACA3;SGK1;GATA2;SMPD1;BAX;IL2RG;SLC11A1;GAS6;CLIP3
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.6295364966776552,1.7036330453259858,0.0,0.04134671160303978,0.988,15/53,10.18%,APOE;UBB;GPX1;HSP90AB1;PSME1;PSME2;TREM2;PINK1;GABARAPL2;PSMC3;FOXF2;NUPR1;XPO1;ALAD;ECSCR
prerank,hydrogen peroxide metabolic process (GO:0042743),0.7445486844271187,1.7029089268126607,0.0062266500622665,0.041542700211801765,0.99,9/19,9.70%,GPX1;PARK7;SOD1;CYBA;PRDX5;PRDX4;PRDX2;GPX3;PRDX1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.6052325613393752,1.7020740004744626,0.0,0.04179551299636487,0.992,38/87,18.07%,UQCC2;NDUFA2;NDUFA13;NDUFB7;NDUFB10;NDUFV3;NDUFB11;NDUFS7;NDUFAF8;NDUFB4;NDUFA6;NDUFS6;COX17;NDUFA3;COA3;NDUFA5;NDUFB3;NDUFC2;NDUFC1;OMA1;NDUFA8;NDUFA1;NDUFB8;NDUFS2;NDUFB9;NDUFS5;NDUFA11;NDUFB5;FOXRED1;NDUFA7;NDUFS8;NDUFA9;UQCRFS1;TMEM126A;DMAC1;NDUFS3;NDUFV1;NDUFB2
prerank,neuron cell-cell adhesion (GO:0007158),0.7985213036265952,1.7011085293464834,0.003952569169960474,0.042149956011290166,0.993,8/14,12.53%,NRXN1;NLGN1;CNTN4;NINJ2;NRXN3;CDK5R1;NCAM2;NRXN2
prerank,homotypic cell-cell adhesion (GO:0034109),0.6658145972109202,1.6992194754112993,0.001148105625717566,0.043119169702172624,0.995,13/39,12.51%,ACTB;ACTG1;PPIA;MYL9;HSPB1;MYL12A;METAP1;FLNA;FN1;CSRP1;P2RY12;ACTN1;CLIC1
prerank,positive regulation of endocytosis (GO:0045807),0.6459805105793037,1.6972489648218243,0.0,0.04435400916280058,0.996,11/45,5.06%,APOE;CLU;B2M;VTN;CD151;C3;CCL19;NLGN1;TREM2;HNRNPK;FLOT1
prerank,positive regulation of locomotion (GO:0040017),0.6966407366059679,1.6969591420929642,0.0024096385542168677,0.04433054295387256,0.996,17/27,21.84%,CAVIN1;CCL19;SPOCK2;TREM2;PDGFB;RARRES2;NTN1;P2RY12;PHPT1;CSF1R;AIF1;F2RL1;TRIM32;TWIST1;STX4;TGFB1;PPM1F
prerank,regulation of leukocyte migration (GO:0002685),0.7543127485941469,1.696537774902707,0.005215123859191656,0.044275422312531725,0.996,4/16,6.43%,CD81;HMOX1;RAC1;RHOG
prerank,hexose biosynthetic process (GO:0019319),0.6479754977284431,1.6946975040652121,0.0,0.04535782573171042,0.996,12/42,9.20%,ALDOA;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;SLC25A11
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.4932212320204802,-1.694001158704524,0.00625,0.3722329365654963,1.0,13/29,19.40%,FER;GHR;STAT5B;IL31RA;PIAS1;IL15;STAT3;STAT2;PKD1;NMI;STAT5A;STAT6;PKD2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4967706357266689,-1.6925420054412446,0.01020408163265306,0.3640703788680475,1.0,8/27,7.96%,PHLDB2;ARHGAP28;ARHGAP6;CGNL1;PRKN;ARHGEF18;PPFIA1;MET
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7497400827361931,1.6918870014707637,0.003931847968545216,0.047094991510806254,0.997,5/16,6.51%,APOE;CLU;TREM2;TNF;LRPAP1
prerank,protein targeting to mitochondrion (GO:0006626),0.6298768077367826,1.6913107467465998,0.002224694104560623,0.047236245547855056,0.997,20/52,16.83%,TSPO;HSP90AA1;TIMM8B;TIMM13;NDUFA13;TOMM5;TOMM7;ROMO1;AIP;TIMM10B;DNLZ;HSPD1;TOMM40L;PMPCB;GDAP1;TIMM50;TOMM20L;TIMM29;MFF;BCAP31
prerank,cellular response to metal ion (GO:0071248),0.5889285236043373,1.6912869719764407,0.0,0.04696459273116755,0.997,41/123,16.40%,MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;B2M;MT3;MT2A;MAPK3;LGMN;AKT1;NLGN1;PRNP;ANK3;DLG2;SYT1;AQP1;HVCN1;SYT12;SYT11;JUN;ATP13A2;SYT6;SYT4;SMPD1;WNT5A;GLRA2;TRPM2;GLRA1;ALOX5AP;CPNE5;SYT10;CPNE6;NCF1;KCNA1;DMTN;ADCY8;SYT2
prerank,nerve growth factor signaling pathway (GO:0038180),-0.7058079274706843,-1.6906017887070528,0.016891891891891893,0.35709194139953165,1.0,5/10,15.41%,RAPGEF2;RAPGEF1;NGF;KIDINS220;BDNF
prerank,positive regulation of monooxygenase activity (GO:0032770),0.7049872615372573,1.6899213936611162,0.0036101083032490976,0.04768045979366327,0.998,5/26,3.71%,APOE;S100A1;PARK7;AKT1;TNF
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.7048213841842067,1.6884105642499811,0.002506265664160401,0.04857176168364399,0.999,9/23,10.13%,RPS27A;UBC;UBB;COPS7A;COPS6;PARP1;UBA52;RBX1;DDB1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6220937744749058,-1.6859983764588045,0.020242914979757085,0.3592340121748977,1.0,10/16,24.58%,PARP9;KMT5C;PARP3;KMT5B;SHLD1;KDM4D;SMCHD1;SHLD2;SHLD3;PRKDC
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.6622556140679525,1.6817757534951219,0.0034883720930232558,0.05359524765807929,1.0,8/33,9.85%,RPS3;CD81;LAPTM5;PRNP;LGALS3;DUSP3;THY1;PHPT1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.44443191939350285,-1.6813345458756856,0.0,0.3594423449512008,1.0,13/50,10.41%,GAB2;PLCE1;PI4KA;PITPNM2;OGT;ADAP2;IRS1;PLCL1;PLCD3;IGF1;PDGFRB;TNFAIP8L3;NGF
prerank,regulation of oxidative phosphorylation (GO:0002082),0.7374528602162601,1.6789508996253428,0.008,0.05547692516369166,1.0,9/16,13.84%,UQCC2;PINK1;COX7A2L;COX7A2;VCP;NUPR1;MLXIPL;AK4;PDE12
prerank,response to interferon-alpha (GO:0035455),0.7607970846686886,1.6781120804042524,0.0013297872340425532,0.05589279416791724,1.0,7/16,14.08%,IFITM3;IFITM2;IFITM1;BST2;GAS6;PDE12;RO60
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.6018621043711596,1.6750963537693198,0.0,0.058228897347915004,1.0,32/86,16.57%,RPS27A;UBC;UBB;PSMB4;ELOB;HMOX1;PSME1;ATF4;KLF2;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;EPAS1;PSMC3;PSMD6;UBA52;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;HSPA1A;PSMB10;EGLN2;DNAJB1;PSMB1;PSMB5;VHL
prerank,response to unfolded protein (GO:0006986),0.6336756708821978,1.6740320127751303,0.0022396416573348264,0.05881353990510247,1.0,24/48,21.15%,HSPA8;HSP90AA1;HSPB1;HSP90AB1;HSPA5;SERPINH1;TMBIM6;HSPE1;HSPA1B;HSPD1;HSPB8;HSPB2;DNAJA1;BAX;DNAJB2;HSPA1A;DNAJB1;DAB2IP;HERPUD1;HSPA4L;HSPA2;HSPA9;BAK1;DDIT3
prerank,intermediate filament organization (GO:0045109),0.7429707401727544,1.6715309396480829,0.01171875,0.06081895009067723,1.0,6/17,13.89%,GFAP;VIM;NEFL;KRT9;EPPK1;DES
prerank,response to interferon-gamma (GO:0034341),0.607202448014928,1.6709021935957113,0.0,0.061157027650554856,1.0,22/67,19.11%,IFITM3;CD74;IFITM2;GAPDH;IFITM1;RPL13A;CCL19;AQP4;SHFL;SIRPA;CXCL16;IRF8;WNT5A;AIF1;SLC11A1;BST2;PDE12;CCL2;CCL3;CCL8;EPRS1;SNCA
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.7314681767926471,1.6707577875404005,0.0039164490861618795,0.060905681848915455,1.0,7/18,9.92%,APOE;CD81;HSP90AA1;ATP5IF1;MSN;PTTG1IP;RNF128
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7991909323131341,1.6671931673607674,0.008253094910591471,0.06397968139647965,1.0,3/11,1.42%,ITM2A;ITM2C;ITM2B
prerank,positive regulation of glycolytic process (GO:0045821),-0.5591031030823523,-1.6668664171471084,0.01809954751131222,0.3749684606224014,1.0,7/20,11.38%,ZBTB20;ARNT;INSR;IGF1;PRKAA2;ENTPD5;PSEN1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5591031030823523,-1.6668664171471084,0.01809954751131222,0.3749684606224014,1.0,7/20,11.38%,ZBTB20;ARNT;INSR;IGF1;PRKAA2;ENTPD5;PSEN1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.6724092910684456,-1.6665191192271842,0.013071895424836602,0.3652230671999005,1.0,3/10,5.44%,HDAC4;PIAS1;SAE1
prerank,glucose metabolic process (GO:0006006),0.6182777872212282,1.6665145985510463,0.0011098779134295228,0.06427555652973706,1.0,23/58,20.38%,ALDOA;APOD;GAPDH;ALDOC;PGAM1;ATF4;TPI1;RBP4;MDH1;ENO1;SLC25A13;PGK1;OMA1;SLC25A11;GAA;DCXR;SLC25A1;ENO3;PPARGC1A;G6PC3;AKR1A1;TFAP2B;GOT1
prerank,histone lysine demethylation (GO:0070076),-0.5125383639168741,-1.6658302736198438,0.0,0.3568974468780723,1.0,10/25,14.04%,KDM3B;KDM2A;KDM7A;JMJD1C;KDM5B;KDM3A;KDM5C;KDM4C;PHF8;KDM4D
prerank,negative regulation of lymphocyte migration (GO:2000402),0.8202862361160213,1.6656520475377887,0.004261363636363636,0.06470592041582039,1.0,2/10,2.16%,APOD;AKT1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.6658834744477291,1.6652700759891632,0.004722550177095631,0.06467967521451018,1.0,14/33,13.09%,CLU;GPX1;AKT1;VAT1;SLC25A5;PINK1;FZD9;GHITM;TMEM14A;TFRC;OMA1;MAPT;ACAA2;HSPA1A
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.8190040458343757,1.664970579464419,0.002886002886002886,0.0645457723936276,1.0,6/10,8.96%,RPS27A;UBC;UBB;UBA52;ISG15;NEDD8
prerank,regulation of B cell proliferation (GO:0030888),0.6347246700224125,1.6643739136065883,0.0011350737797956867,0.0646845934368727,1.0,15/44,20.07%,CD74;CD81;TYROBP;PTPRC;MIF;TIRAP;TFRC;IL2;CD22;CTLA4;VAV3;IKZF3;CD300A;GPR183;MEF2C
prerank,defense response to Gram-positive bacterium (GO:0050830),0.6390921021795707,1.662072247335384,0.005733944954128441,0.06633268967372,1.0,8/40,5.68%,RPL39;MBL2;MPEG1;PGLYRP1;ROMO1;ANG;TIRAP;RARRES2
prerank,positive regulation of phagocytosis (GO:0050766),0.6279516295320394,1.6606210139960231,0.0,0.06736431416362355,1.0,21/47,15.66%,CALR;C4B;C3;CYBA;TREM2;DOCK2;TNF;PTPRC;FCER1G;LMAN2;CAMK1D;SIRPA;IL2RB;SPACA3;GATA2;IL2RG;SLC11A1;GAS6;CCL2;F2RL1;CD300LF
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.7638245058252393,1.6601882374880503,0.00130718954248366,0.0673958100379403,1.0,4/15,8.38%,TMSB4X;HSPB1;LGMN;KDR
prerank,positive regulation of B cell proliferation (GO:0030890),0.6715413645178203,1.659838081549144,0.0024125452352231603,0.06732205059919949,1.0,7/29,8.64%,CD74;CD81;PTPRC;MIF;TIRAP;TFRC;IL2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.7433371537251285,1.6588396539326526,0.007702182284980745,0.06795180933096341,1.0,4/16,3.71%,APOE;S100A1;AKT1;TNF
prerank,cellular response to interferon-beta (GO:0035458),0.7629844983079187,1.658299740333036,0.002631578947368421,0.06799585049121537,1.0,4/14,6.18%,IFITM2;NDUFA13;UBE2G2;CDC34
prerank,regulation of plasminogen activation (GO:0010755),0.7893465178040762,1.6582674089635698,0.004261363636363636,0.0676539841119485,1.0,4/12,8.76%,CTSZ;SERPINE2;ENO1;CLEC3B
prerank,glutamate receptor signaling pathway (GO:0007215),0.6377853246375635,1.6577332580902662,0.005688282138794084,0.06769379228147597,1.0,13/37,10.00%,GRM5;GRIA2;GRID2;HOMER2;GRIK2;GRIN1;GRIN3A;GRM8;GRM7;GRIA4;GRIN2A;CDK5R1;GRM1
prerank,keratan sulfate catabolic process (GO:0042340),0.7784917189083729,1.656880009152302,0.0111731843575419,0.06819484337557874,1.0,4/11,2.91%,HEXB;FMOD;LUM;HEXA
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.7270531902096328,1.6550021744233263,0.007905138339920948,0.06986494814096914,1.0,7/19,4.82%,APOE;CLU;PRNP;NTRK2;RTN4;PIN1;SORL1
prerank,DNA methylation (GO:0006306),-0.5217686333863009,-1.6544838455349198,0.0182648401826484,0.37649187968299425,1.0,8/23,14.96%,DNMT3A;ATF7IP;BAZ2A;PPM1D;EHMT1;TEX15;EHMT2;GATAD2A
prerank,regulation of interleukin-2 production (GO:0032663),0.6214405103307851,1.6539147100835143,0.003432494279176201,0.07052918996586756,1.0,11/43,11.49%,RPS3;LAPTM5;PDE4B;PRNP;CD34;HOMER2;PTPRC;TNFAIP3;NAV3;ZFP36;PNP
prerank,regulation of neuron death (GO:1901214),0.5910474304000146,1.6536480826247977,0.0,0.07040992296304238,1.0,34/82,20.07%,CLU;UBB;C1QA;CTSZ;TYROBP;GPNMB;PARK7;DCC;AKT1;PRNP;ITGB2;CD34;GRID2;NENF;SORL1;MAPT;FAIM2;DHCR24;TRIM2;EGR1;ATP13A2;CHGA;WNT5A;EGLN2;EPHB1;CDK5;PPARGC1A;GRM4;GRIN2B;AKT1S1;NSMF;SNCA;DDIT4;MEF2C
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.696026456607201,1.6526337419888957,0.007407407407407408,0.07092747738024453,1.0,9/20,14.87%,CLU;HSP90AA1;HSP90AB1;PFDN6;CCT2;HSPD1;PSMG3;HSPA1A;PTGES3
prerank,positive regulation of cation channel activity (GO:2001259),0.6308396322474876,1.6524084136433896,0.0022727272727272726,0.07076033465446768,1.0,15/40,19.59%,TMSB4X;CALM1;CTSS;AKAP6;CALM3;ANK3;GSTO1;P2RY6;HAP1;GSTM2;CCL2;LRRC55;CCR2;CALM2;STAC3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.5454643225999409,-1.6510776461630987,0.023474178403755867,0.37487580718513375,1.0,10/20,19.22%,TNRC6B;TNRC6A;TNRC6C;CNOT1;MOV10;CNOT7;LIMD1;AGO2;CELF1;AGO4
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.8000006409450485,1.6509432680003222,0.007102272727272727,0.07180568397034899,1.0,5/11,12.50%,CALM1;HSP90AA1;AKT1;SPR;QDPR
prerank,cellular iron ion homeostasis (GO:0006879),0.6092014765238779,1.6503520912994094,0.0,0.07208014052408612,1.0,17/55,12.88%,FTH1;FTL;BOLA2;HMOX1;SOD1;TMPRSS6;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;TFRC;NEDD8;ATP13A2;LCN2;SLC40A1;ISCU;SLC11A1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.8004345732836405,1.6474654064325107,0.009762900976290097,0.07450070205444433,1.0,1/10,0.03%,APOE
prerank,negative regulation of protein metabolic process (GO:0051248),0.6118653053192827,1.646631254480406,0.0011235955056179776,0.07498310620229168,1.0,11/48,5.34%,APOE;CLU;PFDN5;HSP90AB1;PRNP;TREM2;CRYAB;PFDN6;CD84;PIN1;FLNA
prerank,hydrogen peroxide catabolic process (GO:0042744),0.7879771576506168,1.6459122316517203,0.012195121951219513,0.07535362493598705,1.0,7/11,13.89%,GPX1;PRDX5;PRDX4;PRDX2;GPX3;PRDX1;CAT
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7249948755471521,1.6451016236966196,0.005148005148005148,0.07595814356703595,1.0,6/17,9.85%,LAPTM5;PRNP;LGALS3;DUSP3;THY1;PHPT1
prerank,iron ion homeostasis (GO:0055072),0.6047177844884266,1.6448490297155043,0.001095290251916758,0.07577099738474949,1.0,18/58,12.88%,FTH1;FTL;B2M;BOLA2;HMOX1;SOD1;TMPRSS6;SLC22A17;ATP6V1G1;ATP6AP1;ABCB6;TFRC;NEDD8;ATP13A2;LCN2;SLC40A1;ISCU;SLC11A1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.61695339217795,1.644041668810671,0.0022099447513812156,0.07633708046381706,1.0,24/53,20.34%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;BCKDK;PSMB9;PSMD13;PSMB3;PSMB11;ODC1;PSMB10;PSMB1;PSMB5;PSMA6;OAZ2;PSMA4
prerank,protein targeting to lysosome (GO:0006622),0.7089210727468046,1.6433910112567716,0.00641025641025641,0.07661332766490196,1.0,9/20,19.09%,HSPA8;CLU;LAPTM5;SORL1;M6PR;LAMP2;NCOA4;VPS4A;SNX16
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4930702411143062,-1.642985402031227,0.01098901098901099,0.3865180455246557,1.0,11/28,15.34%,PID1;APPL2;TNS2;IRS1;GRB10;ENPP1;KANK1;NCK1;PTPN2;PIP4K2C;PRKCB
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.7920822858534864,1.6426824432898828,0.008595988538681949,0.0768371804440921,1.0,8/11,14.56%,UQCR11;UQCR10;CYC1;UQCRH;UQCRQ;UQCRC1;UQCRB;UQCRFS1
prerank,negative regulation of viral process (GO:0048525),0.6033808550858788,1.6412608198851042,0.004405286343612335,0.07802057705110536,1.0,22/57,22.29%,IFITM3;PPIA;IFITM2;IFITM1;MBL2;SHFL;TNF;ISG15;TRIM28;PROX1;IFIT1;ZFP36;BANF1;BST2;HEXIM1;TRIM32;OAS3;TRIM13;FAM111A;RSAD2;ISG20;TNIP1
prerank,error-free translesion synthesis (GO:0070987),0.6897316152130046,1.6411312283660828,0.005,0.07774431327556491,1.0,8/22,13.25%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;PCNA;RFC2
prerank,B cell mediated immunity (GO:0019724),0.8024360662195906,1.6400860926824072,0.0041841004184100415,0.07843274160881071,1.0,2/10,4.09%,CD74;FCER1G
prerank,response to reactive oxygen species (GO:0000302),0.6076314768657604,1.6392276458948667,0.0011025358324145535,0.0789393830375183,1.0,19/54,15.91%,APOE;RPS3;APOD;GPX1;HMOX1;SOD1;MAPK3;AKT1;PTPRN;PRDX5;ROMO1;HYAL2;MAPT;JUN;PJVK;CAT;HP;GLRX2;NCF1
prerank,negative regulation of transposition (GO:0010529),-0.5707120858401068,-1.6383956131321102,0.008968609865470852,0.38916471538987546,1.0,7/16,16.08%,UBR2;TUT7;MOV10;MYBL1;TEX15;TUT4;SIRT7
prerank,chemical synaptic transmission (GO:0007268),0.550009616523521,1.6374624305946042,0.0,0.08047550954150758,1.0,121/284,23.37%,APOE;HSPA8;CALM1;GABARAP;MBP;PLP1;MTNR1B;MPZ;SLC17A8;ASIC2;NRXN1;CNP;GABRB1;NLGN1;NSG1;SNAP25;CHRNA9;DLGAP2;GRM5;GRIA2;SLC1A4;SLC1A2;DLGAP1;GRID2;KCNQ3;KCNQ2;DLG2;KCND2;PMP22;GABRG3;DNAJC5;GRIK5;GRIK2;GRIN1;CACNA1A;SYT1;PENK;DRD5;GABRA2;AMPH;RIMS1;SYPL1;RAPSN;SLC12A5;GRM7;GRIA4;GRIN2A;PDYN;PRKAR1A;ERC2;SYN2;HTR2C;SLC6A2;SLC6A5;CRH;VAMP2;PTPRN2;CAMK1;KIF5A;GRID1;GRM1;SLC17A7;PRKAR1B;HAP1;CHRM3;GLRA2;SLC17A6;GRIA1;GLRA1;GABRA3;GABRB3;SYN1;CHRM2;SLC1A1;NRXN2;CHRNA4;CHAT;HCRT;CBLN2;SDCBP;LIN7C;NAAA;PPFIA3;SYT10;CDK5;CPNE6;KCNK3;DOC2A;KCNA1;GABRB2;NAPA;DTNA;HTR7;PRKAR2B;HCRTR1;CHRM5;PCDHB14;CAMKK1;APBA2;GRM4;GRIN2B;PTCHD1;GLRA3;SNCA;UNC119;STAC3;GABBR2;UTS2;GAD1;SST;CACNB4;RIMBP2;NPY5R;GRIA3;GRIK1;CHRNA3;SLC32A1;CACNA1E;HTR3B;SYT5;SLC5A7
prerank,maintenance of blood-brain barrier (GO:0035633),0.6635260049565109,1.6350403216840628,0.007220216606498195,0.08290557416063563,1.0,12/30,14.81%,ACTB;ACTG1;CLDN5;MBP;LAMC1;ESAM;MFSD2A;PECAM1;SLC1A1;LSR;GJA1;JAM3
prerank,defense response to fungus (GO:0050832),0.7112993672772642,1.6332891142949986,0.006329113924050633,0.0845123338809065,1.0,7/17,14.23%,GAPDH;S100A8;S100A9;RARRES2;CLEC6A;CLEC4D;CX3CR1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.7549722207461701,1.632780447964184,0.010958904109589041,0.08472202950398348,1.0,5/13,9.63%,BGN;HEXB;BCAN;HEXA;DCN
prerank,defense response to bacterium (GO:0042742),0.5668845161058407,1.628093335798363,0.0020833333333333333,0.08993976253058747,1.0,28/105,18.13%,RPL30;RPL39;RPS19;MBL2;MPEG1;PGLYRP1;TREM2;ROMO1;FCER1G;ANG;S100A8;S100A9;TIRAP;RARRES2;ISG15;CEBPB;AQP1;ADGRB1;STAB1;CHGA;LYZL4;LCN2;SLC11A1;TLR6;ADAM17;NOS2;SYK;OAS3
prerank,regulation of cellular amine metabolic process (GO:0033238),0.6150878970482583,1.6268457140490151,0.0022271714922048997,0.0909087976941204,1.0,28/50,26.18%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;ODC1;PSMB10;PSMB1;PSMB5;PSMA6;OAZ2;PSMA4;PSMC1;PSMD9;PSMB2;PSMD4;PSMD10
prerank,nuclear migration (GO:0007097),-0.6118207450692983,-1.6243452697756209,0.02032520325203252,0.4184554985067868,1.0,7/13,11.78%,SYNE2;SYNE3;PAFAH1B1;DOCK7;PCM1;FBXW11;CLMN
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.5812727459184903,1.6242101868752046,0.0020920502092050207,0.09368039751483365,1.0,16/84,4.82%,APOE;MRPL13;RPS3;CLU;RACK1;GAPDH;RPL13A;CALR;PRNP;IGFBP5;NTRK2;NCL;ORMDL3;RTN4;PIN1;SORL1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5735408198510653,-1.623155330786811,0.02092050209205021,0.4115844663566332,1.0,6/17,11.61%,PBX1;CREBBP;MAML2;KAT2B;MAML1;RBPJ
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5940318639351467,1.6230307135371465,0.0021598272138228943,0.09472957673102939,1.0,21/62,17.03%,TPT1;PPIA;CLU;HSPB1;CXCL12;NDUFA13;PARK7;AKT1;TMBIM6;PINK1;ENO1;BAG5;CREB3;PTTG1IP;DNAJA1;SYVN1;HSPA1A;YBX3;HERPUD1;TRIM32;NDUFS3
prerank,regulation of neuron apoptotic process (GO:0043523),0.5739735997416674,1.622178552431186,0.0,0.0953456394387841,1.0,43/96,21.80%,APOE;MDK;GRN;MT3;PARK7;SOD1;ATF4;LGMN;PRNP;FOXQ1;TREM2;PINK1;GRID2;TNF;FZD9;NTRK2;CTNNB1;FAIM2;NUPR1;TRIM2;CDK5R1;SET;BAX;WFS1;EGLN2;CCL2;PTPRZ1;CDK5;TYRO3;CCL3;BACE1;PPARGC1A;GRM4;AGAP2;ERBB3;AKT1S1;NSMF;TFAP2B;POU4F1;MEF2C;CRLF1;DDIT3;MAG
prerank,regulation of cholesterol esterification (GO:0010872),0.7908126651751913,1.6218917188721647,0.010115606936416185,0.09529416623629512,1.0,5/10,9.19%,APOE;APOC1;AGT;ABCG1;STARD4
prerank,ATP transport (GO:0015867),0.7888734965359263,1.6218616482016652,0.0084985835694051,0.09486556073823026,1.0,2/10,4.33%,SLC25A5;SLC25A4
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4409496507320119,-1.621803281407458,0.006993006993006993,0.405689600252899,1.0,13/39,14.26%,TSPAN5;ZMIZ1;CREBBP;MAML2;ROBO1;YAP1;KAT2B;STAT3;MAML1;AAK1;RBPJ;JAG1;PRKCI
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.6318723013605264,1.6214623867444042,0.0034285714285714284,0.09487642188046534,1.0,8/40,6.83%,RPL23;RPL11;RPS7;RPL5;CLU;LAPTM5;HIPK2;FOXF2
prerank,embryonic appendage morphogenesis (GO:0035113),-0.6360878902917689,-1.620450833149154,0.039285714285714285,0.39983168471636943,1.0,3/12,3.12%,FBXW4;SKI;LRP6
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.6781939061376056,1.6199421877078828,0.008454106280193236,0.09639260266241576,1.0,10/23,15.08%,HSP90AA1;TIMM8B;TIMM13;NDUFA13;ROMO1;TIMM10B;BAX;PMAIP1;BAD;TIMM29
prerank,regulation of blood coagulation (GO:0030193),0.6514149150687684,1.6183274176743931,0.00813953488372093,0.09803537109171495,1.0,5/27,2.98%,APOE;VTN;THBD;SERPINE2;CD34
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.6472414029245908,1.6178534258746406,0.004761904761904762,0.098194037491908,1.0,17/32,21.18%,PPIA;CALM1;HSP90AB1;CALM3;PPP1R15B;PIN1;DUSP26;SMPD1;DLC1;CDH5;CD300A;PPP1R15A;NSMF;CALM2;TGFB1;CAMTA1;PPP2R5A
prerank,aerobic respiration (GO:0009060),0.6908585108010603,1.6175518340579982,0.012626262626262626,0.09810381592732777,1.0,9/20,14.09%,ATP5F1D;UQCR10;NDUFS7;UQCRH;SDHB;UQCRC1;BLOC1S1;UQCRB;NDUFS8
prerank,actin filament bundle organization (GO:0061572),-0.46679634227710554,-1.6170144661087527,0.007407407407407408,0.39967996758232777,1.0,9/33,4.65%,CALD1;DPYSL3;PAWR;LIMA1;BAIAP2L1;SHROOM2;BAIAP2;MYO1B;EPS8
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5796972353057988,1.6167666020479639,0.0010460251046025104,0.09834929502814412,1.0,22/78,15.19%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CAPZA2;CLTC;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.5796972353057988,1.6167666020479639,0.0010460251046025104,0.09834929502814412,1.0,22/78,15.19%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CAPZA2;CLTC;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,negative regulation of wound healing (GO:0061045),0.6552481552425551,1.6150399678342298,0.007263922518159807,0.1001674676900178,1.0,8/28,9.80%,APOE;VTN;THBD;SERPINE2;CD34;TNF;CLASP1;EPPK1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.6684067488920094,1.6144813817939272,0.007220216606498195,0.10042325500895516,1.0,13/25,20.86%,HSPA8;HSPA5;SDF2L1;HSPE1;HSPA1B;BAG1;SDF2;HSPA1A;PTGES3;DNAJB1;ERO1A;HSPA2;HSPA9
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5829683723978181,1.613707322125836,0.0,0.10105484780775362,1.0,33/74,21.64%,RPS27A;UBC;UBB;PSMB4;ELOB;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;EPAS1;PSMC3;PSMD6;UBA52;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;EGLN2;PSMB1;PSMB5;VHL;PSMA6;NOTCH1;CITED2;PSMA4;SIRT2;ELOC
prerank,neurotransmitter transport (GO:0006836),0.5804895591482377,1.6131428714756584,0.0021344717182497333,0.10122554856418563,1.0,30/73,15.30%,HSPA8;SLC17A8;NRXN1;SNAP25;SLC1A2;DNAJC5;SYT1;GLUL;GABRA2;RIMS1;PPFIA4;PPFIA2;SYN2;SLC6A2;VAMP2;PTPRN2;SLC6A16;SLC17A7;SLC29A1;SLC17A6;SYN1;SLC1A1;NRXN2;CHAT;GLS2;GLS;SLC29A2;LIN7C;NAAA;PPFIA3
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.7304004218137412,1.6130126183297913,0.015193370165745856,0.10088491252556568,1.0,3/14,5.28%,TYROBP;TNF;ATP6AP1
prerank,regulation of protein neddylation (GO:2000434),0.7970936042561805,1.612527325412964,0.0072992700729927005,0.10104183421986628,1.0,4/10,4.55%,RPL11;RPL5;COPS9;EPAS1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.554649640511067,-1.6123344643523763,0.016877637130801686,0.40248090691801575,1.0,4/16,8.25%,PDS5A;NIPBL;PDS5B;POGZ
prerank,anterograde trans-synaptic signaling (GO:0098916),0.5455867923201503,1.612235836776241,0.0,0.10097711330943997,1.0,95/224,23.28%,CALM1;GABARAP;MBP;PLP1;MTNR1B;MPZ;ASIC2;NRXN1;CNP;GABRB1;NLGN1;SNAP25;CHRNA9;GRM5;GRIA2;SLC1A2;DLGAP1;KCNQ3;KCNQ2;DLG2;KCND2;PMP22;GABRG3;GRIK2;GRIN1;CACNA1A;SYT1;PENK;DRD5;GABRA2;AMPH;SYPL1;RAPSN;SLC12A5;GRM7;GRIA4;GRIN2A;PDYN;PRKAR1A;SYN2;HTR2C;SLC6A2;SLC6A5;CRH;CAMK1;KIF5A;GRM1;PRKAR1B;HAP1;CHRM3;GLRA2;GRIA1;GLRA1;GABRA3;GABRB3;SYN1;CHRM2;SLC1A1;NRXN2;CHRNA4;HCRT;SDCBP;SYT10;CDK5;CPNE6;KCNK3;DOC2A;KCNA1;GABRB2;DTNA;HTR7;PRKAR2B;HCRTR1;CHRM5;PCDHB14;CAMKK1;APBA2;GRM4;GRIN2B;PTCHD1;GLRA3;SNCA;UNC119;GABBR2;UTS2;GAD1;SST;CACNB4;NPY5R;GRIA3;GRIK1;CHRNA3;CACNA1E;HTR3B;SYT5
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7719571331538384,1.6115606354256682,0.015427769985974754,0.10104200620560928,1.0,8/11,19.10%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;SRI;FKBP1B;CALM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7719571331538384,1.6115606354256682,0.015427769985974754,0.10104200620560928,1.0,8/11,19.10%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;SRI;FKBP1B;CALM2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.6925195935729547,1.611110301111796,0.006493506493506494,0.10116565356192879,1.0,6/18,12.23%,RPS27A;UBC;UBB;UBA52;SYVN1;MAN1B1
prerank,cellular response to hypoxia (GO:0071456),0.5546183204476799,1.6110644839998765,0.0,0.10077055679317856,1.0,54/126,21.64%,RPS27A;UBC;UBB;PSMB4;ELOB;MT3;HMOX1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PINK1;KCND2;PSMD1;ZFP36L1;EPAS1;PSMC3;PSMD6;PGK1;HIPK2;UBA52;PSMA7;NDRG1;BNIP3L;P4HB;FMN2;AQP1;PSMD5;RBX1;AK4;PSMB9;PSMD13;PSMB3;ACAA2;PMAIP1;PSMB11;PSMB10;EGLN2;BAD;PSMB1;PSMB5;VHL;LMNA;TWIST1;NOP53;PSMA6;SFRP1;PSMA4;MYC;SIRT2;HYOU1;STUB1;ELOC
prerank,'de novo' posttranslational protein folding (GO:0051084),0.6458495543974112,1.6103978961295853,0.008168028004667444,0.10120271234258937,1.0,12/30,16.17%,HSPA8;HSPA5;SDF2L1;HSPE1;CCT2;HSPA1B;BAG1;SDF2;HSPA1A;PTGES3;DNAJB1;ERO1A
prerank,cellular response to heat (GO:0034605),0.62525048850762,1.6102052810806993,0.005813953488372093,0.1010884991057249,1.0,11/35,13.09%,HSP90AA1;HSP90AB1;HSBP1;HMOX1;POLR2D;HSPA1B;YWHAE;VCP;MAPT;PDCD6;HSPA1A
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6939285411317594,1.6076580160134941,0.009186351706036745,0.10396151493219744,1.0,10/18,17.76%,APOE;NSG1;PSENEN;ABCG1;KLK6;ACHE;BACE1;PSEN2;ADAM17;APH1B
prerank,regulation of platelet activation (GO:0010543),0.6858187128168631,1.6066153880857295,0.011583011583011582,0.10477476049529556,1.0,4/21,4.09%,APOE;THBD;PDGFB;FCER1G
prerank,negative regulation of receptor binding (GO:1900121),0.7861898431525278,1.6064710172146666,0.017069701280227598,0.10450140943170312,1.0,2/10,3.42%,B2M;ADAM15
prerank,regulation of lipid catabolic process (GO:0050994),0.6921933066226563,1.60630512714931,0.016518424396442185,0.10424278920136155,1.0,5/19,5.68%,APOC1;TNF;BSCL2;PDE3B;RARRES2
prerank,protein stabilization (GO:0050821),0.5456727220625572,1.6059686763805117,0.0,0.10417987345500285,1.0,56/168,18.27%,RPL23;RPL11;RPS7;RPL5;CLU;GAPDH;LAMP1;TYROBP;HSP90AA1;HSP90AB1;GRN;CALR;MT3;PPIB;PARK7;CRYAB;PINK1;CCT2;CHEK2;GLMP;RTN4;PIN1;HSPA1B;FLOT1;FLNA;BAG5;PFN1;BAG1;DNLZ;CCT7;ATP1B2;HSPD1;TSPAN1;CCT8;MFSD1;TAF9;MTMR9;CDC37;SOX17;MSX1;WFS1;SYVN1;NCLN;HSPA1A;FBXW7;WNT10B;PTGES3;ATP1B1;GOLGA7;PEX6;VHL;PFN2;PPARGC1A;ATP1B3;NOP53;LAMP2
prerank,error-prone translesion synthesis (GO:0042276),0.6919172436845175,1.6057120702753067,0.009150326797385621,0.1040887891976326,1.0,7/21,13.25%,RPS27A;UBC;UBB;RPA2;UBA52;PCNA;RFC2
prerank,actin filament bundle assembly (GO:0051017),-0.45909277377295016,-1.6009214617805636,0.015873015873015872,0.42385655767880137,1.0,9/33,4.65%,CALD1;DPYSL3;PAWR;LIMA1;BAIAP2L1;SHROOM2;BAIAP2;MYO1B;EPS8
prerank,zymogen activation (GO:0031638),0.6173245268314412,1.6008843882893795,0.015028901734104046,0.11016333865532546,1.0,18/39,18.82%,CTSL;LGMN;CD5L;PGK1;OMA1;F9;KLK1;GRIN2A;VSIR;PLAT;RIPK2;CTSH;BAD;HPR;HP;PLAU;MMP14;PRSS12
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5733586817557601,1.599948065016338,0.0020920502092050207,0.11101966241898648,1.0,22/79,15.19%,CTSD;CD74;CTSL;DYNLL2;CTSS;DYNLL1;LGMN;CANX;FCER1G;DCTN3;ACTR1B;SH3GL2;AP2M1;CAPZA2;CLTC;AP2S1;KIF5A;KIF26A;DCTN1;ARF1;CLTA;DCTN2
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4893456383313644,-1.5996371221875196,0.038461538461538464,0.4187906228199231,1.0,7/24,7.96%,PHLDB2;ARHGAP28;ARHGAP6;CGNL1;ARHGEF18;PPFIA1;MET
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6385584367489018,1.598851925575441,0.008353221957040573,0.1120753324124293,1.0,15/32,20.39%,CALM1;AKAP6;CALM3;GPER1;APLNR;GSTO1;P2RY6;THY1;CXCL10;HAP1;GSTM2;TRPC1;CALM2;SNCA;CAPN3
prerank,lipid catabolic process (GO:0016042),0.69802008721495,1.598618417945865,0.013157894736842105,0.11192880745256338,1.0,5/18,8.93%,MT3;PLAAT3;LIPG;LIPE;LPL
prerank,positive regulation of chemokine production (GO:0032722),0.605253994467728,1.594998010480904,0.007909604519774011,0.11695107088749361,1.0,23/44,25.85%,CD74;MBP;HMOX1;TNF;TIRAP;LPL;EGR1;HMGB1;CSF1R;WNT5A;AIF1;F2RL1;TWIST1;ADCYAP1;ADAM17;SYK;OAS3;IL6;PYCARD;APP;AGER;IL33;TLR7
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4590698243798912,-1.5945759121690848,0.0,0.42414146288035093,1.0,14/35,13.79%,NR3C2;RBFOX2;ZMIZ1;UBR5;YAP1;ARID1A;KDM3A;PMEPA1;ESR1;DDX17;RNF14;AR;PLPP1;PPARGC1B
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.73083789084848,1.5933465371704927,0.009358288770053475,0.11890099317677881,1.0,3/15,2.14%,TMSB4X;HSPB1;LGMN
prerank,negative regulation of translational initiation (GO:0045947),-0.5875520899911852,-1.5910077850293924,0.04330708661417323,0.4249190824509418,1.0,7/13,21.61%,EIF2AK4;LARP1;RBM4;PAIP2;AGO2;FMR1;TPR
prerank,regulation of cellular component biogenesis (GO:0044087),0.6067863796774912,1.5909916703492335,0.008045977011494253,0.12198183493061557,1.0,9/39,6.44%,APOE;HSPA8;GFAP;HSP90AA1;CCL19;PINK1;AGT;BAG5;MSN
prerank,positive regulation of translation (GO:0045727),0.560899835810541,1.590431333528913,0.0020855057351407717,0.1222573288273867,1.0,17/94,6.54%,RPL26;RPS9;RPS4X;RPL5;EEF2;VIM;UQCC2;EIF3D;POLR2D;NPM1;RPS27L;EIF5A;EIF5AL1;COA3;PKM;UHMK1;EIF3C
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.45729631456556846,-1.589785096921008,0.017241379310344827,0.41997530481970446,1.0,9/31,10.62%,RANBP3L;SMAD6;CRIM1;SUFU;LRP5;SKI;CDK6;PPARG;TRPM4
prerank,heme biosynthetic process (GO:0006783),0.6741523182985543,1.5896166155522173,0.01507537688442211,0.12289397591630075,1.0,10/22,16.27%,TSPO;PGRMC1;NFE2L1;ATP5IF1;ABCB6;ALAD;PPOX;UROD;ABCB10;HMBS
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.5668389034844934,1.589388152867133,0.0010515247108307045,0.12273474761577798,1.0,24/84,13.59%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;ECRG4;PSMD6;UBA52;PSMA7;PSMD5;PSMB9;PSMD13;BUB3;PSMB3;PSMB11;FBXO5;FBXO31;PSMB10
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.6867896366257282,1.5888153272408576,0.011363636363636364,0.12298036457001281,1.0,11/20,22.36%,GNA11;LY6H;CDK5R1;RGS10;CHRM3;CHRM2;LYPD1;CHRM5;GRK2;AGRN;CHRNA3
prerank,acylglycerol homeostasis (GO:0055090),0.6817586861457905,1.5885419031465224,0.014102564102564103,0.12293523596260665,1.0,4/20,9.13%,APOE;MTLN;LPL;MLXIPL
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.4680788318900246,-1.5866781170903672,0.012578616352201259,0.4200430131007847,1.0,15/29,19.58%,SMAD3;DICER1;DROSHA;SMAD1;ZC3H7A;TUT7;ZC3H7B;SMAD2;PUM2;SRRT;TARBP2;TUT4;AGO2;AGO4;ADAR
prerank,protein-containing complex disassembly (GO:0032984),0.5850108302837624,1.5864657552939436,0.006514657980456026,0.12554510150147113,1.0,10/54,5.80%,RPL23;HSPA8;GABARAP;PPP1CA;MAP1LC3B;MAP1LC3A;GABARAPL2;GABARAPL1;CTNNB1;VCP
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5664415820071451,-1.5861400278315916,0.023622047244094488,0.4133961521303876,1.0,4/15,3.12%,EDA;ANKRD11;GLI2;LRP6
prerank,cellular respiration (GO:0045333),0.6095273625048977,1.5857878143435096,0.009080590238365494,0.12616371016145767,1.0,20/41,23.79%,ATP5F1D;UQCR10;NDUFS7;UQCRH;ETFB;SLC25A13;NDUFA5;MTLN;SDHB;UQCRC1;BLOC1S1;UQCRB;NDUFS8;UQCRFS1;PPARGC1A;CYCS;SDHA;COQ10A;MTFR1L;SLC25A14
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.6142036525633805,-1.5852237954847823,0.046296296296296294,0.40875219590588746,1.0,5/10,17.24%,RAPGEF2;ATP7A;GIPC1;APPL1;CTNS
prerank,cell-cell junction assembly (GO:0007043),0.5826993742624116,1.5851087413258182,0.0010857763300760044,0.12667330052580594,1.0,22/63,16.80%,ACTB;ACTG1;CLDN5;RAMP2;GJA4;GJB2;RHOC;CDH20;CTNNB1;CLDN11;CDH18;RHOA;CDH12;GJA1;CDH19;DCHS1;JAM3;CDH7;CDH24;EPB41L3;CDH10;CDH5
prerank,epithelial cell differentiation (GO:0030855),0.5604489840978961,1.5844801642208193,0.0,0.12722110951778043,1.0,18/88,11.93%,CTSB;TAGLN;ALDOC;TAGLN2;ACADVL;AKT1;ERBB4;TOLLIP;LGALS3;PGK1;EDF1;PROX1;BASP1;KDR;DNPH1;PIH1D1;KDM6B;PCNA
prerank,negative regulation of neuron death (GO:1901215),0.5606937792921523,1.583948772534565,0.0,0.12753889957081682,1.0,17/93,4.82%,APOE;MDK;GRN;GPNMB;MT3;PARK7;SOD1;ATF4;LGMN;AKT1;FOXQ1;CD34;PINK1;FZD9;NTRK2;NENF;SORL1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.746106775329836,1.583098599002351,0.019736842105263157,0.12836480611236034,1.0,4/12,10.15%,RPL26;CD74;MIF;TAF9
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.7274700739799054,1.5819131225010628,0.01335113484646195,0.12979915228672442,1.0,2/14,1.05%,RPS3;CD81
prerank,regulation of calcium ion import (GO:0090279),0.6656704733965152,1.5811833720708106,0.02383939774153074,0.1303754234119563,1.0,11/21,20.24%,SLC30A1;CXCL12;PRNP;PDGFB;LGALS3;CTNNB1;PLN;CCL2;CCL3;PSEN2;SPHK2
prerank,negative regulation of axonogenesis (GO:0050771),0.643348098835889,1.580898608263472,0.019464720194647202,0.13025424535745225,1.0,10/27,15.84%,ARHGDIA;MT3;DCC;RTN4;LRP4;THY1;MAP2;GDI1;RHOA;FGF13
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6970649159983751,1.5807307339845937,0.019329896907216496,0.1300252047565015,1.0,8/18,19.89%,GNA11;CDK5R1;RGS10;CHRM3;CHRM2;CHRM5;GRK2;AGRN
prerank,regulation of mRNA catabolic process (GO:0061013),0.5520072061435964,1.5804428514992281,0.0020491803278688526,0.12999973672310317,1.0,37/121,13.60%,RPS27A;HSPA8;UBC;VIM;UBB;PSMB4;HSPB1;PSME1;AKT1;PSMB6;PSME2;PSMB8;PSMD2;YWHAB;PSMD1;ZFP36L1;PSMC3;ZFP36L2;PRR5L;PSMD6;PCBP4;UBA52;PSMA7;PSMD5;XPO1;SET;ZFP36;PSMB9;EXOSC2;PSMD13;APEX1;PSMB3;PABPC1;PSMB11;HSPA1A;PSMB10;YWHAZ
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6339662717208674,-1.5799574210760932,0.039603960396039604,0.4153444764895479,1.0,4/10,5.46%,ROCK2;ROCK1;IL18;IL15
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.6097435413180614,1.5799488337576422,0.011389521640091117,0.13026112842416337,1.0,8/36,8.89%,APOE;CALM1;S100A1;HSP90AA1;AKT1;TNF;CYGB;SPR
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.6083164234226169,1.5793938971242738,0.014994232987312572,0.13069854270379644,1.0,20/38,19.75%,PRNP;GRM5;AGT;PDGFB;PTPRC;HYAL2;PTK6;THY1;LILRA5;FCGR1A;CSF1R;DOK7;SRCIN1;GAS6;LRP8;CAV1;CASS4;ERBB3;UNC119;EFNA1
prerank,negative regulation of RNA splicing (GO:0033119),0.6941765823247787,1.5785009446732774,0.017857142857142856,0.1315057857878467,1.0,5/19,7.06%,RPS13;RPS26;TMBIM6;PCBP4;SRSF9
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7005762050702575,1.5779257134195268,0.014304291287386216,0.13190940743670168,1.0,5/17,4.03%,CALM1;HSP90AB1;CALM3;PPP1R15B;PTPRC
prerank,positive regulation of neuron death (GO:1901216),0.6037211483102664,1.5773456731858215,0.011325028312570781,0.1322733156682476,1.0,25/46,22.11%,CLU;C1QA;TYROBP;GRN;ATF4;PRNP;ITGB2;TNF;CTNNB1;MAPT;NUPR1;EGR1;CDK5R1;WNT5A;BAX;TLR6;CDK5;CCL3;BACE1;GRIN2B;SNCA;TFAP2B;DDIT4;DDIT3;REST
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.6550633751090648,1.5767322930182581,0.015795868772782502,0.13275138173010317,1.0,8/24,16.32%,RPS27A;UBC;UBB;RPA2;UBA52;PCNA;RFC2;POLD4
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.7698295555741013,1.5757753565000627,0.011095700416088766,0.13391004681410623,1.0,4/11,3.08%,RACK1;PARK7;ATF4;PINK1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.6463874909320381,1.575628183328716,0.0166865315852205,0.13364242573887047,1.0,10/25,16.45%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;TNF;KLF4;DDAH1;TLR6;DDAH2
prerank,peptide cross-linking (GO:0018149),0.6432908255262659,1.5754127236751787,0.014962593516209476,0.13352489452436417,1.0,6/25,13.69%,F13A1;TGM2;FN1;EPB42;COL3A1;EVPL
prerank,response to ethanol (GO:0045471),0.7228972456991525,1.5749822037144245,0.012328767123287671,0.13372133119632126,1.0,7/14,11.81%,SOD1;GRIN1;GRIN3A;GRIN2A;SDF4;GLRA2;GLRA1
prerank,selective autophagy (GO:0061912),0.5901148887179151,1.574797162505989,0.002183406113537118,0.13355059311295056,1.0,11/56,7.70%,RPS27A;UBC;VIM;UBB;DYNLL2;PARK7;DYNLL1;MAP1LC3B;AUP1;UBA52;UFC1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5914559360313935,1.5739260880107961,0.012290502793296089,0.13454927134584388,1.0,11/48,9.82%,TMSB4X;ATP5F1B;HSPB1;HMOX1;AKT1;ATP5F1A;PDGFB;KDR;JCAD;GATA2;HMGB1
prerank,cholesterol transport (GO:0030301),0.5932291601920785,1.573923916766245,0.006787330316742082,0.13405641687204958,1.0,8/45,9.19%,APOE;CLU;NPC2;APOC1;ABCG1;LIPG;TSPO2;STARD4
prerank,sulfur compound catabolic process (GO:0044273),0.6088943005085098,1.573687059812071,0.009174311926605505,0.13392888062561845,1.0,22/38,30.60%,BGN;HEXB;BCAN;FMOD;LUM;HEXA;MPST;DCN;ACAT1;TXN2;TST;VCAN;ACAN;PRELP;ADO;CSPG5;CHAC2;GLB1;GGT5;GGT7;IDS;GNS
prerank,muscle filament sliding (GO:0030049),0.6070161090201814,1.573605463090785,0.01152073732718894,0.13306399901553287,1.0,8/38,15.84%,MYL6;VIM;TPM2;MYL1;MYL6B;TNNI1;DES;TMOD1
prerank,actin-myosin filament sliding (GO:0033275),0.6070161090201814,1.573605463090785,0.01152073732718894,0.13306399901553287,1.0,8/38,15.84%,MYL6;VIM;TPM2;MYL1;MYL6B;TNNI1;DES;TMOD1
prerank,histone H3-K36 demethylation (GO:0070544),-0.6295533132874104,-1.5721616880102105,0.03459119496855346,0.42744876603327875,1.0,4/10,13.40%,KDM2A;KDM7A;KDM4C;PHF8
prerank,positive regulation of chemotaxis (GO:0050921),0.6057497524706328,1.5719348336621275,0.006872852233676976,0.13515840343073962,1.0,19/43,19.83%,TMSB4X;MDK;HSPB1;LGMN;CCL19;TREM2;PDGFB;DSCAM;RARRES2;KDR;P2RY12;AIF1;F2RL1;ADAM17;CCR2;STX4;EDN3;IL6;TGFB1
prerank,protein catabolic process (GO:0030163),0.5708604658090657,1.571492120828342,0.005382131324004306,0.13541671169811145,1.0,15/59,12.97%,APOE;HSPA8;CTSD;HSP90AA1;USE1;NR1D1;CHEK2;UBE2G2;VCP;PRPF19;FBXO27;DDB1;PMAIP1;CLN5;CLN6
prerank,gastrulation (GO:0007369),-0.5477306160128893,-1.5705153996919605,0.04878048780487805,0.4240905159768399,1.0,5/15,13.79%,LRP5;GPC3;TASOR;NPHP3;SMAD2
prerank,kinetochore organization (GO:0051383),-0.5992497866989268,-1.5702235213384257,0.040293040293040296,0.4174795696496848,1.0,8/13,26.50%,POGZ;CENPC;CENPT;CENPE;CENPH;NDC80;MIS12;NUF2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.5505204298733247,1.5699911782887765,0.002066115702479339,0.1374458770586227,1.0,36/94,20.78%,RPS27A;UBC;UBB;PSMB4;MAPK3;PSME1;PSMB6;PSME2;PSMB8;PSMD2;TOLLIP;PSMD1;PSMC3;ST18;PSMD6;UBA52;PSMA7;PSMD5;RBX1;EGR1;PSMB9;PSMD13;PSMB3;PSMB11;RIPK2;PSMB10;UBE2V1;PSMB1;PSMB5;SQSTM1;TAB1;PSMA6;SKP1;IL1RAP;PSMA4;NFKBIA
prerank,triglyceride catabolic process (GO:0019433),0.6866978006924936,1.5686407725721276,0.02402022756005057,0.138839366452356,1.0,7/19,23.45%,PNPLA2;FABP5;LIPG;LPL;FABP7;FABP4;FABP3
prerank,T cell activation involved in immune response (GO:0002286),0.7560241988699641,1.5686227252708325,0.008344923504867872,0.13837639764313156,1.0,7/12,14.62%,CD74;MDK;FCER1G;LCP1;SLC11A1;LILRB1;F2RL1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.6516486646305347,1.5674510937346602,0.014943960149439602,0.13977737848367885,1.0,7/24,7.53%,B2M;CALR;CANX;FCER1G;TAPBP;TAP2;PDIA3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.6339186204317386,1.5666303642196906,0.014545454545454545,0.14050579240244948,1.0,9/28,14.04%,RPS27A;UBC;UBB;TNFAIP3;UBA52;OTULIN;AAMP;RIPK2;UBE2V1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7595997901007758,1.5662391807045464,0.022598870056497175,0.1406371722351609,1.0,4/11,10.04%,GSN;PARK7;ST18;PIH1D1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.6388670102156114,1.5662353784252108,0.014336917562724014,0.1401539366963946,1.0,5/27,6.79%,RPS27A;UBC;UBB;MAPK3;UBA52
prerank,positive regulation of cellular component organization (GO:0051130),0.5481567217623468,1.5661802814314856,0.0020491803278688526,0.13977260754474796,1.0,30/107,11.61%,APOE;RPS3;CLU;RACK1;GPX1;CD151;PARK7;CCL19;NRXN1;NRG1;TREM2;TNF;TMEM30A;RHOC;LGALS3;LRP4;FLOT1;TIRAP;VCP;TFRC;LMAN1;SURF4;MTLN;CAMK1;PIH1D1;SMPD1;TMED9;MMP3;BAX;WARS1
prerank,ganglioside metabolic process (GO:0001573),0.6749551216261555,1.5661068266193132,0.027777777777777776,0.13944810612120598,1.0,9/20,16.06%,GM2A;HEXB;HEXA;B4GALNT1;CLN6;ST8SIA4;ST6GALNAC3;ABCA2;NEU1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.6555903352629475,1.5660051366198167,0.01256281407035176,0.13908199756874423,1.0,8/24,14.04%,RPS27A;UBC;UBB;TNFAIP3;UBA52;AAMP;RIPK2;UBE2V1
prerank,digestive tract development (GO:0048565),-0.45387413231637264,-1.5637694592605567,0.019736842105263157,0.4264438599491936,1.0,10/32,10.39%,RARB;SMO;GLI3;GLI2;NIPBL;COBL;CLMP;PCSK5;FGFR2;PKD1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.642006417607225,1.5632287708120496,0.024509803921568627,0.1429985271530333,1.0,11/24,16.80%,CLU;RACK1;PARK7;UBXN1;TMBIM6;CREB3;WFS1;SYVN1;HSPA1A;NR1H2;HERPUD1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.7247963375616311,1.5628664464756388,0.024759284731774415,0.14309178814581983,1.0,7/13,19.83%,TYROBP;SOD1;ITGB2;MAPT;F2RL1;SYK;TGFB1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6995603399394235,1.5622889019627288,0.014492753623188406,0.1435684059060988,1.0,2/16,7.11%,CLDN5;CLDN11
prerank,positive regulation of response to wounding (GO:1903036),0.6437474393028273,1.561394849563945,0.022004889975550123,0.14452094442474775,1.0,4/24,1.29%,ACTG1;VTN;MDK;GRN
prerank,regulation of ATP biosynthetic process (GO:2001169),0.7034387729781303,1.5612977053017678,0.017591339648173207,0.14415703528994625,1.0,8/16,9.83%,TMSB4X;TREM2;PINK1;ENO1;PARP1;VCP;AK4;DNAJC30
prerank,positive regulation of phosphatase activity (GO:0010922),0.673801483069878,1.561215983755549,0.006321112515802781,0.1438253470712328,1.0,10/21,20.07%,CALM1;HSP90AB1;CALM3;PPP1R15B;MTMR9;BMP2;CD300A;PPP1R15A;CALM2;MEF2C
prerank,neuron maturation (GO:0042551),0.6845933430465065,1.5605987543904716,0.015706806282722512,0.1443555984361998,1.0,6/18,12.93%,MTCH1;C1QA;C3;ADGRB3;B4GALT6;CLN5
prerank,mitochondrial gene expression (GO:0140053),0.6030219339695122,1.558168577983289,0.012074643249176729,0.14792861898261436,1.0,16/42,19.36%,MRPL23;MRPS12;LARS2;MRPS34;MRPS11;MRPS14;MRPL51;MRPL57;MRPL2;NDUFA7;MRPS24;MRPL12;MRPS2;MRPS6;MRPS16;MRPS21
prerank,negative regulation of growth (GO:0045926),0.5369764547679362,1.5581619334142178,0.0010193679918450561,0.14744362944030148,1.0,44/121,20.24%,MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;RACK1;MT3;NDUFA13;MT2A;CCDC85B;ADAM15;ACVRL1;ENO1;RTN4;HSPA1B;PPP2R1A;HYAL2;BTG1;WFDC1;JADE1;APBB1;SOX17;MSX1;DNAJB2;BST2;HSPA1A;GJA1;STK11;ING1;DACT3;SLIT3;NDUFS3;SCGB3A1;CCAR2;INHBA;NOTCH1;TGFB1;ING5;OSGIN1;SFRP1;SPHK2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.6003927271895791,1.5580771795203319,0.009195402298850575,0.1471118859235422,1.0,10/42,12.88%,RPL30;RPS19;MPEG1;TREM2;ROMO1;RARRES2;AQP1;ADGRB1;CHGA;SLC11A1
prerank,protein insertion into ER membrane (GO:0045048),0.5966602146027435,1.5576451708163768,0.025851938895417155,0.1472503283064421,1.0,17/37,21.92%,HMOX1;SEC61B;PRNP;WDR83OS;EMC6;SEC61G;EMC3;EMC10;VAMP2;EMC4;SERP1;SGTA;TRAM1L1;EMC8;VAPA;TRAM1;CYB5A
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.6569902336067529,1.557330031416961,0.017699115044247787,0.147261529180363,1.0,13/22,20.34%,PSMB4;PSMB6;PSMB8;PSMA7;PSMB9;PSMB3;PSMB11;PSMB10;PSMB1;ENC1;PSMB5;PSMA6;PSMA4
prerank,regulation of aerobic respiration (GO:1903715),0.7050397800022182,1.5566880051854546,0.022727272727272728,0.14777302304011403,1.0,6/15,9.44%,UQCC2;PINK1;COX7A2L;COX7A2;VCP;AK4
prerank,cellular response to peptide (GO:1901653),0.5759719758888228,1.555523873358645,0.006528835690968444,0.14920776592704935,1.0,20/56,16.62%,RPL23;VIM;LGMN;PRNP;TREM2;GRM5;GPER1;ZFP36L1;GRIN1;CACNA1A;ATP1A3;GRIN2A;CHMP5;DDX11;GJA1;RIPK2;TLR6;CDK5;CAV1;VCAM1
prerank,response to thyroid hormone (GO:0097066),0.7182510663246343,1.5539826671952623,0.021248339973439574,0.15124875736242993,1.0,3/13,1.67%,CTSB;CTSL;CTSS
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.6307971903896465,1.5530484199982648,0.021739130434782608,0.1522119467185297,1.0,8/26,14.04%,RPS27A;UBC;UBB;TNFAIP3;UBA52;AAMP;RIPK2;UBE2V1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.7297464675633829,1.5520672216898106,0.019021739130434784,0.15337589968501522,1.0,3/12,1.67%,CTSB;CTSL;CTSS
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.5617532783586617,1.5519120079214082,0.004268943436499467,0.1531414072782973,1.0,24/69,20.74%,APOE;MDK;GRN;MT3;PARK7;SOD1;LGMN;FOXQ1;PINK1;FZD9;NTRK2;SET;WFS1;CX3CR1;CCL2;PTPRZ1;NONO;TYRO3;PPARGC1A;AGAP2;ERBB3;POU4F1;MEF2C;CRLF1
prerank,positive regulation of leukocyte migration (GO:0002687),0.6431162516807579,1.551796012448236,0.014723926380368098,0.15284514080068373,1.0,11/27,19.67%,MDK;TNF;LGALS3;THY1;AIF1;F2RL1;JAM3;ADAM17;PLVAP;EDN3;IL6
prerank,regulation of leukocyte activation (GO:0002694),0.714805759281322,1.5517849395098462,0.028225806451612902,0.1523835932445715,1.0,4/14,9.11%,CD74;GPER1;MIF;GPR137B
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.6138743724968042,1.5517305860209143,0.016587677725118485,0.15200050343799437,1.0,8/33,6.09%,APOD;HMOX1;IGFBP3;GPER1;IGFBP5;ANG;NDRG4;TNFAIP3
prerank,natural killer cell mediated immunity (GO:0002228),0.6979251525342336,1.550492095808256,0.028112449799196786,0.1537356426931418,1.0,2/15,1.46%,TUBB;TUBB4B
prerank,gene silencing by miRNA (GO:0035195),-0.43846299561389823,-1.549827922073179,0.0136986301369863,0.4554559771234381,1.0,16/32,19.58%,TNRC6B;TNRC6A;TNRC6C;CNOT1;DICER1;ZC3H7A;MOV10;RBM4;ZC3H7B;CNOT7;PUM2;TARBP2;LIMD1;AGO2;AGO4;ADAR
prerank,transition metal ion homeostasis (GO:0055076),0.6246519787992043,1.5497110443133764,0.01705237515225335,0.15453480792169494,1.0,5/28,1.87%,FTL;B2M;MT3;HMOX1;TMPRSS6
prerank,regulation of B cell activation (GO:0050864),0.6321295427997027,1.5492958383197166,0.01845018450184502,0.15465614790696613,1.0,9/25,21.39%,LAPTM5;ZFP36L1;ZFP36L2;TNFAIP3;CD22;IKZF3;SH3KBP1;IL6;BANK1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5643772176620205,-1.549068944115612,0.05054151624548736,0.4502666452431025,1.0,7/13,22.20%,RANBP2;CBLB;KPNA4;KPNA2;NUP35;KPNA3;KPNA6
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5724951943954034,1.5487829914183053,0.00776914539400666,0.15510578032129496,1.0,14/53,17.09%,MTNR1A;MTNR1B;NPY1R;AGT;SSTR4;HTR2C;VIPR1;MC1R;CHRM3;CHRM2;CCL2;HTR7;PTGIR;CHRM5
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.676569919188885,1.5486623224521672,0.02284263959390863,0.15484080780734222,1.0,5/18,10.12%,LAPTM5;GPNMB;AKT1;DUSP3;FGL1
prerank,dendrite self-avoidance (GO:0070593),0.698609127180428,1.5482774722358752,0.026737967914438502,0.15500629128020815,1.0,8/16,15.44%,BSG;DSCAM;CNTN4;ROBO4;EMB;TNN;IGSF9;DSCAML1
prerank,embryonic eye morphogenesis (GO:0048048),-0.6144169435546588,-1.5481528912336802,0.03642384105960265,0.44544507492836033,1.0,4/11,5.77%,FBN1;LRP6;RARG;EFEMP1
prerank,macrophage migration (GO:1905517),0.7268783067016273,1.5479426536609728,0.019151846785225718,0.15509385387437552,1.0,6/13,19.15%,LGALS3;P2RY12;CCL2;CCL3;CCR2;CXCL17
prerank,proton transmembrane transport (GO:1902600),0.6091361489610835,1.5476461351504598,0.018518518518518517,0.1550643848853021,1.0,11/36,13.03%,ATP5MF;ATP6V0C;ATP5F1B;ATP6V1F;UCP2;ATP6V0E2;ATP1A3;HVCN1;ATP1A4;ATP1A1;SLC25A27
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6893690657612073,1.5468062557670679,0.02526595744680851,0.15604956088358662,1.0,7/16,21.10%,APOE;AGT;DDAH1;MAFA;DDAH2;NOS2;KCNC2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.6349097491891429,1.5444093090933741,0.023989898989898988,0.15954152892532886,1.0,6/22,12.23%,RPS27A;UBC;UBB;UBA52;SYVN1;MAN1B1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.6901004628885347,1.5440355008854383,0.018543046357615896,0.15978386858448929,1.0,5/17,8.35%,APOE;SOD1;RAN;ABCG1;SEC14L2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.6470689316362618,1.5438794126594908,0.017412935323383085,0.15957972282318342,1.0,10/24,16.27%,TSPO;PGRMC1;NFE2L1;ATP5IF1;ABCB6;ALAD;PPOX;UROD;ABCB10;HMBS
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.5981003360309124,1.5433606660716594,0.02040816326530612,0.16000451491013257,1.0,13/34,20.24%,LAPTM5;RBP4;SLC7A5;PTPRC;IL2;VAMP3;WNT5A;F2RL1;DNAJB9;STX4;CD86;IL6;SPHK2
prerank,regulation of superoxide anion generation (GO:0032928),0.71149543066965,1.543297067997995,0.02054794520547945,0.1596084188285358,1.0,7/14,19.83%,TYROBP;SOD1;ITGB2;MAPT;F2RL1;SYK;TGFB1
prerank,neurotransmitter secretion (GO:0007269),0.5856769296603842,1.542518325428281,0.01564245810055866,0.16051634078865137,1.0,27/44,29.01%,HSPA8;NRXN1;SNAP25;DNAJC5;SYT1;RIMS2;RIMS1;SYN2;VAMP2;PTPRN2;SYN1;NRXN2;LIN7C;NAAA;PPFIA3;SYT10;CDK5;GRM4;SNCA;GAD1;SLC32A1;UNC13A;STXBP2;PIP5K1C;CPLX1;PCLO;SNPH
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5673496386974732,-1.5422077685638809,0.045112781954887216,0.4539161541378744,1.0,8/14,22.36%,GHR;STAT5B;PXN;STAT3;PTK2;STAT5A;STAT6;PIK3R1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.5512020682899004,1.5421638200309333,0.0031545741324921135,0.16063535097677475,1.0,26/88,17.55%,APOE;CST3;MRPL13;RPS3;RACK1;GAPDH;RPL13A;CALR;AKT1;SERPINE2;IGFBP5;NCL;CSTB;NELL1;YBX1;PCIF1;ATRAID;PLAT;CAMK2N1;CDK5;ENC1;EIF4A3;DAB2IP;EIF4ENIF1;CLN8;NANOS2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6890281340376081,1.5420536426955838,0.02102496714848883,0.16031548030285028,1.0,6/16,13.45%,IGFBP6;IGFBP3;IGFBP4;IGFBP5;IGFBP2;BMP2
prerank,anterograde axonal transport (GO:0008089),0.6022555943362381,1.5415160558906447,0.012850467289719626,0.16074935608845117,1.0,12/37,12.70%,HSPB1;SOD1;BLOC1S4;MAP1A;DLG2;NEFL;AP3B2;KIF5A;BLOC1S1;BLOC1S3;HAP1;BLOC1S5
prerank,myelin maintenance (GO:0043217),0.7552443516320887,1.5410704905124482,0.027065527065527065,0.16104135147975182,1.0,7/10,16.64%,CLU;SOD1;MYRF;CXCR4;DEGS1;EPB41L3;PRX
prerank,protein K63-linked ubiquitination (GO:0070534),-0.42401736012019686,-1.5389592843002797,0.017543859649122806,0.4562994402598479,1.0,13/41,11.10%,UBE2E2;HECTD1;RNF152;PRKN;TRAF3IP2;ARIH2;TRAF5;RNF135;TRIM5;RNF8;ZFP91;ITCH;RNF115
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.406428616369615,-1.5389056997015578,0.00847457627118644,0.4493836940738037,1.0,16/51,11.55%,FBN1;SMAD6;BMPR1A;CRIM1;SMURF2;SKI;BMPER;SMAD9;SMURF1;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4;CHRDL1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.7513377734641409,1.5372916505738496,0.024045261669024046,0.16759286120092878,1.0,5/10,13.40%,TYROBP;HSP90AB1;FN1;CD24;LILRB1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7150100479100517,1.5370112432290257,0.02051983584131327,0.16757378914880727,1.0,5/13,5.80%,TMSB4X;TREM2;PINK1;ENO1;VCP
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.7533991373912479,1.5359602781696164,0.022191400832177532,0.16899327282561447,1.0,3/10,2.58%,CALM1;PDE4B;CALM3
prerank,positive regulation of dephosphorylation (GO:0035306),0.6293699477645044,1.5355327637829685,0.016928657799274487,0.169262772627022,1.0,14/27,21.18%,PPIA;CALM1;CALM3;PIN1;SMPD1;MTMR9;BMP2;DLC1;CDH5;NSMF;CALM2;TGFB1;CAMTA1;PPP2R5A
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.6606708525869992,1.5352804904532182,0.031407035175879394,0.16926511930099827,1.0,6/19,5.24%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6195998094835282,1.5351509143062285,0.018094089264173704,0.16895325559751528,1.0,11/28,14.57%,RPS3;RAC1;HSPA1B;NAV3;PAK1;CLASP1;MAPT;CDK5R1;DCTN1;HSPA1A;ARL2
prerank,glycine transport (GO:0015816),0.7581177517463662,1.5333991827601876,0.022727272727272728,0.17149158501106845,1.0,3/10,9.09%,SLC38A5;SLC6A17;SLC6A5
prerank,dendritic cell differentiation (GO:0097028),0.6357251216547191,1.5333261556251283,0.025830258302583026,0.1710766263668521,1.0,10/22,19.95%,CCL19;TREM2;IRF8;TRPM2;LILRB1;GAS6;F2RL1;BATF3;FLT3;BATF2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6292962724113869,1.5332264818193773,0.021660649819494584,0.17072179692698847,1.0,6/26,3.71%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;TNF
prerank,transition metal ion transport (GO:0000041),0.6035965457206549,1.532808664933687,0.013126491646778043,0.1710503938484678,1.0,12/35,15.53%,FTH1;ATOX1;MT3;SLC30A1;COX17;TFRC;TTYH1;TRPC7;SLC11A1;TRPC1;SLC31A1;HEPH
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.7490550271482206,1.53112017703159,0.02188782489740082,0.1738822125995452,1.0,5/11,5.54%,TIMM8B;TIMM13;NDUFA13;ROMO1;TIMM10B
prerank,dopamine metabolic process (GO:0042417),-0.5118768217249169,-1.5307686481383092,0.03153153153153153,0.4634673262390372,1.0,4/18,6.77%,SNCAIP;MOXD1;PRKN;ATP7A
prerank,autophagosome maturation (GO:0097352),0.6071472855257319,1.5289248029425402,0.017793594306049824,0.17738612411141005,1.0,7/32,5.80%,CALM1;GABARAP;MAP1LC3B;MAP1LC3A;GABARAPL2;GABARAPL1;VCP
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6019448976398611,-1.5285323521757612,0.04744525547445255,0.46282017459893804,1.0,5/11,18.78%,PDK1;STK24;PRODH;GSKIP;MAP3K5
prerank,regulation of stress fiber assembly (GO:0051492),-0.37538248857103834,-1.5283704981028001,0.0,0.4564790109251185,1.0,20/74,6.21%,ROCK2;PHLDB2;ARHGAP28;ARHGAP6;CGNL1;ABL1;ASAP3;ALMS1;SLC9A1;LPAR1;ROCK1;PPM1E;NRP1;SORBS3;ARHGEF18;ARHGEF10L;CARMIL1;TGFBR1;PPFIA1;PXN
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.7139721221323047,1.5281958002395513,0.020689655172413793,0.178190950056679,1.0,5/14,8.58%,GRN;TREM2;PTPRC;NR1D1;SYT11
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6453940629249743,1.527112433881374,0.01905972045743329,0.17970136271346743,1.0,5/22,6.25%,TMSB4X;TMSB10;GSN;MYADM;PFN1
prerank,negative regulation of macrophage activation (GO:0043031),0.6748604944352314,1.524409663594552,0.01950585175552666,0.18439846808427612,1.0,5/16,8.58%,GRN;PTPRC;NR1D1;LRFN5;SYT11
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6540876733856227,1.52335546725195,0.020942408376963352,0.1860006896604642,1.0,4/20,8.35%,APOE;ACADVL;RAN;SEC14L2
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6990639986816354,1.523086843248298,0.029216467463479414,0.18595443900945163,1.0,8/13,19.10%,CALM1;CALM3;ANK3;IRX3;SLC8A1;CAV1;SRI;CALM2
prerank,receptor signaling pathway via STAT (GO:0097696),-0.4810414649099329,-1.523063832750548,0.04395604395604396,0.4637262224272352,1.0,11/25,19.40%,GHR;STAT5B;IL31RA;PIAS1;STAT3;STAT2;PKD1;NMI;STAT5A;STAT6;PKD2
prerank,positive regulation of ATPase activity (GO:0032781),0.5800678261165172,1.522486349190873,0.012345679012345678,0.1865627959527759,1.0,16/41,18.89%,DYNLL2;DYNLL1;GABARAPL2;PFN1;ATP1B2;DNAJB2;VMP1;HNRNPU;DNAJB1;ATP1B1;RYR2;PFN2;DNAJB11;ATP1B3;AHSA1;DNAJC10
prerank,signal release from synapse (GO:0099643),0.580419710964625,1.5224670430792095,0.016835016835016835,0.1860363519440235,1.0,26/43,29.01%,HSPA8;NRXN1;SNAP25;DNAJC5;SYT1;RIMS1;SYN2;VAMP2;PTPRN2;SYN1;NRXN2;LIN7C;NAAA;PPFIA3;SYT10;CDK5;GRM4;SNCA;GAD1;SLC32A1;UNC13A;STXBP2;PIP5K1C;CPLX1;PCLO;SNPH
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.5873536058177116,1.521990089741053,0.022857142857142857,0.1864734459547142,1.0,15/38,16.45%,CLU;HSP90AA1;HSP90AB1;AKT1;KLF2;CD34;TNF;RAC1;SIRPA;KLF4;DDAH1;CX3CR1;TLR6;CAV1;DDAH2
prerank,mitochondrion localization (GO:0051646),-0.512774591672125,-1.521559245107808,0.043478260869565216,0.4612316577514779,1.0,6/19,8.33%,LRRK2;TRAK1;MFN1;MARK1;BRAT1;MEF2A
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.6662997567057944,1.520240136958152,0.04639175257731959,0.18944999777051452,1.0,6/17,5.24%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,negative regulation of axon extension (GO:0030517),0.6134984218501267,1.520218258606395,0.029832935560859187,0.1889309219192598,1.0,9/30,13.41%,MT3;SEMA3F;SEMA7A;RTN4;SEMA4C;SEMA6D;MAP2;SEMA4A;SEMA4G
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.582773639956481,-1.5196792459232609,0.05653710247349823,0.459984403405451,1.0,4/11,8.88%,TGFBR3;ACVR1;TGFBR1;SMAD7
prerank,positive regulation of DNA replication (GO:0045740),-0.5210537359442221,-1.5188945379634775,0.04830917874396135,0.4557602669392698,1.0,7/16,13.83%,EGFR;GLI2;KAT7;BRPF3;BCAR3;ATAD5;STN1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.6199925739965412,1.5188290224697303,0.03341584158415842,0.1911471381610172,1.0,11/26,19.10%,CALM1;CALM3;FKBP1A;YWHAE;GSTO1;PLN;GSTM2;CBARP;SRI;FKBP1B;CALM2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5471151089549288,1.5186808181098026,0.009513742071881607,0.19088291278022168,1.0,30/68,25.86%,CD74;MBP;TYROBP;CYBA;TNF;TIRAP;HYAL2;HSPD1;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;AIF1;TLR6;F2RL1;TLR1;TWIST1;NOS2;SYK;IL6;SPHK2;TMEM106A;PYCARD;APP;AGER;LBP;IL33;TLR7;POU2F2
prerank,negative regulation of proteolysis (GO:0045861),0.597722204686385,1.5182686257744167,0.023446658851113716,0.19102206958125054,1.0,13/34,12.45%,CST3;TIMP2;AKT1;PRNP;SERPINE2;TMEM59;ECM1;CSTB;TIMP1;GAS1;PLAT;CAMK2N1;TIMP3
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.6315575685337227,1.5180486259567798,0.028083028083028084,0.1909271268962333,1.0,12/26,16.42%,CYBA;RTN4;FLOT1;TIRAP;SLC15A4;TICAM2;HMGB1;NINJ1;F2RL1;TLR5;TLR1;CAV1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5310810730578535,-1.5164109703521678,0.06278026905829596,0.45533376271357723,1.0,5/17,9.60%,PRKAG2;PPARA;NCOR1;PRKAA2;PPARG
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.7093256054103525,1.5158813606121915,0.029216467463479414,0.19482345496371306,1.0,4/13,3.67%,RACK1;PARK7;TXN;GPR37L1
prerank,phospholipid transport (GO:0015914),0.5662227766245432,1.515112427078918,0.014301430143014302,0.19579922651083118,1.0,11/52,10.95%,APOE;PLTP;NPC2;APOC1;TMEM30A;SCP2;ATP8B4;ABCG1;ATP8A2;MFSD2A;ATP8A1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5663936729424304,1.5147224136220108,0.006550218340611353,0.1960237594029955,1.0,20/54,16.86%,RPS3;RPL11;RPL5;PARK7;UBXN1;AKT1;COPS9;HSPA1B;CTNNB1;BAG5;TNFAIP3;ISG15;ADGRB1;DNAJA1;VPS28;HSPA1A;IVNS1ABP;ARRB2;CAV1;SQSTM1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.5271670974514177,-1.514260938417543,0.05357142857142857,0.4550103523611056,1.0,8/17,14.92%,NOTCH2;SMAD6;ROBO1;SLIT2;NFATC1;JAG1;BMP4;HEY2
prerank,regulation of interleukin-8 production (GO:0032677),0.542665504679316,1.5136174492128667,0.005307855626326964,0.1977697004058865,1.0,22/69,21.15%,TMSB4X;CD74;PARK7;TNF;LAMTOR5;PTPRC;HSPA1B;TIRAP;HYAL2;HMGB1;KLF4;HSPA1A;TLR6;F2RL1;TLR5;TLR1;NOS2;SYK;CD14;IL6;PYCARD;DDIT3
prerank,regulation of protein binding (GO:0043393),0.5240963038128115,1.5129879762758582,0.003067484662576687,0.19857483298327758,1.0,31/114,14.55%,ACTB;RPL11;RACK1;CLDN5;B2M;VTN;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;RAN;PDGFB;FKBP1A;PIN1;SORL1;FLOT1;TLE5;ADD2;HIPK2;LRPAP1;IFIT1;CAMK1;BAX;DNAJB2;DDX11;BMP2;RIPK2;HDAC5;TIAM1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.4875989295285086,-1.5125036829113199,0.039603960396039604,0.4535060126953867,1.0,8/23,11.38%,ZBTB20;ARNT;NFKB1;INSR;IGF1;PRKAA2;ENTPD5;PSEN1
prerank,cellular response to interleukin-1 (GO:0071347),0.5172105546330032,1.5120896876150252,0.0,0.19981274915491967,1.0,48/143,20.93%,RPS27A;UBC;UBB;PSMB4;MAPK3;PSME1;CCL19;PSMB6;PSME2;PSMB8;PSMD2;TOLLIP;NR1D1;PSMD1;PSMC3;SIRPA;ST18;PSMD6;HYAL2;UBA52;PSMA7;PSMD5;RBX1;EGR1;PSMB9;PSMD13;PSMB3;PSMB11;SOX9;RIPK2;PSMB10;UBE2V1;CCL2;MAPK11;PSMB1;PSMB5;DAB2IP;CCL3;SQSTM1;CCL8;TAB1;PSMA6;SKP1;SFRP1;IL1RAP;PSMA4;NFKBIA;PYCARD
prerank,intraciliary retrograde transport (GO:0035721),-0.5734945596984804,-1.5116904187307714,0.06007067137809187,0.44972317680585355,1.0,7/12,17.04%,DYNC2H1;WDR35;IFT140;IFT122;WDR19;DYNC2I2;DYNC2LI1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6420831440382717,1.5113539903036657,0.02732919254658385,0.20075849346337926,1.0,7/22,9.85%,LAPTM5;PRNP;LGALS3;DUSP3;THY1;CD22;PHPT1
prerank,negative regulation of neuron projection development (GO:0010977),0.5569625027227058,1.5110427328905636,0.009944751381215469,0.20077833127974848,1.0,12/56,8.34%,APOE;ARHGDIA;ITM2C;MT3;DCC;NLGN1;RTN4;LRP4;SPOCK1;BAG5;CRMP1;THY1
prerank,neuron remodeling (GO:0016322),0.7329653618238747,1.5109022419194242,0.04782608695652174,0.2005330558253301,1.0,3/10,4.22%,C1QA;C3;ADGRB3
prerank,response to UV-B (GO:0010224),0.7075085044712804,1.5099020758489161,0.03905160390516039,0.20207232326054875,1.0,4/12,14.18%,CRIP1;HYAL2;MFAP4;STK11
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5893861593707754,-1.5092658001667691,0.048109965635738834,0.45008655945476017,1.0,8/11,39.06%,SMAD7;RC3H2;SOCS5;ANXA1;JAK3;IL4;FOXP3;TBX21
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.5518876832729153,1.5079878031535068,0.013468013468013467,0.20538412824995234,1.0,24/55,21.42%,RPS3;RACK1;AGT;GPER1;TNF;S100A8;S100A9;HYAL2;TNFSF12;NUPR1;BAX;PMAIP1;BBC3;BAD;DAB2IP;CAV1;BCAP31;DNM1L;LTBR;TNFRSF12A;ING5;PYCARD;DDIT3;FIS1
prerank,morphogenesis of an epithelium (GO:0002009),0.6178201418486705,1.5079447495689735,0.03634085213032581,0.20489730569847647,1.0,2/25,0.25%,ACTB;ACTG1
prerank,regulation of fibroblast proliferation (GO:0048145),0.5772930745467724,1.5078957994594793,0.015401540154015401,0.20442372666203776,1.0,18/45,20.51%,FTH1;CD74;S100A6;AGT;PDGFB;MIF;CTNNB1;FN1;AQP1;WNT5A;GAS6;PDGFA;DAB2IP;TRIM32;CD300A;DDR2;SFRP1;MYC
prerank,axon development (GO:0061564),0.5471580380419728,1.5077400209712606,0.006355932203389831,0.20415339472198718,1.0,25/78,16.84%,ACTB;S100A6;PLP1;DCC;S100B;CTNNA2;ANK3;MAP1A;CNTN4;RTN4;NEFH;NRCAM;GRM7;MAPT;CDK5R1;PAK3;ADGRB1;APBB1;SHTN1;CCK;DSCAML1;SPTBN4;CDK5;GAP43;BRSK2
prerank,positive regulation of inflammatory response (GO:0050729),0.531271574057878,1.5071803791087144,0.008359456635318705,0.204703478841759,1.0,36/86,26.21%,RPS19;CD81;MDK;GRN;AGT;TNF;S100A8;S100A9;DDT;HYAL2;FEM1A;CEBPA;IL2;LPL;NUPR1;LILRA5;KARS1;NINJ1;PLA2G7;WNT5A;VAMP8;TNFRSF1A;GPSM3;CCL3;CCR2;SNCA;IL6;NFKBIA;TNIP1;APP;PLA2G3;LBP;PDE2A;IL33;TLR7;CX3CL1
prerank,positive regulation of macrophage activation (GO:0043032),0.6596190990503538,1.5071488514918097,0.039190897597977246,0.20424214198816565,1.0,8/17,16.37%,TREM2;SPACA3;HSPD1;CEBPA;KARS1;WNT5A;TLR6;CCL3
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5389053300243728,1.5068037539478525,0.003215434083601286,0.20434639580283415,1.0,29/73,20.93%,CLU;TYROBP;HSPB1;CCL19;CYBA;PTPRC;MIF;TIRAP;DDT;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;PF4;IFNGR1;TLR1;RASGRP1;CCL3;TWIST1;SYK;OAS3;CCR2;CD14;CD86;IL6;SPHK2;TMEM106A;PYCARD
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5426377951453573,1.50674447747249,0.0053705692803437165,0.2039146196186906,1.0,28/69,20.93%,CLU;TYROBP;HSPB1;CCL19;CYBA;PTPRC;MIF;TIRAP;DDT;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;PF4;IFNGR1;TLR1;RASGRP1;CCL3;TWIST1;SYK;OAS3;CCR2;CD14;IL6;SPHK2;TMEM106A;PYCARD
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5457230774386665,1.506516932547988,0.010638297872340425,0.2037977638094499,1.0,18/71,10.13%,RPS27A;CTSB;UBC;UBB;CTSL;CTSZ;CTSS;LGMN;NR1D1;VCP;TNFAIP3;OMA1;UBA52;ISG15;PRPF19;NEDD8;OTUD7A;DDB1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.5812072375429387,1.5059228603581132,0.026077097505668934,0.2045414967659612,1.0,13/41,16.90%,GPX4;SCD5;GPX1;SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4;GSTM2;SCD;FADS3;DEGS1;FAAH
prerank,epiboly involved in wound healing (GO:0090505),0.6753941246028498,1.5057885490010603,0.03580901856763926,0.20429144386817719,1.0,7/16,17.95%,CD151;RHOC;MRTFA;FLNA;LCP1;RHOA;TMEFF2
prerank,positive regulation of neutrophil migration (GO:1902624),0.6575284866577542,1.5055344863975202,0.04774193548387097,0.2042804728290535,1.0,6/18,5.24%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,innate immune response (GO:0045087),0.5067580525226982,1.505254482836681,0.0,0.20418450566665092,1.0,55/217,18.49%,IFITM3;RPL39;CD74;IFITM2;B2M;IFITM1;MBL2;TYROBP;C3;PGLYRP1;S100B;CYBA;TREM2;SHFL;ADAM15;FCER1G;SERINC3;ANG;RARRES2;CYBB;RNF187;PPP1R14B;MFAP4;ISG15;CXCL16;CORO1A;TRIM28;CLEC6A;PTK6;CAPZA2;OTULIN;CXCL10;IFIT1;TRIM59;HMGB1;HCK;SMPD1;CHGA;LCN2;SLC11A1;BST2;MSRB1;RIPK2;CLEC4D;CX3CR1;IRF7;SERINC5;NCF1;ATAD3A;PIK3CD;TRIM32;NOS2;SYK;SRMS;SLA
prerank,negative regulation of viral genome replication (GO:0045071),0.5720333264759416,1.504404793838649,0.024110218140068886,0.20532806836314937,1.0,10/40,13.02%,IFITM3;IFITM2;IFITM1;SHFL;TNF;ISG15;PROX1;IFIT1;BANF1;BST2
prerank,long-term memory (GO:0007616),0.6594395996225801,1.5040728438128548,0.035526315789473684,0.20544776675021637,1.0,4/19,7.77%,APOE;PRNP;CALB1;SGK1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.550103447904577,-1.5032957636436837,0.0648854961832061,0.46045974684674196,1.0,10/13,25.91%,RNF152;SESN1;ATM;ITFG2;SPAAR;CASTOR2;CASTOR1;KPTN;SESN2;SESN3
prerank,lipoprotein biosynthetic process (GO:0042158),0.7275876171736644,1.5031854253350387,0.040172166427546625,0.2066842685590313,1.0,1/11,0.03%,APOE
prerank,spliceosomal snRNP assembly (GO:0000387),0.5849058898537964,1.5031594146861904,0.018518518518518517,0.2061774949859233,1.0,13/38,18.55%,SNRPG;GEMIN7;SNRPD2;LSM4;SNRPE;SNRPF;STRAP;CD2BP2;PRPF19;PRPF8;SNRPB;PRPF31;SNRPD3
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5802993055103346,1.502964644009397,0.018433179723502304,0.20603203188512956,1.0,22/41,23.06%,PRNP;GRM5;AGT;PDGFB;NTRK2;DOCK3;LILRA5;FCGR1A;CSF1R;DOK7;FBXW7;SRCIN1;GAS6;LRP8;NCF1;CASS4;ADAM17;ERBB3;UNC119;EFNA1;TGFA;PTPN1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.5339011321594255,1.5029482407555819,0.0030959752321981426,0.20553975572386443,1.0,43/85,26.31%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;RAC1;PSMD1;PSMC3;PSMD6;AP2M1;PFN1;PSMA7;CLTC;PSMD5;AP2S1;PSMB9;PSMD13;WNT5A;PSMB3;PSMB11;RHOA;PSMB10;TIAM1;PSMB1;ARRB2;PSMB5;PRICKLE2;ARHGEF19;PSMA6;PSMA4;FZD2;FZD1;AP2A1;PSMC1;PARD6A;WNT7A;PSMD9;CELSR3;PSMB2;PSMD4;PSMD10;FZD3
prerank,protein autoubiquitination (GO:0051865),-0.3838251409212394,-1.5027363072358522,0.0,0.4562465032429185,1.0,19/61,15.26%,RNF220;CNOT4;PRKN;SH3RF1;SH3RF3;RNF146;RNF213;RNF8;UHRF2;DDB2;RNF41;SH3RF2;NFX1;ITCH;RNF115;ERCC8;WWP2;RNF185;MDM2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6895347207134108,1.5025506629659522,0.03926701570680628,0.20573831770475798,1.0,5/14,13.40%,CD74;LAPTM5;SEMA7A;WNT5A;LILRB1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7282135064009585,1.5020685927297248,0.05322128851540616,0.20615794676145222,1.0,7/11,15.58%,CYBA;TREM2;TIRAP;TNFAIP3;TLR6;F2RL1;TLR1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.6440970654129772,1.5011199869420444,0.03026481715006305,0.2075672212743158,1.0,7/22,10.13%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1
prerank,positive regulation of ERAD pathway (GO:1904294),0.6902838601814602,1.5006250861291273,0.04423592493297587,0.2080201287237226,1.0,8/13,21.24%,UBQLN2;RNFT1;SGTA;CAV1;HERPUD1;BCAP31;TMEM259;USP13
prerank,negative regulation of T cell activation (GO:0050868),0.584192243290226,1.5006143629488924,0.030338389731621937,0.20751404636811263,1.0,8/35,13.40%,LAPTM5;GPNMB;LGALS3;DUSP3;CEBPB;FGL1;SDC4;LILRB1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.6254036576962323,1.5002771339895997,0.027848101265822784,0.20773995137382925,1.0,10/23,25.30%,LAPTM5;PRNP;VSIR;HMGB1;LILRB1;GAS6;INHBA;DDIT3;C1QBP;INHA
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.45748961546583916,-1.4985603806748722,0.033707865168539325,0.4606649795892995,1.0,10/27,15.34%,PID1;TNS2;IRS1;GRB10;ENPP1;KANK1;NCK1;PTPN2;PIP4K2C;PRKCB
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6560515775309008,1.4982058851236921,0.03800786369593709,0.2114901567100879,1.0,1/17,0.01%,TMSB4X
prerank,negative regulation of inclusion body assembly (GO:0090084),0.7427101654744731,1.4981419556057085,0.04583333333333333,0.21107103196202404,1.0,8/10,20.70%,SORL1;HSPA1B;DNAJB2;HSPA1A;SACS;DNAJB1;DNAJA4;HSPA2
prerank,synaptic vesicle cycle (GO:0099504),0.6070342680797759,1.497822643803098,0.020023557126030624,0.21124647370173613,1.0,17/30,28.12%,SLC17A8;NLGN1;SNAP25;DNAJC5;RIMS1;VAMP2;SLC17A7;SLC17A6;SYNDIG1;SYT10;CDK5;SNCA;SLC32A1;WNT7A;PIP5K1C;CPLX1;PCLO
prerank,histone modification (GO:0016570),-0.33990299751528735,-1.4974861392794998,0.0,0.45801717021247745,1.0,32/109,14.95%,EYA2;NSD1;EYA1;PRDM5;KAT6B;CREBBP;USP3;MIDEAS;BAZ2A;HDAC4;MTA3;EHMT1;TBL1X;HUWE1;RCOR1;UFL1;EYA4;BAZ1B;USP16;NSD3;MIER1;USP36;TBL1XR1;EYA3;RCOR3;BRD8;PHF20L1;KAT6A;SIRT1;EHMT2;CARM1;EZH2
prerank,hemidesmosome assembly (GO:0031581),0.7277745118244427,1.4969793024994302,0.037552155771905425,0.21241990102161246,1.0,4/11,9.48%,CD151;LAMC1;PLEC;LAMC2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5940778297753121,1.4965077800128828,0.03002309468822171,0.21283518207382235,1.0,9/29,15.66%,RPS27A;UBC;UBB;UBA52;TICAM2;TLR6;IRF7;TRAF3;CD300LF
prerank,negative regulation of bone remodeling (GO:0046851),0.7236486579989999,1.4958812155114551,0.03536067892503536,0.21361489335642406,1.0,6/11,20.17%,TNFAIP3;P2RX7;GPR137B;TMEM119;IL6;SFRP1
prerank,protein O-linked glycosylation (GO:0006493),-0.3432404039484056,-1.4958799088014871,0.025,0.4567973925247862,1.0,18/96,7.40%,TMTC1;GXYLT2;LARGE1;ST3GAL4;TMTC4;PLOD2;TRAK1;TET2;OGA;OGT;ST3GAL3;GALNT11;TET3;B3GNT2;PGM3;ST6GAL1;GALNT12;CRPPA
prerank,acylglycerol metabolic process (GO:0006639),0.5827051109321331,1.4953201000005945,0.03665521191294387,0.21416983006031856,1.0,8/37,9.18%,APOE;PNPLA2;APOC1;LYPLA2;PLAAT3;DGKH;LPL;DGKI
prerank,water transport (GO:0006833),0.7105668147991182,1.4950949902143713,0.04155495978552279,0.21409294825227246,1.0,2/12,8.41%,AQP4;AQP1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6685021564800625,1.4949827803228755,0.03830911492734478,0.2137747531828016,1.0,4/16,9.25%,TUBB;TUBB4B;CORO1A;VAMP2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.655589277650732,1.4949607279321118,0.03501945525291829,0.2132706356459423,1.0,9/18,11.36%,SLC17A8;GRIA2;SLC1A4;GRID2;GRIK5;GRIK2;GRID1;SLC17A7;SLC17A6
prerank,response to hydrogen peroxide (GO:0042542),0.5703369769771244,1.494811295549774,0.029966703662597113,0.2130459678470098,1.0,14/45,15.71%,RPS3;GPX1;HMOX1;PARK7;SOD1;RHOB;SIRPA;TNFAIP3;AQP1;NET1;TRPM2;CAT;HP;GLRX2
prerank,regulation of mRNA stability (GO:0043488),0.5158805960915455,1.492611603620189,0.0010152284263959391,0.21698780720047767,1.0,55/145,20.34%,RPS27A;HSPA8;UBC;VIM;UBB;PSMB4;HSPB1;PSME1;AKT1;PSMB6;PSME2;PSMB8;PSMD2;NPM1;YWHAB;PSMD1;ZFP36L1;MEX3D;PSMC3;ZFP36L2;PSMD6;PCBP4;UBA52;PSMA7;PSMD5;YBX1;XPO1;SET;ZFP36;PSMB9;EXOSC2;PSMD13;APEX1;PSMB3;PABPC1;PSMB11;SLC11A1;HSPA1A;PSMB10;YWHAZ;HNRNPU;PDE12;CIRBP;YTHDF1;PSMB1;PSMB5;PCID2;EIF4ENIF1;TBRG4;ANP32A;EXOSC9;PSMA6;CARHSP1;SERBP1;PSMA4
prerank,negative regulation of binding (GO:0051100),0.5310940673683012,1.4924824013534363,0.006309148264984227,0.21670666810668177,1.0,21/81,12.09%,ACTB;RACK1;CTSZ;PPP1CA;PARK7;AKT1;TMBIM6;NES;PDGFB;PIN1;SORL1;TLE5;LRPAP1;PLN;IFIT1;JUN;CAMK1;SUMO3;BAX;DNAJB2;DDX11
prerank,cellular response to purine-containing compound (GO:0071415),0.746132346020895,1.4924730881610648,0.03687943262411347,0.21618099003729696,1.0,6/10,15.89%,P2RY6;P2RY1;GSTM2;TRPM2;SLC8A1;RYR2
prerank,cell junction maintenance (GO:0034331),0.6828924491649228,1.4922367405677959,0.054570259208731244,0.2161461601006093,1.0,6/14,14.62%,CHCHD10;MYADM;CSF1R;DCTN1;CBLN2;F2RL1
prerank,regulation of translation (GO:0006417),0.5109020467724585,1.4921063446725005,0.0,0.2158355926788538,1.0,24/173,4.47%,RPL26;MRPL13;RPS3;RPS4X;RPL5;EEF2;VIM;RACK1;GAPDH;RPL13A;HSPB1;CALR;EIF1;RPL10;EIF4G2;EIF3D;GRM5;SHFL;NPM1;RPS27L;EIF1B;METAP1;IGFBP5;NCL
prerank,regulation of dendritic spine development (GO:0060998),0.6490230517831669,1.4916434853537466,0.036036036036036036,0.21622779307709158,1.0,6/19,9.69%,APOE;NLGN1;GRIN3A;PPFIA2;ARF6;CAMK1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5900320055735321,1.4912754086525775,0.025551684088269456,0.216501082465468,1.0,9/30,15.66%,RPS27A;UBC;UBB;UBA52;TICAM2;TLR6;IRF7;TRAF3;CD300LF
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.7192972828611518,1.4911685151996315,0.049315068493150684,0.21620859972141557,1.0,6/11,14.41%,CXCL12;CCL19;HCLS1;LILRB1;GAS6;IRF7
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6222497557821668,1.4897616818673542,0.04697156983930779,0.21860689476862552,1.0,11/24,19.10%,CALM1;AKAP6;CALM3;FKBP1A;GSTO1;GSTM2;JPH4;SRI;FKBP1B;SELENON;CALM2
prerank,respiratory electron transport chain (GO:0022904),0.6867776938112646,1.4894532844056805,0.04588394062078273,0.21868752536258126,1.0,11/14,27.43%,ETFB;SLC25A13;NDUFA5;SDHB;SLC25A22;UQCRFS1;PPARGC1A;SLC25A18;SDHA;GPD2;SLC25A12
prerank,regulation of T cell migration (GO:2000404),0.6505045416486723,1.4884930547843356,0.03316326530612245,0.2201177148872567,1.0,9/18,24.37%,APOD;CXCL12;CXCL10;AIF1;RHOA;DOCK8;TMEM102;PYCARD;APP
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.508672671483689,-1.4881994017168096,0.052132701421800945,0.4710909782231768,1.0,9/18,21.30%,BIRC2;BIRC3;SEC14L1;ANKRD17;DDX60;NPLOC4;PUM2;DHX58;GPATCH3
prerank,regulation of microtubule-based movement (GO:0060632),0.720273235880474,1.4875324119815947,0.04809052333804809,0.22172963771111737,1.0,4/11,11.11%,LAMP1;NEFH;MAP2;HAP1
prerank,regulation of receptor binding (GO:1900120),0.738274161296804,1.4872752763009285,0.04878048780487805,0.22174800849153908,1.0,2/10,3.42%,B2M;ADAM15
prerank,negative regulation of immune system process (GO:0002683),0.6677168252812002,1.4871407252979143,0.048812664907651716,0.22146586734234072,1.0,4/16,13.00%,HMOX1;GPER1;COL3A1;SOX9
prerank,regulation of supramolecular fiber organization (GO:1902903),0.6189709490077251,1.4870960924920194,0.03225806451612903,0.22104226047587552,1.0,8/22,10.83%,APOE;HSPA8;GPX1;PARK7;MAP1A;MAPT;MAP2;AEBP1
prerank,receptor-mediated endocytosis (GO:0006898),0.513378520435562,1.4869297453348742,0.003051881993896236,0.22088463243777803,1.0,45/132,20.31%,APOE;SPARC;CTSL;CD81;RAMP2;HSP90AA1;CALR;MRC1;ITGB2;LRP1B;CANX;HSP90B1;FCER1G;SORL1;CAV2;DNM3;SNAP91;AP2M1;TFRC;CD163;CXCL16;CLTC;AP2S1;FCGR1A;STAB1;LRP3;FNBP1L;FCHO1;RAMP3;MSR1;LILRB1;CLTA;M6PR;HPR;HP;ARRB2;DLL1;CAV1;TMEM108;SYK;SNCA;GRK2;RAB31;HSPG2;CTTN
prerank,hexose metabolic process (GO:0019318),0.5726305803273202,1.4861641106697956,0.029646522234891677,0.22191847769477568,1.0,11/39,10.95%,ALDOA;APOD;ALDOC;OMA1;GALT;PMM1;FUOM;CHST1;GAA;DCXR;FUCA1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6158399971020245,1.4860105114793323,0.032648125755743655,0.22170371733458055,1.0,10/27,15.48%,CD74;S100A6;AGT;PDGFB;MIF;FN1;AQP1;WNT5A;GAS6;PDGFA
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6862548539203236,1.48564347592659,0.044755244755244755,0.22194219649791747,1.0,4/13,3.73%,TYROBP;HSP90AB1;TNF;MAP1A
prerank,regulation of transport (GO:0051049),0.5806009773207561,1.4850824351768572,0.01866977829638273,0.22254276374366838,1.0,15/36,20.21%,ACTB;ACTG1;PINK1;REEP5;REEP6;VAMP2;DNAJA1;RSC1A1;CDK5;EPB41;ICA1;TMEM102;ICA1L;SNCA;TRAT1
prerank,positive regulation of cellular respiration (GO:1901857),0.7158234959628123,1.4830734056548682,0.04843304843304843,0.22627940067312638,1.0,7/11,20.09%,PARK7;PINK1;VCP;NUPR1;ISCU;PRELID1;IL10RB
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.6393588612847019,1.481550893308523,0.032133676092544985,0.22906579075051844,1.0,5/21,5.60%,RPS3;CD81;NFAM1;PTPRC;SLC39A10
prerank,regulation of microglial cell activation (GO:1903978),0.6634168833403062,1.4810769923236502,0.03810775295663601,0.22952121359354694,1.0,5/15,8.58%,GRN;TREM2;PTPRC;NR1D1;SYT11
prerank,regulation of steroid metabolic process (GO:0019218),0.6171457996749822,1.4806530673964877,0.040690505548705305,0.22981636084581705,1.0,3/23,5.55%,APOE;ACADVL;ABCG1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6369117278781786,1.4802185993853687,0.03631647211413749,0.2302564429313727,1.0,3/21,2.84%,APOE;PLTP;TREM2
prerank,protein localization to cell-cell junction (GO:0150105),0.6687626566403814,1.4799427339404703,0.05426356589147287,0.23028617031235582,1.0,2/15,0.25%,ACTB;ACTG1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6111425767199689,1.4798212930285206,0.04294478527607362,0.2300040012457415,1.0,5/24,7.08%,MT3;HSPA5;ATF4;KLF2;CEBPB
prerank,response to axon injury (GO:0048678),0.6558843758005996,1.4790596359940715,0.04330708661417323,0.2311488886041165,1.0,4/18,2.84%,APOD;TYROBP;SOD1;TREM2
prerank,muscle organ development (GO:0007517),-0.37541871108658603,-1.4787726980734437,0.0,0.4904085248347458,1.0,11/54,8.33%,LAMA2;LARGE1;TCF12;VAMP5;MRAS;ITGA11;CHD2;FHL1;UTRN;IGF1;MEF2A
prerank,apoptotic cell clearance (GO:0043277),0.58984381400636,1.4784848671213482,0.03076923076923077,0.23188074007456033,1.0,12/30,20.23%,TYROBP;TREM2;TGM2;RAC1;RHOG;XKR4;HMGB1;ADGRB1;GAS6;TYRO3;RAC2;XKR6
prerank,regulation of activated T cell proliferation (GO:0046006),0.5895652573148232,1.4774869145893235,0.03664302600472813,0.23353341461404525,1.0,9/30,15.42%,RPS3;PRNP;IL2;PRKAR1A;CD24;ICOSLG;HMGB1;IGFBP2;IGF2
prerank,cellular response to chemical stress (GO:0062197),0.5240916358278809,1.4770140949323949,0.008429926238145416,0.23404216180212653,1.0,35/96,21.52%,PPIA;GPX1;MT3;CHCHD2;PARK7;SOD1;ATF4;CYBA;PRDX5;PRDX6;PINK1;PRDX2;HSPA1B;PARP1;PRR5L;PYCR2;CYBB;ATP13A2;GPX3;PRDX1;GPX7;ERMP1;AIF1;HSPA1A;CAT;NCF1;ERO1A;CAV1;PPARGC1A;STX4;SNCA;SOD3;SIRT2;SELENOS;CYCS
prerank,gas transport (GO:0015669),0.722984417128433,1.476912944972265,0.03687943262411347,0.23372757301119795,1.0,6/10,22.17%,CA2;IPCEF1;CYGB;AQP1;MYC;MB
prerank,regulation of tissue remodeling (GO:0034103),0.6445877909391626,1.4768162474607551,0.04659949622166247,0.23339648474625205,1.0,3/18,1.42%,CST3;MDK;GPNMB
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5952276453189114,1.476530838258867,0.029940119760479042,0.2334945515302779,1.0,11/29,13.55%,CALR;CXCL12;LGMN;TNF;LGALS3;CXCL10;CREB3;HMGB1;PLA2G7;AIF1;GAS6
prerank,positive regulation of leukocyte activation (GO:0002696),0.6410047580705007,1.4757753938859224,0.0620253164556962,0.23463756240985975,1.0,10/18,25.77%,SPACA3;HSPD1;CEBPA;KARS1;WNT5A;CLEC4D;TLR6;CRLF2;LBP;IL33
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6774788719911078,1.4757133663818325,0.04227212681638045,0.23425094947673303,1.0,4/15,5.38%,CLU;GPX1;AKT1;GHITM
prerank,cellular protein-containing complex assembly (GO:0034622),0.5035551357172069,1.4756273824336807,0.002028397565922921,0.23389056473441727,1.0,46/159,15.73%,RPL38;CLU;GPX4;HSP90AA1;HSP90AB1;FMOD;NSG1;CYBA;NRG1;HIGD2A;COX7A2L;CSNK2B;PFDN6;CCT2;MID1IP1;FKBP1A;RTN4;COX7A2;POMP;AP2M1;EID2;OMA1;DNAAF3;HSPD1;CLTC;MAPT;VAMP3;VAMP2;AP2S1;HIGD1B;PSMG3;PSMD13;FCHO1;VAMP8;ANLN;HSPA1A;NSG2;VBP1;OTUD6B;TIAM1;ARL2;PTGES3;CLTA;PDE4DIP;MAPK8IP2;TBCA
prerank,lipid droplet organization (GO:0034389),0.6292764402914086,1.4754830524845708,0.04234122042341221,0.23364940345013208,1.0,6/22,7.35%,PPIA;CDS1;AUP1;BSCL2;TSPO2;HSD17B13
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.5843560325288044,1.475282145071041,0.031710079275198186,0.23358862599753527,1.0,8/35,4.63%,CALM1;HSP90AB1;CALM3;CSNK2B;PPP1R15B;HSP90B1;FKBP1A;PPP1R1B
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6029054698617314,1.4749938220980567,0.037897310513447434,0.23362970966183735,1.0,9/26,14.57%,RPS3;RAC1;NAV3;PAK1;CLASP1;MAPT;CDK5R1;DCTN1;ARL2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.6191596414666577,1.4740089772361484,0.03869407496977025,0.23522838167425364,1.0,19/25,32.41%,TMEM50A;CHMP2B;VCP;LEPROT;CHMP5;CHMP6;SORT1;UBXN6;CHMP1B;CHMP7;LYST;CHMP1A;LAPTM4B;CHMP4C;LEPROTL1;MVB12A;TMEM50B;CHMP4A;CHMP4B
prerank,regulation of macrophage chemotaxis (GO:0010758),0.6242942051216784,1.474004062004987,0.04477611940298507,0.23470938100841487,1.0,6/21,10.71%,MDK;MAPK3;MIF;DDT;RARRES2;CSF1R
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.6146687594826402,1.4736422220644005,0.03827160493827161,0.23507228141284445,1.0,13/24,16.60%,TYROBP;GRN;ATF4;PRNP;TNF;CTNNB1;NUPR1;CDK5R1;BAX;FBXW7;CDK5;CCL3;BACE1
prerank,protein-DNA complex assembly (GO:0065004),0.5143622202436454,1.4732796959022036,0.0030737704918032786,0.23534600828131533,1.0,34/116,16.76%,RPS27A;UBC;UBB;PSMB4;H3-3A;PSME1;PSMB6;PSME2;PSMB8;PSMD2;NPM1;PSMD1;PSMC3;MCM5;PARP1;PSMD6;RPA2;UBA52;BRD2;PSMA7;GMNN;PSMD5;RBX1;DDB1;PSMB9;PSMD13;PSMB3;PSMB11;SOX9;PSMB10;PSMB1;PSMB5;NAP1L2;CETN2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.45225948481100997,-1.473222169597035,0.03867403314917127,0.4995327905919408,1.0,12/25,16.73%,SULF1;ZNF423;BMPR1A;FOXD1;SMAD4;RBPJ;NUMA1;BMP4;SMAD2;ACVR2A;BMPR2;ACVR2B
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.5977542921253822,1.4731206384285884,0.04408352668213457,0.23515559161210497,1.0,13/30,19.19%,RPL11;HSP90AB1;PARK7;UBXN1;MAP1A;BAG5;TAF9;SVIP;SDCBP;SGTA;NOP53;CCAR2;DDRGK1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5886881229467766,1.472667400833202,0.04411764705882353,0.23563269801327166,1.0,11/27,19.31%,RPS27A;UBC;UBB;TIRAP;UBA52;HSPD1;TLR6;TLR5;TLR1;TAB1;CD14
prerank,cellular copper ion homeostasis (GO:0006878),0.6809857031635275,1.4722282593894602,0.043941411451398134,0.23605115133892543,1.0,6/14,15.43%,ATOX1;MT2A;PRNP;ABCB6;ARF1;SLC31A1
prerank,macrophage activation involved in immune response (GO:0002281),0.686070621923651,1.4720267243439027,0.05320600272851296,0.23592333480942201,1.0,3/13,2.84%,TYROBP;GRN;TREM2
prerank,response to nitric oxide (GO:0071731),0.6922060146768826,1.4698827493622328,0.057640750670241284,0.24003772505440327,1.0,5/13,11.31%,MT3;CCL19;TXN;AQP1;MMP3
prerank,copper ion homeostasis (GO:0055070),0.6557694874255237,1.4694196916789704,0.04302477183833116,0.24050190061597432,1.0,6/17,15.43%,ATOX1;MT2A;PRNP;ABCB6;ARF1;SLC31A1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.6683107779495558,1.4683586359067753,0.04666666666666667,0.24220501195744598,1.0,10/15,27.17%,CCT2;NOP10;CCT7;NHP2;CCT8;DKC1;CCT4;NAF1;CCT3;RUVBL2
prerank,fatty acid transport (GO:0015908),0.6474201247538778,1.468091877649429,0.045743329097839895,0.2422452897392896,1.0,3/17,8.69%,APOE;FABP5;MFSD2A
prerank,regulation of interleukin-6 production (GO:0032675),0.5151004075676994,1.4679089202033533,0.0051387461459403904,0.24211164536858068,1.0,38/96,26.21%,CD74;MBP;TYROBP;CYBA;TREM2;TNF;TIRAP;SIRPA;HYAL2;TNFAIP3;HSPD1;SYT11;LPL;LILRA5;HMGB1;WNT5A;C1QTNF4;AIF1;GAS6;TLR6;F2RL1;TLR1;TWIST1;NOS2;SYK;IL6;SPHK2;TMEM106A;PTPN6;PYCARD;SELENOS;APP;AGER;LBP;IL33;TLR7;POU2F2;CX3CL1
prerank,heart process (GO:0003015),0.6837784498028979,1.467760280989388,0.04613297150610583,0.24183947238302944,1.0,6/14,20.40%,GPX1;SOD1;SGCZ;RAMP3;SGCG;PPCS
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5386374636951627,1.46753666922929,0.028077753779697623,0.24175001862919115,1.0,20/51,21.28%,TYROBP;HSPB1;CCL19;S100A13;TNF;P2RX7;LPL;EGR1;LILRA5;HMGB1;WNT5A;RIPK2;TLR6;F2RL1;CCL3;NLRP3;IL6;TMEM106A;PYCARD;TMED10
prerank,acylglycerol catabolic process (GO:0046464),0.601691814597438,1.467229951254216,0.039473684210526314,0.241850605526409,1.0,12/30,25.29%,PNPLA2;LYPLA2;FABP5;LIPG;LIPE;LPL;FAAH;FABP7;FABP4;FABP3;ABHD16A;ABHD12
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.5274144837268318,1.4669620724810257,0.017297297297297298,0.24192736382994512,1.0,19/72,13.25%,RPS27A;UBC;UBB;POLR2E;COPS7A;POLR2D;COPS6;POLR2F;RPA2;HMGN1;UBA52;XAB2;PRPF19;RBX1;DDB1;POLR2G;PCNA;POLR2K;RFC2
prerank,energy reserve metabolic process (GO:0006112),-0.4997718892376293,-1.4668202457366657,0.07172995780590717,0.5116752532483397,1.0,5/19,4.38%,PRKAG2;PID1;PHKB;PHKA1;LEPR
prerank,protein kinase B signaling (GO:0043491),0.6173665983567814,1.466057632979336,0.0480295566502463,0.24346979508670633,1.0,12/23,21.36%,MT3;AKT1;TNF;ZFP36L1;KDR;GAS6;CCL2;TYRO3;CCL3;TGFB1;THEM4;SIRT2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.5834524216807436,-1.4657310239872663,0.07936507936507936,0.5085458420834135,1.0,5/10,15.34%,PID1;APPL2;GRB10;ENPP1;PRKCB
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3681991641592496,-1.4655978255958702,0.0,0.5031775749789488,1.0,16/63,9.64%,AUTS2;MCU;SIPA1L1;PHACTR1;FER;PARVA;GAB1;NRP1;PTK7;RICTOR;MYH9;MKLN1;CDC42BPB;PDLIM4;NRK;PIP5K1A
prerank,triglyceride homeostasis (GO:0070328),0.5988138692574041,1.4653400723780274,0.03766707168894289,0.24456306242329778,1.0,4/26,9.13%,APOE;MTLN;LPL;MLXIPL
prerank,positive regulation of interleukin-12 production (GO:0032735),0.5825136364314285,1.464862128838995,0.038929440389294405,0.245036882428826,1.0,9/31,17.99%,MDK;LAPTM5;CCL19;TIRAP;HSPD1;HMGB1;RIPK2;MAPK11;SYK
prerank,glutathione derivative biosynthetic process (GO:1901687),0.6315462212467116,1.4645462519828076,0.058823529411764705,0.24467438113692994,1.0,9/20,20.12%,GSTM1;MGST1;GSTO1;GSTM5;MGST3;GSTM2;HPGDS;AKR1A1;ESD
prerank,glutathione derivative metabolic process (GO:1901685),0.6315462212467116,1.4645462519828076,0.058823529411764705,0.24467438113692994,1.0,9/20,20.12%,GSTM1;MGST1;GSTO1;GSTM5;MGST3;GSTM2;HPGDS;AKR1A1;ESD
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6818744401019117,1.4643986120912855,0.06722689075630252,0.2444649236113554,1.0,2/13,1.79%,APOE;SOD1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.558921765824798,-1.464382871530434,0.0695970695970696,0.4896421984944333,1.0,4/12,14.03%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.558921765824798,-1.464382871530434,0.0695970695970696,0.4896421984944333,1.0,4/12,14.03%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.558921765824798,-1.464382871530434,0.0695970695970696,0.4896421984944333,1.0,4/12,14.03%,NSMCE2;ANAPC5;ANAPC7;CDC27
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5242462520385481,1.4640788314196602,0.010582010582010581,0.24460609039673117,1.0,22/84,11.65%,TMSB4X;SPARC;ATP5F1B;HSPB1;GRN;CALR;RHOB;LGMN;AKT1;ATP5F1A;AGT;PDGFB;RAC1;EMC10;PROX1;KDR;GATA2;HMGB1;PDCD6;WNT5A;AAMP;FLT4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6774215320841713,1.4637606084610766,0.06102635228848821,0.24483441476929815,1.0,4/13,6.98%,CD81;TMEM30A;SORL1;SAR1A
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.5224799492130289,1.463045171422794,0.012738853503184714,0.2457707111785345,1.0,22/80,16.13%,RPL26;RPS4X;RPL5;CLU;EEF2;VIM;RACK1;EIF3D;NPM1;RPS27L;TNF;ABCG1;EIF3C;GSAP;PCIF1;ZCCHC4;TNFRSF1A;IFNGR1;CIRBP;YTHDF1;ABCA2;EIF4A3
prerank,regulation of protein metabolic process (GO:0051246),0.5539410998781755,1.462975793485114,0.0407040704070407,0.2454108905942414,1.0,12/44,12.78%,APOE;HSP90AB1;KLF2;LTBP4;FKBP1A;CHEK2;GSAP;NEDD8;CHMP6;WFS1;ODC1;KLF4
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6741714677762715,1.4627487310463378,0.04862023653088042,0.24535366278636297,1.0,9/15,18.67%,TYROBP;TREM2;FLOT1;CD53;CAMK1;ADGRB1;EHD1;EHD2;SCGB3A1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.7255869339306575,1.4624322693696736,0.06149341142020498,0.24498357928648093,1.0,3/10,12.78%,MBP;MYADM;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.7255869339306575,1.4624322693696736,0.06149341142020498,0.24498357928648093,1.0,3/10,12.78%,MBP;MYADM;KLF4
prerank,positive regulation of cholesterol transport (GO:0032376),0.5984317155386664,1.4621455628782059,0.05115712545676005,0.24514836609903973,1.0,5/27,6.66%,APOE;PLTP;TREM2;SCP2;LIPG
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.3941307993125563,-1.4619317172332926,0.041237113402061855,0.4906172040898881,1.0,22/43,27.58%,BABAM2;FOXN3;RINT1;UIMC1;TAOK3;MRNIP;PABIR1;ATM;RAD17;ORC1;NAE1;TAOK1;CHFR;CLSPN;INTS3;CDC14B;ABRAXAS1;HUS1B;PLK1;CDK1;BRCC3;TICRR
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.6171010512144537,1.4616512058390942,0.04292929292929293,0.24567477647656658,1.0,13/21,31.54%,MDK;NES;FZD9;CTNNB1;PROX1;CX3CR1;TOX;NAP1L1;CX3CL1;FZD3;DLL4;DRD2;DISP3
prerank,negative regulation of MAPK cascade (GO:0043409),0.5159863434788755,1.461450293878093,0.009564293304994687,0.24556623835670943,1.0,21/87,13.40%,APOE;PPIA;AGT;PEBP1;GPER1;PTPRC;PIN1;SORL1;UCHL1;DUSP3;SIRPA;RGS2;HYAL2;DUSP26;P2RX7;SMPD1;CAMK2N1;PTPRR;TIMP3;CNKSR3;SPRY1
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.4111911179582661,-1.4611338743399445,0.02631578947368421,0.4873453879124892,1.0,10/36,14.95%,MGA;YAF2;EHMT1;EPC1;PHC3;APAF1;RBBP8;TFDP1;EHMT2;EZH2
prerank,regulation of autophagosome maturation (GO:1901096),-0.5346376184631507,-1.4610790972705425,0.060836501901140684,0.4823290595558628,1.0,7/13,22.91%,CLEC16A;UVRAG;CLN3;TMEM39A;RUBCN;ADRB2;PHF23
prerank,steroid catabolic process (GO:0006706),0.7191948300991942,1.4604846148074597,0.04854368932038835,0.24702022802731075,1.0,3/10,6.58%,SPP1;YWHAH;HSD17B6
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.4945051893136563,-1.460406860756876,0.06382978723404255,0.4791895921240761,1.0,8/17,14.92%,NOTCH2;ACVR1;BMPR1A;GALNT11;RBPJ;JAG1;BMP4;HEY2
prerank,regulation of proteolysis (GO:0030162),0.5492310253110886,1.460171886323887,0.026875699888017916,0.24718138512458082,1.0,21/48,21.57%,CST3;AURKAIP1;AKT1;SERPINE2;LTBP4;PRSS37;CSTB;GSAP;NEDD8;PLAT;CAMK2N1;CLN6;TRAF3;BAD;CDK5;CAV1;TRIM32;CLN8;CAPN3;BAK1;STUB1
prerank,myeloid cell differentiation (GO:0030099),0.5525786759598198,1.4601480703666971,0.02252252252252252,0.24671517152547864,1.0,11/47,11.15%,RPS14;RPS19;SLC25A5;HCLS1;SPI1;ATP5IF1;TIRAP;HIPK2;CEBPA;IKZF1;IL11
prerank,cellular response to ATP (GO:0071318),0.66571939878743,1.459948617117314,0.05563093622795115,0.24666851155138056,1.0,4/14,9.32%,HSP90B1;P2RX7;P2RY1;P2RY12
prerank,maintenance of protein localization in organelle (GO:0072595),0.622474776014921,1.4595870414334333,0.06274007682458387,0.24696762381340104,1.0,5/19,4.30%,CHCHD10;HSPA5;AKT1;PINK1;ARL2BP
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.6291275423551056,1.458858009338137,0.045103092783505154,0.24809314049478615,1.0,11/19,21.42%,PRNP;GRM5;PTPRC;KDR;TRPM2;RYR2;DMTN;VCAM1;BCAP31;FKBP1B;FIS1
prerank,positive regulation of cellular senescence (GO:2000774),0.7101878636738599,1.4587393958521417,0.059084194977843424,0.24783539477980088,1.0,2/10,2.35%,B2M;YPEL3
prerank,regulation of establishment of planar polarity (GO:0090175),0.5157946610728547,1.45807521824783,0.005154639175257732,0.24872413294886553,1.0,43/88,26.31%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;RAC1;PSMD1;PSMC3;PSMD6;AP2M1;PFN1;PSMA7;CLTC;PSMD5;AP2S1;PSMB9;PSMD13;WNT5A;PSMB3;PSMB11;RHOA;PSMB10;TIAM1;PSMB1;ARRB2;PSMB5;PRICKLE2;ARHGEF19;PSMA6;PSMA4;FZD2;FZD1;AP2A1;PSMC1;PARD6A;WNT7A;PSMD9;CELSR3;PSMB2;PSMD4;PSMD10;FZD3
prerank,carbohydrate derivative transport (GO:1901264),0.6370515883670136,1.4577397756505297,0.06641123882503193,0.2489600519642982,1.0,9/18,15.78%,PLTP;NPC2;ABCG1;MFSD2A;SLC15A4;SLC29A1;SLC29A2;SLC15A2;SLC25A19
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4563362838021148,-1.4575939956984392,0.023952095808383235,0.48130335792287454,1.0,7/26,5.49%,FOXP1;STRN3;DAB2;KANK2;PIAS2;CNOT1;NCOR1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5778357338491453,1.457586052147405,0.028968713789107765,0.24875844165321606,1.0,13/35,17.61%,NLGN1;PCDHGB4;CDH20;SELL;CDH18;CDH12;CDH19;DCHS1;CDH7;CDH24;CDH10;CDH5;PCDHB14
prerank,cellular response to unfolded protein (GO:0034620),0.5982771748876509,1.4571719823580447,0.052503052503052504,0.24913384732007282,1.0,16/26,26.57%,HSPA8;HSPA5;TMBIM6;HSPA1B;HSPD1;HSPB8;BAX;HSPA1A;ABCB10;DAB2IP;HSPA2;HSPA9;BAK1;PTPN1;HSPA14;TM7SF3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5755839762908059,1.456736324491582,0.04540162980209546,0.24962791290940695,1.0,9/36,10.15%,RPL11;HSP90AB1;PARK7;UBXN1;MAP1A;GABARAPL2;BAG5;ALAD;TAF9
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5340076671617382,1.4546820934643758,0.033296337402885685,0.25349483813503626,1.0,16/57,18.03%,PSAP;MTNR1A;GNAI2;NPY1R;GPR37L1;FLNA;GRM8;GRM7;P2RY12;GNAI1;CHRM3;CHRM2;ADCY4;ADCY8;CHRM5;GRM4
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6292884505279476,1.454221038740905,0.057441253263707574,0.2539938818102795,1.0,4/19,15.63%,APOE;RAPSN;CHRNA4;ACHE
prerank,fatty acid biosynthetic process (GO:0006633),0.5292984462789747,1.4538873117747708,0.016411378555798686,0.25420813691614313,1.0,25/63,28.15%,GPX4;SCD5;FADS1;LIPG;ELOVL1;ELOVL2;TECRL;LPL;OXSM;ELOVL7;SCD;ACOT7;FADS3;DEGS1;LTC4S;ASAH2;ACSM5;NDUFAB1;CYP2E1;ELOVL6;ACLY;HACD4;XBP1;GSTM4;HSD17B8
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6451445685881307,1.4538118152061519,0.06182795698924731,0.253847250129635,1.0,9/15,22.11%,GPER1;ZFP36L1;ZFP36L2;FAM107A;SSTR4;ZFP36;HNRNPU;SSTR2;REST
prerank,release of cytochrome c from mitochondria (GO:0001836),0.6421593031067981,1.4535649761470557,0.06728232189973615,0.2537932218795081,1.0,10/17,21.42%,CLU;FZD9;BAX;TIMM50;BBC3;BAD;MFF;DNM1L;BAK1;FIS1
prerank,cellular response to oxidative stress (GO:0034599),0.5037034522343581,1.4529785717436654,0.010309278350515464,0.2546259986132034,1.0,32/118,13.89%,RPS3;PPIA;GPX1;MT3;CHCHD2;HMOX1;PARK7;SOD1;MAPK3;ATF4;AKT1;CYBA;PRDX5;PRDX6;PINK1;PRDX2;ROMO1;HSPA1B;PARP1;PRR5L;PYCR2;CYBB;MAPT;JUN;ATP13A2;GPX3;PRDX1;GPX7;ERMP1;AIF1;HSPA1A;CAT
prerank,activation of protein kinase B activity (GO:0032148),0.5849749471071666,1.4529675846528032,0.056778679026651215,0.2541242657904761,1.0,9/29,4.35%,PPIA;MT3;PARK7;AKT1;TXN;NRG1;PINK1;PDGFB;ANG
prerank,regulation of immunoglobulin production (GO:0002637),0.5984508998584036,1.4529217437281723,0.05025125628140704,0.25368566802604897,1.0,9/23,19.67%,RBP4;PTPRC;IL2;CD22;VAMP3;DNAJB9;STX4;CD86;IL6
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5604144723779705,-1.451614250285809,0.08727272727272728,0.4920588499810836,1.0,5/12,10.73%,NFIB;PAFAH1B1;GLI2;EPHA4;EPHB2
prerank,antibacterial humoral response (GO:0019731),0.6534903394957391,1.4504354247787519,0.07253886010362694,0.2586225972108936,1.0,2/16,4.35%,RPL39;ANG
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.5489235888822818,1.450317170355703,0.034482758620689655,0.25835727931953545,1.0,22/50,27.26%,ACTB;HSP90AB1;CCNI;CCND2;SERTAD1;CDKN1C;CCND1;CDK5R1;CDC37;CAMK2N1;CCNG1;CDK5R2;CCNJL;CDC25A;GADD45A;BLM;CCNA2;CDKN2B;CCNG2;CCNH;CDKN1A;CNPPD1
prerank,positive regulation of protein binding (GO:0032092),0.5284020734055673,1.450089919182858,0.03162486368593239,0.25839276357295066,1.0,11/56,6.46%,APOE;RPL11;CLDN5;B2M;VTN;RAN;FKBP1A;PIN1;FLOT1;ADD2;HIPK2
prerank,central nervous system myelination (GO:0022010),0.7061762525171862,1.449435005194199,0.05726872246696035,0.2593665496802393,1.0,6/11,16.01%,CLU;PLP1;B4GALT6;MYRF;TENM4;ABCA2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4889387153757963,-1.449367762063632,0.059907834101382486,0.48826680363802977,1.0,6/17,16.38%,BRWD1;STAT5B;IRS1;STAT3;STAT5A;JAK1
prerank,cellular response to interleukin-7 (GO:0098761),-0.4889387153757963,-1.449367762063632,0.059907834101382486,0.48826680363802977,1.0,6/17,16.38%,BRWD1;STAT5B;IRS1;STAT3;STAT5A;JAK1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5622300203658595,1.4491072072836395,0.04789719626168224,0.25955790931653616,1.0,16/40,20.93%,CLU;GPX1;AKT1;PINK1;GPER1;GHITM;BAX;PMAIP1;BBC3;BAD;MFF;DNM1L;PDCD5;PRELID1;HGF;PYCARD
prerank,regulation of viral genome replication (GO:0045069),0.536950311779613,1.4490455466338747,0.029900332225913623,0.25915458860394835,1.0,23/56,24.07%,IFITM3;PPIA;IFITM2;IFITM1;SHFL;TNF;ISG15;PROX1;IFIT1;DDB1;BANF1;PABPC1;BST2;PDE12;OAS3;RAD23A;FAM111A;RSAD2;ISG20;TNIP1;VAPB;CD28;BTBD17
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6570446365144337,1.448535705027774,0.06405228758169934,0.25979452345161397,1.0,2/15,3.71%,APOE;TNF
prerank,macrophage chemotaxis (GO:0048246),0.7141960278293322,1.448508617447379,0.05673758865248227,0.25935742981521287,1.0,4/10,19.15%,LGALS3;CCL2;CCL3;CXCL17
prerank,phospholipid homeostasis (GO:0055091),0.7014829351706602,1.4484871134847312,0.05056179775280899,0.2588794939482073,1.0,3/11,6.66%,RCN3;ABCG1;LIPG
prerank,positive regulation of calcium ion import (GO:0090280),0.6679266184285924,1.4481837613574138,0.06915629322268327,0.2590486702127992,1.0,7/12,20.24%,CXCL12;PDGFB;LGALS3;RAMP3;CCL2;CCL3;SPHK2
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3904541503624542,-1.44816390258725,0.03389830508474576,0.48651236038873574,1.0,15/47,11.35%,GOLGA4;VAMP5;MACF1;EXOC4;SPTBN1;RABEP1;EXOC2;BLZF1;RAB10;ARL3;ARFGEF2;GGA2;OPTN;KIF13A;EXOC6B
prerank,global genome nucleotide-excision repair (GO:0070911),0.5996240576190179,1.4477243420056511,0.0583232077764277,0.2595661320922829,1.0,7/26,10.13%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1
prerank,cell junction assembly (GO:0034329),0.5128507451406452,1.4473979566315758,0.010395010395010396,0.25980062291596184,1.0,33/100,19.08%,ACTB;ACTG1;CLDN5;GJA4;NRXN1;SPOCK2;NLGN1;DSCAM;CDH20;FLNA;ADGRL3;DNM3;FN1;KIRREL3;CDH18;NRCAM;DNER;NRXN2;RHOA;CDH12;VMP1;CDH19;DCHS1;CDH7;ACHE;CDH24;CDK5;CDH10;CDH5;PCDHB14;GPM6A;CTNND2;FBLIM1
prerank,translesion synthesis (GO:0019985),0.5506982008564696,1.4473288837557248,0.034129692832764506,0.259438888121829,1.0,7/42,6.97%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15
prerank,heart contraction (GO:0060047),0.5579086629529831,1.4469317235714374,0.03518728717366629,0.25979152983015524,1.0,12/41,19.17%,GPX1;SOD1;SGCZ;SCN4B;GAA;TNNI1;KCNE5;ATP1B1;SLC8A1;RYR2;SGCG;GRK2
prerank,negative regulation of cartilage development (GO:0061037),-0.5364348931277394,-1.44623601651237,0.058823529411764705,0.48714075597451784,1.0,8/13,21.57%,ADAMTS12;TGFBR1;EFEMP1;WNT11;CHADL;WNT9A;ADAMTS7;PTPN11
prerank,positive regulation of T cell proliferation (GO:0042102),0.5298175297170609,1.4459510063801528,0.028353326063249727,0.2614300695377866,1.0,22/55,24.66%,RPS3;CCL19;PTPRC;TFRC;IL2;CD24;ICOSLG;HMGB1;PNP;AIF1;IGFBP2;IGF2;VCAM1;SYK;CCR2;CD86;IL6;PYCARD;IL12RB1;CD28;AGER;CD276
prerank,activin receptor signaling pathway (GO:0032924),-0.5096846286797754,-1.4457556397245352,0.0390625,0.4837266969200909,1.0,6/15,16.73%,SMAD3;ACVR1;TGFBR1;SMAD2;ACVR2A;ACVR2B
prerank,positive regulation of T cell migration (GO:2000406),0.6234765712335071,1.4442487411714995,0.051248357424441525,0.2647955433838162,1.0,12/20,26.19%,CXCL12;CXCL10;WNT5A;AIF1;RHOA;DOCK8;TMEM102;ADAM17;CCR2;PYCARD;APP;OXSR1
prerank,regulation of macrophage activation (GO:0043030),0.5849015837110181,1.4429651096785874,0.039663461538461536,0.2672275800116875,1.0,10/30,14.25%,CD74;LRFN5;MIF;SPACA3;HSPD1;CEBPA;GPR137B;KARS1;WNT5A;TLR6
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.5308724715143636,1.4429042782875157,0.019629225736095966,0.2668586535919828,1.0,22/61,16.42%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;NCOR2;ODC1;PSMB10;PSMB1;PSMB5;CAV1
prerank,positive regulation of synaptic transmission (GO:0050806),0.5153733726042644,1.4427770319747648,0.02006335797254488,0.26661642407452063,1.0,35/72,24.48%,LGMN;NRXN1;NLGN1;GPER1;SLC24A2;TNF;MPP2;SHISA7;GRIK2;FLOT1;SYT1;LGI1;RIMS2;RIMS1;GRIN2A;VAMP2;HAP1;CCL2;ADRA1A;ADCY8;CACNG8;CLSTN2;SQSTM1;CLSTN1;GRIN2B;CCR2;KCTD13;CACNG5;STX4;ZDHHC12;CLSTN3;STX1B;CACNG2;APP;AGER
prerank,DNA-dependent DNA replication (GO:0006261),0.5016216041597571,1.4426026050825305,0.004123711340206186,0.26652477404267183,1.0,47/128,26.18%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;MCM5;PSMD6;RPA2;CDC34;UBA52;PSMA7;GMNN;PSMD5;PSMB9;PSMD13;PSMB3;POLE4;PSMB11;RFC2;PSMB10;RECQL5;PSMB1;PSMB5;POLD4;PSMA6;RFC4;PSMA4;GINS3;POLG;BLM;CDC45;PSMC1;PSMD9;POLD1;PNKP;RPA3;RPAIN;PSMB2;PSMD4;RAD51;PSMD10
prerank,monocyte chemotaxis (GO:0002548),0.5687201294788876,1.442008447758243,0.04420549581839905,0.2673994905634342,1.0,11/32,21.08%,RPS19;CCL19;PDGFB;LGALS3;CCL2;FOLR2;FLT1;CCL3;CCL8;IL6;PTPRO
prerank,leukocyte tethering or rolling (GO:0050901),0.6309718969631936,1.4416136652969296,0.06371911573472042,0.26786515679825595,1.0,8/17,16.62%,TNF;ADD2;SELL;PODXL2;SELPLG;GCNT1;CX3CR1;VCAM1
prerank,regulation of interleukin-4 production (GO:0032673),0.6030975584238317,1.4415691535793733,0.0561941251596424,0.2674364272288566,1.0,11/21,27.85%,SLC7A5;FCER1G;CEBPB;SYK;CD86;NLRP3;DDIT3;CD28;PRKCQ;LEF1;ZFPM1
prerank,cellular response to superoxide (GO:0071451),0.7064752670018452,1.4409520902583466,0.06782106782106782,0.268381362565165,1.0,4/10,9.70%,MT3;SOD1;PRDX2;PRDX1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6707573399073623,1.4406884564024505,0.06391478029294274,0.2684109949131953,1.0,5/13,14.84%,RPS15;NPM1;RAN;XPO1;NUP88
prerank,endothelial cell differentiation (GO:0045446),0.6833331230372115,1.4405286196525915,0.07651006711409396,0.2682270801999673,1.0,7/12,13.18%,SOX18;ACVRL1;EDF1;PROX1;KDR;KDM6B;TIE1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.5891901729385671,-1.4403995893227755,0.08934707903780069,0.48787840689739814,1.0,6/10,17.91%,FTO;ASCC3;ASCC1;MGMT;ALKBH3;MPG
prerank,DNA dealkylation (GO:0035510),-0.5891901729385671,-1.4403995893227755,0.08934707903780069,0.48787840689739814,1.0,6/10,17.91%,FTO;ASCC3;ASCC1;MGMT;ALKBH3;MPG
prerank,negative regulation of protein processing (GO:0010955),0.6724493942784628,1.4399243475664978,0.05379310344827586,0.2690043423734542,1.0,5/12,10.76%,CTSZ;PRNP;SERPINE2;TMEM59;GAS1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6125819717687055,1.4391697533160723,0.08883248730964467,0.2701721423875462,1.0,4/18,9.73%,TYROBP;DOCK2;FCER1G;KARS1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5844579788279703,-1.4389357654152146,0.13127413127413126,0.4869210677702358,1.0,5/10,16.18%,CAMK2D;PRKCE;ATP1A2;HECW2;STK39
prerank,negative regulation of lymphocyte activation (GO:0051250),0.6090746384121063,1.438778046990546,0.05816831683168317,0.27049967329854707,1.0,6/21,10.12%,LAPTM5;GPNMB;LGALS3;DUSP3;TNFAIP3;FGL1
prerank,peptide hormone secretion (GO:0030072),0.5861593126031684,1.4370999127556079,0.05589307411907655,0.2737019795069614,1.0,8/26,19.67%,PARK7;PTPRN;LTBP4;RIMS2;MAFA;ADCYAP1;EDN3;IL6
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7152455151365642,1.4367306771801904,0.06482758620689655,0.27400483478818805,1.0,4/10,14.25%,AKT1;TREM2;CD68;TLR6
prerank,regulation of telomere maintenance (GO:0032204),-0.4403440597639572,-1.4364264824033384,0.05421686746987952,0.4888690231600167,1.0,8/26,13.31%,SMG6;DHX36;SMG1;HDAC8;PML;YLPM1;TERF2;TINF2
prerank,positive regulation of binding (GO:0051099),0.5093747621173103,1.4359577338416543,0.02531645569620253,0.27528006838531915,1.0,26/84,16.42%,APOE;RPL11;CLDN5;B2M;VTN;TXN;NME1;RAN;FKBP1A;PIN1;FLOT1;HES1;ADD2;HIPK2;GMNN;EDF1;HMGB1;DPH3;DDX11;CLN5;BMP2;RIPK2;STMN1;TIAM1;EPB41;CAV1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5705431539073681,1.4359101581011902,0.05748502994011976,0.27484354547538375,1.0,12/32,20.39%,AKAP6;GPER1;APLNR;GRIN1;P2RX7;THY1;CXCL10;RAMP3;TRPC1;CAV1;SNCA;CAPN3
prerank,amide transport (GO:0042886),0.5887766043746266,1.4354097568956923,0.0630952380952381,0.2754577999185332,1.0,7/26,15.31%,SLC38A5;PLTP;TAP2;GLTP;SLC14A1;SLC19A1;FOLR2
prerank,regulation of immune response (GO:0050776),0.492870213336068,1.4353041464408325,0.00816326530612245,0.275204784122139,1.0,33/135,17.99%,B2M;IFITM1;CD81;TYROBP;COL1A1;C3;ITGB2;TREM2;CD34;FKBP1A;TIRAP;SPPL2B;SELL;CD3D;COL3A1;CD22;FGL1;FCGR1A;NPDC1;CD300LG;ELMOD2;COL1A2;LILRB1;IRF7;NCR1;TRAF3;LRP8;PIANP;CD300LF;VCAM1;OSCAR;CD300A;SYK
prerank,positive regulation of nervous system development (GO:0051962),0.5552997584151912,1.434252897517124,0.028026905829596414,0.2770283388744655,1.0,19/42,20.87%,NRXN1;NLGN1;SERPINF1;TGM2;GPER1;GRID2;IL1RAPL1;PTPRD;SNW1;SYNDIG1;LRRC4B;CX3CR1;EPHB1;CLSTN2;CLSTN1;TRIM32;SOX11;IL1RAP;CLSTN3
prerank,regulation of tumor necrosis factor production (GO:0032680),0.49948059110100684,1.4340601122407481,0.004153686396677051,0.2769658174585874,1.0,41/112,21.40%,CLU;TYROBP;HSPB1;CCL19;CYBA;CD34;POMC;PTPRC;MIF;TIRAP;SIRPA;DDT;TNFAIP3;SYT11;VSIR;LPL;LILRA5;HMGB1;ZFP36;MC1R;WNT5A;C1QTNF4;LILRB1;GAS6;CX3CR1;PF4;IFNGR1;TLR1;RASGRP1;CCL3;TWIST1;SYK;OAS3;CCR2;CD14;IL6;SPHK2;TMEM106A;PTPN6;PYCARD;SELENOS
prerank,negative regulation of neurogenesis (GO:0050768),0.5630312814901396,1.433753032895073,0.05970149253731343,0.2771029915168791,1.0,16/34,23.14%,ARHGDIA;B2M;TNF;RTN4;SORL1;YWHAH;LRP4;THY1;GDI1;RHOA;NOTCH1;IL6;MAG;REST;WNT7A;PTN
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.38007499688562457,-1.4334766733215845,0.020618556701030927,0.4917726837258384,1.0,22/50,15.34%,FBXL17;CREBBP;SMO;DCDC2;GLI3;SUFU;GPC3;TTC23;HERC4;DLG5;FGFR2;BTRC;ZIC1;TULP3;INTU;IFT122;RORA;WDR11;GAS8;EVC;UCHL5;KIF7
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.690090794315453,1.4330985652208075,0.0729312762973352,0.27818393408501174,1.0,7/11,24.76%,TERF1;CCT2;CCT7;CCT8;DKC1;CCT4;CCT3
prerank,limb development (GO:0060173),-0.441779893119414,-1.4328916391454918,0.03888888888888889,0.48882956393472565,1.0,8/28,13.22%,SMOC1;GLI3;KREMEN1;KAT2B;PCSK5;IQCE;INTU;IFT122
prerank,negative regulation of chemokine production (GO:0032682),0.6579531088830483,1.432505644000626,0.06910569105691057,0.2790511707873618,1.0,7/14,19.67%,APOD;SIRPA;KLF4;F2RL1;SIGIRR;OAS3;IL6
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5797088721294258,-1.4321457440530219,0.0782312925170068,0.48599225015023106,1.0,5/10,16.27%,MLLT3;HOXB4;UFL1;BATF;TP53
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6001097907740561,1.4316854361529248,0.07389162561576355,0.2804028196544048,1.0,7/23,18.47%,TUBB;TUBA1A;TUBA1B;KIF5A;CCDC88A;HOOK1;KIF5C
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6163016784254745,1.4311056774303557,0.07114624505928854,0.2811300823592122,1.0,8/17,25.94%,SLC7A5;FCER1G;CEBPB;SYK;CD86;NLRP3;CD28;PRKCQ
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.6896678356242043,1.4308172805745767,0.06714285714285714,0.28124007927668054,1.0,5/11,18.77%,TYROBP;ITGB2;SPI1;F2RL1;STX4
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.6739213640480205,1.4306837602775446,0.08185538881309687,0.28104205793949066,1.0,5/12,9.00%,SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.38186540929652457,-1.4302979153319246,0.03305785123966942,0.48640969465893324,1.0,13/43,13.42%,SORBS1;PID1;SIK2;TNS2;OGT;IRS1;GRB10;ENPP1;KANK1;NCK1;PTPN2;PIP4K2C;SIRT1
prerank,regulation of macrophage migration (GO:1905521),0.7085289779856875,1.430117347850284,0.07571428571428572,0.2817947807827593,1.0,3/10,14.23%,CD81;P2RY12;CX3CR1
prerank,central nervous system neuron differentiation (GO:0021953),0.5668503261565965,1.4298505207800691,0.04566744730679157,0.28187048279986304,1.0,10/33,8.81%,MDGA2;GRID2;NTRK2;KNDC1;CTNNB1;SPOCK1;PROX1;MAPT;MAP2;FAIM2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.6299519339204411,1.4286871615517447,0.054616384915474644,0.2840404173103548,1.0,8/18,16.69%,CHCHD10;SLC25A5;FZD9;TMEM14A;BAX;ACAA2;HSPA1A;TMEM102
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5142323913672207,1.427791951075902,0.022532188841201718,0.2856365635470368,1.0,17/71,14.76%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;FCER1G;RAC1;ELMO1;PAK1;ARPC1B;HCK;FCGR1A;ARPC3;ARPC5;VAV1;VAV3;ARPC4
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5333703955483426,1.427728974213201,0.03070175438596491,0.2852583587102349,1.0,21/55,16.22%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;GPR132;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;ATF5;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5
prerank,regulation of macrophage cytokine production (GO:0010935),0.65764907114108,1.4277284382180266,0.08632138114209828,0.28473481050124544,1.0,6/13,13.40%,CD74;LAPTM5;SEMA7A;CUEDC2;WNT5A;LILRB1
prerank,postreplication repair (GO:0006301),0.5461331555030295,1.4270083743948156,0.03546910755148741,0.28597435932926657,1.0,11/45,14.04%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15;PCNA;NSMCE1;RFC2;UBE2V1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.555985277100578,1.4269552991159005,0.03948896631823461,0.2855708730251149,1.0,10/37,13.25%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1;PCNA;RFC2
prerank,cellular response to type I interferon (GO:0071357),0.5569997551650266,1.4258171483883932,0.04072398190045249,0.28712736218981266,1.0,16/41,22.14%,IFITM3;IFITM2;IFITM1;PSMB8;ISG15;IFIT1;EGR1;IRF8;BST2;IRF7;OAS3;RSAD2;IRF9;IFI27;IRF5;ISG20
prerank,type I interferon signaling pathway (GO:0060337),0.5569997551650266,1.4258171483883932,0.04072398190045249,0.28712736218981266,1.0,16/41,22.14%,IFITM3;IFITM2;IFITM1;PSMB8;ISG15;IFIT1;EGR1;IRF8;BST2;IRF7;OAS3;RSAD2;IRF9;IFI27;IRF5;ISG20
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5785928161790832,-1.425096644026581,0.08741258741258741,0.49509114576770347,1.0,5/10,13.42%,CREBBP;KAT7;KAT2B;ESCO1;SIRT1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.543254105652762,1.4248244236985916,0.04308390022675737,0.2890858044494827,1.0,7/42,6.97%,RPS27A;UBC;UBB;VCP;RPA2;UBA52;ISG15
prerank,camera-type eye development (GO:0043010),-0.4456663410807174,-1.4230472757143522,0.056179775280898875,0.4962971377655685,1.0,7/25,7.79%,CACNA1C;FBN1;SHROOM2;SKI;LAMA1;EFEMP1;CEP290
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.4195426918796304,-1.4229445137489491,0.043478260869565216,0.4920850198605717,1.0,7/27,13.32%,KAT6B;CREBBP;KAT7;KAT2B;BRD8;PHF20L1;KAT6A
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6717144115865017,1.4229147571637324,0.06310013717421124,0.2930654303226751,1.0,4/13,6.98%,CD81;TMEM30A;SORL1;SAR1A
prerank,cGMP-mediated signaling (GO:0019934),0.6515802396699693,1.4226693338575755,0.07988980716253444,0.2931420932202296,1.0,3/13,8.96%,APOE;AQP1;HTR2C
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5802781604257383,1.422267039159453,0.05644171779141104,0.29355530382908857,1.0,7/28,7.56%,APOE;TYROBP;LGMN;NSG1;SHISA7;FAM107A;CALB1
prerank,positive regulation of synapse assembly (GO:0051965),0.5856881575685182,1.4216690702845773,0.05903614457831325,0.2944334946996255,1.0,15/27,23.03%,NRXN1;NLGN1;GRID2;IL1RAPL1;SEMA4A;PTPRD;SYNDIG1;LRRC4B;EPHB1;CLSTN2;CLSTN1;AGRN;IL1RAP;CLSTN3;WNT7A
prerank,negative regulation of immune effector process (GO:0002698),0.6653996788909217,1.4209250624008951,0.08,0.2956160035327665,1.0,3/13,4.08%,RPS19;GRN;LGALS3
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6731598068256304,1.4207360100514008,0.0776566757493188,0.2955664873155271,1.0,7/12,23.99%,APOC1;P4HB;MFSD2A;SOAT2;ACSL3;DGAT1;MTTP
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5377061935885756,1.4207324797365155,0.032474804031354984,0.29504443974806405,1.0,14/50,13.55%,GPX1;MT3;PARK7;AKT1;ARL6IP1;TNF;LAMTOR5;YWHAE;BEX3;AQP1;DHCR24;PIH1D1;KLF4;GAS6
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.5954516276876081,1.4205113600039874,0.07169344870210136,0.29506079187918655,1.0,9/22,20.24%,LAPTM5;SLC7A5;TNF;WNT5A;LILRB1;F2RL1;TRIL;CCR2;SPHK2
prerank,macrophage activation (GO:0042116),0.563691498833541,1.4204780237834898,0.04935370152761457,0.2946252622463006,1.0,18/34,24.75%,CLU;C1QA;ITGB2;TREM2;TNF;C5AR1;CD93;MAPT;AIF1;SLC11A1;IFNGR1;TLR1;SYK;SNCA;TMEM106A;APP;AGER;LBP
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6047638158163202,1.4198801197574602,0.08173690932311622,0.2955251786360294,1.0,12/22,19.59%,CALM1;AKAP6;CALM3;GSTO1;P2RY6;HAP1;GSTM2;VMP1;ATP1B1;RYR2;CALM2;STAC3
prerank,response to glucocorticoid (GO:0051384),0.5767956391424772,1.4197123142113637,0.075,0.29542585857325193,1.0,14/26,22.11%,TNF;ZFP36L1;ZFP36L2;FAM107A;SSTR4;ZFP36;HSD3B2;HNRNPU;PDCD7;SLIT3;IL6;GOT1;SSTR2;REST
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.5522457033665967,1.4197043878330828,0.03488372093023256,0.2949121935576414,1.0,10/39,13.25%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1;PCNA;RFC2
prerank,negative regulation of cytokine production (GO:0001818),0.4804098581949396,1.4194772536028293,0.0030272452068617556,0.29492343952450023,1.0,37/163,16.38%,TMSB4X;APOD;TYROBP;LAPTM5;GPNMB;PRNP;TREM2;CD34;CD84;TNF;HOMER2;PTPRC;RAC1;PIN1;SIRPA;TNFAIP3;FN1;CUEDC2;ISG15;NAV3;SYT11;VSIR;SARS1;LILRA5;HMGB1;ZFP36;SRGN;ATP2B1;KLF4;SLC11A1;LILRB1;GAS6;TLR6;F2RL1;SIGIRR;DLL1;HDAC9
prerank,vasodilation (GO:0042311),0.6517707061080856,1.4194305612370932,0.08957219251336898,0.294493758079778,1.0,5/13,18.34%,SOD1;KLF2;GPER1;F2RL1;KCNMA1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.510444578058929,1.4192868832092755,0.02795698924731183,0.29433139150564774,1.0,17/73,14.76%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;FCER1G;RAC1;ELMO1;PAK1;ARPC1B;HCK;FCGR1A;ARPC3;ARPC5;VAV1;VAV3;ARPC4
prerank,diol metabolic process (GO:0034311),0.6102609587349125,1.4191854305947902,0.08,0.2940731217122421,1.0,9/19,21.11%,CALM1;HSP90AA1;AKT1;SPR;NAAA;SGPP1;SPHK2;SGPP2;ASAH2
prerank,lipoxygenase pathway (GO:0019372),0.6514100975086856,1.4188170568354015,0.06878306878306878,0.29432138434518956,1.0,2/14,1.19%,GPX4;GPX1
prerank,phospholipid catabolic process (GO:0009395),0.5839367953870681,1.4187089245592452,0.06487148102815178,0.2940537443386633,1.0,11/24,18.52%,PRDX6;LIPG;ENPP2;SMPD1;PLA2G4F;GDE1;SMPDL3A;PLBD2;GPCPD1;GDPD1;ENPP6
prerank,negative regulation of leukocyte activation (GO:0002695),0.6482619642439651,1.4177278094258194,0.0625,0.2959497674554369,1.0,4/15,4.43%,GRN;GPER1;CD84;LRFN5
prerank,regulation of amyloid-beta formation (GO:1902003),0.5600182670599083,1.41718800447739,0.05847255369928401,0.2966535949069365,1.0,10/34,7.88%,APOE;CLU;PRNP;TNF;NTRK2;RTN4;PIN1;SORL1;ABCG1;GSAP
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5252742973325225,1.4170912324036453,0.04689203925845147,0.2963696056203162,1.0,18/49,21.15%,CD74;PARK7;TNF;LAMTOR5;HSPA1B;TIRAP;HYAL2;HMGB1;HSPA1A;F2RL1;TLR5;TLR1;NOS2;SYK;CD14;IL6;PYCARD;DDIT3
prerank,regulation of B cell differentiation (GO:0045577),0.6274045222916228,1.417090217714471,0.053691275167785234,0.2958513636476997,1.0,11/17,27.81%,ZFP36L1;ZFP36L2;IKZF3;MMP14;SYK;INHBA;SFRP1;ID2;PPP2R3C;INHA;XBP1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.49494992152965445,1.4169281342788038,0.015274949083503055,0.29573654243510167,1.0,28/113,11.61%,RPS3;CLU;RACK1;HSP90AA1;PARK7;TPPP3;NRG1;TERF1;IL5;RASIP1;TNF;RHOC;LGALS3;PSMC3;PARP1;TIRAP;VCP;RPA2;TFRC;ISG15;MTLN;RBX1;LCP1;PIH1D1;DDB1;MMP3;BAX;WARS1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6735725406025931,1.4168130835968429,0.07544581618655692,0.29551680060402824,1.0,9/12,18.13%,CD74;MBP;TNF;TIRAP;LPL;HMGB1;KLF4;F2RL1;OAS3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6123932651002723,1.4163558309246314,0.07974683544303797,0.29605075152915544,1.0,6/20,13.41%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5298131221768982,1.416176253793604,0.03487064116985377,0.2959632682528276,1.0,21/49,21.73%,RACK1;NDUFA13;PINK1;S100A8;S100A9;P4HB;NUPR1;BAX;PMAIP1;BBC3;BAD;CAV1;HERPUD1;BCAP31;NDUFS3;DNM1L;RTKN2;PYCARD;DDIT3;FIS1;PTPMT1
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.4072818145684451,-1.4160443769275655,0.056962025316455694,0.5040148860516155,1.0,11/36,11.01%,AFDN;GOLGA4;VAMP5;MACF1;SPTBN1;GORASP2;BLZF1;RAB10;GGA2;OPTN;KIF13A
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6144729705200876,1.4148098428056861,0.07672634271099744,0.2986643919230594,1.0,11/17,23.14%,MDK;SERPINE2;HES1;TENM4;BMP2;CXCR4;PTPRZ1;NOTCH1;TGFB1;ID2;PTN
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5817186513004433,1.414487992461901,0.054878048780487805,0.29895729865776044,1.0,8/29,10.13%,RPS27A;UBC;UBB;PARP1;RPA2;UBA52;RBX1;DDB1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5316532843584039,1.414341843904528,0.0592841163310962,0.2987692435836022,1.0,18/48,20.39%,CALM1;AKAP6;CALM3;GPER1;FKBP1A;APLNR;GSTO1;THY1;CXCL10;GSTM2;JPH4;TRPC1;SRI;FKBP1B;SELENON;CALM2;SNCA;CAPN3
prerank,action potential (GO:0001508),0.5333297280044208,1.4143196537200307,0.046964490263459335,0.2982977317316943,1.0,19/44,27.61%,AKAP6;ANK3;GPER1;SCN1A;KCND2;GNA11;YWHAH;KCNE4;KCNA2;CHRNA4;KCNE5;KCNA1;SRI;SCN9A;MYH14;SCN8A;SCN2A;KCNMB4;KCNQ1
prerank,protein deneddylation (GO:0000338),0.6839994794361558,1.4142327402439443,0.08199121522693997,0.2979704960942287,1.0,3/10,14.73%,COPS7A;COPS6;COPS8
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.47771196736288635,-1.4141956467757457,0.06787330316742081,0.50453242783279,1.0,6/17,4.47%,ABL1;BAIAP2L1;BCAS3;NRP1;BAIAP2;NTRK3
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5244425991281593,1.4140605919668328,0.04671857619577308,0.29784710166361544,1.0,21/52,25.06%,CXXC1;ACADVL;HSPA5;CTDSP2;SSR1;PDIA6;WFS1;SYVN1;SERP1;DDX11;KLHDC3;DCTN1;DNAJB11;LMNA;DNAJB9;YIF1A;HYOU1;MYDGF;TLN1;VAPB;DNAJC3
prerank,pulmonary valve development (GO:0003177),-0.4773453231363267,-1.4139473364625177,0.06818181818181818,0.5008158206687907,1.0,9/18,16.29%,NOTCH2;SMAD6;ROBO1;SLIT2;NFATC1;JAG1;BMP4;HEY2;BMPR2
prerank,peptidyl-proline modification (GO:0018208),0.5834070971243978,1.4129051648125044,0.07862407862407862,0.30012908485098705,1.0,6/25,5.50%,PPIA;PPIB;FKBP1A;PIN1;FKBP10;FKBP7
prerank,cellular response to topologically incorrect protein (GO:0035967),0.5686562430096298,1.4123192842928436,0.057074910820451845,0.30098744321275805,1.0,15/31,26.57%,HSPA8;HSPA5;TMBIM6;HSPA1B;HSPB8;BAX;HSPA1A;DAB2IP;HSPA2;HSPA9;BAK1;STUB1;PTPN1;HSPA14;TM7SF3
prerank,receptor clustering (GO:0043113),0.5787377665966299,1.412188862048709,0.0692588092345079,0.30080617474586324,1.0,10/27,14.33%,NRXN1;NLGN1;ITGB2;DLG2;LRP4;FLNA;MUSK;THY1;NRXN2;LRRC7
prerank,iron ion transport (GO:0006826),0.5349544002657575,1.4113060409397127,0.050505050505050504,0.3024940168217967,1.0,12/47,12.88%,FTH1;ATP6V0C;ATP6V1F;ATP6V1G1;ATP6AP1;ATP6V0E2;TFRC;TTYH1;CLTC;ATP6V0D2;SLC40A1;SLC11A1
prerank,regulation of interferon-gamma production (GO:0032649),0.5090614871523896,1.4108637368083514,0.030010718113612004,0.30307484977136046,1.0,28/71,28.31%,LAPTM5;PDE4B;PRNP;SLC7A5;SIRPA;ISG15;HSPD1;VSIR;HMGB1;SLC11A1;LILRB1;GAS6;F2RL1;RASGRP1;CCR2;CD14;INHBA;PYCARD;DDIT3;IL12RB1;C1QBP;CD276;INHA;TLR7;CEBPG;IL12RB2;ZFPM1;FZD5
prerank,glycolipid metabolic process (GO:0006664),0.5281322668015198,1.410815515062317,0.05717488789237668,0.3026720701724256,1.0,13/47,16.60%,PSAP;GM2A;HEXB;HEXA;B4GALNT1;SMPD1;FUCA1;CTSA;GLTP;ST6GALNAC3;ABCA2;NEU1;SCCPDH
prerank,detection of calcium ion (GO:0005513),0.659374864559862,1.410419078927888,0.0811554332874828,0.303166198757552,1.0,5/13,19.10%,CALM1;CALM3;SYT1;RYR2;CALM2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5329395031780191,1.410296248414314,0.0365296803652968,0.3029612835743539,1.0,19/51,19.67%,MDK;CALR;CXCL12;MAPK3;LGMN;RARRES2;CXCL10;CREB3;HMGB1;PLA2G7;CSF1R;AIF1;GAS6;F2RL1;ADAM17;CCR2;EDN3;CXCL17;IL6
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.48565721219456787,1.409497765836052,0.0194672131147541,0.30434078912142803,1.0,23/108,11.72%,RPS3;MTCH1;CTSD;RACK1;GSN;LAPTM5;NDUFA13;RPS27L;HSPE1;GPER1;TNF;S100A8;S100A9;ST18;VCP;BEX3;FOXL2;HSPD1;MAPT;HMGB1;PDCD6;BAX;PMAIP1
prerank,Rap protein signal transduction (GO:0032486),-0.5676429987636715,-1.4093003519829155,0.11875,0.5086490222008986,1.0,5/10,18.41%,RAPGEF2;RAPGEF1;RAPGEF3;SGSM3;PLK2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3455339932755634,-1.4092955708707402,0.02531645569620253,0.504367148869395,1.0,13/56,10.54%,BMP6;LDLRAD4;RBPMS;SMAD6;ACVR1;BMPR1A;DAB2;BMPER;TGFBR1;PMEPA1;SMAD7;GDF1;SMAD4
prerank,relaxation of cardiac muscle (GO:0055119),0.6658892269954824,1.409153822352419,0.07692307692307693,0.30471264572018536,1.0,8/13,15.37%,GSN;RGS2;PLN;CHGA;GSTM2;ATP1A1;ATP1B1;SLC8A1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5607766477896761,1.4088286284688343,0.06565064478311841,0.30493033976820305,1.0,12/33,15.50%,NRG3;NLGN1;GRID2;GRIK5;GRIK2;FABP5;LRRC4C;CACNA1A;GRID1;ABR;CX3CR1;LRP8
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5275588915194147,1.4087072549855606,0.04888888888888889,0.3046910021105856,1.0,20/45,25.54%,TYROBP;HSPB1;CCL19;TNF;P2RX7;LPL;EGR1;LILRA5;WNT5A;RIPK2;TLR6;F2RL1;CCL3;NLRP3;IL6;TMEM106A;PYCARD;APP;AGER;CASP1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5983682985446126,1.4083321419614458,0.07323232323232323,0.30511937597992594,1.0,10/21,20.51%,MT3;MAPK3;ZFP36L1;ZFP36L2;KDR;KARS1;SOX9;CTSH;MAP2K2;MYC
prerank,negative regulation of MAP kinase activity (GO:0043407),0.521509437911208,1.4076223036240127,0.06002265005662514,0.30636422100536337,1.0,13/44,19.48%,APOE;AGT;SORL1;UCHL1;RGS2;HYAL2;SMPD1;DNAJA1;MAPK8IP1;SPRY1;DAB2IP;CD300A;SPRY3
prerank,ceramide catabolic process (GO:0046514),0.6401986838111975,1.4075308846691592,0.09646739130434782,0.306059990177675,1.0,3/14,2.91%,GM2A;HEXB;HEXA
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.48684409893840375,-1.4073010134247155,0.10756972111553785,0.5051015868333698,1.0,6/16,13.79%,RBFOX2;ARID1A;ESR1;DDX17;AR;PPARGC1B
prerank,insulin secretion (GO:0030073),0.6062980182480652,1.4071527681835934,0.08132147395171538,0.3064757591547004,1.0,6/19,17.29%,PARK7;PTPRN;RIMS2;PTPRN2;MAFA;ADCYAP1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6289634974642238,1.4070309393887066,0.09066305818673884,0.3062586238523701,1.0,5/15,10.00%,GRM5;HOMER2;GRM8;GRM7;GRM1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.5390885598101725,1.4063259215725592,0.054524361948955914,0.3074461153935051,1.0,12/40,11.72%,UBB;PARK7;SOD1;AKT1;PINK1;ATP5IF1;VCP;MTLN;MAPT;TUSC2;BAX;PMAIP1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6741726302726556,1.4060135415245054,0.07628294036061026,0.3076806712050893,1.0,7/12,24.76%,CCT2;CCT7;CCT8;DKC1;GNL3L;CCT4;CCT3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.44853520734192676,-1.4054799322360878,0.06666666666666667,0.5054285211048716,1.0,9/23,13.79%,TGFBR3;SMAD3;SMURF2;DKK3;SMAD7;SMAD4;LATS2;ITGA3;SMAD2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5678051174160524,1.4054322254995817,0.06775700934579439,0.3086075777739317,1.0,14/27,25.43%,BGN;BCAN;DCN;CHPF2;B3GAT3;CHPF;UGDH;XYLT1;VCAN;CSGALNACT2;CHSY3;B3GAT1;CHST9;CSPG5
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5328415755847302,-1.4053635732329088,0.10861423220973783,0.5014847570932257,1.0,2/12,1.11%,PLEKHH2;LIMA1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.505095986711057,1.4052065467513961,0.03167898627243928,0.3086421740448638,1.0,22/72,16.80%,APOE;HSPA8;CLU;PFDN5;TREM2;CRYAB;PFDN6;MID1IP1;MYADM;PFN1;CORO1A;NAV3;CLASP1;TUBB4A;MAP2;CLIP3;STMN1;VBP1;PFDN1;FGF13;PFN2;CDH5
prerank,central nervous system neuron development (GO:0021954),0.6330076595657702,1.4051680790597578,0.08423913043478261,0.30820534155933954,1.0,6/15,10.09%,HSP90AA1;HSP90AB1;NTRK2;MAPT;MAP2;B4GALT6
prerank,myoblast fusion (GO:0007520),0.6582590931175676,1.404781161754253,0.07344632768361582,0.30860144635257836,1.0,3/12,5.56%,CD81;ADGRB3;ADAM12
prerank,cardiac conduction system development (GO:0003161),-0.44673302821485994,-1.4046741117237267,0.06666666666666667,0.4990219271084745,1.0,9/24,14.92%,NOTCH2;BMPR1A;SMAD1;MAML1;SMAD4;GJB6;CACNA1G;BMP4;HEY2
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5843159911591975,1.404532128048949,0.07913669064748201,0.30871631812691214,1.0,12/25,19.55%,MT3;ANK3;TMTC2;GRIN1;ATP13A2;WFS1;SLC8A1;KCNA1;CAV1;SELENON;SNCA;TFAP2B
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.48734564748715686,1.4044902595316875,0.017435897435897435,0.30828634745471234,1.0,41/114,24.17%,TMSB4X;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;EIF5A;TNF;PSMD1;PSMC3;ST18;PSMD6;PSMA7;TNFSF12;PSMD5;PSMB9;PSMD13;TXNDC17;PSMB3;PSMB11;PSMB10;TNFRSF1A;TRAF3;PSMB1;PSMB5;ADAM17;COMMD7;PLVAP;LTBR;TNFRSF12A;PSMA6;PSMA4;NFKBIA;PYCARD;TNFRSF9;PSMC1;PSMD9;RELA;TNFRSF13B;TNFRSF11A
prerank,dendritic cell chemotaxis (GO:0002407),0.6463115871633425,1.4043865838929401,0.09739368998628258,0.3080181392647509,1.0,7/14,19.50%,CCL19;CCR5;HMGB1;TRPM2;CXCR4;CCR2;GPR183
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5303062870632284,-1.4043339154018495,0.09578544061302682,0.495726901776778,1.0,4/12,5.49%,FOXP1;DAB2;PIAS2;NCOR1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5574306437443481,1.4039228674770359,0.07201889020070838,0.3085720214978805,1.0,13/33,20.94%,APOE;CSNK2B;TNF;ACVRL1;VASH1;HMGB1;KLF4;RHOA;HDAC5;NOTCH1;TGFB1;MEF2C;GADD45A
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5933577635258742,1.4033461633286868,0.07187112763320942,0.30936860021712626,1.0,4/22,3.89%,CALM1;GPNMB;CALM3;PDGFB
prerank,glycosphingolipid metabolic process (GO:0006687),0.5355519411917903,1.4032009143903772,0.06900452488687783,0.30918928614970514,1.0,13/42,16.06%,PSAP;GM2A;HEXB;HEXA;B4GALNT1;B4GALT6;SMPD1;CTSA;GLTP;CLN6;ST6GALNAC3;ABCA2;NEU1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.4704620286359411,-1.4026645974057226,0.08018867924528301,0.4958092389920249,1.0,9/20,19.97%,ST3GAL4;B4GALT1;ST3GAL3;FUT8;B3GALT1;ST6GALNAC6;ST3GAL2;ST3GAL6;ST6GALNAC5
prerank,cellular response to BMP stimulus (GO:0071773),-0.35042437464698173,-1.4018899332887367,0.0,0.4938665119459582,1.0,23/66,16.73%,BMP6;TGFBR3;SMAD3;ADAMTS12;SMAD6;ACVR1;BMPR1A;SMAD9;SMURF1;SMAD1;SMAD7;GDF1;RGMA;SMAD4;PDCD4;HIVEP1;BMP4;SMAD2;TGFB3;RUNX2;ACVR2A;BMPR2;ACVR2B
prerank,regulation of protein targeting to membrane (GO:0090313),0.5657328881844726,1.401670708792062,0.07907542579075426,0.3123732142173439,1.0,11/28,21.42%,PRNP;ITGB2;ANK3;GDI1;HRAS;MTCL1;MIEF2;MFF;DMTN;C2CD5;FIS1
prerank,positive regulation of viral life cycle (GO:1903902),0.5957204680065911,1.4015861221289203,0.08200734394124846,0.3120702960942198,1.0,5/22,10.13%,CD74;LGALS1;CHMP2B;P4HB;DDB1
prerank,fluid transport (GO:0042044),0.667694401446437,1.4013233308268929,0.09358288770053476,0.3122097525101256,1.0,2/12,8.41%,AQP4;AQP1
prerank,innate immune response in mucosa (GO:0002227),0.6897563370386142,1.4011644283978582,0.0988538681948424,0.31212683652002704,1.0,1/10,0.48%,RPL39
prerank,positive regulation of cell death (GO:0010942),0.5103263180623936,1.4005841781949548,0.047304730473047306,0.31300637658719876,1.0,20/59,19.98%,CLU;C1QA;TYROBP;MT3;PRNP;ITGB2;TNF;SLC6A6;MAPT;EGR1;WNT5A;MMP3;RAMP3;RIPK2;HPR;HP;GRIN2B;SNCA;TRIM13;DDIT4
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5565524351998433,1.4004877180645063,0.07009345794392523,0.312721778795198,1.0,8/33,11.56%,RPS3;PARK7;RHOB;SIRPA;TNFAIP3;AQP1;NET1;TRPM2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.5933239374456686,1.4003971228521948,0.06840796019900497,0.3124254857852632,1.0,9/23,23.35%,GPX4;GSTM1;FADS1;GSTM2;ACOT7;LTC4S;ASAH2;CYP2E1;ELOVL6
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.6086702269949553,1.4000461541909561,0.08010335917312661,0.3127553678707926,1.0,8/18,16.62%,TNF;ADD2;SELL;PODXL2;SELPLG;GCNT1;CX3CR1;VCAM1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.49077350672540115,1.399841661234534,0.016666666666666666,0.3121859521835311,1.0,40/104,25.42%,PSMB4;TYROBP;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;TAB1;PSMA6;MUC1;SKP1;PSMA4;PSMC1;PSMD9;ICAM2;RELA;PSMB2;PRKACA;PSMD4
prerank,cellular response to lectin (GO:1990858),0.49077350672540115,1.399841661234534,0.016666666666666666,0.3121859521835311,1.0,40/104,25.42%,PSMB4;TYROBP;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;TAB1;PSMA6;MUC1;SKP1;PSMA4;PSMC1;PSMD9;ICAM2;RELA;PSMB2;PRKACA;PSMD4
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5042382093027588,1.3997996864442677,0.04940923737916219,0.3117889979438264,1.0,16/63,20.07%,CD74;CD81;CCL19;PTPRC;MIF;TIRAP;TFRC;IL2;PNP;AIF1;VAV3;VCAM1;CD86;GPR183;IL6;MEF2C
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6537526989920993,1.3996475968197715,0.09078771695594126,0.31167027476047976,1.0,1/13,0.01%,TMSB4X
prerank,cellular response to fatty acid (GO:0071398),-0.5316413824645243,-1.3996417567928068,0.10727969348659004,0.49560251447464193,1.0,2/12,4.54%,PID1;IRS1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.5983557793962825,1.399370381210399,0.07554417413572344,0.31185656007553547,1.0,7/22,17.00%,MBP;TNF;FLOT1;MYADM;THY1;KLF4;SKAP1
prerank,positive regulation of type 2 immune response (GO:0002830),0.6275992626877301,1.399364242871664,0.07894736842105263,0.3113684651955288,1.0,2/14,1.05%,CD74;CD81
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.5614918773057135,1.399096046546443,0.0545876887340302,0.3115670945630944,1.0,15/34,22.36%,AKT1;GRID2;MPP2;GABRG3;GRIN1;GABRA2;GRIN2A;GLRA1;GABRA3;CHRNA4;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.48965044748267716,1.3990705018435923,0.01557632398753894,0.31112455605057926,1.0,40/105,25.42%,PSMB4;TYROBP;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;PSMD1;PSMC3;PSMD6;PSMA7;MUC15;CLEC6A;PAK1;PSMD5;MUC16;PAK3;PSMB9;PSMD13;PSMB3;HRAS;PSMB11;PSMB10;CLEC4D;PSMB1;PSMB5;SYK;TAB1;PSMA6;MUC1;SKP1;PSMA4;PSMC1;PSMD9;ICAM2;RELA;PSMB2;PRKACA;PSMD4
prerank,negative regulation of cell projection organization (GO:0031345),0.5241343016168416,1.399036267451209,0.04719101123595506,0.3107222365600259,1.0,9/48,6.93%,APOE;ITM2C;MT3;DCC;PRNP;YWHAH;SPOCK1;BAG5;CRMP1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.63205392884586,1.3988096480287255,0.08419689119170984,0.31075977420944967,1.0,4/16,10.70%,C3;GPER1;KLK6;CHGA
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4764347402939592,1.3984953173690629,0.011247443762781187,0.31101690367289875,1.0,43/151,17.61%,APOE;CD74;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;TNF;PDGFB;PTPRC;NTRK2;C5AR1;SEMA7A;MIF;NDRG4;TIRAP;ATP6AP1;DDT;P2RY6;KDR;CCN2;HTR2C;P2RY1;HMGB1;CSF1R;RAMP3;FLT4;HRAS;FBXW7;BMP2;GAS6;CCL2;F2RL1;PDGFA;RASGRP1;ARRB2;ADRA1A;CCL3;GATA4;ADCYAP1;CCL8
prerank,positive regulation of lymphocyte activation (GO:0051251),0.5592341362916611,1.398446398319354,0.07888349514563107,0.3106491150514339,1.0,9/28,20.93%,TYROBP;SIRPA;HSPD1;THY1;CCL2;SH3KBP1;CCR2;IL6;PYCARD
prerank,adenine nucleotide transport (GO:0051503),0.6157319131296808,1.3983932969547683,0.08560311284046693,0.3102747822571092,1.0,4/17,13.31%,SLC25A5;LRRC8A;SLC25A4;SLC19A1
prerank,adherens junction organization (GO:0034332),0.532000800730355,1.3973073974437986,0.053811659192825115,0.3122222755762111,1.0,16/48,16.80%,ACTB;RAMP2;CADM2;ANG;CDH20;CTNNB1;CDH18;CADM3;CDH12;CDH19;DCHS1;JAM3;CDH7;CDH24;CDH10;CDH5
prerank,negative regulation of secretion (GO:0051048),0.6901434803362413,1.3972969966750317,0.07756232686980609,0.31176053986455143,1.0,4/10,11.89%,CD74;NRG1;VAMP3;VAMP8
prerank,cellular response to dsRNA (GO:0071359),0.6278359854557305,1.3968552647607855,0.10150891632373114,0.3122765493867258,1.0,7/15,21.32%,NPM1;FLOT1;PQBP1;IFIT1;PDE12;CAV1;RALB
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.5871613410985957,1.3963775161992875,0.07196969696969698,0.31297637816703117,1.0,8/23,11.75%,SEC61B;HSP90B1;AUP1;VCP;LMAN1;SURF4;TMED9;SYVN1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5036067618809993,1.3963432398670996,0.04090419806243272,0.31255389148728835,1.0,16/70,14.76%,ACTB;ACTG1;HSP90AA1;HSP90AB1;MAPK3;RAC1;ELMO1;PAK1;ARPC1B;HCK;FCGR1A;ARPC3;ARPC5;VAV1;VAV3;ARPC4
prerank,positive regulation of telomerase activity (GO:0051973),0.5511060505659515,1.3961976453649116,0.06872037914691943,0.3123924594966587,1.0,16/33,23.97%,HSP90AA1;HSP90AB1;MAPK3;CCT2;CTNNB1;KLF4;PTGES3;PARM1;DKC1;MAPK15;MYC;MAP2K7;CCT4;GRHL2;NAF1;PNKP
prerank,negative regulation of viral transcription (GO:0032897),0.6529806441556371,1.3958657061090327,0.09176788124156546,0.3126708502029058,1.0,5/13,19.64%,IFITM3;ZFP36;HEXIM1;TRIM32;TRIM13
prerank,triglyceride metabolic process (GO:0006641),0.5225890371596725,1.3950120243981123,0.06084070796460177,0.3140997647769453,1.0,8/48,11.20%,APOE;PNPLA2;APOC1;FABP5;PLAAT3;LIPG;LPL;MOGAT2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.49467691941321945,-1.39426181647005,0.07792207792207792,0.5048874242053173,1.0,9/16,23.30%,SHLD1;FBH1;FANCB;CGAS;SMCHD1;RMI2;SHLD2;SHLD3;POLQ
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.5573918848510292,1.3941596702541768,0.07246376811594203,0.31563065095799003,1.0,10/31,19.97%,TYROBP;GPNMB;CEBPB;SDC4;CTLA4;LILRB1;CD300A;SOX11;CD86;LST1
prerank,interstrand cross-link repair (GO:0036297),0.5127401051208078,1.3938376870296336,0.0565410199556541,0.3159224143086057,1.0,8/53,7.60%,RPS27A;UBC;UBB;VCP;NUCKS1;RPA2;UBA52;CENPX
prerank,cellular response to tumor necrosis factor (GO:0071356),0.47461292154510937,1.3933092839526806,0.005025125628140704,0.31666348467683164,1.0,51/175,20.93%,TMSB4X;RPS3;PSMB4;PSME1;AKT1;CCL19;PSMB6;PSME2;PSMB8;PSMD2;GPER1;EIF5A;TNF;NR1D1;PSMD1;ZFP36L1;PSMC3;ZFP36L2;ST18;PSMD6;HYAL2;PSMA7;TNFSF12;PSMD5;ZFP36;PSMB9;PSMD13;TXNDC17;PSMB3;PSMB11;PSMB10;TNFRSF1A;ERBIN;CCL2;TRAF3;YBX3;PSMB1;PSMB5;DAB2IP;CCL3;ADAM17;CCL8;COMMD7;PLVAP;LTBR;TNFRSF12A;PSMA6;SFRP1;PSMA4;NFKBIA;PYCARD
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.49906613071841643,1.3931032701441097,0.029288702928870293,0.3166833233869988,1.0,32/88,20.89%,RPS3;CLU;RACK1;PARK7;NRG1;TNF;RHOC;LGALS3;FLOT1;TIRAP;VCP;PFN1;TFRC;MTLN;ATP13A2;PIH1D1;SDC4;CHGA;MMP3;BAX;WARS1;SDCBP;DAB2IP;PFN2;CDH5;CRB3;SYK;VPS4A;TGFB1;CDC42EP2;ERCC1;BAK1
prerank,regulation of viral transcription (GO:0046782),0.5385623954790753,1.3930915101708916,0.057579318448883664,0.3162195265284645,1.0,15/39,21.23%,IFITM3;POLR2E;POLR2D;POLR2F;NELFCD;ZFP36;POLR2G;SUPT4H1;POLR2K;HEXIM1;NELFE;TRIM32;TRIM13;POLR2H;CDK9
prerank,retrograde axonal transport (GO:0008090),0.6218551144397187,1.392640069763772,0.08062418725617686,0.3166775513211085,1.0,6/16,11.11%,SOD1;MAP1A;DLG2;NEFL;KIF5A;HAP1
prerank,positive regulation of cell communication (GO:0010647),0.5707752708859971,1.3924021436846985,0.07337278106508875,0.3167876649009817,1.0,15/28,20.87%,ANK3;TNF;GRIK2;SYT1;LGI1;RIMS2;RIMS1;HCRT;CLSTN2;CLSTN1;NMB;KCTD13;EDN3;SOX11;CLSTN3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.47974543305214695,1.392098646004622,0.003051881993896236,0.3170132571611447,1.0,37/152,17.29%,PSAP;MTNR1A;RAMP2;GNAI2;NPY1R;GPER1;GPR37L1;ADGRB3;GNA11;SCTR;ADGRL3;S1PR5;S1PR1;DRD5;GPR6;GRM8;ADGRG1;RXFP1;CXCL10;VIPR1;P2RY12;ADGRB1;MC1R;GNAI1;GNAO1;ADGRB2;CALCB;RAMP3;CHRM2;ADCY4;PF4;ADGRL4;ADRA1D;ADCY8;ADGRE1;PTGIR;ADCYAP1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.565894881963212,1.3920477343892397,0.07345971563981042,0.31663591996641194,1.0,10/29,19.74%,PPIA;HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2;PTGES3;GAR1;TERF2IP;DKC1
prerank,regulation of BMP signaling pathway (GO:0030510),-0.3470616224947174,-1.3914715533143462,0.06666666666666667,0.5081424255061232,1.0,25/73,16.73%,SULF1;SMAD6;ZNF423;BMPR1A;FOXD1;CRIM1;SMURF2;SKI;BMPER;SMAD9;SMURF1;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4;RBPJ;ITGA3;NUMA1;BMP4;SMAD2;ACVR2A;BMPR2;ACVR2B
prerank,positive regulation of cellular process (GO:0048522),0.4605839995495393,1.391269305819113,0.0,0.31801717084989606,1.0,168/565,20.96%,RPL23;RPS9;RPS4X;RPS15A;RPS19;CLDN5;CD81;MDK;HSP90AB1;GRN;CALR;H3-3A;GNAI2;MT3;CAPNS1;CXCL12;RPS6;LGMN;AKT1;TSPAN31;S100B;AKAP6;SLC25A5;CYBA;NRG1;EIF4G2;CCND2;TREM2;DOCK2;TGM2;ERBB4;NPM1;COPS9;S100A13;GPER1;COX17;TNF;MAP1A;EMP2;PDGFB;ROMO1;HCLS1;FCER1G;LMAN2;RAC1;NTRK2;ZFP36L1;S100A8;S100A9;CAMK1D;FLOT1;SSR1;SIRPA;IL2RB;GRIN1;SERTAD1;HES1;FN1;FRMD5;MATK;LGI1;RHOG;RNF187;MLC1;SPACA3;ADGRG1;CCND1;CXCL16;P4HB;NAMPT;PTK6;SLC6A6;PAK1;DUSP26;P2RX7;DDX49;MTLN;PROX1;KDR;CCN2;IL2;MFSD2A;MAPT;VIPR1;NUPR1;MLXIPL;TIMP1;LAMC2;GATA2;LILRA5;HCK;DNPH1;ZFP36;KITLG;EXOSC2;FASN;CSF1R;MYRF;TENM4;WNT5A;IL11;RAMP3;CEP131;FLT4;IL2RG;HRAS;NSMCE1;AIF1;SLC11A1;PRMT1;SOX9;FBXO5;RIPK2;GAS6;CTSH;SDCBP;TIAM1;PDF;FOLR2;IGF2;PDGFA;HPR;HP;RYR2;DLL1;IER5;ADRA1D;FLT1;CAV1;CCKBR;EPB41L4B;VHL;TMEM102;CIAO1;TRIM32;LMNA;MMP14;ADAM17;FKBP1B;CNBP;TBRG4;ERBB3;EXOSC9;MAZ;STX4;HMGN5;EDN3;SOX11;PPP3CA;DDRGK1;CD86;RTKN2;TFAP2B;FLT3;NOTCH1;TRIM13;IL6;RAD23A;MAPK15;TGFB1;CITED2;THPO;SFRP1;MYC;CRLF1;PTPN6;PYCARD;CRLF2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6460815068999113,1.3912608974433023,0.08027210884353742,0.3175571037524053,1.0,6/12,19.10%,CALM1;CALM3;IRX3;CAV1;SRI;CALM2
prerank,histone mRNA catabolic process (GO:0071044),-0.510466621278408,-1.3911817862923788,0.10212765957446808,0.5049824822810896,1.0,8/15,21.79%,TENT4B;XRN1;TUT7;TUT1;ATM;TUT4;TENT2;LSM1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.6032977260659601,1.3911112539329882,0.09578544061302682,0.3174288238638168,1.0,9/18,20.91%,SLC25A5;SLC25A4;ALKBH7;PMAIP1;SPG7;BAD;TMEM102;BAK1;THEM4
prerank,regulation of transmembrane transport (GO:0034762),0.5580073751937833,1.39044828248974,0.06921241050119331,0.31848158301033347,1.0,3/31,5.63%,ACTB;SLC2A1;KCNJ10
prerank,NIK/NF-kappaB signaling (GO:0038061),0.502710667794588,1.3901246588489706,0.028877005347593583,0.3187874488262912,1.0,22/72,16.22%,PSMB4;PSME1;AKT1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;TIRAP;PSMD6;PSMA7;PSMD5;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;TLR6;COPS8;PSMB1;PSMB5
prerank,regulation of mononuclear cell migration (GO:0071675),0.5886355432593329,1.3892674056500092,0.0681265206812652,0.3203869607946671,1.0,8/23,12.35%,MDK;MAPK3;TNF;LGALS3;RARRES2;MSN;CSF1R;AIF1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.5829687928938762,1.3889652486537696,0.0779537149817296,0.3206503482904899,1.0,12/25,22.36%,AKT1;GRID2;MPP2;GRIN1;GRIN2A;GLRA1;CHRNA4;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,"phagocytosis, engulfment (GO:0006911)",0.5433712523816882,1.3887676747539592,0.08304498269896193,0.3206043671288973,1.0,11/36,12.35%,GSN;ITGB2;ARHGAP25;RAC1;ELMO1;RHOG;XKR4;ADGRB1;FCGR1A;MSR1;AIF1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6708634875523258,1.3887567152688889,0.10903873744619799,0.3201363780588911,1.0,2/10,4.96%,ACADVL;ETFB
prerank,T cell migration (GO:0072678),0.6555390703625955,1.3886105877215487,0.09946236559139784,0.31999962322357195,1.0,8/13,24.38%,S1PR1;MSN;CXCL16;CXCL10;CCL3;PIK3CD;GPR183;MYO1G
prerank,stem cell differentiation (GO:0048863),-0.3835548249885744,-1.3873339509291247,0.08333333333333333,0.5101412729710042,1.0,13/39,18.13%,MLLT3;FBXL17;SETD2;LRP6;HOXB4;JARID2;UFL1;FGFR2;KIT;BATF;TP53;PSMD11;METTL5
prerank,positive regulation of macrophage migration (GO:1905523),0.6052403346757117,1.3864499197251563,0.08108108108108109,0.32462865689189685,1.0,8/19,19.15%,MDK;MAPK3;TREM2;RARRES2;P2RY12;CSF1R;CCL3;CXCL17
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.6088559418629812,1.3861821506990384,0.0847682119205298,0.32478776834302137,1.0,6/17,17.60%,EMC6;EMC3;EMC10;EMC4;SGTA;EMC8
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.641421929719858,1.3859780130234647,0.09769335142469471,0.32483892380533763,1.0,7/13,19.19%,RACK1;HSPA5;PPP1R15B;WFS1;PPP1R15A;DNAJB9;DDRGK1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.41690974603692893,-1.3856326510650754,0.07344632768361582,0.5102557304898553,1.0,7/27,14.03%,UBE2E2;ANAPC5;ANAPC1;PRKN;ANAPC7;CDC26;CDC27
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5175127623039053,1.3853798017794563,0.041340782122905026,0.32577781474623696,1.0,12/49,14.81%,CLU;RPL13A;PARK7;HSPA5;TREM2;CRYAB;SORL1;HMGB1;SVIP;THRA;NLRP2B;JAM3
prerank,glutathione metabolic process (GO:0006749),0.54295420461355,1.3853479785351448,0.06995412844036697,0.3253678998430245,1.0,8/38,15.71%,GPX1;PARK7;SOD1;GSTM1;GSTM5;GSTM2;HPGDS;GLRX2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6001538805323096,1.385252726433526,0.08736559139784947,0.32509991741007266,1.0,9/18,22.11%,ZFP36L1;ZFP36L2;FAM107A;SSTR4;AQP1;ZFP36;HNRNPU;SSTR2;REST
prerank,apoptotic mitochondrial changes (GO:0008637),0.5534562732139287,1.3852079389489542,0.07376058041112454,0.32472737912830096,1.0,14/32,21.42%,CLU;ERBB4;FZD9;HSPD1;BAX;TIMM50;BBC3;BAD;MFF;DNM1L;CCAR2;BAK1;THEM4;FIS1
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.5118885726216543,-1.3848884121665377,0.09787234042553192,0.5085204706674277,1.0,6/15,8.33%,ROCK2;SLC9A1;ROCK1;CAMK2D;IGF1;MEF2A
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4640748906284077,-1.384693366940172,0.0787037037037037,0.5052659155711654,1.0,7/19,16.99%,NFAT5;PLCE1;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5821379421098125,1.3845814121639277,0.07711138310893513,0.32575722787675254,1.0,7/24,13.41%,SEMA3F;DSCAM;SEMA7A;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,response to alcohol (GO:0097305),0.5572364408991078,1.384328403431679,0.07322929171668667,0.32589984160685154,1.0,14/27,19.83%,SOD1;CCL19;GRIN1;GRIN3A;CCR5;GRIN2A;SDF4;GLRA1;HSD3B2;ABCA2;CCL3;SLIT3;GRIN2B;TGFB1
prerank,regulation of histone methylation (GO:0031060),-0.5027718199227295,-1.3842224123880997,0.096,0.5026330252218054,1.0,3/13,5.61%,NSD1;JARID2;MTHFR
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.504183426627103,1.3839410959795517,0.031049250535331904,0.3263945717236651,1.0,25/75,16.87%,ACTB;S100A6;DCC;S100B;CTNNA2;ANK3;MAP1A;CNTN4;LRP4;NEFH;NRCAM;MFSD2A;MAP2;PAK3;ADGRB1;APBB1;TMEM106B;SHTN1;CCK;MAPK8IP2;DSCAML1;SPTBN4;CDK5;BRSK2;CDHR1
prerank,membrane repolarization during action potential (GO:0086011),0.6350226978237354,1.3839063651448547,0.10918774966711052,0.32598450617671604,1.0,5/13,15.24%,YWHAE;KCNE4;ATP1A1;KCNE5;ATP1B1
prerank,protein processing (GO:0016485),0.48203202228759395,1.3830059015446134,0.02494802494802495,0.3276918691523849,1.0,35/102,18.82%,CTSL;CTSS;LGMN;CD5L;RCE1;CPXM1;CPD;PSENEN;CPE;OMA1;F9;SPCS1;KLK1;KLK6;VSIR;METAP2;PCSK2;SRGN;AEBP1;MYRF;CPXM2;TMEM208;CLN5;SPCS2;CTSH;SPG7;HPR;HP;BACE1;PSEN2;MMP14;ADAM17;APH1B;SEC11C;PRSS12
prerank,positive regulation of cell division (GO:0051781),-0.3866974616311364,-1.3829034426845035,0.06329113924050633,0.5023479788456269,1.0,9/38,12.16%,SVIL;FGF1;PRKCE;CDC14A;FGFR2;CSPP1;CDC25B;PKP4;GIPC1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.6234445514611217,1.3829026170976537,0.1032171581769437,0.32745077306431486,1.0,4/14,9.22%,CD63;EMP2;FLNA;TIMP1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4855314962217268,1.382817457520421,0.024896265560165973,0.32715102311900246,1.0,37/101,23.88%,RPL26;RPS4X;RPL5;EEF2;VIM;HSP90AA1;AURKAIP1;AKT1;EIF3D;NPM1;RPS27L;AGT;MSN;EIF3C;PTTG1IP;PCIF1;ZCCHC4;KLF4;CLN6;BAD;NR1H2;CIRBP;YTHDF1;EIF4A3;ASPSCR1;TRIM32;INHBA;IL6;TGFB1;CAPN3;NFKBIA;BAK1;STUB1;WNT7A;ELAVL1;PLXNB2;CD28
prerank,histone H3 deacetylation (GO:0070932),-0.5048074922358824,-1.3824067578795338,0.08203125,0.4998998205759852,1.0,6/15,16.08%,HDAC4;PER2;HDAC8;SMARCAD1;SIRT1;SIRT7
prerank,angiogenesis involved in wound healing (GO:0060055),0.6630470710522767,1.3821035170388938,0.11004126547455295,0.3283169169010521,1.0,7/11,24.83%,CD34;KDR;GATA2;MCAM;HPSE;PRCP;SRF
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6449288000706348,1.3818589818642355,0.08869814020028613,0.32839649165003393,1.0,2/13,1.13%,LAMP1;TYROBP
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.6091659965540397,1.3816998160913943,0.09067017082785808,0.32828841401139314,1.0,10/18,24.48%,RPS3;IL2;CD24;ICOSLG;HMGB1;IGFBP2;IGF2;PYCARD;IL12RB1;AGER
prerank,positive regulation of lymphocyte migration (GO:2000403),0.6630416008027123,1.3815558366091027,0.09636871508379888,0.3281489869923687,1.0,8/12,24.37%,CXCL12;CXCL10;AIF1;RHOA;DOCK8;TMEM102;PYCARD;APP
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.5672038324253812,1.38144082829893,0.08343265792610251,0.3279510391503447,1.0,10/27,12.67%,SLC38A5;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC25A29;SLC6A5;SLC3A2;SLC1A1;SLC25A22
prerank,positive regulation of immune response (GO:0050778),0.5034382914428679,1.3812560218653012,0.04057017543859649,0.32790725052128755,1.0,20/64,23.31%,CD74;CD81;GRN;CYBA;ITGB2;PTPRC;IL2;SLC15A4;KARS1;LILRB1;F2RL1;SKAP1;STX4;NLRP3;SPHK2;PYCARD;RSAD2;POLR3D;AKIRIN2;IL12RB1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6307089069291731,1.3798632041394325,0.11333333333333333,0.3306783136781572,1.0,3/13,11.72%,RPL26;MSX1;PMAIP1
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5110980917054351,-1.379785467793174,0.1062992125984252,0.5023591530069729,1.0,7/13,19.29%,LARGE1;OGA;PGM3;MGAT3;RENBP;CHST3;NAGK
prerank,positive regulation of cell aging (GO:0090343),0.6537424265952343,1.3797317332801327,0.10404624277456648,0.33052903305422077,1.0,2/11,2.35%,B2M;YPEL3
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5373108728348596,1.37966261752993,0.0763888888888889,0.3302030025609633,1.0,14/36,21.73%,RPS3;PPIA;TMBIM6;TNF;CX3CR1;MAPK8IP2;DAB2IP;GATA4;MAZ;QARS1;ING5;PYCARD;ASAH2;PTPMT1
prerank,cellular response to organonitrogen compound (GO:0071417),0.48046612389672033,1.3792413946074364,0.033880903490759756,0.33071691424625477,1.0,31/99,20.17%,ACTB;GABRB1;AKAP6;LAMTOR2;LAMTOR4;HSP90B1;LAMTOR5;IGFBP5;ZFP36L1;CTNNB1;P2RY6;P2RX7;AQP1;P2RY1;EGR1;P2RY12;GLRA2;TRPM2;GLRA1;GABRB3;SOX9;LAMTOR3;RRAGC;HCN1;RRAGD;DMTN;GABRB2;HCN3;NSMF;MEF2C;SFRP1
prerank,regulation of mitochondrial translation (GO:0070129),0.590818563280118,1.3788949774330832,0.09351620947630923,0.3310911178632532,1.0,10/21,27.38%,UQCC2;COA3;TRUB2;TSFM;SHMT2;RPUSD4;MTG2;C1QBP;TRMT10C;RCC1L
prerank,protein autoprocessing (GO:0016540),0.6020773761387277,1.3788847608281862,0.09055118110236221,0.33063623380460616,1.0,4/17,10.97%,CTSL;OMA1;KLK6;MYRF
prerank,negative regulation of T cell proliferation (GO:0042130),0.5512069185967435,1.3787558143312386,0.08432304038004751,0.330458273615152,1.0,6/28,13.40%,GPNMB;PRNP;CEBPB;PRKAR1A;SDC4;LILRB1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.641747848318193,1.378581004319031,0.09585492227979274,0.33043545090647347,1.0,4/13,13.55%,CD74;TAF9;WNT5A;GAS6
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.6295212104985618,1.378278828491874,0.10463576158940398,0.33067048771540547,1.0,8/14,26.23%,TIRAP;HNRNPA0;ZFP36;TARDBP;ELAVL4;YBX3;ELAVL1;HNRNPC
prerank,protein targeting (GO:0006605),0.4815750632646244,1.378205914347086,0.012269938650306749,0.33036171715094104,1.0,29/118,15.91%,RPL11;GABARAP;TSPO;NACA;TIMM8B;TIMM13;TOMM5;NLGN1;AKAP6;TOMM7;SRP14;SEC61G;SORL1;AIP;TIMM10B;SPCS1;ICMT;HAP1;CDC37;GDAP1;GOLGA7B;SEC61A1;YIF1B;SPCS2;SDCBP;MFF;GOLGA7;PEX6;NCF1
prerank,regulation of feeding behavior (GO:0060259),-0.5235863052167846,-1.377870535465659,0.1048951048951049,0.5034243819054853,1.0,4/11,6.91%,AGRP;LEPR;EIF2AK4;STAT3
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.6700998375178344,1.377770326018086,0.09672619047619048,0.3309294871432495,1.0,5/10,17.60%,EMC6;EMC3;EMC10;EMC4;EMC8
prerank,negative regulation of RNA metabolic process (GO:0051253),0.6053901423019076,1.3775364181788154,0.10387984981226533,0.33102175578156384,1.0,4/18,3.71%,RPS13;RPS26;TMBIM6;TNF
prerank,erythrocyte differentiation (GO:0030218),0.5235228411694556,1.3764638209928723,0.06727480045610035,0.3331542875552832,1.0,8/44,9.02%,RPS14;RPS19;SLC25A5;HCLS1;ATP5IF1;HIPK2;TSPO2;IKZF1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.42348850022623546,-1.3763363971327145,0.08241758241758242,0.5036049487768413,1.0,12/27,17.61%,EGFR;TNRC6B;DDX6;STAT3;RIPK1;EIF4G1;BMP4;PUM2;LIMD1;TP53;AGO2;FMR1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5243303892369903,1.376332935549041,0.05902004454342984,0.3329955790098367,1.0,11/46,6.09%,APOD;HMOX1;AKT1;IGFBP3;TNF;PDGFB;IGFBP5;ANG;NDRG4;CTNNB1;TNFAIP3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.45057091635290847,-1.376181175867628,0.0730593607305936,0.500354634072697,1.0,7/18,15.00%,SARNP;DDX19A;IWS1;PABPN1;DDX19B;MCM3AP;THOC2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.45611014212634626,1.375894853129182,0.0,0.33353098599065856,1.0,155/532,21.23%,TMSB4X;RPS27A;IFITM3;HSPA8;PPIA;UBC;VIM;IFITM2;B2M;UBB;RPLP0;IFITM1;PSMB4;HSP90AA1;F13A1;MT3;BOLA2;CFL1;CXCL12;HMOX1;SOD1;MT2A;MAPK3;TALDO1;PSME1;AKT1;CCL19;PSMB6;PSME2;PSMB8;ITGB2;PSMD2;IL5;POMC;CNN2;CSNK2B;EIF5A;CANX;TNF;HSP90B1;PDGFB;TOLLIP;FCER1G;PSMD1;SPI1;JUNB;MIF;PSMC3;ST18;AIP;PSMD6;IL2RB;CSF3R;S1PR1;FN1;MSN;UBA52;PSMA7;ISG15;CCND1;CCR5;GSTO1;P4HB;CEBPA;CXCL10;TNFSF12;IL2;IFIT1;PSMD5;RBX1;LCP1;TIMP1;EGR1;HCK;FCGR1A;PSMB9;IRF8;CSF1R;PSMD13;TXNDC17;IL11;MMP3;PSMB3;LCN2;IL2RG;IL3RA;MAOA;PSMB11;COL1A2;BST2;VAV1;RIPK2;PSMB10;YWHAZ;TNFRSF1A;RHOU;UBE2V1;NDN;CCL2;PTPRZ1;IRF7;ARF1;PF4;IFNGR1;TRAF3;LRP8;CSF2RB;CD300LF;IL17RB;PSMB1;PSMB5;CCL3;VCAM1;SQSTM1;PIK3CD;TWIST1;ADAM17;NCAM1;NOS2;CCL8;SYK;OAS3;COMMD7;CCR2;SLA;PLVAP;LTBR;TNFRSF12A;STX4;TAB1;IL20RA;PSMA6;MUC1;CD86;SOS1;FLT3;IL6;HGF;IFNGR2;TGFB1;CSF2RA;IL10RB;SKP1;IL1RAP;PSMA4;MYC;CRLF1;NFKBIA;HSPA9;PTPN6;PYCARD;CRLF2;RSAD2;HNRNPF;IRF9
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.46923747583397507,1.3757568147608155,0.005060728744939271,0.33339883251304037,1.0,47/184,16.89%,RPS27A;TUBB;UBC;UBB;TUBA1A;PSMB4;HSP90AA1;TUBB4B;DYNLL1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;TUBA4A;PSMD1;ZFP36L1;DCTN3;PSMC3;PPP2R1A;ZFP36L2;YWHAE;PSMD6;UBA52;PSMA7;CLASP1;YWHAG;TUBB4A;PSMD5;DDB1;PSMB9;PSMD13;BUB3;PSMB3;CEP131;PSMB11;DCTN1;ANLN;FBXO5;PSMB10;SSNA1;HAUS2;DCTN2;PSMB1;PSMB5;CETN2;PRKAR2B
prerank,calcium-ion regulated exocytosis (GO:0017156),0.556282634744456,1.3749499201071724,0.07272727272727272,0.33481558933245614,1.0,16/27,25.62%,SYT1;RIMS2;RIMS1;SDF4;SYT12;SYT11;VAMP2;SYT6;SYT4;SYT10;SYT2;DOC2B;SCIN;SYT3;SYT5;SYT17
prerank,glutamine family amino acid catabolic process (GO:0009065),0.6388852997671168,1.3743251221017856,0.09335219236209336,0.3358088384075337,1.0,8/13,21.19%,GLUL;DDAH1;GLS2;GLS;NOS2;GLUD1;GAD1;ALDH4A1
prerank,negative regulation of neuron differentiation (GO:0045665),0.5829080346798693,1.3741694356431984,0.09898477157360407,0.33569771537374826,1.0,7/22,15.99%,B2M;CALR;CNTN4;HES1;SOX9;HEY1;DLL1
prerank,regulation of cation channel activity (GO:2001257),0.48867986261841667,1.3729665811744547,0.031413612565445025,0.33816179675299607,1.0,39/89,25.11%,CALM1;CTSS;NLGN1;GRIA2;ANK3;FKBP1A;DLG2;SHISA7;NEFL;FGF14;AHNAK;GRIN1;GRIA4;GRIN2A;CRH;VAMP2;FGF11;FGF12;GRIA1;JPH4;LRRC7;KCNE5;MAPK8IP2;FGF13;CACNG8;FKBP1B;GRIN2B;CACNG5;SELENON;CALM2;MEF2C;CACNB4;GRIA3;KCNAB1;CACNG2;APP;SHISA6;PRRT1;PRKACA
prerank,cellular response to decreased oxygen levels (GO:0036294),0.49553011675907765,1.3729660830469852,0.05585980284775466,0.3376773242648113,1.0,26/65,21.57%,MT3;HMOX1;PINK1;KCND2;ZFP36L1;EPAS1;PGK1;HIPK2;NDRG1;BNIP3L;P4HB;FMN2;AQP1;AK4;ACAA2;PMAIP1;EGLN2;BAD;LMNA;TWIST1;NOP53;SFRP1;MYC;SIRT2;HYOU1;STUB1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5067860154207658,1.3726410182753854,0.06840390879478828,0.3379852059457713,1.0,25/57,22.11%,CTSD;NDUFA13;LGMN;GPER1;TNF;GRIN1;FOXL2;GRIN2A;HMGB1;PDCD6;PMAIP1;RIPK2;BAD;BCAP31;PDCD5;SYK;GRIN2B;NLRP3;MYC;BAK1;PYCARD;FIS1;CYCS;PPM1F;REST
prerank,prostaglandin metabolic process (GO:0006693),0.5732659704336457,1.3724463472492536,0.07371007371007371,0.33800903229235746,1.0,7/26,14.87%,CD74;PTGDS;GSTM1;MIF;PRXL2B;HPGDS;PTGES3
prerank,anterior/posterior pattern specification (GO:0009952),-0.346649200197166,-1.3723968426794768,0.03571428571428571,0.5061289416636209,1.0,19/53,16.73%,WLS;HOXB6;HOXB3;HOXA3;LRP5;SKI;HOXB4;HOXA5;HOXC4;TGFBR1;HOXB5;PCSK5;HOXC6;HOXA6;HOXC5;SMAD2;HEY2;BMPR2;ACVR2B
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6371259053158107,1.3717710311995779,0.10739191073919108,0.3391777388706059,1.0,4/13,8.93%,CD81;ITGB2;FCER1G;LPL
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4784259177646323,1.3717375351597167,0.026096033402922755,0.3387887026664692,1.0,28/98,20.94%,APOE;CD63;MT3;CHCHD2;AKT1;APOC1;AGT;SLCO1C1;PDGFB;ROMO1;GHITM;VAMP3;STARD4;FASN;DCXR;RAMP3;KLF4;SFRP4;NR1H2;ARRB2;SNCA;PRELID1;CBR1;INHBA;TGFB1;IL10RB;NFKBIA;GADD45A
prerank,regulation of primary metabolic process (GO:0080090),0.4709752473197903,1.3713819037097081,0.0296220633299285,0.33912089547040636,1.0,28/126,12.63%,APOE;PSAP;PSMB4;PSME1;PSMB6;PSME2;PSMB8;OAZ1;PSMD2;CERS2;NR1D1;PSMD1;PSMC3;PSMD6;PSMA7;EDF1;LSS;PSMD5;SIN3B;PSMB9;FASN;PSMD13;SCD;PSMB3;SC5D;PSMB11;NCOR2;ODC1
prerank,regulation of cholesterol efflux (GO:0010874),0.5580004339732009,1.3705585493965884,0.07785888077858881,0.3406653658519194,1.0,3/30,2.84%,APOE;PLTP;TREM2
prerank,spermatid development (GO:0007286),-0.40745877691374177,-1.3704887248634332,0.08074534161490683,0.5071773812021928,1.0,18/32,32.44%,CDYL;RNF8;ING2;NECTIN2;RFX2;SYCP3;JAM2;ZMYND15;CIB1;YTHDC2;MKKS;ACRBP;DPY19L2;TDRD5;CCDC63;RSPH1;SOX30;TTC21A
prerank,regulation of chemokine production (GO:0032642),0.535697249708238,1.370270760991681,0.07790697674418605,0.3409126363277719,1.0,19/36,26.10%,CD74;HMOX1;TREM2;TNF;LPL;EGR1;CSF1R;WNT5A;AIF1;F2RL1;SIGIRR;ADAM17;IL6;PYCARD;APP;AGER;IL33;TLR7;ACKR1
prerank,regulation of actomyosin structure organization (GO:0110020),-0.5059707310194097,-1.3700542823089996,0.1245674740484429,0.5047600092565798,1.0,6/13,2.52%,ROCK2;AKAP13;ASAP3;ALMS1;SLC9A1;ROCK1
prerank,negative regulation of cation channel activity (GO:2001258),0.5612685665704984,1.3698591022147522,0.08302354399008674,0.34143584644393804,1.0,9/26,19.10%,CALM1;CALM3;FKBP1A;GSTO1;GSTM2;CBARP;SRI;FKBP1B;CALM2
prerank,epithelium development (GO:0060429),0.4717125350818228,1.369661374591771,0.025853154084798345,0.34143806373865526,1.0,22/107,13.45%,CTSB;TAGLN;ALDOC;TAGLN2;ACADVL;RCN3;SOX18;CD34;TOLLIP;LGALS3;NDRG4;PGK1;PROX1;KDR;MFSD2A;DNPH1;PIH1D1;SOX17;PCNA;SOX8;SOX9;BMP2
prerank,protein K48-linked ubiquitination (GO:0070936),-0.34723867800967756,-1.3690787202393324,0.022727272727272728,0.5037486531009759,1.0,15/54,11.10%,UBE2E2;TTC3;RNF216;RNF152;UBR5;PRKN;RNF146;ARIH2;UBE2R2;UBE2Q2;RNF8;ZNRF1;TOPORS;ITCH;RNF115
prerank,regulation of protein dephosphorylation (GO:0035304),0.5384693324884916,1.3689585825587072,0.08237986270022883,0.34271526327500795,1.0,16/37,21.18%,PPIA;CALM1;CALM3;HSP90B1;YWHAB;PIN1;SMPD1;ARPP19;DLC1;CDH5;PPP1R15A;NSMF;CALM2;TGFB1;CAMTA1;PPP2R5A
prerank,regulation of protein ubiquitination (GO:0031396),0.478831644679159,1.3689166044465155,0.01964839710444674,0.34231411462967687,1.0,32/108,16.86%,RPS3;UBB;HSP90AA1;HSP90AB1;LAPTM5;PARK7;UBXN1;AKT1;PINK1;FKBP1A;HSPA1B;BAG5;TNFAIP3;FAM107A;FOXF2;ISG15;CENPX;PTTG1IP;ADGRB1;DNAJA1;WFS1;VPS28;DNAJB2;NSMCE3;HSPA1A;FBXW7;IVNS1ABP;RIPK2;HSPBP1;ARRB2;CAV1;SQSTM1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.4224458455215717,-1.3686546025626685,0.07100591715976332,0.5011234638384408,1.0,12/25,22.05%,SF3B1;TRA2B;MPHOSPH10;SRRM1;SCAF11;PRPF3;SF3B3;PRPF4;SLU7;DDX23;LSM1;PRPF6
prerank,peptidyl-amino acid modification (GO:0018193),0.6733163509288562,1.3686523535721868,0.11931818181818182,0.3424998418481045,1.0,5/10,15.29%,METAP1;FKBP10;FKBP7;METAP2;PDF
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.6804010964648094,1.3683858752187041,0.11208151382823872,0.34265634718151916,1.0,2/10,2.58%,CALM1;CALM3
prerank,monocarboxylic acid transport (GO:0015718),-0.3547821255362327,-1.3681455291577223,0.06593406593406594,0.49895193089116463,1.0,12/51,12.66%,SLCO3A1;SLC6A13;SLC16A12;NCOA1;SLC6A12;SLC16A9;ABCG2;SLCO2A1;ABCB4;SLC16A6;SLC16A13;ATP8B1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.5726758942818537,1.368091240001951,0.1093167701863354,0.3429516144175787,1.0,6/23,5.24%,CD74;MDK;CCL19;RAC1;CAMK1D;TIRAP
prerank,positive regulation of glucose import (GO:0046326),-0.4405690485590896,-1.3678257764249024,0.10416666666666667,0.4963489944352137,1.0,10/21,16.96%,SORBS1;OSBPL8;IRS1;INSR;IGF1;PRKCI;CREBL2;RHOQ;OCLN;APPL1
prerank,UV protection (GO:0009650),0.6696598290890223,1.3676586517430644,0.12482065997130559,0.3434940842471746,1.0,5/10,13.89%,GPX1;MFAP4;SDF4;MC1R;CAT
prerank,cellular response to gamma radiation (GO:0071480),0.5938271151833907,1.3674051968325032,0.11688311688311688,0.34363356961992064,1.0,4/17,12.02%,RPL26;CRYAB;TMEM109;HRAS
prerank,positive regulation of B cell activation (GO:0050871),0.5025842308935781,1.367395865789382,0.07547169811320754,0.3431733481497302,1.0,14/50,20.07%,CD74;CD81;PTPRC;MIF;TIRAP;TFRC;IL2;VAV3;SH3KBP1;MMP14;SYK;GPR183;IL6;MEF2C
prerank,regulation of intracellular transport (GO:0032386),0.5262938225130007,1.3657883526464125,0.07900943396226415,0.34657942358304067,1.0,12/38,11.11%,LAMP1;CRYAB;NEFH;REEP5;MLC1;REEP6;MAP2;LCP1;ATP13A2;DNAJC30;GAS1;HAP1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.548054503113316,1.3653110595866684,0.08421052631578947,0.3472804974609956,1.0,11/31,15.07%,CHCHD10;YWHAB;YWHAH;YWHAE;YWHAG;BAX;PMAIP1;YWHAQ;YWHAZ;BBC3;BAD
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.6705341820040984,1.365188067437684,0.11473087818696884,0.34707424976526824,1.0,6/10,24.76%,CCT2;CCT7;CCT8;DKC1;CCT4;CCT3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.6358248916999947,1.3642014711955064,0.1092896174863388,0.34904303349196764,1.0,1/13,0.38%,RPS21
prerank,protein localization to chromatin (GO:0071168),-0.46530033354767275,-1.3641088011767932,0.08906882591093117,0.5021824804559631,1.0,7/18,12.24%,NIPBL;WAPL;TASOR;ESR1;PPHLN1;MRNIP;LRWD1
prerank,negative regulation of B cell activation (GO:0050869),0.5868726335321981,1.3639677757816386,0.09974424552429667,0.34914800802467094,1.0,11/21,25.30%,TYROBP;LAPTM5;TNFAIP3;CTLA4;CD300A;INHBA;SFRP1;ID2;BANK1;TNFRSF13B;INHA
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5910937239068419,1.3639364332571986,0.1034928848641656,0.34873518014271276,1.0,7/20,5.04%,VTN;S100A11;IGFBP3;PDGFB;IGFBP5;SORL1;NDRG4
prerank,negative regulation of catabolic process (GO:0009895),0.5050078136130043,1.363775665515299,0.0764904386951631,0.3487070542081317,1.0,10/47,10.10%,CST3;APOC1;TNF;PIN1;BSCL2;FLNA;PDE3B;FMN2;NUPR1;ADGRB1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.48699362712708305,1.363261469781372,0.04597701149425287,0.3494719409664032,1.0,32/80,22.11%,CTSD;GPX1;MT3;NDUFA13;AKT1;ARL6IP1;GPER1;TNF;LAMTOR5;YWHAE;BEX3;FOXL2;AQP1;DHCR24;HMGB1;PDCD6;PMAIP1;KLF4;GAS6;BAD;BCAP31;PDCD5;SYK;SNCA;NLRP3;HGF;MYC;PYCARD;FIS1;CYCS;PPM1F;REST
prerank,receptor internalization (GO:0031623),0.5132881951497256,1.3626238472508834,0.064,0.35051252971482666,1.0,16/44,19.27%,CD81;RAMP2;ITGB2;FCER1G;DNM3;AP2M1;TFRC;CLTC;RAMP3;LILRB1;ARRB2;CAV1;SYK;SNCA;GRK2;RAB31
prerank,positive regulation of cell junction assembly (GO:1901890),0.5054604201501222,1.3625517512304908,0.06054054054054054,0.3502153589025579,1.0,28/56,23.79%,CLDN5;NRXN1;NLGN1;S100A10;AGT;GRID2;CNTNAP2;RAC1;FLOT1;IL1RAPL1;THY1;KDR;PTPRD;SYNDIG1;IRX3;LRRC4B;EPHB1;CAV1;CLSTN2;CLSTN1;CRB3;SFRP1;IL1RAP;CLSTN3;COL16A1;PPM1F;WNT7A;TEK
prerank,prostanoid biosynthetic process (GO:0046457),0.6231535569752018,1.361869300415231,0.11298701298701298,0.3514916313211519,1.0,4/15,9.20%,CD74;PTGDS;MIF;PRXL2B
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5363357115812663,1.3614083728128992,0.07829181494661921,0.3521321984218413,1.0,6/35,7.58%,APOE;SPARC;ATP5F1A;CAV2;ATP5IF1;VASH1
prerank,cholesterol metabolic process (GO:0008203),0.4887256968699003,1.3610940889512149,0.04930332261521972,0.35243598925513986,1.0,18/68,23.49%,APOE;MT3;SNX17;ABCG1;LSS;DHCR24;PIP4P1;ACAA2;CLN6;SOAT2;CLN8;CH25H;PLPP6;OSBPL1A;FDPS;NSDHL;PMVK;ACLY
prerank,atrial septum development (GO:0003283),-0.5249057320521497,-1.360181012024074,0.10909090909090909,0.5085061158394352,1.0,7/13,19.43%,NOTCH2;ANK2;MDM4;NPHP3;HEY2;BMPR2;DAND5
prerank,mesonephric tubule development (GO:0072164),-0.4868238600729312,-1.3599260285408978,0.11382113821138211,0.5057710824233131,1.0,7/15,19.40%,SLIT2;FGFR2;PKD1;SIX1;WNT11;BMP4;PKD2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.4607407979660031,-1.3599016066065301,0.11587982832618025,0.5024814367398649,1.0,7/17,14.17%,CACNA1C;ANK2;ATP1A2;TRPM4;KCNJ2;CACNA1G;CACNA1D
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3802852128821758,-1.359619058676497,0.07142857142857142,0.4999780515442443,1.0,10/38,14.95%,MGA;YAF2;EHMT1;EPC1;PHC3;APAF1;RBBP8;TFDP1;EHMT2;EZH2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.48508951565983915,1.3594309517181917,0.04266389177939646,0.3560898473419914,1.0,29/87,16.22%,PSMB4;GPNMB;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;ZFP36L1;PSMC3;ZFP36L2;PSMD6;GPR132;FAM107A;PSMA7;JADE1;PSMD5;RBX1;CDK2AP2;PSMB9;PSMD13;PSMB3;PSMB11;KLF4;FBXO5;PSMB10;CCL2;PSMB1;PSMB5
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.673240427657841,1.3588103837858052,0.10041265474552957,0.3566508762403764,1.0,6/10,23.50%,AP2M1;CLTC;AP2S1;CLTA;AP2A1;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.673240427657841,1.3588103837858052,0.10041265474552957,0.3566508762403764,1.0,6/10,23.50%,AP2M1;CLTC;AP2S1;CLTA;AP2A1;VLDLR
prerank,calcium ion homeostasis (GO:0055074),0.47236448054882263,1.3586065015703475,0.0383419689119171,0.35664683401508507,1.0,28/95,19.55%,TPT1;CALR;SLC30A1;CXCL12;CCL19;SLC24A4;SLC24A2;TMTC2;GRIN1;DRD5;TMCO1;HTR2C;ATP13A2;CALCB;WFS1;ATP2B1;ATP1B1;SLC8A1;RYR2;CCL3;CAV1;CDH5;CCL8;CCR2;SELENON;EDN3;SNCA;TFAP2B
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5770105287595352,1.3584786332458887,0.09737827715355805,0.3564784256398134,1.0,9/22,16.24%,TREM2;NR1D1;FLOT1;TIRAP;TNFAIP3;TICAM2;NINJ1;F2RL1;DAB2IP
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.46636029952324054,1.3579454856415518,0.028836251287332648,0.3573284909454554,1.0,42/124,20.31%,APOE;PLP1;NLGN1;BLOC1S4;CNTNAP2;RAC1;CNTN4;SH3GL2;GPM6B;GPRIN1;UHMK1;STMN3;MANF;LGI1;PQBP1;ATP1B2;PRDM12;MAPT;MAP2;STMN4;CDK5R1;HMGB1;BLOC1S1;CSF1R;BLOC1S3;BLOC1S5;PRMT1;STMN1;GPRIN2;EHD1;CDK5;NCDN;ADCYAP1;TMEM108;ERCC6;GPM6A;RASGRF1;ATCAY;IL6;VAPA;POU4F1;CTTN
prerank,endothelial tube morphogenesis (GO:0061154),0.6664102038679932,1.3575872347537385,0.1206896551724138,0.35784970537469635,1.0,5/10,13.17%,RHOB;CSNK2B;ACVRL1;CTNNB1;RHOA
prerank,maturation of LSU-rRNA (GO:0000470),0.5546518923218096,1.3574389056712055,0.0925700365408039,0.35771863546329,1.0,4/26,2.38%,RPL7;RPL7A;RPL35;RPL10A
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5869607585309696,1.3571535832152863,0.10128205128205128,0.35794389672099014,1.0,7/19,19.15%,MDK;MAPK3;CAMK1D;RARRES2;CSF1R;JAM3;CXCL17
prerank,regulation of chemotaxis (GO:0050920),0.5501841873002756,1.3567962990582518,0.08902439024390243,0.3584108095011916,1.0,15/30,21.84%,CCL19;TREM2;PDGFB;DUSP3;RARRES2;P2RY12;AIF1;ZSWIM8;CXCR4;F2RL1;YTHDF1;STX4;GPR183;TGFB1;PPM1F
prerank,connective tissue development (GO:0061448),-0.3952916049748876,-1.35669355568443,0.04081632653061224,0.5039290310845876,1.0,11/35,11.14%,SULF1;SOX5;ZBTB16;LRP5;SLC39A13;ATP7A;ITGB8;ARID5B;PKD1;SPTLC2;CREB3L2
prerank,relaxation of muscle (GO:0090075),0.6372732366951586,1.3554727779149984,0.12975098296199214,0.3611985006639554,1.0,7/13,15.37%,GSN;RGS2;PLN;GSTM2;ATP1A1;ATP1B1;SLC8A1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5881435936165103,1.3553402332742834,0.11704834605597965,0.3610294736882308,1.0,10/18,27.17%,CCT2;NOP10;CCT7;NHP2;CCT8;DKC1;CCT4;NAF1;CCT3;RUVBL2
prerank,regulation of protein localization to Cajal body (GO:1904869),0.6554780606657924,1.3550736373347418,0.12073863636363637,0.3607124296832615,1.0,7/11,24.76%,CCT2;CCT7;CCT8;MEPCE;DKC1;CCT4;CCT3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.6554780606657924,1.3550736373347418,0.12073863636363637,0.3607124296832615,1.0,7/11,24.76%,CCT2;CCT7;CCT8;MEPCE;DKC1;CCT4;CCT3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5605510628230234,1.3548108393632106,0.09987357774968394,0.36088083908403823,1.0,8/24,10.88%,PEX5L;SCTR;APLNR;PDE3B;CDC34;PRKAR1A;GNAI1;PRKAR1B
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6016867022565872,1.3542863731964216,0.10185185185185185,0.3617187856509907,1.0,9/17,19.15%,CXCL12;LGMN;CXCL10;CREB3;HMGB1;PLA2G7;AIF1;CCR2;CXCL17
prerank,response to nutrient levels (GO:0031667),0.5959915420484874,1.35425534333046,0.1102257636122178,0.36130238339526155,1.0,4/17,9.67%,ATF4;SCTR;FAM107A;CD68
prerank,positive regulation of ruffle assembly (GO:1900029),0.6370463447377894,1.353593217924788,0.11950549450549451,0.3624996194316441,1.0,5/13,12.02%,NLGN1;PFN1;P2RY12;DEF8;HRAS
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5934340361146568,1.3535734339469185,0.12450331125827814,0.36206507585533393,1.0,5/17,14.60%,AKAP6;ANK3;VAMP2;KCNE4;KCNE5
prerank,ceramide transport (GO:0035627),0.6458896421937362,1.3532771446783218,0.11691884456671252,0.36233057718318407,1.0,2/12,1.44%,PSAP;PLTP
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.61760560289994,1.3523798766043722,0.12234042553191489,0.3641054322464254,1.0,1/14,0.01%,TMSB4X
prerank,negative regulation of phagocytosis (GO:0050765),0.6008482701794078,1.3523193227407884,0.11932555123216602,0.3637741317584189,1.0,6/17,17.78%,RACK1;SIRPA;SYT11;HMGB1;CD300LF;CD300A
prerank,regulation of axon extension (GO:0030516),0.5234053066847948,1.352047532227334,0.09175377468060394,0.363944433449598,1.0,8/37,9.07%,APOE;MT3;SEMA7A;RTN4;NRCAM;MAPT;MAP2;NTN1
prerank,regulation of RNA export from nucleus (GO:0046831),-0.5319951352055551,-1.3519626354174594,0.1180327868852459,0.5122359923174279,1.0,6/11,21.61%,SETD2;IWS1;AKAP8L;CPSF6;KHDRBS1;TPR
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6397415541700333,1.3519118562743144,0.11253561253561253,0.3637951262751842,1.0,5/12,15.67%,HSP90AA1;HSP90AB1;B4GALT6;SPTBN4;EPHB1
prerank,BMP signaling pathway (GO:0030509),-0.3526317216094423,-1.3516926991912057,0.030303030303030304,0.5095869799315387,1.0,22/62,16.73%,BMP6;TGFBR3;SMAD3;SMAD6;ACVR1;BMPR1A;SMAD9;SMURF1;SMAD1;SMAD7;GDF1;RGMA;SMAD4;PDCD4;HIVEP1;BMP4;SMAD2;TGFB3;RUNX2;ACVR2A;BMPR2;ACVR2B
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.6486735674595738,1.3509159719030908,0.1267806267806268,0.36586314574835954,1.0,3/11,7.08%,HSPA5;ATF4;CEBPB
prerank,negative regulation of inflammatory response (GO:0050728),0.45689118266668816,1.3505732150995737,0.005030181086519115,0.36621428364202163,1.0,45/182,19.87%,APOE;RPS19;RAMP2;MDK;GRN;TREM2;POMC;GPER1;NR1D1;LRFN5;SCTR;SIRPA;TNFAIP3;DRD5;CD163;FEM1A;RXFP1;OTULIN;PRKAR1A;VIPR1;CRH;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;KLF4;ADCY4;TNFRSF1A;FNDC4;TYRO3;ADCY8;HTR7;CDH5;PRKAR2B;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;CXCL17;NLRP3;IL6;GIT1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6190463006614639,1.3500193770482851,0.11859838274932614,0.3671526480864511,1.0,8/15,17.44%,MAGEL2;IQGAP2;ARPC1B;ARPC3;ARPC5;ARPC5L;ARPC4;ARPC2
prerank,cellular response to leucine (GO:0071233),-0.5640879369491079,-1.3499172450976322,0.13333333333333333,0.5073393788268001,1.0,8/10,25.91%,UBR1;UBR2;SESN1;LARS1;KLHL22;RPTOR;SESN2;SESN3
prerank,response to leucine (GO:0043201),-0.5640879369491079,-1.3499172450976322,0.13333333333333333,0.5073393788268001,1.0,8/10,25.91%,UBR1;UBR2;SESN1;LARS1;KLHL22;RPTOR;SESN2;SESN3
prerank,positive regulation of calcium ion transport (GO:0051928),0.5222337398273277,1.3496629862023615,0.10070257611241218,0.3675525630581971,1.0,12/36,16.88%,CXCL12;PDGFB;LGALS3;GRIN1;P2RX7;LILRA5;WFS1;ATP2B1;CCL2;CCL3;CAV1;ORAI1
prerank,cellular metal ion homeostasis (GO:0006875),0.46705254129708645,1.3496513018429872,0.04488517745302714,0.3670978309398825,1.0,29/102,18.94%,TPT1;CALR;MT3;SLC30A1;CXCL12;CCL19;SLC24A4;SLC24A2;DRD5;ATP1A3;ATP1B2;TMCO1;HTR2C;ATP13A2;CALCB;ATP1A4;ATP1A1;ATP2B1;ATP1B1;SLC8A1;RYR2;CCL3;CAV1;CDH5;CCL8;ATP1B3;CCR2;KCNMA1;EDN3
prerank,positive regulation of signaling (GO:0023056),0.5316836354873199,1.3495037026854608,0.08868144690781797,0.3669968215157498,1.0,17/37,20.87%,TNF;GRIK2;SYT1;LGI1;RIMS2;RIMS1;VAMP3;RAMP3;HCRT;CLSTN2;CLSTN1;NMB;KCTD13;EDN3;SOX11;SNCA;CLSTN3
prerank,positive regulation of angiogenesis (GO:0045766),0.47130425563297973,1.3478443580356743,0.038461538461538464,0.3707200727630723,1.0,32/108,17.05%,S100A1;RAMP2;MDK;HSPB1;GRN;HMOX1;RHOB;CD34;PKM;ECM1;APLNR;ADAM12;EMC10;BTG1;HIPK2;KDR;AQP1;TNFSF12;GATA2;NINJ1;PDCD6;WNT5A;KLF4;TIE1;CTSH;RRAS;DLL1;FLT1;GATA4;CDH5;PIK3CD;TWIST1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6214812730600836,1.3470219535398822,0.125,0.37235336103414635,1.0,2/14,1.61%,RPL7;RPL35
prerank,carbohydrate biosynthetic process (GO:0016051),-0.44994886908368537,-1.3468367162312394,0.09137055837563451,0.511633364905241,1.0,9/21,19.97%,ST3GAL4;B4GALT1;ST3GAL3;FUT8;B3GALT1;ST6GALNAC6;ST3GAL2;ST3GAL6;ST6GALNAC5
prerank,positive regulation of bone resorption (GO:0045780),0.645170773230777,1.3466974513101395,0.13991769547325103,0.37275785971904835,1.0,6/11,25.10%,SPP1;ATP6AP1;DEF8;SYK;TNFRSF11A;PRKCA
prerank,MAPK cascade (GO:0000165),0.45189177757965315,1.346475609749876,0.002,0.37279022161263037,1.0,94/295,20.67%,RPS27A;UBC;CALM1;UBB;MBP;PSMB4;MT3;MAPK3;PSME1;PSMB6;PSME2;PSMB8;NRG1;PSMD2;ERBB4;IL5;RCE1;LAMTOR2;PEBP1;TNF;PDGFB;YWHAB;DLG2;PSMD1;ZFP36L1;NEFL;PSMC3;ZFP36L2;YWHAE;PSMD6;IL2RB;GRIN1;SHC3;UBA52;PSMA7;CCR5;PAK1;KDR;IL2;PSMD5;RBX1;ABHD17A;KARS1;ZFP36;KITLG;ICMT;PSMB9;RASGRP3;PSMD13;PSMB3;IL2RG;IL3RA;HRAS;GFRA1;PSMB11;SOX9;LAMTOR3;PSMB10;KBTBD7;CTSH;CCL2;LRRC7;ARL2;MAPK11;GOLGA7;PDGFA;CSF2RB;RASGRP1;SPTBN4;FGF13;PSMB1;GFRA2;PSMB5;DAB2IP;CCL3;SPTBN2;NCAM1;RASGRF1;ERBB3;GRIN2B;PLVAP;MAP2K2;KLB;PSMA6;SOS1;FLT3;HGF;TGFB1;CSF2RA;MEF2C;SKP1;PSMA4;MYC;BRAP
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5765973958527737,1.3464415588221963,0.11572327044025157,0.37239587585814476,1.0,6/20,16.01%,ACADVL;APOC1;GPER1;FBXW7;BMP2;ABCA2
prerank,positive regulation of biosynthetic process (GO:0009891),0.5126623355131797,1.344882819759555,0.08255813953488372,0.37576337576521357,1.0,8/40,10.10%,APOE;VIM;AKT1;CYBA;GRIN1;HSD17B13;MLXIPL;ADGRB1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.6664472304435087,1.344360529387143,0.13177159590043924,0.3765791883257288,1.0,6/10,25.01%,APLNR;PDE3B;CDC34;PDE11A;PDE2A;RNF157
prerank,regulation of cell motility (GO:2000145),0.4616622165524435,1.3436719341119452,0.03067484662576687,0.3778317764477135,1.0,24/121,10.78%,TMSB4X;TMSB10;CAVIN1;RHOB;AKT1;CCL19;SPOCK2;SERPINE2;NRG1;ERBB4;RAC1;PIN1;FLNA;FRMD5;ENPP2;SGK1;PKN1;ROBO4;SPOCK3;NTN1;CADM4;PHPT1;CSF1R;DOCK10
prerank,negative regulation of TOR signaling (GO:0032007),-0.36817796480048465,-1.3435309562038447,0.05517241379310345,0.5167966844519893,1.0,16/36,23.13%,RNF152;FNIP1;UBR1;UBR2;PRKAA2;SESN1;ATM;DEPTOR;SIRT1;TSC1;ITFG2;SPAAR;CASTOR2;CASTOR1;KPTN;SESN2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.630645161861303,1.3429591616671528,0.12464985994397759,0.3790912332445187,1.0,5/13,15.47%,CLU;MANF;NUPR1;WFS1;NR1H2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.4653287217698075,1.3426105622638744,0.017311608961303463,0.37953767584848164,1.0,41/145,16.89%,TUBB;TUBA1A;PSMB4;HSP90AA1;TUBB4B;DYNLL1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;TUBA4A;PSMD1;DCTN3;PSMC3;PPP2R1A;YWHAE;PSMD6;GPR132;PSMA7;CCND1;CLASP1;YWHAG;TUBB4A;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;CEP131;PSMB11;DCTN1;FBXO5;PSMB10;SSNA1;HAUS2;DCTN2;PSMB1;PSMB5;CETN2;PRKAR2B
prerank,mononuclear cell differentiation (GO:1903131),0.55501535616893,1.342320344189076,0.11246943765281174,0.37971634520860825,1.0,11/24,20.15%,MT1G;TREM2;IKZF1;IRF8;CSF1R;TRPM2;LILRB1;GAS6;BATF3;FLT3;PDE1B
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.3927109819625084,-1.3422550481479025,0.09883720930232558,0.516495886777596,1.0,10/29,15.71%,TCF7L2;CREBBP;TLE1;PYGO1;BCL9L;ASH2L;TERT;KMT2D;TLE3;CDC73
prerank,organic substance transport (GO:0071702),0.46639183859489874,1.3422515132016566,0.03806584362139918,0.3794213291147536,1.0,31/121,17.51%,RAMP2;PLTP;GM2A;RCN3;SLC18A1;LRP1B;TXNIP;HSP90B1;ABCB6;ABCG1;CHMP2B;TAP2;RD3;ARRDC1;SCAMP3;MFSD2A;SLC6A2;VAMP2;SLC50A1;ATP8A1;SLC48A1;RAMP3;CMTM6;NME4;SLC19A1;SCAMP2;ARRDC3;CHMP1B;ABCA2;MFSD2B;CLN8
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5381824725031938,-1.3421879500558465,0.13804713804713806,0.5134561840812624,1.0,1/10,0.23%,BMP6
prerank,histone H4-K16 acetylation (GO:0043984),-0.43453485716562196,-1.3415191522086025,0.12206572769953052,0.5118761190581991,1.0,6/19,18.15%,OGT;KMT2A;KAT7;KANSL3;JADE2;KAT8
prerank,glutamate metabolic process (GO:0006536),0.5770851487036249,1.341168415277526,0.1229404309252218,0.38169932394231915,1.0,8/19,21.67%,OAT;GLUL;GLS2;GLS;GLUD1;GOT1;GAD1;MTHFS
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6616772837319792,1.341009019446919,0.12931034482758622,0.3816580103652066,1.0,4/10,9.63%,RACK1;FZD9;KDR;DCN
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5620151690039162,1.3406627368147128,0.11352657004830918,0.3820555058127351,1.0,11/21,25.43%,BGN;BCAN;DCN;CHPF2;CHPF;UGDH;VCAN;CSGALNACT2;CHSY3;CHST9;CSPG5
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.657327580168389,1.3406348796957,0.13323353293413173,0.381607088523883,1.0,1/10,1.05%,CD81
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.49840266301781133,-1.3405737203474017,0.13725490196078433,0.5112646269483794,1.0,7/13,22.30%,SNX6;CBLB;ERRFI1;SOCS5;GPRC5A;CBL;TSG101
prerank,defense response to symbiont (GO:0140546),0.4726133309977989,1.3405379356203893,0.04677754677754678,0.38136670250903026,1.0,30/92,22.14%,IFITM3;IFITM2;IFITM1;SHFL;PTPRC;RNASE1;SERINC3;NT5C3A;FLNA;ISG15;PQBP1;BNIP3L;AGBL4;IFIT1;PMAIP1;BST2;LILRB1;PDE12;IRF7;SERINC5;F2RL1;G3BP1;OAS3;IL6;DDIT4;PYCARD;RSAD2;EXOSC4;IFI27;ISG20
prerank,presynapse organization (GO:0099172),0.6608866831408595,1.3402796667543315,0.13777777777777778,0.3814938208396718,1.0,6/10,23.03%,NLGN1;C5AR1;WNT5A;LRRTM3;FZD1;WNT7A
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4731380193750229,1.3399432997356702,0.05213764337851929,0.3819219957205174,1.0,20/88,13.45%,APOE;SPARC;AKT1;ATP5F1A;PDGFB;ACVRL1;ANG;ECM1;CAV2;ATP5IF1;EMC10;VASH1;PROX1;KDR;TNFSF12;PDCD6;WNT5A;FLT4;TIE1;BMP2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.6152381327368582,1.3398651483543589,0.1296043656207367,0.3816096929184803,1.0,8/13,32.36%,ELOVL1;ELOVL2;TECRL;ELOVL7;ELOVL6;HACD4;ELOVL4;ELOVL5
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5922650998919101,1.3396611867139758,0.11025641025641025,0.38162749082252684,1.0,6/19,12.78%,KLF2;SLCO1C1;TNF;PDGFB;WFS1;KLF4
prerank,neutrophil activation (GO:0042119),0.627409126878026,1.3393797463029464,0.13636363636363635,0.38183584210121024,1.0,4/12,17.99%,TYROBP;FCER1G;F2RL1;SYK
prerank,negative regulation by host of viral transcription (GO:0043922),0.6173797861896912,1.3390969618327304,0.14345991561181434,0.3821618540894841,1.0,9/12,34.40%,PSMC3;JUN;TARDBP;CCL3;TFAP4;REST;POU2F3;CCL5;HMGA2
prerank,mitochondrion disassembly (GO:0061726),0.5366272644885626,1.338778984183634,0.09404761904761905,0.3824907599648553,1.0,7/34,5.66%,GABARAP;MAP1LC3B;PINK1;MAP1LC3A;GABARAPL2;GABARAPL1;ATG9A
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.48976119254119027,1.3385695345315782,0.06779661016949153,0.3825147875351994,1.0,30/65,26.18%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;GPR132;PSMA7;PSMD5;RBX1;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;VPS4A;PSMA6;SKP1;PSMA4;PSMC1;PSMD9;PSMB2;PSMD4;CHMP4C;PSMD10
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6680330360625183,1.3384187253345996,0.1339031339031339,0.3819363269214213,1.0,4/10,20.24%,RACK1;TNF;TNFRSF1A;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6680330360625183,1.3384187253345996,0.1339031339031339,0.3819363269214213,1.0,4/10,20.24%,RACK1;TNF;TNFRSF1A;SPHK2
prerank,T cell proliferation (GO:0042098),0.6272816407710141,1.3381825223427977,0.1226158038147139,0.3820648119644903,1.0,5/13,15.62%,MSN;SLC11A1;LILRB1;DOCK8;RASGRP1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.45682307701962116,1.3381599734822847,0.015151515151515152,0.38162996332207766,1.0,41/166,16.45%,RPL26;RPS4X;RPL5;CLU;EEF2;VIM;HSP90AA1;HSP90AB1;PARK7;AKT1;KLF2;CCL19;EIF3D;NPM1;RPS27L;TNF;PDGFB;NR1D1;MID1IP1;CTDNEP1;EIF3C;MFSD2A;MLXIPL;STARD4;EGR1;DDB1;PCIF1;PCNA;ZCCHC4;KLF4;PRMT1;DDAH1;TLR6;ABCB10;ARPP19;IGF2;NR1H2;CIRBP;YTHDF1;EIF4A3;DDAH2
prerank,regulation of programmed cell death (GO:0043067),0.4568402023792097,1.3372098892959776,0.016227180527383367,0.38353047288224335,1.0,38/161,14.37%,TPT1;RPS3;CLU;CTSB;HSP90AA1;CALR;LGALS1;AKT1;NME1;TGM2;PINK1;AGT;IGFBP3;BEX2;MAGED1;TNF;PRDX2;RTN4;VCP;ALPK2;OMA1;NDRG1;BNIP3L;SGK1;CXCL10;TARDBP;GAS1;APEX1;BAX;ZBTB7A;WFS1;PMAIP1;ACTN1;PHLPP1;SOX9;NME2;GLS2;IKZF3
prerank,prostaglandin biosynthetic process (GO:0001516),0.5996229074588479,1.3369939186481725,0.10880829015544041,0.38365029124947625,1.0,6/18,14.87%,CD74;PTGDS;MIF;PRXL2B;HPGDS;PTGES3
prerank,ovarian follicle development (GO:0001541),0.6216250836530669,1.336636188341726,0.13835616438356163,0.3841437190557691,1.0,8/13,25.30%,SOD1;ANG;CEBPB;FOXL2;EIF2B5;INHBA;INHBB;INHA
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.5443699871141888,1.3365739690369725,0.1166077738515901,0.3838042580534756,1.0,12/27,20.93%,MDK;ITGB2;TNF;SIRPA;HSPD1;THY1;RHOA;CCL2;SKAP1;CCR2;IL6;PYCARD
prerank,primary miRNA processing (GO:0031053),-0.5245498631720988,-1.3365565772515309,0.1388888888888889,0.5178565833038093,1.0,5/10,15.02%,SMAD3;DROSHA;SMAD1;SMAD2;SRRT
prerank,C4-dicarboxylate transport (GO:0015740),0.6104416316991508,1.3357213800957575,0.1392904073587385,0.3855709636052635,1.0,10/14,30.04%,SLC1A2;SLC25A13;SLC25A11;SLC1A1;SLC25A22;SLC25A18;SLC25A14;SLC25A12;SLC13A5;SLC25A30
prerank,neural crest cell migration (GO:0001755),0.5217890787227608,1.3354222812987058,0.10693301997649823,0.385854248407479,1.0,10/36,13.41%,ERBB4;SEMA3F;SEMA7A;SEMA4C;FN1;CORO1C;SEMA6D;SEMA4A;SOX8;SEMA4G
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4998391434085643,1.3352582809002018,0.09162011173184358,0.3858027277372768,1.0,17/47,20.94%,TYROBP;SOD1;CYBA;ITGB2;AGT;PDGFB;ROMO1;GRIN1;MAPT;ADGRB1;DCXR;TLR6;F2RL1;SYK;CBR1;TGFB1;GADD45A
prerank,synapse organization (GO:0050808),0.462038498347177,1.3349888202970739,0.03363914373088685,0.3859420062029889,1.0,44/125,19.95%,C1QB;C1QA;CHCHD10;C1QC;NRXN1;SPOCK2;NLGN1;GRM5;ANK3;LRFN5;C5AR1;DSCAM;PIN1;LRP4;ADGRL3;DNM3;LRRC4C;MUSK;GPHN;KIRREL3;NRCAM;PPFIA4;PPFIA2;MAPT;PAK3;DNER;PTPRD;DOK7;NRXN2;DCTN1;CBLN2;LRRC4B;CX3CR1;ELFN1;PPFIA3;ACHE;CDK5;RAB39B;PCDHB14;GPM6A;CTNND2;SNCA;AGRN;POU4F1
prerank,androgen metabolic process (GO:0008209),0.5815803257293479,1.3347947515859953,0.11342894393741851,0.3860040303039356,1.0,4/18,12.81%,SPP1;HSD17B6;HSD17B4;HSD3B2
prerank,negative regulation of endocytosis (GO:0045806),0.5524257285049656,1.3347273347437723,0.11505507955936352,0.3856891741690749,1.0,11/24,19.37%,APOC1;LGALS3;RAC1;SYT11;ARF6;LILRB1;NR1H2;SNX33;CAV1;CD300A;UNC119
prerank,regulation of cellular protein metabolic process (GO:0032268),0.510824583061157,1.3345044465368645,0.091324200913242,0.38577084198367406,1.0,10/47,13.19%,APOE;RPL10;AKT1;GRM5;AGT;METAP1;PCIF1;RBM4B;KLF4;METTL18
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.6116223765392894,1.3340587889406608,0.13918918918918918,0.3864226664449999,1.0,8/15,27.66%,RACK1;TNF;ORMDL3;TNFRSF1A;SPHK2;ORMDL2;PLA2G6;SAMD8
prerank,positive regulation of proteolysis (GO:0045862),0.4969862065389703,1.334007405223011,0.09539473684210527,0.3860756734839925,1.0,18/55,22.29%,APOE;AURKAIP1;NDUFA13;RCN3;PINK1;TNF;ATP5IF1;CLN6;CTSH;BAD;SNX33;TRIM32;CTSC;WDR48;CAPN3;BAK1;STUB1;TNIP1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4869390404784018,1.3335346880093764,0.06703296703296703,0.38680070113604265,1.0,16/63,12.45%,CST3;MT3;TIMP2;AKT1;EIF4G2;TREM2;APOC1;RASIP1;SORL1;NELL1;MFSD2A;NUPR1;TIMP1;MTMR9;ATRAID;TIMP3
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.4634940512913043,1.333436709605818,0.031504065040650404,0.3865522395101644,1.0,60/124,28.47%,CALM1;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FZD9;RAC1;PSMD1;PSMC3;CTNNB1;PSMD6;AP2M1;SFRP5;PFN1;PSMA7;CLTC;PSMD5;AP2S1;PSMB9;PSMD13;GNAO1;WNT5A;PSMB3;PSMB11;RHOA;PSMB10;SFRP4;TIAM1;PSMB1;ARRB2;PSMB5;PRICKLE2;AGO1;ARHGEF19;PPP3CA;PSMA6;SFRP1;PSMA4;FZD2;FZD1;AP2A1;PPP3R1;PSMC1;PARD6A;WNT7A;PSMD9;PDE6G;CELSR3;PSMB2;PSMD4;PSMD10;FZD3;LEF1;PSMC5;VANGL2;FZD5;MAP3K7;CCDC88C
prerank,artery morphogenesis (GO:0048844),-0.39771822475181084,-1.3332805914372887,0.10365853658536585,0.5225206540215139,1.0,12/30,16.91%,BMPR1A;NRP1;ADAMTS9;TGFBR1;SMAD7;PDGFRB;LRP1;JAG1;BMP4;HEY2;BMPR2;NF1
prerank,protein localization to organelle (GO:0033365),0.4532612488132953,1.3331143136363002,0.03160040774719674,0.3868392449159607,1.0,28/133,11.98%,RPL11;LAMP1;CALR;COL1A1;HMOX1;SEC61B;PRNP;WDR83OS;TMEM30A;GABARAPL2;TOLLIP;AUP1;SEC61G;SORL1;IFT20;YWHAE;CTDNEP1;RPA2;ISG15;YBX1;VAMP2;ARF6;CD68;DNAJA1;MSX1;ZBTB7A;SERP1;ARL1
prerank,cAMP biosynthetic process (GO:0006171),-0.555017491760665,-1.332673754909866,0.14743589743589744,0.5208220103522734,1.0,4/10,10.19%,ADCY9;ADCY1;ADCY5;ADCY7
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6439764943210144,1.3326707140445917,0.13933236574746008,0.3875255693217088,1.0,2/11,2.84%,AKAP6;TREM2
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4717892101444508,-1.332511248194366,0.11965811965811966,0.5180549611732006,1.0,6/16,15.43%,FTO;RREB1;SIX1;SIRT1;NAPEPLD;SOX13
prerank,regulation of monooxygenase activity (GO:0032768),0.5584718032917668,1.3311184097322597,0.1172069825436409,0.3909984912305567,1.0,9/23,19.11%,CALM1;HSP90AA1;AKT1;CYGB;SPR;DDAH1;CAV1;DDAH2;SNCA
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5484925819273913,1.330933015157739,0.12546583850931678,0.3909871664560347,1.0,12/24,22.48%,CXCL12;NBL1;LGMN;CXCL10;CREB3;HMGB1;PLA2G7;AIF1;CCR2;CXCL17;CCN3;DUSP1
prerank,negative regulation of vascular permeability (GO:0043116),0.627551773426922,1.3302402311812629,0.13580246913580246,0.39228950570914783,1.0,3/12,5.39%,CLDN5;RAMP2;SH3GL2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.6200464565699703,1.3300866783154066,0.13369713506139155,0.3921804051137802,1.0,6/13,21.18%,BOLA2;GLRX5;LTO1;CIAO1;CIAO2A;CIAO2B
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.5008959213418596,-1.329196537572494,0.12786885245901639,0.5232126699288265,1.0,4/13,5.44%,ATG10;SENP6;UBA3;SAE1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6453374039910621,1.3290692465570284,0.1335149863760218,0.3943752634779439,1.0,3/10,3.67%,PARK7;TXN;GPR37L1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.44777506803532025,1.3289394055321677,0.019153225806451613,0.39421227417958665,1.0,65/214,20.03%,APOE;CD74;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;TNF;PDGFB;PTPRC;NTRK2;C5AR1;SEMA7A;PIN1;MIF;NDRG4;DUSP3;TIRAP;ATP6AP1;SIRPA;DDT;FN1;P2RY6;DUSP26;KDR;CCN2;HTR2C;P2RY1;HMGB1;CSF1R;RAMP3;FLT4;HRAS;CAMK2N1;PTPRR;TIMP3;FBXW7;CNKSR3;SPRY1;NEK10;BMP2;GAS6;YWHAZ;CCL2;RRAS;F2RL1;PDGFA;RASGRP1;EPHB1;ARRB2;ADRA1A;DAB2IP;CCL3;GATA4;ADCYAP1;CCL8;SYK;FAM83D;SPRY3;GPR183;NOTCH1;TGFB1;THPO
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5245786402128124,1.3286296131512945,0.11471610660486674,0.3945097677055232,1.0,11/36,17.48%,CD74;LAPTM5;HSPA1B;TICAM2;WNT5A;C1QTNF4;HSPA1A;GAS6;CXCR4;CD300LF;ADAM17
prerank,regulation of T cell activation (GO:0050863),0.5069867248050833,1.328569731030304,0.09725400457665904,0.39418785952899194,1.0,12/42,20.93%,LAPTM5;GPNMB;LGALS3;DUSP3;SIRPA;HSPD1;THY1;FGL1;CCL2;CCR2;PRELID1;PYCARD
prerank,histone methylation (GO:0016571),-0.40133546166888723,-1.328344152577431,0.08743169398907104,0.5221615467133641,1.0,12/26,20.60%,NSD1;CREBBP;SMYD3;EHMT1;NSD3;EHMT2;CARM1;EZH2;SIRT7;PRMT6;SETD6;PRMT8
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6353021637229557,1.3280758039497775,0.14588859416445624,0.3949890171461994,1.0,3/11,10.15%,CD74;MIF;TAF9
prerank,autophagy of mitochondrion (GO:0000422),0.5228054123543119,1.3280247501681273,0.10385064177362893,0.3946529866013209,1.0,7/38,5.66%,GABARAP;MAP1LC3B;PINK1;MAP1LC3A;GABARAPL2;GABARAPL1;ATG9A
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.4746757381025033,1.3277885990056248,0.05851063829787234,0.39483044684113644,1.0,22/82,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NPM1;TUBA4A;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;ATF5;CEP131;DCTN1;NEK10;SSNA1;HAUS2;DCTN2;CETN2;PRKAR2B
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5413343204052278,1.3274346243914807,0.1095066185318893,0.39530397779850307,1.0,5/30,8.81%,GPX1;HMOX1;PARK7;TNFAIP3;FAIM2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5057539786434452,1.3273492335459995,0.09010011123470522,0.39503896600942456,1.0,12/44,13.55%,GPX1;MT3;AKT1;ARL6IP1;TNF;LAMTOR5;YWHAE;BEX3;AQP1;DHCR24;KLF4;GAS6
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.542712271810095,1.3269076029051177,0.11138014527845036,0.39568807755606517,1.0,3/29,4.50%,LAMP1;TYROBP;SPI1
prerank,aminoglycan metabolic process (GO:0006022),0.6529383578635941,1.3268975794417166,0.15211267605633802,0.3952251111376715,1.0,6/10,25.18%,B3GAT3;CLN6;XYLT1;B3GAT1;GAL3ST3;CHST9
prerank,positive regulation of cytokine production (GO:0001819),0.4436072309147076,1.326318986229016,0.001,0.39620302109241856,1.0,86/292,22.12%,RPS3;CD74;GAPDH;MBP;TYROBP;MDK;LAPTM5;POLR2E;HMOX1;PARK7;SOD1;C3;ATF4;PDE4B;CCL19;CYBA;CD34;SLC7A5;AGT;S100A13;NFAM1;POLR2F;TNF;LAMTOR5;PTPRC;FCER1G;SORL1;MIF;HSPA1B;FLOT1;TIRAP;CTNNB1;HYAL2;ISG15;CEBPB;PQBP1;CLEC6A;HSPD1;IL2;LPL;EGR1;LILRA5;HMGB1;CSF1R;WNT5A;PNP;FLT4;C1QTNF4;AIF1;POLR2K;SLC11A1;HSPA1A;LILRB1;RIPK2;TLR6;IRF7;F2RL1;G3BP1;TLR5;MAPK11;TLR1;RASGRP1;HPSE;GATA4;PIK3CD;TWIST1;ADAM17;NOS2;SYK;CCR2;CXCL17;CD14;CD86;NLRP3;IL6;TGFB1;SPHK2;TMEM106A;PYCARD;CRLF2;POLR2H;DDIT3;TMED10;POLR3K;IRF5;POLR3D
prerank,positive regulation of secretion (GO:0051047),0.6382115701024952,1.3262129502956599,0.14965986394557823,0.39598436322756714,1.0,4/11,18.54%,TRH;AQP1;SCIN;ACSL3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.4010274847530423,-1.3255261423763895,0.07425742574257425,0.5258393740637224,1.0,10/28,16.08%,PARP9;KMT5C;PARP3;KMT5B;SHLD1;MRNIP;CYREN;KDM4D;SMCHD1;SIRT7
prerank,negative regulation of locomotion (GO:0040013),0.6299724659423627,1.325515061076322,0.14937759336099585,0.39724385481755814,1.0,4/12,8.70%,PIN1;DUSP3;FRMD5;SPOCK3
prerank,regulation of ion transport (GO:0043269),0.47611872228900537,1.325504464638952,0.05907626208378088,0.3967918740850361,1.0,21/76,16.40%,B2M;NKAIN2;ANK3;CA2;YWHAH;KCNJ10;SYT1;NKAIN3;P2RX7;SYT12;SYT11;VAMP3;VAMP2;SYT6;SYT4;KCNA2;ATP1A1;CHRNA4;SYT10;SPTBN4;SYT2
prerank,"wound healing, spreading of cells (GO:0044319)",0.5482701014210795,1.3248712083696124,0.12315270935960591,0.39788695409593655,1.0,9/24,17.95%,CD151;RHOC;ACVRL1;MRTFA;FLNA;LCP1;RHOA;ADAM17;TMEFF2
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.30621630807174627,-1.3241418118981703,0.0,0.5258550688178759,1.0,33/108,13.39%,SULF1;NXN;WWOX;TRABD2B;WLS;DCDC2;LRRK2;VGLL4;MACF1;KREMEN1;GPC3;SKI;PTK7;PRKN;NFATC1;AXIN1;TLE1;GRB10;MDFIC;RSPO3;FGFR2;BTRC;KANK1;ESR1;TERT;PSEN1;LRP1;ITGA3;CSNK2A1;NLK;RNF43;ZRANB1;CBFB
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5882854485658966,1.3237383218301098,0.13210039630118892,0.40046222381252106,1.0,4/16,9.52%,HMOX1;APLNR;JCAD;GATA2
prerank,cell differentiation in hindbrain (GO:0021533),0.6283433954154152,1.3235719813291207,0.15664335664335666,0.40041148307360974,1.0,4/11,8.81%,GRID2;KNDC1;PROX1;FAIM2
prerank,ventricular septum development (GO:0003281),-0.36531511843209485,-1.3232272933971077,0.08053691275167785,0.5247675213732876,1.0,11/37,10.54%,TGFBR3;HECTD1;ACVR1;BMPR1A;ROBO1;SLIT2;TGFBR1;ZFPM2;MDM4;SMAD7;SMAD4
prerank,cellular response to virus (GO:0098586),0.5345716505850339,1.3231619315806993,0.11056511056511056,0.40100708593492107,1.0,8/30,15.22%,HSP90AA1;CCL19;EIF5A;CXCL10;RRP1B;BAX;ARF1;MAPK11
prerank,modulation of chemical synaptic transmission (GO:0050804),0.4586142077865495,1.323118844267501,0.04158215010141988,0.4006190071605691,1.0,52/107,28.07%,NRG3;NLGN1;DLGAP2;GRM5;DLGAP1;GRID2;TNF;GRIK5;GRIK2;LRRC4C;CACNA1A;SYT1;LGI1;RIMS2;GRM8;RIMS1;TPRG1L;GRM7;DGKI;GRID1;GRM1;BEGAIN;SYN1;HCRT;ABR;CX3CR1;MAPK8IP2;LRP8;CDK5;CLSTN2;CLSTN1;TMEM108;NPTXR;GRM4;KCTD13;CACNG5;MEF2C;CLSTN3;GRIK1;STX1B;UNC13A;APP;AGER;NPTX1;CACNA1B;SLC4A8;ITGB1;KCNMB4;PSMC5;CPLX1;CHRNA7;HOMER1
prerank,negative regulation of apoptotic process (GO:0043066),0.4412491610609269,1.32304260722497,0.002,0.400371346026495,1.0,125/444,20.86%,APOE;TPT1;RPS27A;PTMA;ARHGDIA;CD74;UBC;UBB;GPX1;MDK;HSPB1;GRN;MT3;CFL1;PARK7;SOD1;RPL10;MAPK3;HSPA5;LGMN;AKT1;FOXQ1;HIGD2A;CCND2;TMBIM6;UBE2Z;TREM2;CRYAB;ARL6IP1;HNRNPK;NPM1;PRDX5;ANXA5;PINK1;TNF;HSP90B1;FZD9;PRDX2;LAMTOR5;HCLS1;GLO1;NTRK2;NAA38;MIF;BNIP2;HSPA1B;CTNNB1;FLNA;YWHAE;IL2RB;LTK;TMEM14A;BEX3;BAG1;TFRC;UBA52;BNIP3L;HSPD1;FMN2;KDR;AQP1;IL2;FAIM2;DHCR24;NUPR1;SET;HCK;TAF9;WNT5A;ATF5;DNAJA1;FLT4;WFS1;SOX8;KLF4;SOX9;HSPA1A;RIPK2;GAS6;YWHAZ;NME2;CAT;CTSH;CX3CR1;CCL2;PTPRZ1;MAPK8IP2;ARF4;DLL1;TYRO3;ATAD3A;CAV1;DDAH2;VHL;GATA4;PIM3;SQSTM1;PSEN2;PCID2;PPARGC1A;ASNS;CIAPIN1;AGAP2;ERBB3;MAZ;QARS1;HMGN5;HYPK;SNCA;PRELID1;DDRGK1;RNF144B;TFAP2B;NOTCH1;IL6;HGF;POU4F1;CITED2;MEF2C;SFRP1;CAPN3;MYC;CRLF1;NFKBIA;HSPA9
prerank,B cell proliferation (GO:0042100),0.5839790806366522,1.3225622546068185,0.13917525773195877,0.40112288900150206,1.0,5/17,20.07%,PTPRC;CD180;HSPD1;RASGRP1;MEF2C
prerank,nitric oxide metabolic process (GO:0046209),0.6126704883583658,1.3222767814613174,0.1364256480218281,0.40136164282730546,1.0,5/14,17.56%,AKT1;CYB5R3;SPR;DDAH2;NOS2
prerank,positive regulation of vascular permeability (GO:0043117),-0.49552059506719665,-1.3222580211353132,0.13380281690140844,0.5240189406702059,1.0,2/12,6.03%,BMP6;ANGPT1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5449956558843992,-1.3221152419811388,0.1553398058252427,0.5213383460365799,1.0,5/10,19.08%,GHR;STAT5B;STAT3;STAT5A;STAT6
prerank,positive regulation of gene expression (GO:0010628),0.4382235542979093,1.3215252315944268,0.001,0.4028249352366258,1.0,117/442,20.24%,ACTB;RPL26;RPL23;RPS3;ACTG1;RPL11;RPS4X;RPS7;RPL5;CD74;CLU;EEF2;VIM;CLDN5;GSN;GAPDH;RAMP2;TYROBP;ACTA2;MT3;POLR2E;PARK7;SOD1;MAPK3;ATF4;AKT1;EIF3D;TREM2;CD34;NPM1;RPS27L;ANK3;AGT;S100A13;NFAM1;GPER1;POLR2F;TNF;PDGFB;LAMTOR5;NTRK2;AMH;MIF;HSPA1B;FLOT1;POLR1B;FN1;MUSK;TFRC;MSN;RIMS2;EIF3C;RIMS1;CLEC6A;P2RX7;VSIR;EGR1;GATA2;ATP13A2;DEK;LRP3;WNT5A;PCIF1;RAMP3;POU3F1;ELAVL4;WARS1;WBP2;TMEM119;CAMK2N1;ZCCHC4;KLF4;POLR2K;SLC11A1;SOX9;HSPA1A;GJA1;LILRB1;BMP2;GAS6;SFRP4;CTSH;TLR6;PF4;IFNGR1;MAPK11;CIRBP;HEY1;YTHDF1;EIF4A3;DNAJA4;CCL3;DNMT3B;EPB41L4B;CDH5;PIK3CD;TWIST1;PDCD5;PPARGC1A;ERCC6;AGO1;MAP2K2;MAZ;HMGN5;SOX11;TBP;DDRGK1;POLR1H;INHBA;NOTCH1;IL6;ERP29;TGFB1;POU4F1;CITED2;MEF2C;SPHK2
prerank,neuron development (GO:0048666),0.4531076319284035,1.3214869168008605,0.036734693877551024,0.4024416695108762,1.0,51/141,20.63%,APOE;PLP1;NLGN1;BLOC1S4;CNTNAP2;NTRK2;CNTN4;SH3GL2;GPM6B;GPRIN1;UHMK1;STMN3;TENM2;TENM3;MANF;LGI1;ATP8A2;PQBP1;PRDM12;MAPT;MAP2;STMN4;CDK5R1;EPHA5;HMGB1;B4GALT6;BLOC1S1;BLOC1S3;TENM4;BLOC1S5;PRMT1;CLN5;STMN1;GPRIN2;EHD1;UGDH;CDK5;NCDN;ADCYAP1;TMEM108;ERCC6;GPM6A;RASGRF1;MYT1L;ATCAY;DCX;IL6;VAPA;POU4F1;MEF2C;SRRM4
prerank,positive regulation of defense response (GO:0031349),0.46772987823784357,1.3214844826602963,0.05235602094240838,0.4019696113112952,1.0,33/89,26.21%,MDK;GRN;CYBA;AGT;TNF;S100A8;S100A9;DDT;HYAL2;FEM1A;CEBPA;IL2;LPL;SLC15A4;LILRA5;NINJ1;PLA2G7;WNT5A;TNFRSF1A;GPSM3;CCL3;CCR2;SNCA;MEF2C;NFKBIA;POLR3D;TNIP1;AKIRIN2;APP;PDE2A;IL33;TLR7;CX3CL1
prerank,mammary gland epithelium development (GO:0061180),0.6022338950291355,1.3214612253024358,0.13965744400527008,0.4015510498442897,1.0,3/14,10.71%,AKT1;ERBB4;CSF1R
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.6521573044041584,1.3210160576468264,0.15481171548117154,0.4022016416934471,1.0,8/10,32.98%,GABRG3;GABRA2;GABRA3;GABRB2;GABRA4;GABRG2;GABRA1;GABRG1
prerank,transferrin transport (GO:0033572),0.5285612782119593,1.3208640288541815,0.1113662456946039,0.4020960878048544,1.0,8/33,11.17%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6AP1;ATP6V0E2;TFRC;CLTC;ATP6V0D2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6150013214899028,1.3207744087644857,0.15081521739130435,0.4018412072208517,1.0,3/13,8.53%,CD74;MIF;PTTG1IP
prerank,positive regulation of cytokinesis (GO:0032467),-0.3949484104670067,-1.320234360800208,0.08888888888888889,0.5230766133926166,1.0,11/32,21.39%,SVIL;PRKCE;CDC14A;CSPP1;CDC25B;PKP4;GIPC1;CDC14B;RACGAP1;PKN2;KIF23
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.6300792339997102,1.3200754785501219,0.14654002713704206,0.40316895633872474,1.0,4/12,13.46%,RPS27L;RPA2;CCND1;FBXO31
prerank,regulation of cellular response to heat (GO:1900034),0.4725195540180807,1.3195903876994335,0.06533192834562697,0.40394986536632577,1.0,23/77,18.99%,HSPA8;HSP90AA1;HSP90AB1;HSBP1;MAPK3;CRYAB;CD34;HSPA1B;YWHAE;RPA2;BAG5;BAG1;MAPT;HSPB8;HSPA1A;NUP85;NUP88;PTGES3;DNAJB1;IER5;NUP50;AKT1S1;CCAR2
prerank,positive regulation of mitochondrial translation (GO:0070131),0.6092338717728304,1.3195548931309096,0.14511873350923482,0.4035573539608937,1.0,7/14,27.38%,UQCC2;COA3;TRUB2;RPUSD4;C1QBP;TRMT10C;RCC1L
prerank,histone H4 deacetylation (GO:0070933),-0.5336061989097824,-1.3195191613651647,0.1605351170568562,0.5216830727758741,1.0,4/10,7.12%,HDAC4;HDAC8;SMARCAD1;RCOR1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6230858076026993,1.3191406604214193,0.12275862068965518,0.4040959115499046,1.0,3/12,13.00%,RBP4;STRAP;SOX9
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.4880379250173493,1.3189898504732767,0.08961748633879782,0.4040326624539265,1.0,27/57,24.99%,NLGN1;DLGAP2;GRIA2;DLGAP1;DLG2;SHISA7;NEFL;GRIN1;GRIA4;LYNX1;GRIN2A;CRH;GRIA1;BEGAIN;LRRC7;MAPK8IP2;CACNG8;NPTXR;GRIN2B;CACNG5;MEF2C;GRIA3;CACNG2;APP;NPTX1;SHISA6;PRRT1
prerank,defense response to virus (GO:0051607),0.4605211233416265,1.318450813413371,0.05761316872427984,0.4049976572390126,1.0,32/100,22.14%,IFITM3;IFITM2;IFITM1;SHFL;PTPRC;RNASE1;SERINC3;NT5C3A;FLNA;ISG15;PQBP1;BNIP3L;AGBL4;CXCL10;IFIT1;PMAIP1;BST2;LILRB1;PDE12;IRF7;SERINC5;F2RL1;G3BP1;ATAD3A;OAS3;IL6;DDIT4;PYCARD;RSAD2;EXOSC4;IFI27;ISG20
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.5262370311014166,1.3182001832211552,0.12117647058823529,0.4052025716460762,1.0,13/30,18.84%,OST4;RPN1;RPN2;DAD1;DDOST;LMAN1;MGAT2;DPM3;MCFD2;ASGR2;DPM2;MAGT1;STT3A
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5486349693939586,1.3179648075008594,0.1341614906832298,0.40535531645016637,1.0,5/25,14.62%,B2M;LAPTM5;SLC7A5;WNT5A;F2RL1
prerank,cellular potassium ion homeostasis (GO:0030007),0.6216089224607303,1.3176686399614799,0.1557377049180328,0.4056212737124089,1.0,7/13,18.34%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;ATP1B3;KCNMA1
prerank,rRNA transcription (GO:0009303),0.5876899638979589,1.3176342027531622,0.13541666666666666,0.4052495108357311,1.0,3/17,4.75%,CAVIN1;ANG;GTF3C6
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.462325763357999,1.3175765187443997,0.08050847457627118,0.40491181425044565,1.0,27/75,23.15%,APOE;AKT1;AGT;RASIP1;SORL1;UCHL1;RGS2;HYAL2;CDKN1C;CEBPA;PRKAR1A;SMPD1;PRKAR1B;SPRY1;HEXIM1;SLC8A1;DAB2IP;PRKAR2B;CD300A;SPRY3;TFAP4;PYCARD;GADD45A;MEN1;DUSP1;PTPN1;TESK1
prerank,activation of GTPase activity (GO:0090630),-0.32275613641020645,-1.3175067149904094,0.08333333333333333,0.5240186456248377,1.0,23/89,12.34%,ARHGAP29;SIPA1L1;ARHGAP42;BCAS3;TIAM2;SGSM2;USP6NL;NTRK3;TBC1D12;RALGAPB;DOCK7;SIPA1L3;TBC1D2B;RABGAP1;TBC1D9B;BCR;TBC1D4;SYDE2;PIP5K1A;TBC1D8B;TBCK;SIPA1;RALGAPA1
prerank,embryonic organ morphogenesis (GO:0048562),-0.3457234525356898,-1.3173457952713779,0.04929577464788732,0.5214490468215628,1.0,9/42,5.77%,FBN1;HOXB3;ACVR1;HOXA3;NIPBL;HOXB4;HOXC4;RARG;EFEMP1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5611457178962878,1.3172995746258436,0.1405672009864365,0.4046783992850992,1.0,9/23,15.07%,YWHAB;YWHAH;YWHAE;YWHAG;PMAIP1;YWHAQ;YWHAZ;BBC3;BAD
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5611457178962878,1.3172995746258436,0.1405672009864365,0.4046783992850992,1.0,9/23,15.07%,YWHAB;YWHAH;YWHAE;YWHAG;PMAIP1;YWHAQ;YWHAZ;BBC3;BAD
prerank,negative regulation of calcium ion transport (GO:0051926),0.5939414128113059,1.3169722863223432,0.1541501976284585,0.4050781658382648,1.0,5/15,16.27%,SLC30A1;TMBIM6;PLN;LILRB1;CBARP
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.6036858074303975,1.3168797969653818,0.14171122994652408,0.4048413583482368,1.0,4/14,10.71%,MDK;MAPK3;RARRES2;CSF1R
prerank,regulation of cell cycle phase transition (GO:1901987),0.465725975694387,1.3168751205211304,0.06465067778936393,0.40437640763568783,1.0,40/91,28.25%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;DDB1;PSMB9;PSMD13;BUB3;PSMB3;PSMB11;FBXW7;NEK10;FBXO5;PSMB10;PSMB1;PSMB5;PSMA6;SKP1;PSMA4;TFAP4;PSMC1;FZR1;PSMD9;CDC20;PSMB2;XPC;PSMD4;PSMD10;ERCC2;CDKN1A;PSMC5;TRIM39;ATP2B4
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.5436255077299804,1.3149198230323902,0.11016949152542373,0.4090732514985236,1.0,11/28,19.19%,CLU;LAPTM5;TREM2;PSMC3;ATP5IF1;NUPR1;ECSCR;FBXW7;DAB2IP;CTSC;DDRGK1
prerank,bone morphogenesis (GO:0060349),-0.47225562976533286,-1.3146972076355157,0.14566929133858267,0.5246304825649217,1.0,4/14,8.39%,LRP5;SKI;LRP6;FGFR2
prerank,myelination (GO:0042552),0.49821358528739074,1.3144641104854764,0.11811023622047244,0.40990304533522703,1.0,16/46,15.94%,MBP;PLP1;MPZ;PLLP;PMP22;MAL;KLK6;GAL3ST1;B4GALT6;MYRF;MALL;CXCR4;BCAS1;NFASC;DEGS1;EPB41L3
prerank,cAMP metabolic process (GO:0046058),-0.49732982366244527,-1.31411109152364,0.17266187050359713,0.5231777146922508,1.0,3/13,2.23%,ADCY9;ADCY1;ADCY5
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5845777367345862,1.3140321904243089,0.13395225464190982,0.4105653653713519,1.0,7/16,23.49%,SCD5;FASN;SCD;ACAT1;SLC25A1;PPCS;ACLY
prerank,neural crest cell development (GO:0014032),0.49960506243166863,1.3136636760671179,0.10449438202247191,0.41104154475434584,1.0,11/44,13.41%,NRG1;ERBB4;SEMA3F;SEMA7A;SEMA4C;CORO1C;SEMA6D;SEMA4A;PDCD6;SOX8;SEMA4G
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4575457387781375,1.3134322274263142,0.05912863070539419,0.41118065582097724,1.0,47/109,27.71%,CALM1;PSMB4;MAPK3;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;RAC1;PSMD1;PSMC3;PSMD6;PSMA7;PAK1;PSMD5;JUN;PSMB9;PSMD13;PSMB3;PSMB11;VAV1;PSMB10;MAPK10;VAV3;PSMB1;PSMB5;LCP2;SYK;TAB1;PPP3CA;PSMA6;SOS1;SKP1;PSMA4;MAP2K7;PPP3R1;PSMC1;PSMD9;RELA;PSMB2;PSMD4;PRKCQ;PSMD10;ITK;IKBKG;PSMC5
prerank,regulation of cytokine production (GO:0001817),0.45436913175832133,1.3133540884503654,0.03480040941658137,0.410859589582604,1.0,32/126,18.30%,GAPDH;GPNMB;SOD1;TREM2;AGT;S100A13;NFAM1;TNF;PLD3;PTPRC;BTN3A3;MIF;FLOT1;SIRPA;ISG15;CLEC6A;SYT11;BCL6B;MOG;ICOSLG;IRF8;SRGN;ATP2B1;SLC11A1;IRF7;TRAF3;TRIL;HDAC9;PIK3CD;TRIM32;NOS2;CCR2
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3014624120607978,-1.3130449329231428,0.0,0.5230075883134729,1.0,25/86,12.69%,AKAP13;NOTCH2;PLCE1;DENND4A;ARHGAP17;KANK2;DENND4C;MAPKAP1;OGT;EPS8;ARHGEF18;RAF1;SHOC2;STARD13;DENND1A;RAPGEF1;BCR;IGF1;KANK1;NGF;EPHB2;OPHN1;MYO9B;DENND3;ARHGEF2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.5324511089031102,1.3130376879652645,0.1201923076923077,0.4112333271633515,1.0,11/29,23.49%,SCD5;ELOVL1;ELOVL2;FASN;ELOVL7;SCD;SLC25A1;ACSL3;ELOVL6;ACSL4;ACLY
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6347621594399304,1.3130260415561057,0.15070422535211267,0.41078331210805075,1.0,2/10,8.68%,PRNP;PRKAR1A
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5239671799286885,1.312989955877006,0.12174940898345153,0.41039288854059985,1.0,9/30,16.39%,BGN;HEXB;BCAN;HEXA;DCN;CHPF2;CHPF;UGDH;VCAN
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.47907519632903467,1.31289760306574,0.0978021978021978,0.4101563185544779,1.0,25/60,24.76%,HSP90AA1;HSP90AB1;MAPK3;CCT2;PDGFB;CTNNB1;CCT7;CCT8;PCNA;KLF4;RFC2;HNRNPA1;PTGES3;PARM1;HGF;DKC1;MAPK15;RFC4;MYC;MAP2K7;CCT4;GRHL2;NAF1;PNKP;CCT3
prerank,intracellular protein transmembrane transport (GO:0065002),0.4980244130294475,1.3127581328510745,0.11225658648339061,0.41005172526633965,1.0,11/42,15.80%,SEC61B;HSPA5;ROMO1;SEC61G;DNLZ;HSPD1;TOMM40L;SEC61A1;TIMM50;TOMM20L;PEX6
prerank,cellular calcium ion homeostasis (GO:0006874),0.4459559276951071,1.3120458848351064,0.04281345565749235,0.41137460046522617,1.0,40/133,18.94%,TPT1;CALR;SLC30A1;CXCL12;SMDT1;CCL19;GPER1;SLC24A4;SLC24A2;FZD9;CAV2;YWHAE;DRD5;CALB1;TMCO1;KCTD17;PLN;SELENOK;HTR2C;ATP13A2;CALCB;BAX;TRPC7;WFS1;ATP2B1;TRPC1;ATP1B1;SLC8A1;RYR2;ADCY8;CCL3;CAV1;CDH5;HERPUD1;HCRTR1;CCL8;FKBP1B;CCR2;ANXA6;EDN3
prerank,receptor metabolic process (GO:0043112),0.48722213607074566,1.3113413853516172,0.10101010101010101,0.4127784795185202,1.0,19/53,19.83%,CD81;RAMP2;LGMN;NSG1;ITGB2;FCER1G;DNM3;AP2M1;TFRC;CLTC;RAMP3;LILRB1;ARRB2;CAV1;SYK;SNCA;GRK2;RAB31;TGFB1
prerank,positive regulation of cell development (GO:0010720),0.5293644472106097,1.3105942592451,0.12396694214876033,0.41427091859792575,1.0,10/31,18.98%,TYROBP;SERPINF1;TGM2;GPER1;ATP6AP1;SNW1;CX3CR1;BAD;TRIM32;SOX11
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.5452703533414698,1.3105878250333982,0.1476846057571965,0.41381096957587277,1.0,9/24,21.42%,PRNP;ITGB2;ANK3;HRAS;MTCL1;MIEF2;MFF;C2CD5;FIS1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5891053432617935,1.3105403498228712,0.14777070063694267,0.413465999155422,1.0,5/17,4.18%,VTN;MDK;S100A11;PDGFB;IGFBP5
prerank,cellular response to reactive oxygen species (GO:0034614),0.48361508415174614,1.3105336474605183,0.0988056460369164,0.41301026159139925,1.0,14/59,11.56%,RPS3;PARK7;RHOB;MAPK3;AKT1;PRDX5;ROMO1;SIRPA;TNFAIP3;AQP1;MAPT;NET1;JUN;TRPM2
prerank,regulation of glycolytic process (GO:0006110),-0.3260508367076642,-1.310454277495146,0.046875,0.5262335056104094,1.0,12/68,8.24%,ZBTB20;PRKAG2;ARNT;RANBP2;HDAC4;OGT;PPARA;NUP98;NCOR1;INSR;IGF1;PRKAA2
prerank,endoplasmic reticulum organization (GO:0007029),0.46913939834229906,1.310023710029029,0.09042553191489362,0.41393508920688565,1.0,27/72,21.92%,HMOX1;SEC61B;PRNP;WDR83OS;LMAN2;SEC61G;RTN4;CAV2;REEP5;LMAN1;REEP6;VAMP2;REEP2;SERP1;SEC61A1;SHTN1;SGTA;TRAM1L1;DNM1L;LNPK;RAB18;MAPK15;VAPA;TMEM33;TRAM1;RTN3;CYB5A
prerank,nitric oxide biosynthetic process (GO:0006809),0.6200735858987003,1.3097748506616884,0.14482758620689656,0.4140975938732496,1.0,5/13,17.56%,AKT1;CYB5R3;SPR;DDAH2;NOS2
prerank,entry into host (GO:0044409),0.6139302021545544,1.3097590065312041,0.15616438356164383,0.41365603913842747,1.0,4/13,13.70%,PPIA;CTNNB1;CCR5;CXCR4
prerank,excitatory postsynaptic potential (GO:0060079),0.5819696779766748,1.3092196734903294,0.14140127388535031,0.4145347591572367,1.0,10/19,22.36%,AKT1;GRID2;MPP2;GRIN1;GRIN2A;MAPK8IP2;ARRB2;GRIN2B;MEF2C;CHRNA3
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5632613392918853,1.308683988266544,0.14102564102564102,0.41551795858008556,1.0,8/20,13.09%,HSP90AA1;HSP90AB1;PINK1;EPAS1;HSPA1B;EGR1;DNAJB2;HSPA1A
prerank,cellular protein catabolic process (GO:0044257),0.4828301728051601,1.3083283757280697,0.0866738894907909,0.4159349639956753,1.0,11/59,9.52%,CTSB;CTSL;CTSZ;CTSS;LGMN;CHEK2;UBE2G2;AP2M1;BNIP3L;CLTC;AP2S1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5896785234038252,1.3082966061672363,0.14925373134328357,0.41506817346153535,1.0,5/15,12.70%,BLOC1S4;AP3B2;BLOC1S1;BLOC1S3;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5896785234038252,1.3082966061672363,0.14925373134328357,0.41506817346153535,1.0,5/15,12.70%,BLOC1S4;AP3B2;BLOC1S1;BLOC1S3;BLOC1S5
prerank,T cell receptor signaling pathway (GO:0050852),0.45080626369307775,1.3080959730239194,0.040526849037487336,0.41513755485779624,1.0,61/138,30.41%,PSMB4;PSME1;PDE4B;PSMB6;PSME2;PSMB8;PSMD2;PTPRC;BTN3A3;PSMD1;PSMC3;PSMD6;PSMA7;CD3D;PAK1;THY1;MOG;PSMD5;ICOSLG;PAK3;PSMB9;PSMD13;RBCK1;PSMB3;PSMB11;CTLA4;RIPK2;PSMB10;PSMB1;PSMB5;PIK3CD;SKAP1;LCP2;EIF2B5;PSMA6;SKP1;TRAT1;PSMA4;NFKBID;PSMC1;PSMD9;INPP5D;CD28;RELA;CD276;RFTN1;PSMB2;PSMD4;PRKCQ;PSMD10;STOML2;ITK;IKBKG;PSMC5;CD3E;MAP3K7;PSME3;TXK;EIF2B1;ZAP70;PSMC2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.4625029163795916,1.3075078698528304,0.07074973600844774,0.416201621504561,1.0,14/86,9.84%,APOE;RPS3;CLU;GPX1;RAC1;PFN1;NAV3;PAK1;PROX1;CLASP1;MAPT;ARF6;CDK5R1;HCK
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.5626380677170549,1.3070465339794015,0.12596401028277635,0.4169261614060388,1.0,11/20,28.15%,SCD5;HSD17B4;FASN;SCD;SLC25A1;ACSL3;DGAT1;ACSL4;ACLY;FAR2;HSD17B8
prerank,myeloid dendritic cell activation (GO:0001773),0.6229522600450474,1.3069974306381826,0.15760111576011157,0.4165893444521896,1.0,5/12,20.93%,DOCK2;HMGB1;BATF3;BATF2;PYCARD
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.478275146656127,1.3068816275215371,0.09846827133479212,0.416395084639108,1.0,14/59,13.82%,RPS27A;UBC;UBB;AKT1;TNF;PRDX4;UBA52;TICAM2;NKIRAS1;RBCK1;TBKBP1;RIPK2;TNFRSF1A;NKIRAS2
prerank,negative regulation of protein transport (GO:0051224),0.5277922737279704,1.3067958098075991,0.14792176039119803,0.41614746453157325,1.0,6/25,21.84%,APOE;DPH3;RSC1A1;ERP29;RSAD2;PPM1F
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5703469885968964,1.3066782337674787,0.16243654822335024,0.41599252666268915,1.0,5/18,7.45%,NRXN1;NLGN1;GRIN1;RIMS2;RIMS1
prerank,positive regulation of embryonic development (GO:0040019),0.5711597629948855,1.3064658427421914,0.14675324675324675,0.4160855141979469,1.0,4/19,11.04%,RACK1;CFL1;OTX2;TENM4
prerank,negative regulation of cellular component organization (GO:0051129),0.46827353854936304,1.3060085903159877,0.08598726114649681,0.41688407427552826,1.0,19/74,18.23%,HSPA8;CLU;HSPA5;CRYAB;TNF;LGALS3;SORL1;HSPA1B;SYT11;SVIP;DNAJB2;HSPA1A;LILRB1;SACS;DNAJB1;DNAJA4;SNX33;TMEFF2;NOP53
prerank,neuron projection development (GO:0031175),0.44407915104839224,1.3059547820137827,0.0262891809908999,0.4165626939511512,1.0,55/168,20.31%,APOE;UBB;PLP1;NBL1;NLGN1;BLOC1S4;CNTNAP2;PACSIN1;CNTN4;NEFH;SH3GL2;GPM6B;GPRIN1;UHMK1;STMN3;MANF;LGI1;PQBP1;PRDM12;KLK8;SGK1;PAK1;GRM7;MAPT;MAP2;STMN4;CDK5R1;HMGB1;PAK3;BLOC1S1;DOCK10;BLOC1S3;NYAP2;BLOC1S5;PRMT1;SHTN1;STMN1;GPRIN2;EHD1;EPHB1;CDK5;NCDN;EPB41L3;DAB2IP;ADCYAP1;TMEM108;ERCC6;GPM6A;RASGRF1;ATCAY;CTNND2;IL6;VAPA;POU4F1;CTTN
prerank,Fc receptor signaling pathway (GO:0038093),0.4542535799455465,1.3058301096145346,0.06198347107438017,0.41642545430891725,1.0,47/110,27.71%,CALM1;PSMB4;MAPK3;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FCER1G;RAC1;PSMD1;PSMC3;PSMD6;PSMA7;PAK1;PSMD5;JUN;PSMB9;PSMD13;PSMB3;PSMB11;VAV1;PSMB10;MAPK10;VAV3;PSMB1;PSMB5;LCP2;SYK;TAB1;PPP3CA;PSMA6;SOS1;SKP1;PSMA4;MAP2K7;PPP3R1;PSMC1;PSMD9;RELA;PSMB2;PSMD4;PRKCQ;PSMD10;ITK;IKBKG;PSMC5
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4871172801325723,1.3054785470725627,0.09966405375139978,0.41684797555301417,1.0,21/46,24.19%,NRXN1;NLGN1;GRM5;TNF;SYT1;GRM8;TPRG1L;GRM7;DGKI;GRM1;CCL2;MAPK8IP2;CDK5;CACNG8;GRM4;CCR2;CACNG5;MEF2C;GRIK1;UNC13A;CACNG2
prerank,regulation of cellular response to stress (GO:0080135),0.4506762992138218,1.3051253163966774,0.045965270684371805,0.4173425344651039,1.0,23/115,9.16%,HSPA8;HSP90AA1;HSP90AB1;HSBP1;CHCHD2;MAPK3;ATF4;CRYAB;NPM1;PINK1;IER3;HSPA1B;YWHAE;MANF;RPA2;BAG5;BAG1;USP51;CEBPB;VASH1;MAPT;NUPR1;HSPB8
prerank,negative regulation of interleukin-17 production (GO:0032700),0.6301739397102408,1.304994114405346,0.1697841726618705,0.41722664477022847,1.0,2/10,8.66%,PRNP;VSIR
prerank,positive regulation of cell killing (GO:0031343),0.6008647905875717,1.3048547586035,0.17458100558659218,0.41713492595502427,1.0,5/13,17.99%,CYBA;RAC1;WNT5A;NOS2;SYK
prerank,metal ion transport (GO:0030001),0.4664862410511713,1.3048436669439363,0.0770042194092827,0.4166873099270205,1.0,24/86,18.52%,TPT1;RAMP2;MT3;SLC30A1;CACNA1A;GRIN3A;CCR5;SELENOK;SLC3A2;NIPAL4;RAMP3;TRPM2;CHRNA4;SLC11A1;TRPC1;SLC8A1;RYR2;CCL3;CAV1;CACNG8;PSEN2;CCL8;MAGT1;NIPA1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6150614423517259,1.3047273275819458,0.15437158469945356,0.41651614731888487,1.0,5/12,17.69%,FXYD1;ANK3;ATP1B2;ATP1B1;ATP1B3
prerank,response to amino acid (GO:0043200),0.5196264768580844,1.304480226192897,0.13405797101449277,0.41672992246045176,1.0,12/31,18.83%,TMBIM6;LAMTOR2;LAMTOR4;LAMTOR5;GRIN1;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF;GLRA3
prerank,regulation of cell development (GO:0060284),0.5062242385912045,1.3044670324183942,0.11826697892271663,0.4163048117720115,1.0,11/36,16.38%,RPS19;GRN;AKT1;CTNNB1;HES1;HES6;BHLHE41;CX3CR1;HEY1;DLL1;HDAC9
prerank,epithelial tube morphogenesis (GO:0060562),0.5162798978769004,1.3044026916288178,0.14251781472684086,0.416015752668657,1.0,11/32,11.29%,RHOB;CSNK2B;RASIP1;ACVRL1;CTNNB1;HES1;PAK1;PODXL;COL4A1;CSF1R;SOX17
prerank,cell cycle checkpoint signaling (GO:0000075),-0.48726166359206674,-1.3042924056180278,0.17375886524822695,0.5391128945964041,1.0,5/12,21.10%,WEE1;PRCC;CHFR;PLK2;ZWILCH
prerank,positive regulation of cell population proliferation (GO:0008284),0.4343350440725342,1.3040308989135465,0.002,0.41652843310981996,1.0,121/423,21.14%,RPL23;RPS9;RPS4X;RPS15A;CD74;S100A6;CLDN5;CD81;MDK;GRN;CALR;GNAI2;CAPNS1;HMOX1;LAMC1;RPS6;LGMN;AKT1;TSPAN31;S100B;SLC25A5;NRG1;NME1;CCND2;ERBB4;NPM1;COPS9;AGT;S100A13;NES;GPER1;COX17;TNF;EMP2;PDGFB;FZD9;ROMO1;PTPRC;HCLS1;NTRK2;C5AR1;MIF;SSR1;SERTAD1;HES1;FN1;MATK;RHOG;RNF187;NAMPT;PAK1;PROX1;KDR;AQP1;IL2;VIPR1;MLXIPL;TIMP1;LAMC2;HCK;KITLG;CSF1R;WNT5A;IL11;CEP131;FLT4;HRAS;TMEM119;SOX8;AIF1;PRMT1;SOX9;BST2;GJA1;BMP2;FBXO5;GAS6;NME2;HNRNPU;CTSH;SDCBP;TIAM1;BAD;PDF;FOLR2;IGF2;PDGFA;DLL1;ADRA1D;HPSE;FLT1;CCKBR;CIAO1;ADAM17;CNBP;TBRG4;DDR2;ERBB3;MAZ;STX4;HMGN5;EDN3;SOX11;TOX;DDRGK1;CD86;RTKN2;TFAP2B;FLT3;NOTCH1;IL6;MAPK15;TGFB1;THPO;MEF2C;SFRP1;MYC;CRLF1;PTPN6;CRLF2;ID2
prerank,neutral amino acid transport (GO:0015804),0.5287008686355066,1.3039660619642208,0.1263408820023838,0.41623437521703616,1.0,7/28,12.43%,SLC38A5;SLC7A5;SLC1A4;SLC6A6;SLC6A17;SLC3A2;SLC1A1
prerank,negative regulation of protein kinase activity (GO:0006469),0.4591417830609662,1.3031740396904463,0.0703781512605042,0.41781107866482,1.0,36/88,23.15%,PPIA;HSPB1;PARK7;AKT1;NPM1;CAMK2N2;PTPRC;SORL1;DUSP3;HYAL2;CDKN1C;DBNDD2;CORO1C;PTK6;DUSP26;THY1;YWHAG;RTRAF;WARS1;CAMK2N1;PTPRB;SRCIN1;SLC8A1;DAB2IP;CAV1;PRKRIP1;AKT1S1;QARS1;TAB1;SNCA;PYCARD;GADD45A;PTPRO;PPM1F;PTPN1;TESK1
prerank,anion transmembrane transport (GO:0098656),0.4760662340877326,1.3029985634766943,0.08733624454148471,0.41778526637276786,1.0,32/67,28.02%,SLC38A5;SLC25A5;LRRC8A;SLC7A5;SLC1A2;SLC25A4;SLC25A13;SLC25A29;SLC6A5;SLC25A11;SLC3A2;SLC1A1;SLC25A21;SLC25A22;SLC19A1;SLC35A3;SLC25A19;SLC25A1;SLC35A1;SLC25A18;SLC35B4;MFSD12;SLC25A14;SFXN1;SLC35B1;SLC6A8;ABCC5;SLC6A9;SLC25A12;SLC35A2;SLC16A7;SLC13A5
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.6174395801101821,1.3029344055703957,0.16,0.4174940186393892,1.0,4/12,17.00%,MDK;AKT1;FUT9;SKAP1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.5628407626626994,1.3027817813763796,0.14901477832512317,0.4174310349015883,1.0,5/20,8.05%,HSP90AB1;C3;TXN;TXNIP;P2RX7
prerank,neuron projection organization (GO:0106027),0.589502291444198,1.302547361708423,0.1635135135135135,0.41755265948481385,1.0,6/15,14.51%,LGMN;PRNP;MAP1A;ATP1A3;DCTN1;ARF1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.35830726523290984,-1.3022237038408937,0.09558823529411764,0.5413078502140173,1.0,9/32,15.37%,BABAM2;FOXN3;RINT1;UIMC1;TAOK3;MRNIP;ATM;TAOK1;CLSPN
prerank,basement membrane organization (GO:0071711),0.59781982297773,1.3014544582067218,0.15323645970937913,0.41988306405135584,1.0,4/14,8.25%,RAMP2;CTSS;LAMB2;COL4A1
prerank,L-amino acid transport (GO:0015807),0.535237332074242,1.300693187960353,0.14268440145102781,0.42123558420575913,1.0,8/28,12.67%,SLC38A5;SLC7A5;SLC1A4;SLC1A2;SLC25A13;SLC3A2;SLC1A1;SLC25A22
prerank,regulation of exit from mitosis (GO:0007096),0.5074119793159386,1.3004656910030639,0.12763466042154567,0.42137400108989187,1.0,3/38,0.82%,RPS27A;UBC;UBB
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.6393593157642633,1.300422810498375,0.15406562054208273,0.4210198664572105,1.0,4/10,15.91%,PTPRC;LILRB1;CX3CR1;ARRB2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.4170924215835671,-1.2998386695648045,0.1111111111111111,0.5445168328775531,1.0,9/23,19.80%,HDAC4;CLK2;PPARA;NCOR1;SIK1;C1QTNF3;CRY1;TIGAR;PFKFB1
prerank,negative regulation of innate immune response (GO:0045824),0.5112166855340866,1.299524011044225,0.1255980861244019,0.4228615915812627,1.0,6/34,9.66%,RPS19;GRN;A2M;TNFAIP3;ISG15;SERPING1
prerank,vesicle organization (GO:0016050),0.4900075274640997,1.2988781423500653,0.11804767309875142,0.4241122204252892,1.0,14/46,17.51%,CD34;CAV2;CHMP2B;SAR1A;CORO1A;SRGN;FNBP1L;SNX11;SORT1;SNX33;CAV1;USP8;SQSTM1;HOOK1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5879174340110642,1.2986058406150311,0.16363636363636364,0.4243416004261994,1.0,13/16,32.41%,TMEM50A;LEPROT;CHMP5;CHMP6;VPS28;CHMP7;VPS36;CHMP4C;SNF8;LEPROTL1;TMEM50B;CHMP4A;CHMP4B
prerank,ameboidal-type cell migration (GO:0001667),0.48342574543724715,1.2985550574619495,0.11712707182320442,0.4239995892018008,1.0,16/51,21.70%,AKT1;ERBB4;SEMA3F;SEMA7A;SEMA4C;CORO1C;SEMA6D;PKN1;SEMA4A;SOX8;SEMA4G;AMOT;ANXA6;SOX10;SGPL1;CCN3
prerank,negative regulation of catalytic activity (GO:0043086),0.5438983048806525,1.2985028366054887,0.14570361145703611,0.42363602466225625,1.0,11/24,19.63%,MT3;NES;ATP5IF1;PLN;IFIT1;TIMP1;PHPT1;HP;TMBIM1;CCAR2;NOTCH1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4575248599424137,1.2983164482469034,0.06583072100313479,0.42367953549362397,1.0,41/95,29.64%,VIM;PDE4B;NR1D1;TIRAP;SIRPA;CD180;TNFAIP3;CCR5;CXCL10;TICAM2;CD68;HMGB1;ZFP36;CHMP5;WNT5A;RHOA;LILRB1;CX3CR1;CCL2;PF4;DAB2IP;CD14;CD86;NLRP3;IL6;GIT1;MEF2C;PYCARD;SIRT2;SELENOS;NUGGC;RELA;LBP;CASP1;XBP1;TNFRSF1B;FZD5;PPBP;TLR2;NOD2;ACOD1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.45993796654703023,-1.298090906902627,0.12653061224489795,0.5459305378884144,1.0,6/16,14.10%,CREBBP;NAA40;KAT2B;NAA16;NAA15;NAA35
prerank,non-motile cilium assembly (GO:1905515),-0.3880333747441036,-1.298079500843505,0.10588235294117647,0.5430413190501829,1.0,14/30,22.09%,PCM1;PIBF1;CEP290;IFT88;RPGRIP1L;CEP89;TMEM80;IFT122;C2CD3;IFT57;TBC1D32;RPGRIP1;GORAB;BBS10
prerank,central nervous system development (GO:0007417),0.43287115271706766,1.2977693677077184,0.01706827309236948,0.42471370600588404,1.0,82/250,22.41%,C1QA;APOD;GSN;MBP;BCAN;C3;MARCKS;ASIC2;S100B;SLC2A1;NES;CNTNAP2;ADAM23;CNTN4;SCTR;NDRG4;MAL;ECRG4;ABCB6;ADGRL3;SH3GL2;SPOCK1;GRIN1;TAGLN3;HAPLN2;NKX2-2;TMX2;ADGRG1;PHGDH;UFC1;NRCAM;KLK6;PROX1;MAST1;COL4A1;GRIN2A;MFSD2A;MOG;SLC6A17;CDK5R1;DNAJC30;MARCKSL1;DNER;AATK;MYRF;HAP1;ATP6AP2;ELP3;SOX8;LSR;CLN5;SOX9;CXCR4;CAPG;CX3CR1;PTPRZ1;IER3IP1;DSCAML1;ROBO2;CDK5;COX7B;DLL1;VCAN;GLIS2;SCIN;GRIN2B;EIF2B5;QARS1;SOX11;RAB18;DCX;NNAT;HSPG2;DDIT4;SOX10;HAPLN4;GRIK1;ROGDI;SNTG2;POU6F2;GRHL2;ACAN
prerank,actin nucleation (GO:0045010),0.5491159969545714,1.2977170818877188,0.1415929203539823,0.42438653987439817,1.0,9/21,17.68%,MAGEL2;IQGAP2;ARPC1B;ARPC3;ARPC5;ARPC5L;ARPC4;ARPC2;SCIN
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6117013461282765,1.2973978059007225,0.1692524682651622,0.42477589444393765,1.0,6/12,19.93%,TRH;MAOA;ODC1;SMS;SRM;OAZ2
prerank,regulation of protein localization to cell surface (GO:2000008),0.5138375917637531,1.2972136874928422,0.12868949232585597,0.4247630559959456,1.0,7/33,7.82%,TYROBP;HSP90AB1;TNF;MAP1A;CTNNB1;GPM6B;LEPROT
prerank,regulation of vasculature development (GO:1901342),0.5288220576408282,1.2967768306204206,0.1330049261083744,0.42547504999221475,1.0,7/26,11.61%,GPNMB;HMOX1;EMP2;CTNNB1;VASH1;RNH1;WARS1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5126894847747049,1.2967184006988732,0.1511216056670602,0.425163231862621,1.0,4/33,4.40%,CD74;TNF;HCLS1;ZFP36L1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5281975109175769,1.2967007506688826,0.161090458488228,0.42474786789835334,1.0,3/25,4.03%,RPS3;PDE4B;PTPRC
prerank,negative regulation of cell death (GO:0060548),0.46096618497474257,1.296600350468191,0.06993736951983298,0.4245710652822076,1.0,25/88,19.95%,CLU;GPNMB;MT3;PARK7;AKT1;CD34;PINK1;NENF;SORL1;HSPA1B;LRPAP1;BNIP3L;CCN2;ATP13A2;CHGA;TMEM109;WFS1;HSPA1A;PDE12;CDK5;GATA4;PPARGC1A;SOX11;SNCA;POU4F1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5981744735060806,1.2965896105658075,0.1632928475033738,0.424142533055566,1.0,7/13,29.62%,NAMPT;KDR;CCL2;SELENOS;IL33;TLR2;NOD2
prerank,positive regulation of response to external stimulus (GO:0032103),0.4463161964583266,1.2963240386485406,0.05527123848515865,0.42435396943893083,1.0,48/128,26.53%,MDK;GRN;THBD;CCL19;CYBA;TREM2;AGT;TNF;PDGFB;S100A8;S100A9;LY86;CD180;DDT;RARRES2;HYAL2;FEM1A;CEBPA;IL2;LPL;SLC15A4;P2RY12;LILRA5;NINJ1;PLA2G7;WNT5A;AIF1;TNFRSF1A;F2RL1;GPSM3;CCL3;CCR2;STX4;SNCA;TGFB1;NFKBIA;PPM1F;POLR3D;TNIP1;AKIRIN2;PTN;APP;PDE2A;PRKCA;IL33;TLR7;CX3CL1;STX3
prerank,rRNA pseudouridine synthesis (GO:0031118),0.630215507788994,1.2962618031752688,0.1729957805907173,0.4240408497411446,1.0,6/10,22.30%,NOP10;NHP2;GAR1;DKC1;RPUSD4;NAF1
prerank,epithelial cell migration (GO:0010631),-0.36312199656285427,-1.2961681456781853,0.11515151515151516,0.5448983609274953,1.0,9/37,6.62%,ABL1;KANK2;ROCK1;NRP1;ADGRA2;STARD13;DPP4;PXN;FAP
prerank,T cell homeostasis (GO:0043029),0.634729184292993,1.2960906366775866,0.16358463726884778,0.42403729060577977,1.0,4/10,23.44%,AKT1;PMAIP1;ZC3H8;PPP2R3C
prerank,regulation of regulated secretory pathway (GO:1903305),0.5110601265697701,1.2960884695628514,0.12276519666269368,0.4235860754448959,1.0,18/34,25.62%,SYT1;RIMS2;RIMS1;RAB15;SYT12;SYT11;SYT6;RAB3D;SYT4;SYN1;SYT10;DOC2A;SYT2;PREPL;SYT3;SYT5;UNC13D;SYT17
prerank,regulation of microtubule polymerization (GO:0031113),0.4921892092114494,1.2956573383989245,0.12687427912341406,0.4242893102915928,1.0,15/40,16.80%,RPS3;RAC1;NAV3;PAK1;CLASP1;MAPT;TUBB4A;MAP2;CDK5R1;DCTN1;CLIP3;STMN1;ARL2;MAPRE3;CDH5
prerank,positive regulation of cell motility (GO:2000147),0.4407625712585149,1.2956470845823127,0.022110552763819097,0.4238565365824034,1.0,62/205,19.83%,ACTG1;RACK1;CAVIN1;MDK;GRN;COL1A1;GPNMB;CD151;CXCL12;HSPA5;CCL19;SPOCK2;GPER1;RHOC;SEMA3F;PDGFB;SEMA7A;SEMA4C;MYADM;FAM107A;CXCL16;SEMA6D;PAK1;PODXL;KDR;VSIR;NTN1;LGR6;LAMC2;PHPT1;SEMA4A;CSF1R;PECAM1;ELP3;HRAS;AIF1;SEMA4G;BMP2;CTSH;SDCBP;TIAM1;F2RL1;PDGFA;FLT1;CCL3;CAV1;PLAU;CDH5;CASS4;PIK3CD;TRIM32;TWIST1;F10;MMP14;ADAM17;MAZ;STX4;PPP3CA;DDRGK1;NOTCH1;HGF;TGFB1
prerank,cellular response to amyloid-beta (GO:1904646),0.5080456705297727,1.2947210787238685,0.13821138211382114,0.4257152319798205,1.0,12/35,16.62%,LGMN;PRNP;TREM2;GRM5;GRIN1;CACNA1A;ATP1A3;GRIN2A;GJA1;TLR6;CDK5;VCAM1
prerank,peptidyl-asparagine modification (GO:0018196),0.513972751243495,1.2943549989630836,0.1336459554513482,0.4261952171811279,1.0,13/31,18.84%,OST4;RPN1;RPN2;DAD1;DDOST;LMAN1;MGAT2;DPM3;MCFD2;ASGR2;DPM2;MAGT1;STT3A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.46813004636153055,1.2942593526287893,0.08378088077336197,0.42598026517676874,1.0,33/73,26.18%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;SPI1;PSMC3;PSMD6;PSMA7;PSMD5;GATA2;KITLG;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;LMO1;PSMA6;PSMA4;PUS7;PSMC1;PSMD9;METTL3;TCF3;METTL14;PSMB2;PSMD4;PSMD10
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.44211817695828104,1.293411215551489,0.034274193548387094,0.42773199850837385,1.0,62/163,27.89%,PSMB4;PSME1;PDE4B;PSMB6;PSME2;PSMB8;PSMD2;NFAM1;PTPRC;BTN3A3;PSMD1;PSMC3;PSMD6;PSMA7;CD3D;PAK1;THY1;MOG;PSMD5;ICOSLG;PAK3;PSMB9;PSMD13;RBCK1;PSMB3;PSMB11;CTLA4;RIPK2;PSMB10;VAV3;SH2B2;PSMB1;PSMB5;PIK3CD;SKAP1;LCP2;SYK;EIF2B5;PSMA6;MEF2C;SKP1;TRAT1;PSMA4;NFKBID;PSMC1;PSMD9;INPP5D;CD28;RELA;PLEKHA1;CD276;RFTN1;PSMB2;PSMD4;BLNK;PRKCQ;PSMD10;STOML2;ITK;IKBKG;PSMC5;CD3E
prerank,negative regulation of protein catabolic process (GO:0042177),0.48859501098612484,1.292935966840529,0.13631156930126,0.4285269937685981,1.0,16/40,21.36%,CST3;TIMP2;PIN1;FLNA;NELL1;FMN2;TIMP1;ADGRB1;ATRAID;CTSA;TIMP3;DAB2IP;AGAP2;SNCA;TIMP4;SIRT2
prerank,actomyosin structure organization (GO:0031032),-0.3119218006163385,-1.2927238048677685,0.019230769230769232,0.5504224833572727,1.0,12/75,7.11%,ROCK2;SORBS1;PHACTR1;TMOD3;FRMD6;ROCK1;ACTN2;EPB41L5;EPB41L2;MYH9;CDC42BPB;MYH10
prerank,sphingolipid metabolic process (GO:0006665),0.4503979032068107,1.2920267483636907,0.06935817805383022,0.4304091558376233,1.0,37/108,23.78%,PSAP;GM2A;HEXB;SERINC1;HEXA;CERS2;ORMDL3;B4GALNT1;PPP2R1A;ELOVL1;ENPP2;ELOVL2;GAL3ST1;SMPD1;ELOVL7;CTSA;GLTP;SPTLC1;ST6GALNAC3;DEGS1;ABCA2;NEU1;FA2H;CSNK1G2;CLN8;CERKL;SPTSSA;VAPA;SGPP1;SPHK2;SGPP2;ASAH2;SGPL1;ORMDL2;ELOVL6;ALDH3B1;VAPB
prerank,neuronal action potential (GO:0019228),0.5479581371493749,1.2918002738946344,0.15782828282828282,0.4305252261214328,1.0,10/22,26.88%,ANK3;GPER1;SCN1A;KCNA2;KCNA1;SCN9A;MYH14;SCN8A;SCN2A;KCNMB4
prerank,B cell receptor signaling pathway (GO:0050853),0.5099994652102922,1.2914844546520572,0.14590747330960854,0.43088215858391216,1.0,13/32,26.68%,NFAM1;PTPRC;BAX;CTLA4;VAV3;SH2B2;PIK3CD;SYK;MEF2C;PLEKHA1;RFTN1;BLNK;ITK
prerank,establishment of spindle localization (GO:0051293),0.5886385400269555,1.2912969741008162,0.15416098226466576,0.43093752391602885,1.0,9/14,32.40%,CFL1;CLASP1;LLGL1;KPNB1;ZBED3;MAP4;ESPL1;CLASP2;DYNC1H1
prerank,regulation of astrocyte differentiation (GO:0048710),0.6075844583501696,1.290930232897639,0.1729957805907173,0.43148738933102415,1.0,6/12,21.14%,SERPINE2;HES1;BMP2;NOTCH1;IL6;ID2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6273544106813689,1.2908784871600458,0.1712230215827338,0.43116343091322024,1.0,6/10,29.62%,NAMPT;KDR;CCL2;IL33;TLR2;NOD2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.5296169697920844,-1.2897522482440948,0.2007168458781362,0.5522685240384319,1.0,6/10,16.99%,NFAT5;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,calcineurin-mediated signaling (GO:0097720),-0.5296169697920844,-1.2897522482440948,0.2007168458781362,0.5522685240384319,1.0,6/10,16.99%,NFAT5;NFATC1;NFATC4;NFATC3;PPP3CB;PPP3CC
prerank,membrane organization (GO:0061024),0.4376668992390667,1.289477304628971,0.026078234704112337,0.43435181347632545,1.0,52/227,16.40%,ACTB;MTCH1;RPS27A;ACTG1;HSPA8;UBC;UBB;ANK3;SGCZ;SYNGR2;SH3GL2;CHMP2B;CTDNEP1;DNM3;AP2M1;MYADM;SYT1;TFRC;UBA52;SYNGR1;SAR1A;CORO1C;AMPH;CD3D;RIMS1;CLTC;VAMP3;VAMP2;EPN1;AP2S1;CHMP5;CHMP6;FNBP1L;FCHO1;WNT5A;ARPC3;VAMP8;SERP1;CHRM2;GLTP;ARPC5;TIMM50;CCDC88A;SYP;ARPC4;CLTA;M6PR;ARRB2;CHMP1B;SH3KBP1;NAPA;SYT2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5416274666996902,1.2890178874767912,0.1580246913580247,0.435058947692554,1.0,2/23,4.50%,TMSB4X;SPI1
prerank,histone H3-K4 methylation (GO:0051568),-0.3944596597469171,-1.288848146102478,0.09876543209876543,0.5516390077498499,1.0,15/26,22.76%,KMT2C;TET2;OGT;TET3;KMT2A;ASH2L;KMT2D;WDR82;SETD4;PRDM9;SETD1B;WDR5B;BEND3;KDM6A;CTR9
prerank,anion transport (GO:0006820),0.5131428213652349,1.2886730946357272,0.16094674556213018,0.4355394020595063,1.0,10/33,19.96%,TSPO;SLC17A8;LRRC8A;SLC26A4;SLC17A7;SLC17A6;SLC19A1;SLC4A2;VDAC2;SLCO1B1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.4598119082336552,-1.2884901112410936,0.15517241379310345,0.5497228523080395,1.0,6/15,9.67%,GPC3;WNT5B;RNF213;RSPO3;NPHP3;SPEF1
prerank,response to amyloid-beta (GO:1904645),0.4908417479056551,1.2884731558186062,0.13580246913580246,0.43559565603000056,1.0,14/44,16.62%,LGMN;PRNP;TREM2;GRM5;GRIN1;CACNA1A;ATP1A3;GRIN2A;MMP3;RAMP3;GJA1;TLR6;CDK5;VCAM1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6309482713193085,1.2879286664229512,0.17585692995529062,0.43654241348387623,1.0,4/10,13.55%,CXCL12;CCL19;LILRB1;GAS6
prerank,autophagosome organization (GO:1905037),0.48716874253615183,1.2876436976780428,0.12070874861572536,0.43680761168703236,1.0,12/50,14.91%,GABARAP;MAP1LC3B;MAP1LC3A;EMC6;GABARAPL2;GABARAPL1;ATG9A;ATP13A2;ULK3;UBQLN2;VMP1;ATG101
prerank,nucleotide-excision repair (GO:0006289),0.4504255585001223,1.287216303710408,0.07979274611398963,0.437402970733745,1.0,38/101,26.90%,RPS27A;UBC;UBB;POLR2E;COPS7A;POLR2D;COPS6;POLR2F;PARP1;RPA2;HMGN1;UBA52;XAB2;PRPF19;RBX1;DDB1;POLR2G;PCNA;POLR2K;RFC2;COPS8;POLD4;CETN2;BRCA2;ERCC6;RAD23A;RFC4;ERCC1;POLR2H;POLD1;PNKP;RPA3;PPIE;XPC;LIG1;GTF2H5;ERCC2;CCNH
prerank,positive regulation of sodium ion transport (GO:0010765),0.6107464586164167,1.2871646196808035,0.18934081346423562,0.43708778732719017,1.0,4/12,14.99%,ANK3;SCN4B;CNKSR3;PRSS8
prerank,glycosaminoglycan catabolic process (GO:0006027),0.46946223485729194,1.2868063023001852,0.10532150776053215,0.43755388133988726,1.0,22/55,20.59%,BGN;HEXB;BCAN;FMOD;LUM;HEXA;HYAL2;GUSB;DCN;SDC4;FUCA1;GPC5;SGSH;NAGLU;HPSE;VCAN;SDC3;HPSE2;HSPG2;TGFB1;AGRN;LYVE1
prerank,regulation of microtubule nucleation (GO:0010968),0.6310163892085612,1.2864039734566706,0.2,0.4381373942964179,1.0,6/10,19.87%,HSPA1B;PAK1;ARHGEF7;DCTN1;HSPA1A;GIT1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.576366232028991,1.2863764277758811,0.18652849740932642,0.4377520798529916,1.0,4/16,6.77%,APOD;TREM2;SIRPA;CUEDC2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.48313464273094575,1.286116284158329,0.1162280701754386,0.4379644339934589,1.0,17/50,16.86%,RPS3;PARK7;UBXN1;AKT1;HSPA1B;BAG5;TNFAIP3;ISG15;ADGRB1;DNAJA1;VPS28;HSPA1A;IVNS1ABP;FBXO5;ARRB2;CAV1;SQSTM1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3372992603125477,-1.2860175209021283,0.07142857142857142,0.5529491534403176,1.0,16/44,14.11%,ROCK2;ABL1;LPAR1;PPM1E;NRP1;SORBS3;ARHGEF10L;CARMIL1;TGFBR1;PXN;TPM1;RAPGEF3;FERMT2;NF2;WNT11;TGFB3
prerank,cell junction organization (GO:0034330),0.46426286237732894,1.2859910056922497,0.11395101171458999,0.43782938707911684,1.0,23/71,19.89%,ACTB;ACTG1;C1QA;GRM5;PIN1;LRP4;FLNA;PPFIA4;PPFIA2;MAPT;PAK3;CBLN2;RHOA;VMP1;ELFN1;PPFIA3;RAB39B;CTNND2;FBLIM1;SNCA;TGFB1;MARVELD2;AGRN
prerank,protein localization to cilium (GO:0061512),-0.3824930034284835,-1.2858601826090241,0.1402439024390244,0.5504378351640002,1.0,11/32,14.54%,ZNF423;RABEP1;BBS9;INVS;ARL3;WDR35;TULP3;IFT140;IFT122;TULP2;WDR19
prerank,regulation of cation transmembrane transport (GO:1904062),0.5184186855003605,1.2858118948029433,0.14595898673100122,0.4378399683128546,1.0,8/29,15.36%,CD63;KCNIP4;DPP10;DPP6;FGF12;KCNN2;KCNE5;KCNIP1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5260447131623626,1.284803274435397,0.1349112426035503,0.4399238535246369,1.0,18/29,31.70%,APOE;SHISA7;GRIK2;SYNGR1;SYP;PPFIA3;NCDN;NSMF;APP;SHISA6;ZDHHC2;NETO1;ACP4;CAMK2B;MCTP1;DRD2;RAB3A;DBN1
prerank,negative chemotaxis (GO:0050919),0.5095527305107543,1.2845485523982059,0.13866039952996476,0.4401685538579838,1.0,14/33,16.96%,SEMA3F;SEMA7A;SEMA4C;SEMA6D;NTN1;LGR6;UNC5C;SEMA4A;LRTM2;RHOA;SEMA4G;PDGFA;SLIT3;SLIT1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4645120735171844,1.2844308823199129,0.10802139037433155,0.43999428260821194,1.0,22/66,20.93%,TYROBP;HSPB1;CCL19;TNF;SIRPA;TNFAIP3;P2RX7;LPL;EGR1;LILRA5;WNT5A;RIPK2;NLRP2B;CX3CR1;TLR6;F2RL1;CCL3;NLRP3;IL6;GIT1;TMEM106A;PYCARD
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5138971756898802,1.2843522595355041,0.14720194647201945,0.4397626808505765,1.0,7/29,9.13%,APOE;AKT1;MID1IP1;CTDNEP1;HSD17B13;MFSD2A;MLXIPL
prerank,positive regulation of T cell cytokine production (GO:0002726),0.5415980572116108,1.2843500757434787,0.16688396349413298,0.43931214920411643,1.0,2/20,1.05%,B2M;CD81
prerank,intracellular sterol transport (GO:0032366),0.5958749325368387,1.284233408244961,0.18005540166204986,0.4391817343265045,1.0,4/13,9.19%,NPC2;ABCG1;TSPO2;STARD4
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5145975662889057,1.2839631547063621,0.16133004926108374,0.43940171842728365,1.0,13/30,23.58%,PTPRC;PPP2R1A;HYAL2;PTK6;THY1;CADM4;SRCIN1;DMTN;CAV1;CD300A;SFRP1;PTPN6;SOCS3
prerank,cellular response to leucine starvation (GO:1990253),-0.5280335919239441,-1.283896364647107,0.19063545150501673,0.5522965791302119,1.0,6/10,25.91%,EIF2AK4;RRAGB;SESN1;LARS1;SESN2;SESN3
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.4415421873476568,1.2837953485041322,0.04989816700610998,0.4393843736307621,1.0,29/148,15.69%,RPL23;RPL11;RPS15;RPL37;RPL5;RPS20;AKT1;CSNK2B;MBD3;CHEK2;PIN1;RPA2;HIPK2;TTC5;BRPF1;SGK1;TAF10;CDK5R1;PIP4P1;TAF9;SSRP1;CCNG1;RFC2;STK11;PRR5;HEXIM1;L3MBTL1;MAPK11;CDK5
prerank,cellular response to cytokine stimulus (GO:0071345),0.42680783276665263,1.283374782025567,0.005005005005005005,0.44001250277966153,1.0,120/416,21.23%,RPS3;RPS27A;HSPA8;MT1X;UBC;VIM;IFITM2;UBB;GAPDH;RPL13A;HSP90AA1;F13A1;CXCL12;HMOX1;NDUFA13;MT2A;AKT1;CCL19;AQP4;AKAP6;ITGB2;IL5;POMC;GPER1;TNF;HSP90B1;NR1D1;HCLS1;ZFP36L1;UBE2G2;JUNB;ZFP36L2;SIRPA;IL2RB;CSF3R;S1PR1;HYAL2;CDC34;FN1;UBA52;CCND1;CCR5;IL1RAPL1;CEBPA;CXCL10;IL2;IFIT1;TIMP1;EGR1;HCK;ZFP36;IRF8;CSF1R;WNT5A;IL11;MMP3;LCN2;IL2RG;IL3RA;MAOA;AIF1;SELPLG;COL1A2;SOX9;VAV1;RHOA;GAS6;DOCK8;YWHAZ;CXCR4;HNRNPU;TNFRSF1A;PDE12;RHOU;ERBIN;RO60;NDN;CCL2;PTPRZ1;PF4;IFNGR1;MAPK11;LRP8;CSF2RB;YBX3;SIGIRR;DAB2IP;CCL3;VCAM1;PIK3CD;TWIST1;NOS2;CCL8;SYK;CCR2;SLA;STX4;EPRS1;IL20RA;MUC1;CD86;SOS1;FLT3;IL6;HGF;IFNGR2;TGFB1;CSF2RA;POU4F1;IL10RB;PDE1B;SFRP1;IL1RAP;MYC;CRLF1;PTPN6;PYCARD;CRLF2;ASAH2;CDK9
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6032301572577239,1.2823582241370424,0.16457461645746166,0.4422105178719112,1.0,5/12,14.96%,SEC61B;HSPA5;SEC61G;SEC61A1;SGTA
prerank,JNK cascade (GO:0007254),0.49032537731253184,1.2822696514395455,0.13488372093023257,0.44200844601490386,1.0,8/40,14.13%,RPS27A;UBC;UBB;UBA52;SH2D3C;RIPK2;UBE2V1;MAPK10
prerank,regulation of neutrophil migration (GO:1902622),0.630098710842228,1.282054814686018,0.16405135520684735,0.4421260009910689,1.0,5/10,25.39%,RAC1;RHOG;JAM3;RAC2;MPP1
prerank,nitrogen compound transport (GO:0071705),0.44157465388863487,1.2820265006380176,0.05322415557830092,0.4417379187646247,1.0,34/141,18.56%,SLC38A5;RAMP2;RCN3;SLC18A1;LRP1B;SLC7A5;SLC1A4;TXNIP;TMEM30A;HSP90B1;ABCB6;CHMP2B;RD3;ARRDC1;SLC25A29;SCAMP3;SLC6A6;AQP1;SLC6A2;SLC15A4;VAMP2;SLC3A2;SLC48A1;SLC7A14;RAMP3;CMTM6;SLC11A1;SCAMP2;ARRDC3;SLC15A2;CHMP1B;ATP11B;SLC52A1;SLC19A2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.552060830648392,1.2820252234581941,0.15612903225806452,0.4412865257812752,1.0,4/20,4.81%,PPIA;PPIB;FKBP1A;PIN1
prerank,sterol homeostasis (GO:0055092),0.466016298750998,1.2819142311327838,0.12727272727272726,0.4411222631969351,1.0,16/65,17.90%,APOE;NPC2;RALY;NR1D1;ABCG1;LIPG;LPL;CD24;MALL;EHD1;NR1H2;ABCA2;HDAC9;CAV1;SOAT2;CNBP
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.44187017839014814,1.281005574759815,0.047764227642276426,0.4430246607209775,1.0,41/159,16.80%,BSG;CLDN5;MPZ;NLGN1;ITGB2;UNC5D;CD84;GRID2;LRFN5;DSCAM;CNTN4;PCDHGB4;CDH20;ADGRL3;LRRC4C;TENM2;TENM3;SELL;CLDN11;KIRREL3;CDH18;ROBO4;IL1RAPL1;EMB;PECAM1;TENM4;FGFRL1;CADM3;PTPRD;CDH12;LRRC4B;CDH19;DCHS1;IGSF9;DSCAML1;ROBO2;CDH7;CDH24;VCAM1;CDH10;CDH5
prerank,positive regulation of cellular protein localization (GO:1903829),0.4623370607925984,1.280949010408889,0.10695187165775401,0.44269916626983535,1.0,23/69,23.15%,TYROBP;HSP90AB1;PARK7;AKT1;TNF;MAP1A;LAMTOR5;ORMDL3;RTN4;TFRC;SYT11;MAPT;GPR137B;VPS28;CCDC88A;SNX33;STX4;DDRGK1;TGFB1;GNL3L;TMEM35A;PARD6A;TESK1
prerank,sensory perception (GO:0007600),0.4806530524202134,1.280866827397107,0.1438278595696489,0.4424760973569399,1.0,14/45,22.51%,C5AR1;PCDH15;PENK;PRDM12;P2RX7;PDYN;TMEM150C;KCNA2;CHRNA4;CCL2;CCR2;NTSR2;SCN9A;USH2A
prerank,regulation of NMDA receptor activity (GO:2000310),0.5139485674169461,1.2808462199270687,0.14642857142857144,0.4420840646788231,1.0,16/32,21.60%,NLGN1;GRIA2;DLG2;NEFL;GRIN1;GRIA4;GRIN2A;CRH;GRIA1;CCL2;LRRC7;MAPK8IP2;GRIN2B;CCR2;MEF2C;GRIA3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6276958425627087,1.2806688586830195,0.18706047819971872,0.4420731450076775,1.0,1/10,0.06%,CST3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.6064484949227114,1.280360736497336,0.18865248226950354,0.4424282443043776,1.0,2/12,2.92%,ACADVL;APOC1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5241016969959241,1.280049891858152,0.16113161131611317,0.4427995075911576,1.0,7/24,15.84%,TPPP3;PIN1;STMN3;MAPT;STMN4;STMN1;FGF13
prerank,negative regulation of kinase activity (GO:0033673),0.4690726795939837,1.279707456665154,0.10515021459227468,0.4432682723233816,1.0,20/62,19.11%,PPIA;HSPB1;PARK7;AKT1;CAMK2N2;PTPRC;CDKN1C;DBNDD2;THY1;YWHAG;MAPT;RTRAF;WARS1;CAMK2N1;HNRNPU;PRKRIP1;AKT1S1;QARS1;TAB1;SNCA
prerank,cholesterol homeostasis (GO:0042632),0.4668583398779038,1.2791303627968673,0.12580645161290321,0.444233819144844,1.0,16/64,17.90%,APOE;NPC2;RALY;NR1D1;ABCG1;LIPG;LPL;CD24;MALL;EHD1;NR1H2;ABCA2;HDAC9;CAV1;SOAT2;CNBP
prerank,regulation of axon regeneration (GO:0048679),0.6174935107620771,1.279079973465578,0.16827586206896553,0.44390083199862035,1.0,3/12,7.62%,GRN;CERS2;KLK8
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.6160803042200516,1.2786691688621308,0.18068965517241378,0.44453426731035905,1.0,6/11,22.11%,PARK7;PINK1;P4HB;MMP3;GATA4;REST
prerank,positive regulation of vasculature development (GO:1904018),0.4518812758369207,1.2784915226481712,0.07570977917981073,0.44455058738685754,1.0,27/94,17.05%,RAMP2;HSPB1;GRN;HMOX1;RHOB;CD34;ECM1;APLNR;ADAM12;EMC10;BTG1;HIPK2;KDR;AQP1;TNFSF12;GATA2;NINJ1;PDCD6;WNT5A;TIE1;CTSH;RRAS;FLT1;GATA4;CDH5;PIK3CD;TWIST1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.44310718300844726,1.2775084718577046,0.09100204498977506,0.4466070098808329,1.0,40/121,19.83%,CD74;VTN;CD81;PRNP;TREM2;GRM5;ERBB4;IL5;AGT;TNF;PDGFB;PTPRC;HCLS1;ARL2BP;MIF;HES1;CLEC6A;ENPP2;PTK6;IL2;LILRA5;FCGR1A;CSF1R;PECAM1;IL11;DOK7;SRCIN1;RIPK2;GAS6;TNFRSF1A;IGF2;LRP8;CASS4;ERBB3;UNC119;FLT3;IL6;HGF;EFNA1;TGFB1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4970420225707801,1.2772736327885643,0.14965197215777262,0.44678001553614644,1.0,14/36,20.94%,APOE;CSNK2B;TNF;ACVRL1;VASH1;DCN;HMGB1;ADGRB1;DAB2IP;DNAJA4;NOTCH1;TGFB1;MEF2C;GADD45A
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.5598900080021818,1.277048354324273,0.17838541666666666,0.44692606236337523,1.0,5/18,15.32%,ATF4;MAF1;FLNA;POLR2K;UBTF
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5304308951029807,1.2770074061906134,0.1825,0.4465795735187554,1.0,7/25,14.18%,AKT1;AGT;GPER1;RTN4;PTK6;HAP1;CCDC88A
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5281510333100133,1.277003083917842,0.15566625155666253,0.4461364212490605,1.0,5/22,9.13%,APOE;AKT1;EEF1A2;HSD17B13;MLXIPL
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4013063867919633,-1.2767177526570408,0.1507537688442211,0.5677456549752746,1.0,11/22,15.71%,SCAF8;BRD4;KAT7;CCNT1;CDK12;TCERG1;CCNK;CDK13;ELL;THOC5;CDC73
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.32205908405627565,-1.2763798548063805,0.06451612903225806,0.5657566150323978,1.0,19/79,10.54%,SULF1;ADAMTS12;SMAD6;BMPR1A;CRIM1;SMURF2;SLIT2;SKI;NIBAN2;BMPER;SMAD9;CASK;SMURF1;SMAD1;VWC2;LEMD3;SMAD7;PPARG;SMAD4
prerank,regulation of ERAD pathway (GO:1904292),0.624172500176504,1.2763680953648442,0.1976911976911977,0.44734965843868907,1.0,5/11,21.24%,UBXN1;RNFT1;HERPUD1;TMEM259;USP13
prerank,copper ion transport (GO:0006825),0.6105468578730835,1.2762174469851242,0.18810511756569848,0.44728940707697257,1.0,4/11,15.43%,ATOX1;COX17;STEAP4;SLC31A1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6328714906483274,1.2762174113846958,0.1958041958041958,0.44683805550575456,1.0,5/10,23.47%,ANK3;KCNE4;KCNE5;CAV1;KCNAB1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.52377764795174,1.2759606761928306,0.16236162361623616,0.44705662427979403,1.0,10/25,20.93%,PINK1;GPER1;BAX;PMAIP1;BBC3;BAD;MFF;DNM1L;PDCD5;PYCARD
prerank,protein import (GO:0017038),0.45026026236729877,1.275816249407254,0.09224318658280922,0.4470027212318918,1.0,18/84,18.27%,APOE;CLU;HSP90AA1;AKT1;RAN;PXMP2;FAM53C;PTTG1IP;GDAP1;IPO4;NUP85;NUP88;SNX33;SPRN;EIF4ENIF1;SYK;NUP50;LAMP2
prerank,fatty acid elongation (GO:0030497),0.5926680451676467,1.2757894577184006,0.18457300275482094,0.44661656082811707,1.0,7/13,32.36%,ELOVL1;ELOVL2;ELOVL7;ELOVL6;HACD4;ELOVL4;ELOVL5
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5489053450109365,1.275683476365229,0.17142857142857143,0.4464343019483857,1.0,5/22,12.45%,APOE;TIMP2;TNF;TIMP1;TIMP3
prerank,cartilage development (GO:0051216),-0.3349603582433086,-1.2752075795243938,0.0625,0.5659327116945719,1.0,20/49,23.96%,SULF1;NFIB;SOX5;ZBTB16;WNT5B;ATP7A;ITGB8;PKD1;CREB3L2;BMP4;RUNX2;TRIP11;GPLD1;FGF2;SULF2;HOXD3;WNT2B;COL11A2;TRPV4;HYAL3
prerank,stress-activated MAPK cascade (GO:0051403),0.4621981490926093,1.2745670161975025,0.11525795828759605,0.44884355899412903,1.0,12/61,15.22%,RPS27A;UBC;UBB;MAPK3;ZFP36L1;UBA52;ZFP36;SH2D3C;RIPK2;UBE2V1;MAPK10;MAPK11
prerank,supramolecular fiber organization (GO:0097435),0.4278308257793589,1.2743234072967462,0.012,0.4489976199800234,1.0,67/333,14.18%,CST3;RPS27A;GFAP;ALDOA;UBC;VIM;B2M;UBB;GSN;HSP90AB1;COL1A1;H3-3A;ITM2B;CD151;PPIB;RHOB;TPPP3;SERPINH1;MARCKS;LUM;TPM2;MFGE8;RHOC;ARHGAP25;EMP2;RAC1;FKBP1A;PLEC;NEFL;PIN1;SORL1;PSENEN;LOX;STMN3;ELMO1;RHOG;TTR;UBA52;MFAP4;CORO1C;P4HB;CORO1A;CALB1;MYO5A;COL6A1;COL4A1;MYO7B;MAPT;COL3A1;STMN4;LAMC2;KRT9;EPPK1;COL9A1;MYO1F;MARCKSL1;MYH11;ACTN1;DCTN1;COL1A2;RHOA;DPT;FLII;CLIP3;DES;STMN1;CCDC88A
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4510497882761788,1.274223102589318,0.09842931937172775,0.4488115758848906,1.0,23/88,16.33%,FTH1;FTL;HSPA8;BLOC1S4;SORL1;SH3GL2;SORCS1;RAB14;SCAMP3;MYO5A;CLVS1;CLTC;VAMP2;CLVS2;BLOC1S1;BLOC1S3;VAMP8;SCAMP2;SORT1;ARF1;CLTA;GOLGA7;NAPA
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.6142103035997564,1.2738737607087895,0.18442622950819673,0.4492843909290668,1.0,3/11,10.24%,AGT;ABCG1;PLA2G7
prerank,positive regulation of hormone secretion (GO:0046887),0.5621463613962264,1.273868314093047,0.18652849740932642,0.44884871007534255,1.0,6/17,18.98%,SPP1;RASL10B;VAMP8;NMB;EDN3;SOX11
prerank,negative regulation of transferase activity (GO:0051348),0.5231281105228598,1.273404681333444,0.1597560975609756,0.4495243925458868,1.0,9/28,13.74%,PARK7;TERF1;BAG5;CDKN1C;MAPT;PHPT1;ZFP36;FBXO5;HNRNPU
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.49604128516979684,-1.2724675573917537,0.20068027210884354,0.5698676930727947,1.0,5/11,9.89%,ATF7IP;RESF1;TASOR;SETDB1;PPHLN1
prerank,regulation of actin filament polymerization (GO:0030833),-0.3173976102178056,-1.2714660182902897,0.025974025974025976,0.5697406582784702,1.0,17/69,11.99%,ARHGAP28;FCHSD2;FER;BAIAP2L1;ARFGEF1;SLIT2;PRKCE;BAIAP2;CARMIL1;NCKAP1;CDC42EP5;PLEKHG2;GBA2;KANK1;SNX9;NCK1;ARHGAP18
prerank,membrane assembly (GO:0071709),0.504584370031925,1.2709753197812834,0.17966903073286053,0.4553713288189481,1.0,10/34,12.53%,NRXN1;NLGN1;S100A10;ANK3;EMP2;LRP4;FLOT1;IL1RAPL1;PTPRD;NRXN2
prerank,regulation of cell death (GO:0010941),0.4425552317979409,1.2707745303093751,0.10412371134020619,0.4554365828666874,1.0,20/94,15.67%,CLU;UBB;CTSZ;MT3;PARK7;DCC;CRYAB;HSPA1B;LRPAP1;BNIP3L;CCN2;DHCR24;RAMP3;TMEM109;HSPA1A;RIPK2;PDE12;HPR;HP;EPHB1
prerank,regulation of sodium ion transport (GO:0002028),0.5008752959353493,1.2707494621099589,0.15357561547479484,0.4550507074714263,1.0,11/34,15.65%,NKAIN2;ANK3;YWHAH;NKAIN3;P2RX7;SCN4B;FGF12;ATP1A1;CNKSR3;PRSS8;SPTBN4
prerank,regulation of cellular component organization (GO:0051128),0.43500434151263534,1.2706066012711676,0.06878850102669405,0.4549517866976089,1.0,30/135,14.19%,APOE;HSPA8;GFAP;HSP90AA1;PARK7;SNX17;NRG3;PINK1;AGT;LAMTOR2;TNF;LTBP4;PACSIN1;SPOCK1;BAG5;TFRC;FAM107A;KLK8;SGK1;WFDC1;CD22;NET1;AP2S1;WNT5A;ATF5;SSRP1;NCLN;HNRNPU;STK11;EGLN2
prerank,cell projection assembly (GO:0030031),0.5327937544291943,1.2704091814944964,0.17987421383647798,0.45497862775411685,1.0,10/22,17.68%,GSN;RAC1;NEFH;RHOG;RHOV;RHOU;CAPG;PDGFA;RAC2;SCIN
prerank,purine nucleotide catabolic process (GO:0006195),0.5948298146121155,1.2703963876422026,0.17914438502673796,0.45456251412722115,1.0,5/13,17.44%,GPX1;HINT1;DNPH1;PNP;NT5C
prerank,lipid homeostasis (GO:0055088),0.4716614953629033,1.2699571061228179,0.11951754385964912,0.455299169642998,1.0,13/57,13.10%,APOE;RCN3;PNPLA2;TREM2;ORMDL3;ABCG1;LIPG;RBP1;CEBPA;MLXIPL;ATP13A2;ABHD8;FBXW7
prerank,L-serine metabolic process (GO:0006563),0.6282119708041258,1.269854175446861,0.1608876560332871,0.45512142762057034,1.0,5/10,20.44%,SERINC3;SDS;PHGDH;SERINC5;SHMT2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5824847767153809,1.269537076249959,0.1933240611961057,0.4555462875123498,1.0,5/12,21.08%,PODXL;BASP1;CD24;PROM1;PTPRO
prerank,microtubule-based transport (GO:0099111),-0.4943484256519417,-1.2695205875736961,0.16412213740458015,0.5720300671356844,1.0,8/12,30.04%,SPAG17;SPA17;DNAAF2;DYNC1I2;ROPN1L;CCDC40;DNAAF4;ADCY10
prerank,dendritic cell migration (GO:0036336),0.5714356430509774,1.2686723506183601,0.20107962213225372,0.4573321984245022,1.0,7/16,19.50%,CCL19;CCR5;HMGB1;TRPM2;CXCR4;CCR2;GPR183
prerank,regulation of hormone secretion (GO:0046883),0.5717020085338528,1.2685748370661725,0.1909814323607427,0.4571155281702148,1.0,7/15,18.98%,SCG5;VAMP3;VAMP2;IL11;NMB;EDN3;SOX11
prerank,regulation of interleukin-10 production (GO:0032653),0.47710301869811,1.2678605116624222,0.14580941446613088,0.4585318636337275,1.0,15/44,24.48%,TYROBP;CD34;ISG15;HSPD1;VSIR;LILRA5;HMGB1;LILRB1;F2RL1;DLL1;SYK;IL6;PYCARD;CD28;AGER
prerank,negative regulation of cellular metabolic process (GO:0031324),0.490846450403263,1.2673024817559042,0.15967365967365968,0.459518019117925,1.0,4/37,6.51%,APOE;MT3;PINK1;LRPAP1
prerank,axonal transport (GO:0098930),0.49838446417474874,1.266998461519982,0.14571092831962398,0.4598828444877579,1.0,10/36,12.87%,SOD1;BLOC1S4;NEFL;AP3B2;MAPT;BLOC1S1;BLOC1S3;HAP1;BLOC1S5;DCTN1
prerank,mesoderm development (GO:0007498),0.5594528310497148,1.2668989575884875,0.20076726342711,0.4596568657542603,1.0,9/18,31.73%,IKZF1;HCK;TIE1;IKZF3;GDF11;MESD;MEST;TCF15;BTK
prerank,eosinophil chemotaxis (GO:0048245),0.5696385749237778,1.266549748594555,0.19921875,0.4596701272947861,1.0,7/14,29.89%,LGALS3;CCL2;CCL3;CCL8;SCG2;CX3CL1;CCL13
prerank,eosinophil migration (GO:0072677),0.5696385749237778,1.266549748594555,0.19921875,0.4596701272947861,1.0,7/14,29.89%,LGALS3;CCL2;CCL3;CCL8;SCG2;CX3CL1;CCL13
prerank,epithelial structure maintenance (GO:0010669),0.616319617146146,1.266544819719702,0.1957142857142857,0.45923237794239175,1.0,2/11,7.22%,RBP4;STRAP
prerank,positive regulation of dendritic spine development (GO:0060999),0.5455202703184168,1.2663810357075491,0.1713917525773196,0.45919178044287556,1.0,2/20,2.44%,APOE;NLGN1
prerank,regulation of endothelial cell migration (GO:0010594),0.4495190742773611,1.2663148152424186,0.10465116279069768,0.4589142902587343,1.0,21/85,11.65%,APOE;SPARC;GRN;CALR;RHOB;AKT1;AGT;EMP2;RAC1;ACVRL1;EMC10;GLUL;VASH1;PROX1;KDR;DCN;ADGRB1;PDCD6;WNT5A;AAMP;FLT4
prerank,membrane raft organization (GO:0031579),0.5702426842619535,1.2662000273494305,0.1862348178137652,0.45874858254440914,1.0,4/15,6.04%,S100A10;EMP2;FLOT1;MYADM
prerank,Golgi to lysosome transport (GO:0090160),0.6110312973210488,1.2661618015968705,0.19204389574759945,0.4584122284901259,1.0,2/11,1.38%,LAMP1;LAPTM5
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.43403339108808336,-1.2655950220190029,0.1590909090909091,0.5792314499237845,1.0,4/17,8.24%,AKAP13;ADCY9;RAPGEF2;ADRA1B
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.45936701413076314,1.2652660314379047,0.11278195488721804,0.4602950769957306,1.0,30/70,26.18%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;PSMD5;GATA2;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;PSMB1;PSMB5;LMO1;PSMA6;PSMA4;PUS7;PSMC1;PSMD9;METTL3;TCF3;PSMB2;PSMD4;PSMD10
prerank,post-translational protein modification (GO:0043687),0.42269295226033277,1.2649494473569216,0.019,0.4606622208602232,1.0,85/332,20.57%,APOE;CST3;PSMB4;ELOB;SPARCL1;SPP1;LGALS1;C3;LAMC1;LAMB2;PSME1;PSMB6;PNPLA2;PSME2;PSMB8;CKAP4;PSMD2;COPS7A;IGFBP3;MFGE8;COPS6;IGFBP4;FBXO15;HSP90B1;KLHL9;IGFBP5;PSMD1;SHISA5;EPAS1;PSMC3;PDIA6;PSMD6;PENK;FN1;PSMA7;P4HB;FN3KRP;FEM1C;FEM1A;FBXL14;APLP2;UBE2M;VWA1;PSMD5;RBX1;NEDD8;FBXO27;TIMP1;DDB1;ICMT;PSMB9;PSMD13;PSMB3;FBXW5;WFS1;PSMB11;MXRA8;ASB13;FBXW7;FBXO30;FBXO31;GAS6;PSMB10;KBTBD7;SPSB3;COPS8;PSMB1;RNF7;PSMB5;VCAN;VHL;EVA1A;SCG3;RBBP5;NOTUM;STT3A;PSMA6;FBXL16;IL6;SKP1;PRSS23;QSOX1;PSMA4;KLHL25;BTBD6
prerank,secondary alcohol metabolic process (GO:1902652),0.48855892742378637,1.2648877576230189,0.12731481481481483,0.4603912791937289,1.0,10/42,23.08%,APOE;ABCG1;PIP4P1;CLN6;SOAT2;CLN8;CH25H;OSBPL1A;IDH3G;NSDHL
prerank,linoleic acid metabolic process (GO:0043651),0.5589171251758339,1.2643630482053916,0.1932555123216602,0.4613347570988396,1.0,4/17,11.13%,FADS1;ELOVL1;ELOVL2;GSTM2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.4993397499264249,1.2636898581294504,0.1730310262529833,0.46267055418357056,1.0,8/32,9.13%,TMSB4X;TREM2;PINK1;ENO1;VCP;P2RX7;NUPR1;MLXIPL
prerank,T cell differentiation in thymus (GO:0033077),0.5814845133687394,1.2636392103421668,0.1911170928667564,0.46235690164983007,1.0,3/14,5.16%,PTPRC;ZFP36L1;ZFP36L2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.5461948704462645,1.2635700975038031,0.18829516539440203,0.46207687644432227,1.0,10/18,28.03%,MDK;HES1;TENM4;CXCR4;PTPRZ1;NOTCH1;SOX1;PTN;TMEM98;TNFRSF1B
prerank,phagosome maturation (GO:0090382),0.4963188515175024,1.2635278737555031,0.15885714285714286,0.46173801916605883,1.0,18/35,32.20%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;RAB14;CORO1A;ATP6V0D2;RAB20;RAB31;ATP6V1A;ATP6V0A1;ATP6V0B;TCIRG1;MREG;ATP6V0E1;RAB38;RAB39A;RAB34
prerank,regulation of protein catabolic process (GO:0042176),0.4414386683074625,1.26323693443057,0.1014344262295082,0.4620476060738944,1.0,28/99,18.18%,EEF1A1;GFAP;NDUFA13;OAZ1;TNF;CHEK2;PIN1;SORL1;FLNA;EEF1A2;VCP;TNFAIP3;FMN2;TNFSF12;ATP13A2;ADGRB1;DDB1;CHMP6;WNT5A;CTSA;VPS28;ODC1;EGLN2;RAB26;DAB2IP;TRIM32;FAM83D;AGAP2
prerank,positive regulation of transferase activity (GO:0051347),0.43257595936614085,1.2625980138410597,0.07894736842105263,0.4632690144901881,1.0,48/142,22.30%,CD74;RPS2;DBI;HSP90AA1;HSP90AB1;MAPK3;SERINC1;TREM2;ERBB4;PINK1;CCT2;NTRK2;PIN1;SORL1;CTNNB1;LTK;MUSK;KDR;EPHA5;CSF1R;FLT4;PCNA;KLF4;FBXW7;TIE1;RFC2;SERINC5;PTGES3;ARRDC3;IGF2;EPHB1;PARM1;FLT1;TYRO3;DDR2;ERBB3;EPM2AIP1;FLT3;DKC1;MAPK15;TGFB1;RFC4;MAGEC2;MYC;MAP2K7;CCT4;GRHL2;NAF1
prerank,peptidyl-arginine modification (GO:0018195),0.5793867707060946,1.262418939586722,0.17086092715231788,0.463274868473823,1.0,3/15,12.90%,PARK7;KRTCAP2;PRMT1
prerank,ESCRT III complex disassembly (GO:1904903),0.6330314964422704,1.2623824331947102,0.2050561797752809,0.462463989991609,1.0,6/10,24.79%,CHMP2B;CHMP5;CHMP1B;VPS4A;CHMP7;CHMP1A
prerank,ESCRT complex disassembly (GO:1904896),0.6330314964422704,1.2623824331947102,0.2050561797752809,0.462463989991609,1.0,6/10,24.79%,CHMP2B;CHMP5;CHMP1B;VPS4A;CHMP7;CHMP1A
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6220595272578733,1.2617668058476494,0.21571428571428572,0.46361563175180015,1.0,5/10,19.11%,MT3;DRD5;AOC3;HP;SNCA
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.37408567338463333,-1.2617125452468292,0.1488095238095238,0.5860799001628875,1.0,10/29,14.87%,STRN3;KANK2;YAP1;AXIN1;CNOT1;UFL1;ESR1;KMT2D;CBFB;CARM1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.45773286743514685,1.2614211457767497,0.11004273504273504,0.4641285003721199,1.0,17/72,16.77%,RPS27A;UBC;UBB;RNASE1;RNASE4;PARP1;RPA2;UBA52;PNRC2;RBX1;DDB1;EDC4;PCNA;RFC2;PDE12;POLD4;MUS81
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.5788850135159092,1.2609774256734592,0.1762295081967213,0.4648536092070241,1.0,7/15,21.40%,SEC61B;HSP90B1;AUP1;VCP;SYVN1;HERPUD1;SELENOS
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5032098252646476,1.260426483688472,0.18627450980392157,0.46579408326062055,1.0,12/29,20.93%,AGT;GPER1;TNF;HYAL2;TNFSF12;PMAIP1;CAV1;LTBR;TNFRSF12A;INHBA;SFRP1;PYCARD
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.41908673790617645,1.2598383104067747,0.008,0.46686809509527966,1.0,91/348,20.07%,RPL23;RPS3;ACTG1;RPL11;RPS7;RPL5;CD74;CLU;CD63;CLDN5;GSN;RAMP2;TYROBP;LAPTM5;ACTA2;MT3;PARK7;MAPK3;ATF4;AKT1;KLF2;TREM2;CD34;ANK3;GPER1;TNF;PDGFB;LAMTOR5;NTRK2;AMH;HSPA1B;FN1;MUSK;TFRC;MSN;RIMS2;RIMS1;TRIM28;P2RX7;VSIR;VAMP3;EGR1;GATA2;ATP13A2;LRP3;WNT5A;RAMP3;POU3F1;WARS1;WFS1;TMEM119;CAMK2N1;KLF4;SLC11A1;SOX9;HSPA1A;GJA1;LILRB1;BMP2;GAS6;SFRP4;CTSH;TLR6;PF4;IFNGR1;MAPK11;HEY1;ARRB2;DNAJA4;CCL3;DNMT3B;EPB41L4B;CDH5;PIK3CD;TWIST1;PDCD5;PPARGC1A;AGO1;MAZ;HMGN5;SOX11;SNCA;DDRGK1;INHBA;NOTCH1;IL6;ERP29;TGFB1;POU4F1;CITED2;MEF2C
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.4930011334612042,1.2595661955563497,0.16210045662100456,0.46714740724831505,1.0,9/35,13.41%,ARHGDIA;SEMA3F;RAC1;SEMA7A;FLNA;SEMA4C;SEMA6D;SEMA4A;SEMA4G
prerank,glycerophospholipid catabolic process (GO:0046475),0.5124082530165363,1.2594572430884023,0.170316301703163,0.4669911165650973,1.0,12/27,26.51%,PRDX6;ENPP2;PLA2G7;PLA2G4F;GDE1;GPCPD1;GDPD1;ENPP6;ABHD16A;GDPD3;ABHD12;PLA2G6
prerank,RNA polyadenylation (GO:0043631),-0.3874432331620925,-1.25918369194483,0.13142857142857142,0.5871328493080521,1.0,12/26,21.82%,SCAF8;TENT4B;WDR33;CSTF3;TUT1;FIP1L1;PAPOLB;CDC73;CPSF1;TENT2;PCF11;CLP1
prerank,mRNA polyadenylation (GO:0006378),-0.3874432331620925,-1.25918369194483,0.13142857142857142,0.5871328493080521,1.0,12/26,21.82%,SCAF8;TENT4B;WDR33;CSTF3;TUT1;FIP1L1;PAPOLB;CDC73;CPSF1;TENT2;PCF11;CLP1
prerank,cellular response to chemokine (GO:1990869),0.47153678997378107,1.2589348347225766,0.15659955257270694,0.4679026716203263,1.0,21/46,34.30%,CXCL12;CCL19;CXCL10;RHOA;DOCK8;CCL2;PF4;CCL3;CCL8;CCR2;DUSP1;OXSR1;CX3CL1;PPBP;CCL13;CCL14;GPR35;ACKR3;LRCH1;CCL5;SLC12A2
prerank,negative regulation of protein modification process (GO:0031400),0.4492164187460724,1.2588563094345775,0.09594882729211088,0.4676808686222473,1.0,18/79,11.61%,PPIA;DBI;PARK7;FKBP8;PRNP;FXYD1;IGFBP3;PPP1R15B;YWHAB;PRR5L;SIRPA;SH3GL2;MYADM;CORO1C;MAPT;CADM4;TARDBP;WARS1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5488101786675869,1.258721891579162,0.19016817593790428,0.46758768475952883,1.0,10/18,27.24%,TREM2;CCT2;TNF;CCT7;CCT8;DKC1;CCT4;CCT3;CHP1;CORO2B
prerank,regulation of apoptotic process (GO:0042981),0.41616405480626084,1.2584981937648358,0.001,0.46775268021807637,1.0,190/676,20.94%,TPT1;RPS3;MTCH1;RPS27A;CTSD;PTMA;PPIA;ARHGDIA;CD74;CLU;CTSB;UBC;RACK1;UBB;HSP90AA1;HSPB1;CALR;LGALS1;MT3;CFL1;PARK7;SOD1;RPL10;RHOB;HSPA5;ATF4;RPS6;AKT1;NME1;HIGD2A;CCND2;TMBIM6;UBE2Z;CRYAB;TGM2;ARL6IP1;HNRNPK;NPM1;PRDX5;ANXA5;PINK1;AGT;IGFBP3;GPER1;GRID2;BEX2;MAGED1;TNF;HSP90B1;FZD9;PRDX2;GLO1;NAA38;RTN4;MIF;BNIP2;HSPA1B;PSENEN;CTNNB1;FLNA;IL2RB;VCP;ALPK2;LTK;TMEM14A;BAG1;TFRC;OMA1;UBA52;NDRG1;BNIP3L;ARHGEF4;FOXL2;SGK1;HSPD1;FMN2;KDR;CXCL10;AQP1;IL2;CSRNP3;FAIM2;DHCR24;NUPR1;NET1;TRIM2;RRP1B;JUN;HMGB1;HCK;ARHGEF7;TAF9;TARDBP;SMPD1;GAS1;APBB1;APEX1;WNT5A;ATF5;DNAJA1;BAX;ZBTB7A;FLT4;WFS1;PMAIP1;PNMA2;TCTN3;SOX8;ACTN1;PHLPP1;CTLA4;MCF2L;SOX9;HSPA1A;VAV1;LILRB1;BMP2;SPTLC1;RIPK2;GAS6;WNT10B;YWHAZ;NME2;CLIP3;NLRP2B;CAT;SFRP4;GLS2;VAV3;ABR;CTSH;EGLN2;IKZF3;TIAM1;BAD;IER3IP1;ARF4;LRP8;CDK5;DAB2IP;ATAD3A;DDAH2;VHL;PIM3;SQSTM1;PSEN2;DNM1L;PDCD5;PCID2;SCIN;ASNS;APH1B;CIAPIN1;GRM4;NOP53;KCNMA1;AKT1S1;ANP32A;TNFRSF12A;NSMF;HMGN5;ARHGEF19;ANP32E;CCAR2;HYPK;SNCA;PRELID1;DDRGK1;RNF144B;SOS1;TFAP2B;FLT3;IL6;HGF;KLF11;ING5;CITED2;OSGIN1;MEF2C;SFRP1;SPHK2;CAPN3;TFAP4;MYC;NFKBIA;HSPA9;BAK1;PTPN6;PYCARD;GADD45A
prerank,regulation of embryonic development (GO:0045995),-0.36630319340106465,-1.2584964527381826,0.11486486486486487,0.5861841194448674,1.0,11/34,9.93%,PHLDB2;TRIP12;NIPBL;DHX36;NIBAN2;EHMT1;WDPCP;INSR;NPHP3;TDG;NR2C2
prerank,B cell differentiation (GO:0030183),0.46959558590130407,1.258258051930166,0.1452894438138479,0.46792199668352036,1.0,20/46,26.78%,SLC25A5;LYL1;NFAM1;PTPRC;IL11;ZBTB7A;SYVN1;IRF2BP2;HDAC5;HDAC9;VCAM1;ADAM17;DNAJB9;FLT3;KLF6;TCF3;BLNK;HHEX;ITGB1;CEBPG
prerank,superoxide metabolic process (GO:0006801),0.502629105933886,1.2581612510112148,0.18259803921568626,0.4677028736181266,1.0,6/29,9.70%,MT3;SOD1;CYBA;PRDX2;CYBB;PRDX1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4320728293816023,1.2581140334373035,0.07092198581560284,0.46738792521780254,1.0,38/144,15.14%,CD81;PRNP;TOMM7;OAZ1;ITGB2;PINK1;ANK3;RAN;TMEM30A;YWHAB;HCLS1;UBL5;SORL1;YWHAH;PRR5L;FLNA;YWHAE;HYAL2;SAR1A;TRIM28;LEPROT;YWHAG;VAMP2;CAMK1;CEP131;PMAIP1;HRAS;B3GAT3;YWHAQ;FBXW7;GAS6;YWHAZ;MTCL1;RHOU;MIEF2;BBC3;BAD;MFF
prerank,aortic valve morphogenesis (GO:0003180),-0.3732683863035577,-1.2580468991976683,0.13414634146341464,0.5845006790283837,1.0,10/30,14.92%,ROCK2;SMAD6;ROBO1;ROCK1;SLIT2;NFATC1;ELN;JAG1;BMP4;HEY2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5097945842823726,-1.2568315581387217,0.20068027210884354,0.5847731900368932,1.0,3/10,9.60%,RARB;RARG;PPARG
prerank,engulfment of apoptotic cell (GO:0043652),0.5641732957062973,1.2563808719252871,0.2070365358592693,0.4714780379700749,1.0,6/15,20.23%,RAC1;RHOG;XKR4;ADGRB1;RAC2;XKR6
prerank,B cell activation (GO:0042113),0.4484031034085052,1.2562543596595661,0.12314225053078556,0.47135314290558084,1.0,27/68,26.78%,SLC25A5;LYL1;NFAM1;PTPRC;HSPD1;CD22;IL11;ZBTB7A;CHRNA4;HDAC5;RASGRP1;HDAC9;VCAM1;PIK3CD;ADAM17;DNAJB9;CD86;GPR183;FLT3;MEF2C;BANK1;KLF6;TCF3;BLNK;HHEX;ITGB1;CEBPG
prerank,cellular response to UV (GO:0034644),0.4513003266918772,1.2561771197460931,0.12379935965848453,0.4711094471873338,1.0,16/76,12.08%,RPL26;CRIP1;ATF4;NPM1;COPS9;PARP1;HYAL2;MFAP4;AQP1;TIMP1;DDB1;SMPD1;MC1R;MMP3;PCNA;NSMCE3
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5471836445914713,1.2556626815376417,0.19872611464968154,0.47205638511042747,1.0,10/20,19.55%,ATP6AP1;ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;SLC8A1;ATP1B3;KCNMA1;TFAP2B
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.4220558464240258,-1.2555283943889735,0.17289719626168223,0.5852689703080304,1.0,8/19,14.38%,PARD3B;PARD3;DLG1;PATJ;SYNJ2BP;MARK2;PRKCI;CLIC4
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6007941527498293,1.2554690582979948,0.20402298850574713,0.4721486588687565,1.0,3/12,4.23%,APOE;PRNP;FKBP1A
prerank,cellular response to interferon-gamma (GO:0071346),0.4470457027274225,1.2554638307360397,0.1069182389937107,0.4717199514499209,1.0,28/88,23.81%,B2M;GAPDH;RPL13A;MT2A;CCL19;AQP4;SIRPA;HCK;FCGR1A;IRF8;WNT5A;AIF1;PDE12;CCL2;IRF7;IFNGR1;CCL3;VCAM1;NCAM1;CCL8;OAS3;EPRS1;IFNGR2;IRF9;IRF5;TRIM68;IL12RB1;CAMK2G
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.4601435203658665,1.255435176347706,0.14823008849557523,0.47136008208763963,1.0,20/54,27.61%,CD63;KCNIP4;AKAP6;DPP10;FLNA;YWHAE;KCNJ10;DPP6;KCNN2;KCNE5;KCNIP1;CAV1;KCNMA1;GABBR2;KCNJ3;KCNAB1;KCNJ6;KCNN4;KCNMB4;KCNQ1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.618812926238955,1.2551775009149924,0.2131837307152875,0.471584085427711,1.0,4/10,14.62%,TIRAP;TICAM2;NINJ1;F2RL1
prerank,negative regulation of protein secretion (GO:0050709),0.48617680195747565,1.2551329196740886,0.15331010452961671,0.4712452100142333,1.0,10/38,23.18%,APOE;DPH3;CHGA;ERP29;SFRP1;RSAD2;INHBB;CCN3;REST;PSMD9
prerank,regulation of microtubule-based process (GO:0032886),-0.35297591694406133,-1.2550235570196584,0.12337662337662338,0.583843948662082,1.0,10/36,14.72%,PHLDB2;EPHA3;MEMO1;MACF1;ROCK1;PRKAA2;DIAPH1;GSK3B;MARK2;TAOK1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.4797951575746603,-1.254889289539272,0.19434628975265017,0.5814362224740952,1.0,5/11,22.44%,CAMK2D;SESTD1;NOS1AP;NOS1;CACNB1
prerank,mitochondrion transport along microtubule (GO:0047497),0.5820340107879165,1.2548166663673181,0.18267929634641408,0.47163756827082803,1.0,3/13,8.71%,UBB;NEFL;MAPT
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5501415543691899,1.2543048765074358,0.19845360824742267,0.4720980042358821,1.0,6/19,12.82%,POLR2E;POLR2D;TERF1;POLR2F;POLR2G;POLR2K
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5501415543691899,1.2543048765074358,0.19845360824742267,0.4720980042358821,1.0,6/19,12.82%,POLR2E;POLR2D;TERF1;POLR2F;POLR2G;POLR2K
prerank,regulation of lipid biosynthetic process (GO:0046890),0.49155814721086305,1.2536704664940688,0.14850299401197606,0.4733166214994483,1.0,7/32,9.13%,APOE;C3;AKT1;GPER1;MID1IP1;HSD17B13;MLXIPL
prerank,negative regulation of cell division (GO:0051782),0.6097621285920976,1.2531956928088335,0.20277777777777778,0.47401879725323115,1.0,6/11,28.98%,TXNIP;VPS4A;MYC;BLM;CHMP4C;AURKB
prerank,regulation of cell growth (GO:0001558),0.42176440394011266,1.253032595397008,0.05443548387096774,0.47400161387211437,1.0,70/204,21.93%,RACK1;H3-3A;MT3;NDUFA13;AKT1;NRG3;AKAP6;EIF4G2;AGT;LAMTOR2;CCDC85B;ADAM15;LTBP4;ACVRL1;ENO1;RTN4;S100A8;S100A9;HSPA1B;PPP2R1A;SPOCK1;HYAL2;BTG1;LGI1;TFRC;FAM107A;CXCL16;SGK1;DDX49;WFDC1;JADE1;IL2;MFSD2A;NET1;DNPH1;EXOSC2;KIF26A;APBB1;SOX17;MSX1;DNAJB2;BST2;HSPA1A;GJA1;STK11;EGLN2;SDCBP;IL17RB;ING1;DACT3;ATAD3A;TRIM32;SLIT3;NDUFS3;MMP14;ADAM17;EXOSC9;SCGB3A1;CCAR2;INHBA;TGFB1;OSGIN1;SFRP1;TMEM97;SPHK2;PAK5;RERG;EXOSC4;CCN3;CDA
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.333280776638656,-1.2527026026843477,0.09900990099009901,0.5844273178945337,1.0,8/45,5.77%,EGFR;PLCE1;GAREM1;BRAF;GAB1;SLC30A10;PDPK1;EFEMP1
prerank,alanine transport (GO:0032328),0.612531957956211,1.2526602180177888,0.2127371273712737,0.47447850703212063,1.0,3/10,9.01%,SLC1A4;SLC6A6;SLC6A17
prerank,negative regulation of programmed cell death (GO:0043069),0.4184015118030358,1.2526462643840308,0.009,0.47406569572563534,1.0,93/355,20.86%,TPT1;RPS27A;PTMA;ARHGDIA;CD74;UBC;GPX4;UBB;HSPB1;LAPTM5;MT3;CFL1;PARK7;RPL10;HSPA5;AKT1;HIGD2A;CCND2;TMBIM6;UBE2Z;TREM2;CRYAB;ARL6IP1;HNRNPK;NPM1;PRDX5;ANXA5;HSP90B1;PRDX2;GLO1;NAA38;MIF;BNIP2;HSPA1B;CTNNB1;FLNA;IL2RB;LTK;TMEM14A;BAG1;TFRC;UBA52;BNIP3L;HSPD1;FMN2;KDR;AQP1;IL2;FAIM2;DHCR24;NUPR1;HCK;TAF9;WNT5A;ATF5;DNAJA1;FLT4;WFS1;SOX8;SOX9;HSPA1A;RIPK2;GAS6;YWHAZ;NME2;CAT;CTSH;ARF4;ATAD3A;DDAH2;VHL;PIM3;SQSTM1;PSEN2;PCID2;ASNS;CIAPIN1;HMGN5;HYPK;SNCA;PRELID1;DDRGK1;RNF144B;TFAP2B;IL6;HGF;POU4F1;CITED2;SFRP1;CAPN3;MYC;NFKBIA;HSPA9
prerank,regulation of exocytosis (GO:0017157),0.4757374505231073,1.2523913023112576,0.15017064846416384,0.4743287393765208,1.0,13/46,11.11%,ATP6AP1;SYT1;RIMS2;RAB15;IL1RAPL1;CLASP1;RAB3C;VAMP2;CADPS;STXBP5L;RAB3D;CHMP6;HAP1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.48814975504307434,1.2522302886747008,0.17988165680473372,0.47431042139313295,1.0,11/33,16.75%,APOE;ACVRL1;CORO1C;VASH1;DCN;EPPK1;ADGRB1;PTPRR;DAB2IP;DNAJA4;PFN2
prerank,lymphocyte chemotaxis (GO:0048247),0.4910662422210842,1.2522192500302298,0.1756440281030445,0.47389983270420594,1.0,10/34,19.50%,CCL19;CXCL16;CXCL10;GAS6;CCL2;CCL3;PIK3CD;CCL8;CH25H;GPR183
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.42478398369860065,1.2519543669000355,0.08730964467005076,0.4741232819939571,1.0,40/149,20.93%,RPS3;RPS27A;PPIA;CLU;UBC;UBB;NPM1;AGT;TNF;LAMTOR5;S100A8;S100A9;HSPA1B;FLOT1;TIRAP;TFRC;UBA52;RBCK1;WNT5A;ZBTB7A;RHEBL1;HSPA1A;RIPK2;UBE2V1;CX3CR1;TLR6;CAV1;TRIM32;TERF2IP;TAB1;PSMA6;DDRGK1;RTKN2;NLRP3;TRIM13;IL6;IL1RAP;CAPN3;NFKBIA;PYCARD
prerank,regulation of DNA repair (GO:0006282),-0.34474655391508124,-1.251758317456395,0.08737864077669903,0.5842241329059148,1.0,15/44,13.42%,EYA2;EGFR;EYA1;BABAM2;TRIP12;UBR5;KAT7;UIMC1;RNF8;PML;EYA4;PARG;EYA3;ERCC8;SIRT1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5429173735693053,1.2516185310047234,0.19367088607594937,0.4745946732222763,1.0,6/20,8.17%,HSP90AB1;AKT1;CCND2;PDGFB;CCND1;PROX1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.5546419764680717,1.2514187218551465,0.20254777070063695,0.474681222303793,1.0,4/16,15.47%,PNPLA2;CTDNEP1;MFSD2A;NR1H2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.42905161035546524,1.2512482264742701,0.07537688442211055,0.4746780418323988,1.0,42/161,16.42%,APOE;IGFBP6;PFDN5;PSMB4;MDK;PSME1;PSMB6;PSME2;PSMB8;PSMD2;IGFBP4;PSMD1;LRP4;PSMC3;TLE5;PSMD6;ANKRD6;SFRP5;PSMA7;JADE1;PSMD5;RBX1;PSMB9;PSMD13;WNT5A;SOX17;PSMB3;PSMB11;IGFBP2;SOX9;BMP2;TNN;PSMB10;AMER2;SFRP4;STK11;TMEM131L;PSMB1;PSMB5;DACT3;DAB2IP;CAV1
prerank,regulation of inflammatory response (GO:0050727),0.42196523992333707,1.2507750371541582,0.0572289156626506,0.47546577060402656,1.0,45/190,19.67%,TMSB4X;APOE;MDK;GRN;PARK7;AGT;GPER1;TNF;NR1D1;LRFN5;SEMA7A;S100A8;S100A9;SIRPA;DDT;HYAL2;TNFAIP3;FEM1A;CEBPA;OTULIN;IL2;BCL6B;LPL;VAMP3;VAMP2;LILRA5;HCK;NINJ1;PLA2G7;WNT5A;MMP3;KLF4;TNFRSF1A;AKNA;GPSM3;FNDC4;TYRO3;CCL3;CDH5;CCR2;SNCA;PSMA6;CXCL17;NLRP3;IL6
prerank,positive regulation of double-strand break repair (GO:2000781),-0.3556065674830229,-1.2507263257655996,0.16428571428571428,0.5841856706328304,1.0,14/39,15.12%,ARID2;PARP9;KMT5C;SPIDR;PARP3;KMT5B;SHLD1;MMS19;MRNIP;FUS;KDM4D;FANCB;MGMT;SMCHD1
prerank,mucosal immune response (GO:0002385),0.5711072336977215,1.2496708319156011,0.20107238605898123,0.47791906451603006,1.0,1/15,0.48%,RPL39
prerank,somite development (GO:0061053),-0.4828988051045233,-1.2496193519614334,0.18360655737704917,0.5844769503750212,1.0,6/11,25.52%,SMO;MEOX2;LOXL3;PPP2R3A;PTCH1;MTHFD1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.4870587969814407,1.2490829433832216,0.1869047619047619,0.4789540380254869,1.0,12/34,19.10%,CALM1;PDE4B;CALM3;RGS2;PLN;CHGA;ATP1B1;SLC8A1;RYR2;ADRA1A;SRI;CALM2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.5741862590482538,1.2489487993883013,0.20757180156657964,0.47885045868087334,1.0,2/14,3.71%,PARK7;TNF
prerank,negative regulation of nervous system development (GO:0051961),0.550878597197581,1.2488972306249095,0.2165206508135169,0.4785462512033958,1.0,9/17,23.03%,B2M;TNF;SORL1;ROBO2;SLIT1;NOTCH1;IL6;REST;WNT7A
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5716852616707969,1.248888057866656,0.2073976221928666,0.4781292442630582,1.0,5/15,15.47%,C3;CTDNEP1;MFSD2A;FBXW7;NR1H2
prerank,regulation of biosynthetic process (GO:0009889),0.5984078387565299,1.2487819139612353,0.2274618585298197,0.47796649090314264,1.0,3/11,20.24%,MID1IP1;SNCA;SPHK2
prerank,neuron projection morphogenesis (GO:0048812),0.4313537944618622,1.2486079862073811,0.07467204843592332,0.4779899330340833,1.0,38/137,16.84%,ACTB;S100A6;UBB;DCC;NBL1;NLGN1;S100B;CTNNA2;ANK3;MAP1A;CNTNAP2;PACSIN1;CNTN4;LRP4;CTNNB1;NEFH;KLK8;SGK1;PAK1;NRCAM;MAP2;PAK3;ADGRB1;DOCK10;APBB1;NYAP2;TMEM106B;SHTN1;CCK;TNN;MAPK8IP2;DSCAML1;SPTBN4;EPHB1;CDK5;EPB41L3;DAB2IP;BRSK2
prerank,cellular response to lipopolysaccharide (GO:0071222),0.4374125994358078,1.2483803120666237,0.1,0.47812368902180635,1.0,32/101,21.40%,VIM;PDE4B;TNF;NR1D1;SIRPA;CD180;TNFAIP3;CCR5;CXCL10;TICAM2;CD68;HMGB1;HCK;ZFP36;CHMP5;WNT5A;RHOA;LILRB1;CX3CR1;CCL2;PF4;DAB2IP;CCL3;CD14;CD86;NLRP3;IL6;TGFB1;GIT1;MEF2C;PYCARD;SELENOS
prerank,ephrin receptor signaling pathway (GO:0048013),0.447609069501557,1.248118105393498,0.1285563751317176,0.4783208415549887,1.0,30/82,19.87%,ACTB;ACTG1;ANKS1B;RAC1;PSENEN;GRIN1;AP2M1;PAK1;CDK5R1;AP2S1;EPHA5;ARPC1B;ARHGEF7;PAK3;ARPC3;HRAS;ARPC5;RHOA;VAV3;SDCBP;TIAM1;ARPC4;EPHB1;PSEN2;EFNB1;ARPC2;APH1B;GRIN2B;EFNA1;GIT1
prerank,regulation of potassium ion transport (GO:0043266),0.4879397673176445,1.2480830544798325,0.17535545023696683,0.47797939987282767,1.0,8/31,15.36%,CD63;KCNIP4;ANK3;DPP10;DPP6;KCNN2;KCNE5;KCNIP1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5117732035751843,1.2479832825860833,0.19138755980861244,0.47782558642290296,1.0,10/27,21.00%,CALM1;FKBP1A;YWHAE;AHNAK;PLN;JPH4;FKBP1B;SELENON;CALM2;CACNB4
prerank,renal absorption (GO:0070293),0.606969441408768,1.247889680981121,0.22779369627507162,0.47762736042969756,1.0,4/10,15.42%,GSN;HYAL2;SGK1;SLC15A2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.5259215091165447,1.2476756085951448,0.1895910780669145,0.47774743863638386,1.0,6/22,9.52%,MDK;NES;TAFA1;FZD9;PROX1;GATA2
prerank,regulation of phospholipase C activity (GO:1900274),-0.4410236619448651,-1.2463235612166947,0.210727969348659,0.5901935819998906,1.0,8/15,19.26%,ABL1;NTRK3;PDGFRB;ESR1;ABL2;KIT;PDGFRA;FGF2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5225618682402153,1.2460865678386688,0.20480404551201012,0.48156129106833945,1.0,10/21,21.84%,RACK1;MLXIPL;CNKSR3;INPP5J;NLRP2B;DMTN;CAV1;DDIT4;GADD45A;PPM1F
prerank,pseudouridine synthesis (GO:0001522),0.5881560129354043,1.2460524066813377,0.21921515561569688,0.48120774533494026,1.0,7/13,20.46%,NOP10;NHP2;TRUB2;PUSL1;GAR1;DKC1;PUS7
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5873935704706562,1.2455634050813482,0.22019635343618513,0.48206610937495886,1.0,4/12,14.25%,CYBA;GRIN1;ADGRB1;TLR6
prerank,negative regulation of developmental process (GO:0051093),0.45058290925228195,1.2452207505271025,0.15823466092572658,0.4825331610465277,1.0,24/69,20.17%,CST3;DCC;VAT1;PINK1;SPI1;MIF;ALPK2;SFRP5;GRIN3A;TFRC;OMA1;VASH1;THY1;MAPT;SOX9;BMP2;GAS6;HEY1;DLL1;BCL11A;SPRY3;NOTCH1;TGFB1;SFRP1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.45097290700858,1.2451254116645705,0.14802981895633652,0.48234860726254924,1.0,24/72,23.69%,CD74;RACK1;HSP90AB1;TNF;PTPRC;TNFAIP3;SPPL2B;OTULIN;CD24;RBCK1;CDC37;GAS6;TNFRSF1A;CLIP3;IFNGR1;SIGIRR;SYK;IFNGR2;PTPN6;PYCARD;SPPL2A;PTPN1;SOCS3;AGPAT2
prerank,regulation of neurogenesis (GO:0050767),0.4658354285715923,1.2448444244907284,0.13100436681222707,0.48266000158945344,1.0,18/55,19.67%,B2M;SERPINF1;TGM2;GPER1;TNF;SORL1;CTNNB1;HES1;HES6;BHLHE41;SNW1;CX3CR1;HEY1;DLL1;TRIM32;SOX11;NOTCH1;IL6
prerank,mRNA metabolic process (GO:0016071),0.4395879479594745,1.2446824627614623,0.13034410844629823,0.4826442712762696,1.0,36/90,25.41%,SNRPG;AURKAIP1;RNASE4;LSM6;SNRPE;HSPA1B;ZFP36L2;SNRPF;SRSF9;HNRNPA0;ZFP36;RNH1;PRPF8;SUPT4H1;SRSF2;SF3A2;SF3B2;HSPA1A;NONO;SNRPB;SF3A3;NUDT16;PPARGC1A;NANOS2;SLBP;TBRG4;SNRPD3;SF3A1;SRSF1;SRRM4;PCBP2;LSM5;ALKBH5;METTL3;PRKACA;PNPT1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4649593040851906,1.2442925138298258,0.16868798235942667,0.48321015989264615,1.0,20/54,22.79%,RACK1;LAPTM5;TNF;HSPA1B;TNFAIP3;SPPL2B;OTULIN;RBCK1;HSPA1A;GAS6;TNFRSF1A;CLIP3;NLRP2B;F2RL1;ADAM17;SYK;TRAIP;PYCARD;SPPL2A;PELI3
prerank,glycerolipid catabolic process (GO:0046503),0.5341833338813965,1.2442415962122861,0.1953727506426735,0.4829202561998694,1.0,10/19,28.06%,PRDX6;LYPLA2;PLA2G4F;GDE1;GPCPD1;GDPD1;ENPP6;GDPD3;ABHD12;MGLL
prerank,regulation of cell killing (GO:0031341),0.5577004191971531,1.2441277806586593,0.22691292875989447,0.4827928274363075,1.0,4/16,11.15%,CYBA;RAC1;WNT5A;IL11
prerank,regulation of T cell proliferation (GO:0042129),0.45551411374956247,1.2436285264742575,0.1476293103448276,0.4837071596783833,1.0,13/61,19.67%,GPNMB;CCL19;PTPRC;LGALS3;TFRC;CEBPB;SDC4;PNP;AIF1;LILRB1;VCAM1;CD86;IL6
prerank,response to ATP (GO:0033198),0.5374227858429261,1.2436117810680527,0.21528662420382166,0.48330452645287086,1.0,4/18,9.32%,HSP90B1;P2RX7;P2RY1;P2RY12
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5599081017954853,1.2435284868371228,0.2222222222222222,0.4831056098023836,1.0,5/15,19.83%,CST3;CLASP1;DDR2;IL6;TGFB1
prerank,presynapse assembly (GO:0099054),0.5537930138235667,1.2432776147977274,0.21220159151193635,0.4833179465874482,1.0,8/16,23.03%,NLGN1;LRP4;IL1RAPL1;WNT5A;PTPRD;LRRTM3;FZD1;WNT7A
prerank,membrane repolarization (GO:0086009),0.5573046442639574,1.2432260769037158,0.21883289124668434,0.4830189508372959,1.0,6/15,17.69%,ATP1B2;KCNE4;ATP1A1;KCNE5;ATP1B1;ATP1B3
prerank,Golgi organization (GO:0007030),-0.2788413687455845,-1.242983061531315,0.037037037037037035,0.5960546219358047,1.0,38/112,16.74%,LRRK2;BCAS3;ARFGEF1;ARHGAP21;CSNK1A1;USP6NL;VTI1A;RAB30;GORASP2;RAB2A;BLZF1;STX16;GOLGB1;HUWE1;UBXN2B;GOLGA2;GBF1;DYNC2H1;OPTN;BET1;UBXN2A;GOLGA5;GOLGA8B;PLEKHM2;MYO18A;OBSL1;ATP8B1;RAB43;PRKD1;TRAPPC11;SEC16A;SEC16B;NPLOC4;TRIP11;FBXW8;ATL2;LMAN2L;GOLPH3L
prerank,regulation of defense response (GO:0031347),0.4445490231684831,1.242795519945386,0.14498933901918976,0.4836640133017299,1.0,14/76,15.50%,TMSB4X;APOE;GRN;PARK7;TREM2;SEMA7A;TIRAP;BCL6B;HCK;WNT5A;ELMOD2;AKNA;TRAF3;LRP8
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6106503343284666,1.2420348297571,0.20383036935704515,0.48528310685932613,1.0,4/10,21.65%,FBXW7;NCF1;ADAM17;TGFA
prerank,positive regulation of protein polymerization (GO:0032273),0.44357244235673554,1.2412366717412744,0.14935064935064934,0.4868843371547099,1.0,13/65,9.84%,RPS3;HSP90AA1;TPPP3;PINK1;RAC1;PFN1;NAV3;PAK1;CLASP1;MAPT;ARF6;CDK5R1;HCK
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4507346215914901,-1.2411623850718707,0.17063492063492064,0.5980152186816172,1.0,4/16,4.58%,PRKAG2;APPL2;LONP2;PPARA
prerank,regulation of acrosome reaction (GO:0060046),0.6087524423689572,1.240724707004601,0.23395149786019973,0.4878252316767855,1.0,2/10,11.81%,PRSS37;GLRA1
prerank,positive regulation of lipid storage (GO:0010884),0.5313737652573508,1.2404968022716556,0.20103092783505155,0.48800497300997153,1.0,5/21,14.66%,C3;LPL;PLIN3;MSR1;EHD1
prerank,vasculature development (GO:0001944),0.5549856302664425,1.239479642162095,0.202365308804205,0.4902206275021705,1.0,7/16,16.80%,SOX18;ACVRL1;APLNR;FLT4;FBXW7;STK11;CDH5
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5635609385374113,1.2392511802791268,0.2291139240506329,0.4903611206460715,1.0,4/15,10.15%,CD74;MIF;PTTG1IP;TAF9
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.595734313498869,1.2391088177149938,0.22925457102672292,0.49029233134172784,1.0,4/12,17.00%,TNF;FLOT1;THY1;SKAP1
prerank,camera-type eye morphogenesis (GO:0048593),-0.49786637660029126,-1.2388523972432777,0.21052631578947367,0.6014209784703372,1.0,5/10,16.91%,SHROOM2;SKI;LRP6;IFT122;NF1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4410387520482697,1.2387990264899007,0.13135593220338984,0.490623872596246,1.0,19/76,21.15%,TMSB4X;SPI1;TNFAIP3;ADORA3;OTULIN;RBCK1;KLF4;NLRP2B;ERBIN;TRAF3;G3BP2;ARRB2;DAB2IP;TCEAL7;COMMD7;NLRP3;NFKBIA;PYCARD;DDIT3
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5405600252458534,1.2384925091311745,0.20151133501259447,0.49098537410278853,1.0,6/18,16.24%,HSP90AA1;MSN;NELL1;PTTG1IP;ATRAID;DAB2IP
prerank,vacuolar acidification (GO:0007035),0.5239416428717663,1.2381748431477806,0.21144278606965175,0.49134360985825404,1.0,7/21,12.97%,GRN;ATP6V0E2;ATP6V0D2;ATP6AP2;SLC11A1;CLN5;CLN6
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.398425522624961,-1.2380603830847527,0.14691943127962084,0.6008305111587279,1.0,7/22,10.54%,ROCK2;SLC9A1;ROCK1;CAMK2D;IGF1;MEF2A;SMAD4
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4737951763322218,1.2376818503260896,0.16991963260619977,0.4922380242374902,1.0,16/42,24.51%,LARS2;GARS1;SARS1;SARS2;KARS1;AARS2;WARS1;NARS1;CARS1;TARS3;PPA1;EPRS1;QARS1;AIMP2;YARS2;MARS2
prerank,Golgi ribbon formation (GO:0090161),-0.46704516457094347,-1.2374887930785552,0.2,0.5994975683945617,1.0,6/13,15.81%,VTI1A;STX16;GOLGA2;OPTN;MYO18A;TRIP11
prerank,chromatin organization (GO:0006325),-0.28601609359840535,-1.2372848093016335,0.0,0.5973966890350711,1.0,37/132,15.01%,BAZ2B;BRWD1;SETD5;BAZ2A;SETD2;HDAC4;HMG20A;EHMT1;NUDT5;KDM5B;HDAC8;ARID1A;KAT2B;JARID2;MYSM1;SMARCAD1;SMARCE1;CHD1;SMARCA5;BAZ1B;TOP1;ZBTB1;CDAN1;INO80;SETDB1;KDM5C;ESR1;MCM3AP;KDM4C;PBRM1;LRWD1;SETD7;SIRT1;KDM4D;RSF1;EZH2;EZH1
prerank,phagosome acidification (GO:0090383),0.5053823155372024,1.2372355041699044,0.1966626936829559,0.4929375442963151,1.0,9/26,23.57%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;ATP6V0D2;RAB20;ATP6V1A;ATP6V0A1;ATP6V0B
prerank,protein localization to mitochondrion (GO:0070585),0.5831527686035172,1.237196815194634,0.22759601706970128,0.4925997578343144,1.0,4/11,11.32%,AKT1;PINK1;ISG15;DNAJA1
prerank,regulation of protein localization (GO:0032880),0.4570616332181631,1.237061009277516,0.1673913043478261,0.49251288350724504,1.0,16/58,18.87%,CTSD;RACK1;HSP90AA1;HSP90AB1;FKBP1A;PARP1;RAB14;SLC26A4;MAP2;CAMK1;FBXW7;MMD2;USP8;ADCYAP1;ATCAY;VPS4A
prerank,negative regulation of cell adhesion (GO:0007162),0.44369466601829255,1.2368633834802838,0.16523605150214593,0.4925885454969426,1.0,29/72,27.78%,ARHGDIA;MDK;PTPRC;ACVRL1;DSCAM;PDE3B;SPOCK1;ARHGDIB;PODXL;ARHGDIG;RHOA;JAM3;DMTN;ERBB3;LPXN;MUC1;NOTCH1;TGFB1;PTPRO;PLXND1;CD164;DUSP1;PLXNB2;TBCD;PLXNB3;CX3CL1;CORO2B;PLXNA3;ADAM22
prerank,cellular response to acid chemical (GO:0071229),0.5016030603498263,1.236853025299673,0.21256038647342995,0.4921756290439066,1.0,10/27,18.74%,KLF2;LAMTOR2;LAMTOR4;LAMTOR5;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.29267486534059534,-1.2362052372849504,0.04838709677419355,0.5975026308934233,1.0,18/76,13.04%,FCHSD2;FER;ABL1;BAIAP2L1;BCAS3;PRKCE;NRP1;BAIAP2;SORBS3;NTRK3;CARMIL1;NCKAP1;CDC42EP5;SNX9;NCK1;KATNBL1;SYNPO2;NUMA1
prerank,positive regulation of immune effector process (GO:0002699),0.4958782392202598,1.2356276019418735,0.18491484184914841,0.4950070096395122,1.0,4/27,8.64%,RPS19;CD81;PTPRC;IL2
prerank,negative regulation of defense response (GO:0031348),0.43269165969781737,1.233928243975775,0.14984059511158343,0.49907089443737856,1.0,21/77,23.79%,APOE;GPER1;NR1D1;LRFN5;SIRPA;TNFAIP3;FEM1A;OTULIN;KLF4;TNFRSF1A;FNDC4;TYRO3;CDH5;CXCL17;NLRP3;SIRT2;SELENOS;CCN3;C1QBP;PCBP2;TEK
prerank,neuropeptide signaling pathway (GO:0007218),0.45221233347210565,1.2338484450147,0.15486725663716813,0.4988185723878532,1.0,16/58,19.65%,SORL1;CPE;SORCS1;PENK;SSTR4;PDYN;GLRA2;PPY;SORCS3;GLRA1;NTS;SORT1;HCRTR1;ADCYAP1;GLRA3;GPR149
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6062362767366317,1.2337563736362036,0.2079646017699115,0.498604736653427,1.0,2/10,1.51%,VTN;MT3
prerank,acute-phase response (GO:0006953),0.5759449133679313,1.2336506504238334,0.2305593451568895,0.4984275571706308,1.0,5/12,24.75%,MBL2;CEBPB;SIGIRR;IL6;LBP
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.512974682885891,1.2331413075377229,0.19751552795031055,0.49932679052214146,1.0,4/22,12.65%,MDK;IL2;VSIR;CTLA4
prerank,protein insertion into membrane (GO:0051205),0.48820107581004796,1.2325882793006553,0.19691577698695137,0.5003244414032457,1.0,12/32,21.92%,HMOX1;SEC61B;PRNP;WDR83OS;SEC61G;VAMP2;SERP1;SGTA;TRAM1L1;VAPA;TRAM1;CYB5A
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.44216522742266673,1.2325333710445718,0.1624203821656051,0.5000092428763893,1.0,31/78,27.26%,ACTB;AKT1;CCNI;CCND2;PDGFB;SERTAD1;CDKN1C;CCND1;CEBPA;PROX1;CDK5R1;CDC37;CCNG1;CDK5R2;HEXIM1;MAPRE3;ADAM17;CCNJL;CDC25A;TFAP4;GADD45A;MEN1;BLM;CCNA2;CDKN2B;CCNG2;HHEX;PSMD10;CCNH;CDKN1A;CNPPD1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.4121156666363024,1.2323028183459237,0.03510531594784353,0.5001868982556411,1.0,68/291,16.24%,ACTB;RPS3;VIM;MT3;NDUFA13;MAPK3;AKT1;PDE4B;AKAP6;TGM2;PRDX5;LAMTOR2;GPER1;LAMTOR4;HSP90B1;PDGFB;LAMTOR5;ROMO1;NR1D1;IGFBP5;ZFP36L1;TIRAP;SIRPA;CD180;VCP;LTK;TNFAIP3;DRD5;BRINP3;CCR5;PTK6;P2RY6;P2RX7;CXCL10;AQP1;MAPT;LPL;P2RY1;EGR1;P2RY12;TICAM2;JUN;CD68;HMGB1;ZFP36;CHMP5;BRINP1;WNT5A;MMP3;GLRA2;RAMP3;GLRA1;BRINP2;SNW1;SOX9;RHOA;LILRB1;LAMTOR3;WNT10B;CX3CR1;CCL2;PF4;RRAGC;HCN1;NCF1;RRAGD;DMTN;DAB2IP
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.4211867636739861,-1.2321420880885297,0.19583333333333333,0.6054275656124016,1.0,5/17,7.71%,BMP6;SASH1;CARD16;TRIM5;LY96
prerank,regulation of dendrite extension (GO:1903859),0.5360043439646975,1.2320871493861465,0.2046936114732725,0.5003014668734155,1.0,11/18,25.62%,SYT1;RIMS2;RIMS1;SYT4;CPNE5;CPNE6;SYT2;SYT3;UNC13A;RNF157;SYT17
prerank,positive regulation of hydrolase activity (GO:0051345),0.4285654153141557,1.2319927675471978,0.10091743119266056,0.5000885026128039,1.0,39/137,20.98%,RPS3;PSAP;RACK1;CALM1;NDUFA13;CCL19;RCN3;S100A10;CALM3;TGM2;PINK1;RHOC;PIN1;CAV2;THY1;NET1;ARHGEF7;RGS10;MTMR9;DOCK10;HRAS;RHOA;BMP2;DOCK8;MTCL1;CTSH;CCL2;F2RL1;RASGRP1;CCL3;ADCYAP1;CCL8;RASGRF1;RGS7;CALM2;AGRN;SFRP1;DOCK9;RGS6
prerank,protein localization to nucleus (GO:0034504),0.42890369466706985,1.2319430964735556,0.12796697626418987,0.49979007704974476,1.0,24/102,18.25%,RPL11;CHCHD10;CALR;COL1A1;AKT1;RAN;ARL2BP;FAM53C;YWHAE;CTDNEP1;PTTG1IP;MSX1;ZBTB7A;IPO4;HNRNPU;NUP85;ARL2;NUP88;LMNA;SPRN;EIF4ENIF1;SYK;NOP53;NUP50
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.44781197270098916,-1.2315590150312816,0.216,0.6042927569840244,1.0,7/15,10.33%,TNRC6B;TNRC6A;TNRC6C;TENT4B;CNOT1;CPEB3;CNOT7
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5847002774480001,1.2310691026175318,0.22344827586206897,0.5016559485667323,1.0,3/12,10.47%,HSPA5;KDELR1;RER1
prerank,negative regulation of cell communication (GO:0010648),0.521071184644751,1.2305233405571034,0.22373300370828184,0.502627393080976,1.0,9/21,23.06%,IGFBP3;PTK6;KIF26A;IL11;GLRA1;ERBB3;SRMS;BRAP;PTPN1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4420943981326012,1.2300300258858432,0.16042780748663102,0.5034447387866063,1.0,21/73,21.57%,ACTB;GPX1;H3-3A;POLR2E;POLR2F;SPI1;POLR1B;CREBZF;DEK;WBP2;POLR2K;HDAC5;IGF2;KDM1B;DNMT3B;ERCC6;TBP;POLR1H;SPHK2;POLR2H;PHF1
prerank,regulation of cellular respiration (GO:0043457),0.547910892685346,1.2299024524733684,0.2154255319148936,0.5033308765809266,1.0,10/17,30.35%,VCP;NOS2;NOP53;PRELID1;IL10RB;SHMT2;PNPT1;IDE;IFNAR1;IFNLR1
prerank,axonogenesis (GO:0007409),0.4173205387607226,1.2297738565325158,0.040160642570281124,0.503219778463284,1.0,64/237,17.53%,ACTB;BSG;S100A6;HSP90AA1;HSP90AB1;CXCL12;MAPK3;DCC;NRXN1;S100B;CTNNA2;ANK3;UNC5D;LYPLA2;MAP1A;SEMA3F;DSCAM;CNTN4;SEMA7A;NEFH;SEMA4C;SHC3;LGI1;NRXN3;DAB1;OTX2;TNR;SEMA6D;ROBO4;NRCAM;LGR6;EMB;UNC5C;CDK5R1;EPHA5;KIF5A;PAK3;B4GALT6;ADGRB1;SEMA4A;LRTM2;APBB1;WNT5A;GFRA1;DOK5;SEMA4G;SHTN1;CCK;CXCR4;IGSF9;DSCAML1;ROBO2;SPTBN4;EPHB1;CDK5;SH3KBP1;GFRA2;SPTBN2;BRSK2;PIK3CD;SLIT3;SLIT1;EFNB1;NCAM1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.49449599055114596,-1.229590627776226,0.2656826568265683,0.6065708407269769,1.0,4/10,16.18%,CAMK2D;PRKCE;HECW2;STK39
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5661776773514603,1.2293977471711104,0.23170731707317074,0.5037825631978854,1.0,5/14,14.67%,AK4;AK3;SMPDL3A;NME2;CMPK2
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.5851161945032356,1.2290807677502302,0.23374827109266944,0.5041617962621986,1.0,2/12,2.16%,NBL1;AKT1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6058738679764264,1.2290572269063347,0.23380281690140844,0.5037851801730449,1.0,7/10,27.39%,JUN;HSPA1A;DNAJB1;VHL;CITED2;SIRT2;HIF1AN
prerank,telomere maintenance via telomerase (GO:0007004),0.50336827124968,1.2288769045021342,0.20168067226890757,0.503815439787987,1.0,9/28,19.74%,HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2;PTGES3;GAR1;TERF2IP;DKC1
prerank,positive regulation of dendrite extension (GO:1903861),0.5413060876825487,1.2288078558785394,0.20887728459530025,0.5035495474003948,1.0,11/17,25.62%,SYT1;RIMS2;RIMS1;SYT4;CPNE5;CPNE6;SYT2;SYT3;UNC13A;RNF157;SYT17
prerank,maintenance of protein location in nucleus (GO:0051457),0.5328097259489885,1.2286022963304946,0.20460358056265984,0.5036734728497412,1.0,10/20,24.59%,CHCHD10;PARK7;ARL2BP;HNRNPU;ARL2;RANGAP1;SYNE1;SKP1;SUN2;BARD1
prerank,DNA double-strand break processing (GO:0000729),-0.41039055216514736,-1.227763841998706,0.2,0.6088438007927256,1.0,5/18,12.01%,SMARCAD1;RBBP8;SLX4;RNF138;ATM
prerank,negative regulation of signaling (GO:0023057),0.5032984949271205,1.2275817300354421,0.20120481927710843,0.5059138159315804,1.0,11/25,23.06%,IGFBP3;PTK6;KIF26A;IL11;GLRA1;ERBB3;SRMS;TRAT1;BRAP;AP1AR;PTPN1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.476713791499915,-1.2274691968830982,0.23049645390070922,0.6070086616872875,1.0,5/12,9.89%,ATF7IP;RESF1;TASOR;SETDB1;PPHLN1
prerank,mitotic recombination (GO:0006312),-0.44155857341499166,-1.2272785326871765,0.2024793388429752,0.6049145147064257,1.0,3/15,7.07%,NSMCE2;TEP1;MSH3
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4753697057903732,1.226949841210565,0.20045300113250283,0.5071301926175014,1.0,14/38,24.36%,RACK1;AKT1;GPER1;HYAL2;SFRP5;PDCD6;PHLPP1;ARRB2;NOP53;THEM4;DDIT3;BANK1;PHLDA3;PLEKHA1
prerank,negative regulation of cellular senescence (GO:2000773),-0.4550446635948001,-1.2259704484153464,0.19924812030075187,0.6056838062370709,1.0,7/13,13.42%,MAP3K3;SLC30A10;CDK6;ZKSCAN3;TERT;TERF2;SIRT1
prerank,protein polymerization (GO:0051258),0.45583109382693754,1.2258296678023166,0.1714922048997773,0.5097248103918264,1.0,11/55,13.12%,GPX4;GSN;TPPP3;RAC1;MID1IP1;ANG;PIN1;FAM107A;MAPT;AIF1;MSRB1
prerank,regulation of catecholamine secretion (GO:0050433),0.49174424961943647,1.2258290327320642,0.19975932611311673,0.5092821064267575,1.0,15/29,25.62%,SYT1;SYT12;SYT11;SYT6;SYT4;CHGA;KCNA2;CHRNA4;SYT10;SYT2;SNCA;GRK2;SYT3;SYT5;SYT17
prerank,regulation of dopamine secretion (GO:0014059),0.4997086130576539,1.2255923785451586,0.207663782447466,0.5095130714381015,1.0,13/25,25.62%,SYT1;SYT12;SYT11;SYT6;SYT4;KCNA2;CHRNA4;SYT10;SYT2;SNCA;SYT3;SYT5;SYT17
prerank,positive regulation of apoptotic process (GO:0043065),0.4096031647545921,1.2255144771069892,0.047,0.5092996547477868,1.0,89/293,21.45%,RPS3;MTCH1;RPS27A;CTSD;CLU;UBC;RACK1;UBB;GRN;SOD1;RHOB;ATF4;RPS6;PRNP;UBE2Z;TGM2;IGFBP3;GPER1;TNF;FZD9;PSENEN;TLE5;CTNNB1;BTG1;OMA1;UBA52;BNIP3L;ARHGEF4;FOXL2;HSPD1;CSRNP3;NUPR1;NET1;CDK5R1;RRP1B;JUN;HMGB1;ARHGEF7;SMPD1;APBB1;DNAJA1;BAX;PMAIP1;PNMA2;TCTN3;CTLA4;MCF2L;VAV1;LILRB1;BMP2;WNT10B;CLIP3;NLRP2B;SFRP4;VAV3;ABR;TIAM1;BAD;DLC1;CDK5;DAB2IP;CCL3;BACE1;SQSTM1;PSEN2;DNM1L;PDCD5;SCIN;APH1B;KCNMA1;TNFRSF12A;ARHGEF19;CCAR2;SNCA;SOS1;TFAP2B;IL6;KLF11;ING5;SFRP1;SPHK2;TFAP4;BAK1;PYCARD;GADD45A;DDIT3;FOXA1;SIRT2;SUDS3
prerank,lipid droplet formation (GO:0140042),0.6045468897211609,1.2249629118104093,0.25316455696202533,0.5102855793594018,1.0,3/10,5.09%,CDS1;AUP1;BSCL2
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5780780765701443,1.2245863784864899,0.24331926863572434,0.510829959427584,1.0,9/12,25.36%,TUBB4A;MAP2;ARHGEF7;CLIP3;STMN1;CDH5;SNCA;TBCD;MAPRE1
prerank,positive regulation of protein metabolic process (GO:0051247),0.4232938505935947,1.224328368090182,0.1380020597322348,0.5110621527478427,1.0,32/110,20.78%,APOE;CLU;NDUFA13;AKT1;KLF2;OAZ1;AGT;TNF;SORL1;VCP;TNFAIP3;TNFSF12;DDB1;WNT5A;WFS1;VPS28;KLF4;PRMT1;EGLN2;ABCB10;NR1H2;RASGRP1;ABCA2;DAB2IP;TRIM32;CD86;INHBA;HECW1;TGFB1;OAZ2;SLC25A37;NFKBIA
prerank,mesonephros development (GO:0001823),-0.4924869160051128,-1.224234901635072,0.20327868852459016,0.6074248880501832,1.0,2/11,2.69%,ZBTB16;FGF1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5104896070482847,1.223345548551738,0.21401752190237797,0.5132432049543572,1.0,5/22,15.32%,ATF4;NCL;PIH1D1;DDX11;UBTF
prerank,apical protein localization (GO:0045176),0.6018031840225435,1.2232226453918165,0.23470839260312945,0.5131318900164873,1.0,2/10,5.26%,ACTB;MAL
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.42647760366199183,1.2228297899338834,0.1505711318795431,0.5137796046010091,1.0,31/93,19.98%,RACK1;HSP90AA1;HSP90AB1;PARK7;AKT1;TXN;PINK1;TNF;HCLS1;MIF;TFRC;PAK1;MLXIPL;CAMK1;IL11;RAMP3;SH2D3C;CNKSR3;RIPK2;INPP5J;GAS6;NLRP2B;SPTBN4;DMTN;CAV1;PFN2;TERF2IP;SNCA;IL6;TGFB1;DDIT4
prerank,histone deacetylation (GO:0016575),-0.34391970007668016,-1.2226036103341589,0.12037037037037036,0.6090734748758643,1.0,12/43,9.37%,PRDM5;MIDEAS;BAZ2A;HDAC4;PER2;MTA3;HDAC8;TBL1X;SMARCAD1;RCOR1;MIER1;TBL1XR1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.4623131784436173,1.222588950393432,0.18480725623582767,0.5139580096062247,1.0,16/42,31.16%,CXCL12;CCL19;CXCL10;CCL2;PF4;CCL3;CCL8;CCR2;THPO;OXSR1;CX3CL1;PPBP;CCL13;CCL14;GPR35;ACKR3
prerank,response to acidic pH (GO:0010447),0.5726382880420036,1.2218624143090189,0.2291950886766712,0.5154353204464704,1.0,2/13,2.14%,CTSS;LGMN
prerank,positive regulation of viral transcription (GO:0050434),0.49768911117380954,1.2217731656425779,0.20797011207970112,0.5152452995251797,1.0,10/25,21.23%,POLR2E;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;POLR2K;NELFE;POLR2H;CDK9
prerank,regulation of angiogenesis (GO:0045765),0.41283550101327054,1.2215017607074088,0.08249496981891348,0.5154940787113681,1.0,53/192,18.30%,SPARC;CLDN5;RAMP2;HSPB1;GRN;GPNMB;HMOX1;RHOB;SERPINF1;CD34;EMP2;ECM1;CTNNB1;APLNR;PDE3B;ADAM12;TNFAIP3;EMC10;BTG1;PGK1;HIPK2;GLUL;VASH1;KDR;CXCL10;AQP1;TNFSF12;SARS1;GATA2;DCN;ADGRB1;ECSCR;NINJ1;STAB1;RNH1;PDCD6;WNT5A;WARS1;KLF4;TIE1;CTSH;RRAS;PF4;DAB2IP;FLT1;GATA4;AMOT;CDH5;PIK3CD;TWIST1;AGO1;ADAMTS1;CCR2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.5797729071869926,1.220995155783231,0.22853185595567868,0.5164075280159967,1.0,3/11,5.67%,NBL1;MIF;DDT
prerank,synapse assembly (GO:0007416),0.44542418028765146,1.2208927647160421,0.16469321851453175,0.5162171607167511,1.0,26/67,23.67%,NRXN1;SPOCK2;NLGN1;GRID2;DSCAM;ADGRL3;DNM3;GABRA2;KIRREL3;NRCAM;DNER;WNT5A;GABRB3;NRXN2;ACHE;CDK5;FGF13;GABRB2;PCDHB14;GPM6A;LRRTM3;POU4F1;PLXND1;FZD1;WNT7A;PLXNB2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5038769485997247,1.2207328621697424,0.2107904642409034,0.516204398542402,1.0,11/25,26.21%,AKAP6;GPER1;APLNR;THY1;CXCL10;RAMP3;TRPC1;SNCA;CAPN3;F2RL3;CX3CL1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4116552444196,-1.2205004118931495,0.19617224880382775,0.6121123857504637,1.0,4/20,8.24%,AKAP13;ADCY9;RAPGEF2;ADRA1B
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.45939891555227336,1.2203904669527397,0.18715393133997785,0.5166770811817688,1.0,11/48,12.82%,ACTB;POLR2E;ELOF1;POLR2F;SERTAD1;POLR1B;H1-0;DEK;WBP2;ZMIZ2;POLR2K
prerank,positive regulation of protein localization to membrane (GO:1905477),0.4269933858450248,1.2203143925626452,0.1368312757201646,0.516456920948237,1.0,30/98,17.19%,CD81;AKT1;PRNP;ITGB2;TREM2;ANK3;GPER1;TNF;YWHAB;LGALS3;DPP10;YWHAH;YWHAE;RHOG;YWHAG;ARF6;ZDHHC5;RAMP3;PMAIP1;HRAS;YWHAQ;YWHAZ;CLIP3;MTCL1;MIEF2;BBC3;BAD;MFF;SQSTM1;PDCD5
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.41495146855964704,-1.220223556430848,0.19491525423728814,0.6101852460107761,1.0,2/19,0.28%,BMP6;AFDN
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4322088253595669,1.2196854783205593,0.14994720168954592,0.5177050862798275,1.0,12/73,8.71%,MTCH1;RACK1;LAPTM5;RPS27L;HSPE1;TNF;S100A8;S100A9;VCP;BEX3;HSPD1;MAPT
prerank,response to endoplasmic reticulum stress (GO:0034976),0.4246870790524675,1.2195521310868824,0.14788004136504654,0.5176119239394293,1.0,37/107,21.40%,HSPA5;ATF4;RCN3;PPP1R15B;HSP90B1;FLOT1;VCP;CEBPB;P4HB;PDIA3;TMCO1;UFC1;SELENOK;JUN;BAX;WFS1;SYVN1;BBC3;UBXN6;ERO1A;DAB2IP;HERPUD1;BCAP31;BRSK2;RASGRF1;PPP1R15A;DNAJB9;EIF2B5;DNAJC10;PDIA4;DDRGK1;TMEM259;TMEM33;BAK1;DDIT3;HYOU1;SELENOS
prerank,zinc ion transport (GO:0006829),0.5191633851148186,1.2194192001274042,0.21238938053097345,0.5175513938977534,1.0,5/21,11.56%,MT3;SLC30A1;SLC39A1;SLC39A7;TRPM2
prerank,arachidonic acid metabolic process (GO:0019369),0.47835826666175396,1.2193650705716281,0.20653442240373396,0.5172538706282015,1.0,3/35,1.19%,GPX4;PTGDS;GPX1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.43608906453850754,1.2193632327880473,0.15425531914893617,0.5168155511547339,1.0,20/76,16.47%,GRM5;TGM2;AGT;C5AR1;GNA11;DRD5;P2RY6;TACR1;HTR2C;P2RY1;P2RY12;GRM1;GPR18;CHRM2;GRPR;CX3CR1;F2RL1;ADRA1D;ADRA1A;CCKBR
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.31158561778755717,-1.2193468722802903,0.08974358974358974,0.6097004475497851,1.0,25/61,19.40%,EYA2;EGFR;EYA1;BABAM2;DHX36;OTUD4;UIMC1;PARP3;RNF8;PML;EYA4;PDGFRB;EYA3;SMOC2;ERCC8;SIRT1;SMCHD1;MECP2;RTEL1;TIGAR;USP9X;ZCWPW1;FGF2;WRN;PRKD2
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5936847532147422,1.218727855274141,0.2361308677098151,0.5176364140588028,1.0,2/10,15.93%,REEP6;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5936847532147422,1.218727855274141,0.2361308677098151,0.5176364140588028,1.0,2/10,15.93%,REEP6;CNGB1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4504503965421495,1.2186403009304456,0.17519042437431992,0.5174476140253234,1.0,19/57,21.42%,CHCHD10;PARK7;TREM2;PINK1;GPER1;KDR;DCN;BAX;PMAIP1;MIEF2;BBC3;BAD;MFF;DNM1L;PDCD5;PPARGC1A;BAK1;PYCARD;FIS1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.46975808151172893,-1.2186355497820833,0.2342007434944238,0.6090624927048435,1.0,4/11,15.02%,CLK2;SIK1;C1QTNF3;CRY1
prerank,snRNA metabolic process (GO:0016073),-0.407938381347929,-1.2185568361747616,0.19672131147540983,0.6067406593379804,1.0,7/17,18.66%,INTS8;INTS6;ZCCHC8;TUT1;MTREX;INTS3;INTS11
prerank,regulation of endocytosis (GO:0030100),0.44779927228080346,1.2184324999093772,0.18429661941112324,0.5175772310352986,1.0,17/61,17.07%,APOE;CD151;CCL19;SNX17;LGALS3;PACSIN1;FLOT1;LRPAP1;SYT11;CD22;AP2S1;SMPD1;LILRB1;CLIP3;DLL1;SNX33;RAB5C
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5849925539311309,1.218122510794105,0.24489795918367346,0.5179656870492196,1.0,4/11,18.23%,NCL;PIH1D1;DDX11;NOP53
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4321009407043949,1.2178942552824679,0.15734989648033126,0.5181053930370095,1.0,36/88,26.27%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;PSMD6;PSMA7;FBXL14;PSMD5;RBX1;FBXO27;PSMB9;PSMD13;PSMB3;FBXW5;PSMB11;FBXW7;FBXO31;PSMB10;PSMB1;PSMB5;PSMA6;FBXL16;SKP1;PSMA4;PSMC1;PSMD9;FBXO2;FBXL3;PSMB2;PSMD4;PSMD10;CUL2
prerank,regulation of protein phosphorylation (GO:0001932),0.4094560431040518,1.2178825634523658,0.055220883534136546,0.5176953988298948,1.0,62/256,15.65%,PPIA;CD74;RACK1;HSP90AA1;HSPB1;GPNMB;MT3;PARK7;SOD1;C3;MAPK3;ATF4;AKT1;FKBP8;PRNP;ITGB2;CCND2;TREM2;GRM5;ERBB4;NPM1;PINK1;IGFBP3;PPP1R15B;GPER1;TNF;RAC1;NTRK2;PIN1;FLOT1;PRR5L;KNDC1;SIRPA;SH3GL2;RARRES2;MYADM;FN1;MUSK;TFRC;CCND1;CEBPB;CORO1C;PAK1;KDR;P2RY1;CADM4;TARDBP;CSF1R;PECAM1;WARS1;FLT4;HRAS;TMEM119;SOX9;BMP2;GAS6;CLIP3;CCDC88A;IGF2;PDGFA;RASGRP1;SPTBN4
prerank,regulation of stem cell differentiation (GO:2000736),0.43079321838255225,1.2177243517684664,0.1511627906976744,0.5177153912221454,1.0,35/89,25.42%,PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PSMC3;ZFP36L2;PSMD6;HES1;PSMA7;PSMD5;GATA2;PSMB9;PSMD13;PSMB3;PSMB11;PSMB10;HNRNPU;PSMB1;PSMB5;LMO1;PSMA6;ESRRB;NOTCH1;PSMA4;PUS7;PSMC1;PTN;PSMD9;METTL3;TCF3;PSMB2;PSMD4
prerank,nucleotide catabolic process (GO:0009166),0.5511274311966083,1.2172746984912026,0.24370860927152319,0.5185486584080559,1.0,5/16,11.49%,GPX1;VCP;DNPH1;NUDT3;PNP
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5524011286863302,1.2172157812569997,0.22941970310391363,0.5182761415556918,1.0,4/16,15.99%,TYROBP;VSIR;LILRB1;DLL1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.47415991563244864,1.2171891585410082,0.19534883720930232,0.5179036246387315,1.0,11/39,16.80%,RAMP2;GPER1;TNF;TNFAIP3;KDR;GATA2;ECSCR;IL11;GAS6;CCL2;CDH5
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5740722039673097,1.2168842771817185,0.2361111111111111,0.5182360223414072,1.0,3/12,5.31%,APOD;NDRG4;IFT20
prerank,protein import into mitochondrial matrix (GO:0030150),0.5352821089113305,1.2160952763934587,0.22397891963109354,0.5198831621514161,1.0,5/18,14.02%,ROMO1;DNLZ;TOMM40L;TIMM50;TOMM20L
prerank,glial cell development (GO:0021782),0.49256007184357126,1.215316855392853,0.22439024390243903,0.5215078043882092,1.0,15/25,32.53%,MDK;MT3;S100A9;MYRF;MXRA8;DLL1;EIF2B5;SOX11;SOX10;APP;CSPG5;TLR2;EIF2B1;SOX4;PRDM8
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5848619509185584,1.215184590841163,0.26956521739130435,0.5214226947325795,1.0,5/10,31.51%,CTNNB1;CX3CR1;CX3CL1;FZD3;DRD2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5178750275787326,1.2150957432505989,0.2042079207920792,0.5212089912089083,1.0,5/23,15.91%,LAMP1;LILRB1;NCR1;RASGRP1;ARRB2
prerank,regulation of cellular protein localization (GO:1903827),0.45910204179548547,1.214512263617245,0.2047244094488189,0.5222352380279051,1.0,13/45,11.05%,HSP90AA1;HSP90AB1;MAP1A;PIN1;PARP1;CTNNB1;VCP;MAPT;MAP2;LCP1;ATP13A2;SUMO3;GPC5
prerank,secretory granule organization (GO:0033363),0.5947816334464578,1.2142654421394214,0.2538787023977433,0.5224542507922296,1.0,6/10,24.33%,BLOC1S1;SRGN;BLOC1S3;BLOC1S2;LYST;F2RL3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5557424849378827,1.2140185183200993,0.2370860927152318,0.5226990680799521,1.0,10/15,31.70%,SRP14;SEC61G;SPCS1;SEC61A1;SPCS2;RYR2;ZFAND2B;SRPRB;SRPRA;SPCS3
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5978274257997731,1.213999087405194,0.22925457102672292,0.5223158443093177,1.0,6/10,24.95%,HSPA5;ATF4;CCL2;HERPUD1;DDIT3;EIF2S1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.43598256025966897,1.2139039944324066,0.16346153846153846,0.5221259677803358,1.0,22/75,17.48%,MDK;HMOX1;AKT1;PDGFB;ANG;ECM1;APLNR;EMC10;PROX1;KDR;TNFSF12;JCAD;GATA2;HMGB1;PDCD6;WNT5A;FLT4;BMP2;IGF2;EGFL7;PIK3CD;ADAM17
prerank,glucose import (GO:0046323),0.569254433356834,1.2137746358740582,0.24081632653061225,0.5220310490814234,1.0,3/13,18.03%,SLC2A1;SORT1;SLC2A3
prerank,Notch signaling pathway (GO:0007219),-0.30320774029504816,-1.212919755131036,0.09411764705882353,0.6188028664369497,1.0,17/59,15.36%,PBX1;GMDS;NOTCH2;ZNF423;CREBBP;MAML2;MIB1;GALNT11;KAT2B;MAML1;ITCH;PSEN1;RBPJ;JAG1;DTX1;HEY2;NLE1
prerank,mesenchymal cell differentiation (GO:0048762),-0.31820606314806804,-1.2129145047063037,0.10101010101010101,0.6162480487232088,1.0,11/51,8.39%,ROCK2;RANBP3L;TGFBR3;FBXL17;ROCK1;LRP6;LIMS1;TGFBR1;DLG5;LOXL3;FGFR2
prerank,positive regulation of cell cycle (GO:0045787),0.44823582091758496,1.2125805033771533,0.16299559471365638,0.524808129381576,1.0,19/62,20.01%,RPS15A;CALR;LGMN;AKT1;CCND2;PDGFB;DUSP3;CCND1;PTK6;PROX1;NUPR1;MAPRE3;NUDT16;TRIM32;ADAM17;ASNS;USP22;RAD23A;CITED2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.48707959634532155,1.2125315382729922,0.22395209580838324,0.5245066856930051,1.0,9/33,17.48%,AKT1;AGT;GPER1;PTK6;HAP1;FBXW7;CCDC88A;NCF1;ADAM17
prerank,regulation of cell size (GO:0008361),0.5047830371427767,1.212225561502744,0.2233128834355828,0.5249528184328481,1.0,8/23,18.36%,LAMTOR4;LAMTOR5;RAC1;MSN;VAV1;RHOA;VAV3;AKT1S1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5193103586961142,1.2119721108166126,0.22900763358778625,0.525163212142869,1.0,10/21,19.10%,CALM1;AKAP6;CALM3;GSTO1;GSTM2;SLC8A1;RYR2;SRI;FKBP1B;CALM2
prerank,Notch signaling involved in heart development (GO:0061314),-0.47515381222757336,-1.2114566145343968,0.2508833922261484,0.617308585357071,1.0,5/11,14.92%,NOTCH2;GALNT11;RBPJ;JAG1;HEY2
prerank,inflammatory response (GO:0006954),0.4087629360829458,1.211425421026116,0.08651911468812877,0.5261661979030624,1.0,54/195,20.09%,CCL19;CYBA;ITGB2;PRDX5;NFAM1;TAC1;TNF;RAC1;C5AR1;S100A8;S100A9;CYBB;ADORA3;CEBPB;CCR5;HNRNPA0;CXCL10;TACR1;CRH;SIGLEC1;HMGB1;TUSC2;AOC3;CSF1R;AIF1;SLC11A1;BMP2;RIPK2;CXCR4;TNFRSF1A;HDAC5;KLRG1;TLR6;CCL2;PF4;TLR5;FOLR2;HPR;HP;TLR1;ADCY8;CCL3;HDAC9;PIK3CD;PTGIR;NOS2;CCL8;CCR2;CD14;NLRP3;IL6;HSPG2;TGFB1;IL10RB
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.4270000205007515,-1.2110862581430075,0.20689655172413793,0.6158310469729537,1.0,3/16,3.19%,SOX5;DHX36;HOXB4
prerank,regulation of cell differentiation (GO:0045595),0.4128027086810867,1.2109874759115276,0.10212335692618807,0.5268898846224779,1.0,28/148,9.69%,MDK;HSP90AB1;UQCC2;ATF4;SPOCK2;NLGN1;TNF;EMP2;LTBP4;NR1D1;LGALS3;ZFP36L1;YWHAH;MCRIP1;PPP2R1A;PLEKHB1;LTK;FADS1;CEBPB;SLC6A6;KLK6;CLASP1;CCN2;YWHAG;BCL6B;CD24;CDK5R1;CAMK1
prerank,response to fatty acid (GO:0070542),-0.4057992743970855,-1.2108695209618685,0.18442622950819673,0.6138823377323507,1.0,3/17,5.03%,PID1;IRS1;FOXO3
prerank,embryonic digestive tract development (GO:0048566),-0.40952988614644215,-1.2107699782605885,0.19230769230769232,0.6116533856421583,1.0,6/18,8.39%,RARB;GLI3;GLI2;NIPBL;PCSK5;FGFR2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.520579425903519,1.2100570171192069,0.2236503856041131,0.528889012811745,1.0,6/19,16.24%,CD63;CADM4;JCAD;DCN;DLL1;DAB2IP
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.5193224825874209,1.2098607058311557,0.2249690976514215,0.528939823064575,1.0,7/20,19.95%,PARK7;LAMTOR5;H1-0;TWIST1;DDRGK1;TGFB1;POU4F1
prerank,mitochondrion organization (GO:0007005),0.4165368054676551,1.20983576303557,0.10393541876892028,0.5285686770334272,1.0,38/165,18.30%,CHCHD10;TSPO;ATP5F1B;ATP5F1D;CHCHD2;TIMM8B;TIMM13;PARK7;TOMM5;TOMM7;HIGD2A;PINK1;COX7A2L;SLC25A4;COX7A2;CAV2;PARP1;AIP;TIMM10B;DNM3;OMA1;BNIP3L;HSPD1;HIGD1B;HAP1;BAX;GDAP1;TMEM70;TIMM50;MIEF2;SPG7;MFF;ATAD3A;BCAP31;DNM1L;PPARGC1A;FMC1;ATCAY
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.47983563506442545,1.2098199496516784,0.2046242774566474,0.5281706410191644,1.0,8/34,16.26%,MT1G;RAMP2;HSPB1;KDR;GAS1;FLT4;DAB2IP;FLT1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4331247504256859,1.2091070449545331,0.1655982905982906,0.5296398329829437,1.0,23/73,19.83%,HSP90AA1;HSP90AB1;PARK7;AKT1;TXN;PINK1;TNF;HCLS1;MIF;TFRC;PAK1;CAMK1;IL11;RAMP3;SH2D3C;RIPK2;GAS6;CAV1;PFN2;TERF2IP;SNCA;IL6;TGFB1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.4999233884879267,-1.2089809816852304,0.237012987012987,0.6140106254897574,1.0,3/10,15.71%,DHX36;CPEB3;CDC73
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.4314603937353685,-1.2088842990125956,0.20930232558139536,0.6117992734663251,1.0,6/16,13.42%,PDK1;PRKN;FOXK2;FOXK1;RORA;SIRT1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.47900618992336663,-1.2087979656899814,0.21694915254237288,0.609537244757182,1.0,5/11,14.92%,BMPR1A;ZFPM2;JAG1;BMP4;HEY2
prerank,regulation of mitotic cell cycle (GO:0007346),0.41203535100848027,1.2087592348011003,0.10111223458038422,0.5301147082941525,1.0,66/171,26.73%,PSMB4;PSME1;LGMN;PSMB6;PSME2;PSMB8;PSMD2;PSMD1;PIN1;CAV2;PSMC3;DUSP3;PSMD6;CDKN1C;BTG1;BRINP3;PSMA7;PSMD5;DDB1;PSMB9;PSMD13;GAS1;BRINP1;BUB3;PSMB3;PSMB11;BRINP2;FBXO5;PSMB10;RNF40;HNRNPU;SDCBP;L3MBTL1;PSMB1;PSMB5;PIM3;ASNS;USP22;BTG4;PSMA6;TGFB1;DYNLT3;SKP1;PSMA4;TFAP4;ASAH2;CDK9;FOXA1;CCDC8;PSMC1;FZR1;PSMD9;MEIS2;CDK10;INTS13;APP;RCC1;CDC20;PSMB2;PRKCA;XPC;KIF20B;PSMD4;PSMD10;CDK11B;ERCC2
prerank,stem cell development (GO:0048864),0.5355676172386487,1.208568889692228,0.2535760728218466,0.5301868867593273,1.0,10/16,32.28%,NRG1;PTPRC;PDCD6;SOX8;SOX11;WNT7A;NOLC1;KBTBD8;CDH2;SHH
prerank,embryonic heart tube development (GO:0035050),0.5420009214640567,1.2080384470244545,0.2419127988748242,0.5311306362216249,1.0,6/14,20.01%,SOX18;NDRG4;HES1;SOX17;RYR2;CITED2
prerank,RNA destabilization (GO:0050779),-0.3989259307383637,-1.2078457820738393,0.20444444444444446,0.6092652197918623,1.0,4/18,5.58%,ROCK2;FTO;ROCK1;YTHDF3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.31012601845460075,-1.2075294308357079,0.14563106796116504,0.6076937102520196,1.0,17/51,14.11%,ROCK2;ABL1;LPAR1;PPM1E;NRP1;SORBS3;ARHGEF10L;CARMIL1;TGFBR1;PXN;TPM1;RAPGEF3;FERMT2;NF2;SYNPO2;WNT11;TGFB3
prerank,ureteric bud development (GO:0001657),-0.41537018290439887,-1.2071060489863872,0.21653543307086615,0.6062702915518348,1.0,6/17,13.72%,GPC3;SLIT2;FGFR2;SIX1;WNT11;BMP4
prerank,positive regulation of cell migration (GO:0030335),0.4068069257845429,1.2069615463032917,0.07021063189568706,0.533649586899572,1.0,73/253,19.83%,ACTG1;RACK1;VTN;MDK;GRN;COL1A1;GPNMB;CD151;CXCL12;S100A11;HSPA5;GPER1;RHOC;SEMA3F;PDGFB;PTPRC;SEMA7A;RTN4;SEMA4C;MYADM;PFN1;FN1;FAM107A;CXCL16;SEMA6D;ENPP2;PAK1;PODXL;CLASP1;KDR;VSIR;LGR6;LAMC2;ARHGEF7;SEMA4A;CSF1R;PECAM1;ELP3;HRAS;AIF1;SOX9;SEMA4G;SHTN1;BMP2;FBXO5;CTSH;SDCBP;TIAM1;F2RL1;PDGFA;DMTN;DAB2IP;FLT1;CCL3;CAV1;PLAU;CDH5;CASS4;PIK3CD;TRIM32;F10;MMP14;ADAM17;DDR2;CCR2;MAZ;NSMF;STX4;PPP3CA;DDRGK1;NOTCH1;HGF;TGFB1
prerank,positive regulation of T cell activation (GO:0050870),0.43795795174258567,1.2054318670331954,0.2025862068965517,0.5374049276955065,1.0,17/62,20.93%,CD81;MDK;CCL19;PTPRC;SIRPA;TFRC;HSPD1;THY1;PNP;AIF1;DOCK8;CCL2;VCAM1;CCR2;CD86;IL6;PYCARD
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5393120246120585,1.205418031992251,0.2593068035943517,0.5369898178261145,1.0,3/17,8.53%,CD74;MIF;PTTG1IP
prerank,cellular response to oxygen levels (GO:0071453),0.5879259440770637,1.2053276502728847,0.2752808988764045,0.5367891806007522,1.0,3/10,8.91%,ATP6V1G1;ATP6AP1;NDUFS2
prerank,peptidyl-threonine modification (GO:0018210),-0.30435615711687597,-1.2051023931258815,0.1,0.6088805845021662,1.0,19/66,14.02%,ROCK2;ACVR1;LRRK2;ROCK1;CAMK2D;GALNT11;PDPK1;TGFBR1;CDC42BPB;DYRK1A;HIPK3;GALNT1;TBK1;CSNK2A1;CSNK2A2;NLK;PRKD1;GSK3B;MARK2
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.30976925395813043,-1.2044865358874841,0.13580246913580246,0.6080642659959471,1.0,17/59,14.02%,ROCK2;ACVR1;LRRK2;ROCK1;CAMK2D;PDPK1;TGFBR1;CDC42BPB;DYRK1A;HIPK3;TBK1;CSNK2A1;CSNK2A2;NLK;PRKD1;GSK3B;MARK2
prerank,regulation of chromosome organization (GO:0033044),-0.36513424422125385,-1.2040805644845478,0.1912568306010929,0.6067544631335842,1.0,6/22,11.44%,SMG6;SMG1;HDAC8;WAPL;YLPM1;TERF2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5283945031556686,1.2037835874617424,0.2422680412371134,0.5405438585215759,1.0,6/18,18.87%,ACTB;VAMP8;CDK5;ABCA2;MMP14;VPS4A
prerank,positive regulation of protein kinase activity (GO:0045860),0.41307015828353016,1.203365146389907,0.13496932515337423,0.5412448992307708,1.0,44/148,19.75%,CLU;CALM1;HSP90AA1;HSP90AB1;CCL19;PRNP;CALM3;GRM5;AGT;TNF;EMP2;PDGFB;PTPRC;PAK1;EGR1;LILRA5;CAMK1;PAK3;PIH1D1;FCGR1A;CSF1R;DOK7;SLC11A1;RHOA;SRCIN1;GAS6;CCDC88A;STK11;MMD2;LRP8;MAPRE3;DAB2IP;CASS4;LCP2;ADCYAP1;CAMKK1;AGAP2;DDR2;ERBB3;MAP2K2;CALM2;SNCA;UNC119;EFNA1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.36403671597086257,-1.202983989547576,0.19205298013245034,0.6072956812918744,1.0,13/30,23.30%,TRIP12;UBR5;SHLD1;RNF169;FBH1;CYREN;FANCB;CGAS;SMCHD1;RMI2;SHLD2;SHLD3;POLQ
prerank,carboxylic acid transport (GO:0046942),0.44717841796343416,1.2018420030437988,0.20801733477789816,0.5449055246734523,1.0,10/55,12.43%,PSAP;SLC38A5;SLC7A5;SLC1A4;SLC25A29;SLC6A6;SLC6A17;SLC15A4;SLC3A2;SLC1A1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.47926550735768686,1.2018378292020697,0.21805392731535755,0.5444699212573091,1.0,15/32,27.24%,CAVIN1;POLR2E;MAPK3;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;ERCC2;CCNH;POLR1F
prerank,regulation of transposition (GO:0010528),-0.44814061205083144,-1.2018191316692668,0.2550607287449393,0.6079035140859635,1.0,4/13,16.08%,UBR2;MYBL1;TEX15;SIRT7
prerank,regulation of osteoblast proliferation (GO:0033688),0.5368938616381399,1.2017340179464508,0.2467866323907455,0.5442895615294928,1.0,9/17,20.17%,NELL1;ATRAID;TMEM119;SOX8;RHOA;BMP2;TNN;HPSE;SFRP1
prerank,extracellular matrix assembly (GO:0085029),0.5065880009166364,1.201715736940987,0.24561403508771928,0.5438967684786831,1.0,8/23,20.16%,RAMP2;LAMB2;GPM6B;MFAP4;MYH11;GAS6;TGFB1;QSOX1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.566080800370903,1.2015381018003093,0.2401129943502825,0.5439537044054679,1.0,7/12,31.38%,FLOT1;PQBP1;IFIT1;CAV1;RALB;DHX9;MAVS
prerank,proteasome assembly (GO:0043248),0.5828947934996614,1.2009848103025553,0.2562326869806094,0.5450077775410187,1.0,7/11,26.18%,POMP;PSMD5;PSMD13;OTUD6B;PSMD9;PSMD4;PSMD10
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5570258823679903,1.200786247619292,0.2600276625172891,0.5451123716566773,1.0,4/12,12.97%,GRN;ATP6AP2;CLN5;CLN6
prerank,regulation of organelle assembly (GO:1902115),-0.2930441687341338,-1.200525515261342,0.13846153846153847,0.6088462773783129,1.0,15/72,8.13%,ALMS1;DCDC2;CEP295;PDCD6IP;MTMR3;SENP6;ATXN2;TBC1D19;USP6NL;TBC1D12;STX18;TBC1D2B;RABGAP1;TBC1D9B;IFT88
prerank,purine ribonucleotide transport (GO:0015868),0.5361080444491813,1.2003307839676087,0.23890339425587467,0.5459047030260907,1.0,3/16,13.31%,LRRC8A;SLC25A4;SLC19A1
prerank,polyamine metabolic process (GO:0006595),0.5572613024341133,1.1999633203000497,0.239247311827957,0.5464448505841527,1.0,5/13,19.93%,ODC1;SMS;SMOX;SRM;OAZ2
prerank,female gonad development (GO:0008585),0.5143262164467451,1.1998960127352762,0.24093264248704663,0.5461755727337793,1.0,9/19,25.30%,SOD1;ANG;CEBPB;FOXL2;EIF2B5;INHBA;INHBB;COL9A3;INHA
prerank,plasma membrane invagination (GO:0099024),0.4846036746401134,1.1997598270196863,0.24349881796690306,0.5461214278519078,1.0,9/29,16.40%,GSN;ITGB2;ARHGAP25;ELMO1;FCGR1A;MSR1;AIF1;RHOA;SNX33
prerank,atrial septum morphogenesis (GO:0060413),-0.49267985978473955,-1.1997512544794753,0.24041811846689895,0.6084897936015322,1.0,2/10,1.44%,NOTCH2;ACVR1
prerank,positive regulation of chromatin organization (GO:1905269),0.5654547827491015,1.1993271231804765,0.2862957937584803,0.5468531382645304,1.0,2/12,2.96%,H3-3A;TERF1
prerank,collagen fibril organization (GO:0030199),-0.28420408107952005,-1.1992090358961665,0.1276595744680851,0.6073788140252909,1.0,24/88,9.97%,COL5A2;COL22A1;COL4A3;COL5A1;COL8A1;COL4A5;PLOD2;ADAMTS2;COL4A6;COL25A1;COL13A1;LOXL1;COL26A1;TLL1;COL12A1;COL27A1;TGFBR1;PXDN;ATP7A;COL4A4;LOXL3;COL11A1;COL8A2;ITGB4
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4041169220079315,1.1990584580294135,0.12916246215943492,0.5470994001718696,1.0,51/173,21.85%,CTSZ;DYNLL2;DYNLL1;USE1;ANK3;LMAN2;DCTN3;ERGIC3;KDELR1;TMED7;F9;TRAPPC2L;LMAN1;SAR1A;TRAPPC5;TRAPPC1;TMED2;CAPZA2;YKT6;ARFGAP2;TICAM2;TEX261;TMED3;TMED9;PDCD6;GRIA1;BET1L;TMED1;DCTN1;YIF1B;GAS6;MCFD2;DCTN2;IER3IP1;ARF4;SPTBN4;NAPA;SPTBN2;BCAP31;F10;TRAPPC3;CTSC;VAPA;YIF1A;GOLT1A;COL7A1;TMED10;HYOU1;COPB2;TGFA;COPG1
prerank,import into nucleus (GO:0051170),0.433965894385364,1.19887022367374,0.18783351120597652,0.5471667879564973,1.0,19/73,18.55%,SNRPG;AKT1;GEMIN7;RAN;SNRPD2;SNRPE;FAM53C;SNRPF;PTTG1IP;IPO4;NUP85;HNRNPA1;SNRPB;NUP88;SPRN;EIF4ENIF1;SYK;NUP50;SNRPD3
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.48391886262697525,1.198585696764241,0.21851851851851853,0.5470311905626148,1.0,10/29,23.49%,DBI;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5;ACLY
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.48391886262697525,1.198585696764241,0.21851851851851853,0.5470311905626148,1.0,10/29,23.49%,DBI;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5;ACLY
prerank,regulation of cellular component size (GO:0032535),0.48588855838581385,1.1982043615958198,0.21495327102803738,0.5476207083613654,1.0,9/30,14.15%,PPP1CA;LAMTOR4;LAMTOR5;RAC1;AP2M1;MSN;ATP13A2;VAV1;VAV3
prerank,endothelial cell proliferation (GO:0001935),0.5215211552078078,1.1966888905846664,0.24533333333333332,0.5512484390229098,1.0,3/17,4.15%,HMOX1;CD34;ACVRL1
prerank,response to calcium ion (GO:0051592),0.42077279638578025,1.1962764274090438,0.1756198347107438,0.5518849186068816,1.0,31/102,20.39%,CALM1;LGMN;NLGN1;CALM3;SLC25A13;SYT1;SYT12;SYT11;SYT6;SYT4;SMPD1;PDCD6;WNT5A;TRPM2;TRPC1;ALOX5AP;CPNE5;SYT10;CPNE6;RYR2;DMTN;ADCY8;SYT2;CAV1;KCNMA1;PPP3CA;CALM2;CPNE4;D2HGDH;MEF2C;CAPN3
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5299975769698637,1.1953113765619432,0.2311756935270806,0.5540493214900015,1.0,6/17,16.80%,SEC61B;HSP90B1;AUP1;VCP;SYVN1;HERPUD1
prerank,regulation of protein transport (GO:0051223),0.48507503406929814,1.1952926108809445,0.24019024970273484,0.5536587588038643,1.0,6/27,11.32%,HSPA8;TNF;LCP1;ATP13A2;STXBP5L;DNAJA1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5889305963747063,1.1947481986710984,0.2629370629370629,0.554666852748285,1.0,4/10,15.85%,PTPRC;TLE5;KLF4;SIGIRR
prerank,regulation of actin nucleation (GO:0051125),0.5652856339580226,1.193645317660966,0.2552594670406732,0.5572859572023819,1.0,4/12,17.68%,GSN;CORO1A;ARF1;SCIN
prerank,negative regulation of response to external stimulus (GO:0032102),0.4118127890926787,1.1931258694119589,0.1628630705394191,0.558214736893333,1.0,28/105,23.79%,APOE;CTNNA2;CERS2;GPER1;GRID2;NR1D1;LRFN5;DUSP3;SIRPA;TNFAIP3;KLK8;FEM1A;OTULIN;EPPK1;KLF4;TNFRSF1A;SIGIRR;FNDC4;TYRO3;CDH5;CXCL17;NLRP3;SIRT2;SELENOS;CCN3;C1QBP;PCBP2;TEK
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5614194007723877,1.192998581544075,0.2593103448275862,0.5581019374376465,1.0,5/12,19.67%,TREM2;TNF;NUPR1;CCL3;IL6
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4742856679104759,1.1926849969028874,0.2390011890606421,0.5584928350447325,1.0,9/29,14.97%,RPS2;PARK7;PINK1;PIN1;BAG5;FEM1A;FBXW7;FBXO5;ARRDC3
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.42144599137890465,1.1924800481391058,0.1725206611570248,0.558624090809526,1.0,23/100,14.29%,RPL11;CLU;RACK1;GABARAP;ELOB;HSP90AB1;PARK7;UBXN1;MAP1A;HSPA1B;VCP;BAG5;FOXF2;USP5;CEBPA;RBX1;XPO1;TAF9;SUMO2;DNAJB2;HSPA1A;HSPBP1;SDCBP
prerank,regulation of cellular component movement (GO:0051270),-0.31254266319108287,-1.1923270075212358,0.16822429906542055,0.6226842997497176,1.0,14/49,11.99%,ROCK2;TGFBR3;EGFR;ABL1;MEMO1;ROCK1;RAF1;TGFBR1;CDK6;SP100;DIAPH1;ABL2;ZSWIM4;ARHGAP18
prerank,negative regulation of response to wounding (GO:1903035),0.5199522209041187,1.192218529066147,0.2604828462515883,0.5588868880875796,1.0,4/19,9.80%,MDK;CERS2;KLK8;EPPK1
prerank,positive regulation of protein modification process (GO:0031401),0.4051939392491841,1.1920966662128238,0.11526794742163801,0.5587848810382103,1.0,56/203,20.03%,PPIA;CD74;RACK1;CALM1;HSP90AA1;GPNMB;MT3;C3;MAPK3;AKT1;TXN;CALM3;CCND2;TREM2;ERBB4;PINK1;GPER1;TNF;RAC1;NTRK2;PIN1;FLOT1;KNDC1;RARRES2;MUSK;TFRC;CCND1;PAK1;KDR;P2RY1;CAMK1;SMPD1;CSF1R;PECAM1;SVIP;FLT4;HRAS;TMEM119;SOX9;BMP2;GAS6;CLIP3;IGF2;DLC1;RASGRP1;ASPSCR1;CDH5;ADAM17;TERF2IP;NSMF;CALM2;HGF;EFNA1;ERP29;TGFB1;THPO
prerank,cellular sodium ion homeostasis (GO:0006883),0.5457076312339127,1.1913204166651328,0.2736842105263158,0.5604940768064013,1.0,7/15,17.69%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;SLC8A1;ATP1B3
prerank,regulation of telomerase activity (GO:0051972),0.44814560810925685,1.190977699971325,0.2223463687150838,0.5609769216618964,1.0,20/45,25.94%,HSP90AA1;HSP90AB1;MAPK3;TERF1;CCT2;CTNNB1;KLF4;PTGES3;PARM1;DKC1;MAPK15;MYC;MEN1;MAP2K7;CCT4;GRHL2;NAF1;PNKP;PIF1;PRKCQ
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.42828518356576084,1.190635561694756,0.21018418201516792,0.5614308476002942,1.0,13/66,9.89%,PARK7;AKT1;RAN;CCT2;LAMTOR5;HCLS1;ORMDL3;FLNA;HYAL2;TFRC;CCT7;TRIM28;CCT8
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4706585509797099,1.190302110043367,0.24162679425837322,0.5618856059426958,1.0,11/33,21.67%,OAT;PYCR2;GLUL;DDAH1;GLS2;GLS;DDAH2;GLUD1;GOT1;ALDH4A1;MTHFS
prerank,response to muramyl dipeptide (GO:0032495),0.5691288589937118,1.1901424660546356,0.2752420470262794,0.5618596466365264,1.0,4/12,14.04%,VIM;CHMP5;RIPK2;ERBIN
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4624601596381335,1.190127856577277,0.24287343215507412,0.5614367901980069,1.0,6/37,6.77%,APOD;TREM2;TNF;PLD3;SIRPA;CUEDC2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.4323793747991642,1.1900808709211368,0.21528525296017223,0.5611213644260784,1.0,21/69,21.85%,SEC61B;HSPA5;HSP90B1;AUP1;UBE2G2;VCP;FBXO27;SEL1L2;WFS1;SYVN1;DNAJB2;MAN1B1;UBQLN2;SGTA;HERPUD1;DNAJB9;DNAJC10;TRIM13;SELENOS;STUB1;AMFR
prerank,microtubule anchoring at centrosome (GO:0034454),-0.4789714468926364,-1.190027138936214,0.23958333333333334,0.6261488092296854,1.0,5/10,17.82%,NIN;NINL;PCM1;CCDC120;CEP19
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5436998538834545,1.1899433749843136,0.26666666666666666,0.5610571503586823,1.0,8/14,23.06%,HSPA5;BAX;DAB2IP;DNAJB9;DDRGK1;TMEM33;BAK1;PTPN1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4982536466278752,1.1898519703711914,0.23833543505674654,0.5608506710897189,1.0,10/24,24.02%,RAMP2;TNFAIP3;KDR;GATA2;IL11;GAS6;CDH5;SCG2;TEK;PAK4
prerank,ERAD pathway (GO:0036503),0.42139970793873993,1.18926489942764,0.1953781512605042,0.5619574578641033,1.0,25/83,21.85%,SEC61B;HSPA5;RCN3;HSP90B1;AUP1;UBE2G2;VCP;FBXO27;SEL1L2;WFS1;SYVN1;DNAJB2;MAN1B1;UBQLN2;SGTA;UBXN6;HERPUD1;BRSK2;DNAJB9;DNAJC10;TRIM13;USP13;SELENOS;STUB1;AMFR
prerank,neuron projection fasciculation (GO:0106030),0.6048157306124456,1.1892307320600954,0.28898426323319026,0.5616053417136245,1.0,4/10,9.33%,CNTN4;RTN4;NRCAM;CDK5R1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.41214787332355396,1.1889821155125586,0.16615698267074414,0.5617877470629846,1.0,28/117,19.67%,CD81;RAMP2;TREM2;POMC;SCTR;DRD5;CD163;RXFP1;PRKAR1A;VIPR1;CRH;KARS1;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;ADCY4;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;IL6
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.551074680085696,1.18879517177298,0.25828729281767954,0.5618643954627583,1.0,6/13,16.12%,NELFCD;SUPT4H1;HNRNPU;HEXIM1;RECQL5;NELFE
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.3966608670580993,-1.1887095934535346,0.21052631578947367,0.6270122603934913,1.0,8/21,15.34%,SMO;DCDC2;TTC23;DLG5;GAS8;EVC;UCHL5;KIF7
prerank,protein-DNA complex disassembly (GO:0032986),0.5332353495606224,1.18870919595403,0.25168236877523553,0.5616162530078929,1.0,1/16,0.13%,RPL23
prerank,carnitine shuttle (GO:0006853),-0.4609818895894099,-1.1883200052547116,0.23986486486486486,0.6256449574172693,1.0,3/11,11.96%,PRKAG2;PRKAA2;CPT2
prerank,cellular response to ionizing radiation (GO:0071479),0.44850358437177923,1.1882218989972237,0.225,0.562505102050211,1.0,8/47,12.02%,RPL26;RHOB;CRYAB;EEF1D;NUCKS1;NET1;TMEM109;HRAS
prerank,regulation of ruffle assembly (GO:1900027),0.5015264795954355,1.187970420780138,0.24968314321926488,0.5627264389618083,1.0,7/23,16.75%,NLGN1;PFN1;P2RY12;DEF8;HRAS;CAV1;PFN2
prerank,steroid metabolic process (GO:0008202),0.4266339545536801,1.1875552700108485,0.20105263157894737,0.5633973190726169,1.0,10/72,12.81%,TSPO;LGMN;SCP2;RDH5;LSS;HSD17B4;DHCR24;FDX2;GC;HSD3B2
prerank,secondary palate development (GO:0062009),-0.4377709527773229,-1.1873954190420244,0.2591093117408907,0.6255891353664641,1.0,5/14,14.11%,TGFBR3;SMAD4;WNT11;SMAD2;TGFB3
prerank,regulation of myoblast fusion (GO:1901739),0.5752338176254972,1.1873837521611472,0.27472527472527475,0.5634244944595117,1.0,6/11,18.67%,FLOT1;CD53;ADGRB1;EHD1;EHD2;SCGB3A1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5332680187575631,1.1873105800898487,0.27553763440860213,0.563176098321785,1.0,1/16,0.71%,VIM
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.3856003174460676,-1.1872408754396744,0.21052631578947367,0.6236258647311507,1.0,7/19,11.61%,TGFBR3;BMPR1A;VGLL4;TGFBR1;ZFPM2;FGFR2;RBPJ
prerank,negative regulation of hydrolase activity (GO:0051346),0.45045692082136607,1.1872405604824046,0.20317820658342792,0.562894935913766,1.0,12/49,16.24%,CST3;ECM1;ATP5IF1;CSTB;TMED2;MAP2;RRP1B;NEIL1;HRAS;PPP1R35;ARL2;DAB2IP
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.471901656122165,1.1868978032060016,0.25,0.5633901774092674,1.0,10/33,19.74%,HSP90AA1;HSP90AB1;TERF1;NOP10;NHP2;PTGES3;GAR1;CTC1;TERF2IP;DKC1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.46007783844424477,-1.1868008796320426,0.28346456692913385,0.6223209122787537,1.0,8/12,30.84%,MAD1L1;CENPC;CENPE;NDC80;MIS12;NUF2;RMDN1;KIF2C
prerank,response to gamma radiation (GO:0010332),0.4847427807673784,1.1867608478741742,0.2596754057428215,0.5632971595857059,1.0,4/24,12.02%,RPL26;CRYAB;TMEM109;HRAS
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.5429700904575463,1.1865766345352715,0.28973277074542897,0.5633796994468959,1.0,6/13,20.24%,LAMP1;ITGB2;F2RL1;SYK;STX4;SPHK2
prerank,tRNA aminoacylation (GO:0043039),0.4631234411699102,1.1863463885352217,0.23598130841121495,0.5635712690982632,1.0,14/37,24.51%,LARS2;GARS1;SARS1;SARS2;KARS1;WARS1;NARS1;CARS1;PPA1;EPRS1;QARS1;AIMP2;YARS2;MARS2
prerank,response to estradiol (GO:0032355),-0.3489839761824778,-1.1854925436328072,0.21333333333333335,0.6234330126898298,1.0,7/31,9.87%,STRN3;EGFR;NRIP1;STAT5B;LCOR;STAT3;ESR1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.42767306865238836,1.1854879544683596,0.19766206163655686,0.5654132417706962,1.0,26/77,19.67%,CLU;GPX1;NDUFA13;PARK7;AKT1;SLC25A5;TMBIM6;PINK1;TNF;FZD9;LGALS3;GHITM;TMEM14A;PIH1D1;ACAA2;HSPA1A;CX3CR1;MAPK8IP2;GATA4;HERPUD1;NDUFS3;MAZ;QARS1;PRELID1;RTKN2;HGF
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.44419372563199333,1.184983592145669,0.2360655737704918,0.5663351172757474,1.0,15/52,15.07%,TOMM7;PINK1;YWHAB;UBL5;YWHAH;YWHAE;LEPROT;YWHAG;PMAIP1;YWHAQ;FBXW7;YWHAZ;RHOU;BBC3;BAD
prerank,muscle contraction (GO:0006936),0.4075358143875001,1.184781138698953,0.16142131979695432,0.5664387731597957,1.0,23/126,16.42%,MYL6;ALDOA;VIM;CALM1;MYL9;ACTA2;MYL12A;FXYD1;TPM2;CRYAB;MYL1;MYL12B;P2RX6;GNAO1;MYL6B;GLRA1;MYH11;TNNI1;DES;SLC8A1;TMOD1;ADRA1A;DTNA
prerank,regulation of cellular localization (GO:0060341),0.4455025624615204,1.184461148382487,0.21524663677130046,0.5668480232856197,1.0,10/46,9.65%,GSN;HSP90AA1;HSP90AB1;PINK1;NR1D1;PARP1;REEP5;REEP6;MAP2;EPHA5
prerank,lymphocyte migration (GO:0072676),0.4735389128144887,1.1839418660117296,0.2540792540792541,0.5678309081013087,1.0,13/32,34.09%,CCL19;S1PR1;MSN;CCL2;CCL3;CCL8;MYO1G;CX3CL1;CCL13;ZAP70;CCL14;ADAM8;CCL5
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4848284803526903,1.1839304839554192,0.2570036540803898,0.5674182267998915,1.0,9/26,21.11%,AKT1;CYB5R3;SPR;SPTLC1;ABCA2;DDAH2;NOS2;SPHK2;ASAH2
prerank,chromatin disassembly (GO:0031498),-0.43531823761942134,-1.1836519892627868,0.22794117647058823,0.6236939254699378,1.0,3/14,6.66%,ARID2;ARID1A;SMARCE1
prerank,nucleosome disassembly (GO:0006337),-0.43531823761942134,-1.1836519892627868,0.22794117647058823,0.6236939254699378,1.0,3/14,6.66%,ARID2;ARID1A;SMARCE1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.46513552499779354,1.1834231695559152,0.24595842956120093,0.5683448367608211,1.0,11/35,12.02%,ARHGDIA;MDK;HCLS1;ARHGDIB;IQGAP2;ESAM;HCK;PHPT1;CSF1R;TRPM2;HRAS
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.574706440875723,1.1830275849520597,0.287292817679558,0.5689575545499345,1.0,1/10,1.89%,MAPK3
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3525004173919027,-1.1827543631070907,0.21390374331550802,0.6236885836961975,1.0,6/26,4.13%,ROCK2;ASAP3;ALMS1;SLC9A1;ROCK1;PRKN
prerank,diterpenoid metabolic process (GO:0016101),0.4376378172301001,1.1825496461998055,0.22797356828193832,0.5697723475718167,1.0,16/55,19.89%,APOE;RBP4;RARRES2;TTR;RDH5;RBP1;LPL;SDC4;GPC5;AKR1B10;LRP8;LRAT;BCO2;SDC3;HSPG2;AGRN
prerank,kidney development (GO:0001822),-0.28554146503805433,-1.182479060889296,0.14772727272727273,0.6220227583724548,1.0,17/65,13.72%,SULF1;KANK2;ZBTB16;GLI2;NIPBL;AGTR1;TGFBR1;PYGO1;ARL3;PCSK5;CEP290;IFT88;NPHP3;PKD1;GREB1L;SIX1;BMP4
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.3214116272755213,-1.182313372664597,0.14018691588785046,0.6201733665112195,1.0,12/44,10.33%,ROCK2;FTO;TNRC6B;ROCK1;TNRC6A;DHX36;TNRC6C;CNOT1;YTHDF3;CPEB3;MOV10;CNOT7
prerank,regulation of centrosome cycle (GO:0046605),0.5080858502894184,1.1820810901106795,0.25757575757575757,0.5705523026344239,1.0,7/21,15.97%,NPM1;CHMP2B;CHMP5;ATF5;CEP131;FBXW5;CHMP1B
prerank,protein ADP-ribosylation (GO:0006471),-0.368134511343074,-1.1818394313634046,0.2261904761904762,0.6191347423156669,1.0,9/28,15.22%,PARP4;PARP9;PARP12;PARP16;PARP3;TNKS2;SIRT1;PARP10;ZC3HAV1
prerank,positive regulation of programmed cell death (GO:0043068),0.39518529959231913,1.1817016363327255,0.089,0.571156512668366,1.0,78/272,21.45%,MTCH1;RPS27A;CTSD;CLU;UBC;RACK1;UBB;LAPTM5;SOD1;RHOB;ATF4;RPS6;UBE2Z;TGM2;IGFBP3;GPER1;TNF;FZD9;PSENEN;CTNNB1;OMA1;UBA52;BNIP3L;ARHGEF4;FOXL2;HSPD1;CSRNP3;NET1;RRP1B;JUN;HMGB1;ARHGEF7;SMPD1;APBB1;DNAJA1;BAX;PMAIP1;PNMA2;TCTN3;CTLA4;MCF2L;VAV1;LILRB1;BMP2;WNT10B;CLIP3;NLRP2B;SFRP4;VAV3;ABR;TIAM1;BAD;DAB2IP;SQSTM1;PSEN2;DNM1L;PDCD5;NOS2;SCIN;APH1B;SYK;KCNMA1;TNFRSF12A;ARHGEF19;CCAR2;SNCA;SOS1;IL6;KLF11;ING5;SFRP1;SPHK2;TFAP4;BAK1;PYCARD;GADD45A;FOXA1;SUDS3
prerank,peripheral nervous system development (GO:0007422),0.5008096063345293,1.1816280952427973,0.25,0.5708977512515195,1.0,10/23,26.05%,ASIC2;PMP22;ADGRB1;ADGRB2;SOX8;NFASC;ERBB3;SOX10;SCN8A;GPC1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.39184913590111004,1.1812272783470619,0.038,0.5714809608307734,1.0,139/509,20.91%,RPL23;RPS3;RPS15;RPL37;CD74;RPS20;RACK1;GAPDH;HSP90AA1;HSP90AB1;LAPTM5;LGALS1;HMOX1;PARK7;CCL19;TXN;NLGN1;S100B;NRG1;TREM2;TGM2;ERBB4;PINK1;AGT;S100A13;LAMTOR2;GPER1;LAMTOR4;GPR37L1;TNF;EEF1D;RHOC;PDGFB;LAMTOR5;PTPRC;HCLS1;RAC1;FKBP1A;NTRK2;SHISA5;ECM1;SCTR;RTN4;S100A8;S100A9;MIF;CAV2;TIRAP;FLNA;FN1;TFRC;RHOG;EPOR;TMEM101;CLEC6A;KDR;NUPR1;P2RY12;TICAM2;JCAD;LILRA5;TMEM9B;DCN;HMGB1;KITLG;MC1R;RBCK1;WNT5A;IL11;BAX;RAMP3;FLT4;PMAIP1;C1QTNF4;HRAS;SOX9;BST2;VAV1;RUNDC3A;RHOA;GJA1;BMP2;LAMTOR3;RIPK2;GAS6;TNFRSF1A;UBE2V1;CX3CR1;TLR6;HEXIM1;BBC3;F2RL1;BAD;GDF15;RRAGC;IGF2;PDGFA;NCF1;ADRA1D;ADRA1A;RRAGD;DAB2IP;HPSE;FLT1;CCL3;CAV1;CASS4;BCAP31;PIK3CD;TRIM32;DNM1L;F10;RAC2;S100A4;GRM4;ERBB3;TERF2IP;LTBR;KLB;MAZ;SOX11;CD14;CD86;RTKN2;FLT3;TRIM13;IL6;HGF;TGFB1;VAPA;THPO;CANT1;TRAT1;SPHK2;GOLT1B;ADRA2B;TMEM106A;PTPN6;THEM4
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5103323056126896,1.1806432569282899,0.2701005025125628,0.5726372947517147,1.0,7/21,18.08%,YWHAB;FKBP1A;PPP1R1B;YWHAE;ARPP19;FKBP1B;PPP1R15A
prerank,negative regulation of cell growth (GO:0030308),0.40825161469730475,1.179957624454942,0.16837782340862423,0.5740356904448544,1.0,40/121,21.93%,RACK1;MT3;NDUFA13;DCC;CCDC85B;ADAM15;ACVRL1;ENO1;RTN4;HSPA1B;PPP2R1A;HYAL2;BTG1;WFDC1;JADE1;MAP2;APBB1;SOX17;MSX1;DNAJB2;BST2;HSPA1A;GJA1;STK11;FGF13;ING1;DACT3;SLIT3;NDUFS3;SCGB3A1;CCAR2;INHBA;TGFB1;OSGIN1;SFRP1;SPHK2;RERG;CCN3;MAG;CDA
prerank,cell projection organization (GO:0030030),0.46691868450039137,1.1798151204474223,0.2704326923076923,0.5739713427975021,1.0,12/30,17.68%,GSN;RAC1;NEFH;RHOG;ATP1B2;P2RY12;RHOV;RHOU;CAPG;PDGFA;RAC2;SCIN
prerank,C21-steroid hormone metabolic process (GO:0008207),0.510654127399008,1.1792892003432027,0.2747395833333333,0.5749167035115769,1.0,4/20,17.42%,TSPO;FDX2;HSD3B2;STARD3NL
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5762776931164358,1.1790657693294146,0.29455081001472755,0.5750912786025761,1.0,2/10,13.40%,CD24;LILRB1
prerank,nervous system development (GO:0007399),0.39165360415757616,1.179033354543064,0.058,0.5747240756508163,1.0,131/429,22.58%,GSN;SCD5;MBP;MDK;ITM2B;BCAN;LSAMP;MPZ;NBL1;MARCKS;ASIC2;NRXN1;SPOCK2;NLGN1;S100B;SLC2A1;NRG1;ERBB4;NES;KCNQ2;FZD9;MOBP;ADAM23;PMP22;DSCAM;CNTN4;MAL;ECRG4;RBFOX3;ADGRL3;SH3GL2;GPM6B;SPOCK1;TAGLN3;HES1;DNM3;STMN3;HAPLN2;FN1;NINJ2;LGI1;LY6H;CRMP1;LRCH4;APLP1;NELL1;PRDM12;NAV3;KIRREL3;NRCAM;KLK6;PROX1;MOG;NDUFS2;ADGRB1;FGF11;NINJ1;MARCKSL1;SMPD1;DNER;ADGRB2;FGF12;HAP1;CHRM3;POU3F1;ELP3;IRF2BPL;GFRA1;SOX8;CHRM2;NRXN2;NRSN2;DCTN1;CLN5;ST8SIA4;CXCR4;CAPG;PTPRZ1;DCHS1;NAGLU;SPG7;NFASC;PRPS1;DSCAML1;ROBO2;RBFOX1;ACHE;EPHB1;CDK5;CPNE6;COX7B;FGF13;DOC2A;GFRA2;GMFB;TYRO3;VCAN;PRX;GLIS2;PPP2R5D;CLN8;PCDHB14;SCIN;ERCC6;GPM6A;APBA2;MYT1L;ERBB3;FABP7;UNC119;INHBA;DCX;TGFB1;POU4F1;MEF2C;GDF11;BTBD6;SRRM4;SOX10;IGF2BP3;PLXND1;HAPLN4;GRIK1;ROGDI;SDHA;SNTG2;POU6F2;GRHL2;CHRNA3;ACAN;DPYSL2
prerank,regulation of cholesterol transport (GO:0032374),0.4999044763541822,1.177729390495234,0.2731829573934837,0.5778143292875402,1.0,6/20,16.01%,TSPO;APOC1;LIPG;OSBPL6;NR1H2;ABCA2
prerank,positive regulation of MAPK cascade (GO:0043410),0.3960374577711623,1.177250238649861,0.11066398390342053,0.5786161332599731,1.0,68/245,20.93%,APOE;CD74;LAPTM5;GPNMB;MT3;MAPK3;CCL19;TREM2;ERBB4;GPER1;GPR37L1;TNF;PDGFB;PTPRC;NTRK2;C5AR1;SEMA7A;MIF;CAV2;NDRG4;TIRAP;ATP6AP1;DDT;SEMA4C;P2RY6;KDR;CCN2;HTR2C;P2RY1;CD24;JCAD;LILRA5;HMGB1;CSF1R;IL11;RAMP3;FLT4;HRAS;FBXW7;NEK10;BMP2;GAS6;CCL2;F2RL1;GDF15;IGF2;PDGFA;RASGRP1;ARRB2;ADRA1D;ADRA1A;DAB2IP;FLT1;CCL3;GATA4;ADCYAP1;CCL8;GRM4;EDN3;GPR183;FLT3;NOTCH1;IL6;TGFB1;THPO;ADRA2B;TMEM106A;PYCARD
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4202884111263325,1.1771243904887054,0.19703389830508475,0.578500166673599,1.0,29/86,21.39%,CD74;VTN;CD81;PRNP;ITGB2;TREM2;IL5;AGT;PDGFB;PTPRC;HCLS1;MIF;CLEC6A;ENPP2;CADM4;PECAM1;IL11;RIPK2;IGF2;PDGFA;LRP8;DMTN;IL6;HGF;EFNA1;TGFB1;SFRP1;PTPN6;BANK1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.49806005973290945,1.1770939804734717,0.29244114002478316,0.5781299462869347,1.0,5/23,16.24%,RPS3;TNF;PAK1;TLR6;DAB2IP
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5232877538596576,1.1763920273956068,0.27994616419919244,0.5795693780957093,1.0,6/15,27.61%,YWHAE;KCNN2;ATP1A1;ATP1B1;KCNJ3;KCNQ1
prerank,regulation of lymphocyte migration (GO:2000401),0.5803884970148839,1.1762665591803885,0.2709497206703911,0.5794800796079889,1.0,2/10,6.44%,AKT1;MSN
prerank,ether lipid biosynthetic process (GO:0008611),-0.4600632341946439,-1.1761329711084967,0.2852112676056338,0.6314198107024315,1.0,4/10,16.43%,PLA2G4A;FAR1;PEX7;PLA2G4C
prerank,cellular response to organic cyclic compound (GO:0071407),0.40204676806595835,1.1758759546654176,0.17457114026236126,0.5801110182147053,1.0,40/141,20.17%,ACTB;SPP1;GABRB1;AKAP6;TGM2;GPER1;TNF;HSP90B1;PDGFB;IGFBP5;ZFP36L1;CTNNB1;MSN;DRD5;ATP1A3;P2RY6;P2RX7;AQP1;P2RY1;EGR1;P2RY12;GNAI1;RAMP3;TRPM2;ATP1A1;GABRB3;SLC1A1;PDE12;CCL2;HCN1;DMTN;GABRB2;ADCY8;CCL3;HCN3;NCOA4;TGFB1;POU4F1;MEF2C;SFRP1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.4192407745129215,-1.1751668433038949,0.24714828897338403,0.6316748829271739,1.0,7/14,22.49%,KMT5C;KMT5B;SHLD1;HMCES;SHLD2;NECTIN2;SHLD3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.45716748885677333,1.1751022461860097,0.25395033860045146,0.5817841631003302,1.0,9/39,10.98%,FXYD5;FXYD1;ANK3;YWHAH;FGF14;SCN4B;FGF11;FXYD7;FGF12
prerank,I-kappaB phosphorylation (GO:0007252),0.5672380679568478,1.1750474946391067,0.2947067238912732,0.5814985702412229,1.0,5/10,29.14%,PRDX4;DAB2IP;TLR7;MAP3K7;TLR2
prerank,regulation of osteoblast differentiation (GO:0045667),-0.27813182230509864,-1.1748264387182112,0.10638297872340426,0.6303141948086932,1.0,28/82,16.73%,BMP6;RANBP3L;SMAD6;ACVR1;BMPR1A;SMOC1;CRIM1;SUFU;LRP5;SKI;YAP1;CDK6;IGF1;FGFR2;PPARG;IL6R;TRPM4;PTK2;FERMT2;ZHX3;PRKD1;BMP4;RUNX2;ACVR2A;LIMD1;WNT4;BMPR2;ACVR2B
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.40682742401841504,-1.1743033326477708,0.24180327868852458,0.6294134592601336,1.0,4/15,11.61%,EGFR;FER;PTPN12;RBPJ
prerank,endoderm development (GO:0007492),0.5468318086286696,1.1742100498067127,0.2895805142083897,0.5833566788907003,1.0,5/13,22.48%,LAMC1;SOX17;GATA4;DUSP2;DUSP1
prerank,nucleocytoplasmic transport (GO:0006913),0.45594398464047065,1.174039579887557,0.24913892078071181,0.5833489008738321,1.0,12/40,18.55%,SNRPG;GEMIN7;NPM1;SNRPD2;SNRPE;SNRPF;RBM15B;XPO1;HNRNPA1;SNRPB;ANP32A;SNRPD3
prerank,chondrocyte differentiation (GO:0002062),-0.3503583886890731,-1.1738804025808451,0.2,0.6283357631875478,1.0,12/32,21.54%,SULF1;NFIB;SOX5;WNT5B;EIF2AK3;CREB3L2;BMP4;RUNX2;BMPR2;GPLD1;SULF2;WNT2B
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.2635597606854085,-1.1734482266235728,0.1111111111111111,0.6271967610022718,1.0,38/140,13.40%,ARHGAP29;AKAP13;ARHGAP28;ARHGAP6;ARHGAP20;PLCE1;ARHGAP10;RHOJ;CGNL1;SOS2;ARHGEF11;ARHGAP17;TIAM2;ARHGAP21;SLIT2;ITSN1;ARHGAP23;ARHGEF18;FGD4;RHOT1;STARD13;ARHGAP12;ARHGAP32;ARHGEF12;FAM13B;PLEKHG2;BCR;VAV2;ARHGEF6;SYDE2;ARHGAP31;OPHN1;TRIO;MYO9B;ARHGAP18;ARHGEF2;ARHGEF17;ARHGAP5
prerank,autonomic nervous system development (GO:0048483),0.5064325528336755,1.1733968795516003,0.28157894736842104,0.5846534672781346,1.0,7/17,21.29%,FN1;KIF26A;PHOX2A;SOX8;SOX11;TFAP2B;SOX10
prerank,ventricular septum morphogenesis (GO:0060412),-0.36115915450429215,-1.172902845542578,0.20348837209302326,0.6262804546049724,1.0,12/27,16.29%,TGFBR3;ACVR1;BMPR1A;ROBO1;SLIT2;TGFBR1;ZFPM2;SMAD7;SMAD4;BMP4;HEY2;BMPR2
prerank,positive regulation of growth (GO:0045927),0.42804405288285335,1.1727050968258432,0.23877327491785322,0.5860992234832975,1.0,22/64,21.84%,H3-3A;AKT1;AKAP6;EIF4G2;S100A8;S100A9;LGI1;CXCL16;DDX49;IL2;MFSD2A;DNPH1;EXOSC2;WFS1;SDCBP;TRIM32;MMP14;ADAM17;EXOSC9;SFRP1;EXOSC4;PPM1F
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.42496231783389693,1.1723280156136309,0.20855614973262032,0.5866280064479651,1.0,11/66,9.80%,APOE;SPARC;B2M;ATP5F1A;MAGED1;CAV2;ATP5IF1;CDKN1C;VASH1;NUPR1;EPPK1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.46896572903994005,1.172282297246859,0.2529832935560859,0.5862853542545711,1.0,14/31,25.62%,SYT1;SYT12;SYT11;SYT6;SYT4;SYT10;DOC2A;CBARP;SYT2;DOC2B;REST;SYT3;SYT5;SYT17
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5749978311011736,1.1722115332054475,0.29124820659971307,0.58602177198683,1.0,5/10,17.75%,FKBP1A;YWHAE;PLN;CBARP;FKBP1B
prerank,negative regulation of B cell proliferation (GO:0030889),0.5729045401436436,1.1721334654579025,0.3256484149855908,0.5858004522678237,1.0,4/11,24.10%,TYROBP;CTLA4;CD300A;TNFRSF13B
prerank,receptor recycling (GO:0001881),0.5711686259829676,1.1721010080022414,0.297554347826087,0.5854413013513445,1.0,2/10,4.82%,NSG1;SORL1
prerank,positive regulation of catalytic activity (GO:0043085),0.44707100804797567,1.1716593641084938,0.2572759022118743,0.586185731969564,1.0,11/37,18.77%,MT3;SOD1;MAPK3;YWHAB;MID1IP1;PSENEN;B3GAT3;IGF2;CAV1;PSEN2;STX4
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.48034864742062744,1.1716062884240113,0.26348039215686275,0.5858932062652914,1.0,7/27,19.38%,CD74;MIF;PTTG1IP;MSX1;PMAIP1;TWIST1;HIC1
prerank,placenta development (GO:0001890),0.5501992252111482,1.1711793959560546,0.29298486932599727,0.5865824974551116,1.0,2/12,4.35%,SOD1;ANG
prerank,inhibitory synapse assembly (GO:1904862),0.5654430911404241,1.1711637349920483,0.27694406548431105,0.586176194783711,1.0,5/11,16.30%,GABRA2;WNT5A;GABRB3;FGF13;GABRB2
prerank,regulation of wound healing (GO:0061041),0.4481503860565911,1.1704880578164225,0.26136363636363635,0.5876097149325515,1.0,12/42,20.13%,ACTG1;VTN;TNFAIP3;CADM4;EPPK1;HRAS;F2RL1;DMTN;CAV1;PLAU;TNFRSF12A;FOXA2
prerank,regulation of cholesterol storage (GO:0010885),0.5300060615470378,1.1701040495871677,0.2853437094682231,0.5881741858440399,1.0,6/15,15.47%,TREM2;ABCG1;LPL;MSR1;EHD1;NR1H2
prerank,anterior/posterior axis specification (GO:0009948),-0.4206062614509324,-1.170076186217489,0.23706896551724138,0.6310737745439045,1.0,3/15,8.57%,WLS;SKI;TASOR
prerank,blood vessel morphogenesis (GO:0048514),0.43344095929482596,1.1699374036657526,0.2530795072788354,0.5881650365954971,1.0,17/54,17.99%,RAMP2;SOX18;ID1;RASIP1;APLNR;LOX;HES1;PROX1;COL4A1;KDR;SOX17;FLT4;SLC1A1;EGFL7;FLT1;CAV1;SYK
prerank,hippo signaling (GO:0035329),-0.36747489798669425,-1.1690601836035435,0.2192513368983957,0.6313960650785623,1.0,7/26,13.23%,TEAD1;STK3;YAP1;TEAD2;LATS2;SAV1;CASP3
prerank,metal ion homeostasis (GO:0055065),0.45793259118145546,1.1690174805834848,0.2552204176334107,0.5901697830479159,1.0,12/40,19.55%,MT3;ANK3;TMTC2;GRIN1;SLC12A5;WFS1;SLC8A1;KCNA1;CAV1;SELENON;SNCA;TFAP2B
prerank,chromosome organization (GO:0051276),0.4092237556977095,1.1689398537324622,0.19833852544132918,0.5899321515438338,1.0,19/99,14.77%,RPS27A;UBC;UBB;H3-3A;HDAC11;COPS7A;COPS6;PARP1;NUCKS1;HMGN1;UBA52;RBX1;DDB1;SUPT4H1;ZBTB7A;FAM50A;HDAC5;COPS8;L3MBTL1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5340823185054413,1.1687328597506312,0.29172141918528255,0.590021741004635,1.0,9/15,27.37%,ARL6IP1;RTN4;REEP2;LNPK;RAB18;TMEM33;RTN3;ZFYVE27;REEP1
prerank,positive regulation of protein transport (GO:0051222),0.4302718306456114,1.1686923477546376,0.22497308934337998,0.5896957112974895,1.0,21/67,19.93%,PPIA;RACK1;OAZ1;TREM2;TNF;ANG;PRR5L;ABCG1;VAMP2;ARF6;ATP13A2;APBB1;CEP131;VPS28;B3GAT3;IER3IP1;ACHE;DNM1L;ACSL3;TGFB1;OAZ2
prerank,DNA duplex unwinding (GO:0032508),0.4404208693802215,1.1685129328028439,0.24266365688487584,0.5897128197993345,1.0,8/50,12.09%,RPS27A;UBC;UBB;PARP1;UBA52;RBX1;DDB1;DDX11
prerank,ear morphogenesis (GO:0042471),-0.39337696161505964,-1.1684809172117347,0.2644230769230769,0.630650821902327,1.0,5/20,13.03%,NIPBL;FGFR2;EPHB2;ZIC1;SIX1
prerank,autophagosome assembly (GO:0000045),0.4381562434543494,1.1684540647402646,0.23542354235423543,0.5894437221728721,1.0,7/52,5.66%,GABARAP;MAP1LC3B;MAP1LC3A;EMC6;GABARAPL2;GABARAPL1;ATG9A
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.265713273761736,-1.1683651715204066,0.047619047619047616,0.6287216643234749,1.0,45/138,18.69%,TEAD1;NOTCH2;NR3C2;RARB;CREBBP;MAML2;NR6A1;MNAT1;THRB;TAF15;YAP1;PPARA;RARG;NCOR1;KAT2B;TBL1X;NR1D2;MAML1;TBL1XR1;TEAD2;PPARG;ESR1;NR2C2;MED26;GTF2E2;RBPJ;TAF2;AR;POLR2A;NR2F1;RORA;GTF2H4;POLR2B;CDK7;POLR2J;GTF2A2;ESRRA;NR3C1;TAF8;ERCC3;TAF7;TAF4B;NR5A2;GTF2H2;MED23
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4392410581364978,1.1676261717384058,0.24608501118568232,0.5912366236520689,1.0,19/48,29.43%,PDE4B;SLC7A5;ISG15;HSPD1;SLC11A1;LILRB1;F2RL1;RASGRP1;CCR2;CD14;PYCARD;IL12RB1;CD276;TLR7;CEBPG;IL12RB2;ZFPM1;FZD5;TXK
prerank,polyol biosynthetic process (GO:0046173),-0.4100351615681844,-1.167144594207909,0.2597402597402597,0.6298918482402319,1.0,6/16,19.26%,ITPKB;ACER3;IP6K2;PPIP5K1;CYP27A1;FGF2
prerank,cation transmembrane transport (GO:0098655),0.44775651558428864,1.1668860401029681,0.24604966139954854,0.5927646827002434,1.0,11/44,15.78%,SLC38A5;ASIC2;SLC7A5;SLC25A29;SLC6A5;ATP13A2;SLC3A2;TRPM2;ABCC8;ATP1B1;SLC25A19
prerank,ERBB2 signaling pathway (GO:0038128),0.4650133169925916,1.1668199219706281,0.269185360094451,0.5924680578049625,1.0,14/31,27.01%,HSP90AA1;NRG1;ERBB4;MATK;PTK6;CDC37;PTPRR;ERBIN;ERBB3;SOS1;STUB1;PRKCA;CPNE3;MYOC
prerank,regulation of protein modification process (GO:0031399),0.43452123253137565,1.1666000767502414,0.2412280701754386,0.5925862114380915,1.0,16/50,18.99%,HSPB1;MT3;PPIB;GRM5;PIN1;FN1;CORO1C;CADM4;WARS1;CCDC88A;IGF2;ABCA2;ASPSCR1;CDH5;NOP53;CCAR2
prerank,regulation of dendrite development (GO:0050773),0.45383930219257074,1.1662491801782142,0.27314285714285713,0.5930717893517097,1.0,18/37,28.26%,DCC;ADGRB3;PACSIN1;CSMD3;CAMK1D;KNDC1;MFSD2A;LRP8;DAB2IP;BCL11A;NSMF;HECW1;CHRNA3;PTN;VLDLR;ALK;LZTS1;RAP2A
prerank,regulation of vasculogenesis (GO:2001212),0.5427906912924676,1.1661294229662074,0.28804347826086957,0.5929508030174271,1.0,5/14,15.74%,CD34;EMP2;KDR;RRAS;HEY1
prerank,cardiac muscle contraction (GO:0060048),0.4618402383676049,1.1660443851347062,0.2593023255813954,0.5927299630310137,1.0,9/34,19.17%,GSN;SCN4B;GAA;TNNI1;KCNE5;ATP1B1;SLC8A1;RYR2;GRK2
prerank,regulation of establishment of protein localization (GO:0070201),0.5367264132643083,1.1655794786267075,0.28888888888888886,0.5936053548088164,1.0,2/13,2.84%,CTSD;TREM2
prerank,integrated stress response signaling (GO:0140467),0.5344444449406194,1.1654039552597906,0.2897196261682243,0.5936311301066804,1.0,7/14,24.95%,HSPA5;ATF4;OMA1;CCL2;HERPUD1;DDIT3;EIF2S1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.44616712684557325,1.1652815225360396,0.2511415525114155,0.5935254986896102,1.0,9/41,13.55%,CD34;POMC;SIRPA;TNFAIP3;SYT11;VSIR;MC1R;LILRB1;GAS6
prerank,smooth muscle cell differentiation (GO:0051145),0.5613840406616106,1.165259814484275,0.3263888888888889,0.5931464892834435,1.0,5/12,20.07%,MRTFA;APLNR;HEY1;TMEM204;MEF2C
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.4082076562925275,1.165142491507578,0.2074688796680498,0.5930201317336575,1.0,40/104,27.26%,ACTB;CALM1;AKT1;CCNI;CALM3;CCND2;SERTAD1;CCND1;THY1;CDK5R1;CAMK1;PIH1D1;CSF1R;CDC37;CCNG1;RHOA;CDK5R2;SLC8A1;DAB2IP;CCNJL;CDC25A;MAP2K2;CALM2;SNCA;PYCARD;GADD45A;RALB;BLM;INCENP;TESK1;CCNA2;CDKN2B;CCNG2;HGS;TRIB1;TRIB3;SNF8;CCNH;CDKN1A;CNPPD1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.4139436917900272,1.1648696909893825,0.23020063357972545,0.5932739966954838,1.0,18/80,16.42%,UBB;RPS2;LAPTM5;PINK1;FKBP1A;PIN1;FAM107A;CENPX;PTTG1IP;RBX1;PDCD6;WFS1;NSMCE3;FBXW7;RIPK2;HSPBP1;ARRDC3;CAV1
prerank,stress granule assembly (GO:0034063),0.5051725067809911,1.164841767264765,0.2853470437017995,0.5928974962446412,1.0,7/20,15.81%,RPS23;MAPT;ATXN2L;CSDE1;G3BP1;CIRBP;YTHDF1
prerank,positive regulation of protein processing (GO:0010954),0.5022787966383371,1.1646929857780017,0.3033854166666667,0.5928600788712189,1.0,3/19,8.76%,GSN;ENO1;CLEC3B
prerank,regulation of neuron projection development (GO:0010975),0.39750359962439796,1.1646524276970966,0.16885743174924167,0.5925275604588969,1.0,29/163,10.03%,APOE;ITM2C;MDK;MT3;CFL1;DCC;AKT1;CTNNA2;NTRK2;CSMD3;S100A9;CAMK1D;NDRG4;KNDC1;SPOCK1;LRRC4C;TENM3;LTK;BAG5;CRMP1;ATP1B2;PTK6;PAK1;IL1RAPL1;PPFIA2;MFSD2A;CDK5R1;CAMK1;PAK3
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.5408537900416039,1.1644476403476423,0.3032345013477089,0.5926540058697053,1.0,5/14,14.67%,AK4;AK3;PNP;NME2;CMPK2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5406224281979897,1.1636735111484884,0.29918032786885246,0.5942924950468281,1.0,5/11,27.61%,YWHAE;ATP1A1;ATP1B1;KCNJ3;KCNQ1
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3044907011311568,-1.1635441499171681,0.16483516483516483,0.6371640523011253,1.0,15/56,10.73%,EGFR;FER;ABL1;EPHA3;EPHA4;EFEMP1;INSR;DYRK1A;FGFR2;PDGFRB;ABI1;ABL2;TPST1;PTK2;EPHB2
prerank,positive regulation of secretion by cell (GO:1903532),0.42484632129670535,1.163359184153781,0.2276595744680851,0.594711190802607,1.0,24/70,22.12%,PPIA;TREM2;GPER1;ANG;ATP6AP1;ABCG1;CLASP1;ARF6;CADPS;ATP13A2;APBB1;BMP2;IER3IP1;ACHE;DNM1L;NMB;EDN3;SOX11;SNCA;GRK2;TGFB1;TMED10;STX1B;RAB27B
prerank,negative regulation of translation (GO:0017148),0.41702776056499213,1.1630402134022293,0.21548117154811716,0.5951285304318937,1.0,9/87,4.59%,MRPL13;RPS3;RACK1;GAPDH;RPL13A;CALR;IGFBP5;NCL;MEX3D
prerank,positive regulation of collagen metabolic process (GO:0010714),0.5137817175562718,1.16296446399927,0.3171052631578947,0.5948909066873539,1.0,2/17,8.66%,VIM;VSIR
prerank,blood circulation (GO:0008015),0.4270588216109832,1.162242941772444,0.25054945054945055,0.5963693542500845,1.0,9/49,9.66%,GPX1;CXCL12;SOD1;SGCZ;CYB5R3;ACVRL1;CXCL10;PLN;SERPING1
prerank,membrane depolarization (GO:0051899),0.4581471373228771,1.1610626199029705,0.29071170084439085,0.5991101566693569,1.0,14/32,26.72%,SCN1A;YWHAH;ATP5IF1;CACNA1A;P2RX7;CHRNA4;CAV1;SCN9A;CACNB4;CACNA1E;CACNG2;CACNA1B;SCN8A;SCN2A
prerank,regulation of interleukin-12 production (GO:0032655),0.4326532849118983,1.1608556153594296,0.25934314835787087,0.599239009239681,1.0,10/47,15.22%,MDK;LAPTM5;CCL19;TIRAP;HSPD1;LILRA5;HMGB1;LILRB1;RIPK2;MAPK11
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4514994493411127,1.1602461357210234,0.2588369441277081,0.6004300601774429,1.0,9/38,20.17%,GPX1;HMOX1;LGALS3;TNFAIP3;FAIM2;PMAIP1;TMBIM1;STX4;SFRP1
prerank,extracellular matrix organization (GO:0030198),0.38831263530290444,1.1602151469560789,0.124,0.6000697194076833,1.0,45/276,9.85%,BSG;SPARC;GSN;VTN;CTSL;BGN;SPP1;COL1A1;CAPNS1;CD151;PPIB;CTSS;BCAN;LAMC1;LAMB2;TMPRSS6;TIMP2;SERPINH1;A2M;SPOCK2;LUM;ITGB2;ADAM15;PDGFB;PLEC;FLOT1;ADAMTS4;GPM6B;ADAM12;LOX;FN1;TTR;MMP21;TNR;APLP1;P4HB;COL6A1;COL4A1;KDR;COL3A1;LCP1;TIMP1;LAMC2;DCN;COL9A1
prerank,negative regulation of transmembrane transport (GO:0034763),0.571879000846835,1.1598569421268723,0.31339031339031337,0.6005729081123337,1.0,2/10,12.48%,AKT1;RSC1A1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5364268834354242,1.159808202378515,0.2968536251709986,0.6002636817387208,1.0,3/12,13.02%,MAPK3;CSF1R;BST2
prerank,negative regulation of cell migration (GO:0030336),0.3933404182144061,1.159612810860955,0.20795107033639143,0.6003441671699528,1.0,27/137,9.80%,CD74;CLDN5;IFITM1;CALR;HMOX1;RHOB;IGFBP3;ADAM15;RAC1;ACVRL1;IGFBP5;DNAI3;MIF;NDRG4;DUSP3;HYAL2;ARHGDIB;ADORA3;ADGRG1;CORO1C;ATP1B2;NAV3;CLASP1;THY1;COL3A1;TIMP1;EPPK1
prerank,negative regulation of angiogenesis (GO:0016525),0.4149224007537912,1.1592222710604145,0.23142250530785563,0.6009139883311823,1.0,23/84,18.30%,SPARC;CLDN5;KLF2;SERPINF1;TNF;CTNNB1;PDE3B;PGK1;VASH1;CXCL10;EPN1;SARS1;DCN;ADGRB1;ECSCR;STAB1;KLF4;PF4;DAB2IP;AMOT;AGO1;ADAMTS1;CCR2
prerank,vasculogenesis (GO:0001570),0.4624672298796098,1.1591717474320307,0.27837514934289126,0.6005994185739788,1.0,10/32,19.83%,RAMP2;SOX18;RASIP1;APLNR;KDR;SOX17;EGFL7;CAV1;NOTCH1;TGFB1
prerank,regulation of chromatin organization (GO:1902275),-0.4137700701060764,-1.159163890018895,0.245136186770428,0.6462491796522755,1.0,5/14,11.57%,MLLT3;SETD5;TLK2;TLK1;PARG
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5452454253429541,1.1585429654749286,0.2917251051893408,0.6018792777119992,1.0,2/11,5.80%,AUP1;VCP
prerank,negative regulation of transport (GO:0051051),0.4337540823287897,1.1571340888815118,0.24698133918770582,0.6052996962647326,1.0,15/51,21.84%,RACK1;NRG1;CRYAB;LGALS3;SIRPA;SYT11;RSC1A1;BST2;LILRB1;NR1H2;SNX33;ERBB3;SNCA;TRAT1;PPM1F
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.5509392809430346,1.1568905920136288,0.292749658002736,0.605515267775712,1.0,6/12,22.05%,CLTC;PF4;TMEFF2;TGFB1;SELENOS;AP2A1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.43956870307564555,1.1568542573800114,0.2633371169125993,0.6051751703685891,1.0,9/43,13.55%,CD34;POMC;SIRPA;TNFAIP3;SYT11;VSIR;MC1R;LILRB1;GAS6
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.334430558798851,-1.1567870364991508,0.24603174603174602,0.6500965716853161,1.0,9/34,14.03%,NSMCE2;LRP5;ANAPC5;INSR;ANAPC7;IGF1;PDGFRB;PHIP;CDC27
prerank,regulation of gastrulation (GO:0010470),0.5292473493438336,1.1565597515137245,0.3100137174211248,0.605551022099512,1.0,4/14,11.04%,RACK1;OTX2;CLASP1;TENM4
prerank,regulation of small molecule metabolic process (GO:0062012),0.46478165479213474,1.1563388397389698,0.28894173602853745,0.6056839365413093,1.0,2/28,1.95%,APOE;ACADVL
prerank,dendritic spine organization (GO:0097061),0.4717729336780498,1.1563305923660512,0.2893157262905162,0.6052582251371341,1.0,8/26,18.74%,LGMN;PRNP;TREM2;PAK3;DOCK10;ARF1;EPHB1;CTNND2
prerank,regulation of coagulation (GO:0050818),0.5585706791255111,1.1562088046110182,0.32226832641770403,0.6051433915701373,1.0,5/11,20.13%,HS3ST5;PROCR;F2RL1;CAV1;FOXA2
prerank,actin crosslink formation (GO:0051764),-0.4372985480095892,-1.1561421429227723,0.26181818181818184,0.6495646465483699,1.0,4/12,4.65%,DPYSL3;BAIAP2L1;BAIAP2;EPS8
prerank,regulation of kinase activity (GO:0043549),0.4143014803731451,1.156026669416774,0.24156118143459915,0.6051858902455832,1.0,22/89,18.23%,EEF1A1;CD74;SOD1;TREM2;ERBB4;EMP2;NTRK2;LTK;CDKN1C;MUSK;KDR;MAPT;EPHA5;CSF1R;FLT4;TIE1;HNRNPU;EPHB1;FLT1;TYRO3;DDR2;ERBB3
prerank,negative regulation of chemotaxis (GO:0050922),0.46129715420554945,1.1558348559860778,0.30552291421856637,0.6052412341348814,1.0,9/31,15.46%,SEMA3F;SEMA7A;DUSP3;SEMA4C;SEMA6D;SEMA4A;AIF1;SEMA4G;ROBO2
prerank,regulation of inclusion body assembly (GO:0090083),0.5632966668196856,1.155781535065829,0.3080110497237569,0.6049339073828722,1.0,8/11,20.70%,HSPA1B;BAG5;DNAJB2;HSPA1A;SACS;DNAJB1;DNAJA4;HSPA2
prerank,chromatin assembly or disassembly (GO:0006333),-0.4516147017801879,-1.1557226424712885,0.2690909090909091,0.6485948333426663,1.0,4/11,16.27%,HDAC8;NOC2L;CDAN1;TP53
prerank,response to muscle stretch (GO:0035994),0.5340810407961871,1.1556303587320658,0.3041095890410959,0.6048905403550686,1.0,4/15,15.89%,GSN;CTNNB1;SLC8A1;RYR2
prerank,pore complex assembly (GO:0046931),-0.3868153913004477,-1.1543822975796236,0.24050632911392406,0.650108430730448,1.0,6/19,11.24%,AFDN;ANO6;NUP98;PLEKHA7;AHCTF1;PDZD11
prerank,cellular lipid catabolic process (GO:0044242),0.4742247264218075,1.1542869088574161,0.28983688833124216,0.6079726448603883,1.0,12/27,32.49%,MT3;NUDT19;LIPG;ENPP2;PLBD2;FAAH;SIRT2;ABHD12;AOAH;PLBD1;CEL;ACOX1
prerank,oxoacid metabolic process (GO:0043436),0.4638066961799745,1.154019706851352,0.27163461538461536,0.6082817442682895,1.0,5/27,8.82%,AGXT;MIF;SULT4A1;BPNT2;GRHPR
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3858957604684351,1.1536857110107075,0.10810810810810811,0.6087211374012471,1.0,92/348,20.03%,PPIA;CD74;RACK1;CALM1;VTN;CD81;HSP90AA1;HSP90AB1;GPNMB;MT3;PARK7;C3;MAPK3;AKT1;CCL19;TXN;PRNP;CALM3;CCND2;TREM2;ERBB4;IL5;PINK1;AGT;CSNK2B;GPER1;TNF;PDGFB;PTPRC;HCLS1;RAC1;ACVRL1;NTRK2;PIN1;MIF;FLOT1;KNDC1;APLNR;RARRES2;MUSK;TFRC;LEFTY2;CCND1;CLEC6A;ENPP2;PAK1;KDR;P2RY1;CAMK1;CSF1R;PECAM1;IL11;RAMP3;FLT4;HRAS;TMEM119;SH2D3C;SOX9;NEK10;BMP2;RIPK2;GAS6;LEFTY1;CLIP3;CX3CR1;SDCBP;MMD2;GDF15;IGF2;PDGFA;LRP8;RASGRP1;MAPRE3;CAV1;PFN2;LCP2;ADCYAP1;ADAM17;CAMKK1;AGAP2;DDR2;TERF2IP;CALM2;SNCA;DDRGK1;INHBA;IL6;HGF;EFNA1;ERP29;TGFB1;THPO
prerank,regulation of lamellipodium assembly (GO:0010591),-0.350642313270998,-1.1534719389557226,0.21678321678321677,0.6502455714152352,1.0,5/34,6.44%,AUTS2;PLCE1;FER;SLIT2;NCKAP1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4668332325956427,1.15334075076861,0.28502994011976046,0.6092105750463189,1.0,7/28,16.24%,GABARAP;TNF;SPI1;BAX;TNFRSF1A;SORT1;DAB2IP
prerank,positive regulation of innate immune response (GO:0045089),0.46011356329735986,1.1531846366831027,0.30917874396135264,0.6091820627895862,1.0,4/30,11.12%,RPS19;SPI1;SLC15A4;WNT5A
prerank,sulfur amino acid catabolic process (GO:0000098),0.5819869103506277,1.1531513720077087,0.32577903682719545,0.6088277975635923,1.0,4/10,24.29%,MPST;TXN2;TST;ADO
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.544118216753894,1.152984529640325,0.3118279569892473,0.608798895366073,1.0,6/13,19.67%,MDK;ITGB2;TNF;RHOA;FUT9;IL6
prerank,long-chain fatty acid metabolic process (GO:0001676),0.42473407092368165,1.1527423894430857,0.24812030075187969,0.6090376927630369,1.0,17/64,23.48%,GPX4;GPX1;SCP2;FADS1;ELOVL1;ELOVL2;HSD17B4;GSTM2;ACOT1;ACOT4;FAAH;LTC4S;ACSL3;ASAH2;CYP2E1;ELOVL6;ACSL4
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.29140767215317565,-1.152712447184841,0.15789473684210525,0.650292819254099,1.0,15/53,13.69%,EYA2;EGFR;EYA1;BABAM2;PLA2R1;UIMC1;RNF8;EYA4;FBH1;FXR2;EYA3;ATM;ERCC8;SIRT1;BCLAF1
prerank,negative regulation of complement activation (GO:0045916),0.5633075813603917,1.1525894162470463,0.312874251497006,0.6089980092263977,1.0,2/10,9.66%,A2M;SERPING1
prerank,regulation of cell migration (GO:0030334),0.3837702160148687,1.1523664781142648,0.092,0.6091844222500143,1.0,99/382,20.17%,TMSB4X;ACTG1;CD74;TMSB10;RACK1;CLDN5;IFITM1;MDK;GRN;COL1A1;GPNMB;CD151;CXCL12;RHOB;HSPA5;AKT1;SERPINE2;ERBB4;CTNNA2;ADAM15;GPER1;RHOC;SEMA3F;PDGFB;RAC1;ACVRL1;IGFBP5;DNAI3;SEMA7A;SORL1;MIF;DUSP3;PRR5L;FLNA;SEMA4C;MYADM;FRMD5;FAM107A;ADORA3;CORO1C;CXCL16;SEMA6D;NAV3;ENPP2;SGK1;PAK1;PODXL;ROBO4;THY1;KDR;VSIR;LGR6;LAMC2;EPPK1;SEMA4A;CSF1R;DOCK10;PECAM1;ELP3;HRAS;AIF1;BST2;RHOA;SRCIN1;SEMA4G;BMP2;CTSH;SDCBP;TIAM1;F2RL1;IGSF10;SLURP1;PDGFA;DLC1;FLT1;CCL3;CAV1;AMOT;PLAU;CDH5;CASS4;PIK3CD;TRIM32;LMNA;F10;MMP14;ADAM17;TMEFF2;MAZ;STX4;PPP3CA;DDRGK1;NOTCH1;HGF;MAPK15;TGFB1;CITED2;OSGIN1;SFRP1
prerank,regulation of stem cell proliferation (GO:0072091),0.505859405732685,1.1517915029970132,0.30708661417322836,0.6102669528795162,1.0,5/17,18.98%,PTPRC;ZFP36L1;GJA1;HNRNPU;SOX11
prerank,sensory perception of sound (GO:0007605),0.4074176819257621,1.1515912359236942,0.23221757322175732,0.6103918358270491,1.0,19/88,13.56%,COL1A1;TIMM8B;TIMM13;SOD1;HOMER2;LHFPL3;LHFPL4;PCDH15;MYO3A;GRM7;SLC26A4;MYO7B;NDUFB9;GRAP;WFS1;TPRN;PAX3;CRYM;PJVK
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.45686476570259293,1.151460824714429,0.26913875598086123,0.6103002132704102,1.0,4/33,7.85%,CALR;H3-3A;PARK7;PKN1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4068345666248922,1.1506426153126843,0.25157232704402516,0.6120507371463589,1.0,19/85,13.56%,COL1A1;TIMM8B;TIMM13;SOD1;HOMER2;LHFPL3;LHFPL4;PCDH15;MYO3A;GRM7;SLC26A4;MYO7B;NDUFB9;GRAP;WFS1;TPRN;PAX3;CRYM;PJVK
prerank,regulation of translational initiation (GO:0006446),0.4199748313396153,1.149912755165321,0.26492942453854507,0.6135529560411217,1.0,12/63,10.28%,HSPB1;EIF1;ATF4;EIF4G2;POLR2D;NPM1;EIF1B;PPP1R15B;UHMK1;CEBPB;MIF4GD;POLR2G
prerank,spinal cord development (GO:0021510),-0.4264896897699248,-1.1497678259221342,0.2695035460992908,0.6562368921335793,1.0,6/12,19.40%,GLI2;VIT;LOXL3;PKD1;NF1;PKD2
prerank,regulation of protein kinase A signaling (GO:0010738),0.4838757057962854,1.149657559218802,0.3083645443196005,0.6138293619114173,1.0,6/20,11.35%,AKAP6;MIF;PRKAR1A;MC1R;PRKAR1B;RAMP3
prerank,hyaluronan catabolic process (GO:0030214),0.5028635986288879,1.1496407915617508,0.3026315789473684,0.6134307046782697,1.0,4/18,8.34%,HEXB;HEXA;HYAL2;GUSB
prerank,protein transport (GO:0015031),0.38466336040826304,1.1494335177408355,0.122,0.6135753554438693,1.0,94/332,22.85%,APOE;CD74;CLU;RAMP2;ATP6V0C;LAPTM5;SNX17;RCN3;ATP6V1F;NPM1;ANK3;LRP1B;TXNIP;CANX;OLFM2;ARF5;HSP90B1;YWHAH;ATP6V1G1;ATP6AP1;ATP6V0E2;ABCG1;CHMP2B;TFRC;TMED7;RD3;ARRDC1;SAR1A;RAB14;RAB15;SCAMP3;TMED2;ARL11;CLTC;RAB3C;SCG5;VAMP2;ARF6;TICAM2;TMED3;RAB3D;ARL4C;TMED9;PDCD6;ATP6V0D2;RAMP3;PPY;CTSA;CMTM6;SGSM1;ARL4D;ARL1;TMED1;SYNDIG1;VMP1;SCAMP2;ARF1;EHD1;TBC1D22B;TVP23A;ARRDC3;UNC93B1;RAB26;GOLGA7;ARF4;CHMP1B;RAB20;NAPA;SNX33;TBC1D9;RAB5C;LAMP2;PREPL;STX4;SYS1;RAB18;PDIA4;RAB31;UNC119;TBC1D10C;ERP29;CTTN;RAB6B;IFT27;TMED10;COPB2;SCG2;COPG1;AP2A1;ATP6V1A;STX1B;RAB28;ATP6V0A1;EVI5L
prerank,DNA biosynthetic process (GO:0071897),0.5169645107884638,1.1483344104684383,0.3165374677002584,0.6160826196472868,1.0,1/16,0.39%,PPIA
prerank,positive regulation of protein catabolic process (GO:0045732),0.40957584380881773,1.148233592229475,0.23983315954118875,0.6159139424256285,1.0,18/84,16.94%,APOE;HSP90AA1;NDUFA13;OAZ1;TNF;SORL1;VCP;TNFAIP3;MSN;PTTG1IP;TNFSF12;DDB1;WNT5A;VPS28;EGLN2;DAB2IP;SNX33;TRIM32
prerank,regulation of cell projection organization (GO:0031344),0.542585397677617,1.14817892895726,0.3225806451612903,0.6156192901781837,1.0,3/13,8.69%,CCL19;TREM2;MFSD2A
prerank,sensory perception of pain (GO:0019233),0.48890218415625913,1.1480829853190655,0.2998745294855709,0.61543710103436,1.0,7/21,20.76%,PRDM12;P2RX7;KCNA2;CHRNA4;CCL2;CCR2;SCN9A
prerank,cellular response to catecholamine stimulus (GO:0071870),0.48334753360327987,1.148037067853345,0.2949194547707559,0.6151030866969427,1.0,6/23,7.25%,MAPK3;ATF4;PDE4B;TGM2;DRD5;APLP1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.4173984877484583,-1.148029187644698,0.27472527472527475,0.6584260551026186,1.0,11/15,30.75%,ANAPC1;ANAPC7;NEK6;HECW2;CDC27;CENPE;TPR;PLK1;RIOK2;UBE2C;CDC16
prerank,T cell activation (GO:0042110),0.4147419350554224,1.1476102782525412,0.2602591792656587,0.6157996366953796,1.0,15/69,16.91%,CD74;MDK;CCL19;PTPRC;FKBP1A;MSN;DDOST;HSPD1;IL2;LCP1;ICOSLG;F2RL1;RASGRP1;JAG2;PIK3CD
prerank,cGMP biosynthetic process (GO:0006182),0.5609774098309905,1.14633806081223,0.3256150506512301,0.6188083705890062,1.0,1/10,2.33%,NPPC
prerank,regulation of protein localization to nucleus (GO:1900180),0.43102233828161496,1.144972210035692,0.27671541057367827,0.6220094785074417,1.0,9/43,10.86%,PARK7;AKT1;LAMTOR5;ORMDL3;PIN1;TFRC;GLUL;ATP13A2;SUMO3
prerank,sodium ion homeostasis (GO:0055078),0.4962808937394142,1.1449496145105933,0.32459425717852686,0.6216134079112643,1.0,8/21,19.55%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;SLC8A1;ATP1B3;TFAP2B
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4132586597602276,1.1444532798700755,0.256136606189968,0.6224856550925976,1.0,20/70,27.02%,DBI;CHKB;CSNK2B;PLAAT3;ENPP2;MFSD2A;PLA2G7;PLA2G4F;CHAT;NR1H2;ACHE;SLC44A5;STARD10;LPCAT2;SLC44A2;PLA2G3;ABCA3;SLC44A1;PLA2G6;MBOAT7
prerank,negative regulation of ossification (GO:0030279),0.48674333691890426,1.1444400835123285,0.293398533007335,0.6220708836100034,1.0,9/23,20.17%,MDK;ECM1;LRP4;SRGN;SOX9;CCL3;NOTCH1;MEF2C;SFRP1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5029448383211382,1.1441667573622778,0.31218274111675126,0.6223397593813118,1.0,4/18,3.71%,PARK7;RFK;AGT;TNF
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5592109639221664,1.1441640080826345,0.3082287308228731,0.6218962882063991,1.0,7/11,25.53%,LEPROT;CAV1;VHL;ADIPOR1;SOCS3;PTPRT;HGS
prerank,detection of visible light (GO:0009584),0.5028637280344913,1.1440423901772745,0.3011734028683181,0.6217591609043359,1.0,3/16,15.93%,GNA11;REEP6;CNGB1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.383114981799414,1.1438423594424088,0.17017017017017017,0.6218270529221851,1.0,75/241,23.82%,HSPA8;PCBP1;SNRPG;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;POLR2F;RALY;SYF2;SNRPD2;LSM4;LSM8;LSM6;UBL5;SNRPE;PUF60;SNRPA;SNRPF;ZMAT2;SRSF9;PQBP1;XAB2;HNRNPA0;CD2BP2;PRPF19;RBM15B;YBX1;POLR2G;PRPF8;SRSF2;SF3A2;PABPC1;RBM4B;SNW1;SF3B2;POLR2K;HNRNPU;HNRNPA1;NONO;CPSF2;SNRPB;SF3A3;PDCD7;EIF4A3;PRPF31;SF3B6;TXNL4A;U2AF1L4;SNRPD3;LSM7;SF3A1;HNRNPA3;ALYREF;BUD31;SRSF1;CDC5L;CPSF4;POLR2H;SNRNP35;DHX35;HNRNPF;SNU13;SNRNP200;DHX38;HNRNPH2;SNRPB2;PPWD1;ELAVL1;PCBP2;LSM5
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5331644481317181,1.143571197813581,0.3128415300546448,0.6221030148337672,1.0,6/13,27.79%,UBE2G2;SVIP;BCAP31;BRSK2;OS9;UBE2J1
prerank,protein secretion (GO:0009306),0.4215855859828257,1.143491497557119,0.2735229759299781,0.6218557431503171,1.0,20/56,23.99%,PARK7;RCN3;PTPRN;CANX;OLFM2;RIMS2;RAB15;RAB3C;RAB3D;PPY;ARL4D;MAFA;TVP23A;ADCYAP1;PDIA4;PORCN;SCG2;COPG1;CAMK2G;MTTP
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3982442971718593,1.143365975678348,0.23681489141675285,0.6217350822678733,1.0,25/122,16.13%,RPL26;RPS4X;RPL5;EEF2;VIM;AKT1;CCL19;EIF3D;NPM1;RPS27L;PDGFB;EIF3C;NAMPT;KDR;PCIF1;PCNA;ZCCHC4;KLF4;PRMT1;CCL2;ABCB10;IGF2;CIRBP;YTHDF1;EIF4A3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4277578919713353,-1.1432147246716964,0.2783882783882784,0.6693172187781958,1.0,6/13,10.33%,TNRC6B;TNRC6A;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.436945898165806,-1.1431545777457333,0.2892857142857143,0.6672238842999737,1.0,5/12,17.82%,NIN;NINL;PCM1;CCDC120;CEP19
prerank,protein N-linked glycosylation (GO:0006487),0.41146022269919125,1.14283370427296,0.25775401069518716,0.6226852561697817,1.0,20/66,18.84%,OST4;KRTCAP2;TMEM258;RPN1;RPN2;DAD1;DDOST;LMAN1;PMM1;GAL3ST1;MGAT2;DPM3;MPDU1;MOGS;MCFD2;ASGR2;ALG3;DPM2;MAGT1;STT3A
prerank,regulation of developmental growth (GO:0048638),0.46175712190767204,1.1425544149638087,0.30097087378640774,0.6229841906922012,1.0,6/29,9.80%,APOE;SOD1;MUSK;NRCAM;MFSD2A;EPPK1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.40078189963151956,1.1424997278626892,0.2563291139240506,0.6226840967576606,1.0,21/94,17.72%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;TUBA4A;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;TCTN3;DCTN1;SSNA1;HAUS2;DCTN2;CETN2;PRKAR2B;TCTN1
prerank,intracellular cholesterol transport (GO:0032367),0.5209167787740051,1.1424624711914506,0.3173076923076923,0.6223315707647599,1.0,4/15,9.19%,NPC2;ABCG1;TSPO2;STARD4
prerank,transcription by RNA polymerase I (GO:0006360),0.45093022717024056,1.1422741620505688,0.28255813953488373,0.6223785083465274,1.0,15/34,27.24%,CAVIN1;POLR2E;MAPK3;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;ERCC2;CCNH;POLR1F
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.46624481872454926,1.1420022455149905,0.30317848410757947,0.6226636108935247,1.0,6/26,13.00%,EEF1A1;ZFP36L1;ZFP36L2;DUSP3;ZFP36;SOX9
prerank,negative regulation of T cell differentiation (GO:0045581),0.5483129721281985,1.142000823690648,0.3108882521489971,0.6222237095776025,1.0,3/10,13.99%,MDK;CTLA4;ZC3H8
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.43712676766401987,1.1419726672277628,0.27986348122866894,0.6218440826287888,1.0,15/46,23.06%,GPER1;PTPRC;PIN1;DUSP3;SIRPA;DUSP26;CAMK2N1;PTPRR;TIMP3;CNKSR3;SPRY1;DAB2IP;SPRY3;TNIP1;PTPN1
prerank,regulation of dephosphorylation (GO:0035303),-0.4064437023374366,-1.1418470144728479,0.2631578947368421,0.668540220302586,1.0,4/15,11.65%,SMG6;MTMR3;SMG7;PPP1R16A
prerank,histone H4-K8 acetylation (GO:0043982),-0.40554567504434325,-1.1415721535882475,0.28512396694214875,0.6648842113842109,1.0,5/15,18.15%,OGT;KAT7;KANSL3;JADE2;KAT8
prerank,histone H4-K5 acetylation (GO:0043981),-0.40554567504434325,-1.1415721535882475,0.28512396694214875,0.6648842113842109,1.0,5/15,18.15%,OGT;KAT7;KANSL3;JADE2;KAT8
prerank,lipid translocation (GO:0034204),0.48904531994964384,1.1411989650474368,0.29949874686716793,0.6234638051222754,1.0,6/21,18.29%,TMEM30A;ATP8B4;ATP8A2;ATP8A1;ATP11B;RFT1
prerank,rRNA modification (GO:0000154),0.4923792714834908,1.140561219309576,0.32375,0.6247702529780055,1.0,9/21,24.44%,TRMT112;NOP10;FBL;NHP2;ZCCHC4;GAR1;DKC1;FTSJ3;THUMPD1
prerank,microtubule nucleation (GO:0007020),-0.3800528546173256,-1.1405193165547467,0.2822966507177033,0.6654084212271286,1.0,10/19,27.27%,AKAP9;GOLGA2;CCDC57;TUBGCP6;NDEL1;TUBGCP5;TPX2;TUBG1;SLAIN2;TUBG2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5366331835100133,1.140446997700709,0.31966053748231965,0.6246214704374071,1.0,2/12,2.21%,CALR;KLF2
prerank,glycolipid biosynthetic process (GO:0009247),-0.3183496691174953,-1.1399112718237545,0.21008403361344538,0.6647885692090966,1.0,17/38,19.97%,LARGE1;ST3GAL4;A4GALT;PGAP2;PIGM;ST3GAL5;PIGN;ST3GAL2;GBGT1;PGAP3;DPM1;PIGO;PIGF;PIGW;PIGL;PIGU;ST6GALNAC5
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.5029512495373776,1.1393701211002334,0.32665832290362956,0.6270905605064503,1.0,6/18,20.51%,FTH1;DAB2IP;TRIM32;CD300A;SFRP1;MYC
prerank,positive regulation of lipid localization (GO:1905954),0.5432368898109903,1.138970807338303,0.33146853146853145,0.6277786389816653,1.0,2/11,8.93%,C3;LPL
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3904862940421649,1.1387914657334273,0.22313203684749233,0.627842123066926,1.0,36/136,21.72%,TMSB4X;ID3;PRNP;ID1;SPI1;FLNA;HES1;SFRP5;TNFAIP3;ADORA3;HES6;PROX1;OTULIN;NUPR1;RBCK1;WFS1;KLF4;GAS6;FOXS1;NLRP2B;SFRP4;ERBIN;TRAF3;SIGIRR;ARRB2;DAB2IP;TCEAL7;GLIS2;COMMD7;NLRP3;FOXA2;NFKBIA;PYCARD;ID2;DDIT3;MEN1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5428853153461943,1.138771796180875,0.3076923076923077,0.6274341687661616,1.0,5/11,21.36%,RAC1;PAK1;STMN1;HGF;SIRT2
prerank,negative regulation of cell population proliferation (GO:0008285),0.3807035502615384,1.138532695765454,0.12,0.627655731278298,1.0,99/351,22.42%,FTH1;IGFBP6;B2M;APOD;IFITM1;GPNMB;HMOX1;S100A11;NME1;TREM2;RBP4;ERBB4;NPM1;IGFBP3;CSNK2B;GPER1;MAGED1;ACVRL1;IGFBP5;ANG;HSPA1B;NDRG4;CTNNB1;ST18;HES1;SFRP5;TNFAIP3;CDKN1C;BTG1;ADORA3;SSTR4;ADGRG1;ATP8A2;NELL1;PAK1;CEBPA;PROX1;NUPR1;GATA2;CGREF1;EPPK1;ADGRB1;ZBTB49;THAP12;CTBP1;WNT5A;ATF5;ATRAID;WARS1;HRAS;DNAJB2;CAMK2N1;AIF1;KLF4;SOX9;HSPA1A;DDAH1;BMP2;TNN;SFRP4;STK11;COPS8;SLURP1;DLC1;DLL1;ADRA1A;DAB2IP;VHL;TRIM32;LMNA;PTGIR;PDCD5;SCIN;CD300A;ADAMTS1;FABP7;BTG4;SOX11;INHBA;TFAP2B;NOTCH1;IL6;KLF11;TGFB1;ING5;SFRP1;TFAP4;MYC;PTPN6;SST;PTPRU;SIRT2;RERG;CCN3;MEN1;SSTR2;REST;TMEM127;CD164
prerank,positive regulation of cell adhesion (GO:0045785),0.40393113195656816,1.1382025658478252,0.27243928194297784,0.6281271357486429,1.0,20/74,20.01%,MDK;CXCL12;TGM2;TNF;PDGFB;RAC1;FRMD5;ADGRG1;P4HB;DUSP26;P2RY12;MAGI1;ARL2;EPB41L4B;TMEM102;FBLN2;SYK;STX4;PPP3CA;CITED2
prerank,synaptic vesicle exocytosis (GO:0016079),0.435949492850529,1.138135984481192,0.30320366132723114,0.6278713492158325,1.0,22/40,31.68%,SNAP25;DNAJC5;SYT1;RIMS2;RIMS1;VAMP2;SYT10;CDK5;SYT2;DOC2B;STX4;SNCA;STX1B;SYT5;UNC13A;STX3;PIP5K1C;CPLX1;PCLO;SNPH;SYT7;RAB3A
prerank,icosanoid biosynthetic process (GO:0046456),0.5537136710650311,1.137220588463959,0.31196581196581197,0.62993020542093,1.0,4/10,17.02%,FADS1;MGST3;ALOX5AP;LTC4S
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5565208449490261,1.1366283010838534,0.3232876712328767,0.6310852965005525,1.0,5/11,23.75%,PCBP1;PCBP4;IGF2BP3;ZNF445;PCBP2
prerank,positive regulation of cell growth (GO:0030307),0.39993983801926686,1.1365825695860527,0.25498426023084997,0.6307805447584429,1.0,40/96,26.70%,H3-3A;AKT1;AKAP6;EIF4G2;SEMA7A;S100A8;S100A9;SYT1;LGI1;RIMS2;CXCL16;RIMS1;DDX49;IL2;MFSD2A;MAPT;NTN1;DNPH1;SYT4;EXOSC2;SHTN1;SDCBP;CPNE5;CPNE6;SYT2;TRIM32;MMP14;ADAM17;EXOSC9;SFRP1;EXOSC4;SYT3;TWF2;UNC13A;RNF157;SYT17;ZFYVE27;TAF9B;PSMD10;TGFB2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5631520795871189,1.1359505956311355,0.3367496339677892,0.6320837896667839,1.0,6/10,32.36%,MID1IP1;MLXIPL;NR1H2;ABCD2;NR1H3;ELOVL5
prerank,pentose-phosphate shunt (GO:0006098),0.5369196585156425,1.1358182039260147,0.3389355742296919,0.6319962935460627,1.0,5/11,18.22%,TALDO1;PGLS;RPIA;PGD;TKT
prerank,negative regulation of gene expression (GO:0010629),0.3819643034022005,1.1357689283824044,0.146,0.6316901726407372,1.0,55/302,13.45%,APOE;MRPL13;RPS3;RPS13;RACK1;CLDN5;GAPDH;RPL13A;RPS26;CALR;H3-3A;GPNMB;PARK7;LGMN;CNPY2;TMBIM6;CD34;PINK1;SLC7A5;GPER1;TNF;PDGFB;ACVRL1;IGFBP5;NCL;SPI1;LSM6;MIF;HSPA1B;ZFP36L2;TLE5;SH3GL2;APLNR;MYADM;CREBZF;KDR;SYT11;MAPT;YBX1;GATA2;ZFP36;TARDBP;LRP3;RNH1;SRGN;PCIF1;HRAS;ATP2B1;MSR1;NCOR2;KLF4;SLC11A1;HSPA1A;FBXW7;BMP2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.43363622694051546,1.1356674566353033,0.2943820224719101,0.6315235887814495,1.0,15/45,23.81%,B2M;MT2A;HCK;FCGR1A;IRF8;IRF7;IFNGR1;VCAM1;NCAM1;OAS3;IFNGR2;IRF9;IRF5;TRIM68;CAMK2G
prerank,protein destabilization (GO:0031648),0.4542141208091724,1.1354777387062382,0.31559854897218864,0.6315619843831666,1.0,4/32,4.06%,SERF2;GSN;PRNP;NR1D1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.36422853221065077,-1.1353531105292023,0.27699530516431925,0.674613450958398,1.0,6/20,16.08%,CLK2;NCOR1;SIK1;C1QTNF3;CRY1;WNT4
prerank,sodium ion export across plasma membrane (GO:0036376),0.5325314519899615,1.1350123499017786,0.33972602739726027,0.6323763023245967,1.0,6/13,17.69%,ATP1A3;ATP1B2;ATP1A4;ATP1A1;ATP1B1;ATP1B3
prerank,negative regulation of heart contraction (GO:0045822),0.5393576436181947,1.134741075444001,0.3224043715846995,0.6326547417601166,1.0,5/11,19.17%,PLN;SPTBN4;SRI;FKBP1B;GRK2
prerank,import into cell (GO:0098657),0.4385303253118179,1.134672567984241,0.30192962542565266,0.6323813502317756,1.0,10/41,14.83%,SNAP25;TREM2;LRRC8A;SLC7A5;GLUL;TSPO2;SLC6A6;SLC29A1;SLC19A1;SLC29A2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.4532501768405042,1.1343103711459654,0.29759036144578316,0.6328990715960183,1.0,7/31,15.80%,ROMO1;DNLZ;HSPD1;TOMM40L;TIMM50;TOMM20L;PEX6
prerank,mitotic cytokinesis (GO:0000281),-0.29864382939252965,-1.1341458518484668,0.20634920634920634,0.6755997974898508,1.0,9/47,7.45%,ROCK2;SON;ROCK1;SPTBN1;PDCD6IP;TTC19;ARL3;MYH10;KLHDC8B
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3992119557396785,1.1340912230815854,0.2731048805815161,0.6330605560480447,1.0,22/92,14.50%,SPARC;GRN;CALR;RHOB;AKT1;AGT;RAC1;RTN4;EMC10;PFN1;ENPP2;PROX1;CLASP1;KDR;ARF6;PDCD6;WNT5A;AAMP;FLT4;SOX9;CTSH;RRAS
prerank,cellular response to amino acid starvation (GO:0034198),0.41087814677604634,1.133980012760967,0.2523860021208908,0.6329231497301262,1.0,10/71,7.08%,ATP6V0C;MAPK3;ATF4;ATP6V1F;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;ATP6V0E2;CEBPB
prerank,proteasomal protein catabolic process (GO:0010498),0.38593763210725357,1.1339675160112337,0.19779116465863453,0.6325113305632463,1.0,60/201,21.77%,PSMB4;UBXN1;PSME1;PSMB6;RCN3;PSME2;PSMB8;PSMD2;KCTD10;NR1D1;PSMD1;PSMC3;UCHL1;CTNNB1;PSMD6;VCP;CDC34;RNF187;PSMA7;KCTD2;FEM1C;NHLRC1;PRPF19;KCTD17;PSMD5;TRIM9;RBX1;TRIM2;TNFAIP1;DDB1;PSMB9;PSMD13;RBCK1;PSMB3;FBXW5;PMAIP1;SYVN1;PSMB11;ZSWIM8;FBXW7;PSMB10;KBTBD7;SPSB3;UBXN6;PSMB1;ARRB2;ENC1;PSMB5;BRSK2;KCTD13;PSMA6;HECW1;TRIM13;RAD23A;PSMA4;DDIT3;SIRT2;UBXN11;STUB1;IFI27
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4380491475988688,1.133964081142073,0.29005847953216374,0.6320810226534959,1.0,11/39,21.84%,MBP;FXYD5;AKT1;MYADM;PODXL;KLF4;BMP2;AKNA;NOTCH1;TGFB1;PPM1F
prerank,negative regulation of DNA metabolic process (GO:0051053),0.4783692611738643,1.1339339706617353,0.33292383292383293,0.6317118773804357,1.0,8/24,22.28%,RPS3;ACVRL1;H1-0;SUB1;TERF2IP;ERCC1;DACH1;BLM
prerank,regulation of multicellular organismal development (GO:2000026),-0.3619339328237015,-1.1337917618848061,0.20812182741116753,0.6742652856680129,1.0,7/25,8.98%,TRIP12;NIPBL;DHX36;EHMT1;MYSM1;INSR;TDG
prerank,organophosphate catabolic process (GO:0046434),0.5487080911881468,1.1330731951859943,0.3283582089552239,0.6336197979191127,1.0,3/11,14.12%,LIPG;ENPP2;PLBD2
prerank,pancreas development (GO:0031016),-0.4288445641865224,-1.1320977487959591,0.2737642585551331,0.6766607366875252,1.0,3/12,8.84%,TCF7L2;MET;NPHP3
prerank,rRNA 3'-end processing (GO:0031125),0.5518662193094194,1.131951164445325,0.33383010432190763,0.636184841976814,1.0,2/10,10.38%,RPS21;EXOSC2
prerank,lymphocyte proliferation (GO:0046651),0.4769335722255116,1.1319449289545667,0.32004981320049813,0.6357572439256234,1.0,6/22,20.07%,PTPRC;MSN;HSPD1;RASGRP1;FLT3;MEF2C
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5059372024580516,1.131888732932793,0.3371501272264631,0.635461202908849,1.0,1/17,1.00%,LAMP1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.44166780753724033,1.131824602348267,0.30980861244019137,0.6351791365652163,1.0,10/30,23.88%,CD34;ISG15;HSPD1;LILRA5;HMGB1;F2RL1;SYK;IL6;PYCARD;CD28
prerank,positive regulation of viral process (GO:0048524),0.4098933506816763,1.131783244592549,0.3001083423618635,0.634863583520915,1.0,18/60,21.23%,PPIA;POLR2E;POLR2D;POLR2F;IFIT1;NELFCD;DDB1;POLR2G;SUPT4H1;PABPC1;POLR2K;PDE12;NELFE;TYRO3;VPS4A;RAD23A;POLR2H;CDK9
prerank,aortic valve development (GO:0003176),-0.3225363092350035,-1.1312162970809123,0.24203821656050956,0.6769368902302352,1.0,6/34,4.95%,ROCK2;SMAD6;ROBO1;ROCK1;SLIT2;NFATC1
prerank,peptide catabolic process (GO:0043171),-0.3567617218435615,-1.1311600219887705,0.27956989247311825,0.6749194914816653,1.0,3/23,5.90%,CPQ;NPEPPS;ANPEP
prerank,mitochondrial membrane organization (GO:0007006),0.45173036077745715,1.1311247733635534,0.3174971031286211,0.6362081153533894,1.0,11/32,20.89%,SLC25A5;MICOS13;SLC25A4;GHITM;PMAIP1;TIMM50;SPG7;BAD;APOO;HSPA9;BAK1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5156919355522525,1.1310972634254746,0.32843791722296395,0.6358381525799702,1.0,6/14,16.80%,PARK7;TMBIM6;CREB3;SYVN1;HSPA1A;HERPUD1
prerank,regulation of Notch signaling pathway (GO:0008593),-0.2724358358547265,-1.13109709271674,0.16417910447761194,0.6729151927249691,1.0,19/76,14.26%,TSPAN5;EGFR;ZMIZ1;CREBBP;MAML2;NIBAN2;GALNT11;YAP1;KAT2B;STAT3;MAML1;AAK1;SYNJ2BP;RBPJ;CD46;JAG1;DTX1;WWP2;PRKCI
prerank,sterol transport (GO:0015918),0.4928543727429481,1.1308725904929537,0.31443298969072164,0.6360238545347978,1.0,5/19,25.64%,NPC2;MSR1;CAV1;NPC1;ABCG5
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4377747359622947,1.1308212921749528,0.3083140877598152,0.6357133218401558,1.0,5/36,5.31%,PPIA;TREM2;PINK1;DUSP3;SIRPA
prerank,positive regulation of developmental process (GO:0051094),0.383106459677416,1.1306105071646972,0.2363083164300203,0.6358536108585641,1.0,39/164,17.16%,APOE;MDK;HSP90AB1;CFL1;NRXN1;NLGN1;PINK1;TNF;PDGFB;PACSIN1;RTN4;SORL1;TFRC;OTX2;CEBPB;CORO1C;ENPP2;SLC6A6;BASP1;CLASP1;KDR;CCN2;DCN;CAMK1;ARHGEF7;WNT5A;TMEM119;SOX8;SOX9;GJA1;BMP2;FBXO5;MIEF2;MFF;LRP8;DAB2IP;VHL;LMNA;DNM1L
prerank,negative regulation of protein phosphorylation (GO:0001933),0.38666897323603566,1.1304274878756486,0.23529411764705882,0.6359019351372709,1.0,49/150,21.84%,PPIA;RACK1;CALM1;HSPB1;PARK7;AKT1;FKBP8;PRNP;CALM3;IGFBP3;PPP1R15B;CAMK2N2;PTPRC;PRR5L;SIRPA;SH3GL2;MYADM;DBNDD2;CORO1C;THY1;YWHAG;MLXIPL;CADM4;RTRAF;TARDBP;WARS1;CAMK2N1;CNKSR3;INPP5J;NLRP2B;DMTN;DAB2IP;CAV1;TWIST1;PRKRIP1;AKT1S1;TERF2IP;QARS1;DNAJC10;TAB1;CALM2;SNCA;TGFB1;DDIT4;SFRP1;PTPN6;SIRT2;MEN1;PPM1F
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3500107211132484,-1.1303795502787437,0.25,0.6725977500985614,1.0,9/30,11.01%,GOLGA4;VAMP5;MACF1;SPTBN1;BLZF1;RAB10;GGA2;OPTN;KIF13A
prerank,regulation of cell-substrate adhesion (GO:0010810),0.42941546263665803,1.1301404957993026,0.30067567567567566,0.6362077789030635,1.0,15/42,21.84%,EMP2;PDGFB;RAC1;SPOCK1;MYADM;CORO1C;THY1;RHOA;ARL2;DMTN;FBLN2;RAC2;NOTCH1;PTPRO;PPM1F
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.48266500024225045,1.1299817971433121,0.3290978398983482,0.6361863847468321,1.0,11/20,22.54%,TGM2;TMCO1;KCTD17;SELENOK;BAX;WFS1;HERPUD1;BCAP31;BAK1;FIS1;ATP2A2
prerank,response to interleukin-6 (GO:0070741),-0.4539179202002113,-1.129929883623861,0.2922077922077922,0.6716994790876379,1.0,3/10,6.32%,PID1;PTGIS;NFKB1
prerank,Rac protein signal transduction (GO:0016601),0.4880166520974505,1.129624971630601,0.32858990944372574,0.6367461435281415,1.0,6/18,17.41%,RAC1;ELMO1;RHOG;AIF1;TIAM1;RAC2
prerank,regulation of autophagy (GO:0010506),0.38099976417255665,1.1295900470374296,0.2020100502512563,0.6364074658295734,1.0,44/216,16.48%,EEF1A1;PSAP;GFAP;GAPDH;ATP6V0C;HSPB1;MT3;CAPNS1;AKT1;EIF4G2;TREM2;PINK1;LAMTOR2;LAMTOR4;RASIP1;LAMTOR5;TMEM59;ORMDL3;ATP6V1G1;UCHL1;ATP6V0E2;EEF1A2;DEPP1;MAPT;NUPR1;GPR137B;CDK5R1;ATP13A2;DCN;HMGB1;MTMR9;ATP6V0D2;SVIP;CTSA;FBXW7;UBQLN2;LAMTOR3;STK11;ATG101;BAD;RRAGC;CDK5;RRAGD;RAB39B
prerank,long-chain fatty acid transport (GO:0015909),0.45539701336668176,1.1295361439391967,0.3125,0.6361116208457591,1.0,4/30,8.69%,APOE;MID1IP1;FABP5;MFSD2A
prerank,positive regulation of exocytosis (GO:0045921),0.44308708601769314,1.1292700542727363,0.30549199084668194,0.6363591438584425,1.0,14/35,26.87%,ATP6AP1;RAB15;CLASP1;CADPS;ATP13A2;RAB3D;SDC4;SDCBP;VPS4A;SNCA;RAB27B;UNC13D;HGS;SNF8
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.29738116320910946,-1.1287976389874863,0.1839080459770115,0.6727242920018451,1.0,13/52,11.64%,CELF2;RBFOX2;RBM5;RBM25;MBNL2;THRAP3;YTHDC1;TRA2B;RBM4;WTAP;FXR2;HNRNPL;DDX17
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5231391033935879,1.128422353558551,0.33467202141900937,0.6382300463911708,1.0,8/13,27.39%,CADM4;PDCD6;DAB2IP;PTPN1;CNMD;HGS;HHEX;MMRN2
prerank,positive regulation of vacuole organization (GO:0044090),0.5507398424581937,1.1283809403664389,0.3256150506512301,0.6379040294324375,1.0,1/10,1.29%,GRN
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3279858745049913,-1.128224992154192,0.2483221476510067,0.6720232136851317,1.0,9/31,11.61%,TGFBR3;BMPR1A;TGFBR1;ZFPM2;FGFR2;SMAD7;SMAD4;TPM1;RBPJ
prerank,retinoid metabolic process (GO:0001523),0.40578671969299046,1.128182962487975,0.28752642706131076,0.6379848384631062,1.0,17/71,19.89%,APOE;RBP4;RARRES2;TTR;RDH5;RBP1;LPL;SDC4;GPC5;AKR1B10;DHRS13;LRP8;LRAT;BCO2;SDC3;HSPG2;AGRN
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4518945014361643,1.1277287049589277,0.32701421800947866,0.6387343207685345,1.0,14/33,26.92%,AKT1;ZFP36L1;LTK;PIK3C2G;NYAP2;TYRO3;PIK3CD;ERBB3;SIRT2;C1QBP;NYAP1;PLEKHA1;PIK3R5;HTR2B
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4367190407220439,1.1275614270783774,0.3212192262602579,0.6387548461749638,1.0,9/35,15.00%,APOE;AKAP6;RIMS2;AQP1;HTR2C;EPHA5;SOX9;NUDT4;CAP1
prerank,RNA transport (GO:0050658),0.40399756881302373,1.1272773869320172,0.29449838187702265,0.6390818378018014,1.0,22/71,22.06%,MAGOHB;MAGOH;DDX39B;ZFP36L1;FLOT1;SRSF9;YBX1;ZFP36;RTRAF;SRSF2;HNRNPA1;RBFOX1;THOC3;TST;EIF4A3;SLBP;U2AF1L4;KIF5C;ALYREF;RAE1;SRSF1;DHX38
prerank,intracellular pH reduction (GO:0051452),0.4455014967343813,1.1271849873837347,0.323220536756126,0.638880073644674,1.0,10/33,23.57%,ATP6V0C;ATP6V1F;ATP6V1G1;ATP6V0E2;ATP6V0D2;SLC11A1;RAB20;ATP6V1A;ATP6V0A1;ATP6V0B
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3756324179140667,1.1270922742910157,0.161,0.6387099962455065,1.0,65/308,17.36%,APOE;RPS19;GAPDH;MDK;COL1A1;PPIB;CFL1;SOD1;GATM;NLGN1;TREM2;AGT;S100A13;NFAM1;UCP2;TNF;PDGFB;EPAS1;FABP5;ENO1;RTN4;SORL1;MIF;FLOT1;BSCL2;CTNNB1;TFRC;LRPAP1;OMA1;OTX2;CEBPB;CLEC6A;IL2;CRH;HAP1;WNT5A;SCD;KDM6B;LCN2;MFAP2;VAMP8;TMEM119;SOX8;THRA;SLC11A1;HCRT;SOX9;GJA1;BMP2;FBXO5;GAS6;NME2;CXCR4;SDCBP;TIAM1;F2RL1;BAD;ACHE;ADRA1D;ADRA1A;CAV1;PIK3CD;TWIST1;ADCYAP1;PPARGC1A
prerank,striated muscle tissue development (GO:0014706),0.46124272296697194,1.1268188046277983,0.2972651605231867,0.6390350088431971,1.0,3/29,3.40%,MYL6;RBP4;SGCZ
prerank,cellular response to inorganic substance (GO:0071241),0.47574395112335977,1.126602026659507,0.328732747804266,0.6391947362151056,1.0,5/21,12.09%,MT3;AQP1;MMP3;NSMCE3;DDX11
prerank,L-glutamate transmembrane transport (GO:0015813),0.5553993064184368,1.1265145859958139,0.34309623430962344,0.638978776568053,1.0,5/10,19.06%,SLC1A2;SLC25A13;SLC1A1;SLC25A22;SLC25A18
prerank,organic hydroxy compound transport (GO:0015850),0.44138678446483093,1.1264166470582322,0.3040462427745665,0.6387831066028672,1.0,11/36,28.11%,NPC2;RBP4;SLCO1C1;SLC10A3;SLC16A1;ABCC3;SLCO1B1;SLC10A6;ABCG5;RALBP1;STRA6
prerank,negative regulation of reproductive process (GO:2000242),0.5096651496540564,1.1259815614828943,0.33514246947082765,0.6394901230017102,1.0,5/17,13.23%,CALR;NPPC;ARHGDIB;TIMP1;GJA1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3500935883357298,-1.1259095552118175,0.3065326633165829,0.6760928634080208,1.0,7/26,6.67%,LGR4;APPL2;OTUD4;BIRC2;FLOT2;IRAK3;BIRC3
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4472463756081354,1.1256026162737365,0.31861575178997614,0.6400564085163948,1.0,5/31,12.81%,SCP2;PYCR2;GPHN;LSS;HSD3B2
prerank,regulation of secretion by cell (GO:1903530),0.41528799414057643,1.1255708298896179,0.30458515283842796,0.639708099520767,1.0,23/54,27.73%,SYT1;RIMS2;RIMS1;RAB15;RAB3C;SCG5;VAMP3;VAMP2;STXBP5L;RAB3D;HAP1;VAMP8;SYN1;HCRT;RAB26;STX4;MEF2C;LLGL1;ARFIP1;KCNMB4;RAB8A;LGI3;CPLX1
prerank,motor neuron axon guidance (GO:0008045),0.5112576475875493,1.1253115303222694,0.34564643799472294,0.6399471305683188,1.0,6/15,17.41%,RAC1;RHOG;NTN1;LAMC2;SLIT1;RAC2
prerank,response to purine-containing compound (GO:0014074),0.4957699030314222,1.125258340208061,0.33725490196078434,0.6396445360084435,1.0,5/17,15.89%,P2RY6;P2RX7;P2RY1;TRPM2;RYR2
prerank,vasoconstriction (GO:0042310),0.5435404247815327,1.1250888027834123,0.3285509325681492,0.6396669122887746,1.0,3/11,18.94%,ACTA2;SLC8A1;EDN3
prerank,negative regulation of DNA replication (GO:0008156),0.5292995747652053,1.124709265733652,0.3389355742296919,0.6402085934494361,1.0,3/13,7.11%,S100A11;TERF1;GMNN
prerank,peptide metabolic process (GO:0006518),0.4064277987884804,1.124342772560362,0.3044397463002114,0.6407435703172045,1.0,19/75,18.39%,GPX1;SOD1;GSTM1;CPXM1;CPD;CPE;SPCS1;GSTM5;AEBP1;CPXM2;GSTM2;CLN5;HPGDS;SPCS2;DNPEP;GLRX2;BACE1;PSEN2;SEC11C
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.40786792837306773,-1.1242033850614088,0.28512396694214875,0.6782555856054308,1.0,6/16,8.33%,ROCK2;SLC9A1;ROCK1;CAMK2D;IGF1;MEF2A
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.3723380386763912,-1.1240771446909363,0.27,0.6764214718399431,1.0,9/20,19.22%,DICER1;DROSHA;ZC3H7A;ZC3H7B;TERT;PUM2;TARBP2;AGO2;AGO4
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4410569683701091,1.1239857981879047,0.2857142857142857,0.6412619212114011,1.0,9/33,13.55%,RAMP2;MDK;TNFAIP3;KDR;NUPR1;GATA2;IL11;WFS1;GAS6
prerank,negative regulation of lyase activity (GO:0051350),0.49511132736198843,1.1238818824623582,0.32526881720430106,0.6410931671082005,1.0,5/16,20.06%,GNAI2;RD3;PHPT1;CCR2;GABBR2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.5450206594907928,1.1238800234545714,0.3460490463215259,0.64066204408759,1.0,4/10,19.11%,APOD;NDRG4;PTGIR;SNCA
prerank,presynaptic endocytosis (GO:0140238),0.46760887837468507,1.1237760585946417,0.32922318125770655,0.6405071478142591,1.0,9/24,19.11%,NLGN1;CANX;PACSIN1;SYT1;AMPH;VAMP2;CDK5;SYT2;SNCA
prerank,negative regulation of cell cycle (GO:0045786),0.40249327247292316,1.1234875836173797,0.2963362068965517,0.6407983389794519,1.0,26/73,25.81%,RHOB;NPPC;GPER1;CDKN1C;BTG1;BRINP3;GMNN;CEBPA;NUPR1;GAS1;BRINP1;CAMK2N1;BRINP2;LILRB1;BMP2;NLRP2B;HEXIM1;BTG4;INHBA;TGFB1;TFAP4;MEN1;DUSP1;CHMP1A;INHA;HHEX
prerank,regulation of neuroinflammatory response (GO:0150077),0.4921477258531825,1.1231221470624664,0.3411458333333333,0.6413010296637704,1.0,5/19,11.31%,TREM2;TNF;NR1D1;NUPR1;MMP3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5143147771319853,1.1227243787446224,0.33636363636363636,0.6419138609218094,1.0,1/16,1.00%,LAMP1
prerank,ncRNA transcription (GO:0098781),0.5288188831173292,1.1224920997163266,0.3436241610738255,0.6421033045745197,1.0,2/13,4.35%,CAVIN1;ANG
prerank,ketone body metabolic process (GO:1902224),-0.454127361714027,-1.1222932352221422,0.29900332225913623,0.6789876014469394,1.0,8/10,29.14%,ACSS3;BDH2;HMGCS2;BDH1;AACS;HMGCLL1;OXCT1;HMGCL
prerank,regulation of MAPK cascade (GO:0043408),0.3838470361913562,1.1216941666525089,0.23123732251521298,0.6437925036651602,1.0,52/157,20.89%,CD74;LAPTM5;MAPK3;PEBP1;GPER1;GPR37L1;PDGFB;PTPRC;NTRK2;CAV2;DUSP3;FN1;PAK1;P2RX7;KDR;CD24;JCAD;LILRA5;HMGB1;PAK3;IL11;ATP6AP2;FLT4;HRAS;PHLPP1;NEK10;BMP2;YWHAZ;RRAS;GDF15;IGF2;PDGFA;RASGRP1;EPHB1;ADRA1D;ADRA1A;DAB2IP;FLT1;CAV1;SYK;GRM4;FAM83D;MAP2K2;LBH;SPRY3;FLT3;IL6;THPO;PAK5;ADRA2B;TMEM106A;PTPN6
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5210637226561696,1.1215594582042212,0.3484646194926569,0.6437289393507319,1.0,6/13,25.49%,PTPRC;HES1;IL6;CRLF2;DOT1L;PTPRT
prerank,negative regulation of phosphorylation (GO:0042326),0.40044057018501944,1.1215005316444766,0.27936507936507937,0.6434503360158378,1.0,26/85,19.87%,PPIA;PARK7;DYNLL1;FKBP8;PRNP;IGFBP3;PPP1R15B;PRR5L;SIRPA;SH3GL2;MYADM;CDKN1C;CORO1C;MAPT;NUPR1;CADM4;TARDBP;WARS1;HNRNPU;DAB2IP;PRKRIP1;TERF2IP;DNAJC10;INHBA;TGFB1;GIT1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.5432734624399908,1.1211901648427254,0.35050071530758226,0.6438538643731362,1.0,3/11,20.21%,TREM2;CCL3;TRAT1
prerank,regulation of AMPA receptor activity (GO:2000311),0.46413407617204244,1.1205381969038828,0.33859223300970875,0.6451687426215956,1.0,9/25,24.99%,NLGN1;SHISA7;MAPK8IP2;CACNG8;CACNG5;MEF2C;CACNG2;SHISA6;PRRT1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.39883005094047197,1.120332937283032,0.2989583333333333,0.6452784036747115,1.0,28/85,21.57%,CLU;RACK1;GABARAP;ELOB;TREM2;HSPA1B;PSMC3;VCP;USP5;CEBPA;RBX1;NUPR1;ECSCR;SUMO2;DNAJB2;HSPA1A;FBXW7;RNFT1;HSPBP1;DAB2IP;NOP53;DDRGK1;RNF144B;RAD23A;TMEM259;USP13;SIRT2;STUB1
prerank,regulation of catabolic process (GO:0009894),0.4950138307568947,1.119685429212976,0.33785450061652283,0.6465629882652284,1.0,9/18,26.87%,CHEK2;RARRES2;CHMP6;ODC1;FAM83D;HGS;ZDHHC2;ITGB1;SNF8
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5002306961871437,1.1191844369336807,0.3592356687898089,0.6474937523502718,1.0,8/17,25.27%,NLGN1;RAB15;RAB3D;SYT4;SYT10;DOC2B;UNC13D;SLC4A8
prerank,positive regulation of DNA binding (GO:0043388),0.44971986432318517,1.118723237696368,0.3298245614035088,0.6483053228079547,1.0,11/31,21.36%,PARK7;TXN;NME1;HES1;EDF1;HMGB1;H1-0;TWIST1;TGFB1;POU4F1;SIRT2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.381441714555481,1.1187139794690213,0.23069207622868607,0.647894650251586,1.0,43/186,16.42%,APOE;IGFBP6;PFDN5;RACK1;PSMB4;MDK;PSME1;PSMB6;PSME2;PSMB8;PSMD2;IGFBP4;PSMD1;LRP4;PSMC3;TLE5;PSMD6;ANKRD6;ALPK2;SFRP5;PSMA7;JADE1;PSMD5;RBX1;PSMB9;PSMD13;WNT5A;SOX17;PSMB3;PSMB11;IGFBP2;SOX9;BMP2;PSMB10;AMER2;SFRP4;STK11;TMEM131L;PSMB1;PSMB5;DACT3;DAB2IP;CAV1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.45611978506991024,1.118588292238928,0.32160194174757284,0.647790103270314,1.0,9/25,19.37%,APOC1;RAC1;LRPAP1;ARF6;UBQLN2;SDCBP;ANKRD13D;ABCA2;UNC119
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.45963724030791075,1.1182255427054577,0.3304130162703379,0.6483258557621754,1.0,6/23,16.91%,MDK;AGT;SOX8;SOX9;GJA1;PIK3CD
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.513097774415104,1.1174584452496723,0.32710280373831774,0.6495271087924643,1.0,3/14,19.96%,HMOX1;BLVRA;SLCO1B1
prerank,heme catabolic process (GO:0042167),0.513097774415104,1.1174584452496723,0.32710280373831774,0.6495271087924643,1.0,3/14,19.96%,HMOX1;BLVRA;SLCO1B1
prerank,regulation of centriole replication (GO:0046599),-0.3906346997531589,-1.1170848378258125,0.3181818181818182,0.6908286275755889,1.0,3/17,5.53%,ALMS1;CEP295;KAT2B
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.44715890286603793,-1.1165738803967191,0.3230240549828179,0.687761264145444,1.0,3/10,5.49%,HDAC4;PPARA;NCOR1
prerank,negative regulation of glycolytic process (GO:0045820),-0.44715890286603793,-1.1165738803967191,0.3230240549828179,0.687761264145444,1.0,3/10,5.49%,HDAC4;PPARA;NCOR1
prerank,regulation of cell population proliferation (GO:0042127),0.3685743094034841,1.1161795105926946,0.082,0.6525410453596311,1.0,167/691,21.14%,FTH1;RPL23;RPS9;RPS4X;RPS15A;CLU;IGFBP6;CLDN5;IFITM1;TSPO;CD81;CALR;GPNMB;GNAI2;CAPNS1;JUND;S100A11;RPS6;LGMN;AKT1;TSPAN31;S100B;SLC25A5;NRG1;NME1;CCND2;ERBB4;NPM1;COPS9;AGT;IGFBP3;S100A13;CSNK2B;GPER1;COX17;EMP2;PDGFB;ROMO1;HCLS1;ACVRL1;NTRK2;ZFP36L1;JUNB;HSPA1B;SSR1;ECRG4;CTNNB1;ST18;SERTAD1;HES1;LTK;SFRP5;EID2;FN1;BTG1;MATK;TFRC;RHOG;RNF187;ADORA3;SSTR4;ADGRG1;ATP8A2;NAMPT;SGK1;PAK1;CEBPA;PROX1;KDR;CXCL10;IL2;BCL6B;VIPR1;NUPR1;MLXIPL;TIMP1;CADM4;LAMC2;JUN;CGREF1;HCK;ADGRB1;ZBTB49;KITLG;CSF1R;THAP12;CTBP1;IL11;ATF5;CEP131;WARS1;FLT4;HRAS;DNAJB2;CAMK2N1;AIF1;KLF4;PRMT1;SOX9;HSPA1A;RHOA;DDAH1;BMP2;FBXO5;SFRP4;CTSH;CCDC88A;STK11;SDCBP;TIAM1;PF4;COPS8;SLURP1;PDF;FOLR2;IGF2;PDGFA;DLC1;DLL1;IER5;ADRA1D;ADRA1A;JAG2;DAB2IP;FLT1;CCKBR;VHL;CIAO1;LMNA;PDCD5;ADAM17;SCIN;CNBP;ADAMTS1;TBRG4;ERBB3;FABP7;BTG4;MAZ;SCGB3A1;STX4;HMGN5;EDN3;SOX11;DDRGK1;CD86;INHBA;RTKN2;TFAP2B;FLT3;NOTCH1;IL6;KLF11;MAPK15;TGFB1;ING5;OSGIN1;THPO;SFRP1;TFAP4;MYC;CRLF1;PTPN6;CRLF2;SST;PTPRU;ID2
prerank,regulation of protein kinase B signaling (GO:0051896),0.37854743549920244,1.1158834489107998,0.24269889224572003,0.6529169628954253,1.0,68/193,26.26%,RACK1;HSP90AA1;HSP90AB1;PARK7;AKT1;CCL19;RCN3;TXN;NRG1;ERBB4;PINK1;GPER1;TNF;PDGFB;HCLS1;RAC1;NTRK2;RTN4;HYAL2;SFRP5;RHOG;P2RY12;KITLG;MC1R;PDCD6;RAMP3;PHLPP1;VAV1;GAS6;CX3CR1;RRAS;GDF15;IGF2;PDGFA;ARRB2;HPSE;CCL3;GATA4;CASS4;PIK3CD;F10;RAC2;ERBB3;NOP53;KLB;MAZ;CD86;FLT3;HGF;TGFB1;THPO;TRAT1;THEM4;DDIT3;BANK1;TGFA;MYDGF;PHLDA3;C1QBP;TEK;CD28;PLEKHA1;PIK3R5;FGF22;MFHAS1;FGFR3;CX3CL1;ITGB1
prerank,chloride transmembrane transport (GO:1902476),0.4256217357225476,1.1152678884167544,0.33223322332233224,0.6541324144815263,1.0,13/48,18.83%,GABRB1;LRRC8A;GABRG3;GABRA2;SLC12A5;GLRA2;GLRA1;GABRA3;GABRB3;SLC1A1;GABRB2;ANO4;GLRA3
prerank,ion transport (GO:0006811),0.38593774761458727,1.1152375411350792,0.2819203268641471,0.6537812568878223,1.0,32/111,19.69%,TSPO;SLC17A8;GABRB1;SLC39A1;LRRC8A;SLC24A4;SLC24A2;SLC1A2;GRIN1;SLC12A5;CNGA3;SLC26A4;TMEM63C;SLC15A4;SLC17A7;LASP1;SLC17A6;KCNN2;GLRA1;ATP1A4;SLC1A1;CHRNA4;SLC25A22;SLC8A1;SLC15A2;CNGB1;ATP11B;SLC9A9;SLC4A2;VDAC2;SLC25A18;PKD2L1
prerank,regulation of neuron differentiation (GO:0045664),0.4012098459175389,1.1150833089268084,0.3095487932843652,0.6537182342026051,1.0,27/76,22.11%,CALR;NBL1;NLGN1;CNTN4;YWHAH;HES1;LTK;BRINP3;NRCAM;YWHAG;CDK5R1;BRINP1;BRINP2;RHOA;BMP2;MMD2;PCP4;TIAM1;HEY1;BEND6;DLL1;TRIM32;SOX11;MEF2C;ADRA2B;ID2;REST
prerank,dopaminergic neuron differentiation (GO:0071542),0.4814744096118742,1.1148912957065937,0.3442838370565046,0.6537522038523808,1.0,6/19,21.30%,CTNNB1;MANF;OTX2;PHOX2A;FOXA2;FOXA1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4479376674114304,1.114753796799548,0.336866902237927,0.6537035838999006,1.0,14/30,27.24%,CAVIN1;POLR2E;POLR2F;POLR1B;POLR2K;UBTF;TBP;POLR1H;POLR2H;POLR1G;GTF2H5;ERCC2;CCNH;POLR1F
prerank,mRNA stabilization (GO:0048255),0.43364440569991325,1.1145607855750672,0.33180252583237657,0.653789479491733,1.0,12/40,17.31%,TIRAP;HNRNPA0;YBX1;ZFP36;TARDBP;ELAVL4;PABPC1;SLC11A1;HNRNPU;CIRBP;YBX3;EIF4ENIF1
prerank,cellular response to retinoic acid (GO:0071300),0.42580323554774907,1.1145115137646109,0.32457142857142857,0.6534845107609241,1.0,11/42,13.56%,NDUFA13;LTK;BRINP3;PTK6;AQP1;BRINP1;WNT5A;BRINP2;SNW1;SOX9;WNT10B
prerank,regulation of protein polymerization (GO:0032271),0.43588154691556497,1.114362479200192,0.32037691401649,0.6534562751015318,1.0,12/35,16.75%,HSP90AA1;TPPP3;HCLS1;PFN1;ESAM;MAPT;MAP2;COTL1;PAK3;ARL2;MAPRE3;PFN2
prerank,zinc ion transmembrane transport (GO:0071577),0.46987551648461245,1.1140876242407038,0.34296482412060303,0.6537904318892944,1.0,5/22,11.56%,SLC30A1;SLC39A1;SLC39A10;SLC39A7;TRPM2
prerank,regulation of protein kinase activity (GO:0045859),0.38989265653327904,1.1138335430289887,0.27909371781668385,0.6540366918240705,1.0,29/106,19.11%,PPIA;HSPB1;PARK7;SOD1;AKT1;CCL19;CAMK2N2;TNF;PTPRC;C5AR1;DBNDD2;THY1;YWHAG;RTRAF;WARS1;CAMK2N1;GAS6;MMD2;MAPRE3;LCP2;ADCYAP1;CAMKK1;PRKRIP1;AGAP2;DDR2;AKT1S1;QARS1;TAB1;SNCA
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.4028859033725774,-1.1135918242554936,0.29961089494163423,0.6939619423320004,1.0,5/13,11.61%,TGFBR3;BMPR1A;ZFPM2;FGFR2;RBPJ
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.348646923550167,-1.1135174732552127,0.29896907216494845,0.6919970829775655,1.0,14/26,32.32%,NSMCE2;ANAPC5;ANAPC7;NEK6;HECW2;CDC27;CENPE;ANAPC4;PLK1;RIOK2;UBE2C;CDC16;CCNB1;RB1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.46889063701839934,1.1134810285859278,0.33885350318471336,0.6545253820992701,1.0,9/22,30.37%,RPS21;EXOSC2;EXOSC9;FTSJ3;ERI1;NOP14;NOL9;URB1;PES1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.4824112777000094,1.1131328137459358,0.3324742268041237,0.6549985423819163,1.0,5/20,14.26%,GSN;GPER1;ECSCR;SFRP4;CCL2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.5015684524668127,1.1130512260790855,0.3472584856396867,0.6547870818656512,1.0,5/16,19.97%,LGALS3;CD22;IKZF3;SOX11;LST1
prerank,sulfation (GO:0051923),-0.4289406354638285,-1.113007413469456,0.3254237288135593,0.6911737507463287,1.0,1/11,0.07%,UST
prerank,positive regulation of DNA recombination (GO:0045911),-0.34415066120673093,-1.1126769933991758,0.27325581395348836,0.6898520412657271,1.0,12/27,19.20%,ARID2;KMT5C;KMT5B;SHLD1;MMS19;MRNIP;FUS;FANCB;PRDM9;HMCES;ZCWPW1;SHLD2
prerank,regulation of epithelial cell differentiation (GO:0030856),0.4872898942229438,1.112524935079675,0.35294117647058826,0.6557827513072694,1.0,5/17,16.42%,CEBPB;CD24;SOX9;DLL1;CAV1
prerank,myeloid leukocyte differentiation (GO:0002573),0.4056783120556044,1.1121865233205652,0.3186221743810549,0.6562257249958101,1.0,18/65,20.15%,MT1G;TYROBP;CCL19;TREM2;GLO1;SPI1;PARP1;CEBPA;DEK;CSF1R;F2RL1;OSTM1;BATF3;OSCAR;PIK3CD;GPR183;BATF2;PDE1B
prerank,negative regulation of myoblast differentiation (GO:0045662),0.516564021164275,1.1119565767245858,0.35939643347050754,0.6563732509625754,1.0,5/13,19.83%,SOX8;SOX9;DLL1;NOTCH1;TGFB1
prerank,protein depolymerization (GO:0051261),0.45145296339517943,1.111843222022618,0.34761321909424725,0.6562484846064887,1.0,7/27,13.97%,GSN;CFL1;STMN3;STMN4;MICAL1;DSTN;STMN1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.47695263745377975,1.1117159322363834,0.33756345177664976,0.6561432142514494,1.0,6/22,19.38%,LGMN;VKORC1;RBP1;GC;LRAT;CBR1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5337945554580333,1.1115800994687643,0.3389121338912134,0.6560593329098392,1.0,3/12,17.42%,TSPO;FDX2;STARD3NL
prerank,purine nucleotide metabolic process (GO:0006163),0.46011498369945725,1.1115554738618385,0.3174019607843137,0.6556840583006677,1.0,11/24,25.99%,GPX1;GART;DNPH1;PNP;PRPS1L1;PRPS1;NT5C;GUK1;GDA;PRPSAP1;ADSL
prerank,negative regulation of cellular process (GO:0048523),0.36871811492119905,1.1115207985120434,0.139,0.6553401478531151,1.0,141/521,22.48%,FTH1;ARHGDIA;CLU;IGFBP6;RACK1;IFITM1;MDK;GPNMB;MT3;NDUFA13;PARK7;RHOB;S100A11;NME1;TMBIM6;TREM2;CRYAB;ERBB4;CD34;NPM1;IGFBP3;TXNIP;CCDC85B;CSNK2B;ADAM15;GPER1;ACVRL1;DSCAM;ENO1;RTN4;MIF;HSPA1B;PPP2R1A;SIRPA;CTNNB1;ST18;PDE3B;HYAL2;SFRP5;ARHGDIB;BTG1;LRPAP1;ADORA3;SSTR4;ADGRG1;ATP8A2;GMNN;BNIP3L;KLK8;PODXL;CEBPA;WFDC1;PROX1;CCN2;SYT11;JADE1;NUPR1;VAMP3;CGREF1;ADGRB1;ZBTB49;ARHGDIG;APBB1;THAP12;BRINP1;CTBP1;SOX17;ATF5;MSX1;TMEM109;WARS1;WFS1;VAMP8;HRAS;DNAJB2;CAMK2N1;ACTN1;KLF4;BST2;HSPA1A;GJA1;DDAH1;LILRB1;BMP2;FBXO5;NLRP2B;PDE12;SFRP4;STK11;COPS8;SLURP1;NR1H2;DLC1;DLL1;ING1;ADRA1A;DACT3;DAB2IP;VHL;SLIT3;LMNA;NDUFS3;PDCD5;SCIN;ADAMTS1;ERBB3;FABP7;BTG4;ANXA6;SCGB3A1;SOX11;CCAR2;LPXN;INHBA;TFAP2B;NOTCH1;IL6;KLF11;TGFB1;ING5;OSGIN1;SFRP1;SPHK2;TFAP4;MYC;PTPN6;SST;PTPRU;SIRT2;PLXND1;RERG;CCN3;MEN1;TDRD9;CDA;SSTR2;REST;TMEM127;BLM;CD164;DUSP1
prerank,protein localization to cell junction (GO:1902414),-0.3555803486106965,-1.1113734578266032,0.32857142857142857,0.6912502599783729,1.0,11/22,21.95%,CGNL1;ARHGEF18;HEG1;DLG4;FERMT2;JAK1;NECTIN1;NLGN2;BSN;PAK2;MPP4
prerank,histone H4 acetylation (GO:0043967),-0.2938956261728733,-1.1111208182053947,0.2641509433962264,0.6897349079565869,1.0,11/47,13.78%,OGT;ZZZ3;KMT2A;NAA40;EPC1;KAT7;ATF2;EP400;KANSL3;BRD8;JADE2
prerank,positive regulation of TOR signaling (GO:0032008),0.43059707459610724,1.1108116870733178,0.33794694348327564,0.6568089549230572,1.0,12/40,16.15%,TREM2;LAMTOR2;LAMTOR4;LAMTOR5;GPR137B;PIP4P1;GPR137C;PIH1D1;LAMTOR3;GAS6;RRAGC;RRAGD
prerank,clathrin coat assembly (GO:0048268),0.4967747200162402,1.1107836714284292,0.351875808538163,0.656448700056172,1.0,6/15,14.97%,NSG1;CLTC;AP2S1;FCHO1;NSG2;CLTA
prerank,cellular response to interleukin-6 (GO:0071354),-0.34331227636046335,-1.1106875105737033,0.2752808988764045,0.6887173021034126,1.0,15/26,22.76%,PID1;FER;PTGIS;YAP1;NFKB1;STAT3;IL6R;SMAD4;JAK1;SBNO2;ST3GAL6;CBL;PTPN11;SRC;CTR9
prerank,response to amino acid starvation (GO:1990928),0.4019809489957795,1.109456428826713,0.29056203605514314,0.6595058503230435,1.0,10/72,7.08%,ATP6V0C;MAPK3;ATF4;ATP6V1F;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;ATP6V0E2;CEBPB
prerank,regulation of heart contraction (GO:0008016),0.3901448580572847,1.1089463977141705,0.3071200850159405,0.6604251142868439,1.0,23/90,17.75%,CALM1;S100A1;NPPC;FXYD1;CALM3;AGT;ADORA3;ATP1A3;ATP1B2;PLN;FXYD7;ATP1A4;ATP1A1;ATP2B1;DES;TRPC1;KCNE5;ATP1B1;SLC8A1;RYR2;SRI;ATP1B3;FKBP1B
prerank,negative regulation of response to stimulus (GO:0048585),0.4094185901946094,1.1084341175981949,0.31596091205211724,0.6613418835999941,1.0,20/60,20.67%,CLU;CD34;IGFBP3;TLE5;PTK6;THY1;COL3A1;YBX1;KIF26A;WFS1;KLF4;DDAH1;FBXO5;NR1H2;PIM3;TWIST1;ERBB3;SRMS;FOXA2;BRAP
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.38654784827105493,-1.1084194259424789,0.2833333333333333,0.692799961319823,1.0,6/16,19.40%,FOXD1;FGF1;SIX1;BMP4;FGF2;PKD2
prerank,cyclooxygenase pathway (GO:0019371),0.5494805950551633,1.108295262622178,0.35966149506346967,0.6612742335162958,1.0,5/10,23.32%,PTGDS;HPGDS;PTGES3;CBR1;TBXAS1
prerank,midbody abscission (GO:0061952),0.49742290421927826,1.1080666375094663,0.3620253164556962,0.6614851187651057,1.0,10/17,32.41%,CHMP2B;CHMP5;CHMP6;CHMP1B;VPS4A;CHMP7;CHMP1A;CHMP4C;CHMP4A;CHMP4B
prerank,cellular amide metabolic process (GO:0043603),0.38723448515844805,1.108028471169232,0.30552659019812306,0.6611551926847943,1.0,32/102,24.24%,DBI;ATF4;CPXM1;CPD;ORMDL3;PPP2R1A;CPE;PLAAT3;SMPD1;AEBP1;OXSM;CPXM2;ACOT1;ACOT7;SLC19A1;GLYAT;DNPEP;NAAA;FOLR2;ABCA2;NIT1;ACOT4;CLN8;SHMT2;THEM4;ASAH2;MTHFS;SGPL1;ACSM5;ORMDL2;CPZ;THOP1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.28030002513083624,-1.1072852097860717,0.2786885245901639,0.6935523905815116,1.0,11/62,10.41%,AUTS2;AKAP13;NOTCH2;ROBO1;LPAR1;SHOC2;RAPGEF1;IGF1;MAP4K4;ALS2;NGF
prerank,apoptotic nuclear changes (GO:0030262),0.4653358229410587,1.1072184086007593,0.3549190535491905,0.6629314362230521,1.0,5/24,10.22%,GPER1;ENDOG;FOXL2;HMGB1;H1-0
prerank,nucleic acid-templated transcription (GO:0097659),0.4183115807203034,1.1071652636138634,0.3333333333333333,0.6626540170965229,1.0,8/42,15.37%,PTMA;POLR2E;POLR2D;POLR2F;XAB2;POLR2G;POLR2K;RRAGC
prerank,regulation of trophoblast cell migration (GO:1901163),0.5136289059806332,1.107077376746763,0.3689189189189189,0.6624644265945769,1.0,4/14,13.23%,CALR;ARHGDIB;TIMP1;GJA1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.42896440484124315,1.106879098440071,0.34251497005988024,0.6625583591698762,1.0,12/34,19.31%,TREM2;NR1D1;TNFAIP3;TICAM2;NLRP2B;TLR6;F2RL1;CD300LF;DAB2IP;TYRO3;CD300A;CD14
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4478275030340984,1.1066775163594311,0.34299516908212563,0.6626859605378145,1.0,6/27,10.98%,FXYD5;FXYD1;YWHAH;SCN4B;FXYD7;FGF12
prerank,regulation of protein processing (GO:0070613),0.46728391918501155,1.1063300506084737,0.34799482535575677,0.6631835891787149,1.0,5/21,10.76%,PRNP;SERPINE2;TMEM59;PRSS37;GAS1
prerank,hepaticobiliary system development (GO:0061008),-0.3591591735400697,-1.1063103662781455,0.30612244897959184,0.6939466887477906,1.0,5/20,7.96%,TGFBR3;NIPBL;COBL;ARID5B;MET
prerank,response to exogenous dsRNA (GO:0043330),0.4799304041015285,1.106291189566298,0.35170603674540685,0.6628502429966833,1.0,9/18,31.38%,FLOT1;PQBP1;IFIT1;SLC3A2;CAV1;RALB;RFTN1;DHX9;MAVS
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4341384796754539,1.1061382244773925,0.33496932515337424,0.6628335911585532,1.0,9/31,19.67%,RBP4;PTPRC;TFRC;IL2;VAMP3;DNAJB9;STX4;CD86;IL6
prerank,covalent chromatin modification (GO:0016569),0.514276464077466,1.105986411195001,0.35714285714285715,0.6628080582775379,1.0,2/14,1.76%,MT3;PARK7
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.48910145165624397,1.1059337963845954,0.35106382978723405,0.6625169193220118,1.0,7/18,23.14%,MDK;CAMK1D;F2RL1;ADAM17;EDN3;IL6;PTN
prerank,iron-sulfur cluster assembly (GO:0016226),0.4645227318421297,1.1058423286987564,0.34624697336561744,0.6623290448351107,1.0,8/24,21.18%,BOLA2;GLRX5;ISCU;CIAO1;CIAPIN1;HSPA9;CIAO2A;CIAO2B
prerank,cellular response to interleukin-15 (GO:0071350),-0.40488741692106756,-1.1057778881433966,0.28294573643410853,0.6911491048833994,1.0,6/13,16.38%,STAT5B;IL15;IL15RA;STAT3;STAT5A;JAK1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.40488741692106756,-1.1057778881433966,0.28294573643410853,0.6911491048833994,1.0,6/13,16.38%,STAT5B;IL15;IL15RA;STAT3;STAT5A;JAK1
prerank,regulation of viral life cycle (GO:1903900),0.468639250360542,1.1052811650227674,0.35994930291508237,0.6633872748559465,1.0,5/21,22.65%,PPIA;HS3ST5;TYRO3;VPS4A;TRIM68
prerank,cellular component maintenance (GO:0043954),0.5256803414927552,1.1050602352459262,0.3625170998632011,0.663528890990768,1.0,2/12,2.84%,PRNP;TREM2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.44830988349748624,1.1050284866590585,0.33978234582829503,0.6631816294610311,1.0,12/28,21.15%,ATF4;CEBPB;SELENOK;BAX;BBC3;ERO1A;DAB2IP;BRSK2;PPP1R15A;DNAJC10;BAK1;DDIT3
prerank,protein localization to cell periphery (GO:1990778),0.379353007350671,1.1049995940942356,0.30225409836065575,0.6628221520893655,1.0,34/133,18.17%,BSG;CD81;RAMP2;KCNIP4;S100A10;ANK3;TNF;EMP2;DPP10;PACSIN1;FLOT1;FLNA;MYADM;RAB15;DPP6;TMED2;MYO5A;RAB3C;P2RY1;RAB3D;RAMP3;GAS6;TNFRSF1A;MAP7;EHD1;LIN7C;ATP1B1;SPTBN4;FGF13;EPB41L3;CAV1;CRB3;ATP1B3;EHD2
prerank,second-messenger-mediated signaling (GO:0019932),0.38878949865037504,1.104288165713644,0.3178947368421053,0.6642330588680616,1.0,18/82,18.94%,APOE;RCAN3;AGT;PPP2R1A;CCR5;P2RY12;CHRM3;DDAH1;CXCR4;MAFA;CX3CR1;NUDT4;RYR2;CCL3;DDAH2;NOS2;CCR2;EDN3
prerank,positive regulation of protein acetylation (GO:1901985),-0.40746832092135954,-1.1042795776860364,0.32116788321167883,0.6931764335362129,1.0,5/12,14.72%,CEP295;FAM161A;PRKAA2;RAPGEF3;TAOK1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.42701821397514317,1.1037908460124466,0.33794694348327564,0.6650702536386188,1.0,13/39,23.48%,RBP4;TRH;LRRC8A;GPER1;CRH;RASL10B;BAD;ADCYAP1;DOC2B;GLUD1;NNAT;PSMD9;ACSL4
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.40783558319417523,1.1037860584353805,0.34602829162132753,0.6646527195435347,1.0,13/59,15.46%,BSG;CD84;DSCAM;CNTN4;TENM3;KIRREL3;ROBO4;EMB;PECAM1;CADM3;IGSF9;DSCAML1;ROBO2
prerank,potassium ion homeostasis (GO:0055075),0.4693426676390064,1.103718128689145,0.36093943139678614,0.6643980964653702,1.0,9/23,19.55%,ATP1A3;ATP1B2;SLC12A5;ATP1A4;ATP1A1;ATP1B1;ATP1B3;KCNMA1;TFAP2B
prerank,response to histamine (GO:0034776),0.5363738394449017,1.1036194532200667,0.35704125177809387,0.6642208316432713,1.0,3/10,16.30%,GABRB1;GABRB3;GABRB2
prerank,response to peptide hormone (GO:0043434),-0.29641578455884493,-1.1034952365107127,0.25210084033613445,0.6931194648097194,1.0,14/43,15.19%,ROCK2;TGFBR3;STAT5B;ROCK1;OGT;IRS1;EIF2B3;STAT3;STAT2;SIRT1;EIF2B2;TSC1;CRY1;STAT5A
prerank,regulation of cell-cell adhesion (GO:0022407),-0.30913076207114565,-1.1021158889546627,0.28125,0.6948886888152042,1.0,11/39,15.56%,AFDN;EPHA7;FLOT2;DPP4;SMAD7;PTK2;CDH1;NF2;JAG1;MDGA1;SPINT2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.36816026409747943,1.101368853977587,0.2648539778449144,0.6698518007444575,1.0,60/234,21.50%,RPS3;RPS27A;PPIA;CLU;UBC;UBB;PARK7;AKT1;NPM1;AGT;NFAM1;BEX1;TNF;LAMTOR5;HCLS1;S100A8;S100A9;CAMK1D;HSPA1B;FLOT1;TIRAP;CTNNB1;TFRC;HIPK2;UBA52;EPHA5;RBCK1;WNT5A;ZBTB7A;RHEBL1;HSPA1A;RIPK2;HDAC5;UBE2V1;CX3CR1;TLR6;TSSK4;LRP8;ADCY8;CAV1;TRIM32;PPARGC1A;DDR2;TERF2IP;TAB1;PSMA6;DDRGK1;RTKN2;NLRP3;TRIM13;IL6;IL1RAP;CAPN3;BUD31;NFKBIA;PYCARD;FZD2;DDIT3;FOXA1;FZD1
prerank,regulation of cell junction assembly (GO:1901888),-0.34540738277159905,-1.1009033697019073,0.25925925925925924,0.6959326742239402,1.0,5/27,2.53%,ROCK2;PDLIM5;SETD5;ROCK1;RAPGEF2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.42164128408336726,1.1007122412939356,0.335946248600224,0.671205360877147,1.0,4/42,6.08%,ACTB;VPS72;MBD3;ZNHIT1
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.36064254043863786,-1.1006738379472623,0.2890995260663507,0.6945235788735187,1.0,5/20,6.44%,ROCK2;FMNL2;ROCK1;DLG1;NCKAP1
prerank,cellular response to hormone stimulus (GO:0032870),0.39609188123620775,1.100447087752299,0.3155080213903743,0.6714978942484353,1.0,18/69,20.17%,CTSB;CTSL;RAMP2;CTSS;GPER1;ZFP36L1;ATP1A3;RAMP3;WBP2;ATP1A1;CTSH;ROBO2;CAV1;SLIT3;NCOA4;NSMF;MEF2C;SFRP1
prerank,cellular component assembly (GO:0022607),0.3731928458626386,1.1003486829723421,0.2535070140280561,0.671310190313709,1.0,63/253,20.49%,ACTB;ACTG1;CD74;GSN;CHCHD10;ELOB;LAMC1;NLGN1;SLC2A1;ARL6IP1;ANK3;RAC1;SYCP2;TAPBP;RTN4;PPP2R1A;NEFH;FLNA;GPM6B;IL2RB;HES1;ADD2;RHOG;FAM107A;OTX2;RIMS1;CAPZA2;MYO7B;LCP1;VAMP3;VAMP2;RHOV;MICAL1;EPPK1;WNT5A;AIF1;SOX9;RHOA;MAGI1;GAS6;YWHAZ;VMP1;RHOU;TSPAN4;CAPG;SPG7;PDGFA;YTHDF1;DMTN;DNM1L;PPARGC1A;RAC2;SCIN;EPRS1;FBLIM1;LPXN;LRRTM3;DCX;TGFB1;QSOX1;IL1RAP;CAPN3;TFAP4
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5147947587501731,1.0998054845510798,0.37092391304347827,0.6722530012073578,1.0,2/13,1.76%,APOD;PARK7
prerank,"base-excision repair, gap-filling (GO:0006287)",0.4314029555116681,1.0992336021859666,0.36729857819905215,0.6733511926862583,1.0,13/35,25.40%,PARP1;RPA2;NEIL1;APEX1;PCNA;RFC2;POLD4;RFC4;POLG;POLD1;PNKP;RPA3;LIG1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.41295361024624044,-1.0990961191892743,0.31985294117647056,0.6967319882461617,1.0,7/13,19.68%,NR3C2;ESR1;AR;PLPP1;BMP4;NR3C1;MED1
prerank,protein acetylation (GO:0006473),-0.32887573196201714,-1.0987443722259331,0.23841059602649006,0.6956295732187674,1.0,11/30,16.20%,CREBBP;NAA40;KAT2B;NAA16;NAA15;ESCO1;KAT6A;SIRT1;NAA35;SPHK1;FOXO1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.3876578628164343,-1.0980902789738451,0.31226765799256506,0.6952565621061039,1.0,6/15,19.25%,NIPBL;TGFBR1;FGFR2;SIX1;PDGFRA;MTHFD1L
prerank,histone deubiquitination (GO:0016578),-0.38381915704278813,-1.0977557403320086,0.3017241379310345,0.6942214375130271,1.0,5/18,8.94%,USP3;UIMC1;USP49;USP16;USP36
prerank,epithelial cell morphogenesis (GO:0003382),-0.38325855467106607,-1.0974345116483757,0.2864321608040201,0.6929837407745923,1.0,3/17,7.96%,COL22A1;SIPA1L3;MET
prerank,phospholipid metabolic process (GO:0006644),0.3913879666744264,1.0969137714559722,0.3305084745762712,0.6790901611210777,1.0,21/71,25.29%,GPX4;PLAAT3;FADS1;LIPG;ENPP2;LPL;PIP4P1;PCYT2;SMPD1;PLA2G4F;GDE1;PLBD2;ABCA2;CLN8;AGPAT5;PLPPR2;PGP;AGPAT2;PLA2G3;PLPPR4;ABHD12
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5275601947770616,1.0968977822101669,0.37518037518037517,0.6786920157550523,1.0,6/12,22.11%,ZFP36L2;HES1;HNRNPU;ESRRB;NOTCH1;REST
prerank,carnitine metabolic process (GO:0009437),-0.42641649303853146,-1.096587081770624,0.34210526315789475,0.693103846702412,1.0,8/12,28.55%,TMLHE;CPT1C;CPT2;ACADM;SHMT1;BBOX1;ALDH9A1;CPT1A
prerank,telomere organization (GO:0032200),0.42140482311112676,1.096093471376602,0.3382352941176471,0.6804235467580393,1.0,15/43,25.09%,H3-3A;TERF1;LTO1;PARP1;RPA2;APEX1;PCNA;PTGES3;POLD4;CTC1;TERF2IP;BLM;POLD1;RPA3;DOT1L
prerank,regulation of T cell chemotaxis (GO:0010819),0.5230847177811876,1.0957256215871642,0.3884057971014493,0.6809791716013641,1.0,5/11,26.19%,CXCL10;WNT5A;ADAM17;CCR2;OXSR1
prerank,myelin assembly (GO:0032288),0.5299735661483597,1.0956176822178407,0.3802228412256267,0.6808119009444288,1.0,7/10,31.34%,PMP22;TENM4;EPB41L3;ABCA2;GPC1;CD9;CNTNAP1
prerank,hemopoiesis (GO:0030097),0.3902520456212711,1.095548958782667,0.35251046025104604,0.6805408491510092,1.0,30/87,20.17%,ATF4;CD34;LYL1;GLRX5;PDGFB;PTPRC;ZFP36L2;TIRAP;SBDS;KIRREL3;CEBPA;KDR;KITLG;CSF1R;WNT5A;FLT4;ARMC6;SELPLG;WNT10B;RRAS;L3MBTL1;DLL1;FLT1;TOX;INHBA;RTKN2;FLT3;TGFB1;TPO;SFRP1
prerank,negative regulation of hormone secretion (GO:0046888),0.5382420450757377,1.095436973030842,0.37656903765690375,0.6804160240521294,1.0,2/10,13.23%,IL11;GJA1
prerank,response to chemokine (GO:1990868),0.5101813517295114,1.0953768151024426,0.3889655172413793,0.6801355653564667,1.0,5/13,26.19%,CXCL12;RHOA;DOCK8;DUSP1;OXSR1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4156716954101302,1.0949873544491284,0.34846765039727584,0.6807308561060295,1.0,15/41,28.85%,CTSS;AKAP6;ANK3;FLNA;KCNJ10;KCNN2;KCNE5;KCNMA1;GABBR2;KCNJ3;KCNJ6;KCNN4;KCNMB4;KCNQ1;STAC
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5143496133065977,1.094964281317249,0.3737796373779637,0.6803493258516865,1.0,4/13,17.48%,MDK;HMGB1;IGF2;ADAM17
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.393296314029796,1.0948806376772622,0.3202127659574468,0.6801387673428475,1.0,20/75,18.30%,SPARC;CLDN5;SERPINF1;CTNNB1;PDE3B;PGK1;VASH1;CXCL10;SARS1;DCN;ADGRB1;ECSCR;STAB1;KLF4;PF4;DAB2IP;AMOT;AGO1;ADAMTS1;CCR2
prerank,lysosome organization (GO:0007040),0.42213048065576086,1.0948494912422437,0.36342592592592593,0.6797905592292727,1.0,8/36,13.30%,GRN;CORO1A;CLVS1;CLVS2;GAA;CLN5;CLN6;TMEM106B
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3925696602539939,1.0947391622751186,0.34112646121147716,0.6796548466446196,1.0,6/76,4.50%,TMSB4X;RPS3;LAPTM5;CCL19;TNF;SPI1
prerank,hyaluronan metabolic process (GO:0030212),0.46068737590740283,1.0946674669860348,0.35633626097867,0.6794083657254067,1.0,4/23,8.34%,HEXB;HEXA;HYAL2;GUSB
prerank,blood vessel endothelial cell migration (GO:0043534),0.4636050425677244,1.094255740009164,0.37957124842370743,0.6800909038280909,1.0,5/22,8.38%,AKT1;SOX18;ID1;EMP2;KDR
prerank,synaptic vesicle localization (GO:0097479),0.5130147278558107,1.09390697874997,0.3679890560875513,0.6805727534293727,1.0,5/13,18.47%,NLGN1;KIF5A;SYNDIG1;CDK5;KIF5C
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.44326510232966293,1.0935904838308634,0.36550060313630883,0.6809519657574502,1.0,12/27,34.98%,CHKB;PLAAT3;PCYT2;NAAA;ETNPPL;PLA2G3;PLA2G6;CEPT1;PNPLA8;PISD;PLAAT1;PLA2G15
prerank,cholesterol biosynthetic process (GO:0006695),0.4336072338617146,1.093383809872938,0.3611111111111111,0.6810316661880438,1.0,12/31,28.43%,LSS;DHCR24;ACAA2;SC5D;PLPP6;FDPS;NSDHL;PMVK;ACLY;INSIG2;EBP;HMGCS1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.47555871678974815,1.0933767557787961,0.3726474278544542,0.6806185900103284,1.0,5/19,17.16%,PARK7;PINK1;ATP13A2;FBXW7;DNM1L
prerank,bone development (GO:0060348),0.4226003328700412,1.0932381636652408,0.3548387096774194,0.6805375930202161,1.0,6/39,6.69%,RPL13;PPIB;VKORC1;TGM2;PTPRC;SBDS
prerank,regulation of response to biotic stimulus (GO:0002831),-0.3205668433257819,-1.0928812133640071,0.27835051546391754,0.7008881619507279,1.0,11/28,18.00%,FOXP1;APPL2;BIRC2;RNF135;BIRC3;TRIM5;CASP8;PTPN22;APPL1;CD55;DHX58
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.4507479811991882,1.0927253898109208,0.3704630788485607,0.6814463748002884,1.0,5/25,7.46%,CTSS;NDUFA4;ANK3;COX17;ATP1B2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4314595556825178,1.092595101038367,0.3556581986143187,0.6813364287818802,1.0,10/37,16.62%,NLGN1;GRID2;TENM2;TENM3;IL1RAPL1;TENM4;CADM3;PTPRD;DCHS1;VCAM1
prerank,telomere maintenance via recombination (GO:0000722),-0.4410802154828077,-1.091951219289075,0.3263157894736842,0.7013949560920556,1.0,2/11,3.01%,NSMCE2;TEP1
prerank,sensory perception of chemical stimulus (GO:0007606),0.490502508176452,1.0918374568335092,0.37349397590361444,0.6828973198076089,1.0,3/15,15.44%,SLC24A4;C5AR1;SYT10
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3529034897236511,-1.0914513499039098,0.2923076923076923,0.7007400286677772,1.0,10/22,19.26%,NTRK3;PDPK1;AGTR1;FGFR2;PDGFRB;ESR1;ABL2;KIT;PDGFRA;FGF2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.42027936270570737,1.091328191012148,0.3684820393974508,0.6838276319745704,1.0,9/39,14.60%,FXYD5;FXYD1;YWHAH;YWHAE;SCN4B;FXYD7;FGF12;CHRM3;KCNE5
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.3500719179007782,-1.0902914936906865,0.30973451327433627,0.7017730796747368,1.0,7/19,16.29%,SMAD6;ACVR1;BMPR1A;MDM4;SMAD4;HEY2;BMPR2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.319268075407711,-1.0902400643780483,0.32515337423312884,0.6998873692640568,1.0,10/31,14.40%,PARD3B;PARD3;PDCD6IP;DLG1;SYNJ2BP;OPHN1;PDZD11;MARK2;PRKCI;MYO9A
prerank,macrophage differentiation (GO:0030225),-0.395814916592936,-1.0897989397954457,0.3295880149812734,0.6990801608561847,1.0,5/13,13.72%,IL31RA;IL15;SIRT1;CASP8;BMP4
prerank,regulation of cellular amide metabolic process (GO:0034248),0.4368281480093742,1.089054328022677,0.3577430972388956,0.6894635333909638,1.0,7/32,13.19%,PGAM1;RPL10;GRM5;METAP1;PCIF1;RBM4B;METTL18
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5319467901321718,1.0887124526110679,0.3842857142857143,0.6899153204286816,1.0,1/10,2.61%,SERPINE2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.39470881661120893,1.0886391218297113,0.34908700322234154,0.6896711501148658,1.0,22/72,20.89%,TREM2;AGT;GPER1;TNF;PDGFB;HCLS1;NTRK2;FN1;EPOR;KDR;DCN;SOX9;F2RL1;PDGFA;NCF1;FLT1;PIK3CD;ERBB3;MAZ;FLT3;HGF;PTPN6
prerank,cellular response to glucose starvation (GO:0042149),-0.2976405833655755,-1.0882236548110695,0.3055555555555556,0.7014552149988681,1.0,12/41,16.27%,PRKAG2;SIK2;MTMR3;FOXO3;EIF2AK3;SIK1;PRKAA2;SESN1;NUAK1;PRKAG1;ITFG2;TP53
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.428417331168277,1.0879400280949942,0.3773148148148148,0.69107290932074,1.0,14/35,25.53%,ERBB4;TNF;PTPRC;HES1;LEPROT;CAV1;VHL;NOTCH1;IL6;IL10RB;ADIPOR1;SOCS3;DOT1L;HGS
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.41725319729623567,-1.087896090121606,0.34210526315789475,0.7003480623895468,1.0,4/12,15.55%,GMDS;FUT8;PARG;GFPT2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.38421997955205867,1.086997289533913,0.35456475583864117,0.693044537204866,1.0,15/80,10.72%,USE1;ARF5;LMAN2;TAPBP;ERGIC3;KDELR1;TMED7;SURF4;TMED2;ARFGAP2;KIF5A;TMED3;RER1;KIF26A;TMED9
prerank,muscle cell differentiation (GO:0042692),0.43437989701319246,1.0869651628615515,0.3583138173302108,0.6926884128302174,1.0,8/32,20.07%,SGCZ;MRTFA;SEMA4C;MTLN;NINJ1;SYNE1;TMEM204;MEF2C
prerank,regulation of organelle organization (GO:0033043),0.38822958229896687,1.086828660157162,0.35412262156448204,0.6926194356765061,1.0,21/80,17.16%,MAPK3;ARL6IP1;PINK1;S100A8;S100A9;STMN3;MSN;LMAN1;SAR1A;SURF4;MYO5A;SYT11;MAPT;ATP13A2;TMED9;PJVK;MIEF2;MFF;PDE4DIP;SQSTM1;DNM1L
prerank,regulation of epithelial cell proliferation (GO:0050678),0.38498757649638676,1.0867319415942833,0.35089567966280294,0.6924285467098471,1.0,21/85,16.56%,B2M;GPX1;GRN;LAMC1;NME1;MAGED1;NR1D1;ACVRL1;ZFP36L1;C5AR1;CDKN1C;NUPR1;EPPK1;ZFP36;HRAS;SOX9;TIE1;NME2;BAD;DAB2IP;EPB41L4B
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.39671384407839116,1.0865707675742007,0.35567567567567565,0.6924158565094055,1.0,10/63,13.46%,RPL26;RPS27L;CHEK2;PCBP4;RPA2;CCND1;BAX;PCNA;PRMT1;FBXO31
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.38470091846388355,1.0863916147689079,0.3347412882787751,0.6924536433458053,1.0,24/87,16.20%,ARHGDIA;MDK;RHOB;RHOC;RAC1;GPM6B;ARHGDIB;IQGAP2;RHOG;FAM107A;ESAM;CORO1A;PAK1;EPHA5;PHPT1;PAK3;CSF1R;TRPM2;BST2;RHOA;CCDC88A;PDGFA;DLC1;DMTN
prerank,regulation of protein kinase C signaling (GO:0090036),0.4980011792135126,1.0862862145156869,0.3838926174496644,0.692289051259428,1.0,6/14,20.24%,MYADM;MC1R;WNT5A;FLT4;ADRA1A;SPHK2
prerank,regulation of neuron projection arborization (GO:0150011),-0.37983744252670065,-1.0861484972264417,0.3514644351464435,0.7031274564377198,1.0,6/15,14.40%,MACF1;MAP3K13;MOV10;DLG4;DVL3;MYO9A
prerank,establishment of protein localization to membrane (GO:0090150),-0.2755095591617619,-1.086141147663639,0.23214285714285715,0.7011331435587145,1.0,9/66,6.61%,AFDN;EGFR;PARD3;SYNE3;BRAF;SEC63;ZDHHC1;GORASP2;RAB10
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5103359277184396,1.0857013521404533,0.38713910761154857,0.6934085649740551,1.0,5/13,15.30%,SHISA7;GRIK2;SYNGR1;SYP;PPFIA3
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3816516601237743,1.0855919987987432,0.32502596053997923,0.693242963141354,1.0,25/110,17.29%,RAMP2;GPER1;ADGRB3;ADGRL3;S1PR5;S1PR1;DRD5;GPR6;ADGRG1;RXFP1;CXCL10;ADGRB1;MC1R;ADGRB2;CALCB;RAMP3;ADCY4;PF4;ADGRL4;ADRA1D;ADRA1A;ADCY8;ADGRE1;PTGIR;ADCYAP1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4704857108245365,1.085504360109399,0.36970474967907574,0.693043810289117,1.0,8/19,23.96%,RPS27L;HIPK2;TMEM109;SNW1;DDIT4;PYCARD;PHLDA3;DYRK2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5067127064245741,1.0852180095644033,0.3795423956931359,0.6933485391254206,1.0,3/13,8.38%,CTNNB1;COL4A1;KDR
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.4078703988944027,-1.085140831218258,0.33221476510067116,0.7018630645419103,1.0,5/12,14.89%,PARP12;PARP16;PARP3;TNKS2;PARP10
prerank,regulation of collagen biosynthetic process (GO:0032965),0.46936619633335425,1.0851122530129083,0.3870967741935484,0.6932004539525027,1.0,1/19,0.71%,VIM
prerank,thymus development (GO:0048538),0.49894554983418854,1.0846485782942978,0.3978494623655914,0.6940095328715898,1.0,2/13,5.71%,SOD1;HES1
prerank,lipid transport (GO:0006869),0.38022714598413726,1.0840264940644675,0.34647302904564314,0.6951849574614485,1.0,13/97,12.54%,APOE;PLTP;GM2A;NPC2;SLCO1C1;SCP2;FABP5;ABCG1;MFSD2A;ATP8A1;SLC10A3;NME4;GLTP
prerank,regulation of platelet aggregation (GO:0090330),0.47219210044301446,1.083367022714403,0.39285714285714285,0.6965057552539275,1.0,6/17,26.80%,SERPINE2;DMTN;SYK;PRKCA;PRKCQ;CD9
prerank,positive regulation of neuron differentiation (GO:0045666),0.4208374806388997,1.082586475915812,0.36281179138321995,0.6981385926152242,1.0,18/40,24.62%,NBL1;BRINP3;NRCAM;PROX1;BRINP1;BRINP2;RHOA;BMP2;MMD2;PCP4;BEND6;TRIM32;SOX11;MEF2C;ADRA2B;REST;ECT2;TCF3
prerank,sensory perception of taste (GO:0050909),0.5166336279434852,1.081946297141864,0.39544807965860596,0.6993642033541957,1.0,5/10,33.38%,ASIC2;PKD2L1;TAS1R1;PKD1L3;CD36
prerank,calcium ion import across plasma membrane (GO:0098703),0.4900226976946557,1.0809787226225644,0.37276478679504815,0.7015184245835308,1.0,5/14,28.25%,SLC24A2;TRPM2;SLC8A1;CACNA2D1;ATP2B4
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.45804780052468574,1.0807956401421415,0.3939393939393939,0.7015367574098907,1.0,2/22,7.89%,B2M;HSPD1
prerank,vitamin D metabolic process (GO:0042359),0.5059744279162499,1.0806337481298836,0.3917112299465241,0.7015148092401667,1.0,2/13,12.74%,LGMN;GC
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.49403992594133284,1.0804436863171873,0.38247011952191234,0.7015678677752712,1.0,4/15,14.67%,ENTPD3;AK4;NME2;CMPK2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.4076480882631143,1.0802816258564925,0.35180995475113125,0.7015696865985892,1.0,10/45,12.33%,AURKAIP1;ZFP36L1;ZFP36L2;CTNNB1;CDKN1C;BTG1;BRINP3;GAS1;BRINP1;BRINP2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5038410422633917,1.0801109212528275,0.38493723849372385,0.7015739384339805,1.0,2/13,6.02%,SULT4A1;BPNT2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3609496882272643,1.0798883694299437,0.2962962962962963,0.7017175180700934,1.0,69/264,21.40%,HSPA8;PCBP1;SNRPG;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;POLR2F;RALY;SYF2;SNRPD2;LSM4;LSM8;LSM6;UBL5;SNRPE;PUF60;SNRPA;SNRPF;ZMAT2;SRSF9;PQBP1;STRAP;XAB2;HNRNPA0;CD2BP2;PRPF19;RBM15B;YBX1;POLR2G;PRPF8;SRSF2;SF3A2;PABPC1;RBM4B;SNW1;SF3B2;POLR2K;HNRNPU;HNRNPA1;NONO;CPSF2;SNRPB;SF3A3;PDCD7;EIF4A3;PRPF31;SF3B6;TXNL4A;U2AF1L4;SNRPD3;LSM7;SF3A1;HNRNPA3;ALYREF;BUD31;SRSF1;CDC5L;CPSF4;POLR2H;SNRNP35;DHX35;HNRNPF;SNU13;SNRNP200
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4927265813604752,1.0798296988561777,0.39617486338797814,0.7014334512336132,1.0,2/14,10.09%,CHKB;PCYT2
prerank,cardiac muscle cell contraction (GO:0086003),0.47572387354223467,1.0795694875453845,0.4007537688442211,0.7016832832418268,1.0,5/19,11.97%,GSN;SCN1A;SCN4B;FGF12;ATP1A1
prerank,neuromuscular process controlling balance (GO:0050885),0.5194669637297821,1.079511806347121,0.37796373779637377,0.7013935198779792,1.0,2/12,5.93%,NRXN1;PCDH15
prerank,thyroid hormone generation (GO:0006590),-0.44423023774440284,-1.0792872649765306,0.3464052287581699,0.7155441747173298,1.0,1/10,0.40%,CPQ
prerank,positive regulation of phosphorylation (GO:0042327),0.363642853511412,1.079255957789695,0.2995991983967936,0.7016011871532406,1.0,51/240,16.32%,PPIA;CD74;RACK1;HSP90AA1;GPNMB;MT3;C3;MAPK3;AKT1;CCND2;TREM2;ERBB4;PINK1;GPER1;TNF;RAC1;NTRK2;ANG;DSCAM;PIN1;MIF;FLOT1;KNDC1;RARRES2;LTK;MUSK;TFRC;CCND1;PAK1;P2RX7;KDR;MLXIPL;P2RY1;EPHA5;CSF1R;PECAM1;FLT4;HRAS;TMEM119;SOX9;TIE1;BMP2;GAS6;CLIP3;SDCBP;PTGES3;IGF2;RASGRP1;EPHB1;FLT1;TYRO3
prerank,response to ionizing radiation (GO:0010212),-0.27119753732815205,-1.079123098182881,0.323943661971831,0.7140598163255836,1.0,22/70,18.08%,EYA1;BABAM2;DCUN1D3;COP1;CLK2;BRAT1;SPIDR;UIMC1;RNF8;NHEJ1;INO80;MRNIP;EYA3;ATM;TNKS1BP1;USP28;SIRT1;KDM4D;TP53;INIP;MAPK14;INTS3
prerank,mRNA destabilization (GO:0061157),-0.295887537487714,-1.0787264932602547,0.2692307692307692,0.7131230804942712,1.0,10/38,10.06%,ROCK2;FTO;ROCK1;DHX36;CNOT1;YTHDF3;TUT7;CPEB3;MOV10;RC3H2
prerank,macroautophagy (GO:0016236),0.37552471143430594,1.0785284002111353,0.32954545454545453,0.7030641383294481,1.0,19/118,12.05%,GABARAP;DYNLL2;DYNLL1;TOMM6;TOMM5;TOMM7;MAP1LC3B;PINK1;MAP1LC3A;CSNK2B;GABARAPL2;GABARAPL1;CHMP2B;VCP;ATP13A2;CHMP6;ULK3;VAMP8;VPS28
prerank,regulation of JUN kinase activity (GO:0043506),0.4286494314952864,1.0776963794876642,0.3847953216374269,0.7047986442978519,1.0,7/33,16.24%,RPS3;TNF;PAK1;DNAJA1;MAPK8IP1;TLR6;DAB2IP
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.3821095518138071,1.0775859597273143,0.3717001055966209,0.7046578962938369,1.0,20/87,13.63%,RPS27A;UBC;CLDN5;UBB;FMOD;ID1;ACVRL1;FKBP1A;EID2;LEFTY2;WFIKKN2;UBA52;ZYX;COL3A1;JUN;AMHR2;ZMIZ2;COL1A2;RHOA;LEFTY1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.40143916707929667,-1.0773844095837593,0.36363636363636365,0.7146780011658614,1.0,2/13,2.98%,KCNK5;KCNT2
prerank,response to tumor necrosis factor (GO:0034612),0.38125059392679106,1.0773305710300107,0.3608786610878661,0.7048678554097928,1.0,18/91,17.61%,RPS3;AKT1;CCL19;GPER1;NR1D1;ZFP36L1;ZFP36L2;HYAL2;CXCL16;ZFP36;SMPD1;ERBIN;CCL2;YBX3;DAB2IP;CCL3;TRIM32;CCL8
prerank,synaptic vesicle recycling (GO:0036465),0.43286454741745356,1.0771178068524105,0.3916167664670659,0.7050152347718192,1.0,18/31,32.93%,NLGN1;CANX;PACSIN1;SYT1;AMPH;VAMP2;CDK5;SYT2;SNCA;WNT7A;SYT5;TBC1D24;PIP5K1C;SYT7;RAB3A;CEL;SNCG;SNCB
prerank,peptidyl-lysine modification (GO:0018205),-0.23802700246611555,-1.0769266988092403,0.2962962962962963,0.7140255252124795,1.0,28/99,18.54%,EYA1;PLOD2;RANBP2;NSMCE2;HDAC4;SENP6;PIAS1;PIAS2;LOXL1;NUP98;SAE1;KAT2B;ATP7A;SENP7;LOXL3;TOPORS;SENP1;TRPM4;ESCO1;STX1A;SIRT1;AAAS;SIRT7;NUP214;NUP35;NDC1;VCPKMT;METTL21A
prerank,response to retinoic acid (GO:0032526),0.39434497417247916,1.0765307080729407,0.38846572361262244,0.7060875534751802,1.0,13/59,14.17%,NDUFA13;RBP4;LTK;BRINP3;PTK6;AQP1;BRINP1;WNT5A;BRINP2;SNW1;SOX9;WNT10B;CTSH
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.38447700437684135,1.076490252997015,0.37697993664202745,0.7057584231456954,1.0,25/78,19.83%,ACTB;AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;TMEM59;AP2M1;RHOG;CLTC;ARF6;ZDHHC5;RAMP3;VAMP8;RSC1A1;CLIP3;CDK5;SQSTM1;MMP14;TMBIM1;STX4;VPS4A;STAC3;TGFB1
prerank,neuron projection regeneration (GO:0031102),0.5332270278662844,1.0763030212747045,0.4,0.7057823817524123,1.0,7/10,40.33%,GAP43;PTN;DHFR;NREP;MTR;OMG;RTN4RL1
prerank,base conversion or substitution editing (GO:0016553),0.5204172522457484,1.0757744345593652,0.4,0.7067067754375989,1.0,4/11,24.56%,APOBEC2;NUDT16;APOBEC1;METTL3
prerank,serine family amino acid biosynthetic process (GO:0009070),0.5059904817211885,1.075425748102376,0.4063745019920319,0.7071830843443866,1.0,3/12,14.54%,SERINC3;PHGDH;SERINC5
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.48155260865674954,1.0753467021783285,0.4005270092226614,0.7069469192132285,1.0,7/17,17.48%,AKT1;CCND2;PDGFB;CCND1;PROX1;MAPRE3;ADAM17
prerank,negative regulation of cell differentiation (GO:0045596),-0.23196731721015182,-1.0751287656695805,0.09090909090909091,0.7171201226714188,1.0,45/181,16.53%,LDLRAD4;RANBP3L;SMAD3;COL5A2;EGFR;ADAMTS12;SMAD6;COL5A1;CRIM1;ZBTB16;SUFU;LRP5;SKI;YAP1;EIF2AK4;PPARA;ADGRV1;TGFBR1;EFEMP1;ASXL1;ZFPM2;CDK6;RUNX1T1;TRIB2;NPHP3;SMAD7;ENPP1;PPARG;PTEN;TRPM4;PDCD4;FERMT2;TRIO;JAG1;RORA;SIRT1;BMP4;DTX1;CHADL;IL17RD;CDC73;LIMD1;FOXO1;ANKRD26;WNT9A
prerank,positive regulation of GTPase activity (GO:0043547),-0.2435562694140878,-1.0746901128198811,0.3333333333333333,0.7163233225351172,1.0,51/188,15.32%,ARHGAP29;AFDN;SIPA1L1;DOCK11;ASAP3;RSU1;ARHGAP42;BCAS3;RAPGEF2;TIAM2;SGSM2;USP6NL;NTRK3;TBC1D12;RALGAPB;LIMS1;DOCK7;SIPA1L3;TBC1D2B;RAPGEF6;RABGAP1;CCL25;RAPGEF1;TBC1D9B;BCR;TBC1D4;MAP4K4;SYDE2;PICALM;PIP5K1A;BCAR3;ALS2;SNX9;PKP4;TBC1D8B;TBCK;RAPGEF3;FERMT2;SIPA1;RIC1;RALGAPA1;DVL3;WNT11;RGS16;GSK3B;RAP1GDS1;TSC1;EZH2;NGEF;NDEL1;LARS1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.4106762914947153,-1.0743623299228557,0.32989690721649484,0.7151774367980619,1.0,2/12,1.09%,NOTCH2;DOCK11
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.2709435335791154,-1.0743622169229787,0.3283582089552239,0.7132018085196143,1.0,17/67,10.73%,EGFR;FER;ABL1;GHR;EPHA3;IL15;EPHA4;EFEMP1;INSR;DYRK1A;PIBF1;FGFR2;PDGFRB;ABI1;ABL2;PTK2;EPHB2
prerank,steroid hormone biosynthetic process (GO:0120178),0.4369487372922093,1.0742743944029711,0.3857315598548972,0.7092863334893229,1.0,6/29,20.73%,TSPO;HSD17B6;FDX2;HSD3B2;STARD3NL;HSD17B11
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4885328151685552,1.0738830524315113,0.39577836411609496,0.7098745450904866,1.0,8/16,19.10%,CALM1;CALM3;GSTO1;GSTM2;SLC8A1;RYR2;FKBP1B;CALM2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4581868436994687,1.0736063652264292,0.40370370370370373,0.7101371317462511,1.0,6/21,18.07%,PDGFB;IGFBP5;P2RY6;JUN;GJA1;ADAMTS1
prerank,granulocyte differentiation (GO:0030851),0.47002959640890407,1.0731652289128963,0.39197930142302717,0.7108677966842051,1.0,3/18,10.36%,SPI1;CEBPA;DEK
prerank,cellular response to starvation (GO:0009267),0.37067176699375765,1.0726100464615427,0.35020242914979755,0.7118950113305325,1.0,18/147,7.08%,HSPA8;GABARAP;ATP6V0C;MAPK3;HSPA5;ATF4;ATP6V1F;MAP1LC3B;MAP1LC3A;LAMTOR2;LAMTOR4;GABARAPL2;LAMTOR5;ATP6V1G1;GABARAPL1;ATP6V0E2;FADS1;CEBPB
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.36780172122386096,1.0726019972240568,0.33163265306122447,0.7114772469264159,1.0,58/151,31.63%,APOE;CHKB;GSTM1;CERS2;CSNK2B;GPHN;MGST1;GSTO1;ELOVL1;ELOVL2;MFSD2A;GSTM5;MGST3;GSTM2;ELOVL7;CHAT;GCNT1;HPGDS;SPTLC1;DEGS1;ACHE;FA2H;CSNK1G2;SPTSSA;AKR1A1;INHBA;VAPA;ESD;SGPP1;SPHK2;SGPP2;SLC44A5;SGPL1;TNIP1;STARD10;LPCAT2;MOCS2;ELOVL6;ALDH3B1;VAPB;SLC44A2;INHA;LCMT2;ASL;HACD4;SLC44A1;SAMD8;CERT1;GSTM4;ALAS2;ASS1;ARG2;CEPT1;SPNS2;ALDH3A2;PCSK1;ELOVL4;ALAS1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4835964016587199,1.072430585110322,0.3888888888888889,0.7114861219301698,1.0,4/15,11.24%,PNPLA2;TREM2;LPL;PLIN3
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.3222670974694727,-1.0724295353954874,0.3192771084337349,0.7163983514800791,1.0,8/29,10.54%,PLEKHH2;LIMA1;ARFGEF1;SLIT2;PRKN;ARPIN;KANK1;SMAD4
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4281890545995865,1.0720678419304435,0.3909952606635071,0.7119904234432327,1.0,8/34,10.02%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;P4HB;ARHGEF7
prerank,regulation of mast cell activation (GO:0033003),0.5306305764122423,1.0715906094846368,0.4028776978417266,0.7127854272846297,1.0,5/10,33.35%,CD84;CD300LF;CRLF2;PLSCR1;MILR1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5057125252419075,1.0711642986508332,0.39185393258426965,0.713465628757853,1.0,5/12,16.12%,NELFCD;HNRNPU;HEXIM1;RECQL5;NELFE
prerank,inorganic cation transmembrane transport (GO:0098662),0.3589656324895359,1.0708424549168718,0.30220883534136544,0.7138689938481565,1.0,61/268,19.69%,ATP5MF;ATP6V0C;ATP5F1B;SLC30A1;ASIC2;ATP6V1F;SLC39A1;UCP2;SLC24A4;SLC24A2;KCNQ3;SCN1A;KCNQ2;KCNC3;FKBP1A;KCND2;ATP6V0E2;KCNJ10;CACNA1A;ATP1A3;SLC39A7;TMCO1;SLC6A6;P2RX7;HVCN1;SLC6A17;SLC6A2;SLC6A5;SCN4B;SLC6A16;KCNC1;KCNA2;TRPM2;TRPC7;KCNN2;SLC40A1;ATP1A4;ATP1A1;KCNK9;SLC11A1;SLC25A27;ABCC8;GAS6;TRPC1;KCNF1;ATP1B1;SLC8A1;HCN1;KCNK3;KCNA1;ORAI1;LRRC55;KCNK10;HCN3;ATP1B3;SLC9A9;KCNH7;KCNH8;KCNK13;KCNQ5;PKD2L1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.527643634165814,1.0708266013371586,0.41690962099125367,0.7134766870890658,1.0,3/10,16.24%,CADM4;DCN;DAB2IP
prerank,protein localization to membrane (GO:0072657),0.363391509254745,1.0708136572184428,0.3383838383838384,0.7130669244386829,1.0,41/187,16.42%,BSG;CD81;RAMP2;KCNIP4;NRXN1;NLGN1;S100A10;ITGB2;ANK3;TNF;EMP2;DPP10;DLG2;PACSIN1;FLOT1;FLNA;CPE;MYADM;RAB15;DPP6;TMED2;MYO5A;THY1;RAB3C;P2RY1;ABHD17A;RAB3D;RAMP3;NRXN2;GAS6;TNFRSF1A;MAP7;LRRC7;EHD1;LIN7C;FRMPD1;ATP1B1;SPTBN4;FGF13;EPB41L3;CAV1
prerank,cellular defense response (GO:0006968),0.41113442044652926,1.070710835406218,0.388180764774044,0.712891921054621,1.0,15/40,26.68%,TYROBP;CD5L;LGALS3BP;C5AR1;CCR5;KLRG1;CX3CR1;NCR1;NCF1;TRAT1;NCF2;RELA;LBP;ITGB1;ITK
prerank,negative regulation of interleukin-6 production (GO:0032715),0.4358188347423033,1.0704532716540438,0.3785103785103785,0.7131214525192054,1.0,7/27,21.40%,TNF;SIRPA;TNFAIP3;SYT11;GAS6;PTPN6;SELENOS
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3662938587332864,1.0699354687507816,0.35264227642276424,0.7140066465192042,1.0,31/158,14.62%,CD74;GAPDH;LGALS1;HMOX1;CCL19;S100B;PINK1;S100A13;TNF;EEF1D;RHOC;LAMTOR5;FKBP1A;SHISA5;ECM1;TIRAP;FLNA;TFRC;TMEM101;CLEC6A;TICAM2;TMEM9B;RBCK1;BST2;RHOA;GJA1;RIPK2;TNFRSF1A;UBE2V1;TLR6;F2RL1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.36206468181344936,1.069695655123969,0.33867735470941884,0.7142244750675735,1.0,53/208,20.93%,CD74;GAPDH;HSPB1;LGALS1;HMOX1;CCL19;S100B;TREM2;PINK1;S100A13;TNF;EEF1D;RHOC;LAMTOR5;NR1D1;FKBP1A;SHISA5;ECM1;TIRAP;FLNA;TNFAIP3;TFRC;TMEM101;CLEC6A;OTUD7A;TICAM2;TMEM9B;TRIM59;RBCK1;WNT5A;BST2;RHOA;GJA1;RIPK2;TNFRSF1A;UBE2V1;TLR6;F2RL1;TRAF3;DAB2IP;SQSTM1;TRIM32;S100A4;TERF2IP;LTBR;TRIM13;VAPA;CANT1;SPHK2;GOLT1B;CAPN3;TMEM106A;PYCARD
prerank,brain development (GO:0007420),0.3679623385673527,1.0694667236638369,0.36475409836065575,0.7143818278728643,1.0,37/136,19.98%,APOD;CTNNA2;NES;CNTNAP2;CNTN4;SCTR;NDRG4;ABCB6;ADGRL3;GRIN1;NKX2-2;TMX2;ADGRG1;PHGDH;UFC1;PROX1;MAST1;COL4A1;GRIN2A;MFSD2A;SLC6A17;CDK5R1;DNAJC30;AATK;HAP1;CLN5;CXCR4;CX3CR1;IER3IP1;DSCAML1;ROBO2;GRIN2B;QARS1;RAB18;NNAT;HSPG2;DDIT4
prerank,regulation of muscle contraction (GO:0006937),0.439628075045729,1.0692757896984189,0.3853779429987608,0.7144377088728044,1.0,8/26,18.66%,MYL9;ENO1;CHRM2;TNNI1;KCNA1;CAV1;SRI;ANXA6
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4779714871006846,1.0687573861408493,0.39823008849557523,0.7153907785063132,1.0,5/17,16.38%,APOC1;LPL;SORT1;NR1H2;HDAC9
prerank,cellular response to light stimulus (GO:0071482),0.3885852059240765,1.0686020133412042,0.38244853737811485,0.7153775449600444,1.0,9/66,12.08%,RPL26;ATF4;NPM1;COPS9;PARP1;AQP1;SMPD1;PCNA;NSMCE3
prerank,response to lipopolysaccharide (GO:0032496),0.36455775565258103,1.0682454764041989,0.358087487283825,0.7158590881882887,1.0,52/138,29.83%,VIM;PDE4B;NR1D1;S100A8;S100A9;TIRAP;SIRPA;CD180;TNFAIP3;CCR5;HNRNPA0;CXCL10;TICAM2;CD68;HMGB1;ZFP36;CHMP5;WNT5A;SLC11A1;RHOA;LILRB1;ERBIN;CX3CR1;CCL2;PF4;DAB2IP;ADAM17;NOS2;SNCA;CD14;CD86;NLRP3;IL6;GIT1;MEF2C;PYCARD;SELENOS;NUGGC;RELA;TNFRSF11A;LBP;CASP1;TRIB1;SCARB1;XBP1;TNFRSF1B;GGT5;PPBP;GGT7;NOD2;ACOD1;IFNAR1
prerank,amino acid import across plasma membrane (GO:0089718),0.4467689136550149,1.0682241946015973,0.3960880195599022,0.7154753352241563,1.0,8/24,12.43%,SLC7A5;SLC1A4;SLC1A2;TSPO2;SLC6A6;SLC6A5;SLC3A2;SLC1A1
prerank,cellular response to calcium ion (GO:0071277),0.3898771412089011,1.0681821279806893,0.36140724946695096,0.715147881490737,1.0,25/67,25.93%,LGMN;NLGN1;SYT1;SYT12;SYT11;SYT6;SYT4;SMPD1;WNT5A;TRPM2;ALOX5AP;CPNE5;SYT10;CPNE6;DMTN;ADCY8;SYT2;CPNE4;MEF2C;CAPN3;SYT3;SYT5;ECT2;SYT17;CPNE3
prerank,regulation of macroautophagy (GO:0016241),0.37627109737280356,1.06757434580779,0.37747653806047965,0.7163124801921039,1.0,24/105,16.15%,GAPDH;ATP6V0C;CAPNS1;AKT1;PINK1;LAMTOR2;LAMTOR4;LAMTOR5;ATP6V1G1;UCHL1;ATP6V0E2;BNIP3L;SCOC;KDR;CDK5R1;ATP13A2;DCN;ATP6V0D2;UBQLN2;LAMTOR3;ATG101;RRAGC;CDK5;RRAGD
prerank,protein localization to synapse (GO:0035418),0.5060149480912973,1.0675124902482163,0.3963585434173669,0.716031778949273,1.0,3/12,12.53%,NRXN1;NLGN1;NRXN2
prerank,mitotic cytokinetic process (GO:1902410),0.4632740858263522,1.0672840310316989,0.40443896424167697,0.7161759008683656,1.0,9/20,25.87%,CHMP2B;CHMP5;CHMP6;RHOA;CHMP1B;VPS4A;CHMP7;CHMP1A;CHMP4C
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.39364315397012783,-1.067243493203223,0.36162361623616235,0.7288135800667143,1.0,6/13,13.72%,NFIB;PPARA;NFATC4;PPARG;NFATC3;BMP4
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.4561891323744488,1.067068099093076,0.40516129032258064,0.7163014798838396,1.0,3/21,3.08%,MT3;PARK7;PINK1
prerank,nucleoside salvage (GO:0043174),0.5276850050700996,1.0670296543577447,0.40816326530612246,0.7159573487393105,1.0,7/10,31.95%,UCK1;UCKL1;CDA;UPP1;TK1;TK2;DCK
prerank,oligodendrocyte development (GO:0014003),0.48310465712068534,1.0668358695140874,0.41106719367588934,0.7160432595159055,1.0,9/15,33.08%,PLP1;B4GALT6;MYRF;EIF2B5;SOX10;EIF2B1;CNTNAP1;PRDM8;B4GALT5
prerank,protein homotetramerization (GO:0051289),0.3960453597014739,1.0667205460392453,0.3844444444444444,0.7159001913167575,1.0,3/49,2.27%,ALDOA;B2M;AQP4
prerank,protein localization to plasma membrane (GO:0072659),0.3670721674549502,1.0665049012141992,0.3761562178828366,0.7160173578360544,1.0,33/129,18.17%,BSG;CD81;RAMP2;KCNIP4;S100A10;ANK3;TNF;EMP2;DPP10;PACSIN1;FLOT1;FLNA;MYADM;RAB15;DPP6;TMED2;MYO5A;RAB3C;P2RY1;RAB3D;RAMP3;GAS6;TNFRSF1A;MAP7;CCDC88A;EHD1;ATP1B1;SPTBN4;FGF13;EPB41L3;CRB3;ATP1B3;EHD2
prerank,T cell mediated immunity (GO:0002456),0.49103446026344544,1.0661290997104258,0.41711229946524064,0.7165880300397114,1.0,5/13,26.73%,EMP2;BTN3A3;CTSH;MYO1G;GNL1
prerank,RNA splicing (GO:0008380),0.37450501337179637,1.0658662646985742,0.3921161825726141,0.7168250633870389,1.0,25/95,19.03%,SNRPG;MAGOHB;MAGOH;DDX39B;SNRPD2;LSM4;LSM6;PPP2R1A;SNRPF;TARDBP;PRPF8;SRSF2;SF3B2;IVNS1ABP;NONO;SNRPB;SF3A3;RRAGC;PDCD7;CELF3;PPARGC1A;TXNL4A;SNRPD3;CCAR2;USB1
prerank,regulation of synapse maturation (GO:0090128),0.5277642918107981,1.065844093970494,0.41333333333333333,0.7164500096055957,1.0,6/10,32.76%,NRXN1;YWHAZ;DAB2IP;CDC20;CAMK2B;RELN
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3591520444660761,1.0650857795711115,0.3123123123123123,0.7179598122047309,1.0,59/314,13.85%,RPS27A;UBC;UBB;PSMB4;SEC61B;UBXN1;HSPA5;PSME1;PSMB6;PSME2;PSMB8;PSMD2;KCTD10;HSP90B1;PSMD1;AUP1;UBE2G2;PSMC3;UCHL1;ECRG4;CTNNB1;PSMD6;VCP;CDC34;RNF187;UBA52;PSMA7;KCTD2;FEM1C;FEM1A;FBXL14;NHLRC1;KCTD17;PSMD5;TRIM9;RBX1;FBXO27;TRIM2;TNFAIP1;DDB1;PSMB9;SEL1L2;PSMD13;RBCK1;BUB3;PSMB3;FBXW5;WFS1;SYVN1;DNAJB2;MAN1B1;PSMB11;ZSWIM8;FBXW7;UBQLN2;FBXO5;FBXO31;PSMB10;KBTBD7
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5115358581594761,1.0648661470410252,0.41815680880330125,0.7181225148336876,1.0,3/11,15.47%,CTDNEP1;MFSD2A;NR1H2
prerank,neural tube closure (GO:0001843),-0.30659963420465786,-1.0646086882172359,0.3223684210526316,0.7340259336962345,1.0,8/34,13.47%,COBL;SKI;LRP6;MTHFR;LMO4;DVL3;IFT122;CELSR1
prerank,regulation of biomineral tissue development (GO:0070167),0.433510487413768,1.064008856945549,0.3959810874704492,0.7199256892799264,1.0,12/26,19.83%,ECM1;S1PR1;CEBPB;SOX9;FBXO5;GAS6;HEY1;TWIST1;DDR2;NOTUM;NOTCH1;TGFB1
prerank,regulation of protein localization to membrane (GO:1905475),0.4265946511170706,1.0635531493152375,0.3896260554885404,0.7206502378530044,1.0,2/28,0.88%,ACTB;GSN
prerank,chloride transport (GO:0006821),0.38896670226811414,1.0632199480254834,0.3901156677181914,0.7210645240631536,1.0,14/74,12.51%,GABRB1;FXYD1;LRRC8A;GABRG3;GABRA2;SLC12A5;TTYH1;GLRA2;GLRA1;GABRA3;GABRB3;SLC1A1;CLIC1;TTYH3
prerank,neuron differentiation (GO:0030182),0.3594040485134707,1.0627994182298766,0.37600806451612906,0.7216764073705355,1.0,57/165,29.18%,ITM2C;NTRK2;PIN1;CTNNB1;SPOCK1;TENM2;TENM3;MANF;OTX2;ATP8A2;IL1RAPL1;CDK5R1;EPHA5;PHOX2A;TENM4;WNT5A;PTPRD;IRX3;WNT10B;UGDH;CDK5;OLIG1;MYEF2;FUT9;BRSK2;ERCC6;MYT1L;BTG4;ACSL3;SOX11;INHBA;DDIT4;MEF2C;FOXA2;FZD2;ID2;FOXA1;HS6ST1;FZD1;USH2A;IER2;WNT7A;ACSL4;OLIG2;SRF;RORB;FZD3;ALK;TGFB2;ERCC2;XBP1;TENM1;ATP2B2;FZD5;MTPN;SNPH;IRX5
prerank,glucan biosynthetic process (GO:0009250),0.49983474552975693,1.0624255856920917,0.40715268225584594,0.7217953470078026,1.0,3/12,8.42%,NR1D1;GYS2;NHLRC1
prerank,glycogen biosynthetic process (GO:0005978),0.49983474552975693,1.0624255856920917,0.40715268225584594,0.7217953470078026,1.0,3/12,8.42%,NR1D1;GYS2;NHLRC1
prerank,ganglion development (GO:0061548),0.5091137742682814,1.0622595289288543,0.40405405405405403,0.7217708018353785,1.0,3/11,9.29%,SEMA3F;CTNNB1;UNC5C
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.368764799007861,1.0621773583786387,0.38022426095820594,0.7215633263955564,1.0,26/116,19.67%,RAMP2;TREM2;POMC;SCTR;DRD5;CD163;RXFP1;PRKAR1A;VIPR1;CRH;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;ADCY4;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;SYK;GPR83;IL6
prerank,odontogenesis (GO:0042476),-0.30653920184478495,-1.0619988913041825,0.32894736842105265,0.7392468315035549,1.0,6/35,8.39%,EDA;ANKRD11;GLI2;LRP6;BCOR;FGFR2
prerank,positive chemotaxis (GO:0050918),0.4707331350579474,1.061882731003786,0.41414141414141414,0.7218847239469081,1.0,3/17,7.45%,GPNMB;LGALS3;CORO1A
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.43679525358772925,1.0618509063809498,0.3965303593556382,0.7215351041370681,1.0,3/23,8.79%,CALM1;METAP1;METAP2
prerank,regulation of protein secretion (GO:0050708),0.36850976541221653,1.0616263506966337,0.3783231083844581,0.7217103792794767,1.0,29/119,21.28%,APOE;PPIA;UQCC2;MTNR1B;SLC2A1;SNAP25;TREM2;TNF;ANG;ABCG1;CACNA1A;ARF6;ATP13A2;DPH3;STXBP5L;APBB1;ABCC8;IER3IP1;ACHE;SLC2A2;DNM1L;NOS2;TFAP2B;IL6;ERP29;TGFB1;KCNC2;RSAD2;TMED10
prerank,transport across blood-brain barrier (GO:0150104),0.3773311884463473,1.0616184244207088,0.38396624472573837,0.7212957656626818,1.0,22/83,16.01%,SLC38A5;SLC2A1;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;FABP5;TFRC;ATP1B2;SLC6A6;MFSD2A;SLC6A17;LRP3;ATP8A1;SLC29A1;ATP1A4;SLC1A1;SLC19A1;SLC29A2;SLC16A1;SLC15A2;ABCA2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3620687104378468,1.0614432779436804,0.3696537678207739,0.72129967268723,1.0,37/142,18.30%,CD52;CHRNA9;GPER1;TAC1;FZD9;C5AR1;CAV2;YWHAE;CACNA1A;CCR5;CALB1;PLN;TACR1;P2RY1;CD24;HMGB1;CALCB;WNT5A;TRPC7;ATP2B1;CXCR4;TRPC1;CX3CR1;F2RL1;SLC8A1;RYR2;ADRA1D;ADRA1A;ADCY8;CAV1;CCKBR;BCAP31;HCRTR1;PTGIR;ADCYAP1;FKBP1B;CCR2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.4837597083421664,1.0612407902918286,0.41709183673469385,0.7213707688442357,1.0,3/16,3.71%,MDK;ITGB2;TNF
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4446364170027933,1.0611755401437792,0.40836408364083643,0.7210949173796709,1.0,13/26,24.86%,MBP;PSME1;PSME2;PSENEN;GRIN1;VSIR;APH1B;GRIN2B;PRELID1;EFNA1;PYCARD;AGER;APH1A
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.4208414747621561,-1.06112658006052,0.35563380281690143,0.739743509321552,1.0,4/11,8.19%,GHR;IRS1;EIF2AK3;IGF1
prerank,protein sumoylation (GO:0016925),-0.2692066949966091,-1.0609050735265542,0.3018867924528302,0.7384391636342669,1.0,13/49,16.30%,EYA1;RANBP2;NSMCE2;PIAS1;PIAS2;NUP98;SAE1;TOPORS;TRPM4;STX1A;AAAS;NUP214;NUP35
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.4922168266708281,1.0606738683328787,0.41737891737891736,0.7219556515341078,1.0,5/12,25.94%,CLEC6A;SLC11A1;CCR2;IL12RB1;PRKCQ
prerank,regulation of mitotic spindle organization (GO:0060236),0.41325545142694653,1.0605110315739716,0.3954022988505747,0.7219480714894366,1.0,10/35,15.97%,HSPA1B;CHMP2B;CLTC;TACC3;CHMP5;GNAI1;DCTN1;HSPA1A;HNRNPU;CHMP1B
prerank,lipid biosynthetic process (GO:0008610),0.3769943765138525,1.0605078599677786,0.40398740818467993,0.721525481321849,1.0,17/77,23.49%,SCD5;SCP2;FADS1;LIPG;LSS;LPL;PCYT2;OXSM;SCD;HSD3B2;CLN8;AGPAT5;PDSS1;ACSM5;NDUFAB1;PRLR;ACLY
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.41795681101541615,1.0602124952340142,0.39315230224321135,0.7218502176025895,1.0,13/32,24.88%,HINT1;RPS27L;HIPK2;TMEM109;PMAIP1;SNW1;STK11;POU4F1;DDIT4;PYCARD;PHLDA3;DYRK2;BOK
prerank,protein autophosphorylation (GO:0046777),-0.23293161702909673,-1.0600649365878758,0.29411764705882354,0.7387364059927095,1.0,33/157,11.17%,GRK5;EGFR;FER;ABL1;DAPK1;LRRK2;CAMK2D;SIK2;MAP3K3;MAP3K13;CLK2;SMG1;EIF2AK4;PDPK1;EPHA4;STK24;CDK12;EIF2AK3;INSR;DYRK1A;MARK3;MAPKAPK3;SIK1;TAOK3;FGFR2;NEK6;AAK1;STK10;PDGFRB;RIPK1;PTK2;SLK;DAPK2
prerank,cortical cytoskeleton organization (GO:0030865),0.4043064637212426,1.059755996723694,0.40162037037037035,0.7225652166946207,1.0,14/41,17.41%,RHOB;NLGN1;TNF;RHOC;RAC1;RHOG;LCP1;ARF6;FMNL1;RHOA;EPB41L3;FMNL3;FHOD3;RAC2
prerank,regulation of neuron migration (GO:2001222),0.43679396466586445,1.059484580968801,0.4092570036540804,0.7228156289976495,1.0,12/26,26.21%,MDK;CTNNA2;ADGRG1;COL3A1;SHTN1;TNN;IGSF10;DAB2IP;NSMF;PLXNB2;KIF20B;CX3CL1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.4199408171827648,1.05922794292053,0.40602409638554215,0.7230366667428975,1.0,11/32,22.36%,SLC30A1;GPER1;RIMS2;RIMS1;SYT11;SYN1;HCRT;PREPL;MEF2C;STX1B;CHRNA3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3221196463689475,-1.0590272903322069,0.3465909090909091,0.7394685097248349,1.0,11/26,16.96%,SORBS1;OSBPL8;BRAF;IRS1;INSR;IGF1;PRKCI;CREBL2;RHOQ;OCLN;APPL1
prerank,negative regulation of synaptic transmission (GO:0050805),0.4367453089904918,1.0587172737692823,0.3952912019826518,0.7238914737137806,1.0,5/23,15.63%,SLC30A1;SLC24A2;SYT11;ARF1;ACHE
prerank,embryonic axis specification (GO:0000578),-0.38027161082666366,-1.0585638362394199,0.3607843137254902,0.738695976097974,1.0,4/15,13.79%,SMAD6;COBL;TASOR;SMAD2
prerank,negative regulation of immune response (GO:0050777),0.3621754678705421,1.058433358612761,0.3731041456016178,0.7241964012015364,1.0,33/154,18.71%,RAMP2;TREM2;POMC;LGALS3;SPI1;SCTR;TNFAIP3;DRD5;CD163;RXFP1;PRKAR1A;COL3A1;VIPR1;CRH;HCK;FCGR1A;MC1R;PRKAR1B;CALCB;RAMP3;LILRB1;ADCY4;TYRO3;ADCY8;HTR7;PRKAR2B;PTGIR;ADCYAP1;ADAM17;CD300A;SYK;CCR2;GPR83
prerank,negative regulation of cell development (GO:0010721),0.4422818679120869,1.0583172581209972,0.4155688622754491,0.7240563360511029,1.0,10/25,23.03%,B2M;TNF;SORL1;RFLNB;FBXW7;LILRB1;NOTCH1;IL6;REST;WNT7A
prerank,negative regulation of cyclase activity (GO:0031280),0.47823582620858346,1.0582015355201444,0.407202216066482,0.7239390623622987,1.0,4/14,20.06%,GNAI2;RD3;CCR2;GABBR2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.3319747126915545,-1.0579256907834973,0.3465346534653465,0.7385620811272152,1.0,5/25,6.88%,EXT1;B3GNT2;HS2ST1;B3GALT1;NDST1
prerank,nucleic acid metabolic process (GO:0090304),0.38036667684731335,1.0578557284148273,0.41862955032119914,0.7244022704500619,1.0,23/69,25.02%,PCBP1;POLR2E;POLR2D;HNRNPK;POLR2F;RAN;LSM8;HNRNPA0;POLR2G;POLR2K;HNRNPU;PDE12;HNRNPA1;RECQL5;WDR74;HNRNPA3;POLR2H;HNRNPF;POLG;HNRNPH2;PCBP2;METTL3;METTL14
prerank,apoptotic DNA fragmentation (GO:0006309),0.47847143861174113,1.0570641072803213,0.4189723320158103,0.7259351081225844,1.0,4/16,10.22%,ENDOG;FOXL2;HMGB1;H1-0
prerank,regulation of protein autophosphorylation (GO:0031952),0.4146099568431034,1.0570523547662647,0.41570438799076215,0.7255412866292681,1.0,4/36,3.89%,CALM1;GPNMB;CALM3;PDGFB
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.276645387426626,-1.0567759455766037,0.3170731707317073,0.7399578803092585,1.0,14/56,14.03%,EGFR;UBE2E2;NSMCE2;BRD4;ANAPC5;ANAPC7;TFDP1;CDC25B;RAD51B;EIF4G1;ANKRD17;KLHL18;CCND3;CDC27
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.4104602315399737,-1.0564628711408877,0.3685897435897436,0.7389758447982272,1.0,4/11,16.27%,EGFR;RIPK1;BMP4;TP53
prerank,establishment of protein localization to organelle (GO:0072594),0.37826561307802975,1.0563895245441433,0.3989473684210526,0.7268135081495434,1.0,16/72,18.27%,LAMP1;AKT1;PINK1;RAN;FAM53C;PTTG1IP;CD68;IPO4;NUP85;NUP88;RYR2;SPRN;EIF4ENIF1;SYK;NUP50;LAMP2
prerank,regulation of protein import into nucleus (GO:0042306),0.4065942306998825,1.0561206906949048,0.4203747072599532,0.7270616363032874,1.0,6/36,7.50%,APOD;RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,protein-containing complex subunit organization (GO:0043933),0.37067243235956465,1.0558669725308765,0.3894628099173554,0.7272655383834411,1.0,28/109,20.49%,CD74;CHCHD10;ELOB;LAMC1;SLC2A1;TAPBP;PPP2R1A;IL2RB;HES1;ADD2;OTX2;RIMS1;CAPZA2;VAMP3;VAMP2;SOX9;MAGI1;TSPAN4;CAPG;SPG7;DMTN;DNM1L;PPARGC1A;EPRS1;LPXN;IL1RAP;CAPN3;TFAP4
prerank,ion homeostasis (GO:0050801),-0.31337857717994677,-1.0557184624572726,0.34146341463414637,0.7391042776131568,1.0,20/30,34.50%,SLC4A10;CAMK2D;FHL1;WNK4;KLHL3;SLC4A3;HCN4;RANGRF;NEDD4L;SLC4A9;SLC4A5;SLC4A4;SLC4A11;AP3D1;SLC4A7;SLC30A2;SLC30A3;SLC30A8;WNK1;RHAG
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.42620935602260224,1.055618825345085,0.4190821256038647,0.727448978723302,1.0,10/28,17.33%,AKT1;ARRDC1;GATA2;ZBTB7A;FBXW7;HEY1;BEND6;DLL1;EGFL7;MMP14
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3563284532273152,1.0555011693579106,0.3554884189325277,0.7273036885225,1.0,50/182,20.21%,APOE;RACK1;CLDN5;HSP90AB1;PARK7;LGMN;CNPY2;CD34;PINK1;SLC7A5;GPER1;TNF;PDGFB;ACVRL1;SPI1;MIF;TLE5;SH3GL2;APLNR;MYADM;LRPAP1;KDR;MAPT;GATA2;TARDBP;LRP3;HRAS;MSR1;KLF4;FBXW7;BMP2;SDCBP;ANKRD13D;SUB1;CCL3;VHL;NOS2;AGO1;MAP2K2;APOBEC1;SOX11;DDRGK1;NOTCH1;ERP29;TGFB1;POU4F1;CITED2;MEF2C;SFRP1;TRAT1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.44116533651320156,1.0554327141653481,0.4338235294117647,0.7270570174927857,1.0,7/22,19.24%,APOD;PARK7;LMAN1;GDI1;DMTN;RANGAP1;CABP1
prerank,histone H2A ubiquitination (GO:0033522),-0.35924445700828944,-1.0544077575916764,0.3933649289099526,0.7407337866203327,1.0,5/17,11.00%,BCOR;RNF8;UBR2;DDB2;CUL4B
prerank,mRNA processing (GO:0006397),0.35238031875101955,1.0541499457199501,0.348,0.7299205958456404,1.0,98/287,26.90%,HSPA8;PCBP1;SNRPG;AURKAIP1;POLR2E;SF3B5;GEMIN7;MAGOHB;MAGOH;POLR2D;HNRNPK;DDX39B;POLR2F;RALY;SYF2;SNRPD2;LSM4;LSM8;LSM6;UBL5;SNRPE;PUF60;SNRPA;SNRPF;ZMAT2;SRSF9;PQBP1;XAB2;HNRNPA0;CD2BP2;PRPF19;RBM15B;YBX1;POLR2G;PRPF8;SUPT4H1;SRSF2;SF3A2;PABPC1;CMTR1;RBM4B;SNW1;SF3B2;POLR2K;HNRNPU;HNRNPA1;NONO;CPSF2;SNRPB;SF3A3;THOC3;PDCD7;EIF4A3;PRPF31;SF3B6;PPARGC1A;TXNL4A;TBRG4;U2AF1L4;SNRPD3;LSM7;SF3A1;HNRNPA3;ALYREF;BUD31;SRSF1;SRRM4;CDC5L;CPSF4;POLR2H;SNRNP35;DHX35;HNRNPF;SNU13;SNRNP200;DHX38;RAMAC;HNRNPH2;SNRPB2;PPWD1;ELAVL1;PCBP2;LSM5;ALKBH5;METTL3;METTL14;PRPF40B;PRKACA;PPIE;DNAJC8;GTF2H5;RPRD1A;SART1;HNRNPC;SYMPK;ERCC2;USP39;CCNH
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.428700945497939,-1.053910034234649,0.3719298245614035,0.7401139782725208,1.0,6/10,20.46%,SETD2;EHMT1;SETD7;SETD4;SETD3;SETD6
prerank,regulation of gluconeogenesis (GO:0006111),-0.30780838017478407,-1.053880565915637,0.34965034965034963,0.738278497494395,1.0,9/27,16.08%,OGT;CLK2;SIK1;C1QTNF3;DGKQ;PTPN2;SIRT1;CRY1;SIRT7
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.41907215304759665,1.0535234564323834,0.4132231404958678,0.7310673678815988,1.0,13/32,25.94%,MAPK3;CCT2;CTNNB1;CCT7;CCT8;HNRNPA1;MAPK15;MAP2K7;CCT4;NAF1;PNKP;CCT3;PRKCQ
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.3177832249773367,-1.0530791293858657,0.39880952380952384,0.7385176653174348,1.0,6/31,8.39%,HOXB3;HOXA3;HOXB4;HOXC4;TGFBR1;FGFR2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5013520166573889,1.0528224009116833,0.42876712328767125,0.7324546927166532,1.0,2/11,9.42%,KLF2;EPN1
prerank,oogenesis (GO:0048477),0.4803031959230894,1.0527948337763573,0.4295212765957447,0.7320875483622921,1.0,6/15,24.56%,MDK;FMN2;NANOS2;IHO1;PTN;METTL3
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4868821347064668,1.052741206016402,0.425531914893617,0.7317944771198376,1.0,5/14,17.36%,AKT1;DDB1;PMAIP1;ARPP19;PPARGC1A
prerank,response to organonitrogen compound (GO:0010243),0.4035662157800452,1.0525836186896986,0.41183431952662725,0.731750135127903,1.0,12/38,21.90%,RCN3;VCP;GLRA2;TRPM2;SYVN1;GLRA1;RRAGC;UBXN6;BRSK2;GLRA3;IL6;IRF5
prerank,icosanoid metabolic process (GO:0006690),0.4065915472649822,1.0518946499901731,0.39931350114416475,0.7330584994025935,1.0,7/40,17.02%,GPX4;GPX1;FADS1;DPEP2;ALOX5AP;FAAH;LTC4S
prerank,regulation of T cell cytokine production (GO:0002724),0.4717827239537336,1.0513872412157872,0.4198675496688742,0.7338944078047874,1.0,1/15,0.77%,B2M
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.2955380427816023,-1.0512095821567375,0.30656934306569344,0.7418909317160366,1.0,7/39,12.93%,PI4KA;TTC7B;SMG1;ITPKB;IP6K2;PIP4K2C;SOCS5
prerank,protein modification by small protein removal (GO:0070646),0.35283647587022493,1.051062137215782,0.35735735735735735,0.73429715153942,1.0,63/252,21.45%,ACTB;RPS27A;UBC;UBB;PSMB4;EIF3F;PSME1;PSMB6;PSME2;PSMB8;PSMD2;COPS7A;RCE1;COPS6;PSMD1;PSMC3;UCHL1;PSMD6;VCP;TNFAIP3;USP51;UBA52;PSMA7;USP5;ABRAXAS2;TAF10;PSMD5;NEDD8;OTUD7A;RNF128;PSMB9;PSMD13;PSMB3;USP29;PSMB11;RHOA;PSMB10;OTUD6B;COPS8;USP26;BABAM1;TRAF3;OTUB1;KDM1B;PSMB1;ARRB2;PSMB5;USP8;USP22;CDC25A;TAB1;PSMA6;DESI2;DESI1;WDR48;NLRP3;RAD23A;PSMA4;MYC;NFKBIA;ACTR5;USP13;SUDS3
prerank,positive regulation of type I interferon production (GO:0032481),0.3760475219449149,1.0503943993392584,0.4087513340448239,0.7356114464349228,1.0,19/73,22.12%,GAPDH;HSP90AA1;POLR2E;POLR2F;FLOT1;CTNNB1;ISG15;PQBP1;HSPD1;POLR2K;RIPK2;IRF7;G3BP1;OAS3;CD14;POLR2H;POLR3K;IRF5;POLR3D
prerank,regulation of receptor internalization (GO:0002090),0.4135256516351357,1.049925566477127,0.4145785876993166,0.7363893359166358,1.0,8/35,15.91%,CD63;FLOT1;LRPAP1;SFRP4;SDCBP;ARF1;ANKRD13D;ARRB2
prerank,acidic amino acid transport (GO:0015800),0.47008328570245955,1.04963562248816,0.4375,0.7366959364432146,1.0,6/17,13.23%,SLC1A2;SLC25A13;SLC6A6;SLC1A1;SLC25A22;GJA1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.2678232390539905,-1.049417283644536,0.37373737373737376,0.744920439411598,1.0,12/52,10.33%,SAMD4A;CNOT4;PAN3;CNOT1;DCP1A;PARN;DDX6;TUT7;PATL1;CNOT10;RC3H2;CNOT7
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3595560954369785,1.0491025413042576,0.37701612903225806,0.7376371753208955,1.0,32/170,15.64%,APOE;CRIP1;PCBP1;HNRNPAB;TREM2;HNRNPK;PTPRC;TAPBP;ZFP36L1;PIN1;FLOT1;SIRPA;APLNR;PCBP4;ALPK2;RNF187;NELL1;PRDM12;PROX1;YBX1;TARDBP;MTMR9;KDM6B;ATRAID;AIF1;RO60;SORT1;ARF1;ATP1B1;DHH;SLC8A1;YBX3
prerank,cell-substrate junction assembly (GO:0007044),0.41484734085807173,1.0486733120382494,0.41852286049237986,0.7383352436228467,1.0,12/33,22.31%,CD151;LAMC1;PLEC;FN1;THY1;LAMC2;ARHGEF7;ACTN1;DLC1;CTTN;THSD1;RCC2
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4368646372668431,1.0485612437932479,0.40870616686819833,0.7381671848877404,1.0,12/24,34.37%,ITGB2;MSN;PECAM1;VCAM1;SYK;CERCAM;TNIP1;ITGB1;SEMA4D;ITGAL;CCL5;FERMT3
prerank,erythrocyte development (GO:0048821),0.5141401911918968,1.048344333643922,0.42857142857142855,0.738276538807632,1.0,5/10,31.63%,ZBTB7A;ABCB10;DMTN;ALAS2;ALAS1
prerank,TOR signaling (GO:0031929),0.4353586133701411,1.0483007003280107,0.41982864137086906,0.7379647594097375,1.0,7/26,14.27%,RPS6;AKT1;PINK1;PRR5L;RHEBL1;CCDC88A;PRR5
prerank,regulation of water loss via skin (GO:0033561),0.4697291271297793,1.0479223415896965,0.4230769230769231,0.7380583648057764,1.0,4/15,16.89%,HRNR;LSR;STMN1;FA2H
prerank,establishment of skin barrier (GO:0061436),0.4697291271297793,1.0479223415896965,0.4230769230769231,0.7380583648057764,1.0,4/15,16.89%,HRNR;LSR;STMN1;FA2H
prerank,Rho protein signal transduction (GO:0007266),0.3879492220159038,1.047902264888175,0.4039955604883463,0.7376725615060079,1.0,13/53,13.96%,ARHGDIA;CFL1;RHOB;ARHGDIB;RHOG;ADGRG1;NTN1;RHOV;ARHGDIG;COL1A2;RHOA;SHTN1;RHOU
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.4366348006302596,1.047878462251471,0.4177997527812114,0.7372929097715701,1.0,5/26,7.45%,NRXN1;NLGN1;GRIN1;RIMS2;RIMS1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.37807294499715133,1.0469917734233103,0.4259459459459459,0.7391378620830903,1.0,15/68,16.69%,DBI;HINT1;RAN;SULT4A1;BPNT2;ADSS1;AK4;AK3;OXSM;ACAT1;ACOT1;ACOT7;GLYAT;BAD;ACOT4
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4689365559686795,1.0468482475871415,0.4199475065616798,0.739047536504723,1.0,4/16,10.25%,ZFP36L1;ZFP36L2;ZFP36;TARDBP
prerank,lipid oxidation (GO:0034440),0.4923324517379592,1.0460479904150477,0.4340659340659341,0.7406788081452498,1.0,5/12,34.11%,PLA2G7;PPARGC1A;ADIPOR1;ACOX1;ADIPOR2
prerank,positive regulation of chromosome organization (GO:2001252),-0.3752430462411518,-1.0457721353036205,0.3651452282157676,0.753048559208607,1.0,4/15,20.89%,DHX36;PML;RTEL1;SIRT6
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4594905354342866,1.0455713113156042,0.4326424870466321,0.7414376944699435,1.0,3/18,14.43%,FCER1G;C5AR1;SH2B2
prerank,regulation of cell communication (GO:0010646),0.40242532555542676,1.0453824030382466,0.4231678486997636,0.7415211986944159,1.0,11/35,19.68%,MTCH1;KAZALD1;YWHAG;SCG5;NCLN;SLC8A1;GLRX2;RYR2;SRI;GRK2;IGFBPL1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.387402431878371,1.045344198428209,0.42380422691879865,0.7411798142177302,1.0,16/55,22.67%,MT3;PINK1;AGT;PDGFB;ROMO1;RAC1;DCXR;ARF4;RAC2;BCO2;SNCA;CBR1;SPHK2;GADD45A;SIRT2;MPV17
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.49875077111101684,1.0453107384194311,0.4444444444444444,0.7408416664087418,1.0,3/11,10.02%,CORO1C;ENPP2;ARHGEF7
prerank,protein deubiquitination (GO:0016579),0.35193019072383075,1.045043738495183,0.3867735470941884,0.7410711528814458,1.0,61/242,21.45%,ACTB;RPS27A;UBC;UBB;PSMB4;EIF3F;PSME1;PSMB6;PSME2;PSMB8;PSMD2;RCE1;PSMD1;PSMC3;UCHL1;PSMD6;VCP;TNFAIP3;USP51;UBA52;PSMA7;USP5;ABRAXAS2;TAF10;OTULIN;PSMD5;NEDD8;OTUD7A;RNF128;PSMB9;PSMD13;PSMB3;USP29;PSMB11;RHOA;PSMB10;OTUD6B;USP26;BABAM1;TRAF3;OTUB1;KDM1B;PSMB1;ARRB2;PSMB5;USP8;USP22;CDC25A;TAB1;PSMA6;DESI2;WDR48;NLRP3;RAD23A;PSMA4;SHMT2;MYC;NFKBIA;ACTR5;USP13;SUDS3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3923602156048649,1.0446008467103554,0.4047085201793722,0.7417901805495067,1.0,14/48,24.88%,CRIP1;RPS27L;CHEK2;HIPK2;BAX;TMEM109;SNW1;HIC1;DDIT4;BAK1;PYCARD;PHLDA3;DYRK2;BOK
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.35875355019354105,-1.0445261593056352,0.37448559670781895,0.7545145734257985,1.0,9/16,17.18%,SMG6;DHX36;SLX4;TNKS2;TERF2;ATM;TINF2;PINX1;RTEL1
prerank,positive regulation of neurogenesis (GO:0050769),0.3787139064283106,1.0443558498036456,0.41088580576307365,0.7419559561746909,1.0,24/68,26.31%,ARHGDIA;SERPINF1;TGM2;GPER1;NTRK2;CTNNB1;IL1RAPL1;SS18L2;PTPRD;SOX8;SNW1;RHOA;CX3CR1;TIAM1;ROBO2;TRIM32;SOX11;PLXND1;SS18L1;PLXNB2;NAP1L1;PLXNB3;CX3CL1;FZD3
prerank,cellular response to lipid (GO:0071396),0.35374088128847025,1.0440649837073763,0.39494949494949494,0.7422523418305452,1.0,51/191,20.24%,VIM;SPP1;NDUFA13;PDE4B;ADAM15;GPER1;NR1D1;SIRPA;CD180;LTK;TNFAIP3;MSN;BRINP3;MGST1;ATP1A3;CCR5;PTK6;CXCL10;AQP1;LPL;TICAM2;CD68;HMGB1;ZFP36;CHMP5;GNAI1;BRINP1;WNT5A;RAMP3;ATP1A1;BRINP2;SNW1;SOX9;RHOA;LILRB1;WNT10B;CX3CR1;CCL2;PF4;DAB2IP;ADCY8;NCOA4;CD14;CD86;NLRP3;IL6;GIT1;POU4F1;MEF2C;SFRP1;SPHK2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.41738202586255874,1.0439974341993965,0.42402826855123676,0.74198246423641,1.0,11/29,31.73%,DBI;PLAAT3;PLA2G4F;NR1H2;LPCAT2;PLA2G3;PLA2G6;MBOAT7;PLBD1;PNPLA8;NR1H3
prerank,axonal fasciculation (GO:0007413),0.5092292908099637,1.043941972133943,0.45264623955431754,0.7417010234579796,1.0,4/12,9.33%,CNTN4;RTN4;NRCAM;CDK5R1
prerank,skeletal muscle tissue development (GO:0007519),0.4156164569797189,1.0430831654902992,0.4055299539170507,0.7434503225607824,1.0,8/32,21.03%,MYL6;CAV2;FOXL2;MYL6B;CAV1;SELENON;MEF2C;MYH14
prerank,modulation by host of symbiont process (GO:0051851),0.408106983275051,1.0430408775393636,0.4161712247324614,0.7431242910191989,1.0,11/31,22.11%,NUCKS1;AQP1;RRP1B;JUN;TARDBP;SNW1;CX3CR1;CCL3;TFAP4;SAP30BP;REST
prerank,regulation of histone acetylation (GO:0035065),0.4110390766740241,1.043013686977457,0.40749148694665155,0.7427613745862581,1.0,9/33,19.11%,PARK7;MAPK3;SPI1;SET;CAMK1;CTBP1;HDAC5;PPARGC1A;SNCA
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4615393728240115,1.0425177486003778,0.4308510638297872,0.7435883709659951,1.0,6/18,18.76%,NRXN1;NLGN1;CCL2;CACNG8;CCR2;CACNG5
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.38699428306793665,-1.0423137840093017,0.3568627450980392,0.7587462636503036,1.0,4/13,8.19%,SORBS1;IRS1;INSR;IGF1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.37248212585802337,-1.0418914731579476,0.3763837638376384,0.7580808155561052,1.0,3/14,4.69%,ACTN2;ANK2;AKAP9
prerank,positive regulation of heart contraction (GO:0045823),0.44848220228892755,1.0416003406365528,0.4296675191815857,0.7454171057277759,1.0,8/19,27.61%,RGS2;CHGA;RYR2;ADRA1A;EDN3;ATP2A2;TGFB2;KCNQ1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.46199909048891913,1.0412775925981599,0.42776203966005666,0.7458425591643707,1.0,3/14,18.30%,CD81;SYK;CCR2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4837864585995527,1.0408138704543082,0.4607190412782956,0.7466161979770982,1.0,2/14,3.41%,PPP1CA;PPP1R15B
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5034436133560716,1.0406452124263907,0.4602272727272727,0.7466069790235473,1.0,5/10,18.76%,DLGAP2;DLGAP1;BEGAIN;NPTXR;CACNG5
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4251717371707862,-1.04061080800772,0.39862542955326463,0.7595750616787419,1.0,3/10,15.22%,SMAD7;RC3H2;NFKBIZ
prerank,heterocycle biosynthetic process (GO:0018130),0.47299936596173897,1.0405184135153178,0.4368279569892473,0.7464976206253868,1.0,2/14,6.40%,PYCR2;GPHN
prerank,regulation of Rho protein signal transduction (GO:0035023),0.377894524535831,1.0404894935252482,0.43130990415335463,0.7461308482885406,1.0,11/72,10.83%,APOE;ARHGDIA;KCTD10;RASIP1;RAC1;ARHGDIB;ADGRG1;COL3A1;NET1;TNFAIP1;GPR18
prerank,axon guidance (GO:0007411),0.3540601670158085,1.040484795348251,0.4198396793587174,0.7457139210841816,1.0,52/201,17.53%,BSG;CXCL12;MAPK3;DCC;NRXN1;UNC5D;LYPLA2;SEMA3F;RAC1;DSCAM;CNTN4;SEMA7A;SEMA4C;SHC3;LGI1;NRXN3;RHOG;DAB1;OTX2;TNR;SEMA6D;ROBO4;NTN1;LGR6;EMB;UNC5C;CDK5R1;LAMC2;EPHA5;KIF5A;SEMA4A;LRTM2;WNT5A;GFRA1;DOK5;SEMA4G;CXCR4;IGSF9;DSCAML1;ROBO2;SPTBN4;EPHB1;GAP43;SH3KBP1;GFRA2;SPTBN2;PIK3CD;SLIT3;SLIT1;EFNB1;RAC2;NCAM1
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.23968929302807437,-1.040211226672643,0.42857142857142855,0.7586949680912634,1.0,41/153,14.26%,ROCK2;LRRK2;ROCK1;CAMK2D;PRKCE;CSNK1A1;MAP3K13;MARK1;SMG1;PDPK1;RICTOR;TLK2;TGFBR1;EIF2AK3;TLK1;MAST2;DYRK1A;MARK3;MAPKAPK3;TOP1;NEK6;MAPK9;HIPK3;RIPK1;DMPK;PKD1;MORC3;TBK1;DGKQ;LATS2;STK38;ATM;CSNK2A1;CSNK2A2;NLK;ULK2;PRKD1;SRPK2;GSK3B;MARK2;PRKCI
prerank,keratan sulfate metabolic process (GO:0042339),0.41388543605512357,1.040011065727914,0.43534994068801897,0.7464522600422907,1.0,6/31,10.09%,HEXB;FMOD;LUM;HEXA;CHST1;B4GALT6
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3977413720740433,-1.0383792080912218,0.38848920863309355,0.7618564498305214,1.0,3/12,6.72%,DPYSL3;DPYD;CTPS2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.24696773097185337,-1.0382704563256968,0.3111111111111111,0.7601766517864111,1.0,9/86,1.92%,BMP6;SULF1;RBPMS;ZNF423;ACVR1;BMPR1A;CREBBP;FOXD1;DAB2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4144729433078951,1.038134608951993,0.43550295857988164,0.7507312461380915,1.0,9/32,26.25%,CHKB;CSNK2B;MFSD2A;CHAT;ACHE;SLC44A5;STARD10;SLC44A2;SLC44A1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.5164754978765584,1.0380067979034777,0.44619799139167865,0.750607479851848,1.0,5/10,19.27%,C3;TREM2;F2RL1;CD300A;RAB31
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5100580578182448,1.037869121656701,0.4518950437317784,0.7505163766030251,1.0,3/10,19.35%,PDE3B;JAM3;MUC1
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.39554261441768357,-1.0378061214159917,0.3951048951048951,0.7596289997189312,1.0,6/14,22.93%,SEC24D;SCAP;SEC24A;SEC24C;SEC31B;RAB1A
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4663183353386735,1.0375397553014765,0.4266666666666667,0.7509123397869758,1.0,2/16,2.92%,ACADVL;APOC1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2843283378423618,-1.037275161983462,0.34558823529411764,0.759066819175666,1.0,10/44,10.85%,FCHSD2;FER;BAIAP2L1;PRKCE;BAIAP2;CARMIL1;NCKAP1;CDC42EP5;SNX9;NCK1
prerank,axonal transport of mitochondrion (GO:0019896),0.498923724952423,1.036933520072466,0.43776223776223777,0.7520448681414694,1.0,3/11,11.11%,NEFL;MAPT;HAP1
prerank,centromere complex assembly (GO:0034508),-0.2933054948412845,-1.0364246964589454,0.35172413793103446,0.7595359975151087,1.0,18/36,26.05%,SMARCA5;POGZ;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPE;CENPU;CENPI;CENPH;MIS18BP1;MIS12;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.39576943665422826,-1.0364087417044456,0.37547892720306514,0.757649313471674,1.0,4/12,8.19%,SORBS1;IRS1;INSR;IGF1
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3301488300659751,-1.0362324601086463,0.39603960396039606,0.7561906866113609,1.0,3/24,6.44%,AUTS2;PLCE1;NCKAP1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.423248292030303,1.0362167318820952,0.44885679903730447,0.7534128550807122,1.0,7/27,18.28%,AKT1;TREM2;CTNNA2;IL1RAPL1;CCDC88A;BRSK2;NCS1
prerank,cellular response to growth factor stimulus (GO:0071363),0.3550458653832557,1.036039623957342,0.43147208121827413,0.7534367021677452,1.0,28/151,14.66%,EEF1A1;MT1G;RACK1;RAMP2;HSPB1;LGMN;AKT1;PDGFB;ACVRL1;NTRK2;ZFP36L1;ZFP36L2;DUSP3;CTNNB1;HYAL2;KDR;MAPT;CLEC3B;ZFP36;GAS1;WNT5A;FLT4;AMHR2;KLF4;SOX9;BMP2;CCL2;EHD1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3496170024079964,-1.0357680220556384,0.3755656108597285,0.7555885817586068,1.0,4/17,5.66%,ROBO1;SLIT2;NRP1;EFNB2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4208450376976438,1.0357152058881187,0.4180929095354523,0.7538272783640982,1.0,5/29,9.32%,CD81;CCL19;PDGFB;EEF1A2;P2RY12
prerank,calcium ion import into cytosol (GO:1902656),0.4641098911397471,1.0354429620352006,0.45108695652173914,0.7540799507452083,1.0,5/15,28.25%,SLC24A2;TRPM2;SLC8A1;CACNA2D1;ATP2B4
prerank,carboxylic acid metabolic process (GO:0019752),0.40645938683787336,1.0352469201131673,0.4130688448074679,0.7541664767643922,1.0,10/33,18.03%,SLC2A1;AGXT;CYB5R3;MIF;GSTO1;GRHPR;GLYAT;ACOT4;GLUD1;SLC2A3
prerank,aorta development (GO:0035904),-0.3881549267752115,-1.0350616949048193,0.379182156133829,0.7556112158699241,1.0,6/14,12.82%,HECTD1;ROBO1;ADAMTS9;PDGFRB;LRP1;JAG1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.4891913073474496,1.034931745714428,0.43646408839779005,0.7545269387004984,1.0,8/12,31.95%,UCK1;UCKL1;CDA;UPP1;TK1;TK2;CAD;DCK
prerank,metal ion export (GO:0070839),0.4119359903691025,1.034719387135868,0.44365361803084225,0.7546170133583784,1.0,10/31,17.69%,ATP1A3;ATP1B2;KCNE4;SLC40A1;ATP1A4;ATP1A1;SLC11A1;KCNE5;ATP1B1;ATP1B3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2638124307500795,-1.0346946410299283,0.3150684931506849,0.7546950039676236,1.0,18/63,13.92%,WWOX;TCF7L2;ACVR1;BIRC6;CFLAR;ZMYND11;SH3RF1;TGFBR1;PML;IGF1;SP100;RIPK1;BCL2L12;AR;DEPTOR;CASP8;BMP4;PHIP
prerank,carbohydrate transport (GO:0008643),0.5040947688703661,1.034578977767273,0.42559109874826145,0.7545163277583088,1.0,3/11,16.51%,AQP1;SLC50A1;SLC2A2
prerank,protein tetramerization (GO:0051262),0.3755492010370338,1.0345770692419303,0.425,0.7540909352859564,1.0,13/67,20.44%,ALDOA;B2M;AQP4;KCNC3;GRIN1;KCNC1;TRPM2;GLS;HCN1;GRIN2B;SNCA;PKD2L1;SHMT2
prerank,regulation of MAP kinase activity (GO:0043405),0.36333959782262404,1.0344764242158058,0.4356020942408377,0.7539127093289948,1.0,22/92,19.83%,APOE;AGT;TNF;PDGFB;SORL1;UCHL1;RGS2;HYAL2;CD24;SMPD1;HRAS;SPRY1;NEK10;PDGFA;RASGRP1;DAB2IP;FLT1;CD300A;EDN3;SPRY3;FLT3;TGFB1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.33569148786664654,-1.0341453390302375,0.38990825688073394,0.7542771202830291,1.0,3/21,2.23%,ADCY9;ADCY1;ADCY5
prerank,negative regulation of signaling receptor activity (GO:2000272),0.42028259379525434,1.033685216512339,0.4273399014778325,0.7554843815596852,1.0,4/25,11.35%,CNRIP1;TNF;CHMP6;RAMP3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.37134895752409514,-1.0334979527302575,0.40213523131672596,0.7541953165098453,1.0,7/14,21.57%,ADAMTS12;TGFBR1;EFEMP1;CHADL;WNT9A;ADAMTS7;PTPN11
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4260938863956834,1.03332100627773,0.45229244114002476,0.755940186105207,1.0,11/24,27.39%,VTN;MT3;CADM4;PDCD6;DAB2IP;TMEM204;PTPN1;CNMD;HGS;HHEX;MMRN2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.39699778435189703,1.0328481807192602,0.44907407407407407,0.7566739658718951,1.0,11/41,18.26%,CCL19;SLC24A2;PTPRC;GRIN1;GRIN2A;HTR2C;TRPM2;SLC8A1;RYR2;ERO1A;GRIN2B
prerank,cellular response to sterol (GO:0036315),-0.39754242168749176,-1.0327073746646962,0.37735849056603776,0.7543906058973455,1.0,7/13,23.75%,SMO;LRP6;GRAMD1C;RORA;GPLD1;PTCH1;RORC
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.30797412037905564,-1.0322703321042692,0.44,0.7536245742592482,1.0,9/30,13.79%,TGFBR3;SMAD3;SMURF2;DKK3;SMAD7;SMAD4;LATS2;ITGA3;SMAD2
prerank,acute inflammatory response (GO:0002526),0.42838076663711344,1.0322005175412599,0.4437577255871446,0.7578558021699919,1.0,6/23,19.67%,MBL2;CEBPB;HPR;HP;SIGIRR;IL6
prerank,regulation of nuclear division (GO:0051783),0.4440612597283761,1.031968918859368,0.46675191815856776,0.758014634391626,1.0,8/20,28.87%,PIN1;CAV2;FBXO5;L3MBTL1;CCDC8;RCC1;KIF20B;MKI67
prerank,regulation of membrane repolarization (GO:0060306),0.47563901762730265,1.031551447514866,0.436241610738255,0.7586372061009438,1.0,4/13,16.42%,AKAP6;YWHAE;KCNE5;CAV1
prerank,regulation of secretion (GO:0051046),0.4848730900378959,1.0315261289055397,0.44813829787234044,0.7582652013800991,1.0,5/13,18.54%,NRG1;SGK1;SCIN;ERBB3;ACSL3
prerank,regulation of intracellular protein transport (GO:0033157),0.40952000592774385,1.0307718048186512,0.44549763033175355,0.7596779005299549,1.0,16/32,28.05%,OAZ1;PRR5L;UHMK1;LCP1;VAMP2;ATP13A2;CEP131;B3GAT3;TGFB1;OAZ2;IFI27;PTPN1;KIF20B;ICE1;PCNT;TENM1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.39324620491110274,1.0305598038156407,0.4411111111111111,0.7597804876723929,1.0,9/47,10.02%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;CORO1C;P4HB;ARHGEF7
prerank,apoptotic process (GO:0006915),0.3487250228153411,1.030359782628812,0.4381909547738693,0.759817625493294,1.0,51/203,20.94%,PPIA;GAPDH;RHOB;DCC;AKT1;NSG1;ITGB2;RFK;ADAM15;IER3;RTN4;BNIP2;PPP2R1A;PARP1;MAL;ELMO1;SFRP5;MAGEH1;HSPD1;TNFSF12;JADE1;DHCR24;TNFAIP1;BAX;PMAIP1;PAX3;CXCR4;STK11;BBC3;BAD;RRAGC;DLC1;CDK5;GLRX2;ADRA1A;PRUNE2;PPP1R15A;ERBB3;ATCAY;TRAIP;CD14;NLRP3;DDIT4;PDE1B;CAPN3;MYC;NFKBIA;PAK5;BAK1;PYCARD;GADD45A
prerank,aminoglycan biosynthetic process (GO:0006023),-0.27147080108432936,-1.0299314244117685,0.4036697247706422,0.7581830945564352,1.0,10/49,8.46%,GPC6;EXT1;GPC4;GPC3;HS3ST3A1;B3GNT2;HS2ST1;B3GALT1;NDST1;SLC35D2
prerank,tight junction assembly (GO:0120192),0.38658501695134406,1.0297715494956856,0.43194600674915634,0.7608335957847638,1.0,15/49,24.27%,ACTG1;CLDN5;RAMP2;CLDN11;ESAM;PECAM1;LSR;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;ECT2;TBCD
prerank,positive regulation of metabolic process (GO:0009893),0.36049565710722664,1.029684496540314,0.44329896907216493,0.7606245447329301,1.0,31/103,23.49%,GATM;UCP2;TNF;EPAS1;FABP5;CAMK1D;BSCL2;OMA1;CEBPB;FASN;SCD;KDM6B;LCN2;MFAP2;THRA;HCRT;GJA1;CXCR4;ACHE;CAV1;ADCYAP1;PPARGC1A;SYK;CCR2;FABP4;ESRRG;ADIPOR1;TSHR;PRLR;ELOVL6;ACLY
prerank,positive regulation of protein secretion (GO:0050714),0.3742120607905659,1.0290734058659925,0.45240641711229945,0.7616836704963682,1.0,20/69,19.83%,PPIA;TREM2;RBP4;TRH;LRRC8A;GPER1;ANG;ABCG1;ARF6;ATP13A2;APBB1;F2RL1;BAD;IER3IP1;ACHE;DNM1L;DOC2B;GLUD1;NNAT;TGFB1
prerank,organic anion transport (GO:0015711),0.36833652150535307,1.0289166667414673,0.4594882729211087,0.7616677157819501,1.0,20/76,20.84%,LRRC8A;SLCO1C1;CA2;SLC25A4;MGST1;AQP1;SLCO4C1;CA4;SLC19A1;SLC35A3;SLC25A19;SLC2A2;MFSD10;SLC52A1;SLC4A2;SLC35A1;SLC35B4;SLCO1B1;CYB5R1;CA3
prerank,miRNA metabolic process (GO:0010586),-0.33955811564492683,-1.0288715641156372,0.3902439024390244,0.7593702549061035,1.0,9/20,16.50%,TENT4B;DICER1;PARN;DROSHA;TUT7;DDX17;TARBP2;TUT4;AGO2
prerank,striated muscle contraction (GO:0006941),0.38009728862342995,1.0284006618055808,0.43646408839779005,0.7625296048535621,1.0,12/53,21.03%,ALDOA;SCN4B;GAA;TNNI1;KCNE5;ATP1B1;SLC8A1;RYR2;DTNA;GRK2;STAC3;MYH14
prerank,neurotransmitter uptake (GO:0001504),0.49461614850501395,1.0283228481124624,0.4597222222222222,0.7622924766487996,1.0,4/12,14.83%,SNAP25;GLUL;SLC29A1;SLC29A2
prerank,mitochondrial genome maintenance (GO:0000002),0.49380711640196373,1.028240139392088,0.4584487534626039,0.7620666469008975,1.0,6/11,30.84%,SLC25A4;PARP1;MPV17;LONP1;SLC25A36;MGME1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.44888136929736555,1.0281258577543553,0.45324675324675323,0.7619204392496832,1.0,5/19,15.15%,GMPPB;PMM1;AMDHD2;NANS;UGDH
prerank,mRNA splice site selection (GO:0006376),-0.31507652414570564,-1.0275632789335833,0.34838709677419355,0.7611469486325744,1.0,7/30,10.92%,CELF2;LUC7L2;SFSWAP;YTHDC1;KHDC4;PRPF39;SETX
prerank,focal adhesion assembly (GO:0048041),-0.3324974738667017,-1.0274752455959186,0.41232227488151657,0.7595241110274575,1.0,6/21,11.07%,SORBS1;ACTN2;BCR;PIP5K1A;TESK2;FERMT2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.49351775744445553,1.0274152798779543,0.4556786703601108,0.7632666221111948,1.0,5/11,24.55%,RPS27L;HIPK2;MUC1;TFAP4;FOXM1
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.2284638842055933,-1.0272142364187797,0.4166666666666667,0.7583376316033651,1.0,52/166,18.69%,TEAD1;NOTCH2;NR3C2;RARB;CREBBP;MAML2;NR6A1;MNAT1;THRB;TAF15;YAP1;PPARA;RARG;NCOR1;KAT2B;TBL1X;NR1D2;TAF1D;SMARCA5;MAML1;TAF1A;GTF3C1;TBL1XR1;TEAD2;PPARG;ESR1;NR2C2;MED26;GTF2E2;RBPJ;TAF2;AR;POLR2A;NR2F1;RORA;GTF2H4;CRCP;POLR2B;CDK7;RSF1;POLR2J;GTF2A2;ESRRA;NR3C1;TAF8;ERCC3;TAF7;TAF4B;RRN3;NR5A2;GTF2H2;MED23
prerank,vascular transport (GO:0010232),0.3661252977170559,1.0271765741902437,0.4397463002114165,0.7634430599678944,1.0,21/81,16.01%,SLC38A5;SLC2A1;SLC7A5;SLC1A4;SLC1A2;SLCO1C1;TFRC;ATP1B2;SLC6A6;MFSD2A;SLC6A17;LRP3;ATP8A1;SLC29A1;ATP1A4;SLC1A1;SLC19A1;SLC29A2;SLC16A1;SLC15A2;ABCA2
prerank,regulation of interferon-beta production (GO:0032648),0.385463947537607,1.0270164137529638,0.44730941704035876,0.7633898579898415,1.0,20/46,32.13%,HSP90AA1;FLOT1;TIRAP;SIRPA;ISG15;LILRB1;RIPK2;IRF7;TRAF3;OAS3;PYCARD;IRF5;POLR3D;TLR7;DHX9;TLR2;TRIM56;POLR3C;MAVS;DDX3X
prerank,actin filament polymerization (GO:0030041),0.41952153667662007,1.0268864898574812,0.47653429602888087,0.7632872248252311,1.0,6/29,13.12%,GSN;RAC1;ANG;FAM107A;AIF1;MSRB1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.34720544328024594,-1.026705430425136,0.3674418604651163,0.7578756426536115,1.0,4/18,2.52%,ROCK2;BCAS3;ARFGEF1;ROCK1
prerank,positive regulation of reproductive process (GO:2000243),0.41449904477332733,1.0267024411501848,0.43847072879330945,0.763316060597296,1.0,8/31,23.51%,PGAM4;PRSS37;TACR1;GLRA1;INHBA;SIRT2;INHBB;C1QBP
prerank,regulation of cell morphogenesis (GO:0022604),0.4143936534252536,1.026381467426676,0.4507531865585168,0.7636837712403046,1.0,2/30,1.57%,SPARC;CFL1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.272290535697776,-1.0262631300942342,0.3883495145631068,0.7571944824677629,1.0,5/45,1.92%,BMP6;RBPMS;ACVR1;BMPR1A;DAB2
prerank,heterochromatin organization (GO:0070828),-0.3733648123101313,-1.0262178498867902,0.4100418410041841,0.7555005385316222,1.0,5/14,15.12%,SETDB1;SETD7;SIRT1;EZH1;SMCHD1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.4769414045490911,1.025971153538606,0.45125348189415043,0.7642668125622284,1.0,5/13,20.89%,LGMN;GRIN2A;RIPK2;BAD;BAK1
prerank,positive regulation of vasculogenesis (GO:2001214),0.5019291992943564,1.0254604387607718,0.4727272727272727,0.7650637224769609,1.0,3/10,14.50%,CD34;KDR;RRAS
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4385882340903354,1.0252872666801294,0.44501278772378516,0.7650695565052914,1.0,9/21,21.40%,PARK7;TMBIM6;CREB3;PMAIP1;SYVN1;HSPA1A;HERPUD1;DDIT3;SELENOS
prerank,positive regulation of behavior (GO:0048520),0.5057269314394638,1.0251530567858675,0.4567901234567901,0.7649553624133794,1.0,3/10,9.16%,NLGN1;INSL5;CRH
prerank,regulation of synapse assembly (GO:0051963),0.3922450339655393,1.0251526248036678,0.468013468013468,0.7645247064487883,1.0,22/46,24.37%,NRXN1;NLGN1;GRID2;LRFN5;LHFPL4;MUSK;IL1RAPL1;PTPRD;SYNDIG1;LRRC4B;ROBO2;EPHB1;CLSTN2;CLSTN1;SLIT1;SNCA;MEF2C;IL1RAP;CLSTN3;SLITRK3;WNT7A;APP
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.4247222112976934,1.0246957352473134,0.4613526570048309,0.7652266127903028,1.0,8/27,16.28%,RNASE1;RNASE4;NHP2;POP7;RNASEH1;TOE1;PDE12;NUDT16
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3466078735456196,1.0244600671022404,0.45271629778672035,0.7653674800602531,1.0,54/190,25.01%,TMSB4X;RACK1;NDUFA13;AKT1;TREM2;PINK1;PEBP1;GPER1;ARHGAP25;NR1D1;SPI1;DUSP3;APLNR;PDE3B;HYAL2;SFRP5;MYADM;TNFAIP3;CDC34;P2RX7;CD22;OTUD7A;TRIM59;PIK3IP1;PDCD6;PHLPP1;ARRB2;DAB2IP;CAV1;HERPUD1;NDUFS3;TWIST1;NOP53;AKT1S1;SPRY3;RTKN2;NLRP3;DDIT4;PDE11A;THEM4;PYCARD;DDIT3;BANK1;CCN3;TMEM127;TNIP1;ADIPOR1;DUSP1;PHLDA3;RELA;PLEKHA1;EPM2A;PDE2A;RNF157
prerank,regulation of interleukin-17 production (GO:0032660),0.4028792930548357,1.02440641872281,0.4314420803782506,0.7650652727494687,1.0,9/31,25.94%,PRNP;SLC7A5;IL2;VSIR;IL6;TGFB1;DDIT3;RFTN1;PRKCQ
prerank,calcium ion transport (GO:0006816),0.35414753281920536,1.0240669494930548,0.4651639344262295,0.7654754979785635,1.0,26/113,17.61%,TPT1;RAMP2;SLC24A4;SLC24A2;FKBP1A;CACNA1A;GRIN3A;CCR5;TMCO1;P2RX7;SELENOK;SLC3A2;RAMP3;TRPM2;TRPC7;CHRNA4;GAS6;TRPC1;SLC8A1;RYR2;CCL3;CAV1;CACNG8;ORAI1;PSEN2;CCL8
prerank,secondary alcohol biosynthetic process (GO:1902653),0.40742829533776603,1.023559239605592,0.45054945054945056,0.7662938160175372,1.0,11/30,28.43%,LSS;DHCR24;ACAA2;PLPP6;FDPS;NSDHL;PMVK;ACLY;INSIG2;EBP;HMGCS1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2514040779847014,-1.023488018101215,0.41333333333333333,0.7610618062396045,1.0,13/62,8.78%,KMT2C;CNOT4;TNRC6B;CREBBP;ZBTB16;TNRC6A;HOXA5;KMT2A;TNRC6C;KAT2B;CDK6;ASH2L;MOV10
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.39149346425130344,1.0233075554358437,0.4636363636363636,0.7664894477891971,1.0,12/41,21.30%,MDK;ANK3;TNF;FLOT1;PODXL;THY1;MAGI1;SKAP1;CITED2;FOXA2;PTPRU;FOXA1
prerank,phospholipid translocation (GO:0045332),0.41867805204138775,1.0229354591395914,0.4612590799031477,0.7669865666220863,1.0,6/28,10.95%,TMEM30A;ATP8B4;ATP8A2;P2RX7;MFSD2A;ATP8A1
prerank,positive regulation of cell cycle process (GO:0090068),-0.24818749841251608,-1.0228429941496389,0.38095238095238093,0.7609136759987635,1.0,26/91,21.61%,SVIL;CEP295;LRP5;PRKCE;INSR;CDC14A;UBXN2B;IGF1;PDGFRB;CSPP1;CDC25B;INO80;PKP4;GIPC1;NUMA1;PHIP;DYNC1LI1;MAD2L1;CDC14B;RACGAP1;NUP62;PKN2;NDC80;KIF23;XRCC3;TPR
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.42740209104673055,1.0226687603404867,0.4539800995024876,0.7672448420572743,1.0,8/24,22.84%,MT3;ACADVL;SLC25A13;MTLN;PPARGC1A;MYC;CYCS;COQ10A
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5066848347268403,1.0224888956209197,0.4827586206896552,0.7672733954799854,1.0,4/10,27.79%,UBE2G2;SVIP;OS9;UBE2J1
prerank,cell differentiation in spinal cord (GO:0021515),0.5004582141872042,1.022426335580286,0.46372688477951635,0.7669990835046443,1.0,1/10,3.02%,MDGA2
prerank,defense response to tumor cell (GO:0002357),0.4956241661925055,1.0221962027232958,0.44782608695652176,0.7671524008786887,1.0,3/10,4.50%,LAPTM5;PRDX2;SPI1
prerank,protein palmitoylation (GO:0018345),0.4139710508623661,1.0221029124883303,0.4444444444444444,0.7669682328122635,1.0,12/30,29.53%,GLUL;SELENOK;ZDHHC5;GOLGA7B;CLIP3;GOLGA7;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,regulation of DNA damage checkpoint (GO:2000001),0.501828671460349,1.0220732577038443,0.4797687861271676,0.7665977646197124,1.0,2/10,5.96%,DDX39B;RPA2
prerank,amino acid transport (GO:0006865),0.3843870650781912,1.0219974964885203,0.46231721034870643,0.7663543337105638,1.0,8/49,11.28%,SLC38A5;SLC7A5;SLC1A4;SLC25A29;SLC6A6;SLC6A17;SLC3A2;SLC7A14
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5053635930607514,1.0218555198440626,0.4650837988826816,0.7662887824121896,1.0,3/10,11.32%,TERF1;MAPT;DNAJA1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.3950565710318181,1.0217770508360737,0.4561200923787529,0.7660425390765897,1.0,13/39,23.99%,RCN3;CANX;OLFM2;RAB15;RAB3C;RAB3D;PPY;ARL4D;TVP23A;PDIA4;SCG2;COPG1;MTTP
prerank,protein prenylation (GO:0018342),0.4961623572467365,1.0216984490976908,0.4885386819484241,0.765822069891984,1.0,1/10,3.04%,RCE1
prerank,positive regulation of interferon-beta production (GO:0032728),0.4023753134312449,1.021610866567069,0.45195729537366547,0.7656143181217947,1.0,15/33,32.13%,HSP90AA1;FLOT1;ISG15;RIPK2;IRF7;OAS3;IRF5;POLR3D;TLR7;DHX9;TLR2;TRIM56;POLR3C;MAVS;DDX3X
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.3592196556979482,-1.021553572993442,0.4263565891472868,0.7626356781983622,1.0,6/15,19.29%,LARGE1;OGA;MGAT3;RENBP;CHST3;NAGK
prerank,protein dephosphorylation (GO:0006470),-0.23319117407377637,-1.021413292189736,0.5,0.7611992684549626,1.0,47/135,19.88%,EYA2;PTPN13;EYA1;PTPN21;PTPN9;PPP1R12A;PTPN14;TNS2;PPM1E;MTMR3;PPM1D;PTPN3;DUSP16;PPP4R1;DUSP10;EYA4;PPEF2;PPP2R5E;PTPN12;DAPP1;PPP4R2;BTRC;PTEN;FBXW11;NCK1;DUSP7;EYA3;PTPN2;PPP2CB;LHPP;RPAP2;PPP6C;PPP2R2A;PTPN22;DUSP11;SSH1;PPP3CB;PPP3CC;PPP2R1B;SDHAF2;PPTC7;CTTNBP2NL;PTPRM;PPP2R3A;CDC14B;PTPRK;PPM1H
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.47788988418363454,1.02140289935747,0.46070460704607047,0.7657287047528991,1.0,6/13,23.62%,BNIP3L;BAX;PMAIP1;BAD;VDAC2;BLOC1S2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3715966641269412,1.0210794400865928,0.46681175190424373,0.7660661147357609,1.0,25/68,27.24%,CAVIN1;SNRPG;POLR2E;POLR2F;SNRPE;POLR1B;SNRPF;POLR2K;CPSF2;SNRPB;UBTF;SLBP;SNRPD3;MAZ;TBP;POLR1H;CPSF4;POLR2H;POLR3K;POLR1G;GTF2H5;SYMPK;ERCC2;CCNH;POLR1F
prerank,ganglioside biosynthetic process (GO:0001574),0.46404861218434257,1.0207006487566073,0.4708860759493671,0.7666007329796758,1.0,4/15,15.57%,B4GALNT1;B4GALT6;ST8SIA4;ST6GALNAC3
prerank,sodium ion import across plasma membrane (GO:0098719),-0.34669734983666844,-1.020597111197829,0.421875,0.7615701679334325,1.0,3/17,10.62%,SLC9A1;SLC9A2;TRPM4
prerank,lytic vacuole organization (GO:0080171),0.40352340786454066,1.0203563073652662,0.46722288438617404,0.7670406174984684,1.0,7/32,13.30%,GRN;CLVS1;CLVS2;GAA;CLN5;CLN6;TMEM106B
prerank,cardiolipin metabolic process (GO:0032048),-0.3782193388723287,-1.0202073488530188,0.4051094890510949,0.7609324136305682,1.0,6/13,26.19%,PLA2G4A;CRLS1;PLSCR3;HADHB;PLA2G5;PGS1
prerank,phospholipid dephosphorylation (GO:0046839),-0.2824556398562381,-1.0201237872537845,0.41830065359477125,0.759295994210725,1.0,18/37,24.14%,PLPP3;MTMR3;MTMR11;PTEN;SACM1L;PLPP5;EPHX2;MTMR10;PLPP1;PIP4P2;PLPP2;INPP5B;PLPPR1;TPTE;PLPPR3;MTMR1;SYNJ2;MTMR7
prerank,histone lysine methylation (GO:0034968),-0.2836002413500844,-1.0200798083406863,0.45695364238410596,0.7575726360207758,1.0,18/33,25.60%,PRDM5;SMYD3;KMT2A;ASH2L;SETDB1;KMT2D;WDR82;EHMT2;EZH2;PRDM9;SETD1B;WDR5B;SETD3;SETD6;KDM6A;SMYD1;DYDC2;N6AMT1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.45188015406517906,1.0192344136641804,0.4630102040816326,0.7694055310028751,1.0,8/17,17.75%,ATP1A3;ATP1B2;ATP1A1;GJA1;ATP1B1;SLC8A1;RYR2;FKBP1B
prerank,response to iron ion (GO:0010039),0.48437695446274237,1.0191354266470207,0.46354883081155435,0.769231607002091,1.0,1/12,0.77%,B2M
prerank,positive regulation of developmental growth (GO:0048639),0.3794686851797485,1.018983698995248,0.45514950166112955,0.7691567188617258,1.0,20/49,25.84%,PPIB;SEMA7A;SYT1;RIMS2;RIMS1;MAPT;NTN1;SYT4;SHTN1;CPNE5;CPNE6;DLL1;SYT2;AGRN;SYT3;TWF2;UNC13A;RNF157;SYT17;ZFYVE27
prerank,epithelial cell-cell adhesion (GO:0090136),-0.40071945968655676,-1.0188835689852354,0.43820224719101125,0.7589834248633098,1.0,5/11,21.36%,VCL;PLEKHA7;KIT;ITGB5;THBS4
prerank,myotube differentiation (GO:0014902),0.4505529286809742,1.0187225159739546,0.45549738219895286,0.7693777368823214,1.0,6/17,20.07%,PLD3;ADGRB3;ADAM12;SORT1;MYEF2;MEF2C
prerank,positive regulation of JNK cascade (GO:0046330),0.36417375905677685,1.0185042793063084,0.4707757704569607,0.7694663262870776,1.0,25/70,25.37%,CCL19;TIRAP;ANKRD6;HIPK2;CCN2;HMGB1;FLT4;HRAS;MAPK8IP1;SDCBP;F2RL1;TRAF3;RASGRP1;NCF1;DAB2IP;MAP4K2;LTBR;PYCARD;GADD45A;WNT7A;DUSP15;UNC5CL;APP;AGER;MFHAS1
prerank,histone ubiquitination (GO:0016574),-0.3300452323685046,-1.018500663999917,0.4095238095238095,0.7581773486449731,1.0,9/21,25.10%,HUWE1;RNF8;UBR2;CDC73;UBE2E1;WAC;RNF20;CTR9;PHC1
prerank,regulation of monocyte differentiation (GO:0045655),0.4721197873036851,1.0184184201783082,0.45586297760210803,0.7692555481774827,1.0,2/14,4.40%,CD74;ZFP36L1
prerank,regulation of fibroblast migration (GO:0010762),0.43828241275266744,1.0183766632505051,0.46547314578005117,0.7689269793674363,1.0,8/20,19.83%,RAC1;PRR5L;HYAL2;CORO1C;ARHGEF7;DMTN;DDR2;TGFB1
prerank,electron transport chain (GO:0022900),0.46393624658582305,1.018155297415497,0.4713114754098361,0.7690135168123171,1.0,6/15,22.11%,ETFB;NDUFA5;SDHB;UQCRFS1;PPARGC1A;SDHA
prerank,ceramide biosynthetic process (GO:0046513),0.3970552760607822,1.0179698988384622,0.45045045045045046,0.7690385890300585,1.0,12/40,21.11%,CERS2;B4GALNT1;B4GALT6;SMPD1;ST8SIA4;SPTLC1;ST6GALNAC3;DEGS1;FA2H;CLN8;SPTSSA;ASAH2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.36502810874679065,1.0178219083870372,0.46977730646871685,0.7689770107371178,1.0,24/78,21.57%,CLU;RACK1;GABARAP;ELOB;HSPA1B;VCP;USP5;CEBPA;RBX1;SUMO2;DNAJB2;HSPA1A;UBQLN2;HSPBP1;SGTA;CAV1;HERPUD1;BCAP31;NOP53;DDRGK1;RNF144B;RAD23A;SIRT2;STUB1
prerank,glycine metabolic process (GO:0006544),0.4884774512448604,1.0177712449034182,0.47802197802197804,0.7686643798834024,1.0,7/12,34.76%,SDS;GLYAT;SHMT2;DLD;RIDA;GCAT;GCSH
prerank,NAD biosynthetic process (GO:0009435),-0.336312056457772,-1.0176982054268244,0.3961352657004831,0.7585044339126479,1.0,8/20,21.13%,PTGIS;PARP9;PARP16;PARP10;NADSYN1;NUDT12;NMNAT2;NMNAT3
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4220414518917423,1.0171991951463637,0.46573604060913704,0.7696989052362041,1.0,7/23,16.42%,PTPRC;HYAL2;PTK6;THY1;CHMP6;SRCIN1;CAV1
prerank,regulation of cell cycle (GO:0051726),0.3403567367705723,1.0170165365485664,0.46546546546546547,0.7696982976888519,1.0,85/271,25.59%,RPL23;RPS15A;RACK1;HSP90AB1;CALR;JUND;RHOB;EIF4G2;GPER1;BEX2;FZD9;PTPRC;JUNB;MIF;UHMK1;HIPK2;USP51;SPATA22;CCND1;GMNN;PTK6;PROX1;DHCR24;NUPR1;MLXIPL;JUN;ZBTB49;TARDBP;APBB1;BRINP1;CTBP1;HRAS;CAMK2N1;SOX9;LILRB1;BMP2;FBXO5;RNF40;HNRNPU;NLRP2B;SND1;STK11;SDCBP;L3MBTL1;CDK5;DAB2IP;PIM3;TRIM32;PPP1R15A;TBRG4;NOP53;CDC25A;BTG4;INHBA;NOTCH1;RAD23A;MLF1;TGFB1;POU4F1;CITED2;DYNLT3;SFRP1;TFAP4;MYC;GADD45A;ASAH2;ID2;CDK9;SIRT2;MEN1;DUSP1;CDK10;INTS13;FOXM1;METTL3;BARD1;CHMP1A;BAP1;CDKN2B;FBXL3;PRKACA;INHA;KIF20B;PNPT1;WDR6
prerank,development of primary male sexual characteristics (GO:0046546),0.3993516232955597,1.0169271932736774,0.44715447154471544,0.7694899335555896,1.0,13/34,28.27%,KITLG;WNT5A;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK
prerank,cellular response to increased oxygen levels (GO:0036295),0.48770142543990924,1.0169221826931025,0.4900568181818182,0.7690763031703062,1.0,4/11,22.07%,ATP6V1G1;ATP6AP1;CAV1;ATP6V1A
prerank,regulation of signal transduction (GO:0009966),0.34360515561926247,1.0165363097959306,0.4717741935483871,0.7695962007094668,1.0,56/190,24.61%,MTCH1;PPIA;CLU;IGFBP6;CD63;RGS5;PRNP;TREM2;IGFBP3;IGFBP4;IGFBP5;PPP2R1A;RGS2;NUCKS1;OTX2;PTK6;KAZALD1;YWHAG;TIMP1;CD24;KIF26A;RGS12;GAS1;DOK5;SNW1;IGFBP2;NCLN;FRMPD1;MAPK8IP2;UBTF;GLRX2;DLL1;ADCYAP1;NCAM1;TMEM108;ERBB3;SRMS;TMEM204;RFNG;GRK2;IGFBPL1;TGFB1;GIT1;BRAP;RGS6;AMFR;FRRS1L;LLGL1;LFNG;PTPN1;ZFAND2B;KCTD8;ANKRD54;APP;RGS4;TCF7L1
prerank,regulation of fibrinolysis (GO:0051917),0.47157187159278036,1.0164701728083787,0.48582995951417,0.7693448255501905,1.0,1/13,1.91%,THBD
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.44730713282211254,1.0157561891432558,0.45838668373879643,0.7706530241548097,1.0,9/18,27.81%,BAX;PMAIP1;RNFT1;TMEM259;BAK1;DDIT3;USP13;BOK;XBP1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.426387134814625,1.0157316709464315,0.444311377245509,0.7702932006862392,1.0,6/24,9.69%,NRG1;CTNNA2;OLFM2;BNIP2;CTNNB1;CAMK1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.34839507309228207,1.0155052786307948,0.47657841140529533,0.7704271050480663,1.0,53/150,27.01%,HSP90AA1;HSP90AB1;PARK7;CCL19;TXN;NRG1;ERBB4;PINK1;TNF;PDGFB;HCLS1;RAC1;RTN4;RHOG;P2RY12;KITLG;MC1R;RAMP3;VAV1;GAS6;CX3CR1;GDF15;IGF2;PDGFA;HPSE;CCL3;CASS4;PIK3CD;F10;RAC2;ERBB3;KLB;MAZ;CD86;FLT3;HGF;TGFB1;THPO;TRAT1;THEM4;TGFA;MYDGF;C1QBP;TEK;CD28;PIK3R5;FGF22;MFHAS1;FGFR3;CX3CL1;ITGB1;TRIB3;MYOC
prerank,purine-containing compound catabolic process (GO:0072523),0.474844157749663,1.015484712194047,0.47319034852546915,0.7700581760780777,1.0,4/13,17.44%,GPX1;DNPH1;PNP;NT5C
prerank,regulation of striated muscle contraction (GO:0006942),0.41403438381235375,1.0153602243230826,0.4658385093167702,0.7699542196417833,1.0,7/27,19.17%,CALM1;CALM3;TNNI1;RYR2;SRI;CALM2;GRK2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4449428255496449,1.0152472158482597,0.4726810673443456,0.7698087111312814,1.0,7/17,21.36%,CALM1;CALM3;CADM4;DMTN;CALM2;DDIT4;SIRT2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4157643015469347,1.0149689354493183,0.4801980198019802,0.7700461622131735,1.0,4/26,3.99%,PRNP;AKAP6;TNF;HOMER2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.27713526400975774,-1.0149582532197337,0.424,0.7640983511426049,1.0,10/43,11.42%,SMAD3;TEAD1;NFIB;PPARA;FOXO3;NFATC4;STAT3;PPARG;TERT;NFATC3
prerank,synaptonemal complex organization (GO:0070193),0.46259049268972846,1.0148143808454053,0.469119579500657,0.7695534009441778,1.0,1/15,4.14%,SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.46259049268972846,1.0148143808454053,0.469119579500657,0.7695534009441778,1.0,1/15,4.14%,SYCP2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4883536858058909,1.014656608979398,0.4663805436337625,0.7694931805127424,1.0,6/11,34.09%,ANK3;SYK;PRKCA;PRKCQ;PLAUR;CCL5
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.4063188227593738,1.0145080285516304,0.46153846153846156,0.7694442132318936,1.0,11/28,21.63%,MAP1A;STMN3;CLASP1;MAPT;MAP2;STMN4;STMN1;ARL2;MAPRE3;MAP1B;FKBP4
prerank,regulation of actin filament-based movement (GO:1903115),0.4926492163364061,1.014369249174248,0.45894428152492667,0.769386780764688,1.0,3/10,17.63%,PDE4B;PLN;SRI
prerank,positive regulation of wound healing (GO:0090303),0.39631381735308924,1.0143401878297074,0.4469078179696616,0.7690346075877958,1.0,2/36,0.90%,ACTG1;VTN
prerank,embryonic hemopoiesis (GO:0035162),0.48047044371648734,1.0137821018709818,0.47547683923705725,0.7699608440110407,1.0,3/12,10.12%,ATF4;KDR;KITLG
prerank,protein O-linked mannosylation (GO:0035269),-0.3467513346845328,-1.013502173348328,0.4618834080717489,0.766387508790689,1.0,3/18,1.53%,TMTC1;LARGE1;TMTC4
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.35586354633087364,1.0133658807515804,0.4765380604796663,0.7705692606939776,1.0,28/101,19.83%,CALM1;AKT1;CALM3;CCND2;TNF;PDGFB;CCND1;PROX1;CD24;CAMK1;PIH1D1;CSF1R;WNT5A;HRAS;RHOA;NEK10;PDGFA;RASGRP1;MAPRE3;DAB2IP;FLT1;ADAM17;MAP2K2;EDN3;CALM2;SNCA;FLT3;TGFB1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.45893533962857563,1.013358717345417,0.48409405255878285,0.7701660173375474,1.0,6/14,17.76%,PSENEN;ABCG1;BACE1;PSEN2;ADAM17;APH1B
prerank,regulation of B cell apoptotic process (GO:0002902),-0.38889252130636187,-1.0133572751831916,0.4169611307420495,0.7650189038588424,1.0,3/12,8.04%,FOXP1;FNIP1;NOC2L
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3565319055023727,-1.0133050136022577,0.4,0.7633690968582652,1.0,6/15,15.83%,PIEZO2;ADGRV1;COL11A1;TMEM120A;KIT;PDZD7
prerank,aminoglycan catabolic process (GO:0006026),0.4028196848952308,1.0129714172866595,0.4732360097323601,0.7706642764577246,1.0,13/28,19.89%,HYAL2;OVGP1;GUSB;SDC4;FUCA1;GPC5;SGSH;NAGLU;HPSE;SDC3;HPSE2;HSPG2;AGRN
prerank,fatty acid transmembrane transport (GO:1902001),-0.328078950400685,-1.0129370880198334,0.4025974025974026,0.7624949933142614,1.0,4/19,11.96%,PRKAG2;ABCD3;PRKAA2;CPT2
prerank,regulation of glycogen metabolic process (GO:0070873),0.4714249943225379,1.0126527439666098,0.4646324549237171,0.7710303818569773,1.0,3/12,21.21%,AKT1;PPP1R3D;KHK
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.39545173877187456,-1.0125912068054375,0.4440789473684211,0.7616886173753186,1.0,3/10,15.98%,DNMT3A;PCGF5;MECP2
prerank,response to UV-A (GO:0070141),0.46453475278802064,1.012495966623057,0.452755905511811,0.7709733638117713,1.0,4/14,11.31%,AKT1;CCND1;TIMP1;MMP3
prerank,cell-matrix adhesion (GO:0007160),0.3578800461329081,1.0120629590870096,0.47297297297297297,0.7716044833940773,1.0,22/95,16.62%,CD63;VTN;ITGB2;CD34;ADAM15;EMP2;RAC1;TIMM10B;FN1;BCAM;PPFIA2;ZYX;THY1;COL3A1;SIGLEC1;ARHGEF7;ACTN1;TNN;TIAM1;DLC1;HPSE;VCAM1
prerank,protein maturation (GO:0051604),0.3587234574386495,1.0120517728005665,0.4696652719665272,0.7712065432683681,1.0,35/95,25.56%,BOLA2;CTSS;CPXM1;CPD;SORL1;PSENEN;CPE;PRSS37;HSPD1;METAP2;PCSK2;SRGN;NAA10;AEBP1;CPXM2;BACE1;DNAJB11;CIAO1;PSEN2;MMP14;ADAM17;APH1B;NNAT;LMF2;CIAO2A;CIAO2B;STUB1;TSPAN32;ECE2;NDUFAB1;AANAT;CPZ;APH1A;PCSK6;LIPT1
prerank,regulation of DNA binding (GO:0051101),0.38528752095222685,1.0119900674475544,0.4512471655328798,0.7709377118177976,1.0,9/44,11.55%,TXN;NME1;CSNK2B;HES1;EDF1;JUN;HMGB1;SUMO3;ZBTB7A
prerank,negative regulation of multicellular organismal process (GO:0051241),0.34166487349786123,1.0117720641737302,0.473313192346425,0.7710332890537186,1.0,54/199,21.30%,RPS19;MDK;GRN;CALR;GPNMB;ATF4;ID1;TNF;NR1D1;SPI1;LRP4;RGS2;ALPK2;ARHGDIB;LRPAP1;CORO1C;SYT11;TIMP1;HS3ST5;PROCR;SRGN;ATP2B1;PTPRR;SLC11A1;SOX9;GJA1;SPRY1;BMP2;GAS6;WNT10B;STK11;ARRDC3;IFNGR1;GDF15;NR1H2;PLCL2;HEY1;DAB2IP;HDAC9;PFN2;BRCA2;ADAM17;IP6K1;VASN;NOTCH1;EFNA1;TGFB1;MEF2C;FOXA2;SFRP1;TWSG1;PTPRO;DDIT3;FOXA1
prerank,cell proliferation in forebrain (GO:0021846),-0.4028794990593442,-1.0117017835123523,0.44594594594594594,0.7624279277996124,1.0,4/10,15.27%,DOCK7;PCM1;NUMBL;NUMB
prerank,response to UV (GO:0009411),0.35802966570048544,1.0115591672429172,0.4801255230125523,0.7711303490818088,1.0,25/95,21.83%,RPL26;GPX1;ATF4;AKT1;NPM1;COPS9;PARP1;MFAP4;CCND1;AQP1;SDF4;SMPD1;MC1R;PCNA;NSMCE3;CAT;CIRBP;TRIM32;ERCC6;CDC25A;CCAR2;MYC;BAK1;MEN1;MAP2K7
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.45921294000356994,1.0112114939720873,0.49206349206349204,0.7715349849288196,1.0,8/15,25.43%,BGN;BCAN;DCN;B3GAT3;VCAN;CSGALNACT2;CHST14;CSPG5
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.49088114010238937,1.0108216417747056,0.4792243767313019,0.7720591217912032,1.0,2/11,13.40%,PTPRC;LILRB1
prerank,early endosome to Golgi transport (GO:0034498),0.48984534550258535,1.0103288145653069,0.46924177396280403,0.7728361709993244,1.0,3/11,10.72%,LMAN1;SURF4;TMED9
prerank,tube closure (GO:0060606),-0.29679806117338764,-1.010254830847209,0.4431137724550898,0.7645648828662631,1.0,7/31,13.47%,COBL;SKI;LRP6;MTHFR;LMO4;IFT122;CELSR1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4779286906419752,1.010220974208551,0.4684931506849315,0.7726834466814724,1.0,4/13,17.58%,SYT1;SYT4;SYT10;DOC2B
prerank,negative regulation of cell motility (GO:2000146),0.350646341592083,1.0101772193251026,0.46790890269151136,0.7723578635175563,1.0,17/108,9.80%,CD74;CLDN5;IFITM1;RHOB;ADAM15;ACVRL1;IGFBP5;DNAI3;PIN1;MIF;DUSP3;FRMD5;ADORA3;NAV3;THY1;SPOCK3;EPPK1
prerank,regulation of cardiac conduction (GO:1903779),0.3726125665974017,1.0091305609854089,0.4850498338870432,0.7745037513716972,1.0,15/54,17.75%,NPPC;FXYD1;AGT;ATP1A3;ATP1B2;FXYD7;ATP1A4;ATP1A1;ATP2B1;TRPC1;ATP1B1;SLC8A1;RYR2;ATP1B3;FKBP1B
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3225570015290024,-1.009034725799119,0.4368421052631579,0.7662154011539618,1.0,5/21,10.73%,CGNL1;SLIT2;MAPKAP1;ARHGAP12;EPHB2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.4745946426951848,1.0090210652318985,0.4816326530612245,0.7743398323510268,1.0,7/12,24.11%,SYT1;RIMS2;RIMS1;SYT2;DOC2B;SYT5;UNC13A
prerank,activation of protein kinase activity (GO:0032147),0.35105616285649177,1.0089703418941822,0.47668393782383417,0.7740449535536844,1.0,24/106,14.73%,PPIA;MT3;PARK7;AKT1;TXN;NRG1;PINK1;EMP2;PDGFB;ANG;TIRAP;PAK1;PRKAR1A;PAK3;PRKAR1B;WNT5A;SLC11A1;GAS6;ADCY4;CCDC88A;STK11;TLR6;PRR5;COPS8
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3817957607756117,1.008808912388962,0.4664429530201342,0.7740362137947485,1.0,11/48,11.85%,MDK;CALR;S100A10;RAC1;FLNA;MYADM;P4HB;IL1RAPL1;ARHGEF7;SS18L2;PTPRD
prerank,positive regulation of histone methylation (GO:0031062),-0.3096877288317416,-1.0087571669390716,0.4416243654822335,0.7652345363221801,1.0,4/24,5.59%,AUTS2;OGT;KMT2A;JARID2
prerank,negative regulation of histone acetylation (GO:0035067),0.4915267122122178,1.0084560710467605,0.4887640449438202,0.7744562437602783,1.0,4/11,19.11%,SPI1;SET;CTBP1;SNCA
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4166158204080247,1.0083283090092283,0.47985347985347987,0.7739322746992428,1.0,9/23,21.72%,HSP90AB1;CDKN1C;HIPK2;SNW1;STK11;SDCBP;ADAM17;CITED2;MEN1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4166158204080247,1.0083283090092283,0.47985347985347987,0.7739322746992428,1.0,9/23,21.72%,HSP90AB1;CDKN1C;HIPK2;SNW1;STK11;SDCBP;ADAM17;CITED2;MEN1
prerank,protein localization to chromosome (GO:0034502),-0.2888113535677245,-1.0079959693048566,0.45517241379310347,0.7655578616330129,1.0,9/34,16.48%,WAPL;PARP3;ESR1;MRNIP;TNKS2;TERF2;TINF2;PINX1;IFFO1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3451001681239313,1.0069101634791224,0.4903357070193286,0.7769053630346167,1.0,31/140,18.30%,CD52;CHRNA9;GPER1;TAC1;C5AR1;GRIN1;CACNA1A;CCR5;P2RX7;TACR1;HTR2C;P2RY1;CD24;HMGB1;GRM1;GPR18;JPH4;CXCR4;CX3CR1;F2RL1;SLC8A1;RYR2;ADRA1D;ADRA1A;ADCY8;CAV1;CCKBR;BCAP31;PTGIR;ADCYAP1;CCR2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.49573852854243255,1.0067453356253333,0.47652916073968704,0.7769108500321268,1.0,5/10,24.55%,RPS27L;HIPK2;MUC1;TFAP4;FOXM1
prerank,regulation of gene expression (GO:0010468),0.33092243699223534,1.0067087303981126,0.463,0.776574248943648,1.0,191/903,20.17%,APOE;RPL23;RPS3;ACTG1;CRIP1;RPL11;RPS7;RPL5;CD74;CLU;PFDN5;RACK1;CLDN5;RPL6;GSN;RAMP2;TYROBP;PCBP1;GPX1;CALR;CXXC1;ACTA2;MT3;PARK7;MAPK3;HNRNPAB;ATF4;LGMN;AKT1;CNPY2;SOX18;TREM2;HINT1;CD34;LYL1;HNRNPK;PINK1;ANK3;SLC7A5;GPER1;MAGED1;TNF;PDGFB;DRAP1;LAMTOR5;PTPRC;HCLS1;ACVRL1;BTN3A3;TAPBP;NTRK2;CHEK2;ZFP36L1;SPI1;PIN1;AMH;MIF;HSPA1B;PPP2R1A;TLE5;SIRPA;SH3GL2;APLNR;AHNAK;PCBP4;ALPK2;MYADM;FN1;BTG1;MUSK;FADS1;TFRC;MSN;RIMS2;RNF187;TBX22;CEBPB;PQBP1;HES6;NELL1;RIMS1;PRDM12;EDF1;CEBPA;P2RX7;PROX1;KDR;VSIR;MAPT;BCL6B;MOG;YBX1;MLXIPL;MLX;EGR1;RRP1B;GATA2;ATP13A2;ICOSLG;TAF5L;TARDBP;HOXB7;LRP3;APBB1;SUPT4H1;WNT5A;SOX17;ATF5;RAMP3;POU3F1;KDM6B;ATRAID;WARS1;FAM50A;HRAS;TMEM119;CAMK2N1;MSR1;AIF1;KLF4;SLC11A1;SOX9;HSPA1A;FBXW7;METTL18;GJA1;LILRB1;BMP2;GAS6;HDAC5;SFRP4;UBE2V1;RO60;MAFA;CTSH;TLR6;SORT1;NONO;PF4;SPIN4;IFNGR1;TRAF3;MAPK11;ATP1B1;DHH;SLC8A1;IGF2;YBX3;GLRX2;HEY1;DNAJA4;CCL3;DNMT3B;EPB41L4B;VHL;GATA4;PRX;CDH5;PIK3CD;TWIST1;PDCD5;BRCA2;PPARGC1A;NOS2;RLIM;AGO1;MLF2;CNBP;ZNF22;TERF2IP;MAP2K2;MAZ;HMGN5;EDN3;SOX11;CCAR2;DDRGK1;ANKRA2;HIC1;INHBA;ESRRB;NOTCH1;IL6;ERP29;MLF1;TGFB1;CHD3;POU4F1;CITED2;MEF2C;SFRP1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3557714864945075,1.0067052133061252,0.4850669412976313,0.7761651219573588,1.0,27/100,19.67%,MAPK3;TREM2;AGT;GPER1;IER3;TNF;PDGFB;HCLS1;NTRK2;FN1;EPOR;KDR;DCN;PIK3IP1;SOX9;F2RL1;PDGFA;NCF1;DAB2IP;FLT1;PIK3CD;TWIST1;ERBB3;NOP53;MAZ;FLT3;HGF
prerank,positive regulation of neuron projection development (GO:0010976),0.35494321400273865,1.006161640579549,0.4984093319194062,0.7770446738894403,1.0,13/85,11.12%,APOE;MDK;PACSIN1;NTRK2;S100A9;CAMK1D;NDRG4;TENM3;LTK;ATP1B2;PTK6;CAMK1;WNT5A
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4321020492058251,1.006089052661594,0.48227848101265824,0.7767996892501476,1.0,4/20,13.45%,MT3;ATF4;CREB3;BMP2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.5009446400462036,1.0056074351036908,0.48450704225352115,0.7775240321561195,1.0,6/10,35.56%,PIH1D1;TAF9;NAF1;RUVBL2;ZNHIT3;NUFIP1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3607248740885099,1.0055542242323083,0.4640171858216971,0.7772220186299447,1.0,18/67,16.26%,HSP90AA1;HSPB1;CYBA;RAC1;ELMO1;CYBB;KDR;CLEC14A;PDCD6;AAMP;FLT4;VAV1;RHOA;VAV3;MAPK11;NCF1;DAB2IP;FLT1
prerank,respiratory tube development (GO:0030323),-0.29599166216906464,-1.005383238146069,0.391025641025641,0.7708309350088604,1.0,8/28,13.72%,GLI2;FGF1;PCSK5;LOXL3;FGFR2;NPHP3;ITGA3;BMP4
prerank,intestinal lipid absorption (GO:0098856),-0.38488295763903524,-1.005377544261474,0.4412811387900356,0.7690741982241989,1.0,1/11,1.11%,LIMA1
prerank,external encapsulating structure organization (GO:0045229),0.339083935339483,1.0051801358593997,0.49899396378269617,0.7776964200503633,1.0,33/205,11.77%,BSG;SPARC;VTN;BGN;SPP1;COL1A1;BCAN;LAMC1;LAMB2;SPOCK2;LUM;ITGB2;ADAM15;HRNR;PDGFB;ADAMTS4;ADAM12;LOX;FN1;TTR;MMP21;TNR;APLP1;COL6A1;COL4A1;KDR;COL3A1;LAMC2;DCN;COL9A1;PECAM1;MMP3;MFAP2
prerank,skin development (GO:0043588),0.3604384132200792,1.0046306053893388,0.47670639219934996,0.7786375961968788,1.0,15/65,16.89%,COL1A1;TXNIP;HRNR;ABCB6;COL3A1;DHCR24;KRT9;WNT5A;LSR;COL1A2;EVPL;STMN1;PDGFA;DLL1;FA2H
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.38976639340122365,-1.0044795287296007,0.4181184668989547,0.7697012987620656,1.0,9/11,31.29%,GRK3;ADM;GTF2H2;SAG;ARRB1;ADRB2;DRD3;ADRB3;ARR3
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.388077023288299,1.0043825845390129,0.47380410022779046,0.7788129531652046,1.0,9/43,13.23%,HMOX1;AKT1;TNF;PDGFB;IGFBP5;P2RY6;JUN;AIF1;GJA1
prerank,regulation of focal adhesion assembly (GO:0051893),0.37363393886175333,1.0043748876020484,0.4781659388646288,0.7784116917613298,1.0,12/54,8.38%,ACTG1;APOD;S100A10;RAC1;ACVRL1;DUSP3;GPM6B;FAM107A;CORO1C;CLASP1;THY1;KDR
prerank,primary neural tube formation (GO:0014020),-0.3013298687385274,-1.0043730326620455,0.4716981132075472,0.7682434078760366,1.0,7/30,13.47%,COBL;SKI;LRP6;MTHFR;LMO4;IFT122;CELSR1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.4393969643923825,1.0037633331871474,0.47381864623243936,0.7794652521124549,1.0,6/19,15.97%,HSPA1B;CHMP2B;CHMP5;HSPA1A;HNRNPU;CHMP1B
prerank,muscle cell development (GO:0055001),0.40232720553795126,1.0034901816471293,0.4853801169590643,0.7797092509898661,1.0,6/30,15.37%,RAMP2;SGCZ;HES1;ALPK2;MYH11;SLC8A1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.34925518367130004,1.003030294626545,0.5031185031185031,0.7803877424354988,1.0,24/112,13.63%,RPS27A;UBC;CLDN5;UBB;ID1;ACVRL1;FKBP1A;ZFP36L1;ZFP36L2;HYAL2;LEFTY2;WFIKKN2;UBA52;ZYX;CLEC3B;COL3A1;JUN;WNT5A;AMHR2;ZMIZ2;COL1A2;SOX9;RHOA;LEFTY1
prerank,histone H2B ubiquitination (GO:0033523),-0.418532891128889,-1.0029872484561595,0.4586206896551724,0.7701024679334425,1.0,6/10,22.76%,RNF8;CDC73;UBE2E1;WAC;RNF20;CTR9
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3350244604580466,1.0027480666673132,0.501,0.7806398421669655,1.0,96/390,19.98%,ACTB;ACTG1;ATP6V0C;HSP90AA1;COL1A1;POLR2E;MAPK3;AKT1;ATP6V1F;CYBA;NRG1;POLR2D;ERBB4;ANKS1B;POLR2F;PDGFB;RAC1;GRB14;NTRK2;ATP6V1G1;CAV2;PSENEN;ATP6AP1;ATP6V0E2;GRIN1;RARRES2;ELMO1;AP2M1;LTK;CYBB;SHC3;MUSK;RAB14;NAMPT;PTK6;PAK1;KDR;MPZL1;CDK5R1;AP2S1;EPHA5;ARPC1B;HCK;ARHGEF7;PAK3;POLR2G;CSF1R;HAP1;ATP6V0D2;FGFRL1;AAMP;ARPC3;PLAT;FLT4;HRAS;ARPC5;POLR2K;VAV1;RHOA;TIE1;STMN1;VAV3;SDCBP;HNRNPA1;SORT1;SH2B2;TIAM1;ARPC4;MAPK11;GDF15;IGF2;PDGFA;EPHB1;NCF1;GFRA2;FLT1;TYRO3;CASS4;PSEN2;LCP2;EFNB1;ARPC2;APH1B;SYK;DDR2;ERBB3;GRIN2B;SRMS;SLA;KLB;SOS1;FLT3;HGF;EFNA1;GIT1;DDIT4
prerank,insulin receptor signaling pathway (GO:0008286),0.36200932418797105,1.0023803375239622,0.47807486631016044,0.7811020464091616,1.0,10/69,7.56%,ATP6V0C;AKT1;ATP6V1F;GRB14;ATP6V1G1;CAV2;ATP6AP1;ATP6V0E2;RARRES2;NAMPT
prerank,calcium ion import (GO:0070509),-0.3033649479174169,-1.0023682030789667,0.41954022988505746,0.7700432491860875,1.0,8/28,14.17%,MCU;CACNA1C;MICU1;MICU2;TRPC4;CACNA1G;AFG3L2;CACNA1D
prerank,glucose transmembrane transport (GO:1904659),0.43390023383058796,1.0021825522857335,0.472400513478819,0.7811817447967716,1.0,9/18,36.98%,SLC2A1;SORT1;SLC2A2;SLC2A3;SLC2A6;PPBP;SLC2A4;SLC2A8;SLC5A3
prerank,autophagy of peroxisome (GO:0030242),0.4721366064610033,1.0021496536915016,0.47950819672131145,0.780839498391325,1.0,3/12,16.86%,MAP1LC3B;PJVK;SQSTM1
prerank,regulation of myoblast differentiation (GO:0045661),0.3972567264107971,1.0016497153692445,0.47017543859649125,0.7816554213757219,1.0,10/32,20.07%,LRRC8A;IGFBP3;ZFP36L1;BTG1;SOX8;SOX9;DLL1;NOTCH1;TGFB1;MEF2C
prerank,proteolysis (GO:0006508),0.3375576168547754,1.0016310045815613,0.5,0.7812930226966409,1.0,72/252,25.64%,CTSD;CTSB;CTSL;CTSZ;CTSS;TMPRSS6;LGMN;CPXM1;CPD;PSENEN;PSMD6;CPE;SPPL2B;F9;SPCS1;VASH1;METAP2;TINAGL1;NEDD8;PGPEP1L;TMPRSS5;PCSK2;SRGN;AEBP1;CPXM2;MMP3;PLAT;CTSA;ERMP1;PSMB11;LAP3;CTSH;SPG7;LRP8;RNPEPL1;PSMB5;NAPSA;VHL;BACE1;PLAU;PSEN2;MMP14;ADAM17;APH1B;CTSC;PSMA6;DESI2;DESI1;HGF;PGPEP1;CAPN3;ATG4D;FAM111A;SPPL2A;CTSE;ACAN;ECE2;ST14;DPP7;ERAP1;LONP1;PRCP;CAPN11;CPZ;FBXO3;THOP1;FBXO2;APH1A;PCSK6;MMP1;CASP1;MMP24
prerank,positive regulation of signaling receptor activity (GO:2000273),0.39738113104611805,1.0010701455005624,0.48346636259977194,0.7822532457204944,1.0,9/36,21.65%,PARK7;FBXW7;CCL2;NCF1;ADAM17;CCR2;BUD31;ADRA2B;TGFA
prerank,positive regulation of organelle organization (GO:0010638),0.39874319744641706,1.0005329409449177,0.4859154929577465,0.7831423696995018,1.0,9/32,20.86%,TREM2;LMAN1;SURF4;P2RX7;TMED9;LNPK;PPARGC1A;DOC2B;C2CD5
prerank,activation of adenylate cyclase activity (GO:0007190),-0.2840453654666126,-1.0001712887722076,0.4329268292682927,0.7742360215583324,1.0,7/35,10.19%,ADCY9;ADCY1;LGR4;ADCY5;RAF1;EDNRA;ADCY7
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.22274146995186336,-1.0,1.0,0.7642846202052774,1.0,381/1646,16.30%,ZBTB20;PBX1;NFIA;TSHZ2;FOXP1;NFAT5;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;WWC2;MLLT3;GLIS3;EGFR;HIVEP2;BNC2;BAZ2B;ZNF148;ATXN1;NR3C2;RBFOX2;ARID1B;TCF4;TCF7L2;PKNOX2;HOXB6;ABL1;SMAD6;BRWD1;PRDM5;SCMH1;ZNF423;KDM3B;KLF12;HOXB3;ZBTB7C;PRRX1;TCF12;ARNT;ACVR1;TSHZ3;SOX5;SETD5;KAT6B;DENND4A;ZMIZ1;CREBBP;FOXD1;PBX3;KDM2A;ZHX2;ARHGEF11;STAT5B;MED13;MXI1;SSBP2;VGLL4;FOXN3;SNX6;ATF7IP;CUX1;IL31RA;TRAK1;BBX;KDM7A;GLI3;HLF;ZBTB16;NR6A1;ZIC4;BICRA;NCOA1;BRD4;SMURF2;SUFU;HOXA3;GLI2;CAMK2D;MIDEAS;NIPBL;BAZ2A;DHX36;LRP5;CCAR1;WWP1;ARNT2;JMJD1C;USP47;MGA;LRP6;DPF3;ZMYND11;HOXB4;ELF1;MNAT1;NR2F2;ATF7;HDAC4;PER2;NFYC;CHD2;TAF15;DKK3;NFXL1;PIAS1;HMG20A;OGT;YAF2;MED13L;HOXA5;PARP9;PIAS2;CBFA2T2;HIVEP3;ZKSCAN2;NIBAN2;PRDM11;MTA3;YAP1;KLF3;THRAP3;NRF1;EHMT1;URI1;ZNF292;KMT2A;TEF;PPARA;NFIX;HOXC4;CREB5;ZFP90;ELP4;EPC1;NFATC1;AXIN1;FOXO3;LIMS1;KDM5B;PHC3;ARID1A;KAT7;APBB2;NFATC4;L3MBTL3;ZNF182;SMAD9;NCOR1;BICRAL;TGFBR1;CCNT1;JARID2;KDM3A;TBX15;TFCP2;FOXP4;EFEMP1;TBL1X;LCOR;TLE1;VGLL3;MEOX2;UIMC1;FBXL19;SP1;NFKB1;ZFPM2;NR1D2;BCOR;FOXK2;HOXB5;ZSCAN26;SMARCE1;ARID4B;MDM4;ELF2;INSR;STAT3;HDGFL3;HIF3A;MTDH;VSX1;NEK4;RCOR1;CRLF3;NAA16;DYRK1A;CHD1;ARID5B;MDFIC;PML;SMARCA5;SMAD1;CCNL1;ZIC2;RUNX1T1;ZFHX3;MBTD1;ZBTB38;CCNL2;BAZ1B;ZFP30;CEP290;RBBP8;ZBTB1;SPEN;MYNN;USP16;ZFHX4;EBF4;IGF1;ZFX;LOXL3;MEF2A;JMY;STAT2;NSD3;RBAK;PRDM15;MMS19;BTAF1;ZBTB26;SMAD7;EBF1;TFDP1;NFX1;TADA1;BTRC;MYBL1;ATF2;SPINDOC;TBL1XR1;SP100;TEAD2;CBX4;PPARG;PICALM;CREBRF;ETV6;KDM5C;SP4;KLF8;NAA15;ESR1;NR2C2;PCGF5;FOXK1;CCNK;IFRD1;HOXC6;ZFP91;ASCC1;CNOT7;ZNF23;SMAD4;MED26;FBXW11;ZKSCAN3;PDCD4;ZIC1;ATF6;ELF4;TULP3;CDH1;HOXA6;CREB3L2;GMEB1;DGKQ;BRD7;ACTR8;YEATS2;PRRX2;PSEN1;MZF1;NFATC3;KMT2D;DNM2;RBPJ;DDX17;ZHX3;ILF2;KDM4C;CD80;RCOR3;ZBTB34;NLK;GPBP1;SLTM;QRICH1;RNF14;AR;POLR2A;HOXC5;TIAL1;PHF20L1;HIVEP1;ATP8B1;IKZF2;ZBTB8A;ZNF8;RREB1;MKX;SIX1;FUS;NR2F1;HSF2;APBB3;KLF7;SIX5;ZKSCAN7;DVL3;TGFB1I1;TASP1;KAT6A;RORA;CBFB;PHF8;SIRT1;PCBD2;WNT11;NFIC;SCML4;BCLAF1;BMP4;PPARGC1B;SMAD2;ORC1;PHIP;ZBTB21;RLF;TGFB3;WWP2;ZFP62;TFCP2L1;ZNF276;PBX4;NPAT;MLXIP;RSF1;CREBL2;EDRF1;GMEB2;GON4L;CARM1;RUNX2;HEY2;EZH2;GATAD2A;SRRT;CRY1;FOXN2;STAT5A;ZBTB5;KIT;MDM2;PRKCB;SOX13;IRF2;ZBTB46;LDB1;NFYB;ZSCAN12;ZBTB6;BRWD3;HOXA2;BATF;RNF111;CAMTA2;MECP2;LIMD1;ING2;HINFP;WNT4;ZNF483;ESRRA;FOXO1;FOXL1;TP53;NUP35
prerank,phosphorylation (GO:0016310),-0.27317017942930405,-1.0,1.0,0.7642846202052774,1.0,114/385,16.84%,PRKAG2;ROCK2;GRK5;EPHA7;FER;ABL1;STK3;ACVR1;DAPK1;BMPR1A;BIRC6;LRRK2;PDK1;PI4KA;ROCK1;SIK3;FAM20A;CAMK2D;BRAF;SIK2;PRKCE;CSNK1A1;MAP3K13;GRK3;CLK2;MARK1;EIF2AK4;PDPK1;TLK2;TGFBR1;CCNT1;AGK;IRAK3;STK24;WNK4;PPP4R1;SNRK;CDK12;CDK6;EIF2AK3;INSR;STAT3;TLK1;MAST2;NEK4;CDC42BPB;DYRK1A;MARK3;DGKA;TYK2;TRIB2;TOP1;SIK1;MAML1;TAOK3;GK5;BCR;PRKAA2;NEK6;AAK1;STK10;MAPK9;FRK;HIPK3;NEK7;MAP4K4;CDC25B;NRK;FGGY;MAP4K3;TESK2;DMPK;MORC3;EPHB2;CDK13;GRK4;TBCK;NUAK1;DAPK2;TBK1;DGKQ;LATS2;MAPK6;NEK3;STK38;ATM;CSNK2A1;NLK;COQ8B;PRKD1;WNT11;SRPK2;GSK3B;MARK2;PRKAG1;PRKCI;CDK7;CDKL3;TAOK1;PRKCB;PANK2;ACVR2A;SPHK1;DCLK1;LIMD1;PASK;STK39;BMPR2;JAK1;RYK;PPP3CB;ULK1;ACVR2B;COQ8A
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.2304041388902785,-1.0,1.0,0.7642846202052774,1.0,396/1668,16.29%,ZBTB20;PBX1;NFIA;TSHZ2;FOXP1;AUTS2;NFAT5;BMP6;PRDM6;NSD1;SMAD3;FOXP2;TEAD1;ZEB1;NFIB;PID1;PHF21A;WWOX;WWC2;GLIS3;EGFR;HIVEP2;BAZ2B;ZNF148;ATXN1;MLLT10;NR3C2;DNMT3A;ARID1B;FHL2;TCF4;TCF7L2;PKNOX2;RARB;HOXB6;ABL1;SMAD6;BRWD1;PRDM5;KDM3B;KLF12;HOXB3;KMT2C;ZBTB7C;PRRX1;TCF12;ARNT;ACVR1;TSHZ3;SOX5;KAT6B;TNRC6B;SLC9A1;ZMIZ1;BMPR1A;CREBBP;FOXD1;MAML2;PBX3;KDM2A;GABPB2;ZHX2;NRIP1;STAT5B;DAB2;MED13;BCAS3;MXI1;SSBP2;KANK2;CUX1;TRAK1;TET2;BBX;KDM7A;GLI3;HLF;ZBTB16;NR6A1;ZIC4;ZFP64;NCOA1;BRD4;SMURF2;SUFU;HOXA3;GLI2;CAMK2D;MIDEAS;FGF1;NIPBL;TNRC6A;ZMYM5;DHX36;PPP1R12A;LRP5;ARNT2;JMJD1C;MGA;SKI;LRP6;DPF3;HOXB4;ELF1;MNAT1;NR2F2;ATF7;HDAC4;PER2;NFYC;THRB;CHD2;PIAS1;OGT;MED13L;HOXA5;PARP9;ASXL2;PIAS2;HIVEP3;ZKSCAN2;MCPH1;CRTC3;PRKN;MTA3;YAP1;PER3;PPM1D;KLF3;THRAP3;TET3;NRF1;ATAD2B;URI1;ZNF292;KMT2A;TEF;PPARA;DCAF6;NFIX;HOXC4;CREB5;OTUD7B;ZFP90;RARG;ELP4;SSBP3;IL18;EPC1;NFATC1;TNRC6C;FOXO3;FNIP1;KDM5B;HDAC8;MED15;DLG1;ARID1A;KAT7;CNOT1;NFATC4;DICER1;ZNF182;SMAD9;NCOR1;KAT2B;CCNT1;KDM3A;TBX15;TFCP2;FOXP4;MYSM1;TBL1X;ASXL1;LCOR;VGLL3;MEOX2;BCLAF3;FBXL19;SP1;NFKB1;ZFPM2;NR1D2;BCOR;FOXK2;HOXB5;ZSCAN26;SMARCE1;ARID4B;CDK12;MDM4;BCL9L;ELF2;TCERG1;STAT3;HDGFL3;HIF3A;MTDH;RCOR1;CRLF3;CHD1;ARID5B;SMARCA5;SMAD1;CCNL1;ZIC2;ZNF462;ZFHX3;ZBTB38;KCNIP3;CCNL2;BAZ1B;ZFP30;RBBP8;MAML1;ZBTB1;MET;SPEN;DNAJA3;MYNN;NOC2L;USP16;CPEB3;ZFHX4;EBF4;IGF1;POGZ;ZFX;MEF2A;JMY;FGFR2;STAT2;RBAK;PRDM15;MOV10;ZBTB26;MIER1;SMAD7;FRK;EBF1;TFDP1;NFX1;TADA1;MYBL1;ATF2;INO80;TBL1XR1;SP100;TEAD2;CBX4;PPARG;CREBRF;ETV6;PTEN;RIPK1;DCAF1;SP4;KLF8;ESR1;NR2C2;PCGF5;PPID;FOXK1;SENP1;CCNK;ECD;IFRD1;HOXC6;ZFP91;RGMA;PKD1;ZNF23;SMAD4;MED26;BCL2L12;ZKSCAN3;CDK13;ZIC1;ATF6;NCK1;ELF4;SETX;HOXA6;CREB3L2;GMEB1;TBK1;DGKQ;BRD7;YEATS2;PRRX2;PSEN1;MZF1;NFATC3;KMT2D;RBPJ;DDX17;ZHX3;KDM4C;SAP130;KANSL3;RCOR3;ATM;ZBTB34;CAPRIN2;AKAP8L;BRD8;SLTM;RNF14;AR;HOXC5;TIAL1;PHF20L1;HIVEP1;ARHGEF2;IKZF2;ZNF507;JAG1;ZBTB8A;ZNF8;RREB1;CXXC5;RPAP2;MKX;PRKD1;SIX1;FUS;NR2F1;HSF2;KLF7;SIX5;ZKSCAN7;DVL3;KAT6A;RORA;CBFB;PHF8;SIRT1;NFIC;BCLAF1;BMP4;PPARGC1B;SMAD2;PHIP;ZBTB21;EHMT2;RLF;TGFB3;WWP2;ZFP62;GTF2H4;TFCP2L1;ZNF276;PBX4;NPAT;MLXIP;METTL23;CDK7;RSF1;GMEB2;RUNX2;HEY2;EZH2;GATAD2A;EZH1;CRY1;N4BP2L2;STAT5A;ZBTB5;KIT;MDM2;PRKCB;SOX13;IRF2;ACVR2A;ZBTB46;LDB2;LDB1;NFYB;CDC73;ZSCAN12;RHOQ;ZBTB6;BRWD3;HOXA2;BATF;RNF111;CAMTA2;MECP2;HINFP;SIRT7;ZNF483;ESRRA;FOXO1;FOXL1;TP53;BMPR2
prerank,transcription by RNA polymerase II (GO:0006366),-0.2339190746237193,-1.0,1.0,0.7642846202052774,1.0,96/305,18.69%,TEAD1;NOTCH2;MLLT3;GLIS3;NR3C2;RARB;PRRX1;SCAF8;SOX5;CREBBP;MAML2;INTS8;NR6A1;SETD2;MNAT1;THRB;TAF15;AFF4;YAP1;PPARA;NFIX;RARG;ELP4;INTS6;NCOR1;KAT2B;CCNT1;TFCP2;TBL1X;SP1;WDR33;NFKB1;NR1D2;CDK12;MAML1;ZBTB1;RNGTT;TAF1A;CSTF3;TFDP1;NFX1;TBL1XR1;IWS1;PABPN1;TEAD2;PPARG;ESR1;TRIM24;NR2C2;CCNK;MED26;CDK13;PIR;SETX;GTF2E2;PMF1;RBPJ;TAF2;ELL;AR;POLR2A;PHAX;RREB1;RPAP2;NR2F1;RORA;CBFB;FIP1L1;NFIC;DTX1;GTF2H4;POLR2B;CDK7;GMEB2;SRRT;POLR2J;CDC73;TRIP11;GTF2A2;ESRRA;ADRM1;NR3C1;RTF1;ICE2;SNAPC3;TAF8;RPRD2;CPSF1;ERCC3;TAF7;TAF4B;INTS3;NR5A2;INTS11;GTF2H2;MED23
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.1976360597302146,-1.0,1.0,0.7642846202052774,1.0,89/336,18.12%,FOXP1;UBE2E2;ABL1;SUSD6;BABAM2;USP3;PDS5A;TRIP12;NIPBL;STXBP4;PARP4;USP47;UBR5;MNAT1;YAP1;KMT5C;BRAT1;UVRAG;TLK2;SPIDR;PDS5B;PARP3;KMT5B;NEK4;MSH3;RNF8;UFL1;PML;ASH2L;ZBTB38;BAZ1B;RBBP8;ZBTB1;RNF169;TAOK3;USP16;DDB2;SLX4;MMS19;ALKBH8;PSME4;ATF2;INO80;FBH1;TOPORS;CCNK;XPA;MRNIP;SETX;CUL4B;BCL2L11;RAD51B;PSEN1;CUL4A;ATM;RAD17;BCL2;MTREX;USP28;SETD7;ERCC8;SIRT1;GTF2H4;BOD1L1;CGAS;TAOK1;MGMT;CRY1;TDP1;FANCC;ETAA1;BATF;HINFP;SIRT7;FOXO1;ALKBH3;TP53;USP45;FANCG;INIP;CEP63;RTEL1;MAPK14;RMI2;WAC;FMR1;ERCC3;INTS3;TIGAR
prerank,protein phosphorylation (GO:0006468),-0.23676385859588797,-1.0,1.0,0.7642846202052774,1.0,140/479,17.68%,PRKAG2;ROCK2;GRK5;TGFBR3;EGFR;FER;ABL1;STK3;ACVR1;DAPK1;BMPR1A;BIRC6;LRRK2;EPHA3;PDK1;ROCK1;SIK3;FAM20A;CAMK2D;BRAF;SIK2;PRKCE;CSNK1A1;MAP3K3;MAP3K13;GRK3;CLK2;MARK1;SMG1;EIF2AK4;PDPK1;RICTOR;TLK2;TGFBR1;CCNT1;EPHA4;EFEMP1;IRAK3;STK24;WNK4;PPP4R1;SNRK;CDK12;CDK6;EIF2AK3;INSR;TLK1;MAST2;NEK4;CDC42BPB;DYRK1A;MARK3;MAPKAPK3;TYK2;TRIB2;BAZ1B;TOP1;SIK1;MAML1;TAOK3;BCR;PRKAA2;FGFR2;NEK6;AAK1;STK10;SMAD7;MAPK9;FRK;PDGFRB;HIPK3;NEK7;MAP4K4;CDC25B;ABI1;NRK;RIPK1;MAP4K3;ABL2;TESK2;DMPK;PKD1;MORC3;PTK2;EPHB2;CDK13;GRK4;TBCK;NUAK1;SLK;DAPK2;TBK1;DGKQ;LATS2;MAPK6;NEK3;STK38;ATM;CSNK2A1;CSNK2A2;NLK;COQ8B;ULK2;PRKD1;WNT11;SRPK2;GSK3B;BMP4;SMAD2;MARK2;GTF2H4;PRKAG1;PRKCI;CDK7;CDKL3;TAOK1;CRY1;KIT;PRKCB;CLSPN;ACVR2A;DCLK1;PASK;STK39;BMPR2;ABI3;JAK1;RYK;PPP3CB;ULK1;ACVR2B;PKDCC;COQ8A;STRADB;MAPK14;STK26;ABI2;PDGFRA;VRK3;EPHA8
prerank,positive regulation of protein import into nucleus (GO:0042307),0.40029874745548427,0.9995065947150858,0.5048543689320388,0.7852175205892474,1.0,5/28,7.50%,RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,RNA metabolic process (GO:0016070),-0.22303285200565637,-0.9993575494658371,0.47368421052631576,0.7642522289025206,1.0,38/127,16.85%,CELF2;RBMS1;RBPMS;ATXN1;RBFOX2;RBM5;FTO;RBM39;DHX36;ATXN2;RNASE3;DICER1;PARN;HNRNPUL1;MPHOSPH10;RBM6;DROSHA;SIDT2;RNGTT;RBM4;WTAP;PABPN1;HNRNPR;SETX;HNRNPL;DDX17;POLR2A;MTREX;PRPF4;POLR2B;PABPC4;RBMS2;DUSP11;POLR2J;ADARB1;NOVA1;AGO2;HNRNPH3
prerank,calcium ion transport into cytosol (GO:0060402),0.4350556690903483,0.9991840603748354,0.5,0.7855607190342443,1.0,10/21,24.68%,GRIN1;GRIN2A;TRPM2;JPH4;SLC8A1;RYR2;ADRA1A;GRIN2B;CACNA2D1;ITPR3
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.34781091189979524,0.9985404825396313,0.5139896373056995,0.7866451385148121,1.0,36/113,23.82%,MDK;GRN;LAMC1;AKT1;NME1;PTPRN;PDGFB;ANG;C5AR1;ECM1;RTN4;EMC10;PROX1;KDR;TNFSF12;PDCD6;WNT5A;FLT4;HRAS;SOX9;BMP2;NME2;BAD;EGFL7;PIK3CD;SOX11;SFRP1;MYC;TGFA;SCG2;MYDGF;AGGF1;WNT7A;PTN;TEK;OSR2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.4383486954369001,0.998507078339086,0.472400513478819,0.7863029931867708,1.0,7/18,20.07%,MDK;HMGB1;CCL2;IGF2;FLT1;ADAM17;MEF2C
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.30816603594213465,-0.9978724334322425,0.5,0.766339362615231,1.0,9/27,16.27%,FBXL17;PER2;PER3;PML;SIK1;RBM4;FBXL12;CRY1;TP53
prerank,peptidyl-glutamic acid modification (GO:0018200),0.41287629320063324,0.997857715670346,0.4825,0.7874262405963435,1.0,7/24,19.07%,VKORC1;PARP1;AGBL4;NAA10;TTLL7;TTLL10;TTLL5
prerank,positive regulation of protein depolymerization (GO:1901881),0.4838121542691279,0.9978384202737683,0.5021520803443329,0.7870602432193374,1.0,6/11,33.95%,NES;F2RL1;WDR1;STMN2;KATNB1;SEMA5A
prerank,diacylglycerol metabolic process (GO:0046339),0.4189603414339734,0.9976803156185715,0.48462484624846247,0.7870261136776119,1.0,10/23,22.74%,PNPLA2;ANG;DGKH;LIPE;DGKI;MOGAT2;DGAT1;DGKK;DGKB;MOGAT1
prerank,positive regulation of myelination (GO:0031643),-0.3963598324816111,-0.9974512752927343,0.4262295081967213,0.7657315418625998,1.0,2/11,5.39%,PARD3;DICER1
prerank,mammary gland development (GO:0030879),0.4275444708510484,0.9972172826551856,0.48488664987405544,0.7877202645138824,1.0,2/21,2.95%,NRG1;ERBB4
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3603723673143676,0.9972114970600396,0.5010570824524313,0.787312335242906,1.0,15/76,14.26%,CLU;RACK1;GABARAP;ELOB;LAPTM5;HSPA1B;VCP;USP5;CEBPA;RBX1;SUMO2;DNAJB2;HSPA1A;FBXW7;HSPBP1
prerank,regulation of response to external stimulus (GO:0032101),0.3445625394306306,0.9971871049125476,0.5,0.7869585349338583,1.0,21/121,16.42%,TMSB4X;CALM1;GRN;PARK7;TREM2;METAP1;SEMA7A;TIRAP;BCL6B;METAP2;P2RY12;HCK;WNT5A;ELMOD2;CXCR4;F2RL1;AKNA;TRAF3;LRP8;CNGB1;CAV1
prerank,SNARE complex assembly (GO:0035493),0.485387288832069,0.9971001088187397,0.4811594202898551,0.7867614669737119,1.0,4/10,19.11%,VAMP3;VAMP2;VAMP8;SNCA
prerank,receptor catabolic process (GO:0032801),0.41085595275775033,0.9970317741073894,0.4867149758454106,0.7865032334454544,1.0,9/24,24.94%,LGMN;AP2M1;CLTC;AP2S1;CLTA;TGFB1;AP2A1;VLDLR;GPRASP1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3230621069225342,-0.9969207057161127,0.4523809523809524,0.7620270254713571,1.0,10/20,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3230621069225342,-0.9969207057161127,0.4523809523809524,0.7620270254713571,1.0,10/20,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3230621069225342,-0.9969207057161127,0.4523809523809524,0.7620270254713571,1.0,10/20,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,regulation of cell division (GO:0051302),0.35634593993499364,0.9967577257985041,0.5048543689320388,0.7867385889904772,1.0,17/72,22.28%,RACK1;CALM1;CALM3;TXNIP;KLHL9;PIN1;CDK2AP2;DLL1;CETN2;INSC;CALM2;ESRRB;GIT1;MYC;SIRT2;CCP110;BLM
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.2850568298326533,-0.9966969455303653,0.4336283185840708,0.760895788242387,1.0,18/42,23.30%,ARID2;SETD2;SPIDR;SHLD1;MMS19;PPP4R2;FBH1;MRNIP;FUS;FANCB;CGAS;SMCHD1;RTEL1;RMI2;SHLD2;SIRT6;SHLD3;POLQ
prerank,proteoglycan metabolic process (GO:0006029),-0.30227302268640915,-0.9965479682318759,0.43125,0.7595921628264305,1.0,4/26,8.26%,SULF1;ADAMTS12;IGF1;CHST11
prerank,synaptic vesicle membrane organization (GO:0048499),0.4342216181598403,0.9962749261673038,0.49607329842931935,0.7874878719773732,1.0,6/17,22.09%,SNAP25;SYNGR2;SYNGR1;SYP;STX4;STX1B
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.4748441764758464,0.9962226286078657,0.4914772727272727,0.7871853796838236,1.0,2/11,4.80%,ARL6IP1;RTN4
prerank,positive regulation of insulin secretion (GO:0032024),0.38924564314219606,0.9960251614262687,0.48664343786295006,0.7872120766327887,1.0,14/36,26.57%,RBP4;TRH;LRRC8A;GPER1;BAD;ADCY8;DOC2B;GLUD1;STX4;NNAT;PSMD9;ACSL4;PLA2G6;TM7SF3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3671960375243391,0.9957703296657194,0.5082690187431091,0.7873668282308289,1.0,16/59,23.49%,PARK7;GATM;SCP2;LIPG;SDS;LPL;HSD17B4;OXSM;OSBPL6;OSBPL3;CH25H;GAMT;ACSM5;OSBPL1A;NDUFAB1;ACLY
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.422815454082301,0.9954995438580817,0.489171974522293,0.7875851665850544,1.0,6/22,21.00%,PDE4B;AHNAK;CBARP;SRI;STAC3;CACNB4
prerank,intracellular protein transport (GO:0006886),0.3337010987374705,0.9949474939758032,0.533,0.7884193743823088,1.0,77/304,22.46%,RPL11;CD74;GABARAP;CALR;LAPTM5;AKT1;SNX17;NLGN1;AKAP6;NPM1;RAN;ARF5;SORL1;YWHAH;FAM53C;TMED7;LMAN1;SAR1A;RAB14;SURF4;TMED2;ARL11;CLTC;PTTG1IP;SCG5;XPO1;ARF6;TICAM2;TMED3;ARL4C;TMED9;PDCD6;HAP1;CDC37;CTSA;SGSM1;ARL4D;ARL1;VPS28;TMED1;SYNDIG1;IPO4;CLIP3;NUP85;ARF1;EHD1;TBC1D22B;NUP88;UNC93B1;ARF4;RAB20;NAPA;TBC1D9;RAB5C;SPRN;EIF4ENIF1;SYK;NUP50;LAMP2;STX4;RAB18;RAB31;DESI1;TBC1D10C;ERP29;TGFB1;CTTN;RAB6B;C2CD5;IFT27;TMED10;HEATR3;COPB2;AP2A1;STX1B;VPS36;RAB28
prerank,male gonad development (GO:0008584),0.3899773762679266,0.9948764996195296,0.4936416184971098,0.7881865215839848,1.0,13/34,28.27%,KITLG;WNT5A;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK
prerank,neuron projection extension (GO:1990138),0.39819788694463604,0.9946380617860976,0.4875444839857651,0.7883476176542185,1.0,5/32,5.39%,HSP90AA1;HSP90AB1;SEMA3F;CTNNB1;SH3GL2
prerank,actin filament organization (GO:0007015),0.3406836534390329,0.9945916729884348,0.5202020202020202,0.7880319375608785,1.0,34/151,17.68%,ALDOA;GSN;RHOB;MARCKS;TPM2;RHOC;ARHGAP25;EMP2;RAC1;FLNA;ELMO1;RFLNB;RHOG;CORO1C;CORO1A;MYO5A;PROX1;MYO7B;LCP1;MYO1F;MARCKSL1;ACTN1;AIF1;DSTN;RHOA;FLII;CAPG;ARPC4;TMOD1;DMTN;CASS4;FHOD3;RAC2;SCIN
prerank,negative regulation of ATPase activity (GO:0032780),0.44661602079494456,0.9944571270652078,0.49933598937583,0.7879473328834757,1.0,3/16,8.67%,ATP5IF1;PLN;IFIT1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.4474874011534932,0.9943905335273766,0.4959893048128342,0.7876726836245462,1.0,6/16,16.15%,LAMTOR5;GPR137B;PIP4P1;GPR137C;PIH1D1;RRAGD
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3512170301860326,0.9942190421613609,0.5181723779854621,0.7876503361384933,1.0,27/90,23.35%,GATM;UCP2;EPAS1;FABP5;BSCL2;OMA1;CEBPB;SCD;KDM6B;LCN2;MFAP2;THRA;HCRT;GJA1;CXCR4;ACHE;CAV1;ADCYAP1;PPARGC1A;SYK;CCR2;FABP4;ESRRG;ADIPOR1;TSHR;PRLR;ELOVL6
prerank,organophosphate ester transport (GO:0015748),0.4079447709673178,0.9938688958292649,0.49019607843137253,0.7880380842053054,1.0,3/24,4.13%,PLTP;NPC2;SCP2
prerank,regulation of calcium ion transport (GO:0051924),0.3647712021617804,0.9935323899866672,0.5186813186813187,0.7884238888598898,1.0,13/54,17.63%,CD84;HOMER2;CTNNB1;PLN;LILRA5;WFS1;ATP2B1;LILRB1;EPB41;CCL3;SARAF;ORAI1;SRI
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.4336260936977654,0.9930787419785737,0.4933510638297872,0.7890532305338878,1.0,4/17,15.07%,BTG1;SOX9;SFRP4;BAD
prerank,pre-miRNA processing (GO:0031054),-0.3641429724963914,-0.9928678757094828,0.4385245901639344,0.7677127971234317,1.0,8/14,19.58%,DICER1;DROSHA;TUT7;TARBP2;TUT4;AGO2;AGO4;ADAR
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3749239249327616,-0.9923174786109172,0.4440677966101695,0.7674919097056422,1.0,8/12,21.61%,PTPN14;RBM4;BMP4;AAAS;SIRT7;NUP214;KHDRBS1;TPR
prerank,T cell differentiation (GO:0030217),0.37864825912954686,0.9922385798066399,0.5115740740740741,0.7905932765465588,1.0,9/40,17.48%,PTPRC;FCER1G;ZFP36L1;SPI1;ZFP36L2;IL2;JAG2;PIK3CD;ADAM17
prerank,superoxide anion generation (GO:0042554),0.4574826083610724,0.9921277900645197,0.5027472527472527,0.7904330490691212,1.0,3/13,15.91%,CYBA;CYBB;NCF1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4260084610425065,0.9921080457374725,0.4837451235370611,0.7900641525598006,1.0,4/19,13.99%,MAF1;PRDX5;CEBPA;ZC3H8
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4059056706025326,0.9920344644193214,0.48954489544895446,0.7898216967314473,1.0,10/26,19.83%,C3;ATF4;SARS1;FLT4;HPSE;GATA4;CCR2;CXCL17;IL6;TGFB1
prerank,regulation of ossification (GO:0030278),0.39620630164506654,0.9917004549226387,0.4925028835063437,0.7901987190781945,1.0,14/36,20.17%,MDK;ECM1;LRP4;S1PR1;WNT5A;SOX9;BMP2;TWIST1;DDR2;NOTUM;SOX11;NOTCH1;MEF2C;SFRP1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.3205145719679565,-0.9916835832925064,0.44387755102040816,0.7656983489671775,1.0,6/21,12.48%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.3205145719679565,-0.9916835832925064,0.44387755102040816,0.7656983489671775,1.0,6/21,12.48%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3457432251466646,0.9903086387114405,0.5103950103950103,0.7930183135153376,1.0,26/95,20.01%,RPS27A;UBC;UBB;HSP90AB1;LTBP4;FKBP1A;PIN1;EID2;CDKN1C;HIPK2;WFIKKN2;UBA52;STRAP;ZBTB7A;SNW1;HSPA1A;SPRY1;STK11;SDCBP;CAV1;ADAM17;PEG10;SOX11;VASN;TGFB1;CITED2
prerank,negative regulation of bone mineralization (GO:0030502),0.46525887669836485,0.9902755134484813,0.49444444444444446,0.7926773690093785,1.0,4/13,16.37%,ECM1;RFLNB;SRGN;CCL3
prerank,positive regulation of cartilage development (GO:0061036),0.44166341971380163,0.9901585556192811,0.4960835509138381,0.7925190994347432,1.0,4/17,13.45%,MDK;ACVRL1;SOX9;BMP2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.43482256661446245,0.9898588245239514,0.5012820512820513,0.7927875377747147,1.0,9/20,19.10%,CALM1;CALM3;GSTO1;GSTM2;ATP1B1;SLC8A1;RYR2;FKBP1B;CALM2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4167252372389192,0.9898358682993167,0.5099255583126551,0.7924294439317119,1.0,7/22,20.96%,ERBB4;TNF;HES1;NOTCH1;IL6;IL10RB;CRLF2
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.4002367951537458,-0.9896140519864437,0.46075085324232085,0.76948908023324,1.0,2/10,5.34%,ACTN2;CARMIL1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.4391565084199281,0.9894308894697453,0.5071151358344114,0.792977305324917,1.0,6/18,23.48%,ELOVL1;ELOVL2;ELOVL7;ACSL3;ELOVL6;ACSL4
prerank,negative regulation of lipid storage (GO:0010888),0.4353714630504957,0.9892640758875861,0.4923469387755102,0.7929488013650083,1.0,4/19,5.55%,PNPLA2;TREM2;TNF;ABCG1
prerank,regulation of p38MAPK cascade (GO:1900744),0.39105026490922995,0.9888528981048933,0.5122235157159488,0.7935141041821663,1.0,13/35,25.37%,TREM2;SPI1;EMC10;PHLPP1;PRMT1;BMP2;RASGRP1;NCF1;DAB2IP;GADD45A;DUSP1;AGER;MFHAS1
prerank,actin filament depolymerization (GO:0030042),0.4778205891353524,0.9885591138023233,0.49859550561797755,0.793763045280399,1.0,4/11,12.83%,GSN;CFL1;MICAL1;DSTN
prerank,cellular response to glucose stimulus (GO:0071333),0.39361923098998763,0.9883308337722315,0.49334945586457074,0.793885889863243,1.0,7/30,16.34%,RACK1;PTPRN;GPER1;MLXIPL;PTPRN2;GAS6;ADCY8
prerank,protein mannosylation (GO:0035268),-0.3144990666328493,-0.9879972191428624,0.4846938775510204,0.7720895511853751,1.0,3/22,1.53%,TMTC1;LARGE1;TMTC4
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3035843206360069,-0.9879784759965441,0.4175824175824176,0.7704640280447537,1.0,9/24,19.49%,SORBS1;IRS1;INSR;IGF1;ENPP1;GSK3B;PASK;PPP1R3B;PPP1R3F
prerank,embryonic digit morphogenesis (GO:0042733),-0.33219978622269947,-0.9877653518691253,0.49099099099099097,0.7693586778586918,1.0,3/18,5.80%,CREBBP;GLI3;WDPCP
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.34494718552361975,0.9876409434895009,0.5414534288638689,0.7950781655643692,1.0,31/118,20.17%,SPARC;GPNMB;CFL1;HMOX1;EMP2;ADGRB3;KNDC1;CTNNB1;LRRC4C;TNFAIP3;VASH1;PAK1;PPFIA2;CLASP1;MAPT;CDK5R1;PAK3;RNH1;WARS1;FLT4;SRCIN1;ZMYM3;CDK5;DLL1;BRSK2;NSMF;HECW1;IL6;TGFB1;MEF2C;SFRP1
prerank,regulation of lipid storage (GO:0010883),0.42201088042694646,0.987354190793274,0.5126903553299492,0.7953030917747674,1.0,7/22,20.78%,C3;TNF;LPL;ALKBH7;FBXW7;IL6;NFKBIA
prerank,RNA catabolic process (GO:0006401),0.37482312183207955,0.986823086537508,0.504424778761062,0.7961220389596723,1.0,15/46,25.41%,LSM6;RNASEH2A;HSPA1B;ZFP36L2;ZFP36;RNASEH1;RNH1;HSPA1A;SND1;NUDT16;NANOS2;ISG20;LSM5;METTL3;PNPT1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.42924008495833965,0.9868178944896584,0.49538866930171277,0.7957208473777134,1.0,4/18,9.52%,HMOX1;KDR;JCAD;GATA2
prerank,inorganic ion transmembrane transport (GO:0098660),0.4741284577835424,0.9864417978083465,0.522633744855967,0.7961859833821334,1.0,3/12,19.69%,ASIC2;ABCC8;PKD2L1
prerank,long-term synaptic potentiation (GO:0060291),0.4158775640135556,0.9863262619500032,0.5139949109414759,0.7960406155687048,1.0,6/21,18.77%,SLC24A2;MPP2;GRIN2A;VAMP2;GRIN2B;STX4
prerank,negative regulation of interleukin-1 production (GO:0032692),0.415331492271046,0.9859737996916109,0.50875,0.7964130897500951,1.0,8/23,28.55%,TNFAIP3;GAS6;NLRP2B;CX3CR1;NLRP3;GIT1;CX3CL1;CPTP
prerank,protein targeting to membrane (GO:0006612),0.35375146251256384,0.985167678695655,0.5321390937829295,0.7978660013731383,1.0,32/83,32.41%,NACA;SSR2;ARL6IP1;SRP14;PXMP2;SSR1;ICMT;GDAP1;GOLGA7B;SEC61A1;YIF1B;SDCBP;SGTA;GOLGA7;NCF1;VPS37C;ZDHHC12;TRAM1;FIS1;NACAD;PEX11B;ZDHHC2;ARL6;RTP3;SRP19;ZDHHC14;SRPRA;ABCD2;ALDH3A2;PEX14;CHMP4A;CHMP4B
prerank,dermatan sulfate metabolic process (GO:0030205),0.45875438621854636,0.9850718320489408,0.508819538670285,0.797669483852099,1.0,3/13,9.63%,BGN;BCAN;DCN
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3333695892596645,0.9849251170526722,0.539,0.7975801816326563,1.0,52/248,16.71%,APOE;IGFBP6;PFDN5;PSMB4;MDK;COL1A1;PPP1CA;PSME1;PSMB6;PSME2;PSMB8;PSMD2;IGFBP4;FZD9;PSMD1;PIN1;LRP4;PSMC3;TLE5;CTNNB1;PSMD6;ANKRD6;VCP;SFRP5;PSMA7;OTULIN;JADE1;PSMD5;RBX1;LGR6;PSMB9;PSMD13;GPC5;WNT5A;SOX17;PSMB3;ATP6AP2;PSMB11;IGFBP2;SOX9;BMP2;PSMB10;AMER2;SFRP4;STK11;TMEM131L;PSMB1;PSMB5;DACT3;DAB2IP;CAV1;USP8
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.4564070884233055,0.9846063628763605,0.513262599469496,0.797899118623305,1.0,7/14,25.99%,RFK;ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,O-glycan processing (GO:0016266),-0.25811473060911627,-0.9835608804655861,0.5319148936170213,0.778720896766404,1.0,7/54,7.17%,GXYLT2;ST3GAL4;ST3GAL3;GALNT11;B3GNT2;ST6GAL1;GALNT12
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3777877097031474,0.9834582287709941,0.5303550973654066,0.8001792398934138,1.0,13/40,27.81%,SLC38A5;SLC7A5;SLC25A11;SLC25A21;SLC19A1;SLC16A1;SLC38A10;SLC7A10;SLC25A14;SLC7A6;SLC38A3;ABCC5;SLC16A7
prerank,striated muscle cell differentiation (GO:0051146),0.4416586092445793,0.9833375117721257,0.5045513654096229,0.8000348485967527,1.0,8/16,20.07%,NRG1;PLD3;MTLN;KDM6B;BMP2;SORT1;MYEF2;MEF2C
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.3365312969003767,-0.9832757669062796,0.4801762114537445,0.7777760136076719,1.0,6/16,11.61%,TGFBR3;BMPR1A;ZFPM2;IGF1;FGFR2;RBPJ
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.3033058457536819,-0.9832116331378682,0.489010989010989,0.77627177007505,1.0,10/25,16.97%,BRD4;ZMYND11;CDK12;TCERG1;RNF8;CDK13;ELL;LDB1;CDC73;WDR43
prerank,cytoskeleton organization (GO:0007010),0.34012991209867294,0.98315539071794,0.5323076923076923,0.8000256047090826,1.0,26/114,17.41%,APOE;MDK;CFL1;RHOB;CNN2;RHOC;MAST3;RAC1;PACSIN1;TNFAIP3;RHOG;MAST1;THY1;MICAL1;ARAP3;RHOA;DES;RHOU;CCL2;ZMYM3;EPB41L3;SH3KBP1;DMTN;CCL3;FMNL3;RAC2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4134302663332849,0.9829203184763287,0.520253164556962,0.8001452566153913,1.0,6/21,18.22%,TALDO1;PGLS;RPIA;PGD;G6PC3;TKT
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3030214730331,-0.9827395740443515,0.4631578947368421,0.7758376184610196,1.0,10/25,16.97%,SCAF8;SETD5;ZMYND11;KAT7;CCNT1;CCNK;ELL;THOC5;LDB1;WDR43
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4634419103233639,0.9824096181986794,0.5149051490514905,0.8009159267539167,1.0,3/12,9.63%,BGN;BCAN;DCN
prerank,positive regulation of lyase activity (GO:0051349),0.44613169867821034,0.9823574945221106,0.5125827814569537,0.8006120209276272,1.0,5/14,17.56%,PARK7;DRD5;ISCU;ORAI1;NOS2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.35169857616535394,0.981146760484209,0.5212187159956474,0.8030083260129703,1.0,9/65,7.22%,RPS27A;UBC;UBB;FKBP1A;PIN1;EID2;WFIKKN2;UBA52;STRAP
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.3927859037772446,-0.9810066015013141,0.46710526315789475,0.7787447302157913,1.0,5/10,19.29%,ST6GAL1;GNE;RENBP;NPL;NAGK
prerank,regulation of macrophage differentiation (GO:0045649),0.4412499756948357,0.9809640693970054,0.508724832214765,0.8030146508449515,1.0,6/15,25.30%,C1QC;PF4;INHBA;ID2;PRKCA;INHA
prerank,photoperiodism (GO:0009648),-0.29944363617001424,-0.9808285112656029,0.4857142857142857,0.7775389046602706,1.0,9/28,16.27%,FBXL17;PER2;PER3;PML;SIK1;RBM4;FBXL12;CRY1;TP53
prerank,cellular response to glucagon stimulus (GO:0071377),-0.33849538707074944,-0.9805230415666967,0.4625,0.7766671253208008,1.0,3/17,2.23%,ADCY9;ADCY1;ADCY5
prerank,cardiac cell development (GO:0055006),0.47923483482303203,0.9804595883161483,0.5241477272727273,0.8037029035628293,1.0,4/11,19.63%,ALPK2;MYH11;SLC8A1;NOTCH1
prerank,extracellular structure organization (GO:0043062),0.33021397517922163,0.9797329804511782,0.5593561368209256,0.8049721490693867,1.0,32/204,11.77%,BSG;SPARC;VTN;BGN;SPP1;COL1A1;BCAN;LAMC1;LAMB2;SPOCK2;LUM;ITGB2;ADAM15;PDGFB;ADAMTS4;ADAM12;LOX;FN1;TTR;MMP21;TNR;APLP1;COL6A1;COL4A1;KDR;COL3A1;LAMC2;DCN;COL9A1;PECAM1;MMP3;MFAP2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.43252652880523873,0.9796427678920583,0.5045513654096229,0.8047793015301875,1.0,8/18,19.75%,CLU;TNF;ABCG1;GSAP;IFNGR1;ABCA2;LRRTM3;EFNA1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.412891340881286,0.9792388254378398,0.5228113440197287,0.8052835760773034,1.0,9/23,26.53%,ELOVL1;ELOVL2;ELOVL7;ACOT7;ACSL3;DGAT1;ELOVL6;ACSL4;FAR2
prerank,regulation of lymphocyte activation (GO:0051249),0.4576192849071562,0.979005432493507,0.5096153846153846,0.8053909406702312,1.0,2/12,14.37%,DCAF15;IKZF3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2810133550807271,-0.9786948929971923,0.48951048951048953,0.7797179189639664,1.0,8/34,11.93%,PTPN13;PTPN9;TNS2;DUSP16;DUSP10;PTPN12;DUSP7;PTPN2
prerank,inorganic anion transmembrane transport (GO:0098661),0.3608127541588485,0.9786573060772417,0.5214132762312634,0.8057907006799137,1.0,14/63,18.83%,GABRB1;LRRC8A;GABRG3;GABRA2;SLC12A5;SLC25A11;GLRA2;GLRA1;GABRA3;GABRB3;SLC1A1;GABRB2;ANO4;GLRA3
prerank,response to growth factor (GO:0070848),0.377500683996783,0.9782563479231696,0.5253456221198156,0.8063096942257592,1.0,5/41,5.33%,RACK1;AKT1;PDGFB;ACVRL1;CTNNB1
prerank,embryonic skeletal system development (GO:0048706),-0.27238273543522634,-0.9778472606554932,0.46835443037974683,0.7802225518127556,1.0,7/35,7.67%,SULF1;HOXB3;HOXA3;HOXB4;HOXC4;KIAA1217;PCSK5
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.4524472705379053,0.9772770194765792,0.5033467202141901,0.8081345691833554,1.0,4/13,16.37%,CD2BP2;PRPF19;PRPF8;PRPF31
prerank,response to hexose (GO:0009746),0.40585314062780964,0.9771291723302113,0.5122850122850123,0.8080472094294789,1.0,8/25,21.40%,PFKL;GYS2;LPL;VAMP2;MAFA;EIF2B5;KHK;SELENOS
prerank,regulation of store-operated calcium entry (GO:2001256),0.4811930807998268,0.9769403518192589,0.5285505124450952,0.8080883974098307,1.0,2/10,3.99%,CD84;HOMER2
prerank,membrane lipid catabolic process (GO:0046466),0.46855897810332237,0.9768263649158138,0.5021459227467812,0.8079382042659474,1.0,4/10,24.78%,ENPP2;FUCA1;SGPL1;NAGA
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.46149438546823957,0.9767718290712443,0.516642547033285,0.8076563443912588,1.0,4/11,25.94%,CLEC6A;NFKBID;IL12RB1;PRKCQ
prerank,cellular glucose homeostasis (GO:0001678),0.369263596563977,0.976606230768409,0.528,0.8076347873619821,1.0,5/41,5.90%,RACK1;LRRC8A;GPER1;NR1D1;NUCKS1
prerank,activation of protein kinase A activity (GO:0034199),-0.3434946467908304,-0.9764997776057943,0.4708333333333333,0.7819288475790868,1.0,3/16,2.23%,ADCY9;ADCY1;ADCY5
prerank,regulation of viral release from host cell (GO:1902186),0.41653472327211977,0.9761731335328353,0.5087939698492462,0.8081903752484754,1.0,6/21,19.64%,CHMP2B;TRIM28;DDB1;TRIM32;VPS4A;TRIM13
prerank,positive regulation of transmembrane transport (GO:0034764),0.45146548010068943,0.9756474732326289,0.5020242914979757,0.808942321734071,1.0,4/13,13.79%,C3;CA2;P2RX7;CLIP3
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.48287844126311424,0.9756257586197065,0.5184135977337111,0.808571329747615,1.0,7/10,34.73%,SYNGR1;SYP;APP;NETO1;CAMK2B;DRD2;NPTN
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.36212234200662424,0.9755505853574293,0.5393873085339168,0.8083272209062737,1.0,16/52,19.59%,RACK1;AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;RHOG;ARF6;ZDHHC5;RAMP3;CLIP3;SQSTM1;ACSL3;STX4;STAC3
prerank,regulation of lipase activity (GO:0060191),0.4589906541927513,0.9753508366322964,0.5339547270306259,0.8083626209722621,1.0,5/13,25.25%,RHOC;LPL;RHOA;SNCA;PCSK6
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.4273052359207849,0.975133996523889,0.5301507537688442,0.8084571911693869,1.0,13/18,38.36%,PCNA;RFC4;GINS3;LIG1;MCM7;POLE3;POLD3;GINS1;RFC3;POLD2;MCM4;LIG3;MCM3
prerank,monocyte differentiation (GO:0030224),0.47416462463995707,0.974318891636283,0.5323033707865169,0.809927135541947,1.0,1/10,0.43%,MT1G
prerank,vesicle transport along actin filament (GO:0030050),0.42408069948682264,0.9738661702930982,0.5089058524173028,0.8105481508178035,1.0,4/19,11.02%,MYO5A;MYO7B;MYO1F;FNBP1L
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.35593798960966916,-0.9737539951007246,0.4899598393574297,0.787382717167175,1.0,4/16,9.11%,FER;ABL1;NRP1;PDGFRB
prerank,snRNA processing (GO:0016180),-0.3360437576447919,-0.9735024842072355,0.4567901234567901,0.7863126918277472,1.0,5/16,18.66%,INTS8;INTS6;TUT1;INTS3;INTS11
prerank,skeletal muscle organ development (GO:0060538),0.4054134842311898,0.9729050824755002,0.5104039167686658,0.812395055113933,1.0,4/26,11.07%,MYL6;FOXL2;BASP1;MYL6B
prerank,negative regulation of protein polymerization (GO:0032272),0.3961969952129551,0.972843495111486,0.524390243902439,0.8121199498770612,1.0,14/27,25.36%,MYADM;PFN1;TUBB4A;MAP2;CLIP3;STMN1;PFN2;CDH5;SNCA;TWF1;SSH2;TWF2;TBCD;MAPRE1
prerank,potassium ion transmembrane transport (GO:0071805),0.3349143623717743,0.9726625782478484,0.5575942915392457,0.8121349427240317,1.0,34/135,19.69%,SLC24A4;SLC24A2;KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;ATP1A3;ATP1B2;SLC12A5;KCNC1;KCNE4;KCNA2;KCNN2;ATP1A4;ATP1A1;KCNK9;ABCC8;KCNE5;KCNF1;ATP1B1;HCN1;KCNK3;KCNA1;LRRC55;KCNK10;HCN3;ATP1B3;SLC9A9;KCNH7;KCNH8;KCNK13;KCNQ5;PKD2L1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4222049332731472,0.9726045723500834,0.5339547270306259,0.81184735489957,1.0,7/18,28.69%,ZFP36L1;ZFP36L2;IKZF3;CCR2;PRELID1;METTL3;XRCC6
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.32550993725631694,-0.9725470646691706,0.5022026431718062,0.7871572509977107,1.0,7/18,16.27%,EGFR;NCOR1;RIPK1;ESR1;TERT;BMP4;TP53
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2920230623483741,-0.9723858889579349,0.478494623655914,0.7859468813801199,1.0,6/26,12.48%,EYA2;EYA1;EYA4;TERT;EYA3;BCL2
prerank,sterol metabolic process (GO:0016125),0.35718895560486374,0.972152565967482,0.5560391730141458,0.8124658062490304,1.0,12/60,23.22%,APOE;ABCG1;PIP4P1;FDX2;SC5D;CLN6;SOAT2;CLN8;CH25H;OSBPL1A;NSDHL;PMVK
prerank,histone mRNA metabolic process (GO:0008334),0.39772302842261353,0.9720751123404822,0.517406962785114,0.812216992237919,1.0,9/27,23.64%,SNRPG;SNRPE;SNRPF;CPSF2;SNRPB;SLBP;SNRPD3;EXOSC4;ERI1
prerank,phagolysosome assembly (GO:0001845),0.4587070699405016,0.9720471019008938,0.5370629370629371,0.8118644292818273,1.0,7/12,34.88%,RAB14;CORO1A;RAB20;SYT7;RAB39A;RAB34;ARL8B
prerank,cytoplasmic translational initiation (GO:0002183),0.42965399387201963,0.9719172190831119,0.5006675567423231,0.8117488346157695,1.0,5/17,20.28%,EIF3D;EIF3I;EIF4A1;EIF4H;EIF3M
prerank,monocarboxylic acid metabolic process (GO:0032787),0.33874474138226995,0.9716787036952399,0.5828220858895705,0.8118772674625375,1.0,26/117,21.68%,BSG;CKB;GATM;AGXT;SCP2;GLO1;LDHA;CKMT1A;GRHPR;LPL;ALKBH7;FASN;ACOT1;ACOT7;GLYAT;NAAA;SLC16A1;ACOT4;FA2H;BCO2;ACSL3;GAMT;THEM4;ALDH4A1;MTHFS;SGPL1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.452989839174636,0.9715177796348523,0.5057142857142857,0.8118102443545384,1.0,3/12,13.00%,AGT;SOX8;SOX9
prerank,regulation of response to cytokine stimulus (GO:0060759),0.42055564338425944,0.9713463294154261,0.525706940874036,0.8117778864206191,1.0,5/19,12.78%,TLE5;CD24;TAF9;WNT5A;KLF4
prerank,regulation of multicellular organism growth (GO:0040014),0.4419213446256269,0.970621543951788,0.5168690958164642,0.8129696722595179,1.0,3/15,8.69%,PPIB;SOD1;MFSD2A
prerank,neurogenesis (GO:0022008),0.362853297897771,0.9706165604498851,0.5340136054421769,0.8125689214254038,1.0,16/43,26.70%,SPOCK1;PRDM12;MAPT;NDUFS2;HAP1;CLN5;CXCR4;DCHS1;EPHB1;ERCC6;BTBD6;ROGDI;METTL3;METTL14;NTN5;TGFB2
prerank,synaptic membrane adhesion (GO:0099560),-0.3432704407754985,-0.9702553061478068,0.48659003831417624,0.7898818109739006,1.0,2/14,1.97%,GPC6;GPC4
prerank,alpha-amino acid metabolic process (GO:1901605),0.36594119061712094,0.969416783396952,0.5331833520809899,0.8148314480991233,1.0,12/45,20.38%,SLC25A13;OAT;PYCR2;GLUL;DDAH1;GLS2;GLS;DDAH2;NAT8L;ASNS;GLUD1;GOT1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.34753802947208706,-0.9690930121746075,0.5,0.7911334864868677,1.0,7/16,14.98%,DPYSL3;TET2;DPYD;UPP2;UPB1;NT5C1A;NT5M
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.4283478919295728,0.9690370554113857,0.511968085106383,0.8152957938551536,1.0,4/16,24.48%,PTPRC;LILRB1;IL12RB1;AGER
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.3968512245822765,0.9688899250846543,0.5334143377885784,0.8152277333516621,1.0,9/26,25.10%,LGMN;DUSP3;HES1;ASNS;USP22;FOXA1;MEIS2;APP;PRKCA
prerank,lamellipodium assembly (GO:0030032),0.39284100327899185,0.968166091381909,0.5295536791314838,0.8164595872512639,1.0,7/26,16.20%,RAC1;S1PR1;ARHGEF4;P2RY12;ARHGEF7;CCDC88A;DMTN
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.44772348442644216,0.9678710025400803,0.5195154777927322,0.8167150637859075,1.0,4/13,19.00%,SOD1;CLPTM1;ZC3H8;TOX
prerank,regulation of neuroblast proliferation (GO:1902692),0.4336814613124287,0.9678695354164537,0.5237449118046132,0.8163057578422774,1.0,6/15,26.31%,TAFA1;CTNNB1;CX3CR1;PTN;CX3CL1;FZD3
prerank,negative regulation of leukocyte migration (GO:0002686),0.47230228608112385,0.9674905022166639,0.5552407932011332,0.8167327582377988,1.0,1/10,1.73%,HMOX1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.382467714741002,0.9668947423889664,0.5201421800947867,0.8176284478497163,1.0,18/32,33.02%,MID1IP1;NAV3;CLASP1;TUBB4A;MAP2;CLIP3;STMN1;FGF13;CDH5;SNCA;FKBP4;TBCD;MAPRE1;CAMSAP3;CLASP2;STMN2;KATNB1;APC
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.35143870282783696,0.9667995652939858,0.5529411764705883,0.8174331003625088,1.0,17/67,17.08%,MDK;CALR;S100A10;EMP2;PDGFB;RAC1;FLNA;MYADM;FN1;P4HB;ARHGEF7;ARL2;DMTN;CCL28;CASS4;SKAP1;FBLN2
prerank,potassium ion import across plasma membrane (GO:1990573),0.37458627594937993,0.9667113255043502,0.5305651672433679,0.8172124056918185,1.0,9/41,17.69%,KCNJ10;ATP1A3;ATP1B2;SLC12A5;ATP1A4;ATP1A1;KCNK9;ATP1B1;ATP1B3
prerank,hematopoietic stem cell proliferation (GO:0071425),0.46082469752759386,0.9661349453651782,0.5293296089385475,0.8180873462970571,1.0,3/11,13.56%,CD34;WNT5A;WNT10B
prerank,cytosolic calcium ion transport (GO:0060401),-0.2953411437364787,-0.9657724659250214,0.48255813953488375,0.798116496057285,1.0,6/28,8.41%,MCU;CACNA1C;MICU1;MICU2;SLC35G1;JPH1
prerank,ERBB signaling pathway (GO:0038127),0.3497969774081104,0.9657470487550756,0.5559105431309904,0.8185398505099456,1.0,18/64,21.65%,HSP90AA1;AKT1;NRG1;ERBB4;SHC3;MATK;PTK6;CDC37;AAMP;PTPRR;SOX9;ERBIN;ADAM17;ERBB3;SOS1;TGFB1;STUB1;TGFA
prerank,peptidyl-lysine methylation (GO:0018022),-0.28563997520664086,-0.9656650636180145,0.4662576687116564,0.7967255831309805,1.0,14/26,27.56%,SETD2;SMYD3;EHMT1;SETD7;EHMT2;SETD4;SETD3;VCPKMT;METTL21A;SETD6;SMYD1;N6AMT1;ETFBKMT;SUV39H1
prerank,catecholamine biosynthetic process (GO:0042423),-0.38248901010809955,-0.9656503441788611,0.46905537459283386,0.7950929226220679,1.0,1/11,2.16%,MOXD1
prerank,regulation of lipid metabolic process (GO:0019216),0.3381231322454527,0.9655656426926505,0.5419287211740041,0.8185401470397135,1.0,14/88,12.47%,PSAP;NPC2;APOC1;CERS2;NR1D1;MID1IP1;RARRES2;EDF1;LSS;SIN3B;FASN;SCD;SC5D;NCOR2
prerank,positive regulation of kinase activity (GO:0033674),0.33922410573664324,0.9655319055000035,0.557157569515963,0.8182124640865309,1.0,28/107,18.23%,CD74;CCL19;TREM2;ERBB4;TNF;PTPRC;NTRK2;EEF1A2;LTK;MUSK;KDR;MAPT;EPHA5;CSF1R;FLT4;TIE1;GAS6;MMD2;EPHB1;MAPRE3;FLT1;TYRO3;LCP2;ADCYAP1;CAMKK1;AGAP2;DDR2;ERBB3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.36293389585533725,0.9648102474253935,0.5487122060470325,0.8194247094173503,1.0,13/47,20.51%,PPIA;MAPK3;SEMA4C;PHLPP1;MAPK8IP1;F2RL1;MAPK8IP2;RASGRP1;EPHB1;DAB2IP;MAP2K2;QARS1;MYC
prerank,purine ribonucleotide catabolic process (GO:0009154),0.4152598088598714,0.9647873243564384,0.5301353013530136,0.8190640971099294,1.0,9/21,24.93%,HINT1;NUDT3;ACAT1;PNP;NUDT4;NUDT16;NUDT10;NUDT11;PDE2A
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3737666998648048,0.9642238777147849,0.5420991926182238,0.819857138303744,1.0,6/37,12.08%,DYNLL2;DYNLL1;IFT20;DYNLRB1;CEP131;DYNLRB2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4123122177040589,0.9639503858815831,0.5414572864321608,0.820082811448476,1.0,6/22,17.58%,AKT1;NTRK2;SH3GL2;MAPT;EHD1;TMEM108
prerank,synaptic vesicle endocytosis (GO:0048488),0.3836315614193512,0.9639307459432567,0.5517647058823529,0.8197180112214936,1.0,8/33,9.25%,NLGN1;CANX;PACSIN1;DNM3;SNAP91;SYT1;AMPH;VAMP2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3287990031564766,0.9638779670901068,0.5812310797174571,0.8194249388918331,1.0,54/198,25.57%,ALDOA;GPX4;CALM1;ALDOC;PPP1CA;MAPK3;AKT1;PFKL;TOLLIP;PTPRC;DUSP3;PLAAT3;PGK1;PAK1;DUSP28;LPL;PIP4P1;BCKDK;NUDT3;PLA2G4F;PTPRD;GDE1;PTPRB;INPP5J;NUDT4;CDK5;PPA1;PIK3CD;NT5C;CLN8;G6PC3;CERKL;IP6K1;PPP3CA;PLPPR2;NUDT10;PGP;TGFB1;SPHK2;PLCH1;DUSP23;DUSP12;INPP5D;DUSP15;AGPAT2;PNKP;NUDT11;ACP2;PLA2G3;PLPPR4;GPD2;TNK2;INPP4B;DUSP8
prerank,protein glycosylation (GO:0006486),-0.22273097274699316,-0.9635379910527142,0.625,0.7990101587268696,1.0,27/125,13.25%,LARGE1;ST3GAL4;B4GALT1;MAN1C1;PLOD2;TRAK1;TET2;OGA;OGT;ST3GAL3;TET3;B3GNT2;PGM3;FUT8;B3GALT1;TUSC3;PMM2;GOLGA2;ALG5;MGAT3;STT3B;ENTPD5;GALNT1;GCNT2;FUT10;ST3GAL5;MGAT5
prerank,protein modification process (GO:0036211),0.34534607410645696,0.9635317105963733,0.5522066738428417,0.8198087718646938,1.0,15/76,13.08%,RPN1;RPN2;UBL5;PARP1;CPE;LOX;CDC34;UBA52;UBE2M;NEDD8;ICMT;CHRM3;PLAT;SERP1;ST8SIA4
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.25450688117805725,-0.9630947036230437,0.5203252032520326,0.7985699047055478,1.0,11/46,21.01%,PLD1;PLA2G4A;DGKA;DGKQ;DDHD2;AGPAT4;GPAT3;ABHD5;GPD1;PLD2;PNPLA3
prerank,regulation of necroptotic process (GO:0060544),0.4055993105165065,0.9628659082619426,0.5233532934131736,0.820891438934976,1.0,7/23,15.64%,HSP90AA1;FZD9;SLC25A4;FLOT1;CDC37;SDCBP;YBX3
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3406454782890885,0.962804295498022,0.5777310924369747,0.8206128599383861,1.0,30/93,25.37%,CCL19;SPI1;TIRAP;ANKRD6;SEMA4C;EMC10;HIPK2;CCN2;HMGB1;FLT4;HRAS;PRMT1;MAPK8IP1;BMP2;SDCBP;F2RL1;TRAF3;RASGRP1;NCF1;DAB2IP;MAP4K2;LTBR;PYCARD;GADD45A;WNT7A;DUSP15;UNC5CL;APP;AGER;MFHAS1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.40442094026425596,0.9624231398130796,0.5276073619631901,0.8210511267667346,1.0,5/21,8.20%,ACTG1;DUSP3;GPM6B;CORO1C;CLASP1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.39380157242135383,-0.9623545159350806,0.5292096219931272,0.7987664287933222,1.0,4/10,21.30%,SEC14L1;NPLOC4;DHX58;GPATCH3
prerank,cGMP metabolic process (GO:0046068),0.4589683771658679,0.9623124671207209,0.5427350427350427,0.8209204739530471,1.0,1/12,2.33%,NPPC
prerank,coenzyme A metabolic process (GO:0015936),0.44066760509661657,0.962065413946542,0.5465425531914894,0.8210540701522493,1.0,6/14,23.83%,ACAT1;ACOT7;COASY;PPCS;ACLY;SLC25A16
prerank,regulation of type I interferon production (GO:0032479),0.34137759823698627,0.962028281568431,0.576235541535226,0.8207287235394005,1.0,30/84,30.38%,GAPDH;POLR2E;POLR2F;PIN1;TIRAP;CTNNB1;TNFAIP3;ISG15;PQBP1;IRF8;POLR2K;IRF7;TRAF3;G3BP1;TRIM32;CD14;POLR2H;POLR3K;IRF5;POLR3D;PCBP2;RELA;NLRP4;DHX9;XRCC6;TRIM25;TRIM56;ACOD1;POLR3C;POLR3E
prerank,modulation by host of viral genome replication (GO:0044827),0.44602633424175087,0.9613615501934464,0.5355191256830601,0.8217468234214504,1.0,5/13,21.77%,PPIB;NUCKS1;CCL8;VAPA;IFI27
prerank,regulation of intracellular pH (GO:0051453),-0.2713531231661168,-0.9613280416863217,0.5197368421052632,0.7997921798514975,1.0,6/34,6.83%,SLC9A1;LRRK2;SLC4A10;SLC9A2;NOX1;TM9SF4
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3245227618485768,-0.9613150522314283,0.48056537102473496,0.7981607164783547,1.0,8/17,22.76%,CCNT1;CPEB3;VIRMA;ZC3H14;CPSF6;ZC3H3;RNF20;CTR9
prerank,cellular protein localization (GO:0034613),0.32038792571611535,0.9612141988845807,0.639,0.8216413855995024,1.0,72/285,22.09%,CD74;CD63;LAPTM5;SNX17;ID1;NPM1;LAMTOR2;GRID2;EMP2;CNTNAP2;ARF5;PACSIN1;YWHAH;CTNNB1;FLNA;CPE;ATG9A;TMED7;SAR1A;RAB14;ESAM;TMED2;ARL11;CLTC;PRPF19;SCG5;ARF6;TICAM2;ABHD17A;TMED3;ARL4C;TMED9;PDCD6;WNT5A;CTSA;SGSM1;ARL4D;ARL1;TMED1;SYNDIG1;GJA1;LAMTOR3;ARF1;EHD1;TBC1D22B;JAM3;UNC93B1;RRAGC;ARF4;EPB41L3;RRAGD;RAB20;NAPA;TBC1D9;AMOT;RAB5C;STX4;WDR45;RAB18;RAB31;HPS6;TBC1D10C;ERP29;CTTN;CAPN3;RAB6B;PTPRU;IFT27;TMED10;COPB2;AP2A1;STX1B
prerank,cation transport (GO:0006812),0.3300518792191367,0.9610057674345952,0.6107178968655207,0.8216911916152269,1.0,30/167,16.10%,SLC38A5;SLC39A1;SCN1A;GRIN1;KCNJ10;SLC25A29;SLC6A6;SGK1;CNGA3;AQP1;TMEM63C;SLC6A17;SCN4B;SLC3A2;KCNC1;KCNA2;TRPM2;KCNN2;ATP1A4;SLC1A1;KCNK9;ABCC8;NDUFA9;KCNF1;ATP1B1;SLC8A1;KCNK3;FGF13;CNGB1;KCNA1
prerank,determination of heart left/right asymmetry (GO:0061371),0.3661934140086216,0.960685284324225,0.5451428571428572,0.8219815592098828,1.0,10/42,20.07%,SOX18;NDRG4;APLNR;MMP21;TBX22;SOX17;DLL1;GATA4;NOTCH1;MEF2C
prerank,positive regulation of protein import (GO:1904591),0.3791150557026199,0.9604300932503866,0.5578069129916567,0.8221069364686421,1.0,5/30,7.50%,RAN;HCLS1;FLNA;HYAL2;TRIM28
prerank,positive regulation of intracellular transport (GO:0032388),0.37614621742295223,0.9603860134818213,0.5471478463329453,0.8217728128792872,1.0,16/38,28.05%,OAZ1;SORL1;PRR5L;MLC1;VAMP2;CEP131;B3GAT3;STK11;EHD1;EHD2;OAZ2;KIF20B;ICE1;PCNT;PGAP1;TENM1
prerank,P-body assembly (GO:0033962),-0.36989680624167226,-0.959486241071572,0.4612546125461255,0.8012535239941356,1.0,4/12,8.40%,ATXN2;LSM14A;DDX6;PATL1
prerank,negative regulation of anoikis (GO:2000811),-0.34897576720762424,-0.9592877153586643,0.4899598393574297,0.8001578971559239,1.0,4/14,12.48%,ITGA5;TLE1;PTK2;BCL2
prerank,cellular response to cAMP (GO:0071320),0.38126839513557986,0.9589362898565391,0.5478971962616822,0.8245389871202494,1.0,11/30,27.61%,AKAP6;IGFBP5;ZFP36L1;AQP1;HCN1;DMTN;HCN3;AANAT;PDE2A;RAP1B;KCNQ1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4143526511340901,0.9583834934246247,0.5692503176620076,0.8253954203430546,1.0,4/22,4.63%,TNF;LGALS3;FKBP1A;PPP1R1B
prerank,cochlea morphogenesis (GO:0090103),0.47230833832167984,0.9583729613953105,0.5352112676056338,0.8250106991496797,1.0,2/10,13.00%,MYO3A;SOX9
prerank,positive regulation of cell projection organization (GO:0031346),0.3304323337255099,0.9583453579261916,0.5857438016528925,0.8246598011219815,1.0,22/115,16.53%,APOE;ARHGDIA;MDK;NTRK2;S100A9;CAMK1D;NDRG4;TENM3;LTK;ATP1B2;PTK6;IL1RAPL1;CAMK1;WNT5A;SS18L2;PTPRD;RHOA;LRRC7;TIAM1;ROBO2;DAB2IP;FUT9
prerank,regulation of cell adhesion (GO:0030155),0.3321129677297566,0.9583439801104799,0.5737704918032787,0.824249673286157,1.0,28/129,19.75%,ARHGDIA;MDK;CXCL12;TGM2;TNF;ACVRL1;DSCAM;PPP2R1A;PDE3B;MYADM;ARHGDIB;FRMD5;ADGRG1;P4HB;PODXL;DUSP26;ARHGDIG;CXCR4;DLL1;EPB41L4B;TMEM102;PLAU;RAC2;ERBB3;STX4;PPP3CA;LPXN;EFNA1
prerank,negative regulation of protein depolymerization (GO:1901880),-0.29158665107222737,-0.9583384612246821,0.5260416666666666,0.8010425053760014,1.0,7/24,14.72%,PLEKHH2;LIMA1;HDGFL3;CAMSAP1;SPEF1;ARHGEF2;TAOK1
prerank,cAMP-mediated signaling (GO:0019933),-0.2926553664402915,-0.9581222789816465,0.4827586206896552,0.7999240309885287,1.0,7/24,11.31%,PDE7B;ADCY1;RAPGEF2;KSR1;PDE7A;RAPGEF3;DGKQ
prerank,regulation of ion transmembrane transport (GO:0034765),0.38028291864794567,0.9578952480848564,0.5356294536817102,0.8248353585356999,1.0,6/33,14.60%,AKAP6;YWHAE;KCNJ10;P2RX7;CHRM3;KCNE5
prerank,regulation of ATP metabolic process (GO:1903578),0.3510616079575227,0.9575375240786824,0.5679824561403509,0.8251959285159609,1.0,15/54,21.42%,UQCC2;PGAM1;PINK1;COX7A2L;COX7A2;ATP5IF1;AK4;ZBTB7A;NUP85;NUP88;NUP50;SPHK2;SHMT2;RAE1;FIS1
prerank,nucleoside catabolic process (GO:0009164),-0.3705770961947995,-0.9572801441070189,0.4847457627118644,0.8004290584237209,1.0,6/11,14.98%,DPYD;UPP2;UPB1;DERA;NT5C1A;NT5M
prerank,transcription by RNA polymerase III (GO:0006383),0.39462632358883826,0.9570764795916551,0.5470085470085471,0.8257428338941325,1.0,10/27,26.42%,GTF3C6;POLR2K;IVNS1ABP;ZC3H8;RO60;TBP;GTF3A;POLR3K;ICE1;GTF3C2
prerank,regulation of T cell differentiation (GO:0045580),0.3743945448694599,0.9570435033254966,0.5408284023668639,0.8253943781949468,1.0,7/33,19.11%,MDK;SOD1;CLPTM1;IL2;CTLA4;CCR2;PRELID1
prerank,neuron apoptotic process (GO:0051402),0.4161370059622688,0.9568821595569443,0.5487646293888166,0.8253318302618926,1.0,5/19,26.72%,GAPDH;CDK5;ERBB3;APP;SCN2A
prerank,7-methylguanosine RNA capping (GO:0009452),0.3788953405888936,0.9567351170811504,0.5495283018867925,0.824816896767682,1.0,6/31,12.82%,POLR2E;POLR2D;POLR2F;POLR2G;CMTR1;POLR2K
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3788953405888936,0.9567351170811504,0.5495283018867925,0.824816896767682,1.0,6/31,12.82%,POLR2E;POLR2D;POLR2F;POLR2G;CMTR1;POLR2K
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.30027374469543366,-0.9567106396172721,0.5260869565217391,0.8002014216656637,1.0,11/23,24.14%,MTMR3;MTMR11;PTEN;SACM1L;MTMR10;PIP4P2;INPP5B;TPTE;MTMR1;SYNJ2;MTMR7
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4319791539758729,0.9566459532118641,0.5266579973992198,0.8246177091405926,1.0,7/14,32.49%,SCP2;HSD17B4;CRAT;ACOX3;EHHADH;DECR2;ACOX1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4476854067304246,0.955950664863984,0.5340909090909091,0.8257226527384438,1.0,5/12,28.22%,MCM5;MUS81;CDC45;MCM7;MCM2
prerank,gonad development (GO:0008406),0.3626338081400145,0.9557666577606122,0.5605022831050228,0.8257246830542969,1.0,15/41,29.18%,BASP1;KITLG;WNT5A;SOX8;SOX9;MEA1;CSDE1;GATA4;NCOA4;INHBA;COL9A3;TGFB2;MAMLD1;BIK;IRX5
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3914285927521409,0.9557516288290476,0.5325301204819277,0.8253475774317304,1.0,7/26,20.24%,PARK7;CYBA;GRIN1;ADGRB1;TLR6;SNCA;SPHK2
prerank,stress fiber assembly (GO:0043149),-0.3396344137837546,-0.9555908239718948,0.5142857142857142,0.7999210771081581,1.0,2/15,0.95%,SORBS1;PHACTR1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3396344137837546,-0.9555908239718948,0.5142857142857142,0.7999210771081581,1.0,2/15,0.95%,SORBS1;PHACTR1
prerank,positive regulation of cell differentiation (GO:0045597),0.32206184196749804,0.9551478197855914,0.6465863453815262,0.8262569508843337,1.0,62/237,20.17%,IFITM1;MDK;HSP90AB1;COL1A1;NBL1;AKT1;CD34;CTNNA2;LRRC8A;AGT;IGFBP3;ACVRL1;CDS1;ZFP36L1;DNAI3;BNIP2;ATP6AP1;CTNNB1;RARRES2;BTG1;BRINP3;CEBPB;NELL1;SLC6A6;NRCAM;KDR;CCN2;LPL;CAMK1;ZFP36;KITLG;LRP3;BRINP1;ATRAID;TMEM119;MSR1;BRINP2;BLOC1S5;SOX9;RHOA;GJA1;BMP2;FBXO5;SDCBP;MMD2;PCP4;RRAS;TIAM1;PF4;MAPK11;BEND6;VHL;TRIM32;TWIST1;DDR2;EDN3;SOX11;IL6;HGF;TGFB1;MEF2C;SFRP1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.35215933155046053,-0.9550546015701088,0.49612403100775193,0.799627134469279,1.0,5/14,14.22%,TNKS2;TERT;TERF2;TINF2;PINX1
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.376617882538439,-0.955019917029137,0.49635036496350365,0.7964784503481948,1.0,5/11,23.89%,PTEN;IMPA2;INPP1;INPP5B;SYNJ2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.376617882538439,-0.955019917029137,0.49635036496350365,0.7964784503481948,1.0,5/11,23.89%,PTEN;IMPA2;INPP1;INPP5B;SYNJ2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.3676206461858825,-0.9550074592254905,0.46534653465346537,0.7949090767959712,1.0,8/12,28.99%,GOLGA2;BTRC;PTEN;CDC14B;GORASP1;RAB1A;PLK1;UBE2C
prerank,response to cytokine (GO:0034097),0.3300254586898494,0.9548918159247178,0.6199186991869918,0.8264059817286444,1.0,37/141,22.39%,IFITM3;CD74;IFITM2;IFITM1;TIMP2;AKAP6;SHFL;HCLS1;TLE5;DDOST;ISG15;CXCL16;IL1RAPL1;COL3A1;TIMP1;TAF9;SMPD1;CSF1R;TIMP3;SLC11A1;BST2;RHOA;CXCR4;SIGIRR;TMEM102;TRIM32;SNCA;FLT3;POU4F1;FOXA2;TIMP4;SHMT2;PTPN6;ASAH2;CDK9;MAP2K7;PTPN5
prerank,oligodendrocyte differentiation (GO:0048709),0.4098419038397937,0.9546528335343546,0.5341055341055341,0.8265269652596059,1.0,7/19,21.29%,MYRF;SOX8;SOX9;PTPRZ1;CDK5;EIF2B5;SOX10
prerank,negative regulation of developmental growth (GO:0048640),0.3809739204346839,0.9545310723475436,0.5428571428571428,0.826391566770737,1.0,6/30,15.84%,MT3;DCC;RTN4;MAP2;GDF15;FGF13
prerank,membrane protein proteolysis (GO:0033619),0.3639798327391479,0.9539188270885154,0.549645390070922,0.8273034304949227,1.0,15/37,25.94%,TMPRSS6;PSENEN;SPPL2B;CTSH;NAPSA;BACE1;PSEN2;ADAM17;APH1B;TGFB1;SPPL2A;ERAP1;RELA;APH1A;PRKCQ
prerank,regulation of Rac protein signal transduction (GO:0035020),0.42744270871532175,0.9537594983676392,0.5423728813559322,0.8272451130785201,1.0,6/16,17.97%,GABARAP;STMN3;CADM4;ARF6;KBTBD7;RASGRF1
prerank,negative regulation of organelle assembly (GO:1902116),-0.27744911039926795,-0.9536142839872944,0.5555555555555556,0.796820334343657,1.0,7/35,10.54%,LRRK2;NBDY;YAP1;KAT2B;SCFD1;CEP97;SMAD4
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.23920007274869404,-0.9535570336641406,0.6,0.7953518210931959,1.0,18/60,16.27%,TCF7L2;TNRC6B;MED13;ATF7IP;TNRC6A;DHX36;PPM1D;TNRC6C;MED15;NFKB1;MOV10;PTEN;MED26;CBFB;RUNX2;HEY2;MECP2;TP53
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.30681596695670016,-0.9533910540941425,0.4948453608247423,0.7941132477350316,1.0,2/21,3.64%,OSBPL8;PLA2G4A
prerank,mitotic nuclear membrane organization (GO:0101024),0.3582537996538976,0.9529332378240307,0.5580357142857143,0.8282673174855798,1.0,23/51,32.41%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;NUP85;CC2D1B;LMNA;RANGAP1;VPS4A;CHMP7;SIRT2;RCC1;VRK1;KPNB1;CHMP4C;NUP205;NUP188;PPP2CA;NUP43;SEH1L;CHMP4A;CHMP4B
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3582537996538976,0.9529332378240307,0.5580357142857143,0.8282673174855798,1.0,23/51,32.41%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;NUP85;CC2D1B;LMNA;RANGAP1;VPS4A;CHMP7;SIRT2;RCC1;VRK1;KPNB1;CHMP4C;NUP205;NUP188;PPP2CA;NUP43;SEH1L;CHMP4A;CHMP4B
prerank,cellular senescence (GO:0090398),0.38723187973963785,0.9524611853873947,0.5418660287081339,0.8288234652225505,1.0,5/27,12.02%,CALR;SPI1;ECRG4;ULK3;HRAS
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.45631214769791745,0.9521055497139544,0.5483870967741935,0.8292031357486246,1.0,6/12,25.99%,ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,sodium ion transmembrane transport (GO:0035725),0.3374684131759175,0.9519978816609296,0.5737009544008483,0.8290381370354944,1.0,20/84,17.76%,ASIC2;SLC24A4;SLC24A2;SCN1A;ATP1A3;ATP1B2;SLC6A6;SLC6A17;SLC6A2;SLC6A5;SCN4B;SLC6A16;ATP1A4;ATP1A1;ATP1B1;SLC8A1;HCN1;HCN3;ATP1B3;SLC9A9
prerank,visual system development (GO:0150063),0.36789336114737237,0.9508291182733234,0.5667828106852497,0.831138960841561,1.0,7/37,13.25%,C1QA;C3;RBP4;HIPK2;SALL2;BLOC1S3;MAB21L1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.40560714834582956,0.9506635404259581,0.5439490445859873,0.8310736898281386,1.0,10/22,24.48%,CLU;TNF;ABCG1;GSAP;IFNGR1;ABCA2;LRRTM3;EFNA1;RELA;AGER
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.33100691761321915,-0.9504761631369719,0.5304347826086957,0.8000734163575706,1.0,4/17,5.49%,PID1;HDAC4;PPARA;NCOR1
prerank,regulation of axonogenesis (GO:0050770),0.3580034044687477,0.9504574643455385,0.5700218818380745,0.8311070386449397,1.0,13/51,16.84%,ARHGDIA;NTRK2;RTN4;LRP4;LRRC4C;PAK1;THY1;PAK3;GDI1;RHOA;TIAM1;ROBO2;BRSK2
prerank,cellular response to arsenic-containing substance (GO:0071243),0.4308883880544982,0.9502541239748968,0.5433911882510013,0.8311456147234954,1.0,3/15,14.41%,VCP;GSTO1;HNRNPA1
prerank,positive regulation of catabolic process (GO:0009896),0.3448622751793366,0.949940784898166,0.5588865096359743,0.8314398584387039,1.0,16/65,19.93%,NDUFA13;OAZ1;TNF;SORL1;VCP;TNFAIP3;TNFSF12;VSIR;DDB1;WNT5A;VPS28;EGLN2;DAB2IP;TRIM32;HECW1;OAZ2
prerank,peptidyl-methionine modification (GO:0018206),0.4399202202965037,0.949898691428329,0.5404663923182441,0.8311314086843453,1.0,4/12,19.99%,METAP1;METAP2;PDF;NAA25
prerank,multivesicular body assembly (GO:0036258),0.38725824393877617,0.9498315391858586,0.566350710900474,0.830867190660979,1.0,16/30,32.41%,CHMP2B;CHMP5;CHMP6;VPS28;CHMP1B;VPS4A;VPS37C;CHMP7;VPS36;CHMP1A;HGS;CHMP4C;SNF8;MVB12A;CHMP4A;CHMP4B
prerank,regulation of establishment of cell polarity (GO:2000114),0.4224539843367212,0.9494030509028082,0.5520304568527918,0.83137208211494,1.0,2/16,0.88%,RACK1;GSN
prerank,melanocyte differentiation (GO:0030318),-0.36636049235545337,-0.9493880090872155,0.45318352059925093,0.8011836829046066,1.0,4/11,16.61%,LRMDA;ENPP1;KIT;MITF
prerank,protein deacetylation (GO:0006476),-0.2636991216783389,-0.9493701033824645,0.5726495726495726,0.7996259434794444,1.0,11/41,13.42%,PRDM5;MIDEAS;BAZ2A;HDAC4;MTA3;TBL1X;RCOR1;MIER1;TBL1XR1;RCOR3;SIRT1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.384186239823936,-0.9493383993892504,0.50625,0.7981215465243311,1.0,5/10,31.63%,IL18;LGALS9;PRKCZ;GATA3;IL4
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3926165023729263,0.9490523486298726,0.5362853628536285,0.8317429134181862,1.0,6/28,10.03%,CXCL12;HCLS1;PFN1;ESAM;COTL1;PAK3
prerank,positive regulation of dendrite development (GO:1900006),0.45873859657753124,0.9487247727202696,0.5398601398601398,0.8320356653775067,1.0,6/10,26.38%,PACSIN1;LRP8;DAB2IP;PTN;VLDLR;ALK
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.34128332438095194,0.9485601692801763,0.5653104925053534,0.8319859687707244,1.0,9/72,12.90%,RPL26;RPS27L;CHEK2;PCBP4;HIPK2;NDRG1;BAX;PCNA;PRMT1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.23960777680701364,-0.9478104642129523,0.575,0.8004009738129281,1.0,19/67,18.10%,PLD1;FER;DCDC2;TBC1D19;USP6NL;TBC1D2B;RABGAP1;TBC1D9B;IFT88;SDCCAG8;FXR2;IFT140;ATP8B1;MYO10;DYNC2LI1;SGSM3;ABITRAM;FMR1;CDKL1
prerank,negative regulation of myotube differentiation (GO:0010832),0.45245207954066613,0.9476217671996425,0.5520974289580515,0.8335324501989061,1.0,6/12,27.81%,BHLHE41;TMEM119;HDAC5;NOTCH1;CCN3;XBP1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.32719149004711334,-0.9475305892389398,0.4959016393442623,0.7996054293674049,1.0,4/16,10.54%,AUTS2;KMT2A;BCOR;SMAD4
prerank,sensory perception of smell (GO:0007608),0.46119532553666354,0.9473364681469898,0.5272988505747126,0.8337115399521101,1.0,2/11,15.44%,SLC24A4;SYT10
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3576632115235667,0.9471861579292301,0.5743473325766175,0.8336258829164863,1.0,11/43,20.07%,SOX18;NDRG4;APLNR;HES1;TBX22;SOX17;RYR2;DLL1;GATA4;NOTCH1;MEF2C
prerank,response to glucagon (GO:0033762),-0.31863891793568655,-0.9470603014367764,0.5272727272727272,0.7993062712421211,1.0,3/19,2.23%,ADCY9;ADCY1;ADCY5
prerank,mesenchymal cell development (GO:0014031),0.4178289166026933,0.946578611407176,0.5558408215661104,0.8344839296851944,1.0,11/18,37.12%,NRG1;PDCD6;SOX8;SOX11;NOTCH1;NOLC1;KBTBD8;CDH2;TBX20;TCOF1;KLHL12
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.3811116963627144,0.9465580610871811,0.5855106888361045,0.8341213061373917,1.0,8/30,17.41%,TOMM7;PINK1;UBL5;LEPROT;FBXW7;RHOU;PDCD5;RAC2
prerank,sodium ion transport (GO:0006814),0.3348102070722362,0.9464373684530607,0.5854166666666667,0.8339581249768815,1.0,19/85,17.69%,ASIC2;SLC24A4;SLC24A2;SCN1A;SLC6A6;SGK1;SLC6A17;SLC6A2;SLC6A5;SCN4B;SLC6A16;ATP1A4;NDUFA9;ATP1B1;SLC8A1;HCN1;FGF13;HCN3;ATP1B3
prerank,lymphocyte differentiation (GO:0030098),0.34088272086905286,0.9461843396906552,0.6043478260869565,0.834110923474022,1.0,24/68,26.78%,SLC25A5;LYL1;NFAM1;PTPRC;IL2;IKZF1;IL11;ZBTB7A;HDAC5;JAG2;HDAC9;VCAM1;PIK3CD;ADAM17;DNAJB9;TOX;FLT3;LFNG;KLF6;TCF3;BLNK;HHEX;ITGB1;CEBPG
prerank,calcium import into the mitochondrion (GO:0036444),-0.37991828105600034,-0.9460511073247488,0.5122699386503068,0.8003581349533558,1.0,3/10,6.11%,MCU;MICU1;MICU2
prerank,cell-cell junction maintenance (GO:0045217),0.4613343905573771,0.9457299381813881,0.556497175141243,0.8346931630630916,1.0,4/11,22.93%,MYADM;CSF1R;F2RL1;PARD6A
prerank,renal water homeostasis (GO:0003091),0.3969757037103502,0.9455780542137148,0.5592592592592592,0.8346210368256815,1.0,9/23,19.55%,AQP4;AQP1;PRKAR1A;PRKAR1B;WFS1;ADCY4;ADCY8;PRKAR2B;TFAP2B
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.4574667284625652,0.9451811092010162,0.5571847507331378,0.8350616151568111,1.0,4/10,26.19%,WNT5A;ADAM17;CCR2;OXSR1
prerank,stabilization of membrane potential (GO:0030322),0.4213917460002894,0.9448554986499073,0.5501319261213721,0.8353614623657832,1.0,5/16,19.26%,CHCHD10;KCNK9;KCNK3;KCNK10;KCNK13
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.32628492128506703,0.9448547741985329,0.6185147507629705,0.8349551151693385,1.0,23/128,13.63%,RPS27A;UBC;CLDN5;UBB;MAPK3;ID1;ACVRL1;FKBP1A;AMH;EID2;LEFTY2;WFIKKN2;UBA52;ZYX;COL3A1;JUN;SLC33A1;AMHR2;ZMIZ2;COL1A2;RHOA;BMP2;LEFTY1
prerank,response to organic cyclic compound (GO:0014070),0.35015837310477527,0.9446526487929191,0.5749167591564928,0.8349616076633338,1.0,14/52,21.30%,SPP1;TNF;IGFBP5;CTNNB1;TRPM2;PMAIP1;SLC1A1;PAQR7;CCL2;ABCA2;CCL3;TGFB1;SFRP1;FOXA1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.44334968898514465,0.9445642991221165,0.5682758620689655,0.834739017497911,1.0,6/12,27.73%,GART;PRPS1L1;PRPS1;PRPSAP1;ADSL;ADA
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.23235371642771913,-0.9442496272319291,0.6142857142857143,0.8034266343041068,1.0,12/69,10.41%,GAB2;PLCE1;PI4KA;PITPNM2;OGT;IRS1;PLCL1;PLCD3;IGF1;PDGFRB;PTEN;NGF
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.4621128359693394,0.9440803198992452,0.5746164574616457,0.8353307937274752,1.0,1/10,1.79%,SOD1
prerank,replication fork processing (GO:0031297),0.3658975468392974,0.9437131132343368,0.5735294117647058,0.8357002331936217,1.0,11/38,22.28%,NUCKS1;CENPX;PCNA;DDX11;BRCA2;TRAIP;MMS22L;ALYREF;FAM111A;CDK9;BLM
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.3109960580164376,-0.943207257253417,0.5447154471544715,0.8045306125090992,1.0,6/18,14.01%,SMAD3;ITGB8;LTBP1;SMAD4;CD46;LGALS9
prerank,endoderm formation (GO:0001706),0.371780030822691,0.9431661797365853,0.5546605293440736,0.8364573241237818,1.0,10/35,22.48%,VTN;ITGB2;FN1;COL6A1;SOX17;MMP14;INHBA;COL7A1;DUSP2;DUSP1
prerank,regulation of nervous system development (GO:0051960),0.36355972353418997,0.9430978224202002,0.571921749136939,0.836203262729916,1.0,9/37,15.99%,CTNNB1;HES1;HES6;BHLHE41;TENM4;CX3CR1;PTPRZ1;HEY1;DLL1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3425568036562097,-0.942675614673434,0.49407114624505927,0.8042617876011343,1.0,5/14,14.18%,ARID2;MMS19;MRNIP;FUS;FANCB
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.2928796110491269,-0.9425703159229868,0.5951219512195122,0.8029420427099391,1.0,5/24,5.77%,ADAMTS12;SOX5;ZBTB16;TGFBR1;EFEMP1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.39998897525118654,0.9424434219087343,0.5441741357234315,0.8372152778654592,1.0,4/21,9.00%,CD81;NFAM1;SLC39A10;CD22
prerank,ceramide metabolic process (GO:0006672),0.35404698856345795,0.9401765540964148,0.5889502762430939,0.8417203982893257,1.0,15/49,22.53%,CERS2;ORMDL3;PPP2R1A;SMPD1;CLN6;SPTLC1;ST6GALNAC3;DEGS1;ABCA2;FA2H;CLN8;SPTSSA;ASAH2;SGPL1;ORMDL2
prerank,negative regulation of cell aging (GO:0090344),-0.33035023540433306,-0.9395680142026697,0.5185185185185185,0.8089680527531133,1.0,7/16,13.42%,MAP3K3;SLC30A10;CDK6;ZKSCAN3;TERT;TERF2;SIRT1
prerank,cellular response to estradiol stimulus (GO:0071392),-0.31443594876977393,-0.9392611544323517,0.5352112676056338,0.8081439989963188,1.0,4/18,9.87%,EGFR;NRIP1;LCOR;ESR1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.33221733012507676,-0.9391686075203338,0.5708502024291497,0.8067892499316471,1.0,5/15,12.34%,PRKCE;IRS1;PPARA;PPARG;ADM
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.33062889360327147,0.9391671872664656,0.6058700209643606,0.8434494948578592,1.0,14/87,14.41%,POLR2E;MAPK3;POLR2D;POLR2F;ZFP36L1;ZFP36L2;HYAL2;RAB14;ZFP36;POLR2G;FGFRL1;POLR2K;CCL2;HNRNPA1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.45135543534491496,0.9387465562044545,0.5669824086603519,0.8439294275618314,1.0,4/11,18.56%,NT5C3A;SLC19A3;SLC25A19;SLC19A2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.44822349968123426,0.938591323298433,0.5444126074498568,0.8438476569636442,1.0,7/12,27.81%,BAX;DAB2IP;TMEM33;BAK1;PTPN1;BOK;XBP1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33510414568067565,0.938266699456107,0.6019522776572668,0.8441281677063376,1.0,22/75,25.01%,CALM1;RGS5;C3;GPER1;METAP1;YWHAB;RGS2;KLK6;METAP2;RGS12;RAMP3;SYP;FRMPD1;CNGB1;ADCYAP1;GIT1;PPEF1;RGS6;KCTD8;RGS4;PDE6G;RNF157
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3432259022615938,-0.9382270233683208,0.5230769230769231,0.8075317507051857,1.0,5/13,17.26%,PTGIS;PARP9;PARP16;PARP10;NUDT12
prerank,positive regulation of response to stimulus (GO:0048584),0.36275212893449643,0.937924735319667,0.5822928490351873,0.8444333577531237,1.0,9/40,21.21%,B2M;YPEL3;TAF9;WNT5A;NSMCE1;IER5;SELENON;MYC;RSAD2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4011284912592241,0.9377404525450029,0.5808457711442786,0.8443914584799057,1.0,8/22,25.37%,SPI1;EMC10;PRMT1;BMP2;NCF1;GADD45A;AGER;MFHAS1
prerank,negative regulation of signal transduction (GO:0009968),0.31331398988280423,0.9375818374700537,0.6703406813627254,0.844308681922869,1.0,64/249,20.17%,RACK1;APOD;CALR;DCC;LGMN;AKT1;TMBIM6;AGT;IGFBP3;TNF;YWHAB;PTPRC;IGFBP5;GRB14;NDRG4;RGS2;VCP;SFRP5;TNFAIP3;LRPAP1;ARRDC1;PTK6;LEPROT;NTN1;CADM4;GATA2;DCN;SMPD1;KIF26A;PDCD6;ULK3;ZBTB7A;FBXW7;SPRY1;BMP2;NLRP2B;SFRP4;CX3CR1;GDF15;MAPK8IP2;HEY1;SIGIRR;BEND6;DLL1;EGFL7;DACT3;DAB2IP;TYRO3;GATA4;GLIS2;PTGIR;APCDD1;MMP14;TMBIM1;ERBB3;NOTUM;SRMS;MAZ;QARS1;SNCA;HIC1;SPRY3;DDIT4;SFRP1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.40275568907093806,0.9362692111414312,0.5752895752895753,0.8466403806173325,1.0,9/20,27.73%,YWHAB;RGS2;APLP1;STMN1;SNCA;GRK2;GPRASP1;RNF157;ADA
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.40879757557771845,0.9352792363544444,0.5528350515463918,0.8482824114997553,1.0,7/19,28.55%,TNFAIP3;NLRP2B;CX3CR1;NLRP3;GIT1;CX3CL1;CPTP
prerank,dicarboxylic acid catabolic process (GO:0043649),0.438534495707667,0.9350280669451994,0.5644090305444888,0.8483932438203804,1.0,6/13,21.67%,GLUL;ACOT4;GLUD1;GOT1;GAD1;MTHFS
prerank,negative regulation of interferon-beta production (GO:0032688),0.46502923611460545,0.9346287977636362,0.5443959243085881,0.8488095557619649,1.0,3/10,20.93%,SIRPA;LILRB1;PYCARD
prerank,positive regulation of macroautophagy (GO:0016239),0.35633875679123367,0.934377944942239,0.6031746031746031,0.8488857760407674,1.0,8/48,9.63%,SLC25A5;PINK1;SLC25A4;BNIP3L;SCOC;KDR;HSPB8;DCN
prerank,regulation of RNA splicing (GO:0043484),0.33701735762637364,0.9340033170884756,0.6010695187165775,0.8492644007366047,1.0,11/69,13.09%,RPS13;RPS26;TMBIM6;HNRNPK;QKI;AHNAK;PQBP1;RRP1B;KHDRBS3;FAM50A;HSPA1A
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3222352963102442,0.9338340540771431,0.6418367346938776,0.849198302299587,1.0,16/132,9.82%,APOE;HSP90AA1;LAPTM5;PNPLA2;TNF;TMEM59;ORMDL3;PRR5L;MSN;LIN28B;P2RX7;MTLN;PTTG1IP;MLXIPL;DCN;HMGB1
prerank,regulation of isotype switching (GO:0045191),-0.3405389039430132,-0.9326616351976809,0.5095785440613027,0.8196477710467631,1.0,4/14,7.38%,KMT5C;PARP3;KMT5B;SHLD1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.24666939213376393,-0.9323746190687282,0.6363636363636364,0.8188181733612351,1.0,11/58,13.42%,BABAM2;KDM2A;NSMCE2;UVRAG;MDC1;UIMC1;RNF8;NHEJ1;ATM;ERCC8;CYREN
prerank,regulation of glucose metabolic process (GO:0010906),-0.2698173696043834,-0.932148468106567,0.5426356589147286,0.8178239064135995,1.0,9/34,13.42%,PDK1;OGT;PRKN;IRS1;FOXK2;FOXK1;DGKQ;RORA;SIRT1
prerank,B cell homeostasis (GO:0001782),0.4533990696862758,0.9321144656571576,0.5835734870317003,0.8522970249321129,1.0,5/10,24.10%,TNFAIP3;DOCK10;MEF2C;PPP2R3C;TNFRSF13B
prerank,sensory organ development (GO:0007423),-0.24127346666980815,-0.932000069357419,0.6379310344827587,0.8166485143725725,1.0,4/51,2.84%,PBX1;SMOC1;PBX3;SHROOM2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.34892172971757834,0.9319038223131605,0.6033333333333334,0.8523152239589848,1.0,4/50,3.71%,RPS3;LAPTM5;CCL19;TNF
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.38089596622639266,0.9316513255537705,0.5870646766169154,0.8524256121978238,1.0,4/26,9.13%,ACADVL;APOC1;MID1IP1;MLXIPL
prerank,response to interleukin-1 (GO:0070555),0.3305684967271006,0.9313139396832616,0.6139240506329114,0.852695423894816,1.0,21/73,26.21%,CCL19;NR1D1;TLE5;SIRPA;HYAL2;TAF9;SMPD1;SOX9;CCL2;MAPK11;DAB2IP;CCL3;CCL8;SNCA;SFRP1;PYCARD;RELA;TNFRSF11A;APP;PRKCA;CX3CL1
prerank,epidermis development (GO:0008544),0.3412166018653136,0.9308719719102836,0.5827886710239651,0.8532142088697778,1.0,17/56,31.94%,GJB5;FABP5;CCN2;YBX1;LAMC2;KRT9;EVPL;DLL1;COL7A1;GRHL2;ATP2A2;PLOD1;PTHLH;POU2F3;ATP2C1;ALDH3A2;EMP1
prerank,coenzyme A biosynthetic process (GO:0015937),0.45258792828552236,0.9307915188038937,0.5864978902953587,0.8521457605654037,1.0,5/11,23.83%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.45258792828552236,0.9307915188038937,0.5864978902953587,0.8521457605654037,1.0,5/11,23.83%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.45258792828552236,0.9307915188038937,0.5864978902953587,0.8521457605654037,1.0,5/11,23.83%,ACAT1;ACOT7;COASY;PPCS;SLC25A16
prerank,vesicle transport along microtubule (GO:0047496),-0.29625969899156945,-0.9307769894094333,0.5841584158415841,0.8181945336621149,1.0,6/23,15.21%,TRAK1;PAFAH1B1;FBXW11;KIF13A;CLN3;NDEL1
prerank,regulation of actin filament-based process (GO:0032970),0.3343628736551741,0.9306342293618817,0.6102783725910065,0.852068296393068,1.0,19/70,17.41%,RHOB;CNN2;RHOC;RAC1;GPM6B;IQGAP2;RHOG;FAM107A;CORO1A;PAK1;EPHA5;PAK3;BST2;RHOA;CCDC88A;PDGFA;DLC1;DMTN;RAC2
prerank,sulfur compound biosynthetic process (GO:0044272),0.3277341475486564,0.9305902891266276,0.6182572614107884,0.8517525344868707,1.0,32/104,25.43%,BGN;BCAN;FMOD;GSTM1;LUM;MPST;MGST1;GSTO1;DCN;CHST1;B4GALT6;GSTM5;MGST3;GSTM2;CHPF2;CHPF;HPGDS;UGDH;VCAN;MAT2A;B3GNT3;AKR1A1;ESD;OPLAH;CSGALNACT2;CHSY3;ACAN;B4GALT3;CHST14;PRELP;CHST9;CSPG5
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.35713074772067954,-0.9305490101649389,0.5231316725978647,0.8156286771276221,1.0,5/11,19.22%,TNRC6A;TNRC6C;RBM4;AGO2;AGO4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.35713074772067954,-0.9305490101649389,0.5231316725978647,0.8156286771276221,1.0,5/11,19.22%,TNRC6A;TNRC6C;RBM4;AGO2;AGO4
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4158408310229166,0.9304106078163216,0.562905317769131,0.8517061063584566,1.0,3/16,6.32%,LRRC8A;IGFBP3;BTG1
prerank,positive regulation of organelle assembly (GO:1902117),0.351686160779914,0.9296261135355337,0.5972382048331415,0.8529291998242083,1.0,10/44,15.60%,IL5;TNF;KCTD17;LCP1;SDC4;CAPG;CCDC88A;SDCBP;G3BP1;G3BP2
prerank,pharyngeal system development (GO:0060037),-0.34240935924083016,-0.9294666679889017,0.5587044534412956,0.8168093315161256,1.0,6/15,21.22%,BMPR1A;TGFBR1;BMP4;BMPR2;BMP5;PTCH1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.31200001589986837,-0.9291260324641658,0.572139303482587,0.8161535624648742,1.0,3/20,3.29%,CAMK2D;ACTN2;PRKCE
prerank,negative regulation of cholesterol transport (GO:0032375),0.4546589808466004,0.9289286697936157,0.5911047345767575,0.8539210101097023,1.0,3/10,25.64%,APOC1;ABCA2;ABCG5
prerank,regulation of mast cell degranulation (GO:0043304),-0.3482787632021467,-0.9286962475304056,0.5384615384615384,0.8156659256255187,1.0,2/14,1.00%,GAB2;FER
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.40859619343483977,0.9285405645079827,0.5796915167095116,0.8543112619831796,1.0,4/18,12.34%,NLGN1;RIMS2;RIMS1;SYN1
prerank,protein export from nucleus (GO:0006611),-0.2776656497262459,-0.9279531384571523,0.5783783783783784,0.8158650365419732,1.0,12/27,17.19%,RANBP3L;SMURF1;DUSP16;NUTF2;PKD1;RANBP17;XPO4;XPO7;CCHCR1;CSE1L;NUP214;STRADB
prerank,positive regulation of translational initiation (GO:0045948),0.40787146379954686,0.9274622330239054,0.5820512820512821,0.8561395819480588,1.0,5/18,18.62%,POLR2D;UHMK1;POLR2G;YTHDF1;EIF2B5
prerank,regulation of fat cell differentiation (GO:0045598),0.33218427800896316,0.927150600870854,0.6228632478632479,0.8563721105240242,1.0,17/74,13.56%,AKT1;CCDC85B;GPER1;TNF;NR1D1;CDS1;ZFP36L1;ZFP36L2;RARRES2;CEBPB;LPL;GATA2;ZFP36;LRP3;WNT5A;BMP2;WNT10B
prerank,generation of neurons (GO:0048699),0.31486322268579264,0.9267247291469761,0.673407482305359,0.8568280427430319,1.0,49/190,23.67%,ITM2C;TAFA1;RAC1;NTRK2;PIN1;CTNNB1;ADGRL3;SPOCK1;HES1;HES6;NRCAM;IL1RAPL1;MAPT;TUBB2B;CDK5R1;BHLHE41;DNER;WNT5A;ELP3;PTPRD;IRX3;CCK;WNT10B;CX3CR1;CDK5;HEY1;FGF13;OLIG1;DLL1;MYEF2;FUT9;BRSK2;TUBB2A;ERCC6;GPM6A;MYT1L;BTG4;ACSL3;SOX11;DCX;DDIT4;MEF2C;MAP1B;FZD2;FZD1;IER2;WNT7A;ACSL4;PLXNB2
prerank,positive regulation of filopodium assembly (GO:0051491),-0.2959718826535041,-0.9264024243266687,0.5346534653465347,0.8182320349011794,1.0,4/24,3.56%,DPYSL3;DOCK11;BCAS3;NRP1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.32023531439547465,0.92608448991255,0.6294363256784968,0.8577310419916966,1.0,12/104,7.22%,RPS27A;UBC;UBB;NBL1;FKBP1A;PIN1;SORL1;EID2;HIPK2;WFIKKN2;UBA52;STRAP
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.4531924023162996,0.9260827276776137,0.5778401122019635,0.8573247525116965,1.0,5/11,35.80%,PKD2L1;LPO;RTP3;PKD1L3;RTP4
prerank,dicarboxylic acid transport (GO:0006835),0.37778401822344154,0.9257553587619493,0.5757211538461539,0.8575952676802856,1.0,8/28,19.06%,SLC1A2;SLC25A13;SLC1A1;SLC25A22;GJA1;SLC19A1;FOLR2;SLC25A18
prerank,regulation of blood circulation (GO:1903522),0.36138461602555416,0.9257491636811378,0.5675675675675675,0.8571991757452133,1.0,7/34,14.60%,S100A1;FXYD1;AGT;ADORA3;PLN;DES;KCNE5
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.2840590424699426,-0.9250338330603232,0.5769230769230769,0.8199591008930975,1.0,7/23,21.10%,WEE1;PRCC;PABIR1;CHFR;INTS3;PLK2;ZWILCH
prerank,osteoclast differentiation (GO:0030316),0.39039024882333784,0.9247854068888427,0.5931558935361216,0.8587741891684005,1.0,7/22,19.50%,TYROBP;TREM2;GLO1;CSF1R;OSTM1;OSCAR;GPR183
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.4428672482255426,0.9246168325963283,0.5947075208913649,0.8587005702284193,1.0,4/13,12.73%,ELOF1;SPI1;SERTAD1;ZMIZ2
prerank,canonical Wnt signaling pathway (GO:0060070),-0.23593318999240176,-0.9244750960467437,0.6607142857142857,0.8197561589832055,1.0,19/68,16.63%,TCF7L2;LRRK2;PLPP3;LRP5;LRP6;CSNK1A1;FZD6;RARG;AXIN1;WNT5B;BCL9L;PTEN;WNT16;DVL3;WNT11;GSK3B;WNT4;WNT9A;RYK
prerank,cardiac muscle cell differentiation (GO:0055007),0.3973802973670781,0.9244330531570641,0.5906801007556675,0.858661310682248,1.0,7/21,15.37%,NRG1;ALPK2;KDM6B;MYH11;IRX3;BMP2;SLC8A1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.37384890273006544,0.9242084121395564,0.5965770171149144,0.8587142547031159,1.0,12/30,20.17%,PTPRC;SBDS;KDR;CSF1R;FLT4;ARMC6;FLT1;INHBA;FLT3;MLF1;TGFB1;SFRP1
prerank,inner dynein arm assembly (GO:0036159),0.4527938502976605,0.9239875980782322,0.5870165745856354,0.8587467795424143,1.0,2/10,11.99%,DNAI3;DNAH1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.40952794156193856,0.9237521395621843,0.58203125,0.8588269320564271,1.0,7/16,19.87%,HSPA5;GABARAPL2;RYR2;BCAP31;PPP1R15A;DDRGK1;VAPA
prerank,cellular response to insulin stimulus (GO:0032869),0.3200638235025234,0.9236497703487991,0.6546762589928058,0.8586318296269672,1.0,31/124,22.64%,ATP6V0C;AKT1;ATP6V1F;PKM;GRB14;ZFP36L1;ATP6V1G1;CAV2;PARP1;ATP6AP1;ATP6V0E2;PDE3B;RARRES2;RAB15;NAMPT;MYO5A;VAMP2;ATP6V0D2;HDAC5;SH2B2;IGF2;HDAC9;EPRS1;RAB31;SOS1;GOT1;C2CD5;SELENOS;INHBB;ATP6V1A;ATP6V0A1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3630175559262824,0.9235650635741188,0.5953488372093023,0.8583985448296951,1.0,18/35,33.18%,MAPK3;CCT2;CTNNB1;CCT7;CCT8;HNRNPA1;MAPK15;MAP2K7;CCT4;NAF1;PNKP;CCT3;PRKCQ;AURKB;HNRNPA2B1;ACD;PKIB;CCT6A
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.34560238293421486,-0.9229210920013591,0.5866141732283464,0.8220235779659049,1.0,4/13,13.42%,SORBS1;IRS1;ECHDC3;SIRT1
prerank,C-terminal protein amino acid modification (GO:0018410),0.434312206563243,0.9225387046485076,0.5828651685393258,0.8601037618512136,1.0,2/11,10.21%,AGBL4;ICMT
prerank,macromolecule catabolic process (GO:0009057),0.3761077762458752,0.9217832159362057,0.5854545454545454,0.8612411596613732,1.0,7/26,20.39%,LGMN;USE1;CLN5;CLN6;CLN8;TGFB1;CAPN3
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.2868859755531624,-0.9217239811918149,0.5580110497237569,0.823463644399302,1.0,12/27,20.34%,SMG6;PARP4;NIBAN2;PDGFRB;TERF2;ATM;SMOC2;PINX1;BMPR2;FGF2;PRKD2;TOM1L1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.31104757464573385,-0.9216884183520845,0.5666666666666667,0.822015551425446,1.0,5/16,15.37%,TIPIN;RAD17;ORC1;NAE1;CLSPN
prerank,heart looping (GO:0001947),0.3532553614394066,0.9213436362668589,0.6085450346420324,0.8617072244834028,1.0,13/39,28.21%,SOX18;NDRG4;APLNR;TBX22;SOX17;DLL1;GATA4;NOTCH1;MEF2C;SRF;VANGL2;ENG;TBX2
prerank,aorta morphogenesis (GO:0035909),-0.3207192238835884,-0.9212524128509948,0.5775862068965517,0.8215327108297408,1.0,8/17,14.92%,BMPR1A;ADAMTS9;MYLK;PDGFRB;LRP1;RBPJ;JAG1;HEY2
prerank,protein import into nucleus (GO:0006606),0.3337374600143886,0.9210564498854015,0.6360725720384205,0.8618743292461941,1.0,12/66,18.25%,RPL23;AKT1;RAN;FAM53C;PTTG1IP;IPO4;NUP85;NUP88;SPRN;EIF4ENIF1;SYK;NUP50
prerank,cell-cell junction organization (GO:0045216),0.32952846209969816,0.9209992365658475,0.6415094339622641,0.8615791849340427,1.0,20/79,19.84%,CLDN5;GJA4;CADM2;ANG;CDH20;MYADM;CDH18;CSF1R;CADM3;CDH12;CDH19;DCHS1;F2RL1;CDH7;CDH24;CDH10;CDH5;CTNND2;TGFB1;MARVELD2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.345038596164594,0.9205651234304324,0.6165919282511211,0.8620720830833951,1.0,9/49,13.76%,ERBB4;TNF;HCLS1;ARL2BP;HES1;PTK6;IL2;CSF1R;TNFRSF1A
prerank,lamellipodium organization (GO:0097581),0.36573501820598564,0.9203810409159967,0.5966386554621849,0.8620378985201088,1.0,9/29,21.08%,RAC1;S1PR1;ARHGEF4;P2RY12;ARHGEF7;CCDC88A;DMTN;CTTN;PTPRO
prerank,serine family amino acid catabolic process (GO:0009071),0.4564269275434106,0.9202560434116326,0.5855728429985856,0.8618683557046063,1.0,5/10,34.76%,SDS;SHMT2;DLD;THNSL2;GCSH
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.43318078240755975,0.919873485818192,0.5929078014184397,0.8618154591361263,1.0,2/12,3.99%,PRNP;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.43318078240755975,0.919873485818192,0.5929078014184397,0.8618154591361263,1.0,2/12,3.99%,PRNP;HOMER2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.24098924037238006,-0.919784062947076,0.6320754716981132,0.8234287555607605,1.0,14/48,17.34%,ADCY9;ADCY1;ADCY5;AMPD3;PANK1;ADCY7;PAPSS2;PAPSS1;ADSS2;SLC26A2;AMPD2;PANK2;GUCY2C;PANK4
prerank,cilium organization (GO:0044782),-0.20027896928040653,-0.9196091390025987,0.75,0.8222864826143513,1.0,78/209,26.76%,PARVA;ASAP1;DCDC2;CC2D2A;EXOC4;CYS1;GALNT11;BBS9;ATP6V0D1;EXOC2;WDPCP;PCM1;ARL3;TTLL3;CCDC66;CDC14A;DZIP1L;PIBF1;CEP290;OFD1;IFT88;CCDC57;FAM161A;GBF1;DYNC2H1;NPHP3;ABLIM1;PKD1;CFAP44;WDR35;CEP162;CEP89;PDE6D;IFT140;INTU;IFT122;WDR11;CLUAP1;WDR19;DYNC2I2;CEP78;AVIL;TTC17;CEP41;RFX3;CEP19;TCTN2;POC1B;RAB8B;PKD2;CDC14B;CFAP70;CPLANE2;RTTN;RFX2;TMEM138;IFT80;IFT81;RAB1A;TMEM231;FOXJ1;RILPL2;CFAP61;CCDC65;MNS1;IFT52;RAB3IP;TEKT2;MAK;PTPDC1;EXOC1;RILPL1;CFAP43;BBS5;ARL13B;CFAP52;KIF3B;SNX10
prerank,regulation of sprouting angiogenesis (GO:1903670),0.36027604792651136,0.9192448948008567,0.5988235294117648,0.8626616301025866,1.0,7/33,15.99%,S100A1;KLF2;PKM;GLUL;EPN1;KLF4;DLL1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.2907678143082212,-0.9185189036665051,0.5958549222797928,0.8234113318279817,1.0,5/23,11.01%,TGFBR3;ADAMTS9;FGFR2;SMAD7;TPM1
prerank,negative regulation of cell cycle process (GO:0010948),-0.23480946323961832,-0.9183038815448924,0.6233766233766234,0.8224100420592904,1.0,15/61,14.95%,TOM1L2;MGA;YAF2;EHMT1;EPC1;PHC3;APAF1;WAPL;RBBP8;TFDP1;TERF2;BMP4;NME6;EHMT2;EZH2
prerank,neuromuscular synaptic transmission (GO:0007274),0.4007047419640702,0.9177885473692385,0.59375,0.8651961814731864,1.0,8/18,24.52%,ERC2;CHAT;DTNA;STAC3;RIMBP2;CHRNA3;SLC5A7;TBC1D24
prerank,regulation of intracellular signal transduction (GO:1902531),0.3065625349624301,0.9177467245801282,0.755,0.8648679638442582,1.0,103/420,20.93%,TMSB4X;RPL11;RPL5;ARHGDIA;HSPB1;RHOB;MAPK3;AKT1;A2M;RCN3;NLGN1;AKAP6;TREM2;CSNK2B;IER3;TNF;RHOC;MBD3;ARHGAP25;RAC1;NTRK2;CHEK2;PEX5L;PIN1;ARHGAP9;RPA2;ARHGDIB;RHOG;HIPK2;TTC5;BRPF1;CLEC6A;ARHGEF4;SGK1;PAK1;ARHGAP15;TAF10;PRKAR1A;MAPT;NET1;SLC15A4;CD24;CDK5R1;RHOV;PIP4P1;ARHGEF7;PAK3;TAF9;ARAP3;ARHGDIG;GNAI1;PRKAR1B;WNT5A;ATP6AP2;SSRP1;TAGAP;PHLPP1;CCNG1;MCF2L;VAV1;RHOA;RFC2;ARHGAP45;DEPDC7;RHOU;VAV3;ABR;STK11;PRR5;RRAS;TIAM1;F2RL1;L3MBTL1;TRAF3;MAPK11;RRAGC;SLC15A2;DLC1;CDK5;DAB2IP;GATA4;SQSTM1;PRKAR2B;RAC2;FAM83D;NOP53;MTA2;ARHGEF19;TBP;LBH;SOS1;ING5;CHD3;POU4F1;DDIT4;RFC4;SPHK2;ARHGAP33;CAPN3;ARAP2;NFKBIA;PAK5;PYCARD
prerank,regulation of insulin secretion (GO:0050796),0.3217245332233852,0.9177059120859462,0.6426364572605562,0.864539597233302,1.0,32/101,23.48%,UQCC2;MTNR1B;SLC2A1;SNAP25;RBP4;TRH;LRRC8A;GPER1;TNF;NR1D1;CACNA1A;EPHA5;CHGA;ABCC8;BAD;SLC2A2;BRSK2;NOS2;DOC2B;GLUD1;TFAP2B;IL6;NNAT;FOXA2;SFRP1;KCNC2;INHBB;CCN3;REST;CACNA1E;PSMD9;ACSL4
prerank,substrate-dependent cell migration (GO:0006929),0.421614114206476,0.917542258148543,0.598404255319149,0.8644612312466986,1.0,5/14,14.29%,PTPRC;NTN1;P2RY12;SHTN1;SDCBP
prerank,amino acid transmembrane transport (GO:0003333),0.35057924411386815,0.9174873383100368,0.6065388951521984,0.8641627282167011,1.0,14/45,25.62%,SLC38A5;SLC7A5;SLC25A13;TSPO2;SLC6A6;SLC3A2;SLC25A22;SLC38A10;SLC25A18;MFSD12;SLC7A10;SFXN1;SLC7A6;SLC38A3
prerank,neuron migration (GO:0001764),0.34985483661991457,0.9174750315148527,0.6258351893095768,0.8637815081992689,1.0,18/48,20.36%,RAC1;NTRK2;ADGRL3;SPOCK1;NRCAM;TUBB2B;CDK5R1;DNER;ELP3;CCK;CDK5;FGF13;TUBB2A;GPM6A;DCX;DDIT4;MEF2C;MAP1B
prerank,cellular response to drug (GO:0035690),0.37856079235919166,0.9173291013310179,0.603448275862069,0.86366281841909,1.0,9/25,28.26%,PDE4B;TFRC;GAS6;MEF2C;MYC;PPM1F;REST;KCNQ1;RAP2A
prerank,positive regulation of receptor internalization (GO:0002092),0.38965216396821045,0.9172327003179442,0.5901234567901235,0.863442078881962,1.0,3/22,15.91%,CD63;SFRP4;ARRB2
prerank,regulation of cytoskeleton organization (GO:0051493),0.31878489326036047,0.9171554016436078,0.6583592938733126,0.8631766723884909,1.0,25/108,16.20%,RHOB;MAPK3;RHOC;RAC1;S100A8;S100A9;GPM6B;STMN3;IQGAP2;RHOG;FAM107A;CORO1A;PAK1;P2RX7;CLASP1;MAPT;CDK2AP2;EPHA5;PAK3;BST2;RHOA;CCDC88A;PDGFA;DLC1;DMTN
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.41989977939431633,0.9171284346551285,0.5804195804195804,0.8628218081899414,1.0,5/14,26.19%,WNT5A;CCL3;ADAM17;CCR2;OXSR1
prerank,negative regulation of DNA recombination (GO:0045910),0.3499374120567075,0.917112666544038,0.6118568232662193,0.862450351488062,1.0,11/43,22.28%,POLR2E;POLR2D;TERF1;POLR2F;H1-0;POLR2G;POLR2K;TERF2IP;POLR2H;RADX;BLM
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.36000827515941225,-0.9165533596754598,0.5412186379928315,0.8251656893785092,1.0,4/11,19.26%,ITPKB;IP6K2;PPIP5K1;FGF2
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.429817854168287,0.916031450126782,0.5834464043419267,0.8638241554638352,1.0,2/12,3.71%,AKAP6;TNF
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.429817854168287,0.916031450126782,0.5834464043419267,0.8638241554638352,1.0,2/12,3.71%,AKAP6;TNF
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.447646940408041,0.9159220026819183,0.5955056179775281,0.8636277180066706,1.0,4/11,15.64%,FZD9;SLC25A4;NUPR1;YBX3
prerank,telomere capping (GO:0016233),0.4088886619124071,0.9159155143555979,0.5950840879689522,0.8632364896614255,1.0,4/16,18.54%,TERF1;DCLRE1C;CTC1;TERF2IP
prerank,regulation of mitochondrial fusion (GO:0010635),0.445558090616322,0.9159141554480527,0.5659574468085107,0.8628337623705437,1.0,3/11,6.54%,VAT1;TFRC;OMA1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.32465043772996766,-0.9158113237012009,0.5791666666666667,0.8254827528686142,1.0,5/15,18.43%,RICTOR;UBR3;RAI2;CELF1;NR5A2
prerank,diol biosynthetic process (GO:0034312),0.41922841104330544,0.9151319265559129,0.598404255319149,0.8639673994704399,1.0,6/15,21.11%,SPR;QDPR;SPTLC1;ABCA2;SPHK2;ASAH2
prerank,regulation of bone mineralization (GO:0030500),0.3354838216262618,0.9149042501445295,0.6217391304347826,0.8640261531502009,1.0,19/55,20.07%,FZD9;ECM1;GPM6B;S1PR1;ISG15;NELL1;P2RX7;SRGN;ATRAID;ATP2B1;TMEM119;BMP2;SLC8A1;CCL3;TWIST1;DDR2;NOTUM;TGFB1;MEF2C
prerank,cellular response to misfolded protein (GO:0071218),0.38898405171158856,0.9147950474123272,0.5938303341902313,0.8638195991458196,1.0,2/20,5.80%,AUP1;VCP
prerank,regulation of cell cycle process (GO:0010564),0.3185744548553649,0.9144264057962254,0.6704545454545454,0.8641439507859303,1.0,27/104,26.13%,CALM1;CALM3;GPER1;KLHL9;PIN1;CAV2;CTNNB1;USP51;ATF5;SOX9;FBXO5;SND1;L3MBTL1;NUDT16;CETN2;CALM2;GIT1;SFRP1;CCP110;IHO1;CCDC8;NUGGC;ECT2;RCC1;CDKN2B;KIF20B;KLHL21
prerank,potassium ion transport (GO:0006813),0.31573579969865445,0.9140375482292438,0.6831275720164609,0.8644998717712822,1.0,29/120,19.69%,SLC24A4;SLC24A2;KCNQ3;KCNQ2;KCNC3;KCND2;KCNJ10;AQP1;KCNC1;KCNA2;KCNN2;ATP1A4;KCNK9;ABCC8;KCNF1;HCN1;KCNK3;KCNA1;LRRC55;KCNK10;HCN3;ATP1B3;SLC9A9;KCNH7;KCNMA1;KCNH8;KCNK13;KCNQ5;PKD2L1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.40690318151864313,0.9138831007110881,0.5810439560439561,0.8644017046876856,1.0,3/15,13.00%,AGT;SOX8;SOX9
prerank,smooth muscle contraction (GO:0006939),-0.34344665946250025,-0.9138398835695057,0.5815602836879432,0.828655411042116,1.0,4/14,7.39%,ROCK2;ROCK1;MYLK;EDNRA
prerank,Golgi localization (GO:0051645),-0.3533883420933215,-0.9134753512529498,0.5435540069686411,0.8280129640898297,1.0,2/11,5.32%,ARHGAP21;UVRAG
prerank,urogenital system development (GO:0001655),0.43198317521330093,0.9133429110590914,0.5997191011235955,0.86504876709245,1.0,8/11,40.05%,AMH;SOX9;OSR2;SHH;PAX2;EPHB3;LHX1;OSR1
prerank,fatty acid metabolic process (GO:0006631),0.319098611702517,0.9133082697332007,0.6642784032753326,0.864715358194859,1.0,46/115,34.98%,GPX4;GPX1;NUDT19;LIPG;LPL;ALKBH7;FASN;OXSM;ACOT1;ACOT7;CRAT;ALOX5AP;NAAA;ACOT4;FA2H;FAAH;LTC4S;PPARGC1A;ACSL3;THEM4;SGPL1;ACSM5;ADIPOR1;NDUFAB1;ACSL4;ACLY;PON2;ACAD9;GPAM;XBP1;HSD17B8;GGT5;CYP4B1;AOAH;ABCD2;PNPLA8;ELOVL4;GNPAT;CEL;ACOX1;ACSF3;CD36;ADIPOR2;CPT1B;PEX2;PLA2G15
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.33661449730274173,0.9130735178349803,0.6365638766519823,0.864772660706734,1.0,9/57,10.71%,ERBB4;TNF;HCLS1;ARL2BP;PPP2R1A;HES1;PTK6;IL2;CSF1R
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.42176506497450095,0.9130332859798125,0.5797872340425532,0.8644369670203668,1.0,4/14,12.35%,IGFBP3;IGFBP5;NDRG4;AIF1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.41076216614198535,0.9129835881695858,0.6050198150594451,0.8641256520688151,1.0,5/16,16.07%,PRDX6;NCL;SNW1;CIRBP;CELF3
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4312949724741309,0.9129071769648357,0.6095890410958904,0.8638777123254479,1.0,5/12,19.83%,TNF;LIN28B;NCOR2;IL6;TGFB1
prerank,cellular response to nutrient levels (GO:0031669),0.3339333573955336,0.912845429902903,0.6158940397350994,0.8636036933889011,1.0,15/62,21.54%,HSPA8;MAP1LC3B;MAP1LC3A;FADS1;FAM107A;MFSD2A;LPL;CD68;RRAGC;RRAGD;LAMP2;WDR45;SFRP1;RALB;INHBB
prerank,body fluid secretion (GO:0007589),0.41446754091114296,0.9121000135440869,0.5989232839838493,0.8646634413828859,1.0,1/15,2.95%,ERBB4
prerank,negative regulation of centrosome duplication (GO:0010826),0.4450149056728969,0.9117422515760435,0.5924308588064047,0.8649617152173014,1.0,1/11,3.04%,NPM1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.37052649934085813,-0.9109160453632957,0.5971223021582733,0.8326632035979904,1.0,4/11,6.10%,SLC30A10;PPARA;COA8;ABCB7
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.40391705557790003,0.9104572775377798,0.5928853754940712,0.8666880384619046,1.0,4/16,7.14%,APOD;ACVRL1;FAM107A;CORO1C
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.40391705557790003,0.9104572775377798,0.5928853754940712,0.8666880384619046,1.0,4/16,7.14%,APOD;ACVRL1;FAM107A;CORO1C
prerank,mRNA catabolic process (GO:0006402),0.34863122306117617,0.9103549494028543,0.6189944134078212,0.8664939072884199,1.0,15/44,25.41%,LSM6;HSPA1B;ZFP36L2;ZFP36;RNH1;HSPA1A;PDE12;NUDT16;NANOS2;AGO1;EXOSC9;EXOSC4;LSM5;METTL3;PNPT1
prerank,mismatch repair (GO:0006298),-0.2703539083575829,-0.9103146583560169,0.6337209302325582,0.8325648052289372,1.0,6/27,8.98%,ABL1;SETD2;MLH3;MLH1;MSH3;TDG
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3736910796947929,0.9102512814362808,0.6014492753623188,0.866294528483464,1.0,6/27,18.08%,NME1;AK4;NME4;NME2;NME3;GUK1
prerank,protein homotrimerization (GO:0070207),0.41180186967848853,0.9101618615248976,0.5751633986928104,0.8656626718398213,1.0,4/14,14.28%,SLC1A2;MIF;STEAP4;ALOX5AP
prerank,protein trimerization (GO:0070206),0.41180186967848853,0.9101618615248976,0.5751633986928104,0.8656626718398213,1.0,4/14,14.28%,SLC1A2;MIF;STEAP4;ALOX5AP
prerank,positive regulation of nervous system process (GO:0031646),0.40444368119689095,0.9100405391496044,0.6002710027100271,0.8655095827494095,1.0,5/18,12.91%,RIMS2;RIMS1;MYRF;TENM4;HCRT
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3390115593980522,0.9095532935924386,0.6465422612513722,0.8661030063214451,1.0,12/51,17.88%,UBB;NBL1;CNTNAP2;PACSIN1;KLK8;SGK1;PAK1;NYAP2;SHTN1;EPB41L3;DAB2IP;GPM6A
prerank,cellular response to alkaloid (GO:0071312),0.4036167769234079,0.909523414779628,0.5978975032851511,0.8657675236533348,1.0,6/17,25.76%,TGM2;GSTM2;SLC8A1;RYR2;BLM;RAD51
prerank,phosphatidylserine metabolic process (GO:0006658),0.35755143467733114,0.909342447625183,0.6120092378752887,0.8657368486894299,1.0,8/32,25.29%,SERINC1;PLAAT3;PLA2G4F;PTDSS1;SERINC5;ABHD16A;PLA2G3;ABHD12
prerank,positive regulation of actin nucleation (GO:0051127),0.4371308034435057,0.9092958825278553,0.5835734870317003,0.865427548366107,1.0,1/11,0.88%,GSN
prerank,cellular biogenic amine catabolic process (GO:0042402),0.4417064141516977,0.9089795054030492,0.5943661971830986,0.86567288000578,1.0,6/10,40.55%,SMOX;SLC44A1;DMGDH;CHDH;SARDH;COMT
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4424281779702259,0.9089549264553802,0.5815899581589958,0.8653120911465296,1.0,4/10,19.75%,NELL1;ATRAID;DAB2IP;EFNA1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.32843448774351847,0.9089339288078692,0.6501614639397201,0.8649547885460008,1.0,21/70,24.56%,LAMC1;LAMB2;ATF4;RAC1;SPI1;FN1;PROX1;VAMP3;ACTN1;RHOA;SRCIN1;TYRO3;TMEFF2;LPXN;EFNA1;MEF2C;GRHL2;USH2A;TEK;TBCD;METTL3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.20278961661561268,-0.9085897352262224,0.7,0.835144758886791,1.0,30/119,19.26%,PTPN13;PI4KA;PITPNM2;MTMR3;TTC7B;PLEKHA4;SMG1;PLEKHA2;PGAP2;ITPKB;PIP5K1A;PTEN;SACM1L;VAC14;PIGM;IP6K2;PIP4K2C;SOCS5;PIGN;PLEKHA8;PGAP3;DPM1;PIGO;PIGF;PIGW;PIGL;PIP4K2A;PIGU;PLCG2;FGF2
prerank,COPII-coated vesicle budding (GO:0090114),0.323942163735743,0.9084518904805301,0.658669574700109,0.8655240420243604,1.0,17/68,21.65%,CTSZ;TRAPPC2L;LMAN1;SAR1A;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;VAPA;COL7A1;TMED10;TGFA
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3528181608540945,0.9080724379155773,0.6129779837775203,0.8658664926485052,1.0,7/35,17.02%,SCD5;FASN;SCD;ACAT1;ALOX5AP;SLC25A1;LTC4S
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4175043135806418,0.9074375513893357,0.5893108298171589,0.86672481793695,1.0,1/13,1.43%,GNAI2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.34322373436176756,0.9064841078217888,0.6510590858416946,0.8682057173298983,1.0,19/51,26.23%,MAPK3;TERF1;CCT2;CTNNB1;CCT7;CCT8;HNRNPU;HNRNPA1;CTC1;MAPK15;GNL3L;MAP2K7;CCT4;NAF1;PNKP;CCT3;PIF1;PRKCQ;HNRNPC
prerank,heart trabecula morphogenesis (GO:0061384),0.398540094221999,0.9064228086210047,0.6166666666666667,0.8679287640164822,1.0,4/18,5.77%,NRG1;RBP4;FKBP1A;S1PR1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.33370570428184776,0.9062705063912364,0.6409691629955947,0.8678258377558479,1.0,16/52,19.59%,AKT1;TREM2;GPER1;TNF;LGALS3;DPP10;RHOG;ARF6;ZDHHC5;GNAI1;RAMP3;CLIP3;EPB41;SQSTM1;STX4;STAC3
prerank,double-strand break repair (GO:0006302),-0.19255907397156516,-0.9060158343866263,0.8181818181818182,0.8396775730951739,1.0,32/158,15.13%,EYA1;BABAM2;KDM2A;NSMCE2;DDX1;PARP9;MDC1;SPIDR;UIMC1;SMARCAD1;PARP3;RNF8;SMARCA5;BAZ1B;RBBP8;NHEJ1;SLX4;INO80;FBH1;RNF138;ERCC5;SETX;RAD51B;ACTR8;EYA3;ATM;TNKS1BP1;CYREN;KDM4D;PALB2;KPNA2;TDP1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.3861555348203699,0.9059235352912423,0.6222493887530562,0.868117513644286,1.0,9/22,28.67%,GLRX5;ISCU;CIAO1;CIAPIN1;HSPA9;CIAO2A;CIAO2B;HSCB;CIAO3
prerank,meiosis I (GO:0007127),-0.2927057968252488,-0.9057591714898839,0.6555555555555556,0.838735388954001,1.0,9/23,25.97%,MYBL1;BCL2L11;ING2;ZCWPW1;ZSCAN21;SYCP3;SGO1;FOXJ3;MEIOB
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.32657988849414077,0.905375034133915,0.6467991169977925,0.8680062480574788,1.0,15/61,21.65%,CTSZ;TRAPPC2L;LMAN1;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;COL7A1;TMED10;TGFA
prerank,COPII vesicle coating (GO:0048208),0.32657988849414077,0.905375034133915,0.6467991169977925,0.8680062480574788,1.0,15/61,21.65%,CTSZ;TRAPPC2L;LMAN1;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;COL7A1;TMED10;TGFA
prerank,vesicle coating (GO:0006901),0.32657988849414077,0.905375034133915,0.6467991169977925,0.8680062480574788,1.0,15/61,21.65%,CTSZ;TRAPPC2L;LMAN1;TRAPPC5;TRAPPC1;TMED2;PDCD6;GRIA1;MCFD2;NAPA;TRAPPC3;CTSC;COL7A1;TMED10;TGFA
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3692413444733929,-0.9048706993926368,0.55,0.8392624986300877,1.0,2/10,2.44%,SOX5;ZBTB16
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.376463838453982,0.9046558904974146,0.6095808383233533,0.8690167680859778,1.0,6/24,9.28%,S100A10;RAC1;DUSP3;THY1;KDR;ARF6
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.30123105818473744,-0.9045429083886946,0.6052631578947368,0.8384728887603584,1.0,3/17,5.81%,SULF1;SLIT2;CASK
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3188253643880479,0.9043446168131479,0.6652849740932643,0.8692266228080666,1.0,23/91,19.61%,MAPK3;SNX17;PTPRC;PACSIN1;SYT1;RIMS2;RAB15;RAB3C;CD22;VAMP2;AP2S1;HCK;STXBP5L;RAB3D;GAS1;HAP1;BET1L;RAB26;RAB5C;SYK;MAP2K2;STX4;RAB4A
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.34073248299806835,-0.9038692184574489,0.5905797101449275,0.8385233766903847,1.0,2/13,3.19%,CACNA1C;ANK2
prerank,cellular response to mechanical stimulus (GO:0071260),0.3412597692825147,0.9038383927597038,0.6283185840707964,0.8698314912637773,1.0,14/46,25.85%,MAPK3;CNN2;AQP1;TMEM150C;SOX9;TNFRSF1A;BAD;TLR5;LTBR;BAK1;GADD45A;PDE2A;CASP1;TLR7
prerank,positive regulation of mitochondrial fission (GO:0090141),0.393789890143903,0.9036928435370787,0.6065989847715736,0.8696949629183811,1.0,9/18,26.09%,PINK1;KDR;DCN;MIEF2;MFF;DNM1L;FIS1;SPIRE1;RALBP1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.36757569090847636,-0.9030965091500255,0.5693430656934306,0.8387523193977947,1.0,3/10,13.24%,PARD3;PRKD3;PLPP1
prerank,nuclear body organization (GO:0030575),-0.3458294593005958,-0.9030223446341092,0.5719424460431655,0.8374104466338224,1.0,4/12,13.51%,USP50;PML;AFF2;SRPK2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.31407807541743404,0.9024717768420046,0.698880976602238,0.8716968849611071,1.0,34/129,20.34%,PSMB4;COL1A1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FZD9;PSMD1;PIN1;PSMC3;PSMD6;VCP;PSMA7;PSMD5;LGR6;PSMB9;PSMD13;GPC5;PSMB3;ATP6AP2;PSMB11;PSMB10;SFRP4;PSMB1;PSMB5;CAV1;USP8;CSNK1G2;CCAR2;PSMA6;TGFB1;SFRP1;PSMA4
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.383533812224578,0.9024212590443187,0.6082337317397079,0.8713866523964843,1.0,9/20,24.86%,PSENEN;SPPL2B;PSEN2;ADAM17;APH1B;TGFB1;SPPL2A;RELA;APH1A
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.42466392778484174,0.9020836612042362,0.6111869031377899,0.8716650748404212,1.0,4/13,21.55%,CPE;RYR2;NOTCH1;NPY5R
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.24375522308060163,-0.9019666480945171,0.6721311475409836,0.8384446049111212,1.0,18/45,22.36%,EGFR;NFKB1;DYRK1A;RIPK1;HEATR1;SETX;POLR2A;BMP4;ZC3H18;DIMT1;SIRT7;TP53;WDR43;SUPV3L1;BUD23;RBM20;DXO;PIK3R1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4092547205270064,0.9015182518225603,0.6126855600539811,0.872348257408321,1.0,8/16,29.07%,PPP2R1A;LEPROT;CAV1;VHL;ADIPOR1;SOCS3;HGS;PPP2CA
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3455754859420531,0.9015043076102306,0.6070175438596491,0.8719743265935882,1.0,5/38,9.10%,GRN;CYBA;LY86;CD180;SLC15A4
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.3721902321882864,0.9013023955109303,0.6156670746634026,0.8719496164320446,1.0,3/25,3.34%,CALM1;CALM3;CTNNA3
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.36501285309176784,0.9012958019799726,0.6132530120481928,0.871558820511611,1.0,12/30,32.49%,ELOVL1;ELOVL2;TECRL;ELOVL7;ACOT1;ACOT4;ELOVL6;HACD4;ABCD2;ELOVL4;ELOVL5;ACOX1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.4096608834367904,0.9012253053966534,0.6085219707057257,0.8712936319385021,1.0,4/15,20.56%,NLGN1;HAP1;ADRA1A;ZDHHC12
prerank,sphingolipid catabolic process (GO:0030149),0.4069385698351788,0.9011972557038483,0.6078167115902965,0.8709529479817295,1.0,5/15,21.68%,ENPP2;SMPD1;SMPDL3A;ASAH2;SGPL1
prerank,melanosome organization (GO:0032438),0.36640871966460026,0.9009923561462966,0.6195786864931846,0.87095279831772,1.0,5/26,12.70%,BLOC1S4;ABCB6;BLOC1S1;BLOC1S3;BLOC1S5
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.30003223033946924,0.9009259779139619,0.827,0.8706873615657083,1.0,121/497,22.16%,MRPL13;RPS3;HSPA8;PFDN5;RACK1;GAPDH;DBI;RPL13A;CALR;MT3;NDUFA13;TMPRSS6;S100A11;ID3;SOX18;NRG1;ID1;CRYAB;TERF1;EID1;CCDC85B;TNF;PDGFB;NR1D1;ACVRL1;IGFBP5;NCL;SPI1;ENO1;TLE5;CTNNB1;HES1;MAGEL2;EID2;CDKN1C;TBX22;GMNN;ARID4A;TRIM28;FOXL2;CREBZF;CEBPA;PROX1;BASP1;RBM15B;YBX1;IKZF1;MLXIPL;MLX;CDK5R1;SET;JUN;BHLHE41;CTBP1;WNT5A;PCIF1;ATF5;L3MBTL4;ZBTB7A;BCL7A;SOX8;MAEL;SNW1;NCOR2;THRA;KLF4;SOX9;YWHAQ;BMP2;GAS6;FOXS1;HDAC5;ZC3H8;HEXIM1;NONO;L3MBTL1;SAMD11;NR1H2;CDK5;HEY1;ENC1;EIF4A3;DAB2IP;HDAC9;TCEAL7;PAX9;GLIS2;TWIST1;EIF4ENIF1;NANOS2;RLIM;ZHX1;COMMD7;CIR1;EPRS1;QARS1;CCAR2;ZBTB14;LBH;TFAP2B;NOTCH1;BEND5;TGFB1;CITED2;SFRP1;SAMD1;CAPN3;PUS7;CBX3;TFAP4;ID2;DDIT3;SIRT2;SELENOS;IGF2BP3;SUDS3;DACH1;MEN1;PPM1F;REST;EIF4E2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3832987609543659,0.9007543830495485,0.5997521685254027,0.8706219320230784,1.0,4/22,10.02%,MDK;ZFP36L1;EPPK1;ZFP36
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.397272872295363,0.9004128287382442,0.6143958868894601,0.8708820866995124,1.0,2/19,3.71%,CLDN5;TNF
prerank,positive regulation of exosomal secretion (GO:1903543),0.41009484026625576,0.9001445822531521,0.616600790513834,0.8709864276799376,1.0,6/15,26.87%,ATP13A2;SDC4;SDCBP;VPS4A;HGS;SNF8
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2711485606260803,-0.9000283979142091,0.6423841059602649,0.8415988854893017,1.0,6/31,8.06%,BABAM2;OTUD4;OTUD7B;USP50;UIMC1;USP16
prerank,regulation of neurotransmitter transport (GO:0051588),0.40294083110374324,0.9000171473139836,0.5932203389830508,0.8708378672880644,1.0,8/16,31.22%,FLOT1;RIMS1;SYN1;HCRT;MEF2C;KCNMB4;CPLX1;MCTP1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.35710370025015087,0.899812669751368,0.6338862559241706,0.8708222272838655,1.0,10/35,19.48%,KCTD10;RASIP1;STMN3;TNFAIP1;SPRY1;STMN1;DLC1;DAB2IP;KCTD13;SPRY3
prerank,retinoic acid metabolic process (GO:0042573),-0.3257350931561411,-0.8996968589444464,0.5895522388059702,0.8408319564491926,1.0,1/14,2.19%,ALDH1A2
prerank,regulation of cytoplasmic transport (GO:1903649),0.4323880034076884,0.899583400508683,0.623641304347826,0.8708549858790092,1.0,1/11,1.89%,MAPK3
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.36371678133583657,0.8994055691935583,0.6074429771908764,0.8707794541832636,1.0,8/30,15.89%,SCN1A;SCN4B;KCNE4;FGF12;ATP1A1;GJA1;KCNE5;RYR2
prerank,positive regulation of neuron migration (GO:2001224),0.4338197713313001,0.8992493125511853,0.5986394557823129,0.8706751647437991,1.0,4/11,18.74%,MDK;SHTN1;DAB2IP;NSMF
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3159875319251187,0.8991422362262186,0.6617954070981211,0.8704827566977305,1.0,33/94,29.04%,CRIP1;ATF4;HINT1;CHEK2;HIPK2;CEBPB;SELENOK;CD24;BAX;PMAIP1;STK11;BBC3;BAD;ERO1A;DAB2IP;BRSK2;PPP1R15A;DNAJC10;HIC1;POU4F1;BAK1;PYCARD;DDIT3;PPM1F;C1QBP;BOK;CUL2;SCN2A;TRIB3;CDKN1A;TNFRSF1B;PDK2;MCL1
prerank,triglyceride biosynthetic process (GO:0019432),-0.30141950114568683,-0.8990276063924894,0.6,0.8409244487654731,1.0,8/18,26.39%,AGMO;MOGAT3;GPAT3;GK;PNPLA3;LPIN2;DGAT2;LPIN3
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3934579541288358,0.8981367011502263,0.6337662337662338,0.8720420316037893,1.0,13/18,35.50%,CLASP1;BMP2;IER3IP1;DDR2;IL6;TGFB1;COLGALT1;EFEMP2;CLASP2;RGCC;FSCN1;RUNX1;MELTF
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3319854651979121,0.8978931078735525,0.643956043956044,0.8721047183700816,1.0,6/54,12.90%,RPL26;CHEK2;PCBP4;BAX;PCNA;PRMT1
prerank,cellular response to nitrogen compound (GO:1901699),-0.2955484821758946,-0.8975988276215368,0.6036866359447005,0.8429035527871865,1.0,2/20,5.78%,ROCK2;SPIDR
prerank,actin polymerization or depolymerization (GO:0008154),0.3358281223146285,0.8971873358345946,0.6433333333333333,0.8730079961524045,1.0,11/50,13.99%,GSN;CFL1;RAC1;ANG;FAM107A;MICAL1;AIF1;DSTN;MSRB1;FLII;CAPG
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3297769394258011,0.8970511961503405,0.6375545851528385,0.8728493895346745,1.0,25/54,26.05%,HEXA;HYAL2;GUSB;HS3ST6;HS3ST5;SDC4;FUCA1;GPC5;B3GAT3;CLN6;SGSH;NAGLU;UGDH;XYLT1;HPSE;SDC3;HPSE2;HS3ST2;HSPG2;AGRN;HS6ST1;B3GAT1;CHST9;HS6ST2;GPC1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.3552244612797027,0.8965839793366205,0.6212303980699638,0.8733596492034094,1.0,9/32,19.63%,HMOX1;KDR;JCAD;GATA2;KLF4;RHOA;HDAC5;HDAC9;NOTCH1
prerank,regulation of response to interferon-gamma (GO:0060330),0.41557878929932357,0.896519111910835,0.6149659863945578,0.8730798983197376,1.0,5/14,23.58%,HSP90AB1;CDC37;IFNGR1;IFNGR2;SOCS3
prerank,clathrin-dependent endocytosis (GO:0072583),0.37155435332157627,0.8957673291713208,0.6303317535545023,0.8741269080322401,1.0,10/26,15.99%,CANX;SNAP91;AP2M1;CLTC;SIGLEC1;AP2S1;FNBP1L;FCHO1;CLTA;DLL1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.34135654101395135,0.8957524349025991,0.6441073512252042,0.873758728056366,1.0,17/40,24.73%,FZD9;GPM6B;ISG15;CEBPB;NELL1;P2RX7;ATRAID;ATP2B1;TMEM119;BMP2;FBXO5;SLC8A1;TGFB1;MEF2C;PTN;OSR2;CCN1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3946463696885866,0.8957003673571213,0.5957161981258366,0.873469906235843,1.0,3/16,7.19%,PUF60;SRSF9;PQBP1
prerank,positive regulation of cilium assembly (GO:0045724),0.38486804946337716,0.8954702000667134,0.6223958333333334,0.8734906785048363,1.0,5/18,24.76%,KCTD17;HAP1;CCDC88A;CCP110;WRAP73
prerank,chromosome condensation (GO:0030261),0.34302873543554413,0.895465226770384,0.629757785467128,0.8731034404781919,1.0,6/36,13.98%,CSNK2B;GPER1;SET;H1-0;BANF1;NCAPG
prerank,rRNA methylation (GO:0031167),0.37883949218760676,0.8953091873851571,0.6098159509202454,0.8729894534301118,1.0,4/22,12.71%,TRMT112;EMG1;FBL;ZCCHC4
prerank,fatty acid beta-oxidation (GO:0006635),0.3339380980899142,0.8953042471399554,0.6622950819672131,0.8726023532809725,1.0,8/51,13.88%,ACADVL;SCP2;ETFB;MTLN;HSD17B4;ACAT1;ACAA2;CRAT
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.30938201965605594,0.8949900757538989,0.7175257731958763,0.8727926224020893,1.0,23/128,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;DCTN1;SSNA1;HAUS2;DCTN2;ARPP19;CETN2;BRSK2;PRKAR2B
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3525248377486168,0.8948704374940829,0.6431095406360424,0.8725899961020734,1.0,9/33,21.11%,SNRPG;SNRPE;SNRPF;CPSF2;SNRPB;SLBP;SNRPD3;MAZ;CPSF4
prerank,multivesicular body organization (GO:0036257),0.3640727510207533,0.8947844733267711,0.6386255924170616,0.8723571883019692,1.0,16/31,32.41%,CHMP2B;CHMP5;CHMP6;VPS28;CHMP1B;VPS4A;VPS37C;CHMP7;VPS36;CHMP1A;HGS;CHMP4C;SNF8;MVB12A;CHMP4A;CHMP4B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.3252201403093458,-0.8947506020883199,0.5933609958506224,0.8465935672221446,1.0,6/15,10.33%,TNRC6B;DHX36;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.3252201403093458,-0.8947506020883199,0.5933609958506224,0.8465935672221446,1.0,6/15,10.33%,TNRC6B;DHX36;TNRC6C;CNOT1;CPEB3;CNOT7
prerank,CENP-A containing chromatin organization (GO:0061641),-0.26736654503323787,-0.8944358580369232,0.6646341463414634,0.8442718123636449,1.0,15/29,26.05%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.26736654503323787,-0.8944358580369232,0.6646341463414634,0.8442718123636449,1.0,15/29,26.05%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,positive regulation of histone acetylation (GO:0035066),0.3760550346975477,0.894158283011961,0.6075,0.8731666523202957,1.0,8/23,27.17%,MAPK3;PIH1D1;WBP2;PPARGC1A;MUC1;SPHK2;PAXIP1;RUVBL2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2139783317007982,-0.8939152325288623,0.7205882352941176,0.843944507834084,1.0,20/80,16.16%,SNX6;DENND2A;VPS54;SGSM2;VTI1A;SNX12;DENND5A;SPAG9;STX16;ANKFY1;GBF1;TRAPPC10;TBC1D23;TMEM87B;RIC1;SNX2;WASHC1;VPS50;SNX1;HEATR5B
prerank,endothelial cell development (GO:0001885),0.3660448106237328,0.8933854955934456,0.6343195266272189,0.8742290761309526,1.0,11/25,27.34%,SOX18;MYADM;MSN;ROBO4;PECAM1;F2RL1;MARVELD2;CNMD;PDE2A;STC1;RAP1B
prerank,regulation of osteoclast differentiation (GO:0045670),0.34796911704334155,0.8933681001025727,0.6264916467780429,0.8738661974945026,1.0,7/33,19.95%,TNF;CEBPB;GPR137B;PRXL2A;LILRB3;CCL3;POU4F1
prerank,negative regulation of biosynthetic process (GO:0009890),0.3977992448791904,0.893089290512206,0.6136662286465178,0.8740114514339592,1.0,2/16,3.42%,PARK7;GPER1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.35425430931838564,0.8929771969453619,0.6376638855780691,0.8738452672806982,1.0,5/32,7.14%,APOD;ADAM15;ACVRL1;FAM107A;CORO1C
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.4390514085597837,0.8927403553752083,0.6354748603351955,0.8738802404766481,1.0,6/10,35.63%,SIRT2;RCC2;ECT2;SPAG5;APC;KNSTRN
prerank,cardiac myofibril assembly (GO:0055003),-0.3268061595041187,-0.892650075630794,0.6245059288537549,0.8454289019826958,1.0,5/15,17.51%,NEBL;MEF2A;PDGFRB;OBSL1;PDGFRA
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.35865550591166917,0.8924493196069322,0.6322115384615384,0.8740103761467667,1.0,8/29,24.56%,HSP90AB1;ISG15;WNT5A;CDC37;OAS3;PTPN6;PTPN1;METTL3
prerank,monoacylglycerol metabolic process (GO:0046462),0.41487100140493816,0.8922138963432485,0.6207349081364829,0.8740500665982489,1.0,7/13,28.06%,MOGAT2;DGAT2L6;FAAH;DGAT1;ABHD16A;ABHD12;MGLL
prerank,histone H3 acetylation (GO:0043966),0.3415269223334595,0.8917133721971537,0.6322360953461975,0.8745810404402214,1.0,7/40,10.15%,SPI1;BRD1;BRPF1;TAF10;JADE1;TAF5L;TAF9
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.2756590433096459,-0.8916508036034649,0.6451612903225806,0.8461778745142081,1.0,5/26,5.23%,ACTN2;ANK2;FHL1;AKAP9;DLG1
prerank,regulation of metal ion transport (GO:0010959),-0.31204589429905605,-0.891194196948481,0.6340425531914894,0.8457368000589021,1.0,6/16,14.26%,ANK2;SLC30A10;DLG1;IL16;BCL2;STIM1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.38702236645789,0.8906989844312333,0.6227154046997389,0.8760727025908361,1.0,5/19,19.31%,ITGB2;TIRAP;TICAM2;TRIL;CD14
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.41570164161472,0.8900699222255674,0.6306429548563611,0.8768273625833221,1.0,3/14,14.26%,GPER1;ECSCR;CCL2
prerank,positive regulation of integrin activation (GO:0033625),0.4283737135336326,0.8899625296275008,0.6256906077348067,0.876624543077427,1.0,3/11,17.00%,RASIP1;P2RY12;SKAP1
prerank,myelination in peripheral nervous system (GO:0022011),-0.3236363832280132,-0.8897791394832109,0.5916030534351145,0.8475219533538335,1.0,3/13,5.39%,PARD3;SKI;DICER1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.31649678728195346,0.8894779719068384,0.6804670912951167,0.877145526539405,1.0,12/76,14.26%,UBB;LAPTM5;PINK1;FKBP1A;FAM107A;CENPX;PTTG1IP;WFS1;NSMCE3;FBXW7;RIPK2;HSPBP1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4232329275327123,0.8889494177144709,0.6354748603351955,0.8777701185367385,1.0,3/12,16.01%,RAN;SEC14L2;ABCA2
prerank,smoothened signaling pathway (GO:0007224),-0.2572614748031211,-0.8888058015911902,0.6687898089171974,0.8482891966104275,1.0,4/32,2.67%,SMO;CC2D2A;GLI3;GLI2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.3284205728556431,-0.8880274329683754,0.6007751937984496,0.8486354657535163,1.0,2/14,5.55%,MOXD1;DAGLA
prerank,nucleus organization (GO:0006997),0.33500665672447505,0.8880236174661787,0.6637069922308546,0.8791206147259168,1.0,13/47,25.87%,RPS19;CHMP2B;CTDNEP1;CHMP5;CHMP6;CHMP1B;SYNE1;VPS4A;CHMP7;SUN2;SPAG4;CHMP1A;CHMP4C
prerank,positive regulation of signal transduction (GO:0009967),0.2991669780452069,0.8874662703610497,0.7791164658634538,0.8797773988016883,1.0,38/238,13.55%,RPS3;CD74;CD63;VTN;ATP6V0C;MT3;C3;KLF2;NRXN1;NLGN1;TREM2;GPER1;EMP2;PTPRC;SORL1;CAV2;LY86;FLNA;CD180;GRIN1;TNFAIP3;RIMS2;RIMS1;CLEC6A;P2RY6;KLK6;LGR6;JCAD;ZDHHC5;PIH1D1;HAP1;ULK3;BAX;ATP6AP2;SNW1;BMP2;PDCL;GAS6
prerank,negative regulation of autophagy (GO:0010507),0.3265534269863371,0.8872855135311437,0.6511627906976745,0.8797165135983406,1.0,9/54,11.66%,MT3;AKT1;EIF4G2;TREM2;PINK1;RASIP1;NUPR1;MTMR9;CTSA
prerank,regulation of cellular metabolic process (GO:0031323),0.3406798430257127,0.8872155389772791,0.6651634723788049,0.8794474656924823,1.0,17/45,28.38%,NPC2;PINK1;FLOT1;ABCG1;FASN;NCOR2;ARF1;ARF4;ABCA2;BCO2;STUB1;MPV17;ACLY;FOXM1;EIF6;MBOAT7;PDK2
prerank,nuclear transport (GO:0051169),0.3948376089494404,0.8869513044707681,0.6345903771131339,0.879542549012817,1.0,4/16,11.38%,NPM1;RBM15B;XPO1;BANF1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.36649357540056265,0.8868468127477104,0.6299019607843137,0.879356684003679,1.0,5/25,16.62%,ITGB2;CTNNA3;NINJ1;JAM3;VCAM1
prerank,circulatory system development (GO:0072359),0.30994777113481164,0.8864984473466472,0.7297019527235354,0.8796156312796541,1.0,32/118,21.14%,CRIP1;RAMP2;PRICKLE4;SOX18;RBP4;ERBB4;PDGFB;ACVRL1;APLNR;FN1;COL3A1;FGF12;SOX17;KDM6B;FLT4;SOX9;FBXW7;BMP2;STK11;HEY1;HDAC9;CDH5;TCF25;ERBB3;NOTCH1;HSPG2;TGFB1;POU4F1;CITED2;MEF2C;CACYBP;ID2
prerank,endodermal cell differentiation (GO:0035987),0.355550716942261,0.8863670654060989,0.6430260047281324,0.8794787021204669,1.0,4/31,8.22%,VTN;ITGB2;FN1;COL6A1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4120201142773947,0.8861549245555294,0.6270491803278688,0.8794651524530335,1.0,3/14,8.69%,AKT1;MTLN;MFSD2A
prerank,cell cycle G2/M phase transition (GO:0044839),0.3057064711257385,0.8858956698363448,0.7386831275720165,0.8795304116573607,1.0,23/129,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CLASP1;YWHAG;TUBB4A;CEP131;DCTN1;SSNA1;HAUS2;DCTN2;ARPP19;CETN2;BRSK2;PRKAR2B
prerank,regulation of response to oxidative stress (GO:1902882),0.43092686354180265,0.8856447847366699,0.6260869565217392,0.879605620772058,1.0,5/11,31.22%,PINK1;SELENON;HEBP2;GGT7;MCTP1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.32804840942139085,-0.8849365179999242,0.5927601809954751,0.8541579050131202,1.0,3/13,8.79%,PLXNA2;NRP1;NRP2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.387438737770346,0.8844677304698756,0.644955300127714,0.8813696784962762,1.0,2/18,3.97%,COX17;COA3
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.2762973244118829,-0.8840219209006434,0.6745283018867925,0.854706996019683,1.0,8/23,21.33%,PAFAH1B1;UBXN2B;FBXW11;NUMA1;NDEL1;MAD2L1;MISP;NDC80
prerank,leukotriene metabolic process (GO:0006691),0.38020798070402406,0.8838692487579459,0.6434892541087232,0.882024832325412,1.0,4/19,17.02%,DPEP2;MGST3;ALOX5AP;LTC4S
prerank,response to sterol (GO:0036314),0.42442184648005793,0.8831444650715414,0.6137339055793991,0.8829540435020521,1.0,5/11,23.22%,CCR5;ABCA2;CCL3;TGFB1;PMVK
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.32431854252545605,-0.8829990635829632,0.6096654275092936,0.8555731446147852,1.0,1/14,0.47%,ZEB1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.31447823409955966,-0.882996462720851,0.6245210727969349,0.854080701225063,1.0,4/14,15.20%,AUTS2;KMT2A;SMAD4;PRDM9
prerank,axon extension (GO:0048675),0.3708827308179914,0.8828013313104486,0.6465408805031446,0.883185263263953,1.0,3/23,3.78%,HSP90AA1;HSP90AB1;SEMA3F
prerank,microtubule polymerization (GO:0046785),0.35238495796068214,0.8824202749423915,0.627497062279671,0.8835048478744583,1.0,4/28,8.71%,TPPP3;PIN1;CLASP1;MAPT
prerank,lysosome localization (GO:0032418),0.34667997653664157,0.8819672505254732,0.6631823461091754,0.8839400196751827,1.0,17/37,34.88%,S100A13;PIP4P1;BLOC1S1;CHGA;DEF8;TMEM106B;PIK3CD;BORCS5;HPS6;BLOC1S2;BORCS6;RAB3A;RAB34;LAMTOR1;MILR1;KLC2;ARL8B
prerank,nuclear membrane reassembly (GO:0031468),0.3291498982405391,0.8819497306657197,0.668141592920354,0.8835770699921631,1.0,24/54,32.41%,RAN;PPP2R1A;CHMP2B;CHMP6;BANF1;NUP85;CC2D1B;LMNA;RANGAP1;VPS4A;CHMP7;SIRT2;RCC1;VRK1;KPNB1;CHMP4C;NUP205;NUP188;PPP2CA;NSFL1C;NUP43;SEH1L;CHMP4A;CHMP4B
prerank,regulation of axon guidance (GO:1902667),0.4352797416269646,0.8815091268613481,0.6336206896551724,0.883998379818851,1.0,3/10,15.81%,TUBB2B;ZSWIM8;YTHDF1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3457056711710731,0.8811420130363323,0.6576151121605667,0.8842684908554774,1.0,13/35,24.36%,ZFP36L1;SPI1;HSPA1B;BRD1;ZFP36;PRMT1;HSPA1A;ABCB10;MAPK11;INHBA;HSPA9;MAFB;ANKRD54
prerank,mitochondrial fission (GO:0000266),0.3923508554670318,0.8809817518488828,0.6286472148541115,0.8841757675583188,1.0,7/16,23.34%,DNM3;GDAP1;MFF;DNM1L;FIS1;DNM1;MTFR1L
prerank,protein-containing complex assembly (GO:0065003),0.29391297476195655,0.8804282193601818,0.8096192384769539,0.8847893711466167,1.0,61/259,21.72%,CD74;CHCHD10;CTSZ;ELOB;CXCL12;LAMC1;SLC2A1;CSNK2B;TNF;TAPBP;PPP2R1A;CTNNB1;IL2RB;HES1;AP2M1;ADD2;FN1;OTX2;TRAPPC2L;LMAN1;TRAPPC5;RIMS1;TRAPPC1;TMED2;P2RX7;CAPZA2;RBX1;VAMP3;VAMP2;PDCD6;GRIA1;SOX9;MAGI1;TNFRSF1A;TSPAN4;CAPG;MCFD2;TIAM1;SPG7;BAD;PDE4DIP;DMTN;NAPA;ADCY8;DNM1L;PPARGC1A;RBBP5;TRAPPC3;CTSC;EPRS1;LPXN;SKP1;IL1RAP;CAPN3;TFAP4;MYC;COL7A1;TMED10;COL16A1;TGFA;MEN1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.409351147400148,0.8803407277206269,0.6229508196721312,0.884553234967289,1.0,2/14,7.06%,PCBP4;SRSF9
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3187162539904443,0.8800988785255555,0.6814254859611231,0.8845877012102383,1.0,13/65,16.24%,AKT1;AGT;GPER1;DUSP3;SH3GL2;PTK6;EPN1;ARHGEF7;HAP1;SPRY1;CCDC88A;SH3KBP1;DAB2IP
prerank,regulation of postsynapse organization (GO:0099175),0.35895037833059773,0.8800283183367197,0.665868263473054,0.8843319729551494,1.0,8/28,15.69%,CFL1;IL1RAPL1;PPFIA2;CDK5R1;ABHD17A;WNT5A;SRCIN1;CDK5
prerank,cellular response to amino acid stimulus (GO:0071230),0.343363562718369,0.8795455600696402,0.63572267920094,0.8848225228395746,1.0,9/33,18.74%,LAMTOR2;LAMTOR4;LAMTOR5;GLRA2;GLRA1;LAMTOR3;RRAGC;RRAGD;NSMF
prerank,regulation of gene silencing by RNA (GO:0060966),0.3277851800684729,0.8794313857629401,0.6530386740331492,0.8842549661006341,1.0,12/50,21.12%,H3-3A;POLR2E;POLR2D;POLR2F;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;RAE1;POLR2H
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3277851800684729,0.8794313857629401,0.6530386740331492,0.8842549661006341,1.0,12/50,21.12%,H3-3A;POLR2E;POLR2D;POLR2F;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;RAE1;POLR2H
prerank,protein hydroxylation (GO:0018126),-0.30766119487122795,-0.8792943381903523,0.6557377049180327,0.8609232206695892,1.0,2/15,5.98%,PLOD2;ASPH
prerank,positive regulation of MAP kinase activity (GO:0043406),0.32042711927123474,0.8790188053664333,0.6852248394004282,0.8845860431574085,1.0,15/66,19.83%,RPS3;TNF;PDGFB;PAK1;CD24;HRAS;NEK10;TLR6;PDGFA;RASGRP1;DAB2IP;FLT1;EDN3;FLT3;TGFB1
prerank,hexose transmembrane transport (GO:0008645),0.3714370032265024,0.8785825570592264,0.6354556803995006,0.8849845677269836,1.0,4/21,18.03%,SLC2A1;SLC50A1;SLC2A2;SLC2A3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.34340145481947026,0.8781179534510409,0.6767091541135574,0.8854349238010241,1.0,8/38,13.96%,TOMM7;PINK1;UBL5;ATP5IF1;LMAN1;LEPROT;FBXW7;RHOU
prerank,nucleotide biosynthetic process (GO:0009165),0.38962940724597683,0.8780543282244123,0.6508951406649617,0.8851740096627139,1.0,7/18,27.35%,GART;PNP;PRPS1L1;PRPS1;PRPSAP1;ADSL;RRM2B
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.4235552370688882,0.8780097176070268,0.6395663956639567,0.8848676514525681,1.0,2/11,6.44%,SORL1;MSN
prerank,inorganic cation import across plasma membrane (GO:0098659),0.31598247897138537,0.8775857342531008,0.6948968512486428,0.8852076294834691,1.0,14/75,17.76%,SLC24A2;SLC39A10;KCNJ10;ATP1A3;ATP1B2;SLC12A5;TRPM2;ATP1A4;ATP1A1;KCNK9;ATP1B1;SLC8A1;ATP1B3;SLC9A9
prerank,regulation of mitochondrion organization (GO:0010821),0.33260165937326525,0.877549087628799,0.6784922394678492,0.8848860291698047,1.0,12/47,17.36%,TREM2;PINK1;OMA1;MAPT;ATP13A2;FBXW7;MIEF2;MFF;TMEM102;SQSTM1;DNM1L;PPARGC1A
prerank,positive regulation by host of viral transcription (GO:0043923),0.38778486438874055,0.8775182040736302,0.6535433070866141,0.8845543858318415,1.0,4/15,12.39%,NUCKS1;RRP1B;JUN;SNW1
prerank,organelle organization (GO:0006996),0.293964694594086,0.8771797202345841,0.853,0.8847615686051155,1.0,81/388,20.79%,APOE;PPIA;CHCHD10;ATP5F1B;MDK;CHCHD2;CFL1;PARK7;PINK1;CNN2;MAST3;LMAN2;PACSIN1;AUP1;ATP8B4;CAV2;BSCL2;PARP1;CHMP2B;PLAAT3;REEP5;BAG5;TNFAIP3;TMED7;LMAN1;SAR1A;RAB14;TSPO2;SURF4;REEP6;HSD17B13;TMED2;CLASP1;MAST1;THY1;TICAM2;MICAL1;TMED3;ARHGEF7;ARAP3;CHMP5;CHMP6;CHGA;TMED9;FNBP1L;ARL1;TMED1;SEC61A1;SNX11;VMP1;DES;RHOU;CCL2;MIEF2;SORT1;ZMYM3;PEX6;YTHDF1;CHMP1B;SH3KBP1;DMTN;ATAD3A;CCL3;CAV1;DNM1L;SYNE1;LNPK;PPARGC1A;FMNL3;KIF5C;STX4;VPS4A;RAB18;RAB31;HPS6;MAPK15;VAPA;CFAP410;MYC;CHMP7;PAK5
prerank,response to glucose (GO:0009749),0.3285316113615899,0.8771013911085754,0.672645739910314,0.8845132536850382,1.0,12/46,21.40%,RACK1;GPER1;PFKL;GYS2;LPL;VAMP2;GAS6;MAFA;ADCY8;EIF2B5;KHK;SELENOS
prerank,tRNA methylation (GO:0030488),-0.2531981644658031,-0.8769187600650318,0.684931506849315,0.8647421542725015,1.0,10/34,14.41%,TRMT13;NSUN6;ALKBH8;THADA;THUMPD3;TRMT5;FTSJ1;TRMO;PRORP;TRMT1L
prerank,chromatin remodeling at centromere (GO:0031055),-0.2550192088829775,-0.8762714151147133,0.7371794871794872,0.8647131985924092,1.0,15/31,26.05%,SMARCA5;HJURP;NASP;CENPC;CENPT;CENPK;RSF1;CENPU;CENPI;CENPH;MIS18BP1;MIS18A;ITGB3BP;CENPQ;OIP5
prerank,nuclear membrane organization (GO:0071763),0.37841231552377247,0.8758526027623107,0.6434892541087232,0.8863688203418769,1.0,6/19,22.40%,GPER1;TARDBP;DCTN1;VPS4A;CHMP7;TMEM43
prerank,regulation of synapse organization (GO:0050807),0.3578675292504687,0.8756478636476184,0.6432889963724304,0.8863373754836641,1.0,7/26,13.60%,CTNNA2;TNF;KLK8;IL1RAPL1;ABHD17A;WNT5A;YWHAZ
prerank,embryonic organ development (GO:0048568),0.31807357946143605,0.8755799913307736,0.6941431670281996,0.8860762414660363,1.0,12/61,11.29%,RPL10;ATF4;SOX18;RBP4;NES;TNF;NDRG4;RARRES2;KDR;MFSD2A;KITLG;SOX17
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.35189049863684657,-0.8755335675643764,0.5955414012738853,0.8649161003534371,1.0,2/10,9.45%,ATP7A;THAP4
prerank,T-helper cell differentiation (GO:0042093),-0.3155565552941988,-0.8753003229703793,0.6382978723404256,0.8639438800707295,1.0,2/14,6.77%,FOXP1;ATP7A
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4241223162185384,0.874913539066567,0.6671428571428571,0.8868831574332098,1.0,3/11,21.02%,VSIR;HMGB1;TWSG1
prerank,regulation of extracellular matrix organization (GO:1903053),0.4011792323102241,0.8743772668735283,0.6452036793692509,0.8874774357142811,1.0,5/15,19.63%,AGT;AEBP1;TIE1;DDR2;NOTCH1
prerank,microtubule depolymerization (GO:0007019),0.3826380711064001,0.8740353259062017,0.6287581699346405,0.8877002696795632,1.0,7/17,32.84%,STMN3;STMN4;STMN1;NCKAP5;CCSAP;STMN2;KATNB1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.398788018738218,0.8739711493866666,0.6604026845637584,0.8874218504359617,1.0,4/15,19.83%,TNF;CUEDC2;LILRB1;TGFB1
prerank,glycerophospholipid metabolic process (GO:0006650),0.31202616355223284,0.8732925443425308,0.6986155484558041,0.888251170528889,1.0,22/75,26.51%,SERINC1;PRDX6;PIGZ;PIGQ;DGKH;PLA2G7;PLA2G4F;CSF1R;GDE1;SERINC5;GPCPD1;CPNE6;GDPD1;DPM2;ENPP6;PGP;GDPD3;PLA2G3;ABCA3;ABHD12;CPNE3;PLA2G6
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3645264583199256,0.8726309636585279,0.673697270471464,0.8890562063081202,1.0,7/23,23.30%,ERBB4;TNF;HES1;NOTCH1;IL6;IL10RB;PRLR
prerank,determination of left/right symmetry (GO:0007368),-0.24643428111463406,-0.872611304501694,0.7338129496402878,0.8685433555501344,1.0,20/36,32.03%,SMO;GALNT11;OFD1;NPHP3;CCDC39;RFX3;CFAP53;PKD2;DAND5;ODAD2;ODAD3;FOXJ1;ODAD4;KIF3B;MKKS;CCDC40;DNAAF4;STIL;PKD1L1;BBS7
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.38385185906359814,0.8725969843994691,0.6383526383526383,0.8887180582672863,1.0,2/17,3.71%,CLDN5;TNF
prerank,myeloid cell development (GO:0061515),-0.28745996130627693,-0.8725082905989427,0.65,0.8672575622984715,1.0,1/18,0.16%,FOXP1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3716244267442165,0.8725037397576174,0.6520618556701031,0.8884803284138804,1.0,2/21,4.78%,AGXT;NUDT19
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.33505564680247546,-0.8721096683091617,0.6283524904214559,0.8666491231592514,1.0,2/12,4.54%,SORBS1;IRS1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.2945624107843219,-0.872014113989906,0.6200873362445415,0.8653885535733553,1.0,6/18,13.89%,OGA;ADAMTS9;NGLY1;STT3B;DERA;MANBA
prerank,negative regulation of receptor internalization (GO:0002091),0.4140081205072691,0.8716987538139624,0.6372549019607843,0.8895249822682257,1.0,4/12,15.36%,LRPAP1;UBQLN2;SDCBP;ANKRD13D
prerank,cellular response to alcohol (GO:0097306),-0.24571997439011187,-0.8707622470862939,0.7338709677419355,0.8666183889646796,1.0,7/42,5.78%,ADCY1;SMO;ADCY5;LRP6;GRAMD1C;LARP1;SPIDR
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.38966203868204047,0.8702208039821532,0.633377135348226,0.89175243243369,1.0,4/15,15.99%,S100A1;PKM;KLF4;DLL1
prerank,positive regulation of hemostasis (GO:1900048),-0.3403338768797174,-0.8699636010086244,0.6173285198555957,0.8653636252387018,1.0,1/10,1.41%,ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),-0.3403338768797174,-0.8699636010086244,0.6173285198555957,0.8653636252387018,1.0,1/10,1.41%,ST3GAL4
prerank,Golgi to endosome transport (GO:0006895),-0.2974474524686216,-0.8695979677548339,0.6428571428571429,0.8646592146769699,1.0,4/16,10.18%,VPS13A;MON2;GBF1;KIF16B
prerank,protein homooligomerization (GO:0051260),0.299990384700878,0.8695882306045497,0.7232510288065843,0.8924537428261151,1.0,23/114,21.10%,ALDOA;B2M;AQP4;SLC1A2;MPP2;MIF;STEAP4;ALAD;NINJ1;TRPM2;RS1;PRMT1;GLS;ALOX5AP;EHD1;G3BP2;HCN1;ADCY8;GLRA3;PKD2L1;SHMT2;PYCARD;KCNC2
prerank,mitotic nuclear division (GO:0140014),-0.21172720198619957,-0.8694573953277491,0.8070175438596491,0.8634842480114865,1.0,30/71,23.71%,EPS8;STAG1;LSM14A;KLHDC8B;PIBF1;OFD1;GOLGA2;INO80;CENPK;AAAS;NDEL1;DSN1;KIF2A;KLHL22;CCDC61;SMC4;MISP;TPX2;KIF18B;CEP192;ARHGEF10;ABRAXAS1;NUP62;NDC80;TUBG1;SMC1A;MIS12;MAP9;SGO1;SMC3
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.32613420136923094,-0.8693962882908304,0.6029411764705882,0.8621340644377143,1.0,1/14,0.28%,SULF1
prerank,glycogen metabolic process (GO:0005977),0.3560121154279395,0.8693741659782298,0.6534653465346535,0.892444575494034,1.0,5/27,10.43%,CALM1;NR1D1;GYS2;NHLRC1;GAA
prerank,nucleotide metabolic process (GO:0009117),0.3690667772188636,0.8693631265878558,0.6678700361010831,0.8920746646189943,1.0,6/23,18.08%,PARK7;AK4;PNP;NME2;CMPK2;GUK1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.3631332279309405,0.8692793128436223,0.6466165413533834,0.8918348068468717,1.0,8/24,19.83%,C3;ATF4;FLT4;HPSE;GATA4;CXCL17;IL6;TGFB1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.33170899212922456,0.8691943268585651,0.6760089686098655,0.8915857755578518,1.0,7/45,13.19%,RPL10;GRM5;METAP1;MEX3D;PCIF1;RBM4B;METTL18
prerank,positive regulation of viral genome replication (GO:0045070),0.34970345703713623,0.868693056217012,0.669501822600243,0.8920677489590242,1.0,5/29,13.84%,PPIA;IFIT1;DDB1;PABPC1;PDE12
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.37873878115526266,0.8678986768256207,0.6399491094147582,0.893124637146267,1.0,6/18,18.75%,KCTD10;RASIP1;TNFAIP1;STMN1;DLC1;KCTD13
prerank,negative regulation of protein localization to membrane (GO:1905476),0.36481231442536055,0.8677882735261665,0.646551724137931,0.8929303205184037,1.0,9/24,21.18%,TMEM59;AP2M1;CLTC;GDI1;RSC1A1;DMTN;TMBIM1;TGFB1;PPP2R5A
prerank,cellular response to interleukin-2 (GO:0071352),0.4126155165151578,0.8674050032166842,0.6458923512747875,0.8928384266560615,1.0,4/11,17.99%,IL2RB;IL2;IL2RG;SYK
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.4126155165151578,0.8674050032166842,0.6458923512747875,0.8928384266560615,1.0,4/11,17.99%,IL2RB;IL2;IL2RG;SYK
prerank,negative regulation of GTPase activity (GO:0034260),-0.28204212083035535,-0.8671169081251152,0.6772486772486772,0.8655443355350511,1.0,3/22,2.28%,LRRK2;BCAS3;ARFGEF1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3533101903060029,-0.8669825751088267,0.6195286195286195,0.8643335253245913,1.0,2/10,10.54%,INO80;SSBP1
prerank,sodium-independent organic anion transport (GO:0043252),0.4231042862221702,0.866888082895742,0.6397774687065368,0.8933638920415428,1.0,4/10,19.96%,SLCO1C1;SLCO4C1;MFSD10;SLCO1B1
prerank,cognition (GO:0050890),0.3331118664898814,0.866811347602742,0.681868743047831,0.8931026224059975,1.0,13/42,20.74%,GRM5;SLC1A4;TNF;C5AR1;CHMP2B;FAM107A;MFSD2A;CHRNA4;MAGT1;CBR3;PTCHD1;JAKMIP1;GPR155
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3313292215869148,0.8662550190431414,0.665911664779162,0.8936695931786801,1.0,13/39,27.24%,ADAM15;SPOCK1;CORO1C;RHOA;DMTN;NOTCH1;PTPRO;RCC2;AP1AR;TBCD;CX3CL1;MYOC;CORO2B
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.3560020767793174,-0.866200487480918,0.6134751773049646,0.8645533398223249,1.0,5/10,16.50%,DICER1;DROSHA;TERT;TARBP2;AGO2
prerank,regulation of JNK cascade (GO:0046328),0.30061159864785914,0.8661793245084715,0.727743271221532,0.8934033198979172,1.0,33/101,25.74%,CCL19;PINK1;DUSP3;TIRAP;SIRPA;ANKRD6;HIPK2;CCN2;HMGB1;FLT4;HRAS;PHLPP1;MAPK8IP1;SDCBP;F2RL1;TRAF3;MAPK8IP2;RASGRP1;EPHB1;NCF1;DAB2IP;MAP4K2;LTBR;PYCARD;GADD45A;MEN1;WNT7A;DUSP15;UNC5CL;APP;AGER;MFHAS1;FKTN
prerank,sister chromatid segregation (GO:0000819),-0.25953289318889333,-0.8652573589347704,0.7204968944099379,0.8651648010856674,1.0,16/31,28.90%,TOP2B;INO80;CENPK;DSN1;KLHL22;SMC4;KIF18B;NDC80;TUBG1;SMC1A;MIS12;SGO1;PLK1;TUBG2;CDCA8;KIFC1
prerank,cell part morphogenesis (GO:0032990),-0.32756301522201436,-0.8647164416494791,0.6541095890410958,0.8648569764338077,1.0,2/13,3.98%,PID1;PACSIN2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3658743038173419,0.8647017599416096,0.6454081632653061,0.8955533171844144,1.0,9/22,27.10%,DYNLL1;CDKN1C;PRKRIP1;INHBA;CDA;TESK1;CDKN2B;INHA;CDKN1A
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.36013309750056066,0.8644810645982397,0.6636942675159235,0.8955513418107736,1.0,2/23,2.58%,CALM1;CALM3
prerank,replicative senescence (GO:0090399),0.4132797991931441,0.8643841895107682,0.6407103825136612,0.8953299973346851,1.0,2/12,4.36%,ROMO1;CHEK2
prerank,cranial nerve development (GO:0021545),0.416855329456272,0.8638931238506159,0.6469740634005764,0.8957984810415635,1.0,3/11,19.95%,TMEM126A;ERBB3;POU4F1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.34940540600091036,-0.8635367458466252,0.6051660516605166,0.8659484920331343,1.0,3/10,16.08%,OGT;DGKQ;SIRT7
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3810197872299878,0.8633634620848742,0.6736020806241872,0.8963581280023832,1.0,7/18,23.18%,CRH;CHGA;SFRP1;INHBB;CCN3;REST;PSMD9
prerank,regulation of cellular senescence (GO:2000772),0.34823982475119875,0.8631048088530925,0.6603995299647474,0.8964125889023367,1.0,4/28,8.92%,B2M;YPEL3;VASH1;YBX1
prerank,modified amino acid transport (GO:0072337),0.39192889116493196,0.8629367837532762,0.6608344549125168,0.8963238339447596,1.0,4/15,15.31%,SLC1A4;MGST1;SLC19A1;FOLR2
prerank,wound healing (GO:0042060),0.3121905137313757,0.8627552227976577,0.7006437768240343,0.896223724789681,1.0,18/62,19.08%,HMOX1;NRG1;PLEC;PAK1;SYT11;COL3A1;EPPK1;SMPD1;WNT5A;SLC11A1;EVPL;PDGFA;HPSE;EPB41L4B;GATA4;ERBB3;ANXA6;PPP3CA
prerank,negative regulation of cell junction assembly (GO:1901889),0.3537152649831654,0.8610464469553092,0.6776556776556777,0.8988051367516546,1.0,9/25,16.96%,APOD;TNF;ACVRL1;FAM107A;CORO1C;ROBO2;DLC1;DMTN;SLIT1
prerank,negative regulation of defense response to virus (GO:0050687),-0.35217589034995866,-0.8609884233271438,0.5971223021582733,0.8699938957117522,1.0,3/10,15.47%,ITCH;ILRUN;TARBP2
prerank,respiratory chain complex IV assembly (GO:0008535),0.36620119810684654,0.8609255446603384,0.6839506172839506,0.8986308517423751,1.0,2/21,3.97%,COX17;COA3
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4163334966286174,0.8608994039197196,0.658008658008658,0.8982850462766448,1.0,3/11,19.63%,RGS2;LMNA;NOTCH1
prerank,nucleosome assembly (GO:0006334),0.33966729779275157,0.860763204897229,0.6615384615384615,0.8981339624186726,1.0,6/31,16.59%,H3-3A;NPM1;BRD2;SOX9;IPO4;NAP1L2
prerank,lipid phosphorylation (GO:0046834),0.4236482429918422,0.8606888962219122,0.6657342657342658,0.8978664081904975,1.0,6/10,30.97%,DGKH;DGKI;DGKK;DGKB;DGKZ;DGKG
prerank,regulation of cilium assembly (GO:1902017),-0.21689167790809788,-0.8601661784034053,0.75,0.8702878854508602,1.0,11/62,12.10%,DCDC2;TBC1D19;YAP1;USP6NL;TBC1D2B;RABGAP1;TBC1D9B;IFT88;CEP97;SDCCAG8;IFT140
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3112188068465656,0.8598316203973524,0.7107258938244854,0.8989356232791369,1.0,12/66,14.26%,GPNMB;PSME1;AKT1;PSME2;CCND2;FAM107A;CCND1;JADE1;CDK2AP2;AIF1;KLF4;CCL2
prerank,organophosphate biosynthetic process (GO:0090407),0.3330221916432485,0.8596885888884824,0.684393063583815,0.8988030262363877,1.0,8/37,18.57%,TPI1;FADS1;GPHN;PCYT2;PNPO;AGPAT5;TKT;IP6K1
prerank,acyl-CoA metabolic process (GO:0006637),0.3336803312461252,0.8592514404154576,0.6947115384615384,0.8992038509337346,1.0,8/35,21.99%,DBI;OXSM;ACOT1;ACOT7;GLYAT;ACOT4;THEM4;ACSM5
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.23033427725887534,-0.8591148653286872,0.7226890756302521,0.8710553924630421,1.0,12/43,16.93%,EGFR;SNX6;CBLB;ERRFI1;PTPN3;STAM2;RNF115;PTPN2;SOCS5;GPRC5A;STAM;EPS15L1
prerank,ethanol metabolic process (GO:0006067),-0.31595939538138595,-0.8588588826237092,0.6288659793814433,0.8701168652201189,1.0,1/12,1.42%,ALDH1A1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4272962104864537,0.8585622235778916,0.6606896551724138,0.8999956992990694,1.0,1/10,1.76%,PARK7
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.32327621360379094,0.8583947723493254,0.6951080773606371,0.8999066565135505,1.0,15/44,27.61%,AKAP6;FLNA;KCNJ10;ATP1B2;KCNN2;KCNE5;ATP1B1;ATP1B3;KCNMA1;GABBR2;KCNJ3;KCNJ6;KCNN4;KCNMB4;KCNQ1
prerank,tyrosine metabolic process (GO:0006570),-0.3412275948295964,-0.8580350600300866,0.6459016393442623,0.8704545715654951,1.0,3/11,24.98%,THAP4;GSTZ1;HGD
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.24895215229872703,-0.8579219230412739,0.7181208053691275,0.869235024419865,1.0,4/32,6.44%,AUTS2;PLCE1;CARMIL1;NCKAP1
prerank,neurotrophin signaling pathway (GO:0038179),-0.2793994204950685,-0.8577216833703203,0.6901408450704225,0.868228822767357,1.0,7/21,15.41%,RAPGEF2;FRS2;RAPGEF1;NGF;KIDINS220;CASP3;BDNF
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.375916890426236,0.8576503665958611,0.6695652173913044,0.9007893721839998,1.0,2/18,6.44%,MAPK3;MSN
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3841543597853335,0.8572254602713807,0.6555407209612817,0.9011128270218136,1.0,2/15,12.50%,IDO2;QDPR
prerank,gland development (GO:0048732),0.3158510464846093,0.8572059232787357,0.7259978425026968,0.9007531302725456,1.0,9/59,13.00%,MDK;SOD1;NRG1;HES1;MSN;CEBPA;PROX1;LSR;SOX9
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.38796140269831686,0.8567868677776639,0.6558265582655827,0.9010889453395079,1.0,4/15,17.36%,MID1IP1;MLXIPL;NR1H2;PPARGC1A
prerank,DNA modification (GO:0006304),0.3656812077870486,0.8566660530098164,0.7004950495049505,0.9009121286458815,1.0,6/22,21.52%,TERF1;PARP1;NEIL1;NEIL2;TERF2IP;EXOSC4
prerank,phosphatidic acid metabolic process (GO:0046473),-0.22705159902450295,-0.85659088494558,0.7339449541284404,0.8692135836493365,1.0,11/48,21.01%,PLD1;PLA2G4A;DGKA;DGKQ;DDHD2;AGPAT4;GPAT3;ABHD5;GPD1;PLD2;PNPLA3
prerank,positive regulation of stem cell proliferation (GO:2000648),0.38088926446570964,0.8558613257604506,0.6892950391644909,0.9019123302963211,1.0,5/17,20.03%,PTPRC;GJA1;HNRNPU;SOX11;THPO
prerank,regulation of pH (GO:0006885),0.41132040481393295,0.8557553611633737,0.6699576868829337,0.9017033693444908,1.0,3/11,11.96%,ATP6AP1;SLC26A4;ATP1A4
prerank,response to cholesterol (GO:0070723),-0.29597487176701376,-0.8549464863453765,0.6275303643724697,0.8712698973601917,1.0,4/17,5.54%,SMO;LRP6;GRAMD1C;TGFBR1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.36618562408405536,0.8547285141181798,0.6679438058748404,0.9030632262182956,1.0,3/19,17.05%,PNPLA2;MTLN;TWIST1
prerank,Ras protein signal transduction (GO:0007265),0.2910502553435164,0.8545306338627301,0.7833163784333672,0.9030042777582266,1.0,28/137,15.62%,ARHGDIA;CFL1;PARK7;RHOB;RAC1;ELMO1;ARHGDIB;SHC3;RHOG;ADGRG1;TRIM28;NTN1;JUN;GRAP;ARHGDIG;RASGRP3;GDI1;HRAS;AIF1;COL1A2;RHOA;SHTN1;RRAS;TIAM1;G3BP1;MAPK11;G3BP2;RASGRP1
prerank,cardiac muscle cell action potential (GO:0086001),0.34804926363420263,0.8544125750493308,0.6752136752136753,0.9028085473613506,1.0,7/30,15.37%,SCN1A;YWHAE;SCN4B;FGF12;ATP1A1;ATP1B1;SLC8A1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4088422038026913,0.8543759015179836,0.6662087912087912,0.9020925813582622,1.0,4/12,22.68%,CORO1C;DMTN;RCC2;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4088422038026913,0.8543759015179836,0.6662087912087912,0.9020925813582622,1.0,4/12,22.68%,CORO1C;DMTN;RCC2;AP1AR
prerank,regulation of transferase activity (GO:0051338),0.3728102102554345,0.8543683162588445,0.6503225806451612,0.9017176653014999,1.0,3/17,7.78%,EMP2;BAG5;FEM1A
prerank,establishment of endothelial barrier (GO:0061028),0.342563648657622,0.8542308530612935,0.6897374701670644,0.901559281088738,1.0,6/29,14.62%,SOX18;MYADM;MSN;ROBO4;PECAM1;F2RL1
prerank,organelle disassembly (GO:1903008),-0.2481071272208048,-0.8539772540853873,0.6993464052287581,0.8718355015321191,1.0,8/33,12.61%,UFL1;ATG2B;GOLGA2;RB1CC1;GBF1;ATG2A;KLC1;ULK2
prerank,negative regulation of blood pressure (GO:0045776),0.3902083685102622,0.8535173306869253,0.6467315716272601,0.9024011949548931,1.0,3/13,23.55%,GPR37L1;NOS2;PRCP
prerank,tRNA processing (GO:0008033),0.31369181414164404,0.8525011644271427,0.7242489270386266,0.9037451791908035,1.0,19/61,25.96%,METTL1;ELAC2;SARS1;KARS1;AARS2;POP7;RTRAF;TSEN15;RTCB;CTU1;TSEN54;CPSF4;ADAT2;URM1;TRNT1;THUMPD1;TRMT10C;CTU2;LCMT2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.30446504448375866,0.8519243304792947,0.7326943556975506,0.9043569433253373,1.0,20/70,26.70%,GABARAP;DCC;TNF;P2RX7;TNFSF12;BAX;TNFRSF1A;SORT1;BAD;DAB2IP;SIVA1;ERBB3;INHBA;TGFB1;BAK1;IFI27;BLOC1S2;BOK;FGFR3;TGFB2
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3563411285289586,0.8511771917492387,0.6736196319018405,0.9052287737006584,1.0,6/21,21.50%,PPP1CA;CTNNB1;FRAT2;CAV1;FZD2;FZD1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.30576805684469177,0.8507456209893554,0.7286486486486486,0.9055571505923778,1.0,10/62,12.82%,ELOB;POLR2E;ELOF1;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;SSRP1;POLR2K
prerank,positive regulation of cyclase activity (GO:0031281),0.3903123329030104,0.8506735966044449,0.6822429906542056,0.9052880267400497,1.0,4/14,17.56%,MAPK3;DRD5;ORAI1;NOS2
prerank,prostanoid metabolic process (GO:0006692),0.3983640087404475,0.850101424632412,0.6813186813186813,0.9058955690381858,1.0,2/13,13.37%,GSTM1;HPGDS
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.36564924901746065,0.8499463440552154,0.6900510204081632,0.9057693393885002,1.0,5/20,21.67%,GATM;PTDSS1;GAMT;OPLAH;MTHFS
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.37855853711209725,0.8491052497950956,0.6536388140161725,0.9067818549500669,1.0,3/16,13.34%,GPR37L1;KLK1;DDAH1
prerank,cell cycle G1/S phase transition (GO:0044843),-0.21411073046635434,-0.8482510407377608,0.8181818181818182,0.8823533788127818,1.0,18/61,19.26%,ACVR1;MNAT1;CDK6;CRLF3;NASP;CUL4B;CUL4A;LATS2;PHF8;PPP6C;CDK7;HINFP;USP37;CUL5;PLK2;POLE;KHDRBS1;CACUL1
prerank,dendritic spine morphogenesis (GO:0060997),0.3775492849290955,0.8479934192054994,0.660574412532637,0.9082999935175533,1.0,5/15,23.03%,PAK3;DOCK10;EPHB1;CTNND2;WNT7A
prerank,neuron fate commitment (GO:0048663),0.3856579118883885,0.8478919387915951,0.6802631578947368,0.9080886542782659,1.0,7/14,32.28%,DLL1;MYT1L;POU4F1;ID2;DLL4;POU3F2;SHH
prerank,positive regulation of ion transport (GO:0043270),0.31878712647004936,0.8471239802676894,0.6994219653179191,0.9090071643778261,1.0,11/48,16.88%,ANK3;P2RX7;LILRA5;SCN4B;WFS1;VAMP8;ATP2B1;CNKSR3;PRSS8;CCL3;ORAI1
prerank,heart development (GO:0007507),0.2899273442404987,0.8470358211870955,0.7955465587044535,0.90877111944176,1.0,36/150,21.14%,CRIP1;RAMP2;PRICKLE4;SOX18;RBP4;ERBB4;SGCZ;PDGFB;ACVRL1;FKBP1A;NDRG4;APLNR;ALPK2;FN1;MMP21;COL3A1;FGF12;SOX17;KDM6B;SOX9;BMP2;LEFTY1;DLC1;HDAC9;GATA4;SGCG;CRELD1;TCF25;ERBB3;NOTCH1;TGFB1;POU4F1;CITED2;MEF2C;CACYBP;ID2
prerank,positive regulation of blood coagulation (GO:0030194),-0.28892489044272907,-0.8470115713560774,0.6588785046728972,0.8834054595587908,1.0,3/17,7.65%,ST3GAL4;ANO6;F3
prerank,glycoprotein metabolic process (GO:0009100),-0.21818584251651993,-0.8469688039161496,0.8181818181818182,0.8820311511285781,1.0,12/53,16.22%,LARGE1;ST3GAL4;MAN1C1;OGA;ADAMTS9;FUT8;NGLY1;STT3B;MANBA;ST6GALNAC6;MAN2A1;ST3GAL2
prerank,DNA replication initiation (GO:0006270),0.33525667789964053,0.8468097719507135,0.6982658959537572,0.9087593507984635,1.0,5/37,12.19%,MCM5;RPA2;CDC34;GMNN;POLE4
prerank,cellular response to organic substance (GO:0071310),0.2950507715228237,0.8466878563603562,0.77482088024565,0.9085798169460975,1.0,31/116,21.23%,RACK1;RAMP2;PARK7;AKAP6;TNF;PDGFB;HCLS1;ACVRL1;IGFBP5;CTNNB1;IL1RAPL1;CLEC3B;CSF1R;RAMP3;SLC1A1;AMHR2;KLF4;RHOA;CXCR4;CCL2;ROBO2;SIGIRR;CCL3;SLIT3;FLT3;TGFB1;POU4F1;SFRP1;PTPN6;ASAH2;CDK9
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3348757285642723,-0.8466715886494289,0.6612377850162866,0.8811477699708469,1.0,3/11,14.01%,RAPGEF2;SIRT1;LGALS9
prerank,regulation of protein export from nucleus (GO:0046825),0.3581799624668636,0.8465471996736134,0.6797546012269938,0.9084179146480439,1.0,9/23,24.59%,PARK7;YWHAE;UHMK1;CAMK1;GAS6;RANGAP1;IFI27;ANP32B;BARD1
prerank,regulation of microtubule depolymerization (GO:0031114),0.3474022549275786,0.8463866672698951,0.6805896805896806,0.9082977469079901,1.0,4/25,8.20%,MAP1A;MID1IP1;NAV3;CLASP1
prerank,negative regulation of cellular component movement (GO:0051271),0.3878599950794609,0.846254727561217,0.6742627345844504,0.9081236304198494,1.0,4/15,12.28%,PIN1;FRMD5;SPOCK3;ACTN1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.33054963286596584,0.8459730558476798,0.684757505773672,0.9081927909855558,1.0,8/37,20.07%,GPER1;PDGFB;IGFBP5;P2RY6;JUN;GJA1;ADAMTS1;MEF2C
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3340209476342979,0.844803820440413,0.6908442330558858,0.9097412241186226,1.0,7/33,12.78%,TNF;PDGFB;SPI1;EGR1;GATA2;JUN;KLF4
prerank,nucleosome organization (GO:0034728),0.3130743270800687,0.8447785359079495,0.7251655629139073,0.9093864961855682,1.0,8/55,13.00%,H3-3A;VPS72;NPM1;ZNHIT1;BRD2;SET;H1-0;SOX9
prerank,glucose homeostasis (GO:0042593),0.2999504685849192,0.8445881054515882,0.7544973544973544,0.9093213758016055,1.0,16/83,19.67%,PARK7;MTNR1B;RPS6;RBP4;LRRC8A;NR1D1;NUCKS1;CEBPA;MLXIPL;WFS1;STK11;BAD;ADCY8;PPARGC1A;TFAP2B;IL6
prerank,regulation of nervous system process (GO:0031644),0.36609989236422213,0.8443961585175818,0.6849673202614379,0.9092397152774258,1.0,9/18,24.58%,DLGAP2;DLGAP1;HTR2C;BEGAIN;TMEM108;NPTXR;CACNG5;APP;NPTX1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.29240912832050714,0.8439866965692311,0.8156028368794326,0.9095409079736224,1.0,37/152,20.34%,PSMB4;ATP6V0C;COL1A1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FZD9;PSMD1;PIN1;PSMC3;PSMD6;VCP;TNFAIP3;PSMA7;PSMD5;LGR6;PSMB9;PSMD13;GPC5;PSMB3;ATP6AP2;PSMB11;BMP2;PSMB10;SFRP4;PSMB1;PSMB5;CAV1;USP8;CSNK1G2;CCAR2;PSMA6;TGFB1;SFRP1;PSMA4
prerank,"phototransduction, visible light (GO:0007603)",0.3823872978990411,0.8433044713781495,0.6712707182320442,0.9102422891005977,1.0,3/14,24.44%,GNA11;CNGB1;PDE6G
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4136316639113365,0.8431373959830551,0.6769662921348315,0.9101255338408291,1.0,1/10,3.60%,PFKL
prerank,protein methylation (GO:0006479),-0.22607154432832374,-0.8428672322325749,0.7559055118110236,0.8874153374708332,1.0,12/40,18.54%,NSD1;EHMT1;NSD3;CAMKMT;EHMT2;CARM1;EZH2;PRMT6;METTL22;SETD3;VCPKMT;METTL21A
prerank,histone exchange (GO:0043486),0.32721328035213826,0.8423573462387133,0.7139507620164126,0.9110244631010233,1.0,4/37,7.60%,VPS72;NPM1;ZNHIT1;CENPX
prerank,atrioventricular valve development (GO:0003171),-0.3046441246128972,-0.8423070909518301,0.7042801556420234,0.8870628065285886,1.0,3/14,6.73%,ACVR1;BMPR1A;MDM4
prerank,reticulophagy (GO:0061709),-0.3240028483019228,-0.8421649720091287,0.6328671328671329,0.8858936476825868,1.0,6/12,16.72%,UFL1;ATG2B;RB1CC1;ATG2A;ULK2;ULK1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3029873443391229,0.842140690514165,0.7567567567567568,0.9110064224344507,1.0,10/64,12.82%,ELOB;POLR2E;ELOF1;POLR2D;POLR2F;NELFCD;POLR2G;SUPT4H1;SSRP1;POLR2K
prerank,protein import into peroxisome matrix (GO:0016558),0.3931029170654646,0.8417093928322453,0.6860158311345647,0.9113103596543488,1.0,6/12,35.64%,PEX5L;PEX6;PEX1;PEX14;PEX2;PEX13
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3251615292406472,0.8410706264562611,0.7174163783160323,0.9119908799841266,1.0,5/38,9.75%,TREM2;NR1D1;TNFAIP3;OTUD7A;TRIM59
prerank,N-terminal protein amino acid modification (GO:0031365),0.38795343462709675,0.8406748128275516,0.6860622462787551,0.9122560993295354,1.0,4/14,15.29%,METAP1;METAP2;NAA10;PDF
prerank,regulation of sequestering of calcium ion (GO:0051282),0.39175930425076877,0.8405079731154219,0.6761904761904762,0.9121598640459491,1.0,4/12,18.66%,MTLN;RYR2;FKBP1B;ANXA6
prerank,negative regulation of nuclear division (GO:0051784),0.40397547425738844,0.8403477619049422,0.6722689075630253,0.9120389228086347,1.0,3/11,17.55%,AURKAIP1;FBXO5;NANOS2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3598095201145395,0.8403369877041467,0.7216624685138538,0.9116657693535576,1.0,7/21,20.93%,MT3;GRIN1;BEX3;PSMB9;PCID2;GRIN2B;PYCARD
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3799889886769103,0.8402550766392926,0.6867469879518072,0.9114023193107891,1.0,5/15,19.98%,NTRK2;HAP1;SORT1;SOS1;DDIT4
prerank,positive regulation of axonogenesis (GO:0050772),0.3218418889426238,0.840078674359891,0.7096045197740113,0.911292168901148,1.0,9/43,15.46%,ARHGDIA;NTRK2;SEMA7A;MAPT;NTN1;RHOA;SHTN1;TIAM1;ROBO2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3448971409687796,0.8396820163322268,0.72,0.9115685573761917,1.0,10/26,30.01%,C1QC;GPR137B;LILRB3;CCL3;INHBA;MYC;MAFB;INHA;ZFPM1;TMEM178A
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.39341599408551964,0.8387278292239497,0.6729222520107239,0.9127747549626039,1.0,7/13,27.91%,LGMN;SHISA7;ADCY8;SQSTM1;APP;ZDHHC2;CHRNA7
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3048745962570004,-0.8376999607906744,0.7004048582995951,0.8932611907266766,1.0,4/15,11.93%,YTHDF3;STAT2;CNOT7;PTPN2
prerank,regulation of spindle assembly (GO:0090169),0.3441206739008068,0.8372766797139318,0.7049576783555018,0.9147336211548357,1.0,12/25,32.41%,HSPA1B;CHMP2B;CHMP5;HSPA1A;HNRNPU;CHMP1B;CHMP1A;CHMP4C;CCSAP;SPAG5;DYNC1H1;CHMP4B
prerank,bile acid and bile salt transport (GO:0015721),0.34663565430663423,0.8365325391062756,0.6834975369458128,0.9155515004833209,1.0,5/24,20.82%,SLCO1C1;SLC10A3;ABCC3;SLCO1B1;SLC10A6
prerank,apical junction assembly (GO:0043297),0.3117538090989032,0.8353932119184209,0.7441340782122905,0.9170237480645838,1.0,15/53,24.27%,CLDN5;RAMP2;RHOC;CLDN11;ESAM;PECAM1;RHOA;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;ECT2;TBCD
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3475127357962418,-0.8353278651749315,0.6468646864686468,0.8967305403952872,1.0,4/10,14.99%,DUSP10;HIPK3;PDCD4;PTPN22
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.35357992503368807,0.8347665329968342,0.6973039215686274,0.9176288368992089,1.0,6/23,20.07%,AKAP6;NRG1;PROX1;MMP14;TGFB1;MEF2C
prerank,regulation of response to stress (GO:0080134),0.40395491792856986,0.8346722679238563,0.6952247191011236,0.9173933739780655,1.0,3/10,27.24%,MLC1;ADCY8;CORO2B
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.3783503540649533,0.8346097749231054,0.691156462585034,0.9171095879679798,1.0,4/15,14.72%,AGT;LPL;MSR1;PF4
prerank,actin filament capping (GO:0051693),0.3673678584554583,0.8344958854628254,0.6901960784313725,0.916527534134105,1.0,8/18,22.96%,GSN;ADD2;CAPZA2;FLII;CAPG;SCIN;TWF1;TWF2
prerank,barbed-end actin filament capping (GO:0051016),0.3673678584554583,0.8344958854628254,0.6901960784313725,0.916527534134105,1.0,8/18,22.96%,GSN;ADD2;CAPZA2;FLII;CAPG;SCIN;TWF1;TWF2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3204456460655053,0.8338766361900136,0.7349260523321957,0.9171504454988602,1.0,14/43,20.07%,IFITM1;DNAI3;ATP6AP1;NELL1;LRP3;ATRAID;TMEM119;BMP2;FBXO5;DDR2;SOX11;IL6;HGF;MEF2C
prerank,negative regulation of fat cell differentiation (GO:0045599),0.32740280567708363,0.8337082505858374,0.7393364928909952,0.9170281622831372,1.0,8/34,13.56%,CCDC85B;GPER1;TNF;ZFP36L2;GATA2;LRP3;WNT5A;WNT10B
prerank,skeletal system development (GO:0001501),0.28395466496929694,0.8331290572301844,0.8113017154389506,0.9175777062372517,1.0,13/148,6.12%,RPL13;COL1A1;PPIB;BCAN;VKORC1;RBP4;TGM2;ETS2;ADAMTS4;HYAL2;BPNT2;HAPLN2;RFLNB
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.4130267673578165,0.8330715077824803,0.6694560669456067,0.9172855375326812,1.0,3/10,19.11%,SET;CTBP1;SNCA
prerank,regulation of cell aging (GO:0090342),0.3941425921972316,0.8326469888647227,0.672972972972973,0.917574984153013,1.0,5/11,25.41%,MIF;VASH1;LMNA;FOXM1;PNPT1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3925203225843123,0.8324651020944454,0.705547652916074,0.9174732191387471,1.0,6/13,32.60%,CCL19;ABCA2;IL33;CHP1;ALG10B;RAMP1
prerank,axoneme assembly (GO:0035082),-0.24796730727575528,-0.832336970752046,0.7466666666666667,0.9013049582542565,1.0,11/30,24.61%,DNAI4;TTLL3;SPEF1;GAS8;CCDC39;LRGUK;SPAG17;RP1;FOXJ1;CCDC65;DNAAF2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3590124349462457,0.8321552761546087,0.6894803548795945,0.9175886525145979,1.0,6/20,19.83%,TNF;HCK;CCL2;CCL3;CD14;TGFB1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.22268656724381303,-0.8317108005716971,0.8428571428571429,0.9010745005698758,1.0,4/41,5.12%,PRKAG2;RANBP2;OGT;NUP98
prerank,regulation of endocytic recycling (GO:2001135),0.4078446569569032,0.8313924217713997,0.6909340659340659,0.9184123782036728,1.0,4/11,24.65%,SORL1;EHD1;EHD2;PLA2G3
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3562600866393439,0.831378485250368,0.7021013597033374,0.9180545757559264,1.0,5/20,14.29%,HSP90AA1;FLOT1;NUPR1;CDC37;SDCBP
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.2620087773963229,-0.8313428311243037,0.7839195979899497,0.9003297928326883,1.0,9/23,23.02%,CAMK2D;ANK2;ATP1A2;DIAPH1;NOS1AP;NOS1;PTK2B;CACNB1;CASQ1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.3982476814282795,0.8297682217076089,0.7010014306151645,0.9202614948019779,1.0,1/11,1.37%,H3-3A
prerank,negative regulation of ion transport (GO:0043271),0.3498143295153528,0.8296608856960225,0.6988564167725541,0.920020994829916,1.0,5/24,19.11%,GPM6B;SYT11;PLN;LILRB1;SNCA
prerank,regulation of phosphatase activity (GO:0010921),-0.24957188769703054,-0.8296012997785922,0.770949720670391,0.9023915333539874,1.0,8/24,17.56%,PPP6R3;URI1;GPATCH2;PPP6R2;SH3RF2;TSC1;ZCCHC9;SH2D4A
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3845713239596018,0.8292544420867711,0.6937931034482758,0.9203035328434381,1.0,3/13,9.45%,RAN;AK4;AK3
prerank,DNA packaging (GO:0006323),0.37272092053101336,0.8291194122641471,0.7026315789473684,0.9201326816395926,1.0,3/16,11.38%,H1-0;NAA10;BANF1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.34621964337700173,0.8289848216063916,0.7221542227662179,0.91994849551429,1.0,4/23,11.19%,RACK1;VCP;RFX4;ULK3
prerank,pyroptosis (GO:0070269),0.3776049729589654,0.8287261494776916,0.6951219512195121,0.9199669658015065,1.0,1/15,2.84%,TREM2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3220492431396672,0.8286758583693311,0.721120186697783,0.9196524126433748,1.0,7/39,11.11%,MYO5A;PPFIA2;MYO7B;MYO1F;SYT4;FNBP1L;HAP1
prerank,mitotic DNA replication (GO:1902969),0.41135509322289693,0.8285891816140865,0.6943661971830986,0.9193854430825862,1.0,7/10,38.36%,GINS3;CDC45;LIG1;MCM2;GINS1;MCM4;MCM3
prerank,melanosome transport (GO:0032402),0.36155064261866604,0.8285591933979831,0.6956521739130435,0.9186667249585785,1.0,7/18,30.82%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,pigment granule transport (GO:0051904),0.36155064261866604,0.8285591933979831,0.6956521739130435,0.9186667249585785,1.0,7/18,30.82%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,pinocytosis (GO:0006907),0.40054744042653256,0.8283741011466381,0.689051094890511,0.9185858776432935,1.0,4/10,24.63%,DOCK2;SNX33;PYCARD;SNX5
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3300302258997106,0.8283010322630512,0.7200956937799043,0.9183267257665513,1.0,5/30,12.47%,H3-3A;PARK7;PKN1;ZBTB7A;NCOR2
prerank,establishment of epithelial cell polarity (GO:0090162),-0.27773462909349644,-0.8281646353777953,0.6816143497757847,0.9036839202054499,1.0,5/19,14.40%,PARD3;SIPA1L3;OPHN1;MYO18A;MYO9A
prerank,extracellular transport (GO:0006858),-0.3138093326546506,-0.8278298443625662,0.7235494880546075,0.9029129793745613,1.0,9/12,30.04%,WWP2;SPAG17;TSG101;SPA17;DNAAF2;ROPN1L;CCDC40;DNAAF4;ADCY10
prerank,glycerol metabolic process (GO:0006071),0.4028709948601345,0.8267706252976115,0.7083926031294452,0.920380367926362,1.0,4/10,26.79%,TPI1;PGP;GOT1;COQ2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.36310762482808834,0.8262889427490318,0.695322376738306,0.920714351194706,1.0,2/17,10.56%,PLAAT3;PLA2G4F
prerank,response to cAMP (GO:0051591),0.32066694191081657,0.825861272838851,0.7471131639722863,0.9209988403670953,1.0,11/37,27.61%,AKAP6;IGFBP5;ZFP36L1;AQP1;HCN1;DMTN;HCN3;AANAT;PDE2A;RAP1B;KCNQ1
prerank,signal peptide processing (GO:0006465),0.3995043963476223,0.8256175172158544,0.6825174825174826,0.9209960592775752,1.0,4/11,18.39%,SPCS1;CLN5;SPCS2;SEC11C
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.36654447645297483,0.8248591686734889,0.7097186700767263,0.9217954966355955,1.0,6/18,21.70%,BHLHE41;TMEM119;BMP2;HDAC5;NOTCH1;CCN3
prerank,regulation of integrin activation (GO:0033623),0.3651133407052667,0.8243798712489119,0.7055630936227951,0.9221636710432094,1.0,4/15,19.08%,RASIP1;JAM3;SKAP1;FBLIM1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3101864863369522,-0.8240229000488087,0.7094339622641509,0.9087304237766136,1.0,4/13,15.43%,RREB1;SIX1;NAPEPLD;SOX13
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.41328786153738706,0.823394643931611,0.6935251798561151,0.9233407983720199,1.0,3/10,12.78%,PSMC3;HMGB1;THRA
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2763440153034213,0.8233487922127508,0.9179179179179179,0.9230318204914411,1.0,82/341,21.85%,PSMB4;UBXN1;PSME1;PSMB6;PSME2;PSMB8;PSMD2;PINK1;KCTD10;TOLLIP;PSMD1;UBE2G2;PSMC3;UCHL1;CTNNB1;PSMD6;VCP;TNFAIP3;CDC34;RNF187;ARRDC1;PSMA7;KCTD2;FEM1C;FEM1A;FBXL14;UBAP1L;NHLRC1;KCTD17;PSMD5;TRIM9;RBX1;NEDD8;TRIM2;OTUD7A;TNFAIP1;RNF128;DDB1;PSMB9;PSMD13;RBCK1;BUB3;PSMB3;FBXW5;SYVN1;VPS28;PSMB11;ZSWIM8;FBXW7;UBQLN2;PSMB10;RNF40;KBTBD7;RNF150;SPSB3;PSMB1;ARRB2;RNF7;PSMB5;HERPUD1;SQSTM1;TRIM32;RNF149;RLIM;KCTD13;VPS4A;VPS37C;PSMA6;RNF144B;HECW1;TRIM13;RAD23A;RNF11;PSMA4;KLHL25;DDIT3;SIRT2;UBXN11;STUB1;ELOC;IFI27;AMFR
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.37508413073068503,0.8233018213158856,0.6828309305373526,0.9227170149437752,1.0,3/15,14.25%,TREM2;NLRP2B;TLR6
prerank,programmed necrotic cell death (GO:0097300),0.35863328865670935,0.822349295854679,0.7150063051702396,0.9238745935664258,1.0,9/18,36.22%,ALKBH7;TICAM2;DNM1L;CD14;PGAM5;MLKL;PPIF;IPMK;ITPK1
prerank,toxin transport (GO:1901998),-0.3300903841325634,-0.8222070964870903,0.6551724137931034,0.9106229643153606,1.0,10/10,67.02%,ANTXR2;RAB29;ANTXR1;ANTXRL;SLC22A1;SLC22A3;SLC22A2;ADAM10;RAB40B;SLC29A4
prerank,cellular protein modification process (GO:0006464),0.2710288028160035,0.8216815831037088,0.991,0.9245629994829232,1.0,248/983,25.11%,APOE;CST3;PSMB4;ELOB;SPARCL1;SPP1;F13A1;LGALS1;PPP1CA;MT3;PARK7;C3;LAMC1;LAMB2;MAPK3;PSME1;AKT1;PSMB6;PNPLA2;PSME2;PSMB8;CKAP4;PSMD2;RPN1;COPS7A;TGM2;RCE1;PINK1;IGFBP3;MFGE8;COPS6;IGFBP4;METAP1;FBXO15;HSP90B1;PDGFB;KLHL9;PTPRC;CTDSP2;ACVRL1;IGFBP5;CHEK2;PSMD1;RPN2;SHISA5;EPAS1;UBL5;PSMC3;PDIA6;PPP2R1A;DAD1;PARP1;PSMD6;CPE;LOX;CTDNEP1;LTK;CDC34;PENK;FN1;MATK;HIPK2;CDK8;DDOST;UBA52;BRD2;PSMA7;ISG15;P4HB;EPB42;PTK6;SGK1;FN3KRP;FEM1C;FEM1A;PKN1;PAK1;FBXL14;DUSP26;APLP2;MAST1;UBE2M;VWA1;LIPE;METAP2;PSMD5;COL3A1;RBX1;NEDD8;FBXO27;TIMP1;PTPRN2;HS3ST5;CAMK1;CTDSP1;HCK;PHPT1;BCKDK;PAK3;DDB1;ICMT;PSMB9;PSMD13;PRKAR1B;AATK;CTBP1;CHRM3;B3GNT9;PSMB3;PLAT;FBXW5;WFS1;PTPRD;SERP1;CDK19;MAP3K21;PSMB11;PTPRB;MXRA8;PTPRR;AMHR2;CDKL4;ASB13;ST8SIA4;FBXW7;FBXO30;NEK10;BMP2;FBXO31;GAS6;PSMB10;YWHAZ;EVPL;KBTBD7;TIMM50;CDC42BPA;MAPK10;STK11;CCL2;SPSB3;PTPRZ1;COPS8;PIGS;TSSK6;TSSK4;ALG3;PDF;ARF4;CDK5;PSMB1;RNF7;ERO1A;GMFB;PSMB5;VCAN;FUT9;VHL;PDP2;PIM3;BRSK2;PIK3CD;EVA1A;SCG3;CSNK1G2;PPP2R5D;B3GNT3;PPM1J;MAP4K2;RBBP5;SYK;PDP1;NOTUM;ST6GALNAC2;STT3A;WDR45;TAB1;SLC35A1;PPP3CA;MKNK1;PSMA6;ST8SIA5;GRK2;FBXL16;IL6;TGFB1;PPEF1;NEK1;PORCN;SKP1;PRSS23;QSOX1;PSMA4;KLHL25;BTBD6;GAD1;SSH2;PAK5;PTPN6;PTPRU;PTPRO;PPP2R5A;CDK9;SIRT2;DUSP2;QPCT;ELOC;MEN1;SCG2;PPM1F;ENGASE;PTPN5;DUSP12;DUSP1;B3GALT5;MGAT1;CCDC8;CDK18;PSMC1;KCTD7;PTPN1;PSMD9;NUS1;B3GALT2;TGM7;PTPRE;SOCS3;CDK10;SBF1;DYRK2;PAK4;NPC1;DYRK1B;RCN1;APP;FBXO2;LMTK3;CCN1;BAP1;WSB2;PPP1CB;PRRT1;MACROD2;VRK1;FBXL3;DNAJC3;PSMB2;PRKCA;PRKACA
prerank,regulation of phosphorylation (GO:0042325),0.28475680025811845,0.8216335230674179,0.8039014373716632,0.9242515960906837,1.0,42/120,29.07%,HSPB1;PGAM1;DYNLL1;GRM5;EMP2;ANG;DSCAM;PIN1;MIF;CDKN1C;FN1;CORO1C;CD24;CADM4;ZBTB7A;CCDC88A;NUP85;SDCBP;NUP88;PTGES3;CDH5;PRKRIP1;NOP53;NUP50;INHBA;RAE1;SIRT2;TESK1;PLXNB2;APP;BARD1;CDKN2B;INHA;EIF6;SLC2A6;CDKN1A;ITGA6;MCM7;CCDC88C;NUP205;NUP188;PPP2CA
prerank,ether lipid metabolic process (GO:0046485),-0.3037697865697754,-0.8216079244557264,0.708,0.9102780761602883,1.0,4/14,10.78%,AGMO;PAFAH1B1;FAR1;PEX7
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.40369658323274515,0.8209527304142955,0.6872427983539094,0.9248943119568406,1.0,5/10,31.36%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1
prerank,regulation of double-strand break repair (GO:2000779),-0.22853555763049813,-0.8209305517793279,0.7829457364341085,0.9101143357605544,1.0,13/39,19.20%,TRIP12;SETD2;UBR5;SPIDR;PML;RNF169;PPP4R2;MRNIP;MGMT;SIRT7;RTEL1;ZCWPW1;SHLD2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.341663885345518,0.8209284966791812,0.706766917293233,0.9245445676385856,1.0,7/24,18.66%,CCL19;PTPRC;HTR2C;TRPM2;RYR2;ERO1A;ANXA6
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.2982289889907024,0.8207363604794813,0.7942122186495176,0.9244472418518818,1.0,8/74,6.09%,GPX1;HMOX1;PARK7;AKT1;TNF;LGALS3;HSPA1B;TNFAIP3
prerank,amino sugar biosynthetic process (GO:0046349),-0.313923053846315,-0.8203368760399372,0.7068965517241379,0.9096987490263051,1.0,4/12,19.29%,PGM3;GFPT2;RENBP;NAGK
prerank,inorganic anion transport (GO:0015698),0.307669407979816,0.820300828833225,0.7428884026258206,0.9247533135825831,1.0,8/53,12.88%,FXYD1;TTYH1;SLC26A4;SLC25A11;GLRA1;CLIC1;TTYH3;SLC11A1
prerank,cellular amino acid catabolic process (GO:0009063),0.2915593743153197,0.8202252210659162,0.7939011566771819,0.9244918110695736,1.0,19/87,21.19%,BCAT2;GLUL;SDS;BCKDK;IDO2;ACAT1;QDPR;SLC25A21;DDAH1;CRYM;GLS2;GLS;ECHS1;NOS2;GLUD1;GOT1;SHMT2;GAD1;ALDH4A1
prerank,indolalkylamine catabolic process (GO:0046218),0.3956432933133901,0.8201221117142543,0.6787790697674418,0.9242689244974017,1.0,1/10,11.01%,IDO2
prerank,bicellular tight junction assembly (GO:0070830),0.31047312298494434,0.819632690875073,0.7627695800227015,0.9246498373136505,1.0,13/46,24.27%,CLDN5;RAMP2;CLDN11;ESAM;PECAM1;ARL2;CDH5;CRB3;MARVELD2;GRHL2;PARD6A;ECT2;TBCD
prerank,cellular response to fluid shear stress (GO:0071498),0.3896693191136529,0.8194564465868303,0.7069199457259159,0.9245340925837747,1.0,3/12,20.07%,KLF2;KLF4;MEF2C
prerank,regulation of cell-matrix adhesion (GO:0001952),0.2972592313030889,0.818932851617513,0.7663451232583065,0.9249646362594615,1.0,8/64,8.34%,ACTG1;ADAM15;EMP2;DUSP3;GPM6B;CORO1C;CLASP1;THY1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.36532155227263013,0.8188641704428689,0.7002688172043011,0.9246846234358743,1.0,2/16,3.71%,SHFL;TNF
prerank,glial cell differentiation (GO:0010001),0.33069854680635397,0.8186823829550541,0.7168674698795181,0.9246004700650368,1.0,16/28,32.84%,MYRF;SOX8;SOX9;PTPRZ1;CDK5;ERBB3;EIF2B5;SOX11;SOX10;MMP24;GPC1;SOX4;CDH2;SHH;RELN;PAX2
prerank,regulation of chromatin binding (GO:0035561),-0.33955494035093337,-0.8185500208637322,0.689419795221843,0.9116337783715657,1.0,4/10,14.04%,PARP9;WAPL;BTAF1;KDM4D
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3806588827319993,0.8181855359795561,0.7056451612903226,0.9249647307329134,1.0,2/13,5.34%,YWHAB;FLNA
prerank,sympathetic nervous system development (GO:0048485),0.3648326759946142,0.8180146153269121,0.7133507853403142,0.9248486924107527,1.0,4/15,19.55%,SEMA3F;CTNNB1;SOX11;TFAP2B
prerank,calcium-mediated signaling (GO:0019722),0.28319165913500677,0.817431460562808,0.7917525773195876,0.9254022918494171,1.0,23/93,19.08%,RCAN3;PRNP;GRM5;PTPRC;CCR5;P2RX7;KDR;P2RY12;CHRM3;TRPM2;CXCR4;CX3CR1;NUDT4;ATP1B1;SLC8A1;RYR2;DMTN;CCL3;VCAM1;BCAP31;FKBP1B;CCR2;PPP3CA
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3275250227275733,-0.8170983125022355,0.67,0.9128169629313198,1.0,5/10,14.98%,DPYD;UPP2;UPB1;NT5C1A;NT5M
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3897360756751349,0.816993150608922,0.6851595006934813,0.9256699280928135,1.0,4/11,21.52%,FBL;EXOSC2;DKC1;EXOSC4
prerank,negative regulation of mRNA processing (GO:0050686),0.3727520339632313,0.8163687851016678,0.7125668449197861,0.9262525150941876,1.0,2/15,7.06%,PCBP4;SRSF9
prerank,activation of phospholipase C activity (GO:0007202),0.3277271534252837,0.8155529215921511,0.7253012048192771,0.9270945393211848,1.0,5/29,9.32%,NTRK2;ANG;C5AR1;P2RY6;P2RY12
prerank,RNA biosynthetic process (GO:0032774),-0.24131354855393777,-0.8152744120552439,0.8246753246753247,0.9147010588698481,1.0,9/31,23.43%,TTF1;SMARCA5;SETX;TERT;POLR2A;RSF1;TAF7;NCOA6;BRF1
prerank,regulation of exosomal secretion (GO:1903541),0.36058683739625086,0.815014409198095,0.7347715736040609,0.9275368980566492,1.0,7/19,26.87%,ATP13A2;SDC4;CHMP6;SDCBP;VPS4A;HGS;SNF8
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4019458585271365,0.8149744922092681,0.717391304347826,0.9272166617041927,1.0,3/10,21.50%,CTNNB1;WNT5A;FZD1
prerank,regulation of protein sumoylation (GO:0033233),0.36195340438313633,0.814758057188374,0.7142857142857143,0.9271542781807036,1.0,3/17,9.30%,PARK7;CTNNB1;EGR1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3054151398947323,0.8143938375958122,0.7328072153325818,0.9272935931871714,1.0,7/46,9.69%,RAN;HCLS1;FLNA;YWHAE;HYAL2;TRIM28;CAMK1
prerank,regulation of anoikis (GO:2000209),-0.27364709530092884,-0.813350031175312,0.7546296296296297,0.9168371116791472,1.0,5/19,12.48%,ITGA5;TLE1;SIK1;PTK2;BCL2
prerank,mitochondrial protein processing (GO:0034982),0.39436594244742684,0.8129727122685343,0.7152974504249292,0.9290934846121526,1.0,3/11,14.65%,OMA1;PMPCB;SPG7
prerank,regulation of gene silencing by miRNA (GO:0060964),0.29676013465303336,0.81291878815026,0.7786177105831533,0.9287823655777959,1.0,16/62,23.94%,H3-3A;POLR2E;POLR2D;POLR2F;ZFP36;POLR2G;POLR2K;NUP85;NUP88;AGO1;NUP50;TGFB1;RAE1;POLR2H;ELAVL1;DND1
prerank,glucan catabolic process (GO:0009251),0.36320007274323657,0.8128324602043545,0.7034574468085106,0.9285368973602778,1.0,2/15,10.43%,CALM1;GAA
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4010731725134997,0.812540017106194,0.7191011235955056,0.9285976130941014,1.0,3/10,19.11%,AKT1;PMAIP1;SNCA
prerank,phosphatidylcholine catabolic process (GO:0034638),0.3982991837575963,0.812474485118998,0.7009873060648801,0.9283071266051521,1.0,2/10,10.24%,ENPP2;PLA2G7
prerank,mitotic cell cycle phase transition (GO:0044772),0.275359606060697,0.8121188591984007,0.8809283551967709,0.9284864922288925,1.0,32/203,16.89%,TUBB;TUBA1A;HSP90AA1;TUBB4B;DYNLL1;CCNI;CCND2;NES;TUBA4A;CHEK2;DCTN3;PPP2R1A;YWHAE;CDC34;GPR132;CCND1;CLASP1;YWHAG;TUBB4A;TACC3;CEP131;USP29;CCNG1;DCTN1;SSNA1;HAUS2;USP26;DCTN2;ARPP19;CETN2;BRSK2;PRKAR2B
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3466181088301094,0.8110432084934959,0.7353689567430025,0.9296718366307868,1.0,4/23,10.22%,ENDOG;FOXL2;HMGB1;H1-0
prerank,mesenchyme development (GO:0060485),-0.29687172210202595,-0.8108805829592153,0.7222222222222222,0.9199461782388774,1.0,6/15,19.40%,TGFBR1;FGFR2;WNT11;BMP4;BMPR2;PKD2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.3915314871891437,0.8108128684387866,0.710124826629681,0.9296407018815451,1.0,2/11,11.44%,CD34;ATP6AP2
prerank,response to molecule of bacterial origin (GO:0002237),0.2903980828049257,0.810548341206963,0.7834941050375134,0.9296756254816735,1.0,24/69,29.83%,C4B;S100A8;S100A9;TIRAP;TNFAIP3;HNRNPA0;CD24;SLC11A1;ERBIN;ADAM17;NOS2;SNCA;CD14;IL6;SIRT2;IRF5;TNFRSF11A;LBP;TRIB1;FZD5;GGT5;GGT7;ACOD1;IFNAR1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.22103793472799713,-0.8104484253064634,0.8333333333333334,0.9193408760558573,1.0,4/41,5.12%,PRKAG2;RANBP2;OGT;NUP98
prerank,regulation of receptor recycling (GO:0001919),0.3636122623828071,0.8103581253989494,0.7278731836195509,0.9295853098591372,1.0,9/16,35.29%,VAMP3;RAMP3;SNCA;TRAT1;AP1AR;ECE1;ANXA2;LAMTOR1;NSF
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3083060995096869,0.8099574391338485,0.7666290868094702,0.9298121645435059,1.0,9/47,13.74%,AKT1;CDS1;ZFP36L1;RARRES2;CEBPB;LPL;ZFP36;BMP2;HNRNPU
prerank,regulation of hemopoiesis (GO:1903706),-0.32487348875765415,-0.809651950249239,0.6948051948051948,0.9193838519243229,1.0,5/10,16.59%,CREBBP;MYSM1;CBFB;PRKCB;IL17D
prerank,gliogenesis (GO:0042063),-0.2889956613917187,-0.8092039734464052,0.7073170731707317,0.9187490975447625,1.0,2/15,6.80%,NFIB;CDK6
prerank,spliceosomal complex assembly (GO:0000245),0.30193644945892056,0.809111154462359,0.7575418994413408,0.9307391145811039,1.0,17/46,25.45%,SNRPG;DDX39B;SNRPD2;SNRPE;PUF60;SRSF9;PRPF19;SF3A2;SF3A3;CELF3;TXNL4A;SF3A1;SRSF1;SNRNP200;LUC7L3;CELF4;CELF5
prerank,histone H2A monoubiquitination (GO:0035518),-0.2753683638358497,-0.809028728685683,0.7743362831858407,0.917659972541847,1.0,4/17,11.00%,BCOR;DDB2;PCGF5;CUL4B
prerank,long-chain fatty acid import into cell (GO:0044539),0.3947027500630356,0.8086322325932463,0.7162346521145976,0.9310655928157887,1.0,1/10,2.52%,SLC2A1
prerank,negative regulation of histone methylation (GO:0031061),-0.3310863609647222,-0.8085460417910968,0.694006309148265,0.9171139390016055,1.0,2/10,6.41%,JARID2;BCOR
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.3953205627559332,0.8082980160113283,0.7082111436950147,0.9311857247822478,1.0,4/10,20.24%,CAMK1;PIH1D1;HDAC5;SPHK2
prerank,liver development (GO:0001889),-0.23065561521306954,-0.808280307464714,0.803921568627451,0.9161236105326489,1.0,5/32,8.84%,TGFBR3;COBL;ARID5B;MET;NPHP3
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.34157124624245877,0.8082535114537953,0.7480211081794196,0.9308582417439607,1.0,9/21,25.94%,PSENEN;SPPL2B;BACE1;PSEN2;ADAM17;SPPL2A;ERAP1;APH1A;PRKCQ
prerank,regulation of cellular pH (GO:0030641),0.31899537059284727,0.8081857278646691,0.7479289940828402,0.930568139124715,1.0,3/29,5.28%,ATP5F1B;CA2;ATP6AP1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3998077022150316,0.8077708370445323,0.7198275862068966,0.9308075936466911,1.0,3/10,18.54%,APEX1;DCLRE1C;TERF2IP
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.3369265687174225,0.8077128010490893,0.7311960542540074,0.9305097754873375,1.0,8/25,19.95%,PARK7;H1-0;ZBTB7A;HEY1;TWIST1;SOX11;TGFB1;POU4F1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.34589371936187374,0.8072443723195505,0.7337579617834394,0.9308490952443638,1.0,6/20,29.04%,DCC;BAX;ERBB3;BAK1;BOK;MCL1
prerank,cellular response to hexose stimulus (GO:0071331),0.3387170826117757,0.8071496004708656,0.7336683417085427,0.9306032954099307,1.0,2/23,3.42%,RACK1;GPER1
prerank,plasma membrane tubulation (GO:0097320),0.37826218273686085,0.80713997422186,0.7119565217391305,0.93023265282705,1.0,5/13,24.61%,PACSIN1;FNBP1L;SNX33;EHD2;CAVIN2
prerank,positive regulation of protein maturation (GO:1903319),-0.3146098379654634,-0.806454696506677,0.7384105960264901,0.9180078078961816,1.0,4/11,24.19%,RHBDD1;CCBE1;BAG2;NLRC4
prerank,chordate embryonic development (GO:0043009),0.29392189449764955,0.8053832406837177,0.7732749178532311,0.9324290491008863,1.0,10/55,15.42%,COL1A1;RBP4;FOXD3;PROX1;WNT5A;SOX8;PTPRR;BMP2;XYLT1;IGF2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.36259359788070616,0.8049525188165051,0.7152974504249292,0.9327017708750361,1.0,4/14,20.75%,CCL19;CD86;NLRP3;NFKBID
prerank,primary alcohol metabolic process (GO:0034308),0.3353365051855582,0.8045362573542074,0.7528089887640449,0.9329619394106902,1.0,9/25,30.91%,RBP4;GDE1;NAAA;LRAT;GDPD1;GDPD3;GPD2;ALDH3A2;ADH1A
prerank,sterol biosynthetic process (GO:0016126),0.31377522664564866,0.8043533394092114,0.7511904761904762,0.9328692431398287,1.0,13/33,28.43%,LSS;DHCR24;ACAA2;SC5D;CH25H;PLPP6;FDPS;NSDHL;PMVK;ACLY;INSIG2;EBP;HMGCS1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.37051823770173453,0.8038370409138572,0.7405913978494624,0.9332495473004428,1.0,5/14,21.11%,RTRAF;TSEN15;RTCB;TSEN54;CPSF4
prerank,negative regulation of histone modification (GO:0031057),0.378232738634745,0.8036766759941055,0.7218259629101283,0.9331186729374618,1.0,5/14,20.24%,SET;CTBP1;TWIST1;SNCA;SPHK2
prerank,early endosome to late endosome transport (GO:0045022),-0.2679467142979131,-0.8033592620805056,0.7684729064039408,0.9220202245332069,1.0,4/20,10.18%,STX8;EEA1;ANKRD27;KIF16B
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3562741221390804,0.8031824355581021,0.7381258023106547,0.9335112712383318,1.0,5/18,16.34%,CAMK1D;EPHA5;TSSK4;LRP8;ADCY8
prerank,protein O-linked glycosylation via serine (GO:0018242),0.387681154050869,0.801919317759381,0.7134670487106017,0.9349752560267363,1.0,4/10,30.94%,POGLUT3;GALNT13;GALNT2;POGLUT1
prerank,positive regulation of bone mineralization (GO:0030501),0.31290941911126363,0.8017397435602887,0.7644287396937574,0.9348612950522547,1.0,15/35,24.73%,FZD9;GPM6B;ISG15;NELL1;P2RX7;ATRAID;ATP2B1;TMEM119;BMP2;SLC8A1;TGFB1;MEF2C;PTN;OSR2;CCN1
prerank,retinol metabolic process (GO:0042572),0.3672753287344229,0.8013097873133518,0.7369826435246996,0.9350908866762199,1.0,2/14,16.23%,RBP4;LRAT
prerank,protein polyubiquitination (GO:0000209),0.26887071453556916,0.8012892182010345,0.9379379379379379,0.9347450524958554,1.0,45/297,14.04%,RPS27A;UBC;UBB;PSMB4;PSME1;PSMB6;PSME2;PSMB8;PSMD2;FBXO15;PSMD1;UBE2G2;ANAPC13;PSMC3;CTNNB1;PSMD6;IRF2BP1;UBE2Q1;MAGEL2;TNFAIP3;CDC34;DCAF15;RNF187;UBA52;PSMA7;FBXL14;NHLRC1;PRPF19;PSMD5;RBX1;FBXO27;TRIM2;PSMB9;PSMD13;RBCK1;PSMB3;FBXW5;SYVN1;PSMB11;FBXW7;FBXO30;FBXO31;PSMB10;KBTBD7;UBE2V1
prerank,organelle assembly (GO:0070925),0.2678876992211134,0.8011896149324598,0.959,0.9345064962927214,1.0,69/384,20.64%,RPS23;RPS3;GABARAP;GSN;DYNLL2;DYNLL1;MAP1LC3B;CD34;NPM1;MAP1LC3A;EMC6;GABARAPL2;CDS1;AUP1;LSM4;GABARAPL1;BSCL2;IFT20;ABCB6;FLNA;CHMP2B;ATG9A;CORO1A;CNGA4;MAPT;CHMP5;CHMP6;FNBP1L;CEP131;FHDC1;TCTN3;VPS28;SAC3D1;ANLN;ATXN2L;UBQLN2;FLII;VMP1;HAUS2;EHD1;CSDE1;ATG101;G3BP1;ARF4;CIRBP;MAPRE3;YTHDF1;TMOD1;CNGB1;CHMP1B;TMEM17;E2F4;CCDC28B;EIF4ENIF1;TCTN1;EXOC7;EHD2;VPS4A;WDR45;VPS37C;NOTCH1;BBIP1;NEK1;EXOC5;CAPN3;CFAP410;CFAP54;CHMP7;EXOC8
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3187655392449364,-0.8009115331665694,0.7352941176470589,0.9248285522001892,1.0,4/11,19.29%,PGM3;GFPT2;RENBP;NAGK
prerank,positive regulation of axon extension (GO:0045773),0.34000662981049906,0.8007417037274778,0.7307692307692307,0.9347719986446602,1.0,5/22,13.44%,DSCAM;SEMA7A;MAPT;NTN1;SHTN1
prerank,Wnt signaling pathway (GO:0016055),0.2827119228788549,0.8001533127211323,0.8292939936775553,0.9352332838831563,1.0,10/92,9.26%,RPS27A;UBC;UBB;FZD9;CTNNB1;CPE;SFRP5;UBA52;RBX1;CD24
prerank,protein localization to centrosome (GO:0071539),-0.2735664528890279,-0.7998133442636903,0.7838983050847458,0.9252754539436817,1.0,6/17,20.57%,PCM1;GOLGB1;PIBF1;C2CD3;CCDC14;CEP192
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.36657091941067893,0.7995239204240625,0.7465940054495913,0.9357658325562587,1.0,5/14,22.79%,GAS6;NLRP2B;F2RL1;TRAIP;PELI3
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3000878951034264,0.7994164806409113,0.7611940298507462,0.9355430746812635,1.0,11/46,19.75%,LAMC1;LAMB2;RAC1;FN1;VAMP3;RHOA;SRCIN1;TYRO3;TMEFF2;LPXN;EFNA1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.31753933978859006,0.7990103963505333,0.7520372526193247,0.9357622433217159,1.0,10/32,22.36%,ADGRB3;YWHAH;KNDC1;IL1RAPL1;SS18L2;PTPRD;NSMF;HECW1;SS18L1;CHRNA3
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3039345415929344,0.7986151105157898,0.7616345062429057,0.9359749086110927,1.0,8/39,16.24%,LGMN;DUSP3;SH3GL2;EPN1;ARHGEF7;SPRY1;SH3KBP1;DAB2IP
prerank,positive regulation of isotype switching (GO:0045830),-0.29534971102745616,-0.7983464495698672,0.7209302325581395,0.9264254540595706,1.0,6/15,22.49%,KMT5C;KMT5B;SHLD1;HMCES;SHLD2;SHLD3
prerank,heterochromatin assembly (GO:0031507),0.3448817527731803,0.7982514486228317,0.7336747759282971,0.9361071848723891,1.0,1/20,1.37%,H3-3A
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.3620015318542131,0.7981051045198148,0.7496688741721854,0.9359328395132934,1.0,5/15,21.11%,RTRAF;TSEN15;RTCB;TSEN54;CPSF4
prerank,regulation of peptide hormone secretion (GO:0090276),0.28980829468257263,0.7979996518908177,0.7957219251336899,0.9356994110604876,1.0,14/67,21.10%,UQCC2;MTNR1B;SLC2A1;SNAP25;TNF;CACNA1A;HTR2C;RASL10B;ABCC8;SLC2A2;NOS2;TFAP2B;IL6;KCNC2
prerank,tRNA wobble base modification (GO:0002097),0.36756777984620087,0.7975434857405,0.7486979166666666,0.9359835865670729,1.0,6/14,24.68%,DPH3;ELP3;CTU1;ADAT2;URM1;CTU2
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.348317449165144,0.7974169092385127,0.7139107611548556,0.9357929342744683,1.0,5/18,16.37%,GPR137B;FBXW7;LILRB3;LILRB1;CCL3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3213318054899858,0.79740364211769,0.7476525821596244,0.9354269504711963,1.0,6/30,14.62%,RAC1;ADGRG1;COL3A1;NET1;GPR18;F2RL1
prerank,regulation of defense response to virus (GO:0050688),0.3635692698141489,0.7973140826671423,0.73342175066313,0.9351732139038756,1.0,7/14,30.35%,TNFAIP3;ELMOD2;TRAF3;C1QBP;PCBP2;DHX9;IFNLR1
prerank,regulation of centrosome duplication (GO:0010824),0.32638415416325156,0.7972824254082214,0.7682198327359617,0.934842452986298,1.0,6/29,15.97%,NPM1;CHMP2B;CHMP5;CEP131;FBXW5;CHMP1B
prerank,positive regulation of potassium ion transport (GO:0043268),0.30440962296294455,0.7968718607807049,0.7605956471935853,0.9350539275339939,1.0,12/38,27.61%,AKAP6;FLNA;KCNJ10;KCNN2;KCNE5;KCNMA1;GABBR2;KCNJ3;KCNJ6;KCNN4;KCNMB4;KCNQ1
prerank,regulation of chromosome segregation (GO:0051983),-0.2835875208295507,-0.7967523254606634,0.7224669603524229,0.927690265822772,1.0,5/16,17.49%,CSNK2A1;CSNK2A2;NUMA1;PUM2;RMI2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3489730858342593,0.7966628627078431,0.720360824742268,0.9349790020806683,1.0,9/19,31.73%,MDK;GAS6;MMP14;SYK;PPP2R3C;XBP1;XRCC6;ZAP70;BTK
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.3013153765616802,-0.7963571438679021,0.7587412587412588,0.9268954042251187,1.0,4/13,11.86%,FBN1;LTBP1;CHRDL1;CD46
prerank,cellular response to ketone (GO:1901655),0.31200078980152746,0.7961082145058593,0.7667844522968198,0.9353925360262887,1.0,9/35,20.24%,SPP1;ADAM15;MSN;AQP1;GNAI1;ADCY8;NCOA4;SFRP1;SPHK2
prerank,protein monoubiquitination (GO:0006513),-0.2255006257843684,-0.7959877203754637,0.8455882352941176,0.9260801191077047,1.0,9/36,18.97%,PRKN;UBE2R2;HUWE1;TOPORS;CDC73;UBE2E1;KLHL22;WAC;RNF20
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3221906116193486,0.7956981806125532,0.7855421686746988,0.9356141526332956,1.0,15/31,34.73%,LSM4;LSM6;POLR2G;EXOSC2;EDC4;EXOSC9;LSM7;EXOSC4;LSM5;LSM2;CNOT8;HBS1L;EXOSC3;CNOT6;DCPS
prerank,homocysteine metabolic process (GO:0050667),0.3841503031545356,0.7954313899117856,0.7164591977869986,0.9356020088666912,1.0,2/11,15.82%,MPST;TST
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.30780571125084305,0.7953657903941026,0.7771493212669683,0.9353182601479628,1.0,12/40,25.76%,NUCKS1;CENPX;PCNA;DDX11;TRAIP;MMS22L;ALYREF;FAM111A;CDK9;BLM;POLD1;RAD51
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.38312441270089953,0.7951890349835375,0.7369165487977369,0.934453078402564,1.0,3/10,22.28%,TERF1;ERCC1;BLM
prerank,telomere maintenance via telomere trimming (GO:0090737),0.38312441270089953,0.7951890349835375,0.7369165487977369,0.934453078402564,1.0,3/10,22.28%,TERF1;ERCC1;BLM
prerank,t-circle formation (GO:0090656),0.38312441270089953,0.7951890349835375,0.7369165487977369,0.934453078402564,1.0,3/10,22.28%,TERF1;ERCC1;BLM
prerank,AMP metabolic process (GO:0046033),0.36850842891143676,0.795091851458723,0.7335958005249343,0.9342232314977463,1.0,3/13,9.45%,ADSS1;AK4;AK3
prerank,serine family amino acid metabolic process (GO:0009069),0.3550618491319982,0.7950107920325433,0.7482993197278912,0.9339668950371124,1.0,4/16,20.44%,SARS1;GLYAT;SEPSECS;SHMT2
prerank,regulation of spindle organization (GO:0090224),0.34560495731930685,0.7949754098659421,0.7298701298701299,0.93364410452644,1.0,4/18,12.87%,CLTC;TACC3;GNAI1;DCTN1
prerank,organic acid transport (GO:0015849),0.27927306855526796,0.7942778550850007,0.8231644260599793,0.9342477877249089,1.0,22/94,25.79%,SLC38A5;SLC1A4;SLCO1C1;SLC25A29;SLC6A6;MFSD2A;SLC25A11;SLC3A2;SLC10A3;SLC7A14;SLC19A1;FOLR2;SLC16A1;ABCC3;SLCO1B1;SLC10A6;SLC7A10;SLC25A14;SLC7A6;SLC43A2;SLC38A3;SFXN5
prerank,myoblast differentiation (GO:0045445),0.36374552958112283,0.7942065091295314,0.7207446808510638,0.93397921362469,1.0,2/14,4.55%,NRG1;EPAS1
prerank,chromatin assembly (GO:0031497),0.30779612036102627,0.7941560306930119,0.7917620137299771,0.9336799157562793,1.0,6/38,16.59%,H3-3A;NPM1;BRD2;H1-0;SOX9;NAP1L2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.238513337321538,-0.7937919036147353,0.8235294117647058,0.9283791688913255,1.0,3/26,4.62%,SNX6;CBLB;ERRFI1
prerank,RNA interference (GO:0016246),-0.2735448672049593,-0.7937874005433612,0.7435897435897436,0.9269388570362156,1.0,8/17,21.82%,DICER1;DROSHA;TERT;TARBP2;AGO2;CELF1;AGO4;CLP1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.1779189005696142,-0.7936369079390815,0.9411764705882353,0.9257695664915719,1.0,24/109,19.26%,PTPN13;PI4KA;PITPNM2;MTMR3;PLA2G4A;PLEKHA4;PLEKHA2;MTMR11;PDGFRB;PIP5K1A;PTEN;SACM1L;VAC14;PIP4K2C;MTMR10;PLCD1;PIP4P2;PLEKHA8;PLA2G4C;PGAP3;PIGW;PIP4K2A;PLCG2;FGF2
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3497017345811606,0.7935285517964421,0.7369791666666666,0.9342041651159736,1.0,1/16,0.80%,CALM1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3243699051900324,0.7931208820360538,0.7560975609756098,0.9344172733582767,1.0,9/27,25.72%,CCL19;PDGFB;P2RY12;FLT1;AGAP2;FLT3;TGFB1;TEK;FGFR3
prerank,DNA recombination (GO:0006310),0.30605513098444126,0.7927703519684578,0.7629213483146068,0.9345406307077023,1.0,9/37,25.76%,ENDOG;HMGB3;HMGB1;TSN;RECQL5;ERCC1;BLM;RPAIN;RAD51
prerank,cellular macromolecule catabolic process (GO:0044265),-0.21436724994599143,-0.7926369170182811,0.8469387755102041,0.9260431319313698,1.0,13/49,14.83%,OGA;PRKN;RNASE3;ADAMTS9;SIDT2;NGLY1;RIPK1;STT3B;DNASE1L1;DENND3;MTREX;MANBA;PABPC4
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.2969467113219398,0.792632918845868,0.7936865839909808,0.9343573301906603,1.0,8/47,16.42%,ACADVL;APOC1;CD34;SIRPA;PROX1;FBXW7;ABCA2;CAV1
prerank,membrane lipid biosynthetic process (GO:0046467),0.288802579978247,0.791107575042278,0.7807775377969762,0.9361542805612875,1.0,27/58,32.48%,CERS2;ELOVL1;ELOVL2;ELOVL7;SPTLC1;DEGS1;SCCPDH;FA2H;CSNK1G2;SPTSSA;VAPA;SGPP1;SPHK2;SGPP2;SGPL1;ELOVL6;ALDH3B1;VAPB;HACD4;SAMD8;CERT1;SPNS2;ALDH3A2;ST8SIA6;ELOVL4;ELOVL5;CERS6
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.26036661040129516,0.7902645897909873,0.97,0.9369913885695169,1.0,108/476,22.28%,APOE;CD74;CXXC1;SPP1;COL1A1;ACTA2;MT3;HNRNPAB;ATF4;AKT1;KLF2;SOX18;ERBB4;LYL1;NPM1;AGT;ETS2;TNF;PDGFB;NR1D1;ACVRL1;CHEK2;YWHAH;CTNNB1;HES1;CDKN1C;RHOG;HIPK2;RNF187;OTX2;FOXF2;CEBPB;BRPF1;TRIM28;EDF1;FOXL2;SEC14L2;MLXIPL;EGR1;JUN;KARS1;NPAS3;APBB1;MYRF;WNT5A;SOX17;ATF5;POU3F1;WBP2;SOX8;KLF4;SOX9;PAX3;BMP2;RAI1;NME2;UBE2V1;ATMIN;NUP85;IRF7;MED30;NR1H2;MAPRE3;EBF3;HEY1;NCF1;ING1;VHL;GATA4;SKAP1;GLIS2;PCID2;BRCA2;PPARGC1A;MRPL12;CNBP;USP22;MAP2K2;MAZ;HMGN5;SOX11;CD86;INHBA;LBH;ESRRB;TFAP2B;NOTCH1;IL6;TGFB1;ING5;CITED2;MEF2C;FOXA2;SFRP1;CAPN3;TFAP4;MYC;FZD2;ID2;DDIT3;SOX10;FZD1;ZXDC;SS18L1;MAP2K7;REST;ESRRG;BLM
prerank,filopodium assembly (GO:0046847),0.3593348919098172,0.7902005429416746,0.7280927835051546,0.936712811640212,1.0,2/16,7.71%,DNM3;ARHGEF4
prerank,magnesium ion transport (GO:0015693),0.3795190236210817,0.7901767653618861,0.7493297587131368,0.9363731672946429,1.0,6/12,31.06%,NIPAL4;MAGT1;NIPA1;NIPAL1;NIPAL3;MMGT1
prerank,DNA metabolic process (GO:0006259),0.26666618322900215,0.7900756344964859,0.9148296593186372,0.9361418904145767,1.0,59/270,25.76%,RPS27A;UBC;UBB;PARK7;TERF1;NPM1;ENDOG;RAN;RNASEH2A;LTO1;MCM5;PARP1;HMGB3;VCP;RPA2;CDC34;UBA52;GMNN;TRIM28;HMGB1;DDB1;NEIL1;RNASEH1;APEX1;PCNA;NSMCE3;POLE4;CHRNA4;RFC2;TSN;PTGES3;GLRX2;RECQL5;POLD4;MUS81;CNBP;CTC1;NOP53;TERF2IP;RFC4;ERCC1;GADD45A;POLG;MEN1;ZNF445;BLM;CDC45;LONP1;POLD1;PNKP;BARD1;ATRIP;RPA3;RPAIN;DOT1L;XPC;LIG1;UBE2A;RAD51
prerank,glycogen catabolic process (GO:0005980),0.35181241160398014,0.7898855173592338,0.7276368491321762,0.936035623790237,1.0,1/15,0.80%,CALM1
prerank,positive regulation of ossification (GO:0045778),0.3042474368918259,0.7898250400927033,0.7686996547756041,0.9357504690636395,1.0,17/39,24.73%,FZD9;GPM6B;ISG15;NELL1;P2RX7;WNT5A;ATRAID;ATP2B1;TMEM119;BMP2;SLC8A1;SOX11;TGFB1;MEF2C;PTN;OSR2;CCN1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.33221325187418305,0.7896991585038744,0.772554002541296,0.9355544092546703,1.0,8/22,27.10%,CDKN1C;CEBPA;CAMK2N1;HEXIM1;TFAP4;MEN1;HHEX;CDKN1A
prerank,acylglycerol biosynthetic process (GO:0046463),-0.2526029553148766,-0.789166882493275,0.8106508875739645,0.9306775546831703,1.0,3/23,3.64%,PLCE1;AGMO;PLA2G4A
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3524667264059946,0.7887191436146795,0.77431906614786,0.9365725237957151,1.0,7/17,33.58%,MPDU1;DOLK;ALG3;NUS1;DPAGT1;ALG6;ALG2
prerank,regulation of vacuole organization (GO:0044088),0.3337941854648356,0.7886150316922339,0.7413572343149808,0.9363326731118949,1.0,4/20,16.28%,ENO1;IFT20;UBQLN2;ENO3
prerank,muscle tissue morphogenesis (GO:0060415),-0.2835415928920958,-0.7877875087748633,0.7887931034482759,0.9314715679720574,1.0,4/16,14.92%,TGFBR3;MYLK;BMP4;HEY2
prerank,mitochondrial fusion (GO:0008053),0.3425591344234732,0.7875755256713657,0.7647058823529411,0.9374318013734378,1.0,6/18,21.42%,BAX;GDAP1;MIEF2;SPG7;MFF;FIS1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3401229875223144,0.7875622798475159,0.7638888888888888,0.9370758351179602,1.0,8/20,25.99%,ADSS1;GART;AK4;AK3;IMPDH1;PAICS;IMPDH2;ADSL
prerank,regulation of DNA replication (GO:0006275),0.2993127811769097,0.7874991958541122,0.7953539823008849,0.9367874480398704,1.0,9/49,14.18%,S100A11;TERF1;ACVRL1;PPP2R1A;NUCKS1;GMNN;PCNA;FBXO5;CCDC88A
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.27908373273803644,-0.7873889504388256,0.7647058823529411,0.9306946263973278,1.0,5/17,17.44%,IL18;STAT3;CD46;JAG1;CD55
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.34427737316305684,0.7868613222916456,0.7456953642384105,0.9372855020258195,1.0,6/17,27.89%,PODXL;P2RY12;SKAP1;SYK;TGFB2;CD3E
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.29781231425845506,-0.7868371156568067,0.725925925925926,0.9301602124974668,1.0,3/12,10.62%,CACNA1C;DLG1;TRPM4
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3313350626580533,0.7864658803422969,0.7593052109181141,0.9374605594005784,1.0,5/21,15.99%,CTSL;ZFP36L1;ZFP36;SFRP4;DLL1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.2615890918757992,-0.7864420557819274,0.7903930131004366,0.9293060202401465,1.0,4/20,7.42%,MCU;MICU1;MICU2;SLC8B1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2619314986735601,0.7860503295991309,0.966,0.9376545141225854,1.0,98/417,21.84%,HSPA8;PFDN5;CALR;MT3;NDUFA13;TMPRSS6;ID3;SOX18;NRG1;ID1;CRYAB;EID1;CCDC85B;TNF;PDGFB;NR1D1;SPI1;ENO1;TLE5;CTNNB1;HES1;MAGEL2;EID2;CDKN1C;TBX22;GMNN;ARID4A;TRIM28;FOXL2;CREBZF;CEBPA;PROX1;BASP1;RBM15B;IKZF1;MLXIPL;MLX;CDK5R1;SET;JUN;BHLHE41;CTBP1;WNT5A;ATF5;L3MBTL4;ZBTB7A;BCL7A;SOX8;MAEL;SNW1;NCOR2;THRA;KLF4;SOX9;YWHAQ;BMP2;GAS6;FOXS1;HDAC5;ZC3H8;HEXIM1;NONO;L3MBTL1;SAMD11;NR1H2;CDK5;HEY1;DAB2IP;HDAC9;TCEAL7;PAX9;GLIS2;TWIST1;RLIM;ZHX1;COMMD7;CIR1;QARS1;CCAR2;ZBTB14;LBH;TFAP2B;NOTCH1;BEND5;TGFB1;CITED2;SFRP1;SAMD1;CAPN3;CBX3;TFAP4;ID2;DDIT3;SIRT2;SUDS3;DACH1;MEN1;PPM1F
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.36370607262559596,0.7860022843670076,0.7466487935656837,0.9373453852710925,1.0,6/14,32.08%,RASL10B;EDN3;CORIN;ECE1;ENPEP;ACE
prerank,regulation of muscle cell differentiation (GO:0051147),0.316805340090274,0.7852746791748839,0.7730496453900709,0.9379841158432906,1.0,12/31,24.83%,CTNNA2;BNIP2;CTNNB1;CAMK1;MAPK11;IGF2;HDAC9;MEF2C;ID2;CDK9;TCF3;SRF
prerank,negative regulation of autophagosome assembly (GO:1902902),0.35194154128058397,0.7852254788199109,0.7369127516778523,0.9376832513535348,1.0,2/13,9.04%,PINK1;NUPR1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.31960967847941235,0.7847782185090141,0.7575392038600723,0.9379361556632401,1.0,6/27,15.47%,AGT;ABCG1;LPL;MSR1;PF4;NR1H2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.33957861142552914,0.7838702302113838,0.7692307692307693,0.9388394890605387,1.0,1/18,0.84%,APOD
prerank,regulation of stem cell population maintenance (GO:2000036),0.33954099511142594,0.7831131589058509,0.7483617300131061,0.939480092829778,1.0,6/18,23.63%,TAF5L;ESRRB;MYC;REST;PTN;ELAVL1
prerank,positive regulation of T cell differentiation (GO:0045582),-0.21621224478300466,-0.7827504639924107,0.8543046357615894,0.933872080210821,1.0,5/36,7.93%,ZMIZ1;GLI3;GLI2;DUSP10;ZBTB1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.31459304131403415,0.782744413705651,0.7604290822407628,0.9396234970204626,1.0,9/29,28.00%,FKBP1A;S1PR1;PROX1;BMP2;NOTCH1;TGFB1;TCAP;ZFPM1;ENG
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.3027503463472787,-0.7822595618612516,0.7593984962406015,0.9332728966159972,1.0,4/11,17.61%,STAT3;PUM2;LIMD1;FMR1
prerank,histone H2A acetylation (GO:0043968),-0.26905476466367384,-0.781245099475671,0.7768595041322314,0.9334520658644887,1.0,4/16,12.29%,NAA40;EPC1;EP400;BRD8
prerank,negative regulation of insulin secretion (GO:0046676),0.34460098720058285,0.7809285810724192,0.7602564102564102,0.9417690156571968,1.0,7/17,23.18%,CHGA;PIM3;SFRP1;INHBB;CCN3;REST;PSMD9
prerank,myofibril assembly (GO:0030239),-0.2149146204043716,-0.7808978895509289,0.8947368421052632,0.9325669823245405,1.0,7/42,14.99%,TMOD3;CFLAR;ACTN2;PDGFRB;TPM1;OBSL1;TNNT3
prerank,iron ion transmembrane transport (GO:0034755),0.3788035656818473,0.7808781116696282,0.7382352941176471,0.9414662010652253,1.0,4/10,26.25%,ABCB6;SLC40A1;SLC25A37;ABCC5
prerank,base-excision repair (GO:0006284),0.29436093911582784,0.7807361214064297,0.8110236220472441,0.9412808795204646,1.0,15/48,25.40%,PARP1;RPA2;NEIL1;APEX1;PCNA;RFC2;POLD4;NEIL2;ERCC6;RFC4;POLG;POLD1;PNKP;RPA3;LIG1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.24889540360154616,-0.7806274345820222,0.8226600985221675,0.9316449457119813,1.0,10/21,28.31%,MAD1L1;ATM;MAD2L1;KLHL22;TTK;TPR;TRIP13;PLK1;KNTC1;BUB1
prerank,dephosphorylation (GO:0016311),0.26946919245477174,0.7803833735339233,0.8837920489296636,0.9413958745667595,1.0,52/147,25.89%,PPP1CA;PTPRC;CTDSP2;PPP2R1A;DUSP3;CTDNEP1;DUSP28;DUSP26;PTPRN2;CTDSP1;PHPT1;PTPRD;PTPRB;PTPRR;TIMM50;STK11;PTPRZ1;PDP2;NT5C;PPP2R5D;PPM1J;PDP1;PLPP6;TAB1;PPP3CA;PLPPR2;PGP;PPEF1;SGPP1;SSH2;SGPP2;PTPN6;PTPRU;PTPRO;PPP2R5A;DUSP2;DUSP23;PPM1F;PTPN5;DUSP12;DUSP1;PTPN1;PTPRE;DUSP15;SBF1;PNKP;ACP2;PPP1CB;PLPPR4;PTPRT;DUSP8;DUSP6
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.2575028241162311,-0.7801161486892724,0.8,0.931142330206068,1.0,6/20,14.92%,TGFBR3;TGFBR1;PDCD4;RBPJ;BMP4;HEY2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.30699509725238905,-0.7800775403904442,0.7275985663082437,0.9298006983689574,1.0,2/11,5.66%,FRS2;EFNB2
prerank,neuromuscular junction development (GO:0007528),0.323035981503053,0.7800196141816591,0.7512437810945274,0.9415420977027681,1.0,6/24,12.87%,ANK3;LRP4;MUSK;GPHN;DOK7;DCTN1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3828549198228975,0.7799631344248584,0.7614424410540915,0.9412437202582155,1.0,4/10,22.50%,B3GAT3;XYLT1;CSGALNACT2;B3GAT1
prerank,mitotic sister chromatid segregation (GO:0000070),-0.1765046464565286,-0.7799622672331472,0.9473684210526315,0.928579852595018,1.0,30/98,23.42%,EML4;PDS5A;NIPBL;PDCD6IP;MCPH1;PDS5B;PIBF1;POGZ;INO80;CSNK2A1;CSNK2A2;AKAP8L;CENPK;PHF8;PINX1;DSN1;CENPE;KLHL22;SMC4;KIF18B;NUP62;NDC80;KIF23;DIS3L2;TUBG1;KIF22;SMC1A;NCAPD3;MIS12;SGO1
prerank,negative regulation by host of viral process (GO:0044793),-0.3128282048476456,-0.7795619310330922,0.7100977198697068,0.9277997034275193,1.0,3/10,10.17%,PRKN;EIF2AK4;CCNK
prerank,amino sugar metabolic process (GO:0006040),-0.31759918480073795,-0.7793579441359776,0.7491525423728813,0.9267087878725087,1.0,3/10,15.55%,ST6GAL1;GNE;GFPT2
prerank,regulation of glucose transmembrane transport (GO:0010827),0.34002772458050257,0.778798586171395,0.7601572739187418,0.9424964065145682,1.0,4/18,13.79%,C3;SLC2A1;RSC1A1;CLIP3
prerank,smooth muscle tissue development (GO:0048745),-0.31834218915481755,-0.7785255268988389,0.7388535031847133,0.9266582367789234,1.0,5/10,21.22%,SMO;MYLK;BMP4;NF1;PTCH1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.29999346429906837,-0.7783315327257795,0.7643312101910829,0.925526281308516,1.0,4/12,14.99%,ELF1;ELF2;CBFB;PTPN22
prerank,defense response to protozoan (GO:0042832),0.37086537391865604,0.7782379619950017,0.7450424929178471,0.9428818485861108,1.0,4/12,23.93%,SLC11A1;PF4;BATF2;LYST
prerank,amino acid import (GO:0043090),0.3333223789028892,0.7782105662518647,0.7682775712515489,0.9425416013794314,1.0,4/21,12.43%,SLC7A5;TSPO2;SLC6A6;SLC1A1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.186824607464964,-0.7779530110209028,0.9574468085106383,0.9247315976697758,1.0,22/83,19.26%,ACVR1;BRD4;MNAT1;CDK6;CRLF3;NASP;TFDP1;CUL4B;CUL4A;LATS2;PHF8;PPP6C;ORC1;NPAT;CDK7;HINFP;USP37;CUL5;PLK2;POLE;KHDRBS1;CACUL1
prerank,establishment of vesicle localization (GO:0051650),0.3429224015494112,0.777916648884962,0.7780645161290323,0.9425686096704154,1.0,7/18,31.28%,SYT11;KIF5A;CDK5;KIF5C;TESK1;IKBKG;SPG11
prerank,protein localization to phagophore assembly site (GO:0034497),0.37374434231293274,0.7778692323538867,0.7318116975748931,0.9422677167858677,1.0,4/11,32.45%,ATG9A;WDR45;WIPI2;ATG13
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.31572359023808744,0.7776891273235621,0.7645631067961165,0.9421398060347828,1.0,11/27,31.51%,HTR2C;GRM1;GPR18;F2RL1;F2RL3;C3AR1;GPR17;OPRL1;F2RL2;GPR35;DRD2
prerank,regulation of cellular biosynthetic process (GO:0031326),0.31229324473430997,0.7768471535069839,0.7704326923076923,0.9429331860249206,1.0,3/28,5.31%,C3;RAC1;SIRPA
prerank,metanephros development (GO:0001656),-0.23151053671279878,-0.7766398288898048,0.8693467336683417,0.9253577645920095,1.0,10/26,24.71%,FOXD1;NIPBL;PKD1;SIX1;BMP4;NF1;PKD2;PTCH1;GDNF;FGF10
prerank,eye photoreceptor cell development (GO:0042462),-0.26580880717051647,-0.7762575938452446,0.7846715328467153,0.924587801379368,1.0,3/15,9.39%,CEP290;RPGRIP1L;TOPORS
prerank,V(D)J recombination (GO:0033151),0.37409653068629967,0.7754353542684828,0.7545327754532776,0.9444668341527402,1.0,3/11,25.40%,HMGB1;TCF3;LIG1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3154286234101358,0.7752845296630191,0.7792682926829269,0.9443000760664285,1.0,6/26,16.17%,CCL19;PTPRC;HTR2C;TRPM2;RYR2;ERO1A
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.30758553980733544,0.7744572878638206,0.7845968712394705,0.9450135068887876,1.0,3/31,4.81%,RPS2;PINK1;PIN1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.2915462634658753,-0.7743091402198308,0.7732342007434945,0.9261771458770982,1.0,5/12,25.75%,BDH2;GGCT;GGT1;GCLC;MGST2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.27212613410586084,0.7739167836377593,0.8574401664932362,0.945377721847762,1.0,35/95,26.25%,BGN;BCAN;FMOD;LUM;HEXA;HS3ST6;HS3ST5;DCN;CHST1;B4GALT6;SDC4;GPC5;CHPF2;B3GAT3;CHPF;UGDH;XYLT1;VCAN;B3GNT3;SDC3;HS3ST2;HSPG2;AGRN;CSGALNACT2;HS6ST1;CHSY3;ACAN;B4GALT3;CHST14;PRELP;CHST9;CSPG5;HS6ST2;GPC1;ABCC5
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.2725270064497082,-0.7735891476755353,0.8008130081300813,0.9258738758845363,1.0,5/14,17.16%,GAB1;NRP1;VEGFB;VEGFC;VEGFD
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.32424648795209243,0.7734903429725571,0.7735148514851485,0.9455866256566282,1.0,6/23,23.58%,HSP90AB1;CDC37;IFNGR1;NR1H2;IFNGR2;SOCS3
prerank,regulation of mitochondrial fission (GO:0090140),0.3231042457516627,0.7731202325863515,0.7882496940024479,0.9457030794051229,1.0,9/24,22.92%,PINK1;KDR;MAPT;DCN;MIEF2;MFF;DNM1L;FIS1;SPIRE1
prerank,neuromuscular process (GO:0050905),0.3511823844174812,0.7727184024091489,0.7536423841059603,0.9458736368505245,1.0,3/16,16.10%,NRXN1;DCTN1;KCNA1
prerank,positive regulation of histone modification (GO:0031058),0.30627294292624213,0.7726158684682072,0.789044289044289,0.9456410172599323,1.0,8/33,27.17%,MAPK3;APLNR;CTBP1;PPARGC1A;SAP30BP;CDK9;PAXIP1;RUVBL2
prerank,protein import into peroxisome membrane (GO:0045046),0.3239285408770243,0.7723137713900351,0.7679697351828499,0.9456659042553316,1.0,10/22,35.64%,PXMP2;GDAP1;FIS1;PEX11B;ABCD2;ALDH3A2;PEX14;PEX2;ATAD1;PEX13
prerank,blood vessel diameter maintenance (GO:0097746),0.3048319477327929,0.7718576289052614,0.7983392645314353,0.9459180474789133,1.0,3/34,3.42%,KLF2;AGT;GPER1
prerank,renal system development (GO:0072001),0.28385022143373223,0.771515981917526,0.821826280623608,0.9460145685918474,1.0,8/52,11.69%,RBP4;AGT;LRP4;HYAL2;PROX1;C1GALT1;SOX17;WFS1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.31136657769207776,0.7712913913945032,0.797153024911032,0.9459360878561379,1.0,8/29,23.94%,YBX1;PABPC1;SLC11A1;HNRNPU;CIRBP;EIF4ENIF1;ELAVL1;DND1
prerank,microvillus organization (GO:0032528),0.3563078260144328,0.7712564168487532,0.7479108635097493,0.9456076547921788,1.0,1/13,1.80%,FXYD5
prerank,mitochondrion distribution (GO:0048311),0.36375171954885194,0.7712239203669802,0.7482614742698191,0.9452737312539373,1.0,5/12,18.82%,MAPT;HAP1;DNM1L;ATCAY;ARMC1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.29934538473387057,-0.7711508489915498,0.7582417582417582,0.9282004020720036,1.0,3/12,16.59%,IL18;CD80;IL17D
prerank,regulation of vasoconstriction (GO:0019229),0.3165501678760636,0.7706926734818486,0.7789855072463768,0.9456213207567437,1.0,6/27,16.42%,AGT;CHRM3;ATP2B1;ADRA1D;ADRA1A;CAV1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.297896108639806,-0.7706699318502621,0.7644787644787645,0.9274966284160974,1.0,7/12,34.64%,BDP1;GTF2A2;TAF7;TAF1;POLR1E;GTF2B;TAF7L
prerank,positive regulation of vasoconstriction (GO:0045907),0.3592250135120809,0.7704912715274103,0.7621696801112656,0.9455166914857495,1.0,3/13,16.42%,ADRA1D;ADRA1A;CAV1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.19233489831681475,-0.7704864742984061,0.9459459459459459,0.9264291897605984,1.0,15/57,17.54%,BABAM2;FOXN3;RINT1;MDC1;UIMC1;TAOK3;ATF2;MRNIP;TIPIN;ATM;RAD17;TAOK1;CLSPN;TP53;WAC
prerank,positive regulation of telomere capping (GO:1904355),0.3393898844471882,0.7694541196008148,0.7805194805194805,0.9465434756465925,1.0,8/17,33.04%,MAPK3;MAPK15;MAP2K7;PNKP;PRKCQ;AURKB;HNRNPD;PKIB
prerank,mRNA modification (GO:0016556),0.3276263392403446,0.7689592936372622,0.7785977859778598,0.9468247122533584,1.0,8/22,25.02%,PCIF1;CMTR1;TRUB2;DKC1;PUS7;TRMT10C;METTL3;METTL14
prerank,intestinal absorption (GO:0050892),0.35563981219936613,0.7677793900491049,0.7691275167785235,0.9479848311399852,1.0,7/13,43.31%,SLC2A2;KCNQ1;CD36;SLC26A6;F11R;ADRA2A;UGCG
prerank,tRNA 5'-leader removal (GO:0001682),0.3610441233144436,0.7670975360467337,0.75,0.9485233998997676,1.0,2/13,13.83%,POP7;POP4
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.2937835976870189,0.767086998668113,0.8136363636363636,0.9481617268222569,1.0,10/40,19.83%,MDK;COL1A1;CTNNB1;BMP2;SDCBP;TIAM1;TWIST1;NOTCH1;IL6;TGFB1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.37399531133812536,0.7669911484280529,0.7748251748251749,0.9479115293970352,1.0,4/11,20.07%,GPER1;GATA4;TGFB1;MEF2C
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3124168699241107,0.7663846996870178,0.7822878228782287,0.9483536223734074,1.0,6/26,18.07%,AKT1;CCND2;CCND1;AIF1;ADAM17;ADAMTS1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2532015535216508,0.7662723755975639,0.997,0.9481424897751599,1.0,164/807,20.51%,RPL23;RPS27A;HSPA8;RPS14;UBC;PFDN5;UBB;CALR;MT3;HSBP1;VPS72;NDUFA13;RPL10;TMPRSS6;ATF4;KLF2;MAF1;ID3;SOX18;NRG1;ID1;CRYAB;PRDX5;EID1;CCDC85B;ETS2;TNF;PDGFB;DRAP1;NR1D1;SPI1;ENO1;PARP1;TLE5;CTNNB1;FLNA;HES1;TENM2;IRF2BP1;MAGEL2;EID2;CDKN1C;TBX22;UBA52;CCND1;CEBPB;GMNN;ARID4A;FOXD3;PRDM12;TRIM28;FOXL2;CREBZF;DUSP26;CEBPA;CBX6;PROX1;BASP1;NR2F6;RBM15B;BCL6B;IKZF1;MLXIPL;MLX;CDK5R1;SARS1;SET;JUN;SIN3B;HMGB1;BHLHE41;ZFP36;H1-0;IRF8;APBB1;AEBP1;SUPT4H1;CTBP1;WNT5A;ATF5;L3MBTL4;ZBTB7A;WFS1;IRF2BPL;BCL7A;SOX8;MAEL;SNW1;NCOR2;IRX3;THRA;KLF4;THAP11;SOX9;YWHAQ;IRF2BP2;CRYM;BMP2;GAS6;LEFTY1;FOXS1;HNRNPU;HDAC5;ZC3H8;HEXIM1;SDCBP;IRF7;IKZF5;NONO;L3MBTL1;DNAJB1;SAMD11;IGF2;NR1H2;KDM1B;CDK5;HEY1;MIER2;DAB2IP;HDAC9;BATF3;CAV1;DNMT3B;TCEAL7;VHL;PAX9;GLIS2;TWIST1;RIPPLY2;BCL11A;RLIM;ZHX1;TCF25;CNBP;MYT1L;COMMD7;NOP53;CIR1;MAZ;MTA2;QARS1;SOX11;CCAR2;SNCA;MUC1;HIC1;ZBTB14;LBH;TFAP2B;NOTCH1;KLF11;EFNA1;BEND5;TGFB1;CHD3;POU4F1;CITED2;MEF2C;SFRP1;SAMD1;CAPN3;CBX3;TFAP4;MYC
prerank,purine-containing compound biosynthetic process (GO:0072522),0.31917406486383254,0.7662388587414944,0.7926829268292683,0.9478204628436763,1.0,12/25,31.95%,APRT;GART;PNP;PRPS1L1;PRPS1;PAICS;SHMT2;PRPSAP1;ADSL;ADA;DGUOK;DCK
prerank,ruffle organization (GO:0031529),0.34545717340915966,0.7661883534826699,0.7566844919786097,0.9475097522881255,1.0,4/16,12.35%,RAC1;ARF6;CSF1R;AIF1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.30300535725371397,0.7661359921174891,0.7933094384707288,0.9471905145555128,1.0,8/34,19.83%,CCL19;PDGFB;P2RY12;PIK3IP1;DAB2IP;FLT1;FLT3;TGFB1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.2935770860397566,0.7660243855374981,0.8072855464159812,0.9469679711447448,1.0,8/37,15.68%,STMN3;FAM107A;CLASP1;MAPT;STMN4;CDK2AP2;STMN1;MAPRE3
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.28684847754865056,0.7657274952300696,0.8335195530726257,0.9469753763096087,1.0,12/48,19.67%,TREM2;PTPRC;ISG15;GAS6;NLRP2B;F2RL1;NR1H2;SIGIRR;SLIT3;OAS3;TRAIP;IL6
prerank,heart morphogenesis (GO:0003007),0.2863932055357971,0.7656778315539443,0.8189944134078212,0.9466753876829911,1.0,11/50,15.89%,ACVRL1;FKBP1A;HES1;ALPK2;SOX17;SOX9;BMP2;LEFTY1;DLC1;HEY1;RYR2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.35642505045416534,0.765401250520595,0.78125,0.9466718598609791,1.0,6/13,33.58%,MPDU1;ALG3;ALG11;DPAGT1;ALG6;ALG2
prerank,regulation of TORC1 signaling (GO:1903432),0.30473076389788206,0.7652500270754471,0.8173190984578885,0.9464902122741842,1.0,8/33,16.15%,LAMTOR5;GPR137B;PIP4P1;GPR137C;PIH1D1;STK11;RRAGC;RRAGD
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3301675357221142,0.7650332989479047,0.7876447876447876,0.9464011574179301,1.0,2/19,6.02%,SULT4A1;BPNT2
prerank,negative regulation of cellular protein localization (GO:1903828),0.30156162257581065,0.7649602650337404,0.8059701492537313,0.9461281042817993,1.0,6/34,11.32%,MAP1A;SPI1;GPM6B;LEPROT;MAPT;DNAJA1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.324419805610252,0.764855932109374,0.7747747747747747,0.94590316458116,1.0,6/22,20.06%,GNAI2;DRD5;CAP1;ORAI1;CCR2;GABBR2
prerank,"transcription, DNA-templated (GO:0006351)",0.25792469324904105,0.7648004791896863,0.9323915237134208,0.9456061992434094,1.0,39/207,21.89%,PTMA;ELOB;TSC22D1;POLR2E;ATF4;POLR2D;POLR2F;DRAP1;BTF3;GTF3C6;PARP1;XAB2;TAF10;NELFCD;TAF5L;TAF9;POLR2G;DEK;SUPT4H1;SSRP1;THRA;POLR2K;IVNS1ABP;RO60;UBTF;RRAGC;ARRB2;NELFE;MRPL12;ERCC6;KLF13;TBP;MLF1;GTF3A;POLR2H;IRF9;CDK9;ELOC;POLR3K
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.28748829863847647,-0.7644582171998643,0.7931034482758621,0.9339282644328267,1.0,2/13,13.39%,GLI3;CBFB
prerank,endocrine system development (GO:0035270),0.3243882152953235,0.7641150821924653,0.793233082706767,0.9461519950066836,1.0,1/21,1.22%,MDK
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3182906093455461,0.7637143073626919,0.7957393483709273,0.9463013253095081,1.0,8/22,31.75%,SLC7A5;IL2;IL6;TGFB1;RFTN1;PRKCQ;NOD2;LY9
prerank,nuclear export (GO:0051168),0.27196883774517094,0.7635282342119468,0.8688699360341151,0.946164348461078,1.0,17/80,20.61%,CALR;MAGOHB;MAGOH;DDX39B;RAN;SRSF9;XPO1;SRSF2;HNRNPA1;THOC3;EIF4A3;U2AF1L4;DESI1;TGFB1;ALYREF;RAE1;SRSF1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.30870133864389804,0.7633698223441745,0.7736077481840193,0.9460153373113481,1.0,3/25,6.54%,AUP1;VCP;OMA1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3115640619432411,0.7630291910773823,0.8053204353083434,0.946092485425762,1.0,14/29,34.73%,LSM4;LSM6;EXOSC2;EDC4;EXOSC9;LSM7;EXOSC4;LSM5;LSM2;CNOT8;HBS1L;EXOSC3;CNOT6;DCPS
prerank,negative regulation of metabolic process (GO:0009892),0.28268978459640653,0.762911739611784,0.8304347826086956,0.9458886463818227,1.0,14/54,21.42%,ATF4;ID1;APOC1;NR1D1;WNT10B;STK11;ARRDC3;NR1H2;PLCL2;ADAM17;IP6K1;NOTCH1;DDIT3;FIS1
prerank,protein deacylation (GO:0035601),0.3219297066823974,0.7621376496871375,0.7843631778058008,0.9465012695239922,1.0,5/23,21.36%,LYPLA2;ABHD17A;HDAC5;NOTUM;SIRT2
prerank,negative regulation of JNK cascade (GO:0046329),0.3048126614769703,0.7620198038781404,0.8079231692677071,0.946278110071209,1.0,6/31,14.62%,PINK1;DUSP3;SIRPA;DNAJA1;MAPK8IP1;F2RL1
prerank,respiratory system development (GO:0060541),0.3058851843925912,0.7620158789688386,0.8104046242774566,0.9459165293359316,1.0,4/32,8.19%,RBP4;CEBPA;PROX1;BASP1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3412384641298636,0.7619652615958176,0.7771883289124668,0.9456146592022947,1.0,2/15,4.23%,CSNK2B;FKBP1A
prerank,regulation of histone deacetylation (GO:0031063),-0.2836185482717476,-0.7619131302632672,0.7940074906367042,0.9362793727594853,1.0,5/13,16.75%,CAMK2D;NIPBL;AKAP8L;ING2;PRMT6
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3578250916862021,0.7618282923951173,0.7720488466757124,0.9454269167128058,1.0,5/12,23.94%,TNF;NCOR2;TGFB1;ELAVL1;DND1
prerank,male meiosis I (GO:0007141),-0.2707686253466833,-0.7616796279727102,0.8026315789473685,0.935237203096824,1.0,12/16,43.18%,MYBL1;ING2;ZSCAN21;SYCP3;FOXJ3;SLC25A31;BRDT;MOV10L1;CCNA1;DNMT3L;MEIOC;BTBD18
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.2908572534907005,-0.7615169282391343,0.7627118644067796,0.934112672699602,1.0,4/12,15.12%,YTHDC1;CDYL;PCGF5;SMCHD1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.31943444791234776,0.7614803906716917,0.7851662404092071,0.945525642956393,1.0,3/24,7.94%,H3-3A;SPI1;CREBZF
prerank,protein neddylation (GO:0045116),0.35511174743339213,0.7614295524609501,0.7920656634746922,0.9452216306936426,1.0,4/13,16.09%,UBE2M;RBX1;NEDD8;RNF7
prerank,secretion (GO:0046903),-0.27892427435601097,-0.7613483042649614,0.8,0.9329429551808797,1.0,3/14,14.26%,SLC22A4;SLC22A6;PRKCI
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.2733966372051416,-0.7611931130373869,0.79296875,0.9318050985001908,1.0,4/13,15.22%,CNOT1;MOV10;CNOT7;ZC3HAV1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2693322786830753,0.760993074289984,0.8419388830347735,0.9454080418375181,1.0,19/80,20.52%,CCL19;NLGN1;RAC1;TENM2;PFN1;P2RX7;KCTD17;P2RY12;DEF8;FNBP1L;HRAS;ANLN;CCDC88A;F2RL1;RAC2;ARPC2;GPM6A;AGRN;CDC42EP2
prerank,regulation of interleukin-1 production (GO:0032652),0.34021027378389435,0.7609141189610648,0.7653194263363755,0.9451436020761098,1.0,4/15,21.28%,SIRPA;HMGB1;GAS6;TMED10
prerank,organelle fission (GO:0048285),0.3164140096181497,0.7608499037815831,0.7829268292682927,0.9448676608616996,1.0,9/24,26.03%,DNM3;CORO1C;GDAP1;MFF;DNM1L;FIS1;DNM1;MTFR1L;PEX11B
prerank,regulation of mitotic nuclear division (GO:0007088),0.2833613858297456,0.7607600835145641,0.8201997780244173,0.9446157164615283,1.0,14/55,25.38%,AURKAIP1;PDGFB;PIN1;CAV2;FBXO5;L3MBTL1;IGF2;EDN3;TGFA;DUSP1;CCDC8;CD28;RCC1;KIF20B
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.37051142405128085,0.7604968845784804,0.7695473251028807,0.94458773744293,1.0,3/11,16.40%,GPM6B;LEPROT;SNX33
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.350619223645696,0.7602858494941779,0.7912087912087912,0.9444888655233225,1.0,5/13,23.30%,B3GNT9;B3GNT3;B3GALT5;GAL3ST3;B3GALT2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.34476923140626814,0.7595592649213906,0.7828418230563002,0.9450578419546103,1.0,2/16,5.85%,PIGZ;PIGQ
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.31653624428087423,0.7595088451034482,0.7836185819070904,0.9447462855610756,1.0,6/25,19.11%,ANG;DSCAM;MIF;SDCBP;PTGES3;SNCA
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.29543434005420827,-0.7594929339231624,0.7758007117437722,0.9328024715727175,1.0,5/12,19.09%,SDK2;STAT3;CEP290;NKD1;AGTPBP1
prerank,ncRNA 3'-end processing (GO:0043628),0.3473772302389337,0.7594446361704328,0.7684069611780455,0.944465488877634,1.0,7/14,32.10%,ELAC2;TOE1;TRNT1;ERI1;INTS12;INTS5;INTS6L
prerank,regulation of innate immune response (GO:0045088),0.2774152093965079,0.7592966240387146,0.8514851485148515,0.9442843377127204,1.0,13/57,23.06%,HSP90AB1;TREM2;TIRAP;TNFAIP3;SLC15A4;CDC37;LRP8;TYRO3;PTPN6;POLR3D;AKIRIN2;ERAP1;PTPN1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.221565760094453,-0.7586336443546101,0.9191176470588235,0.9325559797457195,1.0,8/38,14.17%,CACNA1C;CAMK2D;ANK2;AKAP9;TRPM4;KCNJ2;CACNA1G;CACNA1D
prerank,dendrite morphogenesis (GO:0048813),0.2977813992925739,0.7585649362130008,0.8105882352941176,0.9448525115954168,1.0,11/35,23.14%,CTNNA2;LRP4;MAP2;PAK3;DOCK10;TMEM106B;MAPK8IP2;EPHB1;CTNND2;WNT7A;PTN
prerank,regulation of keratinocyte differentiation (GO:0045616),0.3122401903905948,0.7583288966030223,0.8132678132678133,0.9447699490291044,1.0,4/24,13.67%,CTSL;ZFP36L1;ZFP36;NME2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.32823250436967527,0.7582829491674818,0.7921419518377694,0.9440962366955001,1.0,4/21,10.13%,PARP1;RPA2;RBX1;DDB1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.32823250436967527,0.7582829491674818,0.7921419518377694,0.9440962366955001,1.0,4/21,10.13%,PARP1;RPA2;RBX1;DDB1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.36806514686388936,0.7582358927397882,0.7902097902097902,0.9437922861359717,1.0,3/11,12.73%,ELOF1;SERTAD1;ZMIZ2
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.28751636074634523,-0.758065211127722,0.764,0.9320041823907883,1.0,2/13,7.68%,ADHFE1;DLST
prerank,lipid modification (GO:0030258),0.2904513098279022,0.7578559046642609,0.8074745186862967,0.9439139160297522,1.0,18/37,33.27%,DGKH;DGKI;PLA2G7;PLPP6;PLPPR2;PORCN;SGPP1;SGPP2;DGKK;DGKB;CYP2E1;PLPPR4;MBOAT7;PLPP4;DGKZ;DGKG;PLPPR5;MBOAT1
prerank,dorsal/ventral pattern formation (GO:0009953),0.3208570329183633,0.7576540014569886,0.7833125778331258,0.9438119689652816,1.0,2/20,4.15%,NBL1;ACVRL1
prerank,bile acid biosynthetic process (GO:0006699),0.31336751384063444,0.7567035932646093,0.7955665024630542,0.9446806555448949,1.0,6/24,22.19%,SCP2;HSD17B4;OSBPL6;OSBPL3;CH25H;OSBPL1A
prerank,positive regulation of mRNA processing (GO:0050685),0.3205378533940286,0.7563798133375443,0.7997481108312342,0.9447319934465279,1.0,5/21,16.07%,PRDX6;NCL;SNW1;CIRBP;CELF3
prerank,epithelial cell development (GO:0002064),0.32605061664293655,0.7558186122050233,0.792191435768262,0.9450500350848251,1.0,1/20,1.46%,ACTA2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3620871332387856,0.7555555761703846,0.7865771812080536,0.9450348119548633,1.0,2/12,4.18%,PDGFB;IGFBP5
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.33448645088997364,0.7551977538055753,0.7799736495388669,0.9451283149061698,1.0,4/17,16.21%,CTNNA2;DNAI3;ARF1;GMFB
prerank,epithelial to mesenchymal transition (GO:0001837),0.28445098839818006,0.7550684755629118,0.8352272727272727,0.9449242081769264,1.0,14/47,19.83%,HNRNPAB;CTNNB1;FOXF2;TRIM28;WNT5A;SOX9;BMP2;AKNA;HEY1;S100A4;FAM83D;NOTCH1;HGF;TGFB1
prerank,histone monoubiquitination (GO:0010390),-0.23493108781685879,-0.7547021939714408,0.8704663212435233,0.9353086531863,1.0,9/24,23.84%,BCOR;DDB2;CUL4B;CDC73;UBE2E1;WAC;RNF20;CTR9;RYBP
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.3647561635173694,0.7544269252894114,0.7727910238429172,0.9453581821517347,1.0,1/11,3.61%,CANX
prerank,regulation of cartilage development (GO:0061035),0.3337231860338314,0.7542509926993122,0.7902187902187903,0.9452140551307151,1.0,4/18,17.68%,MDK;SOX9;BMP2;SCIN
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.34318474175320457,0.7540630778033178,0.7878378378378378,0.9450861340214385,1.0,3/14,14.73%,TIRAP;TLR6;COPS8
prerank,endomembrane system organization (GO:0010256),0.2557228948675109,0.7521538751552629,0.920523138832998,0.9471474938950784,1.0,34/178,17.51%,ANK3;LMAN2;ATP8B4;SYNGR2;CAV2;CHMP2B;CTDNEP1;REEP5;BAG5;TMED7;SYNGR1;LMAN1;SURF4;REEP6;TMED2;CLASP1;TICAM2;TMED3;ARHGEF7;SRGN;TMED9;SERP1;ARL1;TMED1;SEC61A1;VMP1;SYP;SNX33;USP8;SQSTM1;DNM1L;SYNE1;LNPK;HOOK1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.33363057537534946,0.752137959689878,0.8075949367088607,0.9468016265230811,1.0,4/17,18.54%,TERF1;NEIL1;NEIL2;TERF2IP
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.35907856071892935,0.7521278566647807,0.7651933701657458,0.9464485479583808,1.0,3/11,21.50%,CTNNB1;WNT5A;FZD1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.24609809197148347,0.7516571414910522,1.0,0.9466596898289005,1.0,231/1082,22.29%,APOE;RPS27A;CD74;UBC;UBB;CHCHD10;CD81;PCBP1;CXXC1;SPP1;COL1A1;ACTA2;MT3;CHCHD2;JUND;PARK7;TMPRSS6;MAPK3;HNRNPAB;ATF4;AKT1;KLF2;SOX18;PTPRN;ELOF1;ERBB4;LYL1;POMC;NPM1;AGT;DDX39B;GPER1;EIF5A;ETS2;BEX1;TNF;PDGFB;DRAP1;NR1D1;HCLS1;ACVRL1;CHEK2;SPI1;EPAS1;GLMP;JUNB;PIN1;YWHAH;PSMC3;PARP1;MRTFA;CTNNB1;ST18;GRIN1;SERTAD1;HES1;HYAL2;CDKN1C;HMGN1;RHOG;HIPK2;CDK8;RNF187;OTX2;UBA52;FOXF2;CEBPB;FOXD3;BRPF1;TRIM28;EDF1;NAMPT;SALL2;FOXL2;CEBPA;PROX1;SEC14L2;CXCL10;CREB3L4;CREB3;CSRNP3;YBX1;MLXIPL;MLX;EGR1;RRP1B;HOXD4;GATA2;JUN;DCN;CAMK1;KARS1;HMGB1;ZBTB49;TAF9;RFX4;RTRAF;H1-0;HOXB7;PHOX2A;MC1R;NPAS3;IRF8;APBB1;SUPT4H1;MYRF;APEX1;WNT5A;IL11;SOX17;ATF5;POU3F1;KDM6B;SS18L2;IRF2BPL;WBP2;HRAS;PTOV1;SOX8;SNW1;IRX3;ZMIZ2;DBP;THRA;KLF4;HOXD8;SLC11A1;SOX9;PAX3;LILRB1;BMP2;RIPK2;RAI1;NME2;HNRNPU;TNFRSF1A;HDAC5;ZC3H8;UBE2V1;ATMIN;NUP85;IRF7;MED30;F2RL1;PF4;AKNA;LAGE3;UBTF;IGF2;ARF4;NR1H2;KDM1B;MAPRE3;EBF3;HEY1;NCF1;DLL1;IER5;ING1;DAB2IP;E2F4;VHL;GATA4;BCL11B;SQSTM1;SKAP1;GLIS2;TWIST1;PCID2;ADCYAP1;BRCA2;PPARGC1A;MED21;MRPL12;ERCC6;AGO1;CNBP;TOX2;LMO1;USP22;MAP2K2;MAZ;HMGN5;NRL;SOX11;PPP3CA;DDRGK1;CD86;INHBA;LBH;NLRP3;ESRRB;TFAP2B;NOTCH1;IL6;HGF;TGFB1;AGRN;ING5;ALYREF;POU4F1;CITED2;MEF2C;FOXA2;SFRP1;CAPN3;TFAP4;MYC;NFKBIA;FOSL2;FZD2;CDC5L;ID2;DDIT3;CEBPZ;CDK9;SOX10;FOXA1;CKAP2;SIRT2;FZD1;ZXDC;MEN1;SS18L1;MAP2K7;IRF5;REST;ESRRG;BLM;GRHL2;TNIP1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3063662604707703,0.7506555231535776,0.8265424912689173,0.9475416187826189,1.0,8/30,19.63%,TGM2;EPOR;VAV1;ERBIN;MMD2;RASGRP1;RASGRF1;NOTCH1
prerank,negative regulation of DNA binding (GO:0043392),-0.2256165463119883,-0.7502770626400908,0.8608247422680413,0.9400411917109402,1.0,6/28,14.92%,SMO;PER2;SP100;ILRUN;RSF1;HEY2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.2672783008462887,-0.7501769725548731,0.8205128205128205,0.9388118630904031,1.0,3/15,8.51%,DAB2;SMAP1;AAK1
prerank,protein ubiquitination (GO:0016567),0.2489739919622037,0.7498243932335786,0.988,0.9482249486167235,1.0,86/471,20.67%,RPS27A;UBC;RACK1;UBB;PSMB4;ELOB;PSME1;PSMB6;PSME2;PSMB8;PSMD2;UBE2Z;PINK1;KCTD10;FBXO15;KLHL9;PSMD1;EPAS1;UBE2G2;PSMC3;CTNNB1;PSMD6;VCP;IRF2BP1;UBE2Q1;CDC34;DCAF15;RNF187;UBA52;ARRDC1;PSMA7;ISG15;USP5;FBXL14;OTULIN;NHLRC1;PRPF19;PSMD5;RBX1;NEDD8;FBXO27;TRIM2;TNFAIP1;DDB1;PSMB9;PSMD13;RBCK1;KLHL7;PSMB3;FBXW5;SYVN1;PCNA;PSMB11;ZSWIM8;FBXW7;FBXO30;FBXO31;PSMB10;RNF40;UBE2V1;RNFT1;PSMB1;ARRB2;RNF7;ENC1;PSMB5;VHL;TRIM32;RUSC1;RNF181;RLIM;USP22;TRAIP;RNF208;KCTD13;PSMA6;RNF144B;FBXL16;HECW1;TRIM13;RNF11;SKP1;PSMA4;UBE2QL1;KLHL25;BRAP
prerank,ncRNA metabolic process (GO:0034660),-0.21391384848927397,-0.7495505898060429,0.9090909090909091,0.9382872074142885,1.0,10/37,16.50%,TENT4B;DICER1;PARN;DROSHA;ZCCHC8;TUT7;DDX17;TARBP2;TUT4;AGO2
prerank,calcium ion transmembrane transport (GO:0070588),0.26490313607916444,0.7493018350395734,0.8856243441762854,0.9485087033861392,1.0,17/86,15.37%,SMDT1;SLC24A4;SLC24A2;FKBP1A;GRIN1;CACNA1A;TMCO1;P2RX7;GRIN2A;PMPCB;TRPM2;TRPC7;ATP2B1;GAS6;TRPC1;SPG7;SLC8A1
prerank,fat cell differentiation (GO:0045444),0.276108986222287,0.7492110072125775,0.8494505494505494,0.9482593827698264,1.0,14/57,17.36%,PSMB8;BSCL2;CEBPA;STEAP4;SDF4;CTBP1;IL11;ATF5;ZBTB7A;SOX8;KLF4;CLIP3;TRIM32;PPARGC1A
prerank,telomere maintenance (GO:0000723),0.2800694214643006,0.7491832619854379,0.8315098468271335,0.9479267001749934,1.0,14/50,25.76%,TERF1;LTO1;PARP1;RPA2;APEX1;PCNA;PTGES3;POLD4;CTC1;TERF2IP;BLM;POLD1;RPA3;RAD51
prerank,regulation of GTPase activity (GO:0043087),0.2570440037784949,0.749040576538429,0.9284994964753273,0.9477430452760653,1.0,40/177,21.45%,RACK1;SOD1;CCL19;S100A10;TGM2;RASIP1;NTRK2;PIN1;CAV2;STMN3;ARHGAP9;TMED2;ARHGAP15;THY1;NET1;GPR137B;RRP1B;EPHA5;ARHGEF7;RGS10;DOCK10;HRAS;VAV1;DOCK8;VAV3;CCL2;ARL2;F2RL1;RASGRP1;DAB2IP;CCL3;ADCYAP1;CCL8;RASGRF1;RGS7;AGRN;SFRP1;DOCK9;RGS6;PLXND1
prerank,response to peptide (GO:1901652),0.30167677362345324,0.7488009482614052,0.8109393579072532,0.9476937104968954,1.0,15/33,29.85%,PRNP;CACNA1A;GNAI1;MMP3;RAMP3;ERBIN;EIF2B5;IRF5;AGER;CACNA1B;STAT4;CHRNA7;NOD2;EIF2B1;MMP2
prerank,microvillus assembly (GO:0030033),0.34391264676404387,0.7482274887878546,0.7830319888734353,0.9480199713267403,1.0,1/14,1.80%,FXYD5
prerank,keratinocyte differentiation (GO:0030216),-0.22904774585726306,-0.7480723250324568,0.8705882352941177,0.9389000130751601,1.0,7/29,14.38%,ADAM9;BCR;PIP5K1A;WNT16;JAG1;CASP3;CLIC4
prerank,lymphocyte mediated immunity (GO:0002449),0.3500556823181126,0.7478073053781608,0.7983539094650206,0.9481806211993982,1.0,1/12,4.16%,BTN3A3
prerank,cardiac atrium morphogenesis (GO:0003209),0.33749900156796975,0.7477601051067994,0.821522309711286,0.9478780171454193,1.0,8/16,28.00%,PROX1;BMP2;GATA4;NOTCH1;TGFB2;ZFPM1;DLL4;ENG
prerank,spindle assembly (GO:0051225),0.2717747134230523,0.7474453446273386,0.8644610458911419,0.9479009031727058,1.0,11/67,18.88%,RPS3;CHEK2;FLNA;ABRAXAS2;CLASP1;SAC3D1;RHOA;HAUS2;MAPRE3;TOGARAM2;KIFC2
prerank,membrane lipid metabolic process (GO:0006643),0.31508688917352345,0.7474389729890579,0.8121890547263682,0.9475458129746334,1.0,5/22,20.24%,SERINC1;GAL3ST1;SPTLC1;CERKL;SPHK2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.30116851759291735,0.7468848237015163,0.8281622911694511,0.9478707623735233,1.0,6/31,14.26%,GPNMB;FAM107A;JADE1;CDK2AP2;KLF4;CCL2
prerank,regulation of hydrolase activity (GO:0051336),0.26937847082316413,0.7467578460008324,0.8731501057082452,0.9476661310651522,1.0,13/71,16.42%,SOD1;RASIP1;NTRK2;ATP5IF1;STMN3;ARHGAP9;ARHGAP15;GPR137B;EPHA5;VAV1;VAV3;DAB2IP;CAV1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.19504542626609206,-0.7466611147909097,0.96,0.9393544080806077,1.0,16/48,23.06%,PRKAG2;RANBP2;OGT;NUP98;PRKAG1;AAAS;NUP214;NUP35;NDC1;TIGAR;NOA1;JMJD8;NUP62;TPR;NUP93;NUP160
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3604447625827225,0.7465397500614679,0.7847919655667145,0.9475560375368051,1.0,2/10,24.44%,CNGB1;PDE6G
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2636771435867718,0.746430508054707,0.8789144050104384,0.9473431399131388,1.0,18/84,16.07%,MAGOH;HNRNPK;PRDX6;QKI;NCL;PUF60;RBFOX3;PCBP4;SRSF9;RBM15B;KHDRBS3;ZBTB7A;SNW1;HNRNPU;HNRNPA1;RBFOX1;CIRBP;CELF3
prerank,vitamin transport (GO:0051180),0.299537310203701,0.7459133344324737,0.8202653799758746,0.9476164312554278,1.0,10/29,32.18%,GC;SLC19A1;FOLR2;SLC2A2;SLC52A1;SLC19A2;TCN2;SLC2A6;SLC52A3;SLC52A2
prerank,endothelial cell migration (GO:0043542),0.28594675694195437,0.7457249673608392,0.8252656434474617,0.9474808732410605,1.0,11/37,22.55%,SOX18;ID1;EMP2;TNFSF12;RHOA;CDH5;LPXN;PLXND1;CCN3;SCG2;LGALS8
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.32225135173182917,0.7456628437799827,0.8198529411764706,0.9471947877494448,1.0,4/19,8.38%,S100A10;RAC1;THY1;KDR
prerank,cellular response to radiation (GO:0071478),0.2916559788974217,0.7453676735868351,0.8481012658227848,0.947188557150039,1.0,14/40,33.41%,RHOB;EEF1D;NET1;NSMCE3;GADD45A;BLM;ECT2;RAD51;RAD9A;CDKN1A;RHNO1;GRB2;CLOCK;SWI5
prerank,sphingolipid biosynthetic process (GO:0030148),0.2699727588365507,0.745277251507642,0.8796198521647307,0.9469339427420951,1.0,22/71,23.78%,CERS2;ELOVL1;ELOVL2;B4GALT6;SMPD1;ELOVL7;SPTLC1;DEGS1;FA2H;CSNK1G2;CLN8;ST8SIA5;SPTSSA;VAPA;SGPP1;SPHK2;SGPP2;ASAH2;SGPL1;ELOVL6;ALDH3B1;VAPB
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.29720146843175876,0.7449712000151067,0.8186101295641932,0.9469481987078292,1.0,6/33,14.26%,GPNMB;FAM107A;JADE1;CDK2AP2;KLF4;CCL2
prerank,actin filament-based transport (GO:0099515),0.31956141407111605,0.7449177012047312,0.7854454203262233,0.9466538618502225,1.0,4/21,11.02%,MYO5A;MYO7B;MYO1F;FNBP1L
prerank,positive regulation of positive chemotaxis (GO:0050927),0.3373394762459844,0.7447579307428721,0.7986666666666666,0.9464919483433932,1.0,3/15,14.62%,CXCL12;KDR;F2RL1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.30771191777896667,0.7441298910133423,0.8145859085290482,0.9468935482298713,1.0,7/25,19.43%,HSPA1B;BRD1;PRMT1;HSPA1A;ABCB10;MAPK11;INHBA
prerank,mitochondrion morphogenesis (GO:0070584),-0.29494027641588666,-0.7440044182740364,0.7941176470588235,0.9414438443391908,1.0,1/11,0.51%,PID1
prerank,positive regulation of DNA repair (GO:0045739),0.27804722051889674,0.743118085822664,0.843680709534368,0.94780066412555,1.0,7/46,12.09%,RPS3;PARP1;TRIM28;FMN2;HMGB1;PCNA;DDX11
prerank,cell chemotaxis (GO:0060326),0.2705594994610611,0.7425396156514843,0.8518518518518519,0.948161512779337,1.0,16/60,26.77%,CXCL12;PDGFB;RHOG;CCR5;CXCR4;CX3CR1;EPHB1;ARRB2;CCL28;CCR2;HGF;CCN3;PRKCQ;PLXNB3;CX3CL1;LEF1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3168750188632799,0.7424717978189017,0.803129074315515,0.9478846520967593,1.0,4/21,14.60%,FLNA;SCN4B;KCNE4;KCNE5
prerank,regulation of DNA recombination (GO:0000018),-0.22017389391168546,-0.7422545292092068,0.9090909090909091,0.9423403401340047,1.0,10/32,20.89%,SETD2;SPIDR;SMARCAD1;MSH3;PPP4R2;KPNA2;RTEL1;ZCWPW1;SHLD2;SIRT6
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.2735605926673556,-0.7419841699397779,0.8072289156626506,0.9413646093004945,1.0,6/14,19.18%,DPYD;UPP2;UPB1;NT5C1A;NT5M;DHODH
prerank,lung development (GO:0030324),0.2940699303214306,0.7408557706925648,0.8311840562719812,0.9494574858192345,1.0,4/33,8.17%,RCN3;RBP4;CEBPA;PROX1
prerank,regulation of epithelial cell migration (GO:0010632),0.27497212525541015,0.7402873609599633,0.8609865470852018,0.9497696324782743,1.0,12/51,16.75%,EMP2;RTN4;PFN1;GLUL;CORO1C;ENPP2;CLASP1;PTPRR;SOX9;CTSH;DAB2IP;PFN2
prerank,lung epithelium development (GO:0060428),0.35759100993471493,0.7400828995090858,0.7875722543352601,0.9496579316789748,1.0,1/10,2.36%,RCN3
prerank,natural killer cell activation (GO:0030101),0.30769284933174196,0.7399244853269338,0.8046398046398047,0.9494857702717938,1.0,7/23,19.00%,PTPRC;IL2;PRDX1;NCR1;RASGRP1;PIK3CD;TOX
prerank,response to prostaglandin E (GO:0034695),0.3610196172757934,0.7396883286936444,0.7946927374301676,0.9494023091372126,1.0,1/10,2.23%,CCL19
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.26371570263596894,0.7387824432590222,0.8849840255591054,0.9501135208535669,1.0,9/72,14.41%,POLR2E;MAPK3;POLR2D;POLR2F;RAB14;POLR2G;FGFRL1;POLR2K;HNRNPA1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.2833972440233015,0.738488397991306,0.8313953488372093,0.9500951552594815,1.0,7/39,13.45%,RASIP1;CTNNB1;PAK1;COL4A1;KDR;TIE1;BMP2
prerank,small GTPase mediated signal transduction (GO:0007264),0.256259716767799,0.7383490431864607,0.9026178010471204,0.9499153482211323,1.0,37/103,27.10%,PARK7;RAC1;SHC3;TRIM28;RGS19;NTN1;JUN;GRAP;RASGRP3;HRAS;RHEBL1;RUNDC3A;SHTN1;ABR;CCDC88A;RRAS;TIAM1;G3BP1;MAPK11;RRAGC;G3BP2;RASGRP1;USP8;RAB18;SOS1;ARHGAP33;BRAP;RALB;RERG;CCNA2;RAB42;TNK2;KSR2;RGL2;RALBP1;CHP1;CDKN1A
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3210492318947794,0.7383006668653297,0.8084291187739464,0.9496170270600545,1.0,7/20,21.18%,TMEM59;AP2M1;CLTC;RSC1A1;TMBIM1;TGFB1;PPP2R5A
prerank,fibrinolysis (GO:0042730),0.3439931705529418,0.7381502357869817,0.8015978695073236,0.9494515345133562,1.0,2/13,16.74%,PLAT;PLAU
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3035584470513457,0.7380464039485606,0.8068459657701712,0.9492132636800976,1.0,4/26,10.09%,FMOD;LUM;CHST1;B4GALT6
prerank,endocardial cushion development (GO:0003197),0.31458710117385974,0.7379003451958714,0.7895408163265306,0.9490175003782755,1.0,10/21,28.21%,ACVRL1;SOX9;BMP2;HEY1;GATA4;CRELD1;NOTCH1;TGFB2;ENG;TBX2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2446353928414531,0.7378045112393379,0.984,0.948770376286811,1.0,87/366,25.24%,PFDN5;RPL6;CALR;CXXC1;RPL10;ATF4;SOX18;HINT1;GRM5;LYL1;MAGED1;METAP1;DRAP1;HCLS1;ACVRL1;CHEK2;SPI1;PPP2R1A;NUCKS1;BTG1;FADS1;TBX22;CEBPB;GMNN;PQBP1;HES6;EDF1;CEBPA;YBX1;MLXIPL;MLX;TAF5L;HOXB7;APBB1;SUPT4H1;PCIF1;SOX17;ATF5;RBM4B;METTL18;BMP2;FBXO5;UBE2V1;MAFA;CCDC88A;NONO;SPIN4;IGF2;PDGFA;GLRX2;VHL;GATA4;BRCA2;PPARGC1A;MLF2;CNBP;ZNF22;TERF2IP;HMGN5;SOX11;CCAR2;HIC1;ESRRB;NOTCH1;MLF1;CHD3;MEF2C;ACTR5;DDIT3;USP13;PHF1;REST;ESRRG;POU6F2;SOX1;TAF5;SP3;RELA;MAFB;APP;TCF7L1;TCF3;CCNA2;EIF2A;PPIE;RORB;MYCBP
prerank,tRNA metabolic process (GO:0006399),0.33172545589616953,0.7375049158757753,0.8028534370946823,0.9487742668987179,1.0,3/17,10.06%,SARS1;KARS1;POP7
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.28844737576911633,-0.7374644141907927,0.8083623693379791,0.9457367360220167,1.0,2/10,6.10%,LRP6;ARHGAP12
prerank,cardiocyte differentiation (GO:0035051),0.36710840062144007,0.7362561524807094,0.8067226890756303,0.949890643177477,1.0,3/10,13.45%,NRG1;KDM6B;BMP2
prerank,carboxylic acid catabolic process (GO:0046395),0.3473826008833458,0.7359164768403258,0.7972789115646258,0.9499018247340482,1.0,3/12,16.69%,AMDHD2;BCKDK;ACOT4
prerank,plasma membrane organization (GO:0007009),0.2637186376463495,0.7358912482087039,0.8732240437158469,0.9495790627744752,1.0,15/61,18.77%,ANK3;PACSIN1;P2RX7;SYT11;SMPD1;FNBP1L;SERP1;CXCR4;DEGS1;EPB41L3;SNX33;FA2H;EHD2;ANXA6;STX4
prerank,regulation of lipid kinase activity (GO:0043550),0.3524984644377903,0.7357565010487099,0.799163179916318,0.9493777295108442,1.0,1/11,5.39%,EEF1A2
prerank,organonitrogen compound catabolic process (GO:1901565),0.2716110991633507,0.7357407487612168,0.8593238822246456,0.949037055030567,1.0,15/57,24.29%,USE1;MPST;ENPP2;AMDHD2;BCKDK;PLA2G7;CLN5;CLN6;TXN2;TST;CLN8;CAPN3;SGPL1;ERAP1;ADO
prerank,negative regulation of cilium assembly (GO:1902018),0.3463329958507439,0.7352259080239719,0.8005540166204986,0.9492888937120868,1.0,7/12,30.10%,CCP110;EVI5L;TESK1;CDK10;TCHP;TBC1D7;MAP4
prerank,genitalia development (GO:0048806),0.35272737475606136,0.7348756977389906,0.8093959731543624,0.9493380628142457,1.0,2/12,11.12%,FOXF2;WNT5A
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3164150514689056,0.733995200316908,0.8181818181818182,0.9500226376641462,1.0,1/20,1.89%,MAPK3
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3493010662112708,0.7338600446497614,0.819060773480663,0.9498237160107763,1.0,8/12,38.64%,GLUD1;IDH3G;ACLY;IDH1;ASS1;IDH3A;SIRT4;IDH3B
prerank,organic cation transport (GO:0015695),-0.25011027597291274,-0.7331697767779305,0.8398268398268398,0.9497295691034278,1.0,5/20,16.82%,SLC47A1;SLC22A4;SEC14L1;SLC25A26;SLC22A18
prerank,regulation of oxidoreductase activity (GO:0051341),0.33717632284534066,0.7330263623907209,0.8061911170928667,0.9504526321173756,1.0,1/13,1.51%,MT3
prerank,positive regulation of RNA splicing (GO:0033120),0.29241249088823873,0.7320658773413478,0.8331360946745562,0.9512425936780802,1.0,6/29,16.07%,PRDX6;NCL;SNW1;HSPA1A;CIRBP;CELF3
prerank,proteoglycan biosynthetic process (GO:0030166),-0.21139613150448977,-0.7314670881777777,0.8881118881118881,0.9504519886050214,1.0,9/31,20.76%,EXT1;IGF1;CHST11;GLCE;EXT2;FOXL1;BMPR2;B3GALT6;PXYLP1
prerank,response to lipid (GO:0033993),0.2522715730217732,0.7307158166874465,0.8965873836608066,0.9524745984500295,1.0,20/105,19.83%,SPP1;RBP4;S100A8;S100A9;TIRAP;CTNNB1;ABCG1;HNRNPA0;GPX3;SCD;SLC11A1;SOX9;PAQR7;ERBIN;CTSH;ABCA2;ADAM17;NOS2;SNCA;TGFB1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3462620480729853,0.7306261793545842,0.8002793296089385,0.9522249134812041,1.0,2/12,12.09%,CTNNB1;DDX11
prerank,response to laminar fluid shear stress (GO:0034616),0.36038962785888545,0.7304171310547785,0.8278688524590164,0.9521294367832043,1.0,2/10,12.78%,KLF2;KLF4
prerank,isotype switching (GO:0045190),0.3640308265245061,0.7299944980175384,0.8162393162393162,0.9522984374965353,1.0,1/10,7.89%,HSPD1
prerank,carbohydrate homeostasis (GO:0033500),0.26385329742985547,0.7296083639071415,0.8880516684607105,0.9523934661971993,1.0,14/67,22.34%,PARK7;MTNR1B;RPS6;RBP4;CEBPA;MLXIPL;WFS1;STK11;BAD;ADCY8;TFAP2B;IL6;PYGL;ADIPOR1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.28033913796607357,0.7295634954323464,0.8543123543123543,0.9520857183759861,1.0,10/40,22.21%,IER3;RPA2;USP51;MAPT;NSMCE1;FBXO5;UBE2V1;MYC;CDK9;RADX
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3209053928404618,0.7295350705797362,0.8246318607764391,0.9517566496161022,1.0,3/17,11.97%,GPER1;ATP1A3;ATP1A1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.24181116566847594,0.7291439439916174,0.999,0.9518477580643274,1.0,119/572,21.77%,RPL23;RPS27A;RPS14;UBC;UBB;CALR;HSBP1;VPS72;RPL10;TMPRSS6;ATF4;KLF2;ID3;SOX18;ID1;EID1;ETS2;TNF;PDGFB;DRAP1;NR1D1;SPI1;ENO1;PARP1;TLE5;HES1;TENM2;IRF2BP1;TBX22;UBA52;CCND1;CEBPB;FOXD3;PRDM12;DUSP26;CBX6;PROX1;NR2F6;BCL6B;MLX;SARS1;JUN;SIN3B;HMGB1;BHLHE41;ZFP36;H1-0;IRF8;APBB1;AEBP1;SUPT4H1;CTBP1;ZBTB7A;WFS1;IRF2BPL;SOX8;SNW1;NCOR2;IRX3;THRA;KLF4;THAP11;SOX9;HSPA1A;IRF2BP2;CRYM;BMP2;LEFTY1;HNRNPU;HDAC5;HEXIM1;SDCBP;IRF7;IKZF5;DNAJB1;IGF2;NR1H2;KDM1B;HEY1;MIER2;DAB2IP;HDAC9;BATF3;CAV1;DNMT3B;VHL;GLIS2;TWIST1;RIPPLY2;BCL11A;ZHX1;TCF25;CNBP;MYT1L;NOP53;CIR1;MAZ;MTA2;SOX11;SNCA;HIC1;TFAP2B;NOTCH1;KLF11;EFNA1;CHD3;POU4F1;CITED2;MEF2C;MYC;GADD45A;ID2;DDIT3;SOX10;SIRT2;SUDS3;DACH1;MEN1;IFI27
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.23133465971978828,-0.7289175480354462,0.8994974874371859,0.9522053570048991,1.0,4/25,9.77%,SLIT2;YAP1;CEP97;KANK1
prerank,organelle fusion (GO:0048284),0.3076347100727147,0.7284966082084978,0.8384710234278668,0.9522413990151368,1.0,7/22,21.42%,BAX;GDAP1;MIEF2;SPG7;MFF;STX4;FIS1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.24904341791990509,-0.7282702382217997,0.8340425531914893,0.9516542787538871,1.0,5/17,14.11%,PPARG;PTEN;PDCD4;TPM1;TGFB3
prerank,adipose tissue development (GO:0060612),0.35156609037384823,0.7281409164175939,0.8160442600276625,0.9523140128979315,1.0,3/11,12.21%,NAMPT;PGRMC2;SOX8
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3539421797285018,0.7263767857357774,0.8019662921348315,0.9539965576053097,1.0,4/11,20.51%,WNT5A;SOX9;PDGFA;MYC
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.28758485515908694,-0.7262455373017723,0.8428571428571429,0.9527922640999367,1.0,6/11,17.85%,P4HTM;EGLN1;P4HA1;EGLN3;P4HA2;P4HA3
prerank,negative regulation of biomineral tissue development (GO:0070168),0.30672468712827317,0.7259598742735841,0.8212005108556832,0.9541184097402644,1.0,8/21,19.83%,ECM1;SRGN;SOX9;GAS6;HEY1;CCL3;NOTCH1;TGFB1
prerank,axonemal dynein complex assembly (GO:0070286),0.2937883506312743,0.7255383244077364,0.8226779252110977,0.954221946884328,1.0,4/27,13.35%,DNAI3;DNAAF3;DNAH1;LRRC49
prerank,GTP metabolic process (GO:0046039),0.3287214675683157,0.7254690610465631,0.821236559139785,0.9539413973806335,1.0,3/15,9.45%,RAN;AK4;AK3
prerank,plasma membrane repair (GO:0001778),-0.2778678693830024,-0.7254669176023514,0.8419117647058824,0.9523540470551509,1.0,2/13,5.20%,MYOF;MYH9
prerank,bicarbonate transport (GO:0015701),0.30229399331999934,0.7247957059098833,0.8351515151515152,0.9543730659809673,1.0,6/25,20.84%,CA2;AQP1;CA4;SLC4A2;CYB5R1;CA3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.30810545405385126,0.7244581913230125,0.8260869565217391,0.9543828274249537,1.0,8/20,24.14%,ZFP36L1;ZFP36;PRMT1;PF4;HSPA9;HOXB8;MEIS2;MAFB
prerank,megakaryocyte differentiation (GO:0030219),0.3534177730906296,0.7244510653934538,0.8257887517146777,0.9540359345141725,1.0,4/11,27.85%,IL11;THPO;CDKN2B;ZFPM1
prerank,DNA conformation change (GO:0071103),0.32044862408809155,0.7242950662917257,0.8113456464379947,0.9538675581095658,1.0,3/17,10.81%,HMGB3;HMGB1;NAA10
prerank,regulation of TOR signaling (GO:0032006),0.2642572691946458,0.7238916727294353,0.8673139158576052,0.9539876846867494,1.0,13/67,19.98%,TREM2;LAMTOR2;LAMTOR4;LAMTOR5;PIH1D1;PDCD6;LAMTOR3;GAS6;RRAGC;RRAGD;FAM83D;AKT1S1;DDIT4
prerank,brain morphogenesis (GO:0048854),0.34172746884920635,0.7227695010633457,0.8062755798090041,0.9548751059968537,1.0,1/12,3.11%,CTNNA2
prerank,fatty acid oxidation (GO:0019395),0.26516545480025405,0.7224512936251656,0.8819068255687974,0.9548821177714915,1.0,8/57,17.37%,ACADVL;SCP2;MTLN;HSD17B4;ACAT1;ACAA2;PPARGC1A;ECHS1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.30556945030893345,0.7215870812604124,0.832274459974587,0.9554950174961446,1.0,3/21,8.20%,MID1IP1;NAV3;CLASP1
prerank,sphingosine metabolic process (GO:0006670),0.3219317425670454,0.720846428696616,0.8428761651131824,0.9559702037290257,1.0,7/17,21.11%,SPTLC1;NAAA;ABCA2;SGPP1;SPHK2;SGPP2;ASAH2
prerank,peroxisomal membrane transport (GO:0015919),0.29358985066922116,0.7204953758326808,0.8475609756097561,0.9560138219109455,1.0,12/27,35.64%,PXMP2;GDAP1;PEX6;FIS1;PEX11B;PEX1;ABCD2;ALDH3A2;PEX14;PEX2;ATAD1;PEX13
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3040408881617658,0.720082893328694,0.8287841191066998,0.9557730771101582,1.0,7/22,28.67%,GOLGA7B;CLIP3;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3040408881617658,0.720082893328694,0.8287841191066998,0.9557730771101582,1.0,7/22,28.67%,GOLGA7B;CLIP3;GOLGA7;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.2915857606367121,0.719597716654034,0.8422330097087378,0.9559653727457836,1.0,7/27,17.63%,PDE4B;CTNNA3;PLN;FGF13;RYR2;CAV1;SRI
prerank,protein complex oligomerization (GO:0051259),0.25352437598371086,0.7182746941867916,0.8938428874734607,0.9570773783283427,1.0,26/85,26.36%,LRRC8A;KCNC3;MPP2;ALAD;NINJ1;KCNC1;RS1;PRMT1;EHD1;UGDH;G3BP2;ADCY8;MAT2A;DNM1L;GLRA3;SNCA;SHMT2;PYCARD;KCNC2;BLM;ELAVL1;ECT2;BOK;PNPT1;EHD3;STOML2
prerank,modification-dependent protein catabolic process (GO:0019941),0.2430052378197446,0.7175255145030709,0.9534412955465587,0.957575910022285,1.0,30/193,17.66%,RPS27A;UBC;UBB;PINK1;KCTD10;TOLLIP;UBE2G2;CDC34;UBA52;ARRDC1;ISG15;FEM1C;FEM1A;FBXL14;RBX1;NEDD8;RNF128;DDB1;PSMD13;BUB3;SYVN1;UBQLN2;RNF40;RNF150;RNF7;HERPUD1;SQSTM1;TRIM32;RNF149;RLIM
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2604418208756453,0.7166380035034635,0.894054054054054,0.9582359566047625,1.0,28/68,33.85%,SLC2A1;RFK;CYB5R3;GSTO1;SLC19A1;PNPO;SLC19A3;FOLR2;SLC25A19;SLC2A3;SLC52A1;SLC19A2;SHMT2;MTHFS;CYB5A;TCN2;DHFR;ACP5;AASDHPPT;SLC52A3;ALDH1L1;SLC52A2;PCCB;MTHFD2L;MTRR;LMBRD1;MTR;NNMT
prerank,RNA processing (GO:0006396),0.2427801576635325,0.7163042850150665,0.9544994944388271,0.9582605154939866,1.0,42/176,21.22%,SNRPG;AURKAIP1;MAGOHB;MAGOH;HNRNPK;DDX39B;SNRPD2;LSM4;LSM6;PPP2R1A;SNRPF;SRSF9;LIN28B;HNRNPA0;TARDBP;PRPF8;SUPT4H1;SRSF2;SF3A2;ELAVL4;SF3B2;IVNS1ABP;HNRNPU;MRPL44;NONO;SNRPB;SF3A3;RRAGC;PDCD7;CELF3;PPARGC1A;SNRPD3;APOBEC1;CCAR2;USB1;SF3A1;DKC1;TSEN54;SRSF1;SRRM4;SNRNP35;HNRNPF
prerank,regulation of defense response to virus by host (GO:0050691),0.28515454738072205,0.7159633902219146,0.855036855036855,0.9582629806503459,1.0,3/30,7.19%,HSP90AA1;TNFAIP3;PQBP1
prerank,regulation of phosphate metabolic process (GO:0019220),0.31864610935847054,0.7158524517112757,0.8154450261780105,0.9580339190320133,1.0,2/16,9.26%,PGAM1;CD24
prerank,B cell activation involved in immune response (GO:0002312),0.33477090123525266,0.715325614506001,0.8355978260869565,0.9582964736821362,1.0,2/13,19.50%,CD180;GPR183
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.281405262716249,-0.7147338969652016,0.84,0.9636110994006717,1.0,2/10,9.43%,ERRFI1;ENPP1
prerank,amyloid-beta metabolic process (GO:0050435),0.32085344086544487,0.7145480802509883,0.8218623481781376,0.9587919930954114,1.0,8/16,32.12%,PSENEN;BACE1;PSEN2;APH1B;APH1A;IDE;ACE;NCSTN
prerank,mesenchymal to epithelial transition (GO:0060231),0.34633377745694705,0.7140422746361702,0.8236994219653179,0.9590031196173672,1.0,1/10,8.19%,BASP1
prerank,cellular response to UV-A (GO:0071492),0.3481552187968827,0.7131145859552147,0.8146067415730337,0.9596620017046827,1.0,2/11,11.31%,TIMP1;MMP3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.27859288179743635,0.7129192634682769,0.8455971049457177,0.9595285334764287,1.0,8/33,19.19%,AKT1;CCND2;CCND1;AIF1;ADAM17;FAM83D;ADAMTS1;DDRGK1
prerank,arachidonic acid secretion (GO:0050482),-0.2880994225458197,-0.7128956535404808,0.8113207547169812,0.9628595191739701,1.0,10/10,71.21%,ANXA1;PLA2G5;DRD3;BDKRB2;DRD4;PLA2G1B;ACE;DRD2;PNPLA8;NMUR2
prerank,arachidonate transport (GO:1903963),-0.2880994225458197,-0.7128956535404808,0.8113207547169812,0.9628595191739701,1.0,10/10,71.21%,ANXA1;PLA2G5;DRD3;BDKRB2;DRD4;PLA2G1B;ACE;DRD2;PNPLA8;NMUR2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2739375817641948,0.7127700339500449,0.8734177215189873,0.9593464359653188,1.0,5/38,15.49%,H3-3A;NPM1;CENPX;IPO4;CENPL
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.25444997442262224,0.7125505668109784,0.9172043010752688,0.9592167922132938,1.0,19/74,22.34%,MDK;COL1A1;MCRIP1;CTNNB1;CLASP1;SPRY1;BMP2;SDCBP;TIAM1;DAB2IP;TWIST1;VASN;IL6;EFNA1;TGFB1;FOXA2;SFRP1;FOXA1;ADIPOR1
prerank,visual perception (GO:0007601),0.2512771361298118,0.7125052097271709,0.9071949947862357,0.9589032961452907,1.0,9/84,13.24%,COL1A1;OAT;SFRP5;RD3;GRM8;REEP6;WFS1;RS1;CRYBA1
prerank,cilium movement (GO:0003341),-0.18635694403804726,-0.7124545294888943,0.9320388349514563,0.9619941913923502,1.0,24/47,30.30%,DNAI4;CFAP251;SPEF1;GAS8;ODAD1;CCDC39;CFAP53;CFAP70;DNAAF5;ODAD2;SPAG17;ODAD3;CFAP61;SPA17;DNAAF2;ODAD4;TEKT2;ROPN1L;CCDC40;DNAAF4;CCDC63;TTC29;ADCY10;TEKT5
prerank,regulation of keratinocyte migration (GO:0051547),0.3321464441518206,0.7113254029171909,0.8035714285714286,0.9598577251952916,1.0,3/12,16.56%,ARF6;EPPK1;EPB41L4B
prerank,mRNA 3'-end processing (GO:0031124),0.25186738996380875,0.7110858951801006,0.9059196617336153,0.9597691234692768,1.0,16/78,22.06%,MAGOHB;MAGOH;POLR2D;DDX39B;SRSF9;SRSF2;PABPC1;CPSF2;THOC3;EIF4A3;SLBP;U2AF1L4;ALYREF;SRSF1;CPSF4;DHX38
prerank,oligosaccharide metabolic process (GO:0009311),0.26979003350773983,0.7109932470302812,0.8905027932960894,0.9595116150718077,1.0,20/46,32.56%,MAN2B2;MAN1B1;MPDU1;ST8SIA4;ST6GALNAC3;MAN2C1;NEU1;ST6GAL2;FUT9;ST8SIA5;B3GALT5;GAL3ST3;B3GALT2;NAGA;NEU3;MAN2B1;ST8SIA6;AMY1A;AMY1B;AMY1C
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3100070398936117,0.7109459401875556,0.8284250960307298,0.95922116388106,1.0,7/20,21.18%,TMEM59;AP2M1;CLTC;RSC1A1;TMBIM1;TGFB1;PPP2R5A
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.24535614543547346,-0.7089903186331008,0.8823529411764706,0.964388626251802,1.0,4/17,14.72%,TAOK3;MID1;KLHDC10;TAOK1
prerank,motile cilium assembly (GO:0044458),0.3353281094380666,0.7085331014391097,0.8189533239038189,0.9614560750623136,1.0,3/12,20.35%,DNAAF3;E2F4;BBOF1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2891948200204375,0.7072430983973331,0.8457008244994111,0.9624596141763138,1.0,11/30,27.10%,TERF1;ACVRL1;HNRNPU;HNRNPA1;CTC1;DACH1;MEN1;GNL3L;PIF1;HNRNPC;CDKN1A
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.28437851309791623,0.7064789811898229,0.875886524822695,0.9629209884151736,1.0,7/31,15.69%,CFL1;NLGN1;PPFIA2;CDK5R1;SRCIN1;LRP8;CDK5
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.2789346465931466,-0.7064007076000266,0.8350877192982457,0.9659433337573216,1.0,4/11,20.93%,PTGIS;FAP;TP53;DFFA
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.2933336639986469,0.7056228252983592,0.8387096774193549,0.9634866692747359,1.0,2/21,2.94%,SMDT1;TGM2
prerank,phosphate ion transmembrane transport (GO:0035435),0.33083969751496445,0.7051410303411881,0.8375,0.9636831025195769,1.0,8/12,40.28%,SLC25A11;SLC25A14;SLC25A30;SLC25A3;SLC37A2;XPR1;SLC20A1;SLC37A1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.22358974641735557,-0.704546063630284,0.8944723618090452,0.9666651199318682,1.0,2/26,1.41%,LARGE1;ST3GAL4
prerank,icosanoid secretion (GO:0032309),0.32531904697816916,0.7043715713195933,0.8151862464183381,0.9641453091530687,1.0,5/12,32.08%,NOS2;NMUR2;PNPLA8;DRD2;ACE
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.2359612611198939,-0.703299122963584,0.8834080717488789,0.9666394673336384,1.0,7/19,17.93%,CUX1;DHX36;CAPRIN2;OBSL1;CDKL3;FBXW8;CUX2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3260678844662739,0.702890907099048,0.8365384615384616,0.9653773346928596,1.0,6/14,27.99%,KLF4;RHOA;HDAC5;NOTCH1;MMRN2;DLL4
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.25268953400679406,-0.7025193514182476,0.8577586206896551,0.9660764966826725,1.0,3/15,12.42%,GGACT;PRODH;HOGA1
prerank,negative regulation of type I interferon production (GO:0032480),0.272685497706214,0.7021770654790089,0.8789659224441834,0.9657843519283442,1.0,4/40,6.97%,PIN1;SIRPA;TNFAIP3;ISG15
prerank,phosphate ion homeostasis (GO:0055062),0.35119692753493825,0.7018542600581625,0.8137535816618912,0.9657513530796402,1.0,2/10,19.55%,SFRP4;TFAP2B
prerank,regulation of cellular catabolic process (GO:0031329),0.2560941192712789,0.7017454507295187,0.9074889867841409,0.9655221047351745,1.0,6/62,9.11%,PSAP;HSPB1;DEPP1;MAPT;NUPR1;GPR137B
prerank,positive regulation of autophagy (GO:0010508),0.25167122761534566,0.7016821892725247,0.9233193277310925,0.9652302555349054,1.0,12/81,15.07%,PARK7;PINK1;TMEM59;ORMDL3;BNIP3L;SCOC;KDR;DCN;HMGB1;SVIP;STK11;BAD
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2764404688455885,0.700823235992739,0.8710843373493976,0.9657593517336768,1.0,9/33,20.03%,HSPA1B;BRD1;PRMT1;HSPA1A;ABCB10;MAPK11;SCIN;INHBA;THPO
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.2469395906034078,-0.7006358022024108,0.8619246861924686,0.9667261418477927,1.0,4/15,12.43%,MDC1;ATF2;TIPIN;RAD17
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.32164791946105087,0.70055779801154,0.8320209973753281,0.9656712138537428,1.0,3/15,16.28%,POP7;RNASEH1;NUDT16
prerank,negative regulation of macroautophagy (GO:0016242),0.2866916419108009,0.7001187435477009,0.8636363636363636,0.9657604942938957,1.0,3/26,9.04%,AKT1;PINK1;NUPR1
prerank,renal filtration (GO:0097205),0.339069255289586,0.7000844319636707,0.8274894810659187,0.9654367533489302,1.0,3/10,11.09%,CD34;TMEM63C;MCAM
prerank,positive regulation of defense response to virus by host (GO:0002230),0.28513684307767634,0.7000026065357181,0.8571428571428571,0.9651730412348859,1.0,3/24,13.40%,HSP90AA1;PQBP1;LILRB1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.30164654784318984,0.6999709963020169,0.8545006165228114,0.9648529761890031,1.0,5/21,22.31%,NPM1;CCND1;FBXO5;CDC25A;RCC2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.27238516500095156,0.6996928235388993,0.8695652173913043,0.9647903776135497,1.0,7/33,19.75%,PDE3B;P2RY12;JAM3;PLAU;SYK;MUC1;EFNA1
prerank,protein localization to cell surface (GO:0034394),0.285564205511536,0.6993843549240981,0.8508014796547472,0.9647492829287424,1.0,9/26,25.82%,EMP2;CTNNB1;FLNA;ARF6;JAM3;PTPRU;UNC50;PRRT1;MESD
prerank,autophagy of nucleus (GO:0044804),-0.25132663688432005,-0.6988971827908594,0.8554216867469879,0.9672539760817267,1.0,5/16,16.72%,ATG2B;RB1CC1;ATG2A;ULK2;ULK1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.25506176387506063,0.6985939281922483,0.8985823336968375,0.9652255189752148,1.0,16/56,24.04%,RHOB;ANK3;RHOC;DCTN3;ANLN;RHOA;STMN1;SNX33;USP8;VPS4A;UNC119;CKAP2;SPIRE1;INCENP;RTKN;ECT2
prerank,regulation of T cell mediated immunity (GO:0002709),0.3434291870759294,0.6981413115394587,0.8057142857142857,0.9653311723717221,1.0,4/10,28.03%,HMGB1;CCR2;AGER;TNFRSF1B
prerank,purine-containing compound salvage (GO:0043101),-0.2608641008645727,-0.6979019287010724,0.8530612244897959,0.9669305295246098,1.0,4/12,16.79%,AMPD3;ADK;AMPD2;GMPR
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.34590512103515797,0.6975167727980006,0.8428781204111601,0.9656257257915039,1.0,2/10,16.47%,PRDM12;DNMT3B
prerank,glycoprotein catabolic process (GO:0006516),0.3141988440001777,0.6971959941919108,0.8335535006605019,0.9655993829046297,1.0,2/17,9.13%,CTSL;FBXO27
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.238620881446346,-0.69690217475571,0.9181034482758621,0.9666367082607348,1.0,6/20,21.04%,SULF1;SMOC2;FGF2;PRKD2;SULF2;CREB3L1
prerank,response to insulin (GO:0032868),0.24971994288618635,0.6965380446113967,0.9271383315733897,0.9659232501468317,1.0,26/80,28.30%,AKT1;PKM;ZFP36L1;PARP1;PDE3B;RAB15;MYO5A;VAMP2;HDAC5;SORT1;HDAC9;EPRS1;RAB31;EPM2AIP1;GOT1;C2CD5;KHK;SELENOS;INHBB;ZBED3;EIF6;INSIG2;TRIB3;RAB8A;XBP1;USF1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.29633450154029223,0.6963502355798808,0.8535031847133758,0.9657662131107226,1.0,10/21,26.05%,HS6ST3;HS3ST5;B3GAT3;SGSH;UGDH;XYLT1;HPSE;HS6ST1;HS6ST2;GPC1
prerank,sphingoid biosynthetic process (GO:0046520),0.3416456575373567,0.6963062678802242,0.8433908045977011,0.9651001835038415,1.0,4/11,21.11%,SPTLC1;ABCA2;SPHK2;ASAH2
prerank,sphingosine biosynthetic process (GO:0046512),0.3416456575373567,0.6963062678802242,0.8433908045977011,0.9651001835038415,1.0,4/11,21.11%,SPTLC1;ABCA2;SPHK2;ASAH2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.31230184751168505,0.6958007384082502,0.8466494845360825,0.9652786837138576,1.0,3/15,10.90%,MAPK3;KDR;AATK
prerank,DNA damage checkpoint signaling (GO:0000077),0.28423694512565106,0.6954457605602182,0.8818615751789977,0.9653045485859939,1.0,11/28,33.32%,CHEK2;PRPF19;ERCC6;CDC5L;STK33;ATRIP;DOT1L;RAD9A;RHNO1;CLOCK;DONSON
prerank,negative regulation of telomere maintenance (GO:0032205),0.3167395074671384,0.6953443189076837,0.8428761651131824,0.9650493620580705,1.0,2/15,5.17%,TERF1;PARP1
prerank,cardiac muscle cell development (GO:0055013),0.3043769385630908,0.694789314597353,0.8507653061224489,0.9652643585991214,1.0,5/20,17.41%,ALPK2;MYH11;SORBS2;SLC8A1;FHOD3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.27608848541699094,-0.694651433013738,0.8683274021352313,0.9675622378555578,1.0,2/10,13.39%,SH3RF1;CBFB
prerank,regulation of cilium movement (GO:0003352),-0.2864047200602561,-0.6944136780601264,0.8633333333333333,0.9663982986169989,1.0,10/10,71.38%,CCDC39;ODAD2;CCDC65;CFAP43;CCDC40;DNAAF1;CFAP298;DNAH11;DRC1;CFAP206
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.26372070486578614,0.6939351803200624,0.9014396456256921,0.9657685664390848,1.0,16/42,27.89%,S100A10;EMP2;RAC1;THY1;KDR;RRAS;CCL28;SKAP1;SFRP1;COL16A1;PPM1F;TEK;EFEMP2;CX3CL1;MYOC;CD3E
prerank,response to organophosphorus (GO:0046683),-0.24519498511353183,-0.6938400230783272,0.9016393442622951,0.9656315464239794,1.0,6/16,26.29%,DGKQ;TRPC3;VGF;ABCC9;NDUFS4;TYMS
prerank,fatty acid catabolic process (GO:0009062),0.25202053297077576,0.6933837661770286,0.919957310565635,0.9659795842142068,1.0,7/67,11.50%,ACADVL;SCP2;NUDT19;MTLN;HSD17B4;ACAT1;ACAA2
prerank,sensory perception of light stimulus (GO:0050953),0.24474598516229695,0.6927887989959582,0.9277486910994764,0.9662224575072836,1.0,9/87,13.24%,COL1A1;OAT;PCDH15;SFRP5;RD3;GRM8;WFS1;RS1;CRYBA1
prerank,tRNA 5'-end processing (GO:0099116),0.3191439454109852,0.6922673161183007,0.8411843876177658,0.9663816019912194,1.0,5/15,33.22%,POP7;POP4;TRMT10C;POP5;HSD17B10
prerank,cilium assembly (GO:0060271),0.2308776466206856,0.6919966559671236,0.987,0.9663017969232887,1.0,48/296,20.64%,TUBB;GSN;TUBA1A;HSP90AA1;TUBB4B;DYNLL2;DYNLL1;TUBA4A;DCTN3;PPP2R1A;IFT20;FLNA;YWHAE;DNAAF3;DYNLRB1;CLASP1;CNGA4;YWHAG;TUBB4A;FNBP1L;CEP131;FHDC1;TCTN3;DYNLRB2;DCTN1;SSNA1;HAUS2;EHD1;DCTN2;ARF4;CNGB1;TMEM17;E2F4;CETN2;PRKAR2B;CCDC28B;TCTN1;EXOC7;EHD2;DCX;NOTCH1;BBIP1;NEK1;EXOC5;BBOF1;CFAP410;CFAP54;EXOC8
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.27932940414290186,0.6915321758057265,0.8737980769230769,0.966414254800507,1.0,7/26,20.13%,NR1D1;EPHA5;ADCY8;PIM3;BRSK2;STX4;FOXA2
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3380840589438294,0.6912306678157953,0.8399452804377565,0.9663497674409719,1.0,2/10,10.44%,MFSD2A;MTMR9
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.25048906757292244,-0.6905768966585968,0.8782608695652174,0.9674380612709838,1.0,1/15,2.16%,MOXD1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2523314165783339,0.6892624950476697,0.9167579408543264,0.967952486521236,1.0,23/59,27.55%,CTNNB1;CDK8;CCND1;CEBPB;TRIM28;JUN;CSF1R;BAX;THRA;SOX9;MED31;MED30;TWIST1;AGO1;IL6;RELA;CCNC;MED7;LEF1;CDKN1A;MED16;MED25;MED12
prerank,in utero embryonic development (GO:0001701),0.28559230576902694,0.6888423697069271,0.8610086100861009,0.96798614310788,1.0,5/25,15.42%,FOXD3;SOX8;PTPRR;BMP2;IGF2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.30579327587252436,0.6884581866996778,0.8638184245660881,0.9680087776312638,1.0,3/17,15.89%,KCNE4;KCNE5;RYR2
prerank,bile acid metabolic process (GO:0008206),0.2801848534387068,0.686058294357388,0.8995157384987893,0.9700176681014134,1.0,7/27,24.21%,SCP2;HSD17B4;OSBPL6;OSBPL3;CH25H;OSBPL1A;NPC1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3024856423321257,0.6860039179843261,0.8684863523573201,0.9697137605440169,1.0,7/19,26.23%,TERF1;HNRNPU;HNRNPA1;CTC1;GNL3L;PIF1;HNRNPC
prerank,folic acid metabolic process (GO:0046655),0.29867628234089866,0.6850188922229911,0.8558558558558559,0.9703541150613686,1.0,8/18,32.90%,SLC19A1;FOLR2;SHMT2;MTHFS;DHFR;ALDH1L1;MTHFD2L;MTRR
prerank,nucleoside phosphate catabolic process (GO:1901292),0.3217964194023059,0.6843927062441179,0.8644536652835408,0.9706202791282844,1.0,2/13,13.49%,ENTPD3;SMPDL3A
prerank,regulation of protein acetylation (GO:1901983),0.3268901649575646,0.6842359411468238,0.8500687757909215,0.9704177600341228,1.0,2/12,9.69%,PARK7;CAMK1
prerank,mitotic spindle organization (GO:0007052),0.23341284827546788,0.682929254578319,0.9706477732793523,0.9713304325280447,1.0,20/153,17.38%,RPS27;DYNLL2;DYNLL1;RAN;CHEK2;FLNA;VCP;SBDS;ABRAXAS2;CLASP1;XPO1;BUB3;RHOA;STMN1;NUP85;DCTN2;CENPL;NUDC;RANGAP1;TOGARAM2
prerank,amide biosynthetic process (GO:0043604),0.25517211082275315,0.6825447891033253,0.8994535519125683,0.971357099275518,1.0,15/47,32.48%,CERS2;SMPD1;SPTLC1;DEGS1;FA2H;CLN8;SPTSSA;ASAH2;AANAT;ASL;SAMD8;ASS1;ARG2;PCSK1;CERS6
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3114260043187239,0.6812643546010153,0.8705583756345178,0.9722019113994014,1.0,5/16,19.16%,B4GALNT1;B4GALT6;ST8SIA4;ST6GALNAC3;ST8SIA5
prerank,signal transduction by p53 class mediator (GO:0072331),0.27280779139343747,0.6810643785169737,0.8900966183574879,0.9720468469668155,1.0,9/30,28.38%,HINT1;NDRG1;PMAIP1;STK11;POU4F1;PYCARD;BOK;PAXIP1;PDK2
prerank,positive regulation of rRNA processing (GO:2000234),0.33293576052147905,0.6808448472891041,0.844213649851632,0.9719120429776321,1.0,1/10,4.39%,TRMT112
prerank,protein acylation (GO:0043543),0.26557632692144345,0.6808435390962524,0.9016018306636155,0.971560387109693,1.0,12/38,29.53%,GLUL;SELENOK;ZDHHC5;NAA10;NAT9;ING5;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;ZDHHC14;ZDHHC16
prerank,regulation of smooth muscle contraction (GO:0006940),0.29779694723426464,0.6807839637026,0.8737113402061856,0.9712598491656724,1.0,9/20,31.78%,CHRM3;ATP2B1;CHRM2;CAV1;CTTN;CHRNA3;SRF;NMUR2;NMU
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2894670143187162,0.68071029107447,0.8548972188633616,0.9709793022190021,1.0,8/22,28.79%,UBAP1L;VPS28;VPS4A;VPS37C;VPS36;RNF126;SNF8;MVB12A
prerank,methylguanosine-cap decapping (GO:0110156),0.3367834060306152,0.6804974221871929,0.8487031700288185,0.9708401405195025,1.0,2/10,11.69%,PNRC2;EDC4
prerank,detection of mechanical stimulus (GO:0050982),-0.22447096142917422,-0.6801537250606231,0.9425837320574163,0.9758285463368865,1.0,4/19,10.70%,PIEZO2;PIEZO1;PKD1;PTK2
prerank,myotube cell development (GO:0014904),-0.2740372089208283,-0.6793028685972932,0.839041095890411,0.975268498994948,1.0,3/10,13.03%,SKI;IGF1;SIX1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.2696960467905322,0.6790419603355037,0.9124700239808153,0.9719049202421078,1.0,11/33,29.26%,PSME1;PSME2;FBXW7;FAM83D;DDRGK1;PTPN6;ID2;CDKN1A;TRIM39;ATP2B4;PSME3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.2978122308384518,0.6788644433599109,0.8754813863928113,0.9717172040515064,1.0,3/18,8.00%,SPI1;ST18;CEBPA
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2252466658649584,0.6787790072820097,0.992,0.9714435971542736,1.0,65/327,22.43%,PFDN5;RPL6;CALR;CXXC1;ATF4;SOX18;HINT1;LYL1;RALY;MAGED1;DRAP1;HCLS1;ACVRL1;CHEK2;SPI1;PPP2R1A;BTG1;FADS1;TBX22;CEBPB;PQBP1;HES6;EDF1;CEBPA;YBX1;MLXIPL;MLX;TAF5L;HOXB7;APBB1;SUPT4H1;SOX17;ATF5;BMP2;UBE2V1;MAFA;NONO;SPIN4;IGF2;GLRX2;VHL;GATA4;BRCA2;PPARGC1A;MLF2;CNBP;ZNF22;TERF2IP;HMGN5;SOX11;CCAR2;HIC1;ESRRB;NOTCH1;MLF1;CHD3;MEF2C;ACTR5;DDIT3;USP13;PHF1;REST;ESRRG;POU6F2;SOX1
prerank,phagosome-lysosome fusion (GO:0090385),0.33248102918206285,0.6770012302412748,0.8646288209606987,0.9727667487557009,1.0,7/10,39.86%,RAB20;SYT7;RAB39A;RAB34;ARL8B;RAB7A;RAB7B
prerank,negative regulation of phosphatase activity (GO:0010923),0.28549856231322684,0.6767458889358786,0.8756218905472637,0.9726518532084804,1.0,11/25,33.07%,FKBP1A;PPP1R1B;PPP1R35;FKBP1B;PPP1R15A;CHP1;TGFB2;PPP1R11;BOD1;PTPA;SEMA4D
prerank,inositol phosphate catabolic process (GO:0071545),0.32401976223647816,0.6764836653814749,0.8641975308641975,0.9725507762038558,1.0,2/12,13.53%,NUDT3;INPP5J
prerank,RNA 3'-end processing (GO:0031123),0.2451610435748687,0.6762639314208353,0.9467969598262758,0.9724110460176473,1.0,14/69,22.06%,MAGOHB;MAGOH;DDX39B;SRSF9;LIN28B;SRSF2;CPSF2;THOC3;EIF4A3;U2AF1L4;ALYREF;SRSF1;CPSF4;DHX38
prerank,synaptic vesicle transport (GO:0048489),0.3231093431884682,0.6761816919604748,0.8502080443828016,0.9721373313736891,1.0,3/11,18.47%,KIF5A;CDK5;KIF5C
prerank,neural crest cell differentiation (GO:0014033),0.2988982830718158,0.676155404308067,0.8704663212435233,0.971810340800148,1.0,9/18,32.03%,NRG1;PDCD6;SOX8;SOX11;MEF2C;HTR2B;NOLC1;KBTBD8;CDH2
prerank,DNA replication (GO:0006260),0.234227308287722,0.6761415473822905,0.9420289855072463,0.9714705749011191,1.0,33/105,32.26%,PTMS;RNASEH2A;MCM5;RPA2;SET;RFC2;RECQL5;POLD4;ING5;RFC4;FAM111A;POLG;BLM;CDC45;POLD1;PNKP;BARD1;NAP1L1;ATRIP;RPA3;RPAIN;PIF1;RAD9A;RMI1;MCM7;MCM2;POLE3;KAT5;DNA2;RHNO1;UPF1;TOPBP1;TBRG1
prerank,cilium-dependent cell motility (GO:0060285),0.2899075125809488,0.6756072964590697,0.8789731051344744,0.9716225202502196,1.0,3/22,11.99%,DNAI3;DNAH2;DNAH1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.30513873414100395,0.6754301491619558,0.85578231292517,0.9714243395976189,1.0,3/14,23.84%,CD84;RASGRP1;PAEP
prerank,positive regulation of phospholipase C activity (GO:0010863),0.2604066440911262,0.6753173302190697,0.8968713789107764,0.9711715002644663,1.0,8/40,16.26%,NTRK2;ANG;C5AR1;P2RY6;P2RY12;HRAS;ADRA1A;FLT1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.23757892796734636,-0.6737460320337585,0.9094488188976378,0.9789351078685711,1.0,3/14,16.01%,FOXO3;EARS2;MTERF2
prerank,regulation of cytokinesis (GO:0032465),0.2365057059804782,0.672684803184415,0.9429778247096093,0.9732586745586954,1.0,4/78,4.81%,CALM1;CALM3;KLHL9;PIN1
prerank,protein targeting to peroxisome (GO:0006625),-0.19931234583644622,-0.6724009385431863,0.9573170731707317,0.9786956258253157,1.0,3/29,4.26%,LONP2;ZFAND6;ABCD3
prerank,sulfur amino acid metabolic process (GO:0000096),0.28105611027973465,0.6705427652043962,0.885143570536829,0.974873945964434,1.0,4/24,15.82%,MPST;SMS;TXN2;TST
prerank,cobalamin metabolic process (GO:0009235),-0.22982731554160124,-0.6703985946912946,0.902542372881356,0.9790679377832935,1.0,17/17,77.05%,CUBN;MMADHC;MMAA;TCN1;AMN;ABCD4;ABCC1;CTRC;CBLIF;MMACHC;CD320;MMUT;MMAB;MTR;LMBRD1;MTRR;TCN2
prerank,mRNA methylation (GO:0080009),0.3044073889652637,0.6700132390567896,0.868766404199475,0.9749949110603604,1.0,5/15,25.02%,PCIF1;CMTR1;TRMT10C;METTL3;METTL14
prerank,positive regulation of heart rate (GO:0010460),0.2880958695210023,0.6690916439568857,0.878748370273794,0.9754809585494694,1.0,6/17,27.61%,RYR2;ADRA1D;ADRA1A;EDN3;ATP2A2;KCNQ1
prerank,protein kinase A signaling (GO:0010737),0.31358588543183175,0.669070223142848,0.8741450068399452,0.9751482127930785,1.0,3/12,30.60%,LCP1;PRKACA;PRKACB
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.25197643974339445,-0.668816055391925,0.8745519713261649,0.9790664416890269,1.0,5/13,22.41%,TUT1;FIP1L1;CPSF6;CPSF1;CSTF2T
prerank,sulfur compound transport (GO:0072348),0.2720888922235476,0.6686076924006278,0.9125748502994012,0.9752100582610919,1.0,6/27,18.56%,MGST1;SLC6A6;SLC26A4;SLC25A11;SLC25A19;SLC19A2
prerank,mRNA transport (GO:0051028),0.2357241929542402,0.6680786040768023,0.9592901878914405,0.9753478976475114,1.0,22/101,22.06%,MAGOHB;MAGOH;DDX39B;ZFP36L1;SRSF9;RBM15B;ZFP36;SRSF2;NUP85;CPSF2;NUP88;THOC3;EIF4A3;SLBP;NUP50;U2AF1L4;KIF5C;ALYREF;RAE1;SRSF1;CPSF4;DHX38
prerank,cardiac muscle tissue development (GO:0048738),0.25333191974686275,0.6674869309490836,0.9323725055432373,0.9755315245473467,1.0,10/50,17.12%,NRG1;RBP4;SGCZ;MSX1;KDM6B;GJA1;BMP2;HEY1;GATA4;SGCG
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.2576405392200479,0.6673491488804545,0.9150174621653085,0.9753154917945702,1.0,9/37,21.36%,CALM1;CALM3;CADM4;RIPK2;DMTN;CALM2;TGFB1;DDIT4;SIRT2
prerank,phospholipid biosynthetic process (GO:0008654),0.26252846910625893,0.6667413148968786,0.9086705202312139,0.9755115991253474,1.0,14/36,33.27%,FADS1;PCYT2;DOLK;CPNE6;AGPAT5;SPHK2;FDPS;NUS1;CPNE3;GPAM;SAMD8;DPAGT1;GNPAT;MBOAT1
prerank,striated muscle cell development (GO:0055002),0.30222924027855824,0.6667328865962143,0.8578947368421053,0.9751694140741506,1.0,7/14,35.91%,FLII;TMOD1;CAPN3;KLHL41;LMOD1;LMOD3;SDC1
prerank,establishment of spindle orientation (GO:0051294),-0.19996822848453072,-0.666592156842393,0.96,0.9795581450703194,1.0,9/28,21.33%,PAFAH1B1;UBXN2B;FBXW11;NUMA1;NDEL1;MAD2L1;MISP;LLGL2;NDC80
prerank,RNA modification (GO:0009451),0.2482111053522418,0.6665651087030788,0.9319429198682766,0.9749740320485191,1.0,14/54,25.96%,METTL1;NOP10;RBM15B;AARS2;CTU1;MEPCE;PUS7;FTSJ3;ADAT2;URM1;THUMPD1;METTL3;CTU2;LCMT2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.2806608089963273,0.6665456313832608,0.9024096385542169,0.9746406783347362,1.0,8/24,26.23%,TERF1;PARP1;HNRNPU;HNRNPA1;CTC1;GNL3L;PIF1;HNRNPC
prerank,xenobiotic transport (GO:0042908),0.2964893131472472,0.6665233547612823,0.8861578266494179,0.9743072149181472,1.0,6/17,26.25%,SLC7A5;GJA1;SLC15A2;ABCC3;ABCA3;ABCC5
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.25117069716947943,0.665653103921814,0.9156492785793563,0.9747248517848316,1.0,12/46,21.15%,ATF4;ID1;NR1D1;WNT10B;STK11;ARRDC3;NR1H2;PLCL2;ADAM17;IP6K1;NOTCH1;DDIT3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.28696767276129964,0.6649317428735739,0.8955613577023499,0.9750167989193393,1.0,6/20,25.81%,CDKN1C;CEBPA;HEXIM1;TFAP4;MEN1;HHEX
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.3145919053062531,0.6642394391525096,0.8742937853107344,0.9752533707292195,1.0,3/12,16.24%,CADM4;DCN;DAB2IP
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.29903203622324737,0.6637144953838532,0.8642765685019206,0.9753773870436497,1.0,3/15,19.67%,TNF;TLR6;IL6
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.2736027467429356,0.6621255780425122,0.9057971014492754,0.9764063559883104,1.0,7/23,33.27%,PLAAT3;PLA2G4F;PLA2G3;PLA2G6;PLBD1;PNPLA8;MBOAT1
prerank,transport along microtubule (GO:0010970),0.3103877358939633,0.6619943916792405,0.8661087866108786,0.9761671456351293,1.0,6/13,31.28%,CLIP3;BORCS5;COPG1;APP;CAMSAP3;SPG11
prerank,membrane fusion (GO:0061025),0.25891776539984124,0.6609020783831195,0.90625,0.9768077451711744,1.0,9/33,22.52%,DNM3;RIMS1;VAMP3;VAMP2;NAPA;DNM1L;GCA;VAPA;DNM1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.31007357565871746,0.6606570522232968,0.8731241473396999,0.9766713766379556,1.0,1/12,3.71%,TNF
prerank,acetyl-CoA metabolic process (GO:0006084),0.29744948922633835,0.6600496405912447,0.8783422459893048,0.9768134756698046,1.0,5/15,28.43%,ACAT1;PPCS;PMVK;ACLY;HMGCS1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.23100881415176083,0.6600213416628207,0.9628099173553719,0.9764898320489187,1.0,24/102,22.37%,AKT1;GPER1;PKM;ZFP36L1;PARP1;PDE3B;RAB15;MYO5A;PRKAR1A;VAMP2;PRKAR1B;ADCY4;HDAC5;ADCY8;HDAC9;CAV1;PRKAR2B;EPRS1;RAB31;GOT1;C2CD5;SELENOS;INHBB;TSHR
prerank,mesoderm formation (GO:0001707),-0.23131171253892396,-0.6593835509500412,0.923728813559322,0.9841093399964544,1.0,4/17,16.29%,ITGB4;ITGA3;SMAD2;BMPR2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.24915735528592833,0.6586936403512194,0.9355932203389831,0.977282931168409,1.0,8/44,18.10%,PARK7;SCP2;HSD17B4;OSBPL6;SC5D;PNPO;OSBPL3;CH25H
prerank,mesenchyme morphogenesis (GO:0072132),0.2879219988981997,0.6586182622735228,0.8884514435695539,0.9769990259041994,1.0,8/17,28.21%,ACVRL1;SOX9;BMP2;HEY1;NOTCH1;TGFB2;ENG;TBX2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.28932004681619566,0.6584927724316425,0.8941935483870967,0.9767622902699333,1.0,8/19,32.90%,SLC19A1;FOLR2;SHMT2;MTHFS;DHFR;ALDH1L1;MTHFD2L;MTRR
prerank,chemical homeostasis (GO:0048878),0.24119467678892753,0.6565812189033845,0.9427645788336934,0.9780597562720446,1.0,8/61,13.10%,AQP4;PNPLA2;TREM2;RBP1;CEBPA;ATP13A2;ABHD8;FBXW7
prerank,N-glycan processing (GO:0006491),-0.22179077263234742,-0.6559243052204813,0.9321266968325792,0.9855074211075415,1.0,2/18,5.76%,MAN1C1;FUT8
prerank,leukotriene biosynthetic process (GO:0019370),0.3010737909414231,0.6556410089011837,0.896,0.978524715500781,1.0,5/14,29.45%,MGST3;ALOX5AP;LTC4S;GGT5;GGT7
prerank,protein alkylation (GO:0008213),0.27848722108542195,0.6554053195487805,0.9006134969325154,0.978374222049386,1.0,5/22,22.90%,EEF1AKMT2;PRMT1;SNRPB;SNRPD3;ETF1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.30793433389905694,0.6553580945790316,0.8932584269662921,0.978057083620165,1.0,4/12,23.30%,B3GNT9;B3GNT3;B3GALT5;B3GALT2
prerank,intracellular lipid transport (GO:0032365),0.2778742612473951,0.6551749260566673,0.9106699751861043,0.9778655389009151,1.0,2/21,4.19%,NPC2;MID1IP1
prerank,endocardial cushion morphogenesis (GO:0003203),0.2848854718291428,0.6550803515122502,0.8929503916449086,0.9775918557887335,1.0,8/18,28.21%,ACVRL1;SOX9;BMP2;HEY1;NOTCH1;TGFB2;ENG;TBX2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.27398373487643374,0.6550537733058965,0.9093167701863354,0.9772666608419502,1.0,5/25,20.21%,TREM2;MAPT;CD22;CCL3;TRAT1
prerank,glycoprotein biosynthetic process (GO:0009101),0.23320024771279865,0.6549100667613722,0.9482576557550159,0.9770388315267241,1.0,23/79,25.18%,DAD1;DDOST;B3GNT9;SERP1;ST8SIA4;GCNT1;ALG3;XYLT1;FUT9;B3GNT3;ST6GALNAC2;ST8SIA5;CANT1;TMEM106A;CSGALNACT2;TNIP1;B3GALT5;MGAT1;GAL3ST3;NUS1;B3GALT2;NPC1;CHST9
prerank,peroxisome organization (GO:0007031),-0.20357270631736746,-0.6544553279925374,0.9608938547486033,0.9852764678860297,1.0,7/25,16.53%,LONP2;ABCD3;ACOT8;PEX7;TMEM135;SEC16B;PEX11A
prerank,sprouting angiogenesis (GO:0002040),0.24201082024434867,0.6538314030282103,0.9342825848849945,0.9776004390907462,1.0,5/51,8.38%,RAMP2;AKT1;ACVRL1;OTULIN;KDR
prerank,integrin-mediated signaling pathway (GO:0007229),0.23504072075303345,0.6536470179538353,0.9497863247863247,0.9774090523047453,1.0,11/73,14.04%,ITGB2;ADAM15;SEMA7A;FN1;ISG15;ZYX;THY1;COL3A1;HCK;NME2;ERBIN
prerank,response to estrogen (GO:0043627),0.2600584643532533,0.6524455449816328,0.9005988023952096,0.9780505231388115,1.0,9/31,23.98%,CD24;WBP2;CAV1;RBBP5;NCOA4;CITED2;SFRP1;SFR1;KRT19
prerank,RNA export from nucleus (GO:0006405),0.22930184089235445,0.6522004558998653,0.970954356846473,0.9779072634046265,1.0,35/100,32.54%,MAGOHB;MAGOH;DDX39B;RAN;SRSF9;RBM15B;SRSF2;NUP85;HNRNPA1;CPSF2;NUP88;THOC3;EIF4A3;SLBP;NUP50;U2AF1L4;ALYREF;RAE1;SRSF1;CPSF4;DHX38;ALKBH5;HHEX;SYMPK;NUP205;NUP188;DDX25;HNRNPA2B1;NUP43;NUP210;SEH1L;XPO5;UPF1;POLDIP3;U2AF1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.201962372001679,-0.6518634821098914,0.9698795180722891,0.9858505814221596,1.0,7/27,17.06%,VPS13A;VPS13D;GBF1;OPTN;OBSL1;ARL5B;GBP5
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.22547471685004103,0.6510427348998508,0.9692622950819673,0.9785460217511156,1.0,15/125,17.27%,RPS27;DYNLL2;DYNLL1;RAN;SBDS;CLASP1;XPO1;TACC3;BUB3;STMN1;NUP85;DCTN2;CENPL;NUDC;RANGAP1
prerank,ureteric bud morphogenesis (GO:0060675),-0.2266767577939638,-0.650971618622147,0.9336099585062241,0.9851970759984197,1.0,7/16,27.15%,SIX1;WNT11;BMP4;FGF2;PKD2;GDNF;NPNT
prerank,cellular response to estrogen stimulus (GO:0071391),-0.2393891430821895,-0.650719761867549,0.956,0.9840360097205381,1.0,3/14,12.45%,BCAS3;TRIM24;AR
prerank,protein lipidation (GO:0006497),0.24200274346417494,0.6505003129982667,0.93007769145394,0.9786633487594434,1.0,16/59,29.53%,PIGZ;PIGQ;GLUL;SELENOK;ZDHHC5;DPM3;DPM2;WDR45;PORCN;ZDHHC12;ZDHHC8;ZDHHC2;WIPI2;PGAP4;ZDHHC14;ZDHHC16
prerank,negative regulation of viral release from host cell (GO:1902187),0.30450986553136666,0.6504081936880366,0.8836565096952909,0.9783861062325196,1.0,3/13,19.64%,TRIM28;TRIM32;TRIM13
prerank,estrogen metabolic process (GO:0008210),0.298732118865904,0.6503270194339428,0.8743455497382199,0.97811217435569,1.0,4/15,33.22%,HSD17B4;HSD17B11;HSD17B8;HSD17B10
prerank,regulation of Golgi organization (GO:1903358),0.2863233891964646,0.649447179819068,0.889171974522293,0.9784574087648111,1.0,4/17,18.59%,MAPK3;MYO5A;PDE4DIP;MAP2K2
prerank,actin filament network formation (GO:0051639),0.31139648018945465,0.6487946804022446,0.8896551724137931,0.9786330187445514,1.0,4/11,22.92%,LCP1;ACTN1;FHOD3;SPIRE1
prerank,necroptotic process (GO:0070266),0.28883282399578986,0.6485628172260078,0.8881748071979434,0.9784608824453964,1.0,7/16,36.22%,TICAM2;DNM1L;CD14;PGAM5;MLKL;IPMK;ITPK1
prerank,modulation by symbiont of entry into host (GO:0052372),0.2876079662926029,0.6479680298280981,0.8871181938911022,0.9786038963607363,1.0,9/16,37.83%,HS3ST5;CAV1;EXOC7;TRIM68;TRIM25;TRIM27;TRIM21;TRIM14;TRIM6
prerank,aspartate family amino acid metabolic process (GO:0009066),0.28814064792149796,0.6469582636637019,0.8983268983268984,0.9790596526945449,1.0,8/18,29.25%,SLC25A13;SMS;NAT8L;ASNS;GOT1;SLC25A12;ADI1;ASS1
prerank,endocytic recycling (GO:0032456),0.24500650130742702,0.6465982854225532,0.9534883720930233,0.9790076708687866,1.0,8/50,18.17%,SNX17;RAB14;ARF6;ARL4C;CMTM6;EHD1;DENND1C;EHD2
prerank,histone acetylation (GO:0016573),0.23137727916849574,0.6462317461328131,0.9515789473684211,0.9789274312670625,1.0,9/69,10.80%,SPI1;BRD1;BRPF1;TAF10;JADE1;MORF4L2;TAF5L;TAF9;APBB1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.22261916664228937,0.6461769051822112,0.984725050916497,0.9786268353195532,1.0,26/138,18.49%,NPPC;ERBB4;NTRK2;LTK;SHC3;MUSK;PTK6;KDR;MPZL1;EPHA5;HCK;CSF1R;FLT4;PTPRD;TIE1;EPHB1;GFRA2;FLT1;TYRO3;CASS4;LCP2;SYK;DDR2;ERBB3;SRMS;SLA
prerank,regulation of presynapse assembly (GO:1905606),0.2845621723870452,0.6457607223907025,0.9010152284263959,0.978278941018179,1.0,8/18,24.37%,LRFN5;IL1RAPL1;PTPRD;LRRC4B;SNCA;SLITRK3;WNT7A;APP
prerank,regulation of presynapse organization (GO:0099174),0.2845621723870452,0.6457607223907025,0.9010152284263959,0.978278941018179,1.0,8/18,24.37%,LRFN5;IL1RAPL1;PTPRD;LRRC4B;SNCA;SLITRK3;WNT7A;APP
prerank,regulation of protein localization to centrosome (GO:1904779),-0.2586036449684351,-0.64545163205032,0.9111111111111111,0.9865165532148987,1.0,3/10,21.07%,UBXN2B;GSK3B;NUP62
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.29343266003819213,0.6444312080257856,0.8853333333333333,0.9789884785028785,1.0,3/14,16.89%,PRKAR1A;PRKAR1B;PRKAR2B
prerank,nuclear pore organization (GO:0006999),-0.23684914675639412,-0.6437173290314953,0.9372384937238494,0.9864442472875254,1.0,6/14,22.27%,NUP98;AHCTF1;NUP35;NDC1;TPR;NUP93
prerank,RNA methylation (GO:0001510),0.23884307423606926,0.6435714965960181,0.9581958195819582,0.9793193116046203,1.0,15/60,26.11%,METTL1;TRMT112;FBL;RBM15B;PCIF1;CMTR1;ZCCHC4;MEPCE;FTSJ3;TRMT10C;METTL3;METTL14;WDR6;LCMT2;TYW3
prerank,chromatin remodeling (GO:0006338),0.22760706209660164,0.6434704283050744,0.9607032057911065,0.9790518201277513,1.0,17/100,21.30%,ACTB;NPM1;MBD3;PAK1;NPM3;PIH1D1;KDM6B;ZBTB7A;SOX9;HDAC5;ERCC6;MTA2;CHD3;CBX3;MYC;ACTR5;FOXA1
prerank,cellular response to interleukin-4 (GO:0071353),-0.2678257594777806,-0.6432056979080243,0.8773584905660378,0.9854475843371696,1.0,10/10,73.24%,STAT6;JAK3;GATA3;TCF7;RUFY4;XCL1;DCSTAMP;SHPK;XBP1;LEF1
prerank,tRNA transport (GO:0051031),0.2524493470600456,0.6425084749491002,0.9253208868144691,0.9794887547144054,1.0,14/35,31.91%,RAN;YBX1;TOMM20L;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L;TOMM20
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.23236239784335716,0.6424196940480555,0.9550321199143469,0.9792024682914506,1.0,18/69,27.29%,POLR2E;POLR2D;POLR2F;TAF9;POLR2G;POLR2K;ZC3H8;TBP;POLR2H;CDK9;TAF5;INTS13;ICE1;RPRD1A;ELL2;POU2F2;INTS12;TAF13
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.24121477903078747,0.6421738116616507,0.9448818897637795,0.9790567193956623,1.0,10/49,20.07%,MYL9;H3-3A;PRMT1;PF4;L3MBTL1;SCIN;RBBP5;AGO1;THPO;MEF2C
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.24066838998905415,-0.6409315628543996,0.9246031746031746,0.985641846062048,1.0,5/14,22.41%,TUT1;FIP1L1;CPSF6;CPSF1;CSTF2T
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2110293740607791,0.6409096989898948,1.0,0.979707742228537,1.0,175/834,22.83%,RPS27A;UBC;UBB;CD81;PCBP1;CHCHD2;JUND;PARK7;TMPRSS6;MAPK3;ATF4;KLF2;SOX18;PTPRN;POMC;NPM1;GPER1;EIF5A;BEX1;TNF;PDGFB;DRAP1;NR1D1;HCLS1;ACVRL1;SPI1;EPAS1;GLMP;JUNB;PIN1;PSMC3;PARP1;MRTFA;CTNNB1;ST18;GRIN1;HES1;HYAL2;HIPK2;CDK8;OTX2;UBA52;FOXF2;CEBPB;FOXD3;NAMPT;SALL2;CEBPA;PROX1;CXCL10;CREB3L4;CREB3;CSRNP3;YBX1;MLXIPL;MLX;EGR1;RRP1B;HOXD4;GATA2;JUN;DCN;CAMK1;HMGB1;ZBTB49;TAF9;RFX4;RTRAF;HOXB7;PHOX2A;MC1R;IRF8;APBB1;SUPT4H1;APEX1;WNT5A;IL11;SOX17;ATF5;KDM6B;SS18L2;IRF2BPL;WBP2;HRAS;PTOV1;SOX8;SNW1;IRX3;ZMIZ2;DBP;THRA;KLF4;HOXD8;SLC11A1;SOX9;PAX3;LILRB1;BMP2;RIPK2;NME2;HNRNPU;TNFRSF1A;HDAC5;ATMIN;IRF7;MED30;F2RL1;PF4;AKNA;LAGE3;IGF2;ARF4;NR1H2;KDM1B;SUB1;HEY1;DLL1;IER5;MEPCE;DAB2IP;E2F4;GATA4;BCL11B;SQSTM1;SKAP1;GLIS2;TWIST1;ADCYAP1;PPARGC1A;MED21;AGO1;CNBP;TOX2;LMO1;NRL;SOX11;PPP3CA;DDRGK1;MUC1;INHBA;NLRP3;ESRRB;TFAP2B;NOTCH1;IL6;HGF;TGFB1;AGRN;POU4F1;CITED2;MEF2C;FOXA2;MYC;NFKBIA;FOSL2;CDC5L;DDIT3;CEBPZ;CDK9;FOXA1;CKAP2;SIRT2;PLXND1;MEN1;SS18L1;IRF5;REST;GRHL2;TNIP1;SOX1;MYDGF;CSRNP1;IER2;AKIRIN2;PPP3R1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3063485092332734,0.6406757396430772,0.8953168044077136,0.9795368265460997,1.0,2/11,13.45%,EGR1;BMP2
prerank,regulation of phospholipase activity (GO:0010517),0.3150439897112513,0.6400182517935875,0.9052197802197802,0.9796931323492697,1.0,4/10,25.72%,RGS2;RASGRP1;SNCA;FGFR3
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.2770219075892998,0.6395006492726069,0.9089759797724399,0.9797380428432221,1.0,5/19,15.24%,HS6ST3;HS3ST5;B3GAT3;UGDH;XYLT1
prerank,RNA stabilization (GO:0043489),0.2526233041678732,0.6390308894649895,0.9356376638855781,0.9797726210905824,1.0,10/33,23.94%,YBX1;PABPC1;SLC11A1;HNRNPU;CIRBP;EIF4ENIF1;DKC1;NAF1;ELAVL1;DND1
prerank,regulation of cytoplasmic translation (GO:2000765),0.2970941881173076,0.6388042605321933,0.8995929443690638,0.9796056995011817,1.0,3/14,17.90%,PKM;YBX3;CNBP
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.28174172391356517,0.6379795825583865,0.9141025641025641,0.9798780737508334,1.0,2/18,13.44%,AQP4;NEK10
prerank,tryptophan catabolic process (GO:0006569),0.3048805659922203,0.63754465116128,0.9038737446197992,0.9798614609396838,1.0,1/11,11.01%,IDO2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.23322242450875763,-0.6371511688029664,0.9154411764705882,0.9869092059483829,1.0,13/13,76.70%,PVR;NECTIN2;IL12A;IL23A;IL23R;IL12B;XCL1;SLC22A13;MR1;FADD;STX7;CYRIB;IL12RB1
prerank,snRNA transcription (GO:0009301),0.23013034080041034,0.6370628519759629,0.9572649572649573,0.9798949182361716,1.0,18/70,27.29%,POLR2E;POLR2D;POLR2F;TAF9;POLR2G;POLR2K;ZC3H8;TBP;POLR2H;CDK9;TAF5;INTS13;ICE1;RPRD1A;ELL2;POU2F2;INTS12;TAF13
prerank,establishment of melanosome localization (GO:0032401),0.27583789501854505,0.636717598514542,0.8983050847457628,0.979815931667517,1.0,7/19,30.82%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,artery development (GO:0060840),0.2644086961633605,0.6362449478715474,0.8981366459627329,0.9798116928002172,1.0,3/23,5.71%,ACVRL1;APLNR;HES1
prerank,tRNA wobble uridine modification (GO:0002098),0.2942315912957595,0.6355984405783315,0.9168900804289544,0.9799516507165302,1.0,5/14,24.68%,DPH3;ELP3;CTU1;URM1;CTU2
prerank,regulation of histone modification (GO:0031056),0.2968962071151336,0.6351168613395072,0.9083769633507853,0.9799788661944546,1.0,1/13,1.76%,PARK7
prerank,protein K48-linked deubiquitination (GO:0071108),0.26590706224621596,0.6348780287253417,0.9049382716049382,0.9798318512474136,1.0,5/23,16.71%,TNFAIP3;USP5;OTUD7A;OTUB1;USP8
prerank,regulation of filopodium assembly (GO:0051489),0.2457542646848735,0.6345804356089897,0.9380841121495327,0.9797075211563595,1.0,9/38,19.89%,NLGN1;TENM2;ARF6;FNBP1L;TRPM2;GAP43;DMTN;GPM6A;AGRN
prerank,response to ketone (GO:1901654),0.26166380808407286,0.6342158737077083,0.9259259259259259,0.9796475785102965,1.0,6/24,19.83%,CCL19;WBP2;HSD3B2;CAV1;SLIT3;TGFB1
prerank,regulation of RNA metabolic process (GO:0051252),0.23368565217436102,0.6337239439238689,0.9663774403470716,0.9796680246658126,1.0,15/59,23.75%,PCBP1;AHNAK;PCBP4;PQBP1;RRP1B;FAM50A;METTL18;PRX;OAS3;SRRM4;HNRNPF;IGF2BP3;HNRNPLL;HNRNPH2;PCBP2
prerank,epidermal cell differentiation (GO:0009913),0.24072406659313528,0.633515158630568,0.942987457240593,0.9794902238972749,1.0,4/41,13.69%,TXNIP;CTNNB1;WNT5A;EVPL
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.27952323027778603,0.6327755641870836,0.8837209302325582,0.9796832493365137,1.0,4/15,23.89%,PNP;SYK;CCR2;HSPH1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.24306117715660092,0.6325686280651107,0.9398410896708286,0.9794891742895501,1.0,10/41,21.55%,FKBP1A;CPE;PROX1;HEY1;GATA4;SOX11;NOTCH1;TGFB1;MEF2C;NPY5R
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.2930343798456039,0.631258642566842,0.9121171770972037,0.9801378601080364,1.0,3/14,19.20%,ENTPD3;NUDT16;NUDT9
prerank,regulation of mRNA processing (GO:0050684),0.25255278841716367,0.6304796417430785,0.9290865384615384,0.9803321611684961,1.0,3/32,4.40%,HNRNPK;QKI;ZFP36L1
prerank,cellular response to hydroxyurea (GO:0072711),0.30584350184211556,0.6303566603321225,0.8955431754874652,0.9800735796471797,1.0,3/10,22.28%,NSMCE3;DDX11;BLM
prerank,response to progesterone (GO:0032570),0.2748169637623631,0.6296343184469388,0.9154557463672391,0.9802742470192185,1.0,8/18,32.88%,WBP2;CAV1;TGFB1;TGFB2;UBE3A;ACOD1;NR1H3;CATSPER2
prerank,peptidyl-serine modification (GO:0018209),0.2135942788265279,0.6293684809419218,0.9868020304568528,0.9801225817441632,1.0,29/166,19.17%,AKT1;PNCK;PINK1;MAST3;PDGFB;CAMK1D;PARP1;UHMK1;HIPK2;SGK1;PKN1;MAST1;CDK5R1;CAMK1;NAA10;POGLUT3;ULK3;GAS6;DCLK3;SBK1;STK32C;CAMKV;CDK5;HIPK4;GALNT13;CSNK1G2;STK32A;MKNK1;GRK2
prerank,regulation of autophagosome assembly (GO:2000785),0.24415759284142094,0.6292198358475175,0.9388954171562868,0.9798803644254941,1.0,4/33,13.21%,PINK1;IFT20;NUPR1;UBQLN2
prerank,lipoprotein transport (GO:0042953),-0.2503859888920116,-0.6290339409994561,0.9250936329588015,0.9907283655176956,1.0,3/10,15.34%,PPARG;LRP1;PRKCB
prerank,polyol metabolic process (GO:0019751),0.24213813108488838,0.628947223226167,0.9472502805836139,0.97974018677095,1.0,10/46,25.49%,CALM1;NUDT3;INPP5J;NUDT4;IP6K1;NUDT10;PLCH1;INPP5D;NUDT11;INPP4B
prerank,regulation of myelination (GO:0031641),0.25864887220523447,0.6279078815187781,0.9325153374233128,0.9801337998072672,1.0,8/25,28.03%,KLK8;MYRF;TENM4;PTPRZ1;SIRT2;PTN;TMEM98;TNFRSF1B
prerank,organelle transport along microtubule (GO:0072384),0.24959612610239076,0.6279016964256546,0.9404761904761905,0.9797948012284897,1.0,3/31,11.11%,UBB;MAPT;HAP1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.2930249894858769,0.6277313473869285,0.9102209944751382,0.9795857110719104,1.0,4/12,26.53%,SNAP25;STX4;STX1B;STX3
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.2836698922665987,0.6271733713284184,0.9057104913678619,0.9796356781966764,1.0,6/16,25.99%,ADSS1;GART;IMPDH1;PAICS;IMPDH2;ADSL
prerank,regulation of lamellipodium organization (GO:1902743),0.2858954908115988,0.6264156742452568,0.906578947368421,0.9798389978940687,1.0,4/14,22.96%,RAC1;DMTN;TWF1;TWF2
prerank,Golgi inheritance (GO:0048313),-0.2468337668133725,-0.626036373186965,0.9192982456140351,0.9911537495143746,1.0,2/11,8.20%,GOLGA2;GBF1
prerank,sphingoid metabolic process (GO:0046519),0.29609820567993356,0.6245691889694414,0.9094707520891365,0.9808346836884587,1.0,5/12,21.11%,NAAA;SGPP1;SPHK2;SGPP2;ASAH2
prerank,response to steroid hormone (GO:0048545),0.24606056420855626,0.6238432768142498,0.927710843373494,0.9809881609853335,1.0,7/31,19.83%,ATP1A3;WBP2;ATP1A1;PAQR7;ABCA2;CAV1;TGFB1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.2985840872419062,0.6226406810009847,0.8918918918918919,0.98150064531171,1.0,3/12,17.36%,MTLN;TWIST1;PPARGC1A
prerank,digestive tract morphogenesis (GO:0048546),-0.23018076823828815,-0.6223070923215449,0.9550561797752809,0.9919600630375317,1.0,2/14,8.39%,NIPBL;FGFR2
prerank,transepithelial transport (GO:0070633),0.27894822497338867,0.6214708673797606,0.9234760051880675,0.981963525042894,1.0,2/15,12.43%,SLC1A2;SLC1A1
prerank,phosphate ion transport (GO:0006817),0.2761296781781772,0.6212746225955056,0.9163398692810457,0.9817674294618596,1.0,8/16,40.28%,SLC25A11;SLC25A14;SLC25A30;SLC25A3;SLC37A2;XPR1;SLC20A1;SLC37A1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.2614404785330793,0.6209165565758513,0.9400749063670412,0.981678040166904,1.0,10/22,32.37%,PSMC3;MED30;SUB1;SRF;PAXIP1;MED16;MED12;PSMC5;PSMC2;MED4
prerank,regulation of myotube differentiation (GO:0010830),0.2616169586208711,0.6209078487493161,0.9303482587064676,0.9813437573423773,1.0,7/24,21.70%,BHLHE41;TMEM119;HDAC5;HDAC9;MMP14;NOTCH1;CCN3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.2079649077552829,0.6208983549987227,0.9979919678714859,0.9810076729395875,1.0,44/259,21.08%,GSN;DYNLL2;DYNLL1;FXYD5;EMP3;EMP2;RAC1;PMP22;IFT20;FLNA;S1PR1;DNM3;ARHGEF4;P2RX7;CNGA4;NTN1;ARF6;P2RY12;ARHGEF7;FNBP1L;CEP131;FHDC1;TCTN3;AIF1;SHTN1;CCDC88A;SDCBP;EHD1;ARF4;CNGB1;DMTN;TMEM17;CCDC28B;TCTN1;EXOC7;EHD2;NOTCH1;BBIP1;NEK1;EXOC5;CFAP410;CFAP54;EXOC8;PTPRO
prerank,inositol phosphate metabolic process (GO:0043647),0.23858765493282225,0.6195304303241882,0.9560315670800451,0.981589258311489,1.0,10/46,25.49%,CALM1;NUDT3;INPP5J;NUDT4;IP6K1;NUDT10;PLCH1;INPP5D;NUDT11;INPP4B
prerank,regulation of mRNA metabolic process (GO:1903311),-0.24996445208414192,-0.6194040165727603,0.9473684210526315,0.9921902864838134,1.0,3/11,13.51%,IWS1;SLTM;SRPK2
prerank,endodermal cell fate commitment (GO:0001711),-0.2508030243667435,-0.6182857553923046,0.8993288590604027,0.991507206085982,1.0,4/10,22.76%,CDC73;RTF1;SOX2;CTR9
prerank,protein oxidation (GO:0018158),0.2961816806330212,0.6179547337117224,0.9135977337110481,0.9823066834752572,1.0,1/11,5.58%,LOX
prerank,positive regulation of protein export from nucleus (GO:0046827),0.2795230179538127,0.6177262925424091,0.900131406044678,0.982114605296096,1.0,3/15,13.55%,YWHAE;CAMK1;GAS6
prerank,cellular response to pH (GO:0071467),-0.21288886888355496,-0.6152446180481592,0.9512195121951219,0.9918310180034001,1.0,2/17,10.93%,SLC9A1;RAB11B
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.3051669695645269,0.6150042603084435,0.9134199134199135,0.9835669664765612,1.0,6/10,34.37%,PODXL;SKAP1;ADA;CD3E;CCL5;FERMT3
prerank,nuclear membrane disassembly (GO:0051081),0.2830231585094804,0.61466233471674,0.922971114167813,0.9834409417448652,1.0,4/14,25.10%,CTDNEP1;DCTN1;VRK1;PRKCA
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.24788457662807348,0.6142666277801326,0.9432624113475178,0.9833650949551211,1.0,8/32,22.85%,PCNA;FBXO5;CDK5;ESRRB;KLF11;ID2;CDC45;CDK18
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.23994842299093053,0.6140492943467837,0.9663182346109176,0.9831583676145369,1.0,13/36,28.40%,CALM1;CTNNB1;GNAO1;WNT5A;AGO1;PPP3CA;FZD2;PPP3R1;PDE6G;FZD3;LEF1;FZD5;MAP3K7
prerank,DNA strand elongation (GO:0022616),0.2693856532386498,0.6135465550321607,0.9323797139141743,0.983126977667361,1.0,10/18,39.78%,RFC4;GINS3;MCM7;POLD3;GINS1;RFC3;POLD2;MCM4;MCM3;DCLRE1B
prerank,protein heterooligomerization (GO:0051291),0.2687722513136868,0.6126290897738437,0.9028497409326425,0.9833775796912408,1.0,4/17,21.10%,GRIN1;MAT2A;GRIN2B;KCNC2
prerank,response to hydroxyurea (GO:0072710),-0.23607355309480915,-0.6112325866888233,0.950354609929078,0.9926979263265775,1.0,2/11,5.78%,KAT7;SPIDR
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.2946439082648794,0.6111540014801036,0.9137199434229137,0.9839788265539282,1.0,1/11,4.40%,ZFP36L1
prerank,cytosolic transport (GO:0016482),0.2138125832578281,0.6088206192957091,0.9885892116182573,0.9851330676305403,1.0,18/108,19.61%,LAMP1;LAPTM5;EMP2;MAGEL2;RAB14;CLTC;YKT6;VAMP3;BET1L;ARL1;DCTN1;CLN5;SORT1;HOOK1;PREPL;SYS1;SNX16;TBC1D10C
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.26641043229731837,0.6075872109841126,0.9260237780713342,0.985561376110473,1.0,6/17,29.41%,SCN4B;KCNE4;KCNE5;CACNA2D1;KCNQ1;SCN1B
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.28444981029445293,0.6067860022224688,0.9178885630498533,0.9857142235693737,1.0,3/12,23.31%,SLC11A1;CCR2;IL12RB1
prerank,lipoprotein localization (GO:0044872),-0.23317749069813437,-0.606384427283026,0.9592592592592593,0.9938547626736965,1.0,3/11,15.34%,PPARG;LRP1;PRKCB
prerank,mRNA export from nucleus (GO:0006406),0.21316264848374283,0.6061865942500285,0.9906832298136646,0.9857235245825609,1.0,21/102,22.06%,MAGOHB;MAGOH;POLR2D;DDX39B;SRSF9;RBM15B;SRSF2;NUP85;CPSF2;NUP88;THOC3;EIF4A3;PCID2;SLBP;NUP50;U2AF1L4;ALYREF;RAE1;SRSF1;CPSF4;DHX38
prerank,piRNA metabolic process (GO:0034587),0.26164678706900546,0.6057363297275616,0.9394703656998739,0.9856639917163292,1.0,3/19,21.87%,ASZ1;MAEL;TDRD9
prerank,determination of bilateral symmetry (GO:0009855),0.2502933135257411,0.6056152683995316,0.9444444444444444,0.9853947168651424,1.0,5/24,20.01%,MMP21;LEFTY1;DLL1;NOTCH1;CITED2
prerank,photoreceptor cell development (GO:0042461),0.27936327711743847,0.6055815626141988,0.919889502762431,0.9850733698277029,1.0,4/14,25.21%,MFSD2A;CDHR1;DCX;RORB
prerank,DNA repair (GO:0006281),0.20279982877735014,0.6048254735438998,0.9959919839679359,0.9852106177140949,1.0,63/284,25.98%,RPS27A;UBC;UBB;PARK7;UBXN1;NPM1;CHEK2;RNASEH2A;PARP1;VCP;NUCKS1;RPA2;UBA52;TRIM28;CENPX;DDB1;NEIL1;MC1R;APBB1;APEX1;PCNA;NSMCE1;NSMCE3;CHRNA4;RFC2;TEX264;UBE2V1;BABAM1;RECQL5;POLD4;CETN2;MUS81;BRCA2;DCLRE1C;NEIL2;ERCC6;NOP53;TRAIP;WDR48;RAD23A;RFC4;ERCC1;ACTR5;FAM111A;GADD45A;MEN1;FAAP20;BLM;POLD1;PNKP;ALKBH5;BARD1;ATRIP;BAP1;RPA3;RPAIN;DOT1L;XPC;LIG1;UBE2A;GTF2H5;RAD51;ALKBH2
prerank,protein modification by small protein conjugation (GO:0032446),0.20103600964884197,0.6040460206106862,0.998998998998999,0.9853622580405256,1.0,61/361,21.85%,RPS27A;UBC;RACK1;UBB;ELOB;UBE2Z;PINK1;KCTD10;KLHL9;EPAS1;UBE2G2;VCP;CDC34;DCAF15;RNF187;UBA52;ARRDC1;ISG15;USP5;TRIM28;UFC1;UBE2M;OTULIN;RBX1;NEDD8;TNFAIP1;DDB1;SUMO2;SUMO3;KLHL7;FBXW5;SYVN1;PCNA;ZSWIM8;FBXW7;RNF40;NUP85;NUP88;ARRB2;RNF7;ENC1;VHL;TRIM32;BCL11A;RANGAP1;RNF181;RLIM;NUP50;TRAIP;KCTD13;DDRGK1;HECW1;TRIM13;SKP1;KLHL25;RAE1;BRAP;SELENOS;STUB1;ELOC;AMFR
prerank,positive regulation of histone deacetylation (GO:0031065),0.28723579295528545,0.6034205579760333,0.9141274238227147,0.9854204983735196,1.0,2/12,10.93%,APLNR;CTBP1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.2851803252257159,0.602891225915016,0.9164383561643835,0.9854009234450634,1.0,1/13,3.61%,CANX
prerank,protein polyglutamylation (GO:0018095),0.28887460548173427,0.6027201701841026,0.9192634560906515,0.9851669661844401,1.0,4/11,27.00%,TTLL7;TTLL5;TPGS1;TTLL1
prerank,cardiac ventricle development (GO:0003231),0.2622556730866585,0.6026415653281506,0.9361979166666666,0.9848769830059815,1.0,8/20,28.11%,HES1;HEY1;GATA4;NOTCH1;PDE2A;DLL4;ENG;STRA6
prerank,mitochondrial transcription (GO:0006390),-0.24295559087197957,-0.6019307268332976,0.9490909090909091,0.994872460425185,1.0,2/10,16.01%,FOXO3;MTERF2
prerank,melanosome localization (GO:0032400),0.2561725796798717,0.6016642285895469,0.937984496124031,0.9851280324971182,1.0,7/21,30.82%,MYO5A;BLOC1S3;BLOC1S5;RAB27B;ARL6;MREG;MLPH
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.2592486298174865,0.6016092127664281,0.9393564356435643,0.9848238059301477,1.0,7/22,25.89%,PPP1CA;PDP1;DUSP2;PPM1F;DUSP1;DUSP8;DUSP6
prerank,female gamete generation (GO:0007292),0.24110094131239157,0.6005951497775512,0.9362214199759326,0.9850810861447171,1.0,2/29,8.15%,MDK;FMN2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.28345623451453594,0.6003908983507991,0.9252717391304348,0.9848604115640048,1.0,3/12,23.20%,GMNN;BLM;NUGGC
prerank,quinone biosynthetic process (GO:1901663),-0.2175905723680393,-0.6003143844589296,0.9602888086642599,0.9943048292910495,1.0,7/14,25.63%,COQ10B;COQ8B;COQ9;COQ8A;PDSS2;COQ3;FDXR
prerank,GPI anchor biosynthetic process (GO:0006506),0.24375710925746719,0.6000566400584882,0.9459783913565426,0.9847255372123059,1.0,5/30,16.85%,PIGZ;PIGQ;DPM3;PIGS;DPM2
prerank,nuclear envelope organization (GO:0006998),0.2581331058299041,0.5998291157364573,0.9281210592686002,0.9845242761520299,1.0,5/20,23.68%,CTDNEP1;VPS4A;TMEM43;SUN2;SPAG4
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.2856353989087677,0.599444210086312,0.9176788124156545,0.9844100851989769,1.0,3/12,20.78%,ABCG1;NR1H2;NFKBIA
prerank,membrane depolarization during action potential (GO:0086010),0.2477594087684647,0.5992429591344235,0.9451887941534713,0.9841859208131961,1.0,4/26,15.37%,SCN1A;YWHAH;SCN4B;SLC8A1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2356163949795742,0.5989875015309232,0.9542857142857143,0.984000818681929,1.0,15/36,36.97%,CHEK2;PRPF19;ERCC6;CDC5L;CDC45;ATRIP;DOT1L;RAD9A;DNA2;RHNO1;CLOCK;DONSON;TIMELESS;SETMAR;RAD1
prerank,microtubule bundle formation (GO:0001578),-0.16622523513019824,-0.598841891025572,0.9745762711864406,0.9936640516439648,1.0,17/42,29.03%,NAV1;TTLL3;CCDC66;SPEF1;NUMA1;GAS8;AAAS;MAP1S;LRGUK;CAPN6;RP1;FOXJ1;PLK1;NCKAP5L;PSRC1;CCDC40;SPAST
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.27634108464085283,0.5976787026325591,0.9292517006802721,0.9844059612598278,1.0,3/13,17.54%,NEIL1;NT5C;NEIL2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.25759150416764276,0.5968901840702622,0.9445145018915511,0.9841619717124552,1.0,4/20,17.37%,BCAT2;BCKDK;ACAT1;ECHS1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.25759150416764276,0.5968901840702622,0.9445145018915511,0.9841619717124552,1.0,4/20,17.37%,BCAT2;BCKDK;ACAT1;ECHS1
prerank,inner ear morphogenesis (GO:0042472),-0.19221103926909178,-0.5963106845863949,0.9743589743589743,0.9935577007017782,1.0,4/22,13.03%,FGFR2;EPHB2;ZIC1;SIX1
prerank,skeletal muscle contraction (GO:0003009),0.25769339225769694,0.5937564207240364,0.9426020408163265,0.985586218419989,1.0,5/19,28.85%,TNNI1;STAC3;MYH14;TCAP;STAC
prerank,negative regulation of potassium ion transport (GO:0043267),-0.2224737826536971,-0.5930544950981022,0.9540229885057471,0.9937541061316271,1.0,4/13,20.58%,ACTN2;STK39;NOS1;PTK2B
prerank,response to interleukin-4 (GO:0070670),0.2891036906854128,0.5919661719694492,0.9339080459770115,0.9862256428496733,1.0,10/10,71.11%,LEF1;XBP1;SHPK;DCSTAMP;XCL1;CITED1;RUFY4;TCF7;GATA3;JAK3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.22534023349966464,-0.5917438680254153,0.9471698113207547,0.9929678975697218,1.0,5/13,21.61%,DYNC1LI1;MAD2L1;NDC80;XRCC3;TPR
prerank,DNA geometric change (GO:0032392),0.24752832044042739,0.5909676317763851,0.9614427860696517,0.9864335122425993,1.0,9/24,31.45%,HMGB3;HMGB1;DDX11;RECQL5;BLM;PIF1;DHX9;HNRNPA2B1;DNA2
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.2071299843369493,-0.590682147466195,0.966804979253112,0.9921216489715519,1.0,4/16,15.58%,TOP2B;SLX4;HFM1;FANCM
prerank,protein localization to microtubule organizing center (GO:1905508),-0.21199606292366635,-0.5897841678035133,0.9705882352941176,0.9912050049201119,1.0,5/15,20.57%,PCM1;PIBF1;C2CD3;CCDC14;CEP192
prerank,regulation of acute inflammatory response (GO:0002673),-0.19536548605877918,-0.5892647136580735,0.9793388429752066,0.9901290512624138,1.0,18/18,80.49%,OSMR;PTGES;KLKB1;IL4;GSTP1;CREB3L3;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B;IL6ST;F12;DNASE1L3;C2CD4A;ADAM8;IL6;NLRP3
prerank,homeostasis of number of cells (GO:0048872),0.27742347441170834,0.5882434424117957,0.9245541838134431,0.987571094581939,1.0,4/12,27.82%,CX3CR1;NOTCH1;CCN3;OCIAD2
prerank,cellular response to osmotic stress (GO:0071470),0.2504239855872261,0.5877236633655227,0.9216182048040455,0.987516455337081,1.0,6/21,26.72%,ZFP36L1;AQP1;YBX3;CAPN3;OXSR1;SCN2A
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.2709547729713685,0.5873706737410381,0.9493844049247606,0.9873785953945247,1.0,2/14,15.24%,ANK3;ATP1B1
prerank,regulation of adaptive immune response (GO:0002819),-0.19614417836365314,-0.5857905199218305,0.9770642201834863,0.9902728653423434,1.0,3/18,13.42%,EIF2AK4;ADCY7;SIRT1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.25286212926633916,0.5845715150792652,0.9550561797752809,0.9884972973575059,1.0,8/19,32.13%,HSPD1;RIPK2;IRF7;IRF5;TLR7;DHX9;MAVS;DDX3X
prerank,negative regulation of dephosphorylation (GO:0035305),0.25109153944281626,0.5843610548692496,0.9382239382239382,0.988276662179159,1.0,8/18,32.33%,YWHAB;PPP1R35;ARPP19;PPP1R15A;MFHAS1;CHP1;PTPA;PPP1R16B
prerank,regulation of rRNA processing (GO:2000232),0.25928565687532235,0.5837130472533428,0.9425133689839572,0.988283650303408,1.0,3/16,16.28%,TRMT112;METTL18;NUDT16
prerank,UV-damage excision repair (GO:0070914),0.2755282803463428,0.5818609247309597,0.9278074866310161,0.9889040282700209,1.0,5/12,25.37%,DDB1;MC1R;ERCC1;ACTR5;XPC
prerank,establishment of apical/basal cell polarity (GO:0035089),0.2686986993496974,0.5809941990798444,0.9385026737967914,0.9890116025807334,1.0,6/14,33.25%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1;FSCN1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.2825578670222725,0.5797591567170767,0.9241011984021305,0.9892782691983047,1.0,3/11,22.28%,GMNN;FBXO5;BLM
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.259085945814055,0.5785868532369305,0.9510869565217391,0.9895184009204695,1.0,9/16,39.01%,RECQL5;BLM;RAD51;MCM7;MCM2;TWNK;RECQL;MCM4;PURA
prerank,mitotic spindle assembly (GO:0090307),0.22086583187534356,0.576836952886862,0.9734411085450346,0.9900291314396279,1.0,7/42,18.88%,CHEK2;FLNA;ABRAXAS2;CLASP1;RHOA;TOGARAM2;KIFC2
prerank,DNA catabolic process (GO:0006308),-0.2231298784226201,-0.5762763924563051,0.9578947368421052,0.9926839881081141,1.0,2/11,9.95%,FBH1;DNASE1L1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.2718485132636962,0.5754031597767901,0.9381294964028777,0.990408842918383,1.0,4/12,30.13%,ADCY8;STX4;PLA2G6;C2CD2L
prerank,ubiquinone metabolic process (GO:0006743),-0.2042782891934242,-0.5749185108647404,0.9657794676806084,0.9918753807579933,1.0,7/15,25.63%,COQ10B;COQ8B;COQ9;COQ8A;PDSS2;COQ3;FDXR
prerank,steroid biosynthetic process (GO:0006694),0.20973622210751702,0.5744786658947715,0.9792802617230099,0.9905163831674548,1.0,11/56,23.30%,SCP2;LSS;HSD17B4;OSBPL6;SC5D;HSD3B2;OSBPL3;CH25H;OSBPL1A;PMVK;PRLR
prerank,positive regulation of macrophage differentiation (GO:0045651),0.2744758223275151,0.5741679891658779,0.9328671328671329,0.9903307130764688,1.0,4/11,25.10%,PF4;TGFB1;ID2;PRKCA
prerank,manganese ion transport (GO:0006828),0.2641176284450778,0.5741013231966987,0.9410112359550562,0.9900196308939403,1.0,3/14,14.00%,TRPC7;SLC11A1;TRPC1
prerank,endochondral bone morphogenesis (GO:0060350),-0.22324640193902573,-0.5732839998773273,0.9477351916376306,0.9911290771839223,1.0,3/11,16.29%,COL13A1;BMP4;BMPR2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2727493932553073,0.5730871469851011,0.9425444596443229,0.9901415078624778,1.0,1/12,4.36%,CHEK2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.24052199057709536,0.5728083645340858,0.9571788413098237,0.9899358580901952,1.0,8/21,27.55%,JUN;MED30;SUB1;TWIST1;SRF;PAXIP1;MED16;MED12
prerank,positive regulation of protein deacetylation (GO:0090312),0.2624102399607638,0.5725337923987789,0.940379403794038,0.9897217001315356,1.0,2/14,10.93%,APLNR;CTBP1
prerank,muscle tissue development (GO:0060537),-0.21717158039284012,-0.5712570635970013,0.9609929078014184,0.99061002236161,1.0,4/13,21.22%,SMO;BMP4;NF1;PTCH1
prerank,positive regulation of nuclear division (GO:0051785),0.23668752563353462,0.5705594294298558,0.9711191335740073,0.9903317223238625,1.0,6/25,23.88%,PDGFB;IGF2;EDN3;SIRT2;TGFA;CD28
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.2224772831884237,-0.5697779400828851,0.9651567944250871,0.9898373861248404,1.0,1/11,2.94%,ACTN2
prerank,regulation of urine volume (GO:0035809),0.27894707565143534,0.5693005521081852,0.9371428571428572,0.9905869609943235,1.0,2/10,19.55%,HYAL2;TFAP2B
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.2284460600611266,0.5686028178935515,0.9692671394799054,0.990556568798511,1.0,1/29,4.14%,SYCP2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2004982380876748,0.5681594478704636,0.9937694704049844,0.9904208903923817,1.0,32/96,32.54%,MAGOHB;MAGOH;DDX39B;SRSF9;RBM15B;SRSF2;NUP85;CPSF2;NUP88;THOC3;EIF4A3;SLBP;NUP50;U2AF1L4;ALYREF;RAE1;SRSF1;CPSF4;DHX38;ALKBH5;HHEX;SYMPK;NUP205;NUP188;DDX25;HNRNPA2B1;NUP43;NUP210;SEH1L;UPF1;POLDIP3;U2AF1
prerank,nuclear pore complex assembly (GO:0051292),0.2810614911229524,0.5679775863429917,0.9424964936886395,0.9901687428288571,1.0,1/10,4.80%,RTN4
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.2517986800237549,0.5675265776112498,0.9512516469038208,0.9900243263938933,1.0,2/15,13.94%,NME2;SFRP4
prerank,aspartate family amino acid catabolic process (GO:0009068),0.2520037059931791,0.5674364465131306,0.9592875318066157,0.989726690049472,1.0,4/19,20.38%,SDS;SLC25A21;CRYM;GOT1
prerank,polarized epithelial cell differentiation (GO:0030859),0.2697163073813469,0.5655683600287952,0.9569313593539704,0.9902128387290859,1.0,5/13,31.36%,MSN;RHOA;RAP2A;CAMSAP3;SH3BP1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.22615048129236057,-0.5654864534574763,0.9672131147540983,0.9900882824841623,1.0,5/10,31.27%,NUMA1;MED1;NCOA3;PRKCH;VDR
prerank,regulation of DNA metabolic process (GO:0051052),0.2146753913139232,0.564356001127582,0.9772468714448237,0.9904137838342966,1.0,12/44,22.67%,NUCKS1;UBE2V1;KDM1B;PDGFA;SUB1;TERF2IP;ALYREF;MYC;CDK9;RADX;GRHL2;MPV17
prerank,snRNA 3'-end processing (GO:0034472),0.24168609946648723,0.5638458425313008,0.9544270833333334,0.9903112522371282,1.0,9/19,33.89%,EXOSC2;TOE1;EXOSC9;USB1;EXOSC4;INTS12;INTS5;INTS6L;EXOSC3
prerank,mitotic chromosome condensation (GO:0007076),0.22649178580449209,0.5637673064289839,0.9721549636803875,0.9900092844064619,1.0,3/26,13.98%,CSNK2B;SET;NCAPG
prerank,positive regulation of keratinocyte migration (GO:0051549),0.27208851083323954,0.5622257590235057,0.9521800281293952,0.9903171008911298,1.0,2/10,16.56%,ARF6;EPB41L4B
prerank,ncRNA export from nucleus (GO:0097064),0.21877900266602704,0.5608050190420294,0.9813084112149533,0.9905677446408476,1.0,12/36,30.80%,NPM1;RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L
prerank,endosome organization (GO:0007032),0.2176227704646162,0.5606392042051072,0.9687137891077636,0.9903034086295872,1.0,10/41,27.57%,CHMP2B;CORO1C;SNX33;USP8;SQSTM1;HOOK1;EXOC8;DNM1;LAPTM4B;AKTIP
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.25118059434331663,0.5605363055019523,0.9512855209742895,0.9900015239166665,1.0,2/14,15.15%,ZDHHC5;TLR5
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.19048214425610022,0.5604396341544559,0.9989868287740629,0.9897074541297558,1.0,38/172,27.25%,CHKB;CSNK2B;CDIPT;CDS1;RAB14;DGKH;MFSD2A;PIK3C2G;PCYT2;MTMR9;CHAT;ABHD8;INPP5J;PTDSS1;ARF1;ACHE;CPNE6;PIK3CD;AGPAT5;RAB4A;SLC44A5;DGKB;STARD10;LPCAT2;INPP5D;ETNPPL;AGPAT2;SBF1;PLEKHA1;SLC44A2;PIK3R5;INPP4B;CPNE3;SLC44A1;MTMR6;MBOAT7;GPAM;PIP5K1C
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.21653118711107383,-0.5601390570051158,0.9665551839464883,0.9906361768432447,1.0,5/11,28.65%,RIPK1;CASP8;COLEC12;SCARA3;TLR3
prerank,GPI anchor metabolic process (GO:0006505),0.233356798061422,0.5578687317933821,0.966542750929368,0.9904414896522593,1.0,4/26,16.85%,PIGZ;PIGQ;DPM3;DPM2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.2735397145234382,0.5571546725392177,0.9363507779349364,0.9904182450100658,1.0,1/10,5.11%,PPP2R1A
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.22119768206724946,0.556487450178217,0.9774614472123369,0.9903470931267468,1.0,8/29,26.39%,GABARAPL2;NAPA;TRAPPC3;RAB6B;COPB2;COPG1;COG8;COPE
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.24765434132897207,0.5537627431967467,0.9460188933873145,0.9910930476639949,1.0,3/15,19.19%,NPM1;FAM83D;DDRGK1
prerank,protein heterotetramerization (GO:0051290),0.2599988209647139,0.5525571585557046,0.9606741573033708,0.9912231850569351,1.0,2/13,18.26%,GRIN1;GRIN2B
prerank,microtubule anchoring (GO:0034453),0.2596107313801808,0.5518567342127211,0.9583911234396671,0.991149190858214,1.0,6/12,36.49%,CLASP1;CAMSAP3;CLASP2;PEX14;GCC2;BICD2
prerank,negative regulation of interleukin-12 production (GO:0032695),0.2516008547465143,0.5509861060666725,0.9552845528455285,0.9911415879351079,1.0,2/14,13.40%,LILRA5;LILRB1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.22626587761067887,0.5507562789118419,0.9692496924969249,0.9909000608064132,1.0,9/26,30.99%,TNFAIP3;SIGIRR;TYRO3;SIRT2;C1QBP;PCBP2;TRIB1;ACOD1;TRAFD1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.2160657435207297,0.5491462113637118,0.9895104895104895,0.991163668442055,1.0,7/37,22.14%,RNASEH2A;ENTPD3;RNASEH1;SND1;NUDT16;NUDT9;ISG20
prerank,tryptophan metabolic process (GO:0006568),0.2622095149203804,0.5483593758326055,0.958273381294964,0.9911296908439817,1.0,1/11,11.01%,IDO2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.24227570930509962,0.5480786817350438,0.9584954604409858,0.9908979721393425,1.0,10/18,37.02%,KCNE5;CBARP;CAV1;SLC43A2;COMMD1;PPIF;CAB39;BIN1;KCNH2;SLC43A1
prerank,sulfate transport (GO:0008272),0.25224035241145715,0.5473341102737056,0.9698558322411533,0.9908502688850754,1.0,2/14,9.20%,SLC26A4;SLC25A11
prerank,ncRNA catabolic process (GO:0034661),0.22234262855755696,0.5473098086971857,0.9836065573770492,0.9905249277089535,1.0,7/28,21.52%,LIN28B;EXOSC2;SND1;NUDT16;EXOSC9;RBM7;EXOSC4
prerank,positive regulation of transporter activity (GO:0032411),-0.20337934461803897,-0.5458665298597801,0.9683098591549296,0.993605587290185,1.0,3/13,16.18%,KMT2A;TRPC6;STK39
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.2702745784402709,0.5427340065718412,0.9602836879432625,0.9917947998690716,1.0,5/10,32.28%,SOX9;PDGFA;MYC;CHRD;SHH
prerank,cytoplasmic microtubule organization (GO:0031122),0.20184966739378934,0.5418432938581983,0.987012987012987,0.9917705408324587,1.0,14/54,28.62%,STMN3;CLASP1;MAPT;DCTN1;RHOA;CLIP3;CCDC88A;HOOK1;KATNA1;KPNB1;CHP1;KATNAL1;CCDC88C;CAMSAP3
prerank,homologous chromosome segregation (GO:0045143),-0.17575387195843237,-0.5413759266149379,0.981651376146789,0.9934775514867584,1.0,7/20,25.97%,CENPC;PRDM9;SIRT7;ZCWPW1;SGO1;MAJIN;MEIOB
prerank,dicarboxylic acid metabolic process (GO:0043648),0.20145852525846428,0.5399773626924051,0.9923076923076923,0.9920585655765161,1.0,17/52,32.90%,MDH1;SLC19A1;FOLR2;ACOT4;D2HGDH;GOT1;SHMT2;MTHFS;SDHA;ACLY;IDH1;DHFR;ASS1;L2HGDH;ALDH1L1;MTHFD2L;MTRR
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.2149611593286041,-0.5397816461603873,0.971830985915493,0.9925542618241578,1.0,5/10,26.29%,MTHFR;MTHFD1L;SHMT1;MTHFD1;TYMS
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.25084180590480093,0.5350456373739008,0.9542936288088643,0.9933483387883473,1.0,3/12,25.10%,CTDNEP1;VRK1;PRKCA
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.2511237995352921,0.5335357633218456,0.9607046070460704,0.9934902934983515,1.0,2/13,15.19%,AMDHD2;SLC35A3
prerank,glutathione biosynthetic process (GO:0006750),-0.20475801895675097,-0.532951217974293,0.9715302491103203,0.9929115190129806,1.0,11/11,79.54%,GGCT;GGT1;GCLC;MGST2;GCLM;GSS;CHAC1;CNDP2;HAGH;CHAC2;OPLAH
prerank,metanephric mesenchyme development (GO:0072075),0.26134828411095307,0.5289716593965512,0.9601706970128022,0.9945515677238738,1.0,1/10,8.19%,BASP1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.1868775664685721,-0.5287831979905099,0.9920948616600791,0.9925337760832176,1.0,4/17,25.41%,PLA2G4A;CRLS1;SERAC1;PLA2G5
prerank,muscle cell migration (GO:0014812),0.2546987468666395,0.5267744186616129,0.9716713881019831,0.9948330047014344,1.0,3/10,21.70%,AAMP;PLAT;CCN3
prerank,maturation of 5.8S rRNA (GO:0000460),0.23156583983805512,0.5236453635289848,0.9685362517099864,0.9953724466052887,1.0,8/17,33.67%,EXOSC4;FTSJ3;RRP15;EIF6;NOL9;URB1;PES1;LAS1L
prerank,regulation of telomere capping (GO:1904353),0.21872341187636127,0.5202412947698118,0.9798994974874372,0.9959558554175907,1.0,1/23,1.89%,MAPK3
prerank,tetrapyrrole metabolic process (GO:0033013),0.23060385779945058,0.5200625021979672,0.9698952879581152,0.9956659982821479,1.0,1/18,5.32%,ABCB6
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.2083320193539832,0.5154288617491054,0.9852034525277436,0.996533756617382,1.0,8/29,22.34%,SPRY1;DAB2IP;VASN;EFNA1;FOXA2;SFRP1;FOXA1;ADIPOR1
prerank,outer dynein arm assembly (GO:0036158),-0.18982001291634182,-0.515205088172413,0.981203007518797,0.9941173882199746,1.0,7/14,29.09%,ODAD1;DNAAF5;ODAD2;ODAD3;ODAD4;DNAAF4;CCDC63
prerank,rRNA catabolic process (GO:0016075),0.2301893015444464,0.5118301307640798,0.9818181818181818,0.9970797690242622,1.0,7/16,35.60%,EXOSC2;EXOSC9;EXOSC4;TRIR;PELO;EXOSC3;DEDD2
prerank,response to X-ray (GO:0010165),0.23426764499812414,0.5108528605079369,0.9848901098901099,0.9969806861490392,1.0,4/14,28.69%,NUCKS1;BLM;IKBIP;XRCC6
prerank,ubiquinone biosynthetic process (GO:0006744),0.2318425170197213,0.5103052015408618,0.9757085020242915,0.9967718478602069,1.0,5/15,26.79%,COQ6;NDUFA9;PDSS1;COQ10A;COQ2
prerank,alpha-amino acid catabolic process (GO:1901606),-0.1513348639095104,-0.5057605530688362,1.0,0.9943778183107456,1.0,5/29,18.75%,DDO;PRODH;HOGA1;ACADSB;GSTZ1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.17636409553508434,0.5028389489912027,0.9989550679205852,0.9981630653677215,1.0,23/95,29.98%,SEM1;MCM5;PARP1;NUCKS1;RPA2;NSMCE1;RECQL5;MUS81;BRCA2;MMS22L;MORF4L1;AP5S1;BLM;CDC45;SFR1;RPA3;RAD51;RMI1;MCM7;MCM2;SMC6;AP5Z1;POLN
prerank,establishment of mitotic spindle localization (GO:0040001),0.20014209456064436,0.5026604652946498,0.9888198757763975,0.9978707571750501,1.0,9/28,30.49%,CLASP1;DCTN1;GJA1;INSC;KPNB1;ITGB1;ESPL1;CLASP2;NSFL1C
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.2484681162290221,0.5018460024748034,0.9785407725321889,0.9973846200810156,1.0,4/10,33.96%,F2RL1;CDC42EP2;APC;CDC42EP3
prerank,regulation of pseudopodium assembly (GO:0031272),0.2484681162290221,0.5018460024748034,0.9785407725321889,0.9973846200810156,1.0,4/10,33.96%,F2RL1;CDC42EP2;APC;CDC42EP3
prerank,recombinational repair (GO:0000725),0.17822939133198182,0.5014378165201068,0.9989539748953975,0.9971334516129151,1.0,22/77,33.41%,SEM1;PARP1;NUCKS1;RPA2;NSMCE1;RECQL5;BRCA2;MMS22L;MORF4L1;AP5S1;BLM;SFR1;RPA3;RAD51;RMI1;SMC6;AP5Z1;POLN;PSMD14;RHNO1;RAD51C;SWI5
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.24241418514221902,0.5013603659538922,0.9704225352112676,0.9968111302252964,1.0,3/11,27.81%,PF4;TMEM106A;XBP1
prerank,lysine metabolic process (GO:0006553),0.23899351088336723,0.5011110743335115,0.966804979253112,0.9961965632370475,1.0,2/12,13.43%,SLC25A21;CRYM
prerank,lysine catabolic process (GO:0006554),0.23899351088336723,0.5011110743335115,0.966804979253112,0.9961965632370475,1.0,2/12,13.43%,SLC25A21;CRYM
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.22264445366537566,0.5010813474089989,0.9834183673469388,0.9958686723604243,1.0,4/18,22.31%,CCND1;FBXO5;CDC25A;RCC2
prerank,positive regulation of immune system process (GO:0002684),-0.17201555176531727,-0.49782848744697017,0.9914529914529915,0.9942793794199749,1.0,2/16,14.01%,IL15;LGALS9
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.20213757895662646,0.49772996696185323,0.9878048780487805,0.9962169967643626,1.0,9/24,38.03%,PLA2G4F;PLA2G3;ABCA3;GPAM;CDS2;PNPLA8;PLA2G15;LPCAT1;LPGAT1
prerank,regulation of interleukin-13 production (GO:0032656),0.22465637494162044,0.48978008612463275,0.9929676511954993,0.997423106021937,1.0,3/13,26.77%,LILRA5;SPHK2;LEF1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.21158260290242253,0.4894429548424078,0.986198243412798,0.997152272048844,1.0,8/19,31.95%,APRT;PNP;CDA;POLD1;ADA;POLD3;DGUOK;DCK
prerank,positive regulation of telomere maintenance (GO:0032206),0.19390507825152503,0.48920196947992384,0.9918032786885246,0.996858445902655,1.0,11/31,33.04%,MAPK3;MAPK15;ERCC1;MAP2K7;NAF1;PNKP;PRKCQ;AURKB;HNRNPA2B1;HNRNPD;PKIB
prerank,regulation of interferon-alpha production (GO:0032647),0.2052177916151968,0.48844119663360125,0.9902080783353733,0.9966574824567029,1.0,8/23,32.13%,HSPD1;RIPK2;IRF7;IRF5;TLR7;DHX9;MAVS;DDX3X
prerank,exit from mitosis (GO:0010458),0.23050695369847063,0.48816447228928744,0.9819444444444444,0.9963698908536509,1.0,4/12,32.41%,CLASP1;CHMP7;CLASP2;CHMP4B
prerank,glycerolipid metabolic process (GO:0046486),0.23595681835230076,0.4863086355163469,0.984869325997249,0.9963717141610883,1.0,6/11,34.98%,GAL3ST1;PGP;DGKB;DGKZ;DGKG;PLA2G15
prerank,tRNA modification (GO:0006400),0.17711185980523797,0.48388548913774615,1.0,0.9964771909352088,1.0,13/62,26.11%,METTL1;TRMT112;AARS2;CTU1;PUSL1;PUS7;ADAT2;URM1;THUMPD1;CTU2;WDR6;LCMT2;TYW3
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.21595952511754396,0.48370405063261257,0.988,0.996173330829023,1.0,8/16,35.67%,SRSF1;SNRNP200;SART1;WBP4;WBP11;CWC15;DCPS;PSIP1
prerank,regulation of sensory perception of pain (GO:0051930),0.2284155828511374,0.4818001250429375,0.9798561151079137,0.9961651202685442,1.0,3/11,28.06%,CCL3;CCN3;MGLL
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.1922536706232969,0.4812424003011718,0.9952153110047847,0.9955855637162063,1.0,11/32,30.80%,RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L
prerank,tRNA export from nucleus (GO:0006409),0.1922536706232969,0.4812424003011718,0.9952153110047847,0.9955855637162063,1.0,11/32,30.80%,RAN;NUP85;NUP88;NUP50;RAE1;NOL6;NUP205;NUP188;NUP43;NUP210;SEH1L
prerank,mitotic metaphase plate congression (GO:0007080),0.1797686893896432,0.4796862409868859,0.9989094874591058,0.995517031551647,1.0,11/51,25.87%,CHMP2B;CHMP5;CHMP6;DCTN2;CHMP1B;NUDC;VPS4A;CHMP7;CHMP1A;KPNB1;CHMP4C
prerank,retinal metabolic process (GO:0042574),0.2289279953201597,0.4769982280330592,0.986468200270636,0.9956177030373612,1.0,2/12,18.13%,DHRS13;BCO2
prerank,sarcomere organization (GO:0045214),0.19232547473255293,0.4676519568273504,0.994026284348865,0.9966334045214729,1.0,7/27,30.25%,CSRP1;FHOD3;CAPN3;KRT19;TCAP;WDR1;SYNPO2L
prerank,neural tube development (GO:0021915),0.20834828033117522,0.4649321484697435,0.9827357237715804,0.9966543142354246,1.0,4/15,22.29%,PROX1;SOX11;TGFB1;GRHL2
prerank,monosaccharide transmembrane transport (GO:0015749),0.2075923532972297,0.46109538802749345,0.9907773386034255,0.9968324988307711,1.0,2/16,16.51%,SLC50A1;SLC2A2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.1913092068927895,0.45355190557311026,0.9912170639899623,0.9973396559154878,1.0,10/23,35.70%,SLC12A5;SLC26A4;TFAP2B;PDK2;SLC12A9;SLC12A6;SLC9A7;CLCN3;SLC12A2;KCNH2
prerank,signal transduction in response to DNA damage (GO:0042770),0.16577198324889977,0.44098043373132717,0.9977703455964325,0.9982043592569225,1.0,11/49,26.94%,CHEK2;NDRG1;PRPF19;ERCC6;GADD45A;CDC5L;STK33;ATRIP;DOT1L;PAXIP1;RAD9A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.19309262166405028,0.4397213253013815,0.9933065595716198,0.9979737607237821,1.0,17/17,80.71%,BUB3;AURKB;BOD1;IK;CENPA;ZW10;MTBP;HASPIN;CHAMP1;CTCF;RB1;SPDL1;KNL1;CDK1;MIS12;ZWILCH;TTK
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.20425916496354576,0.4390128700360702,0.9930555555555556,0.9977040465488137,1.0,5/13,36.05%,UNC93B1;TLR7;IRAK2;PIK3AP1;MYD88
prerank,phasic smooth muscle contraction (GO:0014821),0.21676582474944964,0.43826680838841936,0.9913669064748202,0.9974335391800768,1.0,3/10,31.51%,EDN3;HTR2B;DRD2
prerank,protein localization to condensed chromosome (GO:1903083),0.20177677385226245,0.43221816676328406,0.9956709956709957,0.9975948905331127,1.0,1/12,11.18%,BUB3
prerank,response to light stimulus (GO:0009416),0.1480256790882339,0.39730182202588044,1.0,0.9991392480322511,1.0,20/55,35.34%,MAPK10;CIRBP;TRIM32;ERCC6;CCAR2;MEN1;MAP2K7;AANAT;POLD1;UBE2A;ERCC2;USF1;FECH;DRD2;CLOCK;TYR;CPT1B;ERCC4;DTL;GPR88
prerank,protein localization to kinetochore (GO:0034501),0.16025251739493918,0.3522055078848526,1.0,0.9997588622967588,1.0,3/14,28.98%,BUB3;RCC2;AURKB
